data_2kcu_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kcu _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.236 0.344 0 CA-C-O 121.239 0.542 . . . . 73.310000000000002 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.030000000000001 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 54.130000000000003 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 61.020000000000003 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.349999999999994 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 74.519999999999996 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.109999999999999 109.317 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 74.400000000000006 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.439999999999998 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 62.140000000000001 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 72' ' ' GLU . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.925 ' HB ' HG21 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.230000000000004 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 71.140000000000001 110.465 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.420000000000002 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.717 HG23 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.230000000000004 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 65.430000000000007 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.513 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.109999999999999 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 74.420000000000002 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.030000000000001 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 38.369999999999997 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 51.240000000000002 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.752 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 65.230000000000004 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.413 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 75.230000000000004 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.299999999999997 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.540000000000006 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.621 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.210000000000001 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.239999999999995 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.129999999999995 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.239999999999995 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.722 HD22 HD22 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 73.510000000000005 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 70.439999999999998 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.722 HD22 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.230000000000004 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.48 HD23 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.140000000000001 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 64.120000000000005 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.219999999999999 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.200000000000003 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.450000000000003 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.150000000000006 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.540000000000006 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 64.140000000000001 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.219999999999999 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.349999999999994 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.239999999999995 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 75.540000000000006 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.100000000000001 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.329999999999998 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 74.519999999999996 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 74.409999999999997 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.530000000000001 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.939 ' HA ' ' HE2' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.040000000000006 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.120000000000005 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.509999999999998 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.120000000000005 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.513 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 74.120000000000005 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.340000000000003 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.540000000000006 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.559 ' HB3' HD21 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.150000000000006 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.752 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.340000000000003 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.450000000000003 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.230000000000004 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 72.329999999999998 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.416 ' OE1' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.450000000000003 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.329999999999998 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.119999999999997 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.120000000000005 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.239999999999995 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.299999999999997 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.049999999999997 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.150000000000006 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.925 HG21 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 75.519999999999996 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.635 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.540000000000006 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.430000000000007 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.420000000000002 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.430000000000007 110.025 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 62.439999999999998 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.120000000000005 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.409999999999997 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 74.340000000000003 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.329999999999998 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.319999999999993 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.299999999999997 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.049999999999997 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.229999999999997 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 74.400000000000006 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.109999999999999 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.329999999999998 109.468 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.609 ' O ' HG11 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.781 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.340000000000003 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.609 HG11 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 72.310000000000002 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.781 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.299999999999997 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.310000000000002 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.019999999999996 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.340000000000003 110.692 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.049999999999997 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.040000000000006 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.61 ' HA ' HD21 ' A' ' 123' ' ' ASN . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 65.140000000000001 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.109999999999999 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.409999999999997 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.61 HD21 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.439999999999998 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.597 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.409999999999997 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.343 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.707 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.310000000000002 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 74.519999999999996 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.120000000000005 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.439999999999998 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.219999999999999 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 75.310000000000002 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 63.25 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.414 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.049999999999997 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.409999999999997 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.646 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 74.0 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 62.049999999999997 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.519999999999996 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.898 ' HA ' HD22 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.439999999999998 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.040000000000006 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.239999999999995 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.219999999999999 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.200000000000003 112.254 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.781 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.430000000000007 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 71.049999999999997 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.898 HD22 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.400000000000006 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.299999999999997 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.230000000000004 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.109999999999999 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 71.430000000000007 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.219999999999999 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.540000000000006 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.939 ' HE2' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 73.340000000000003 110.211 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 73.430000000000007 110.379 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 71.400000000000006 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.549999999999997 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.549999999999997 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.420000000000002 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 75.25 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.209999999999994 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 63.240000000000002 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.100000000000001 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.519999999999996 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.019999999999996 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 73.5 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.239999999999995 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.219999999999999 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.439999999999998 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.824 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.340000000000003 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.210000000000001 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.430000000000007 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 71.030000000000001 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.340000000000003 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 72.099999999999994 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.219999999999999 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.140000000000001 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.340000000000003 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.030000000000001 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.530000000000001 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.109999999999999 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.099999999999994 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 64.340000000000003 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.219999999999999 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.519999999999996 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.129999999999995 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 75.219999999999999 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.420000000000002 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.219999999999999 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 71.319999999999993 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 73.010000000000005 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.400000000000006 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.010000000000005 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.420000000000002 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 73.120000000000005 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' HG23 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.019999999999996 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 75.129999999999995 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 75.420000000000002 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.519999999999996 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.350000000000001 112.125 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.230000000000004 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.641 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.340000000000003 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 74.420000000000002 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.040000000000006 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 73.450000000000003 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.239999999999995 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.230000000000004 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.299999999999997 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.099999999999994 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.319999999999993 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.200000000000003 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.209999999999994 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.299999999999997 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.239999999999995 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.824 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.411 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 72.340000000000003 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.510000000000005 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 73.349999999999994 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.450000000000003 113.254 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 63.200000000000003 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.59 ' OE2' HG22 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.030000000000001 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.240000000000002 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.019999999999996 112.366 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.59 HG22 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.129999999999995 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 70.329999999999998 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 62.43 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.435 ' N ' HD21 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 71.420000000000002 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.329999999999998 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.439999999999998 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.545 HG23 ' HG3' ' A' ' 86' ' ' ARG . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.319999999999993 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 43.229999999999997 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.53 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 74.409999999999997 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.310000000000002 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 74.230000000000004 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.420000000000002 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 74.540000000000006 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 73.140000000000001 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HB3' HD13 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.329999999999998 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.120000000000005 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.519999999999996 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.010000000000005 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 73.420000000000002 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 62.32 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.579 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 73.200000000000003 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.585 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.757 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.439999999999998 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.409999999999997 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.340000000000003 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 62.420000000000002 110.272 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.562 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 74.329999999999998 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.010000000000005 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.219999999999999 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.562 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 73.439999999999998 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.019999999999996 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 75.219999999999999 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.319999999999993 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.230000000000004 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.45 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.129999999999995 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 74.420000000000002 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 73.530000000000001 111.296 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.129999999999995 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.617 HD22 ' HB2' ' A' ' 130' ' ' GLU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.109999999999999 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.099999999999994 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.689 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.519999999999996 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.239999999999995 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.340000000000003 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.409999999999997 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.641 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.415 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.230000000000004 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.140000000000001 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.498 ' HB2' HD11 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.400000000000006 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.039999999999999 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 64.120000000000005 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.310000000000002 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.310000000000002 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.637 HG21 HD21 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.209999999999994 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.757 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.539999999999999 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.340000000000003 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.200000000000003 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.540000000000006 110.125 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.109999999999999 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.109999999999999 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 73.299999999999997 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.420000000000002 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.349999999999994 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.689 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.310000000000002 111.023 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.886 0.374 . . . . 73.230000000000004 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 71.230000000000004 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.129999999999995 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.430000000000007 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.422 ' C ' HD22 ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.239999999999995 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.809 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.129999999999995 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.409999999999997 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 72.140000000000001 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.430000000000007 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.109999999999999 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.229999999999997 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.230000000000004 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.140000000000001 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.549999999999997 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.140000000000001 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.450000000000003 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.510000000000005 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.549999999999997 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.329999999999998 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.030000000000001 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.010000000000005 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.439999999999998 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.350000000000001 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 71.219999999999999 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.030000000000001 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.439999999999998 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.409999999999997 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 71.510000000000005 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.219999999999999 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.230000000000004 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.549999999999997 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.219999999999999 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 73.540000000000006 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.409999999999997 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.200000000000003 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 40.439999999999998 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.439999999999998 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.439999999999998 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.040000000000006 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.520000000000003 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.420000000000002 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.453 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.209999999999994 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.140000000000001 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.530000000000001 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 72.040000000000006 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 73.230000000000004 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.747 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 72.420000000000002 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.109999999999999 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.310000000000002 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.319999999999993 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 62.32 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 75.019999999999996 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.510000000000005 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.847 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.109999999999999 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.540000000000006 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 72.109999999999999 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.140000000000001 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.040000000000006 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 64.430000000000007 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.581 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.129999999999995 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.430000000000007 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.239999999999995 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 73.340000000000003 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.149999999999999 110.49 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 73.209999999999994 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 64.340000000000003 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 73.219999999999999 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.439999999999998 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.329999999999998 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.420000000000002 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 71.129999999999995 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.329999999999998 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.219999999999999 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.129999999999995 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 71.219999999999999 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 72.200000000000003 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.884 ' HB2' HG22 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 62.409999999999997 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.040000000000006 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.568 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.109999999999999 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.55 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.540000000000006 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.010000000000005 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 62.109999999999999 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.409999999999997 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.520000000000003 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.661 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 60.009999999999998 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.430000000000007 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.540000000000006 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.884 HG22 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.340000000000003 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.140000000000001 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.329999999999998 110.714 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.457 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 60.409999999999997 109.527 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.540000000000006 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.430000000000007 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.140000000000001 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.049999999999997 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.200000000000003 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.520000000000003 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.611 ' HB2' HG21 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.329999999999998 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.239999999999995 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.420000000000002 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.310000000000002 108.013 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.030000000000001 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.129999999999995 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.747 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.129999999999995 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.510000000000005 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.120000000000005 110.371 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 65.319999999999993 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.808 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.439999999999998 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.679 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.200000000000003 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.678 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.010000000000005 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.678 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.430000000000007 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 73.099999999999994 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.109999999999999 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.209999999999994 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 65.340000000000003 111.215 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.329999999999998 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.219999999999999 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 75.109999999999999 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.55 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.209999999999994 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.239999999999995 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.209999999999994 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.646 ' HE3' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.119999999999997 111.286 -176.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.986 -0.375 . . . . 75.409999999999997 109.986 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.230000000000004 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.230000000000004 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.510000000000005 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.510000000000005 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.010000000000005 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.129999999999995 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.399999999999999 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' THR . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.129999999999995 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 72.329999999999998 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.030000000000001 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 64.0 110.754 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 70.129999999999995 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.129999999999995 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.230000000000004 108.777 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.725 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.140000000000001 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.340000000000003 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.603 ' HB ' HD23 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.319999999999993 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.319999999999993 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 75.120000000000005 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 73.0 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.400000000000006 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 62.310000000000002 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.299999999999997 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.120000000000005 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.239999999999995 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.140000000000001 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.319999999999993 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.319999999999993 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 72.230000000000004 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.439999999999998 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.349999999999994 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.099999999999994 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.419 ' NE2' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.019999999999996 111.515 -173.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.150000000000006 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 75.530000000000001 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' NE2' ' A' ' 44' ' ' GLN . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.319999999999993 112.599 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.140000000000001 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.099999999999994 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG3' HD11 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.129999999999995 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.418 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.230000000000004 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.409999999999997 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.319999999999993 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.602 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.219999999999999 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.120000000000005 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.219999999999999 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.409999999999997 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 72.439999999999998 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.62 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.299999999999997 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.019999999999996 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.349999999999994 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 65.010000000000005 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.230000000000004 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 75.420000000000002 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.62 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 75.340000000000003 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.310000000000002 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.618 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.519999999999996 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 61.509999999999998 111.712 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 71.120000000000005 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 74.230000000000004 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 71.209999999999994 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 54.32 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 62.420000000000002 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.229999999999997 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 63.100000000000001 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.439999999999998 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.030000000000001 109.986 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.210000000000001 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.420000000000002 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.439999999999998 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.340000000000003 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.319999999999993 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.439999999999998 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 74.329999999999998 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 75.109999999999999 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HB3' HD22 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 74.120000000000005 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.439999999999998 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.030000000000001 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.129999999999995 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.409999999999997 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.310000000000002 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.966 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.530000000000001 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.040000000000006 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.439999999999998 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.310000000000002 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.619 ' HE1' HD12 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.299999999999997 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 55.020000000000003 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.319999999999993 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.619 HD12 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 72.340000000000003 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.120000000000005 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.519999999999996 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 110' ' ' GLU . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.319999999999993 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.200000000000003 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.329999999999998 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.604 ' HE3' ' HA ' ' A' ' 114' ' ' ASP . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.040000000000006 111.037 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.409999999999997 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 75.010000000000005 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 111.165 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.200000000000003 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.519999999999996 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.010000000000005 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.329999999999998 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.519999999999996 109.248 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 75.5 110.927 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 73.439999999999998 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.219999999999999 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.040000000000006 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.530000000000001 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 73.209999999999994 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.716 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.040000000000006 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.642 HD22 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.621 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.120000000000005 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 71.329999999999998 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.539999999999999 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.439999999999998 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 74.349999999999994 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.25 111.421 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.019999999999996 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.349999999999994 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 71.409999999999997 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 75.439999999999998 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.716 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.299999999999997 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 73.319999999999993 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.099999999999994 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 73.230000000000004 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 50.0 ttp . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.510000000000005 109.35 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 109.578 -0.527 . . . . 72.540000000000006 109.578 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.540000000000006 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 62.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.519999999999996 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.219999999999999 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.439999999999998 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.349999999999994 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.520000000000003 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.329999999999998 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.43 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.239999999999995 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.019999999999996 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.856 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 74.420000000000002 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.340000000000003 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 1.046 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.200000000000003 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.340000000000003 108.048 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 71.239999999999995 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.129999999999995 109.878 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.420000000000002 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.209999999999994 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.129999999999995 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.349999999999994 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.349999999999994 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.539999999999999 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 73.540000000000006 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.120000000000005 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.400000000000006 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.420000000000002 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.149999999999999 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.130000000000003 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.483 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.510000000000005 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.129999999999995 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 71.439999999999998 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.129999999999995 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.219999999999999 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.310000000000002 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.040000000000006 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.030000000000001 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.661 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 73.140000000000001 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.049999999999997 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 63.210000000000001 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.140000000000001 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 71.140000000000001 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.109999999999999 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.921 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.329999999999998 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.430000000000007 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.140000000000001 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.952 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.239999999999995 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.549999999999997 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.340000000000003 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.409999999999997 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.230000000000004 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.019999999999996 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.686 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.219999999999999 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.483 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 1.046 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.010000000000005 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.921 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.349999999999994 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.409999999999997 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 61.32 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.099999999999994 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 70.140000000000001 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.519999999999996 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.209999999999994 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.519999999999996 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 75.109999999999999 111.115 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.150000000000006 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.299999999999997 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.429 HG21 HD13 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.25 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 60.149999999999999 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.200000000000003 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 74.519999999999996 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.230000000000004 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.119999999999997 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.409999999999997 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.349999999999994 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.340000000000003 110.269 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.430000000000007 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.200000000000003 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.430000000000007 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.598 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.230000000000004 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.099999999999994 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.420000000000002 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 64.120000000000005 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 42.329999999999998 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.119999999999997 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 74.439999999999998 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.230000000000004 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.439999999999998 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.040000000000006 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.738 ' CD2' HD12 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.030000000000001 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.119999999999997 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.240000000000002 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.813 HD22 HD13 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.200000000000003 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.719 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.109999999999999 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.430000000000007 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.506 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.493 HG23 ' HB2' ' A' ' 125' ' ' PHE . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.230000000000004 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.219999999999999 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.439999999999998 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.310000000000002 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 75.420000000000002 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.649 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.230000000000004 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.109999999999999 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.649 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.229999999999997 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.239999999999995 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.952 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.530000000000001 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 75.219999999999999 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 75.519999999999996 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.521 ' O ' HG21 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.209999999999994 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 75.040000000000006 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.446 ' H ' HD13 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.329999999999998 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 71.420000000000002 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 63.329999999999998 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.530000000000001 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.319999999999993 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.230000000000004 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.120000000000005 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.519999999999996 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.109999999999999 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 73.329999999999998 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 72.310000000000002 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.129999999999995 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.598 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.299999999999997 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 71.049999999999997 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.140000000000001 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.109999999999999 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.813 HD13 HD22 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 70.129999999999995 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.230000000000004 111.315 -178.543 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.943 -0.392 . . . . 72.219999999999999 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 74.030000000000001 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.430000000000007 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.310000000000002 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.796 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 65.209999999999994 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.299999999999997 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.409999999999997 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.150000000000006 109.781 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.230000000000004 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.520000000000003 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.109999999999999 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 75.310000000000002 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 73.349999999999994 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.735 HG23 HD23 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.420000000000002 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.039999999999999 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.219999999999999 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.310000000000002 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 52.119999999999997 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.209999999999994 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.129999999999995 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 71.230000000000004 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 73.120000000000005 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD23 HG23 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.400000000000006 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.530000000000001 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 72.030000000000001 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.420000000000002 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.519999999999996 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.409999999999997 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.010000000000005 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.605 ' HB ' HG22 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 70.430000000000007 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 73.340000000000003 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.617 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.149999999999999 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.439999999999998 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.439999999999998 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.450000000000003 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.450000000000003 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 110.609 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.420000000000002 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.439999999999998 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.219999999999999 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.129999999999995 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.439999999999998 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 74.349999999999994 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.109999999999999 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.695 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 74.219999999999999 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.229999999999997 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.020000000000003 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.581 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.239999999999995 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.209999999999994 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 71.310000000000002 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.109999999999999 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.230000000000004 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.581 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 64.310000000000002 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.539999999999999 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 64.299999999999997 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.409999999999997 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.510000000000005 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.150000000000006 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.340000000000003 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.439999999999998 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 73.530000000000001 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.540000000000006 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.439999999999998 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.340000000000003 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.210000000000001 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 63.240000000000002 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.150000000000006 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.782 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 74.349999999999994 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.487 ' O ' HD11 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.420000000000002 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.310000000000002 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.549999999999997 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 72.209999999999994 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 74.019999999999996 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.239999999999995 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.119999999999997 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.240000000000002 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.299999999999997 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB3' HD12 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.530000000000001 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.530000000000001 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.575 HD23 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 75.040000000000006 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.140000000000001 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.239999999999995 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.219999999999999 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.200000000000003 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 71.439999999999998 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.299999999999997 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.606 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 71.439999999999998 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.525 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.450000000000003 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.525 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.329999999999998 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.519999999999996 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.219999999999999 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.420000000000002 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.140000000000001 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.310000000000002 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 70.150000000000006 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.109999999999999 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 74.299999999999997 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 74.409999999999997 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.409999999999997 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.230000000000004 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.450000000000003 110.319 176.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 109.873 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.795 ' HA ' ' HE3' ' A' ' 154' ' ' MET . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.549999999999997 110.226 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.519999999999996 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.549999999999997 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.150000000000006 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.349999999999994 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.450000000000003 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.200000000000003 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 72.129999999999995 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 73.230000000000004 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 63.219999999999999 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 110.376 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 74.5 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.100000000000001 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.450000000000003 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.654 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.430000000000007 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.140000000000001 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.349999999999994 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.310000000000002 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.681 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.140000000000001 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 74.230000000000004 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 72.120000000000005 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.510000000000005 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.795 ' HE3' ' HA ' ' A' ' 128' ' ' SER . 57.0 mtp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.540000000000006 110.335 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.9 t80 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 74.540000000000006 109.63 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.099999999999994 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.109999999999999 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.797 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.239999999999995 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.520000000000003 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.299999999999997 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.849 HD13 ' HH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.420000000000002 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.540000000000006 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.340000000000003 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.230000000000004 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.530000000000001 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.239999999999995 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 71.530000000000001 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.619 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 73.329999999999998 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.763 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 64.209999999999994 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.664 HG21 HG22 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.430000000000007 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.549999999999997 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.664 HG22 HG21 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 71.010000000000005 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.350000000000001 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.040000000000006 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.450000000000003 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.540000000000006 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG22 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.040000000000006 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 75.349999999999994 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.019999999999996 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.299999999999997 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.109999999999999 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.140000000000001 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.450000000000003 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.549999999999997 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.019999999999996 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.239999999999995 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.527 HD21 HD22 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.209999999999994 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 55.399999999999999 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.450000000000003 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.229999999999997 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HG3' HG21 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.019999999999996 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 74.349999999999994 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.230000000000004 112.334 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.310000000000002 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.009999999999998 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.100000000000001 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.219999999999999 112.365 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.628 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.120000000000005 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.340000000000003 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.150000000000006 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 71.019999999999996 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.219999999999999 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.872 ' HE3' ' HA ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.310000000000002 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 71.239999999999995 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.030000000000001 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.340000000000003 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.520000000000003 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.049999999999997 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.450000000000003 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.420000000000002 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.239999999999995 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 74.310000000000002 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 73.099999999999994 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.140000000000001 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.584 HG13 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.099999999999994 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.349999999999994 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 35.850000000000001 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.099999999999994 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.627 HG21 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.109999999999999 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.219999999999999 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.230000000000004 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.310000000000002 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.040000000000006 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 54.219999999999999 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 60.420000000000002 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.439999999999998 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.340000000000003 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.209999999999994 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.439999999999998 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 75.25 110.284 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.340000000000003 109.695 177.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 61.109999999999999 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 74.310000000000002 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.711 HD13 HD12 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 74.109999999999999 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.841 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.150000000000006 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.310000000000002 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 74.310000000000002 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.530000000000001 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.841 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.319999999999993 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.150000000000006 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.572 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.420000000000002 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.140000000000001 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.299999999999997 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.601 HG23 HD22 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 74.129999999999995 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.340000000000003 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 71.120000000000005 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 73.109999999999999 111.398 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.030000000000001 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.109999999999999 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.329999999999998 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.797 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.239999999999995 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 74.049999999999997 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.405 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.240000000000002 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.109999999999999 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.310000000000002 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.786 ' HB2' HG21 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.329999999999998 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.409999999999997 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 75.150000000000006 112.69 -176.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.420000000000002 109.848 172.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.230000000000004 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.400000000000006 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.84 ' HB1' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 35.850000000000001 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.849 ' HH ' HD13 ' A' ' 14' ' ' LEU . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.340000000000003 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.676 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.628 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 70.430000000000007 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 70.340000000000003 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.708 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.450000000000003 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.48 ' HB2' HG23 ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.239999999999995 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.329999999999998 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 141' ' ' GLU . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 73.420000000000002 113.645 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 62.310000000000002 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 139' ' ' PRO . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.409999999999997 111.307 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.230000000000004 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.239999999999995 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.140000000000001 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.030000000000001 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . 23.8 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 71.420000000000002 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 64.25 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 75.049999999999997 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.120000000000005 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 73.120000000000005 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.399999999999999 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.607 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.329999999999998 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.84 ' HG3' ' HB1' ' A' ' 131' ' ' ALA . 59.3 mtm . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.319999999999993 110.931 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 110.161 -0.311 . . . . 72.109999999999999 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.129999999999995 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.129999999999995 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.240000000000002 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.722 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 54.039999999999999 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.239999999999995 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.439999999999998 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.349999999999994 109.434 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.340000000000003 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.310000000000002 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.209999999999994 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.340000000000003 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.540000000000006 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 75.230000000000004 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.340000000000003 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 74.349999999999994 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.119999999999997 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 70.319999999999993 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 72.400000000000006 111.673 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 73.129999999999995 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.540000000000006 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.040000000000006 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.509999999999998 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 73.010000000000005 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 74.319999999999993 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 73.310000000000002 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.310000000000002 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.020000000000003 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.319999999999993 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.319999999999993 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 61.25 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.420000000000002 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 73.340000000000003 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.049999999999997 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.229999999999997 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.409999999999997 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 65.319999999999993 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 72.049999999999997 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.209999999999994 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 64.310000000000002 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.219999999999999 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 72.040000000000006 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.549999999999997 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.509999999999998 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.310000000000002 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.310000000000002 110.064 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.349999999999994 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.409999999999997 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 61.509999999999998 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.420000000000002 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.049999999999997 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.439999999999998 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.430000000000007 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.310000000000002 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 74.510000000000005 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.530000000000001 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.209999999999994 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.678 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 74.230000000000004 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 75.120000000000005 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.549999999999997 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.439999999999998 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.299999999999997 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.530000000000001 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.310000000000002 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.030000000000001 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.503 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.519999999999996 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.540000000000006 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.120000000000005 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.434 ' H ' HG11 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.150000000000006 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 38.609999999999999 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.140000000000001 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.540000000000006 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 72.120000000000005 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.310000000000002 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 75.340000000000003 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 71.340000000000003 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.099999999999994 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.450000000000003 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.420000000000002 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.722 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.329999999999998 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.319999999999993 110.498 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.499 ' CB ' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 60.229999999999997 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.530000000000001 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.040000000000006 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.310000000000002 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 72.540000000000006 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.150000000000006 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.119999999999997 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.219999999999999 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 75.409999999999997 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.219999999999999 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.439999999999998 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.310000000000002 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 73.409999999999997 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.039999999999999 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.120000000000005 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.523 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.329999999999998 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.319999999999993 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.439999999999998 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.230000000000004 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.120000000000005 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.409999999999997 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.869 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.120000000000005 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.230000000000004 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.219999999999999 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.030000000000001 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.120000000000005 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 74.510000000000005 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 127' ' ' LEU . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.299999999999997 110.603 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.430000000000007 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.585 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.439999999999998 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.416 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.420000000000002 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.219999999999999 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 64.450000000000003 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.030000000000001 108.901 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 62.219999999999999 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.546 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.120000000000005 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.230000000000004 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.603 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.140000000000001 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.603 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.340000000000003 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.239999999999995 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.140000000000001 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 75.25 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.230000000000004 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 146' ' ' GLN . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.420000000000002 111.218 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 54.219999999999999 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 144' ' ' PRO . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 71.319999999999993 109.847 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.439999999999998 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.030000000000001 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.340000000000003 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.209999999999994 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 74.140000000000001 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.209999999999994 111.416 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.432 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.457 -0.572 . . . . 74.230000000000004 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.140000000000001 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 71.299999999999997 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 61.420000000000002 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.43 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 63.039999999999999 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 54.240000000000002 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.209999999999994 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 75.439999999999998 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.040000000000006 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.409999999999997 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.009999999999998 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.219999999999999 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.430000000000007 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.468 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 75.129999999999995 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.299999999999997 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.510000000000005 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.349999999999994 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.439999999999998 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 74.230000000000004 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 62.329999999999998 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.130000000000003 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.130000000000003 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 75.140000000000001 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.530000000000001 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 74.409999999999997 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 75.120000000000005 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 75.329999999999998 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.230000000000004 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.520000000000003 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.509999999999998 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.310000000000002 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 74.0 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.230000000000004 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.420000000000002 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.43 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 64.340000000000003 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.340000000000003 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.209999999999994 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.530000000000001 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 72.150000000000006 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.130000000000003 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 72.219999999999999 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 63.219999999999999 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.340000000000003 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 60.130000000000003 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.510000000000005 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.140000000000001 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HD1' HG23 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.240000000000002 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.519999999999996 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.771 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.019999999999996 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CD2' HG13 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 71.430000000000007 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.78 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 74.209999999999994 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.099999999999994 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.120000000000005 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.409999999999997 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.140000000000001 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.229999999999997 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HD1' HG12 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 75.0 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 25' ' ' GLN . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.299999999999997 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 74.450000000000003 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.140000000000001 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.468 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.340000000000003 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.200000000000003 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.92 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.030000000000001 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.120000000000005 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.040000000000006 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.539999999999999 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.329999999999998 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 74.25 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 75.230000000000004 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.310000000000002 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.219999999999999 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.010000000000005 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 75.420000000000002 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 54.210000000000001 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 51.340000000000003 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.039999999999999 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.510000000000005 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 72.120000000000005 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 62.43 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.109999999999999 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 74.450000000000003 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.099999999999994 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.230000000000004 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.230000000000004 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.409999999999997 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.099999999999994 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.439999999999998 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.420000000000002 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 64.349999999999994 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.450000000000003 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.439999999999998 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 73.319999999999993 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 73.019999999999996 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.319999999999993 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.340000000000003 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.43 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 71.109999999999999 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.120000000000005 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.408 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.099999999999994 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 73.450000000000003 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.489 ' HB2' HG23 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 75.319999999999993 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 54.439999999999998 110.277 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.140000000000001 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 65.430000000000007 111.497 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.140000000000001 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.78 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.099999999999994 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.109999999999999 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.65 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 64.019999999999996 109.753 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.219999999999999 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.420000000000002 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.400000000000006 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.755 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.109999999999999 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.209999999999994 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.519999999999996 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.78 ' HB3' HD12 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.439999999999998 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.409999999999997 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.129999999999995 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.299999999999997 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.420000000000002 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.299999999999997 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.329999999999998 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.140000000000001 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.109999999999999 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.646 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.230000000000004 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 75.549999999999997 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.120000000000005 110.392 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.65 ' HE2' ' HB2' ' A' ' 132' ' ' TYR . 25.7 mmt . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 110.293 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 109.936 -0.394 . . . . 75.209999999999994 109.936 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 62.109999999999999 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.420000000000002 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.420000000000002 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.430000000000007 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.310000000000002 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.319999999999993 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.099999999999994 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 64.239999999999995 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.409999999999997 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 37.729999999999997 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.299999999999997 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 63.340000000000003 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 64.420000000000002 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.019999999999996 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 71.140000000000001 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.530000000000001 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.020000000000003 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 73.200000000000003 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.400000000000006 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.439999999999998 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.219999999999999 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 75.519999999999996 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.219999999999999 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.129999999999995 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 72.329999999999998 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.540000000000006 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.646 HD13 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.329999999999998 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 63.450000000000003 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.46 HD23 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.329999999999998 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.349999999999994 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.299999999999997 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.592 HE22 HG13 ' A' ' 81' ' ' VAL . 71.3 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.329999999999998 109.701 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.340000000000003 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.209999999999994 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 71.099999999999994 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.520000000000003 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.539999999999999 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.340000000000003 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.658 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 63.100000000000001 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.310000000000002 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 75.150000000000006 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.49 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.200000000000003 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.423 ' HD2' ' HE2' ' A' ' 69' ' ' PHE . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.915 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.329999999999998 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.329999999999998 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.040000000000006 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.450000000000003 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.423 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 74.319999999999993 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.010000000000005 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 73.010000000000005 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.803 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.129999999999995 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 70.409999999999997 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.329999999999998 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.646 ' HE1' HD13 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.209999999999994 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.530000000000001 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.400000000000006 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.310000000000002 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.329999999999998 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.519999999999996 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HE22 ' A' ' 49' ' ' GLN . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.439999999999998 108.473 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.450000000000003 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.140000000000001 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.430000000000007 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.420000000000002 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.530000000000001 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD11 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.219999999999999 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 71.329999999999998 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.129999999999995 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.299999999999997 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 53.049999999999997 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.230000000000004 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.319999999999993 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.405 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.030000000000001 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.450000000000003 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.030000000000001 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.530000000000001 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.420000000000002 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.584 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.129999999999995 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.329999999999998 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.310000000000002 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.340000000000003 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.239999999999995 111.367 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.040000000000006 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.240000000000002 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.230000000000004 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.439999999999998 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.319999999999993 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.010000000000005 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.510000000000005 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.618 ' HA ' HD13 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 71.219999999999999 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.310000000000002 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.420000000000002 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.420000000000002 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.787 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.319999999999993 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.420000000000002 110.895 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 72.430000000000007 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.019999999999996 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.150000000000006 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.45 ' C ' HD23 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.019999999999996 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 126' ' ' ASP . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.219999999999999 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 37.729999999999997 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.714 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.430000000000007 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 62.43 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 73.450000000000003 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 74.329999999999998 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.200000000000003 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 75.120000000000005 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.299999999999997 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 74.340000000000003 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.539999999999999 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.049999999999997 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 71.120000000000005 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.010000000000005 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.510000000000005 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.319999999999993 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.349999999999994 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 70.239999999999995 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.140000000000001 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 71.450000000000003 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.329999999999998 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.120000000000005 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.556 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.200000000000003 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.420000000000002 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 74.430000000000007 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.319999999999993 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 73.439999999999998 109.421 174.503 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.308 0.575 . . . . 72.439999999999998 111.063 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.450000000000003 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 72.400000000000006 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.239999999999995 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.535 HD23 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 62.5 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.329999999999998 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.530000000000001 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.200000000000003 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 74.310000000000002 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.439999999999998 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 1.1 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.239999999999995 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.676 HD12 HD22 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.010000000000005 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.409999999999997 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.439999999999998 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.409999999999997 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.540000000000006 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.329999999999998 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.430000000000007 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.099999999999994 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 64.239999999999995 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.109999999999999 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.030000000000001 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.549999999999997 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.019999999999996 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.230000000000004 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 71.340000000000003 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.510000000000005 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.299999999999997 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.439999999999998 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.540000000000006 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.350000000000001 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.319999999999993 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.119999999999997 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.676 HD22 HD12 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.329999999999998 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 73.209999999999994 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.329999999999998 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 62.109999999999999 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.476 HE22 ' HG ' ' A' ' 45' ' ' LEU . 2.0 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.219999999999999 110.086 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.340000000000003 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.439999999999998 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.340000000000003 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.319999999999993 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.540000000000006 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.439999999999998 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.030000000000001 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.329999999999998 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.150000000000006 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.349999999999994 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HD1' HG13 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 73.299999999999997 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 73.230000000000004 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.129999999999995 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.030000000000001 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 75.329999999999998 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 75.120000000000005 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.430000000000007 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.530000000000001 109.363 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.409999999999997 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 71.450000000000003 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.724 HG13 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.400000000000006 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.913 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.109999999999999 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 75.430000000000007 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.855 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.200000000000003 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.530000000000001 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 75.450000000000003 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.450000000000003 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 61.109999999999999 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 HE21 ' A' ' 49' ' ' GLN . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.219999999999999 109.923 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.464 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.539999999999999 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.099999999999994 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 54.409999999999997 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 70.409999999999997 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 74.019999999999996 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.783 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 71.430000000000007 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.319999999999993 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.319999999999993 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.210000000000001 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.240000000000002 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HB3' ' HE3' ' A' ' 154' ' ' MET . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.299999999999997 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.200000000000003 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HD3' HD23 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.420000000000002 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.140000000000001 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.349999999999994 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 74.209999999999994 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.84 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.040000000000006 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.54 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 75.200000000000003 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.200000000000003 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.572 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.230000000000004 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 74.040000000000006 111.821 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.129999999999995 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.420000000000002 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.129999999999995 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.340000000000003 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.239999999999995 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.219999999999999 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 73.439999999999998 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.109999999999999 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.530000000000001 110.83 176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.409999999999997 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 110.777 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.530000000000001 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.439999999999998 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.206 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.039999999999999 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.150000000000006 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.209999999999994 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.140000000000001 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.239999999999995 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 75.150000000000006 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.405 ' HB3' ' HB3' ' A' ' 154' ' ' MET . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 71.439999999999998 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 38.07 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.539999999999999 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.340000000000003 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.487 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.349999999999994 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.310000000000002 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.120000000000005 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.409999999999997 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.433 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.409999999999997 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.030000000000001 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.409999999999997 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 75.530000000000001 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 139' ' ' PRO . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 74.049999999999997 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.140000000000001 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 73.409999999999997 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 146' ' ' GLN . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.409999999999997 111.472 168.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.64 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.329999999999998 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' PRO . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 75.219999999999999 108.716 170.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 74.129999999999995 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HB3' HG23 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.129999999999995 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.54 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.450000000000003 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.84 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.010000000000005 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.210000000000001 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.586 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.530000000000001 110.355 176.788 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.842 0.829 . . . . 75.140000000000001 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.209999999999994 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.310000000000002 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 71.519999999999996 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.109999999999999 109.6 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 73.200000000000003 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 64.430000000000007 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 63.109999999999999 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.240000000000002 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.040000000000006 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.039999999999999 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.340000000000003 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.452 ' HB2' HG12 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.319999999999993 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.099999999999994 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 73.109999999999999 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.451 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.140000000000001 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 62.530000000000001 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 63.140000000000001 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 75.530000000000001 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.450000000000003 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.130000000000003 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.420000000000002 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.530000000000001 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.329999999999998 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.019999999999996 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.450000000000003 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.310000000000002 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 73.120000000000005 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 73.439999999999998 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.400000000000006 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.150000000000006 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.230000000000004 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 64.310000000000002 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.239999999999995 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.340000000000003 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.340000000000003 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.530000000000001 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 64.019999999999996 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.099999999999994 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 71.019999999999996 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 72.439999999999998 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.430000000000007 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 50.119999999999997 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.329999999999998 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.209999999999994 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.230000000000004 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.040000000000006 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.200000000000003 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 74.340000000000003 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.409999999999997 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.464 ' SD ' ' HE1' ' A' ' 154' ' ' MET . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.319999999999993 109.884 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.530000000000001 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 73.239999999999995 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.350000000000001 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.230000000000004 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.140000000000001 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.040000000000006 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.409999999999997 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.200000000000003 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.310000000000002 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.553 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 75.439999999999998 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.099999999999994 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.310000000000002 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.420000000000002 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 74.230000000000004 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 70.120000000000005 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.099999999999994 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.040000000000006 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.319999999999993 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.240000000000002 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 71.209999999999994 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.469 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.439999999999998 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.530000000000001 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 70.140000000000001 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.340000000000003 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.219999999999999 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 75.030000000000001 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.140000000000001 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 41.25 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HG2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.219999999999999 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.200000000000003 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.400000000000006 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 73.519999999999996 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.120000000000005 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.489 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.209999999999994 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.450000000000003 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.299999999999997 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.430000000000007 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.399999999999999 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.420000000000002 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 73.5 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.140000000000001 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.140000000000001 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.200000000000003 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.519999999999996 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.109999999999999 111.575 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.239999999999995 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.319999999999993 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 71.430000000000007 110.07 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.209999999999994 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.450000000000003 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 70.310000000000002 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.319999999999993 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.420000000000002 112.007 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 75.129999999999995 110.191 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.150000000000006 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.209999999999994 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.230000000000004 109.969 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.530000000000001 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.109999999999999 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.585 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.400000000000006 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.219999999999999 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.319999999999993 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 74.329999999999998 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.340000000000003 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.230000000000004 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.349999999999994 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 139' ' ' PRO . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.420000000000002 110.677 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 60.219999999999999 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 74.420000000000002 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 146' ' ' GLN . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.039 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.140000000000001 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 144' ' ' PRO . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.409999999999997 110.396 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 142' ' ' THR . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.319999999999993 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.120000000000005 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.653 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.019999999999996 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 73.409999999999997 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 74.439999999999998 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.464 ' HE1' ' SD ' ' A' ' 64' ' ' MET . 51.7 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.219999999999999 110.89 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.016 0.436 . . . . 74.25 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 72.439999999999998 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.140000000000001 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.510000000000005 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.340000000000003 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.120000000000005 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 72.430000000000007 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.039999999999999 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.772 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.400000000000006 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.047 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.430000000000007 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.310000000000002 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 HG11 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.530000000000001 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.751 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.530000000000001 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.240000000000002 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.239999999999995 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.340000000000003 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.109999999999999 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 75.5 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.439999999999998 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.540000000000006 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.340000000000003 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.219999999999999 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 74.450000000000003 111.205 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.530000000000001 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.109999999999999 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.019999999999996 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.530000000000001 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 70.140000000000001 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 60.009999999999998 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 74.150000000000006 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.430000000000007 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.200000000000003 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.676 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 73.349999999999994 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.82 HD22 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 73.400000000000006 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.816 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.319999999999993 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.319999999999993 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.399999999999999 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 62.0 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.099999999999994 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.816 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.439999999999998 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.049999999999997 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 65.439999999999998 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.120000000000005 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 64.450000000000003 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.530000000000001 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.89 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 109.831 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 71.340000000000003 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.140000000000001 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.641 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.450000000000003 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 54.229999999999997 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.450000000000003 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.310000000000002 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.299999999999997 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.129999999999995 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.409999999999997 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.209999999999994 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.956 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 75.349999999999994 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 61.130000000000003 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.74 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 72.310000000000002 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 74.200000000000003 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.89 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 75.430000000000007 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.540000000000006 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 75.140000000000001 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.409999999999997 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.329999999999998 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.703 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.030000000000001 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.099999999999994 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.82 ' HA2' HD22 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 73.5 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.399999999999999 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 73.010000000000005 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.039999999999999 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.299999999999997 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 74.319999999999993 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.049999999999997 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.010000000000005 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.401 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.219999999999999 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.772 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.450000000000003 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 70.010000000000005 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.030000000000001 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.109999999999999 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.400000000000006 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.109999999999999 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 74.230000000000004 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.340000000000003 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.430000000000007 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.209999999999994 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.329999999999998 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.509999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.530000000000001 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.530000000000001 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.040000000000006 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.129999999999995 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.120000000000005 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.150000000000006 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 HD12 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.140000000000001 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.400000000000006 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 71.109999999999999 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.209999999999994 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.310000000000002 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.418 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 73.040000000000006 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.230000000000004 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.010000000000005 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 38.109999999999999 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.633 ' HB3' HD13 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.409999999999997 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.400000000000006 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.140000000000001 109.779 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 74.439999999999998 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 64.0 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.349999999999994 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.039999999999999 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.010000000000005 110.297 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 141' ' ' GLU . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.140000000000001 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.010000000000005 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.140000000000001 110.501 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 75.310000000000002 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.049999999999997 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.743 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 71.230000000000004 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.502 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.209999999999994 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 72.099999999999994 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.420000000000002 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.340000000000003 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.439999999999998 110.546 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 74.430000000000007 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 73.219999999999999 109.904 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.109999999999999 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 111.363 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.725 0.297 . . . . 72.209999999999994 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 72.140000000000001 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.329999999999998 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 64.400000000000006 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 55.549999999999997 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.400000000000006 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.202 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.329999999999998 112.093 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 63.310000000000002 109.646 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.030000000000001 112.138 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.510000000000005 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.530000000000001 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.129999999999995 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.329999999999998 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.441 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 75.340000000000003 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.319999999999993 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.8 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.400000000000006 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.540000000000006 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.040000000000006 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.129999999999995 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.329999999999998 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.420000000000002 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 63.210000000000001 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 74.209999999999994 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.310000000000002 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.420000000000002 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.129999999999995 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 73.450000000000003 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.039999999999999 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.457 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.230000000000004 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.030000000000001 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.049999999999997 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.340000000000003 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.129999999999995 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.400000000000006 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.150000000000006 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.549999999999997 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.329999999999998 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.310000000000002 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.219999999999999 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 70.310000000000002 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.409999999999997 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 73.239999999999995 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.310000000000002 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 112.23 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.130000000000003 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 74.219999999999999 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.329999999999998 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.019999999999996 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.771 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 73.439999999999998 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.420000000000002 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.602 ' HE1' ' SD ' ' A' ' 154' ' ' MET . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.120000000000005 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.340000000000003 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.430000000000007 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.64 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.530000000000001 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HE1' HD22 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.239999999999995 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.8 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.771 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.409999999999997 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 54.539999999999999 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 73.400000000000006 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.409999999999997 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.530000000000001 109.45 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.129999999999995 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 72.299999999999997 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.140000000000001 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.420000000000002 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.099999999999994 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 75.519999999999996 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.510000000000005 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.712 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.210000000000001 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.439999999999998 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.319999999999993 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.239999999999995 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 37.539999999999999 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 75.400000000000006 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 73.310000000000002 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.129999999999995 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 71.5 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.329999999999998 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.299999999999997 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 74.319999999999993 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.020000000000003 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 74.400000000000006 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.049999999999997 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.209999999999994 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.349999999999994 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 74.230000000000004 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.140000000000001 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.409999999999997 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.030000000000001 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.340000000000003 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.439999999999998 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 74.420000000000002 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.784 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.340000000000003 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HG ' HD22 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.230000000000004 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.129999999999995 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.430000000000007 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.553 ' O ' ' HE3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.109999999999999 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.310000000000002 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.150000000000006 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.647 HD22 HD11 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.310000000000002 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.049999999999997 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.516 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 71.230000000000004 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.481 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.319999999999993 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.129999999999995 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 37.539999999999999 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.030000000000001 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.593 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.239999999999995 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.450000000000003 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.794 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.400000000000006 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.625 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.557 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.140000000000001 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.546 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 75.540000000000006 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.514 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.399999999999999 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.230000000000004 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.349999999999994 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 141' ' ' GLU . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.001 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.409999999999997 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 139' ' ' PRO . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 72.310000000000002 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 73.219999999999999 112.971 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 61.32 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.140000000000001 109.675 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.340000000000003 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 73.209999999999994 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.319999999999993 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.794 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 72.400000000000006 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.762 HD22 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 75.219999999999999 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.602 ' SD ' ' HE1' ' A' ' 64' ' ' MET . 2.8 mpp? . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 110.448 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 113.64 0.978 . . . . 72.150000000000006 113.64 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.209999999999994 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.099999999999994 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.140000000000001 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.501 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 75.109999999999999 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.140000000000001 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 64.430000000000007 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.340000000000003 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.329999999999998 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.319999999999993 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.329999999999998 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.329999999999998 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.219999999999999 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.691 HD21 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.120000000000005 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 61.130000000000003 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.776 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 41.9 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.530000000000001 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.401 HG22 HG13 ' A' ' 71' ' ' VAL . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.319999999999993 111.086 -176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.239999999999995 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.77 HD11 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 52.399999999999999 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.486 ' N ' HD23 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.420000000000002 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.099999999999994 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.310000000000002 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.129999999999995 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.510000000000005 111.21 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.329999999999998 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 73.530000000000001 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.340000000000003 110.993 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 74.5 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 71.040000000000006 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.230000000000004 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.109999999999999 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 63.130000000000003 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.230000000000004 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.530000000000001 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.140000000000001 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 72.549999999999997 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.519999999999996 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.409999999999997 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.040000000000006 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 75.540000000000006 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.140000000000001 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.439999999999998 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 51.219999999999999 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.400000000000006 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.310000000000002 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.530000000000001 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 71.430000000000007 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.409999999999997 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.477 ' HE1' ' HH ' ' A' ' 113' ' ' TYR . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.409999999999997 110.035 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.549999999999997 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.329999999999998 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.210000000000001 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 74.439999999999998 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.430000000000007 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 71.349999999999994 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.643 HG12 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.099999999999994 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.030000000000001 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA3' HD21 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.439999999999998 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.450000000000003 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.120000000000005 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.340000000000003 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.340000000000003 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.420000000000002 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 62.340000000000003 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 53.539999999999999 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.140000000000001 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.010000000000005 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.754 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 74.439999999999998 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 72.540000000000006 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.400000000000006 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.400000000000006 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.129999999999995 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.349999999999994 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 64.230000000000004 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.129999999999995 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 73.120000000000005 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 73.329999999999998 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.400000000000006 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 74.209999999999994 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.420000000000002 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.109999999999999 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.439999999999998 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.209999999999994 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.540000000000006 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.229999999999997 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.310000000000002 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.239999999999995 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 73.150000000000006 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.129999999999995 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.468 HG12 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.420000000000002 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.477 ' HH ' ' HE1' ' A' ' 64' ' ' MET . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 72.310000000000002 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.140000000000001 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.210000000000001 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.430000000000007 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.439999999999998 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.140000000000001 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.129999999999995 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.350000000000001 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.420000000000002 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.040000000000006 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.529 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.409999999999997 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.099999999999994 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.71 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.430000000000007 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.520000000000003 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.976 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 74.019999999999996 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.782 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.299999999999997 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.608 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.349999999999994 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 73.030000000000001 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.319999999999993 112.375 169.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.200000000000003 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.340000000000003 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.120000000000005 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.229999999999997 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.109999999999999 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.530000000000001 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.400000000000006 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.150000000000006 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 71.099999999999994 109.524 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 61.210000000000001 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.530000000000001 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.647 HG23 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.519999999999996 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.617 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.329999999999998 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.782 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.439999999999998 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.409999999999997 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 73.0 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.894 ' HE2' ' HA ' ' A' ' 154' ' ' MET . 11.6 mmt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.420000000000002 111.093 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.044 0.45 . . . . 75.230000000000004 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 71.5 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.511 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.310000000000002 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 75.099999999999994 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.409999999999997 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.299999999999997 110.621 179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.310000000000002 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 45.009999999999998 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.209999999999994 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 65.209999999999994 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 73.109999999999999 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.310000000000002 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 71.140000000000001 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.340000000000003 110.508 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.310000000000002 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.340000000000003 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.430000000000007 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.409999999999997 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.239999999999995 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.109999999999999 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.540000000000006 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.340000000000003 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.120000000000005 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 74.150000000000006 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 74.299999999999997 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.420000000000002 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.200000000000003 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.430000000000007 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.672 ' HA ' HG21 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.310000000000002 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.540000000000006 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.420000000000002 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.672 HG21 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 74.420000000000002 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.150000000000006 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.319999999999993 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.430000000000007 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.430000000000007 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.329999999999998 110.45 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.329999999999998 111.826 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.439999999999998 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.219999999999999 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HG2' HD13 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 73.010000000000005 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.439999999999998 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.463 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 74.120000000000005 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.120000000000005 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.598 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.399999999999999 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.329999999999998 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.120000000000005 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 74.109999999999999 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.150000000000006 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.219999999999999 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 73.329999999999998 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.200000000000003 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.409999999999997 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.349999999999994 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.729 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 75.109999999999999 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.420000000000002 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.420000000000002 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.439999999999998 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.519999999999996 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.319999999999993 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.230000000000004 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.420000000000002 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG12 HD13 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.200000000000003 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA2' HG11 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.140000000000001 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.130000000000003 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 73.129999999999995 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.319999999999993 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.539 HG11 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 73.030000000000001 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.219999999999999 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.109999999999999 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 71.439999999999998 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.349999999999994 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.239999999999995 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.681 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 73.200000000000003 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.445 ' HB3' HD13 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.140000000000001 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 74.140000000000001 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 65.329999999999998 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 63.240000000000002 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.200000000000003 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HH ' ' HG3' ' A' ' 108' ' ' GLU . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.219999999999999 108.688 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.79 HD11 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.239999999999995 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.200000000000003 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.120000000000005 111.599 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HE1' HG22 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.150000000000006 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.239999999999995 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' HH ' ' A' ' 102' ' ' TYR . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.349999999999994 110.483 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.409999999999997 109.819 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 71.430000000000007 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.120000000000005 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 109' ' ' ILE . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.340000000000003 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.109999999999999 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.319999999999993 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.450000000000003 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.589 HD23 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.099999999999994 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.519999999999996 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.439999999999998 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.209999999999994 110.57 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 73.209999999999994 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 72.140000000000001 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.150000000000006 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 64.150000000000006 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.567 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.310000000000002 108.727 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 71.430000000000007 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 63.350000000000001 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.099999999999994 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.420000000000002 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.731 ' HB1' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.140000000000001 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.150000000000006 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.598 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.450000000000003 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.791 HD13 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.329999999999998 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 62.509999999999998 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.65 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.239999999999995 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.519999999999996 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.484 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.340000000000003 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.697 ' HB3' HD11 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.319999999999993 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.040000000000006 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.319999999999993 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.479 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.010000000000005 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.433 ' HB1' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.130000000000003 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.310000000000002 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.549999999999997 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.433 ' OE1' ' HB1' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.310000000000002 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.150000000000006 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.79 ' HG2' HD11 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.430000000000007 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.484 HG22 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.109999999999999 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.040000000000006 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.409999999999997 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.589 ' HB3' HD23 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.040000000000006 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.731 ' HG3' ' HB1' ' A' ' 131' ' ' ALA . 40.7 mtm . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.030000000000001 109.124 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.979 0.419 . . . . 74.439999999999998 111.645 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB3' HD12 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 71.109999999999999 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.587 ' O ' HD11 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.109999999999999 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.009999999999998 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.759 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.230000000000004 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 71.319999999999993 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 38.229999999999997 109.975 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.409999999999997 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.519999999999996 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.109999999999999 113.695 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.229999999999997 110.746 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.400000000000006 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.409999999999997 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 72.219999999999999 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.219999999999999 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.420000000000002 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.430000000000007 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 70.510000000000005 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.439999999999998 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.219999999999999 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.549999999999997 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.209999999999994 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 70.140000000000001 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 55.25 110.283 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.329999999999998 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.230000000000004 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.009999999999998 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 75.430000000000007 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 75.129999999999995 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.310000000000002 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.439999999999998 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.219999999999999 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.409999999999997 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.329999999999998 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 74.319999999999993 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.329999999999998 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.299999999999997 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.409999999999997 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 54.439999999999998 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 74.319999999999993 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 72.239999999999995 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.109999999999999 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.420000000000002 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.239999999999995 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.409999999999997 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.481 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.349999999999994 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 63.420000000000002 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.230000000000004 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.754 ' HB3' HG11 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.209999999999994 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.439999999999998 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.010000000000005 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 73.25 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.329999999999998 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.329999999999998 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.020000000000003 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 75.030000000000001 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.319999999999993 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.140000000000001 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.109999999999999 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.120000000000005 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.319999999999993 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.009999999999998 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.120000000000005 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 73.319999999999993 109.719 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.450000000000003 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.430000000000007 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.239999999999995 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.509999999999998 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.150000000000006 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.030000000000001 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HA ' HD12 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 65.349999999999994 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.540000000000006 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.150000000000006 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 75.109999999999999 112.6 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.340000000000003 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.452 ' HB ' HD22 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.439999999999998 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.549999999999997 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.200000000000003 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.340000000000003 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.439999999999998 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 110.935 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB3' HD13 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 74.340000000000003 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 110.876 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 74.040000000000006 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.329999999999998 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.942 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.299999999999997 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.329999999999998 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.030000000000001 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.510000000000005 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.568 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 61.020000000000003 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.239999999999995 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 74.040000000000006 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.129999999999995 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.310000000000002 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 63.409999999999997 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.430000000000007 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.340000000000003 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 70.230000000000004 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.019999999999996 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.519999999999996 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.319999999999993 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.030000000000001 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.439999999999998 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.540000000000006 109.188 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 72.430000000000007 108.745 164.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 72.439999999999998 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.230000000000004 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.588 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.310000000000002 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.299999999999997 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.049999999999997 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.824 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 75.409999999999997 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.409999999999997 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.049999999999997 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.219999999999999 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.510000000000005 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 70.549999999999997 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 45.32 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.019999999999996 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.519999999999996 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 141' ' ' GLU . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.329999999999998 111.848 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 75.439999999999998 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.430000000000007 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 74.120000000000005 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.219999999999999 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.866 ' HD3' HD12 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.329999999999998 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.824 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 74.109999999999999 109.353 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 75.010000000000005 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.430000000000007 110.727 178.787 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.634 -0.876 . . . . 73.030000000000001 108.634 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.299999999999997 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.030000000000001 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.450000000000003 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.150000000000006 110.373 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.349999999999994 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 62.439999999999998 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.109999999999999 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.664 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.109999999999999 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.200000000000003 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.200000000000003 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.399999999999999 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.641 HD22 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.219999999999999 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.513 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 75.010000000000005 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.544 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 72.420000000000002 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.502 ' H ' HG21 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.409999999999997 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.310000000000002 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.420000000000002 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.746 HG22 HD23 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 72.400000000000006 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.606 ' HE1' ' HG3' ' A' ' 30' ' ' GLU . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.409999999999997 112.336 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HG3' ' HE1' ' A' ' 28' ' ' MET . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 64.340000000000003 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.746 HD23 HG22 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 72.209999999999994 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 60.0 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.340000000000003 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 75.510000000000005 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.536 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 61.399999999999999 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.340000000000003 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.120000000000005 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.010000000000005 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.552 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.420000000000002 110.228 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.420000000000002 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.329999999999998 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 73.099999999999994 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 73.310000000000002 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 72.239999999999995 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.509999999999998 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.019999999999996 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.400000000000006 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.450000000000003 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.209999999999994 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.140000000000001 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.120000000000005 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.120000000000005 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.420000000000002 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.400000000000006 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.120000000000005 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 71.140000000000001 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 62.43 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.513 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.439999999999998 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 73.450000000000003 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 1.0 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.319999999999993 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.540000000000006 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.109999999999999 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 71.349999999999994 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 71.349999999999994 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 74.530000000000001 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.420000000000002 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 70.450000000000003 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 1.0 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.040000000000006 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.140000000000001 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 50.299999999999997 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.209999999999994 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 37.18 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 75.329999999999998 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.219999999999999 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.641 HG21 HD22 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.340000000000003 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . 0.626 ' H ' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.340000000000003 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.430000000000007 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.450000000000003 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.430000000000007 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 81' ' ' VAL . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 109.916 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 37.18 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.340000000000003 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.109999999999999 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 73.140000000000001 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.219999999999999 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.319999999999993 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.200000000000003 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.319999999999993 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.219999999999999 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.010000000000005 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.129999999999995 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.664 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.510000000000005 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.329999999999998 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 55.119999999999997 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.340000000000003 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.049999999999997 110.983 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.411 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.049999999999997 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 74.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.476 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 75.409999999999997 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 65.209999999999994 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.130000000000003 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.519999999999996 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.130000000000003 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.239999999999995 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.688 ' O ' HG13 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.439999999999998 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.912 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.109999999999999 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.519999999999996 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.100000000000001 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.912 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 74.230000000000004 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 73.340000000000003 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.310000000000002 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 61.130000000000003 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.699 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 63.32 111.445 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 74.019999999999996 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.455 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.140000000000001 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.310000000000002 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.329999999999998 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.299999999999997 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.329999999999998 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.57 ' CE1' ' HA ' ' A' ' 120' ' ' VAL . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.209999999999994 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.329999999999998 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.517 HD13 ' HE2' ' A' ' 117' ' ' MET . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.219999999999999 109.386 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 154' ' ' MET . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.430000000000007 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.519 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.109999999999999 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.030000000000001 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.099999999999994 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.209999999999994 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.400000000000006 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.577 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.310000000000002 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.421 HD21 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 65.109999999999999 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 70.219999999999999 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.409999999999997 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.310000000000002 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.329999999999998 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.510000000000005 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.200000000000003 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.310000000000002 110.779 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.409999999999997 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 63.409999999999997 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.099999999999994 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.484 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.239999999999995 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 74.239999999999995 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.239999999999995 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.409 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.010000000000005 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 65.510000000000005 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.200000000000003 109.167 171.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' MET . . . . . 0.53 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? . . . . . 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.510000000000005 110.529 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.898 -0.408 . . . . 74.140000000000001 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.019999999999996 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.737 ' H ' HD22 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 74.030000000000001 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.329999999999998 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.030000000000001 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 74.239999999999995 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.329999999999998 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 73.049999999999997 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 75.450000000000003 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.510000000000005 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.239999999999995 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.835 HD12 HG23 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.219999999999999 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.329999999999998 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.689 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.329999999999998 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.415 ' CB ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.340000000000003 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.150000000000006 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.109999999999999 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.310000000000002 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.030000000000001 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.240000000000002 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.219999999999999 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.329999999999998 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.409999999999997 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 63.340000000000003 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 64.549999999999997 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.040000000000006 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.310000000000002 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.020000000000003 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 65.010000000000005 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.209999999999994 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 62.210000000000001 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.430000000000007 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.439999999999998 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.049999999999997 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 70.420000000000002 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.140000000000001 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.530000000000001 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.329999999999998 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.409999999999997 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.150000000000006 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.219999999999999 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.140000000000001 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 73.150000000000006 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.109999999999999 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.596 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.420000000000002 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.209999999999994 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.8 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 74.340000000000003 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.515 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 71.040000000000006 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.530000000000001 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.319999999999993 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.540000000000006 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.400000000000006 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 63.530000000000001 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.400000000000006 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 70.420000000000002 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.530000000000001 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.450000000000003 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.689 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.349999999999994 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.219999999999999 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.299999999999997 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 73.140000000000001 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.120000000000005 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.219999999999999 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.100000000000001 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.240000000000002 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.749 ' H ' HG12 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 73.239999999999995 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.239999999999995 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 74.409999999999997 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.651 HG23 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.329999999999998 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.319999999999993 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.439999999999998 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.040000000000006 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' SER . . . . . 0.75 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.340000000000003 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 61.240000000000002 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 62.350000000000001 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB3' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.109999999999999 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.530000000000001 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB2' HD23 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.510000000000005 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.519999999999996 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.150000000000006 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.099999999999994 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.340000000000003 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.340000000000003 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 74.510000000000005 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.239999999999995 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . 0.634 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.119999999999997 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.310000000000002 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.219999999999999 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . 0.634 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.219999999999999 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.120000000000005 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.129999999999995 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.644 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.420000000000002 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . 0.695 ' HZ2' ' HB3' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 74.120000000000005 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.968 ' HA ' HD21 ' A' ' 123' ' ' ASN . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.210000000000001 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.239999999999995 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.329999999999998 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . 0.968 HD21 ' HA ' ' A' ' 120' ' ' VAL . 42.8 m-80 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.229999999999997 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.299999999999997 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.010000000000005 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 73.049999999999997 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.240000000000002 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.540000000000006 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.010000000000005 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.8 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 75.310000000000002 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 72.510000000000005 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.319999999999993 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 62.009999999999998 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.908 ' HB3' HG23 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.019999999999996 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . 0.407 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 141' ' ' GLU . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.009999999999998 112.763 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 64.040000000000006 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 139' ' ' PRO . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.310000000000002 109.612 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.120000000000005 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.120000000000005 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.409999999999997 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.299999999999997 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 72.219999999999999 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.219999999999999 108.431 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . 0.529 ' CG ' HD13 ' A' ' 101' ' ' LEU . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 75.239999999999995 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.517 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . 0.41 ' HD2' HD13 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.409999999999997 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.509999999999998 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 61.219999999999999 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.773 ' H ' HD12 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.530000000000001 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.129999999999995 111.343 -169.625 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.057 0.456 . . . . 73.310000000000002 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.48 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 65.409999999999997 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 73.209999999999994 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 50.25 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.771 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 72.519999999999996 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.239999999999995 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.319999999999993 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HB2' HD22 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.299999999999997 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 72.219999999999999 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.130000000000003 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HG ' HG11 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 74.230000000000004 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.479 HD13 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.409999999999997 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.555 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.010000000000005 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.748 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 73.239999999999995 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 74.519999999999996 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.881 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.530000000000001 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.200000000000003 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 72.409999999999997 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.439999999999998 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.439999999999998 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 63.039999999999999 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.039999999999999 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.329999999999998 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.409999999999997 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 61.539999999999999 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.299999999999997 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.030000000000001 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 71.140000000000001 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . 0.688 HG23 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.219999999999999 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.688 ' H ' HG23 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.200000000000003 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.430000000000007 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.299999999999997 109.562 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 61.25 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.530000000000001 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.109999999999999 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.628 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.420000000000002 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.239999999999995 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.349999999999994 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 71.549999999999997 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.229999999999997 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.519999999999996 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.119999999999997 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 71.049999999999997 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' TYR . . . . . 0.845 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.230000000000004 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.583 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.230000000000004 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.319999999999993 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.420000000000002 111.685 -172.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 71.129999999999995 110.446 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.520000000000003 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 71.219999999999999 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.881 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.239999999999995 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 74.430000000000007 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' OE1' HD13 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 74.120000000000005 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.439999999999998 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.329999999999998 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 64.140000000000001 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.340000000000003 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.430000000000007 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.319999999999993 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB3' HD11 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.140000000000001 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 54.43 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.439999999999998 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 87' ' ' VAL . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 72.019999999999996 111.409 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.400000000000006 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.555 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.540000000000006 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.049999999999997 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.239999999999995 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.149999999999999 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.450000000000003 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.442 ' HG1' ' HD2' ' A' ' 93' ' ' PRO . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 53.43 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD2' ' HG1' ' A' ' 92' ' ' THR . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.310000000000002 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.420000000000002 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.519999999999996 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.841 ' HD3' HD13 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.340000000000003 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 53.119999999999997 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.420000000000002 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' SER . . . . . 0.523 ' HB2' HD23 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 72.239999999999995 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 74.150000000000006 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 72.150000000000006 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.420000000000002 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.340000000000003 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.430000000000007 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.010000000000005 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.549999999999997 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.230000000000004 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.702 HD13 HG22 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 74.340000000000003 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.409999999999997 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 70.219999999999999 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.140000000000001 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.140000000000001 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.409999999999997 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 63.439999999999998 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 73.349999999999994 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.54 ' HA ' HG13 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.420000000000002 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.420000000000002 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.049999999999997 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.310000000000002 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 71.340000000000003 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 72.439999999999998 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.430000000000007 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.229999999999997 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.150000000000006 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 127' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.009999999999998 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.811 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 74.25 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.319999999999993 110.688 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.583 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.209999999999994 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . 0.845 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.200000000000003 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.888 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.030000000000001 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 73.239999999999995 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.340000000000003 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.409999999999997 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.109999999999999 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.219999999999999 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.530000000000001 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.439999999999998 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 52.229999999999997 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.409999999999997 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.450000000000003 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.329999999999998 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.329999999999998 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.030000000000001 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLN . . . . . 0.447 ' H ' ' C ' ' A' ' 144' ' ' PRO . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.329999999999998 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.099999999999994 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.439999999999998 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.702 HG22 HD13 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 63.310000000000002 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' SER . . . . . 0.888 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 74.540000000000006 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.340000000000003 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.420000000000002 109.7 175.597 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.089 0.471 . . . . 74.310000000000002 111.042 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.36 -68.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 73.120000000000005 109.669 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -83.56 85.35 7.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.224 -0.443 . . . . 74.430000000000007 110.203 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -99.76 -32.19 11.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 109.773 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.3 m 63.19 97.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.17 -0.923 . . . . 71.099999999999994 111.64 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -149.21 113.49 5.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.088 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 64.94 -178.74 0.18 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.719 -0.673 . . . . 73.310000000000002 111.643 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.030000000000001 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 54.130000000000003 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.453 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 61.020000000000003 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.49 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.349999999999994 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.453 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 74.519999999999996 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.109999999999999 109.317 175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 74.400000000000006 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.519 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.439999999999998 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 74.310000000000002 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 62.140000000000001 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.634 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.559 HD21 ' HB3' ' A' ' 72' ' ' GLU . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.925 ' HB ' HG21 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.230000000000004 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 71.140000000000001 110.465 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.420000000000002 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.717 HG23 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.230000000000004 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 65.430000000000007 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.513 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.109999999999999 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 74.420000000000002 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.030000000000001 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 38.369999999999997 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 51.240000000000002 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.752 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 65.230000000000004 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.413 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 75.230000000000004 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.299999999999997 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.540000000000006 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.621 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.210000000000001 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.239999999999995 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.129999999999995 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.239999999999995 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.722 HD22 HD22 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 73.510000000000005 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 70.439999999999998 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.722 HD22 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.230000000000004 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.48 HD23 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.140000000000001 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 64.120000000000005 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.219999999999999 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.200000000000003 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.450000000000003 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.150000000000006 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.540000000000006 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 64.140000000000001 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.219999999999999 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.646 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.349999999999994 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.239999999999995 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 75.540000000000006 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.100000000000001 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.512 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.329999999999998 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.544 ' HB3' HG13 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 74.519999999999996 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.44 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 74.409999999999997 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.530000000000001 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.939 ' HA ' ' HE2' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.040000000000006 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.120000000000005 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.509999999999998 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.120000000000005 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.513 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 74.120000000000005 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.553 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.340000000000003 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 HG13 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.540000000000006 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.559 ' HB3' HD21 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.150000000000006 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.752 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.340000000000003 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.526 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.450000000000003 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.441 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.230000000000004 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 72.329999999999998 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.416 ' OE1' HG21 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.450000000000003 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.329999999999998 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.119999999999997 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.416 HG21 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.120000000000005 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.239999999999995 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.635 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.299999999999997 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.049999999999997 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.150000000000006 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.518 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 75.109999999999999 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.925 HG21 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 75.519999999999996 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.635 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.540000000000006 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.430000000000007 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.519 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 75.340000000000003 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.420000000000002 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.430000000000007 110.025 178.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 62.439999999999998 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.120000000000005 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.409999999999997 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 74.340000000000003 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.329999999999998 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.578 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.319999999999993 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.299999999999997 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.781 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.049999999999997 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.229999999999997 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 74.400000000000006 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.109999999999999 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.42 ' CD ' ' HD1' ' A' ' 165' ' ' HIS . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.329999999999998 109.468 173.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.609 ' O ' HG11 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.781 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.340000000000003 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.609 HG11 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 72.310000000000002 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.781 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.299999999999997 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.310000000000002 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.019999999999996 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.556 ' HE3' ' HB3' ' A' ' 159' ' ' LEU . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.340000000000003 110.692 175.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.049999999999997 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.652 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.040000000000006 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.759 HG21 ' HB3' ' A' ' 155' ' ' LEU . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 65.140000000000001 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.109999999999999 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.409999999999997 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.61 HD21 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.439999999999998 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.597 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.409999999999997 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.442 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 74.109999999999999 111.343 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.707 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.310000000000002 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 74.519999999999996 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.120000000000005 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.44 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.439999999999998 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 74.219999999999999 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 75.310000000000002 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 63.25 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.414 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.049999999999997 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.409999999999997 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.646 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 74.0 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 62.049999999999997 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.472 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.519999999999996 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.898 ' HA ' HD22 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.439999999999998 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.040000000000006 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.239999999999995 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 75.329999999999998 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.219999999999999 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.200000000000003 112.254 -177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.781 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.430000000000007 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 71.049999999999997 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.898 HD22 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.400000000000006 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.299999999999997 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.414 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.230000000000004 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.578 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.109999999999999 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 71.430000000000007 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.219999999999999 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.503 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.540000000000006 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.939 ' HE2' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm -71.19 148.15 47.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 73.340000000000003 110.211 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 120' ' ' VAL . 59.6 mt -94.38 104.34 16.32 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.975 -0.557 . . . . 71.519999999999996 111.895 -171.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.8 t60 63.24 78.14 0.3 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.887 -0.597 . . . . 64.400000000000006 111.864 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -138.15 -51.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 74.329999999999998 111.012 175.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.509 ' H ' ' CD ' ' A' ' 157' ' ' GLU . 26.8 t -176.24 -67.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.192 -0.67 . . . . 55.32 109.192 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.556 ' HB3' ' HE3' ' A' ' 117' ' ' MET . 0.2 OUTLIER 46.46 43.78 12.39 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.14 0.9 . . . . 70.430000000000007 111.551 179.446 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.77 90.26 5.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.714 0.768 . . . . 70.040000000000006 110.552 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.461 ' CD2' ' HG3' ' A' ' 110' ' ' GLU . 58.7 t60 -133.52 115.89 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.811 -1.086 . . . . 64.209999999999994 108.491 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.779 ' HA ' ' HG2' ' A' ' 110' ' ' GLU . 36.9 m80 -145.21 131.68 19.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.698 0.285 . . . . 74.549999999999997 111.189 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -81.64 -55.81 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 74.239999999999995 109.684 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 73.0 t60 70.09 105.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.802 0.689 . . . . 62.32 111.153 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.42 ' HD1' ' CD ' ' A' ' 108' ' ' GLU . 52.9 p-80 -107.3 79.34 1.3 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.525 0.679 . . . . 75.129999999999995 110.783 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.536 -0.745 . . . . 75.549999999999997 109.922 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.595 ' HA ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.932 -0.396 . . . . 72.329999999999998 109.932 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -177.41 179.48 0.95 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.319 -0.401 . . . . 70.530000000000001 110.006 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -107.74 -31.44 8.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.744 -0.465 . . . . 74.109999999999999 109.744 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 54.4 25.38 5.99 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.461 -0.791 . . . . 74.319999999999993 111.561 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.6 m 51.61 51.78 15.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.938 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 70.33 108.38 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.805 0.691 . . . . 63.409999999999997 111.215 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -61.93 148.67 42.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.591 -0.731 . . . . 73.430000000000007 110.379 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 71.400000000000006 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.549999999999997 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.549999999999997 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.524 HD13 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.420000000000002 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 75.25 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.209999999999994 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 63.240000000000002 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 73.439999999999998 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.100000000000001 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.519999999999996 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.019999999999996 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 73.5 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.53 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.239999999999995 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.219999999999999 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.432 HD12 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.439999999999998 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.824 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.340000000000003 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.210000000000001 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.430000000000007 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 71.030000000000001 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.340000000000003 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 72.099999999999994 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.219999999999999 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.140000000000001 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.402 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.340000000000003 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.030000000000001 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.530000000000001 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.109999999999999 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.099999999999994 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 64.340000000000003 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.445 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.219999999999999 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.519999999999996 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.129999999999995 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 75.219999999999999 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.445 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.420000000000002 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.446 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 74.140000000000001 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.219999999999999 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 71.319999999999993 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.446 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 73.010000000000005 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.400000000000006 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.010000000000005 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.420000000000002 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 73.120000000000005 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.502 ' HG3' HG23 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.019999999999996 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 75.129999999999995 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 75.420000000000002 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.519999999999996 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.350000000000001 112.125 179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.230000000000004 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.641 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.340000000000003 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.412 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 74.420000000000002 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.408 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.040000000000006 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.499 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 73.450000000000003 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.532 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.239999999999995 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.230000000000004 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.299999999999997 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.099999999999994 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.319999999999993 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.200000000000003 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.209999999999994 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.532 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.299999999999997 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.239999999999995 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.824 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.411 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 72.340000000000003 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.510000000000005 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.411 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 73.349999999999994 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.450000000000003 113.254 -173.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 63.200000000000003 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.59 ' OE2' HG22 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.030000000000001 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.240000000000002 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.019999999999996 112.366 -178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.59 HG22 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.129999999999995 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 70.329999999999998 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 62.43 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.435 ' N ' HD21 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 71.420000000000002 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.329999999999998 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.545 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.439999999999998 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.545 HG23 ' HG3' ' A' ' 86' ' ' ARG . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.319999999999993 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 43.229999999999997 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.53 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 74.409999999999997 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.310000000000002 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.436 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 74.230000000000004 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.420000000000002 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 74.540000000000006 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 73.140000000000001 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' HB3' HD13 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.329999999999998 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.120000000000005 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.519999999999996 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.010000000000005 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 73.420000000000002 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 62.32 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.579 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 73.200000000000003 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.585 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.757 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.439999999999998 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.409999999999997 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.340000000000003 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.595 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 62.420000000000002 110.272 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.587 ' O ' HG23 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.562 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 74.329999999999998 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.010000000000005 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.219999999999999 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.562 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 73.439999999999998 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.572 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.019999999999996 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 75.219999999999999 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.572 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.319999999999993 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . 0.415 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.230000000000004 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.45 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.129999999999995 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 74.420000000000002 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.664 ' HB3' HD11 ' A' ' 155' ' ' LEU . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 73.530000000000001 111.296 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.129999999999995 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 155' ' ' LEU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.109999999999999 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.099999999999994 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.689 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.519999999999996 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.617 ' HB2' HD22 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.239999999999995 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.412 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.340000000000003 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.7 ' HB3' HG22 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.409999999999997 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.641 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.415 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.230000000000004 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.41 ' N ' HD22 ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.140000000000001 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.498 ' HB2' HD11 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.400000000000006 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.506 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.039999999999999 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.454 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 64.120000000000005 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.310000000000002 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.310000000000002 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.637 HG21 HD21 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.209999999999994 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.757 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.539999999999999 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.340000000000003 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.637 HD21 HG21 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.200000000000003 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.540000000000006 110.125 -177.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.109999999999999 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.437 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.109999999999999 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.7 HG22 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 73.299999999999997 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.46 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.420000000000002 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.632 HD11 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.349999999999994 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.689 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp -67.53 124.34 22.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.310000000000002 111.023 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.882 ' HB2' ' HB2' ' A' ' 127' ' ' LEU . 91.8 mt -68.88 161.52 28.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.061 -1.089 . . . . 75.010000000000005 108.061 168.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.561 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.1 t60 76.0 129.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -164.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.59 134.38 24.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.136 -0.484 . . . . 65.549999999999997 111.948 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 m -54.19 127.49 27.13 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.002 -0.999 . . . . 72.010000000000005 112.361 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.35 -43.54 56.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.601 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.67 ' HG3' ' HD2' ' A' ' 162' ' ' HIS . 10.0 tp10 -64.89 119.57 10.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.658 -0.701 . . . . 64.140000000000001 109.355 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -85.92 80.91 8.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 51.119999999999997 111.549 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.67 ' HD2' ' HG3' ' A' ' 160' ' ' GLU . 15.0 m-70 -114.95 114.9 26.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.59 . . . . 72.349999999999994 109.727 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -140.95 72.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.095 0.474 . . . . 73.310000000000002 111.629 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -110.52 128.03 55.45 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.907 -0.588 . . . . 72.219999999999999 109.526 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . 0.409 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 73.9 m80 -73.91 -76.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.426 -0.583 . . . . 73.239999999999995 109.426 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 165' ' ' HIS . 14.3 t-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.388 -0.815 . . . . 72.030000000000001 109.937 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.177 0.513 . . . . 74.129999999999995 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.36 179.73 5.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.81 -0.632 . . . . 74.140000000000001 109.424 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -109.01 106.1 15.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.464 0.649 . . . . 75.129999999999995 110.09 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.46 7.16 22.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.182 -0.917 . . . . 64.049999999999997 111.096 -174.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.0 p -134.17 74.21 1.53 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.348 0.594 . . . . 72.409999999999997 110.698 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.406 ' HG2' ' HA ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -100.29 109.08 21.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.67 -0.695 . . . . 72.219999999999999 110.11 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 63.89 -170.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.331 -0.85 . . . . 73.230000000000004 111.321 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 71.230000000000004 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.129999999999995 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.430000000000007 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.422 ' C ' HD22 ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.239999999999995 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.809 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.129999999999995 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.432 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.409999999999997 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 72.140000000000001 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.430000000000007 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.466 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.109999999999999 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.467 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.229999999999997 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.230000000000004 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.140000000000001 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.542 HD11 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.549999999999997 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.442 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.140000000000001 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.450000000000003 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.569 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.510000000000005 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.662 HG23 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.549999999999997 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.329999999999998 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 73.340000000000003 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.030000000000001 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.010000000000005 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.439999999999998 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.350000000000001 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 71.219999999999999 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.662 HD21 HG23 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.030000000000001 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.439999999999998 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.409999999999997 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 71.510000000000005 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.219999999999999 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.230000000000004 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.549999999999997 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.219999999999999 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 73.540000000000006 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.409999999999997 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.200000000000003 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 40.439999999999998 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.439999999999998 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.439999999999998 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.040000000000006 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.520000000000003 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.420000000000002 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.453 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.209999999999994 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.808 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.140000000000001 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.541 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.530000000000001 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.847 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 72.040000000000006 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 73.230000000000004 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.747 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 73.540000000000006 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 72.420000000000002 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.109999999999999 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.310000000000002 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.319999999999993 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 62.32 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 75.019999999999996 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.510000000000005 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.847 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.109999999999999 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.447 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.540000000000006 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 72.109999999999999 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.541 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.140000000000001 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.581 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 73.439999999999998 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.040000000000006 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 64.430000000000007 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.581 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.129999999999995 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.430000000000007 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.239999999999995 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 73.340000000000003 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.149999999999999 110.49 176.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 73.209999999999994 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 64.340000000000003 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 73.219999999999999 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.439999999999998 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.329999999999998 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.420000000000002 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.466 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 71.129999999999995 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.329999999999998 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.432 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.219999999999999 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.129999999999995 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 71.219999999999999 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 72.200000000000003 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.884 ' HB2' HG22 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 62.409999999999997 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.040000000000006 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.568 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.109999999999999 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.55 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.540000000000006 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.51 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.010000000000005 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 62.109999999999999 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.409999999999997 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.454 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.520000000000003 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.661 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 60.009999999999998 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.544 ' HA ' ' CD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.430000000000007 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.540000000000006 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.884 HG22 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.340000000000003 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.544 ' CD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 74.510000000000005 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.140000000000001 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.329999999999998 110.714 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.633 HD23 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.494 ' HE1' ' HA ' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 72.420000000000002 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 60.409999999999997 109.527 177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.540000000000006 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.611 HG21 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.430000000000007 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.140000000000001 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.049999999999997 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.200000000000003 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.520000000000003 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.611 ' HB2' HG21 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.329999999999998 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.239999999999995 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.563 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.420000000000002 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.87 ' HB2' HD21 ' A' ' 155' ' ' LEU . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.310000000000002 108.013 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.030000000000001 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.129999999999995 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.747 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.129999999999995 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.510000000000005 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.120000000000005 110.371 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 65.319999999999993 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.808 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.439999999999998 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.679 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.200000000000003 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.678 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.010000000000005 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.678 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.430000000000007 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 73.099999999999994 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.109999999999999 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.679 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.209999999999994 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 65.340000000000003 111.215 -174.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.329999999999998 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.51 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.219999999999999 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 75.109999999999999 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.55 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.209999999999994 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.568 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 75.109999999999999 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.821 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.239999999999995 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.209999999999994 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.646 ' HE3' ' HB2' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -64.06 135.06 56.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.119999999999997 111.286 -176.643 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.87 HD21 ' HB2' ' A' ' 128' ' ' SER . 4.3 mm? -74.4 100.13 3.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.787 -0.642 . . . . 72.319999999999993 109.442 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.742 ' HD1' ' HG3' ' A' ' 157' ' ' GLU . 14.3 p80 60.7 159.52 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.758 1.623 . . . . 72.109999999999999 113.52 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.742 ' HG3' ' HD1' ' A' ' 156' ' ' HIS . 41.3 mt-10 66.27 26.16 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.846 -1.07 . . . . 72.099999999999994 111.883 -176.395 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.2 p -81.89 117.33 22.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.411 -0.588 . . . . 71.519999999999996 109.411 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.11 91.58 1.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.291 -0.413 . . . . 73.439999999999998 111.851 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 179.28 122.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 72.420000000000002 109.975 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.28 21.08 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.496 . . . . 75.530000000000001 112.341 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -94.97 16.29 16.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.388 0.613 . . . . 74.010000000000005 110.099 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -63.13 134.37 55.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.165 -0.925 . . . . 74.450000000000003 110.433 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -92.86 170.34 9.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.027 -0.533 . . . . 75.209999999999994 110.685 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -115.56 -11.31 11.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.279 0.562 . . . . 73.099999999999994 109.852 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.4 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.149 -0.932 . . . . 74.510000000000005 108.792 174.08 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.473 0.178 . . . . 72.129999999999995 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.463 ' CG ' ' H ' ' A' ' 3' ' ' PHE . 4.4 p-10 -77.94 -85.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.454 -0.498 . . . . 71.200000000000003 111.289 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.463 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 86.8 t80 178.75 -41.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.833 0.349 . . . . 70.230000000000004 111.397 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.28 91.16 6.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.347 0.594 . . . . 70.239999999999995 112.353 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -127.07 84.34 2.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 73.400000000000006 109.197 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.26 100.87 12.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 111.001 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -97.64 139.46 33.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.974 -0.557 . . . . 75.409999999999997 109.986 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.230000000000004 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.230000000000004 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.510000000000005 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.454 HD22 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.510000000000005 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.010000000000005 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.129999999999995 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.479 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.399999999999999 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 92' ' ' THR . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.129999999999995 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 72.329999999999998 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.030000000000001 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 64.0 110.754 -178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.574 HD13 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.618 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 70.129999999999995 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.482 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.129999999999995 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.230000000000004 108.777 177.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.725 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.140000000000001 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.463 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.340000000000003 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.603 ' HB ' HD23 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.319999999999993 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.319999999999993 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 75.120000000000005 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 73.0 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.507 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.400000000000006 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 62.310000000000002 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.299999999999997 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.120000000000005 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.725 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.239999999999995 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.140000000000001 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.319999999999993 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.319999999999993 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 72.230000000000004 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.439999999999998 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.349999999999994 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.099999999999994 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.419 ' NE2' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.019999999999996 111.515 -173.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.150000000000006 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 75.530000000000001 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.419 ' HA3' ' NE2' ' A' ' 44' ' ' GLN . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.319999999999993 112.599 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.140000000000001 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.099999999999994 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.442 ' HG3' HD11 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.129999999999995 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.418 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.230000000000004 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.409999999999997 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.319999999999993 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.602 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.219999999999999 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.120000000000005 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.579 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.219999999999999 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.491 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.409999999999997 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 72.439999999999998 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.62 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.299999999999997 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.019999999999996 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.349999999999994 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 65.010000000000005 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.230000000000004 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 75.420000000000002 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.62 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 75.340000000000003 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 61' ' ' TYR . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.310000000000002 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.491 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 74.099999999999994 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.618 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.519999999999996 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 61.509999999999998 111.712 -176.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.593 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 71.120000000000005 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 74.230000000000004 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 71.209999999999994 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 54.32 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 62.420000000000002 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.406 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.229999999999997 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 63.100000000000001 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.439999999999998 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.030000000000001 109.986 178.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.210000000000001 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' HD13 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.420000000000002 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.439999999999998 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.340000000000003 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.319999999999993 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.439999999999998 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 74.329999999999998 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 75.109999999999999 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HB3' HD22 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 74.120000000000005 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.439999999999998 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.863 ' HB3' HD11 ' A' ' 155' ' ' LEU . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.030000000000001 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.129999999999995 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.482 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.409999999999997 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.310000000000002 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.966 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.530000000000001 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.040000000000006 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.439999999999998 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.310000000000002 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.619 ' HE1' HD12 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.299999999999997 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 55.020000000000003 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.319999999999993 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.619 HD12 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 72.340000000000003 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.120000000000005 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.519999999999996 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.437 ' CB ' ' HA ' ' A' ' 110' ' ' GLU . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.319999999999993 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.604 ' HA ' ' HE3' ' A' ' 117' ' ' MET . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.200000000000003 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.768 ' HB3' HD22 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.329999999999998 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.604 ' HE3' ' HA ' ' A' ' 114' ' ' ASP . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.040000000000006 111.037 -178.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.409999999999997 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 75.010000000000005 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.573 HG23 ' HB2' ' A' ' 155' ' ' LEU . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 111.165 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.200000000000003 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.519999999999996 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.010000000000005 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.329999999999998 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.855 ' HD2' HD13 ' A' ' 155' ' ' LEU . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.519999999999996 109.248 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.636 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 75.5 110.927 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.472 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 73.439999999999998 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.219999999999999 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.040000000000006 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.579 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.530000000000001 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 73.209999999999994 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.716 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 75.129999999999995 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.040000000000006 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.642 HD22 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.621 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.120000000000005 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.428 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 71.329999999999998 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.448 ' HA ' HD12 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.539999999999999 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.439999999999998 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.621 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 74.349999999999994 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.25 111.421 -175.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.402 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.402 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.019999999999996 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.349999999999994 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 71.409999999999997 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.966 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 75.439999999999998 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.716 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.299999999999997 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 73.319999999999993 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.099999999999994 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.768 HD22 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 73.230000000000004 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.472 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 50.0 ttp -75.66 89.71 2.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.510000000000005 109.35 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.863 HD11 ' HB3' ' A' ' 98' ' ' ALA . 2.1 pt? -79.67 45.82 0.72 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.113 0.958 . . . . 54.530000000000001 111.172 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.471 ' HB2' ' HG2' ' A' ' 154' ' ' MET . 7.5 t-80 -71.12 -64.81 0.84 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.377 -1.283 . . . . 74.109999999999999 108.37 176.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.52 ' OE2' ' HA ' ' A' ' 163' ' ' HIS . 54.0 mp0 -139.75 -41.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.194 -0.912 . . . . 75.140000000000001 109.261 168.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.3 p -163.82 -73.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 72.530000000000001 111.588 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.403 HD23 ' OH ' ' A' ' 113' ' ' TYR . 3.4 tm? -166.53 -37.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.272 -0.876 . . . . 74.230000000000004 108.683 -170.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.12 133.52 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.754 -0.657 . . . . 74.010000000000005 110.966 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.58 95.26 1.81 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.345 0.593 . . . . 70.109999999999999 110.116 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.5 -173.12 2.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.52 ' HA ' ' OE2' ' A' ' 157' ' ' GLU . 8.2 t-160 -143.88 106.18 4.4 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.61 -0.436 . . . . 72.340000000000003 110.387 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -122.46 46.74 2.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.392 0.615 . . . . 75.340000000000003 109.779 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -169.74 154.3 5.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.076 -1.083 . . . . 65.209999999999994 108.076 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.528 -0.749 . . . . 72.340000000000003 110.231 179.073 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.793 0.33 . . . . 74.040000000000006 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.15 105.43 15.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.581 -0.282 . . . . 75.109999999999999 110.699 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.02 96.33 2.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.967 0.413 . . . . 74.549999999999997 111.142 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 44.29 77.88 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.07 -0.968 . . . . 62.219999999999999 112.118 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -115.79 88.43 2.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.233 0.54 . . . . 72.219999999999999 110.584 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -97.92 98.08 9.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 74.040000000000006 110.549 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -128.63 105.39 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 72.540000000000006 109.578 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.540000000000006 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.427 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 62.0 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.519999999999996 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.219999999999999 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.439999999999998 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.608 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.349999999999994 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.520000000000003 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.329999999999998 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.409 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.43 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.239999999999995 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.019999999999996 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.856 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 74.420000000000002 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.340000000000003 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 1.046 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.200000000000003 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.340000000000003 108.048 165.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.403 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 71.239999999999995 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.129999999999995 109.878 172.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.420000000000002 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.209999999999994 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.129999999999995 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.441 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.349999999999994 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.349999999999994 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.539999999999999 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.441 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 73.540000000000006 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.436 HD11 ' O ' ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.120000000000005 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.400000000000006 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.420000000000002 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.149999999999999 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.504 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.130000000000003 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.483 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.510000000000005 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.504 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.129999999999995 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 71.439999999999998 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.129999999999995 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.219999999999999 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.310000000000002 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.040000000000006 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.030000000000001 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.661 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 73.140000000000001 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.661 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.049999999999997 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 63.210000000000001 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.140000000000001 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.758 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 71.140000000000001 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.109999999999999 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.921 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.329999999999998 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.430000000000007 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.539 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.140000000000001 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.952 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.239999999999995 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.674 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 75.420000000000002 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.5 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 73.040000000000006 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.549999999999997 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.340000000000003 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.568 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.409999999999997 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.674 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.230000000000004 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.447 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.019999999999996 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.686 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.219999999999999 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.483 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 1.046 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.010000000000005 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.921 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.349999999999994 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.856 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.409999999999997 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.5 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 61.32 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.577 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.099999999999994 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.5 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 70.140000000000001 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.519999999999996 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.572 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.209999999999994 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.519999999999996 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 75.109999999999999 111.115 -177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.150000000000006 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.572 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.299999999999997 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.429 HG21 HD13 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.25 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 60.149999999999999 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.200000000000003 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 74.519999999999996 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.230000000000004 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.409 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.119999999999997 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.409999999999997 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.349999999999994 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.785 ' H ' HD23 ' A' ' 155' ' ' LEU . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.340000000000003 110.269 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.51 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.430000000000007 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.427 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.200000000000003 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.430000000000007 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.598 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.230000000000004 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.099999999999994 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.420000000000002 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 64.120000000000005 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 42.329999999999998 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.411 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.119999999999997 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.436 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 74.439999999999998 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.230000000000004 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.439999999999998 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.040000000000006 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.738 ' CD2' HD12 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.030000000000001 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.119999999999997 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.240000000000002 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.813 HD22 HD13 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.200000000000003 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.719 ' HA ' ' HE2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.109999999999999 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.430000000000007 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.506 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.99 HG22 ' HB2' ' A' ' 155' ' ' LEU . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.230000000000004 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.219999999999999 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.439999999999998 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.310000000000002 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.493 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 75.420000000000002 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.649 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.230000000000004 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.109999999999999 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.649 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.229999999999997 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.239999999999995 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.952 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.530000000000001 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.652 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 75.219999999999999 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.407 ' HG2' HG22 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 75.519999999999996 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.521 ' O ' HG21 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.209999999999994 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 75.040000000000006 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.446 ' H ' HD13 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.329999999999998 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 71.420000000000002 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 63.329999999999998 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.530000000000001 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.319999999999993 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.230000000000004 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.120000000000005 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.597 ' HB3' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.519999999999996 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.109999999999999 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 73.329999999999998 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.597 ' HB2' ' HB3' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 72.310000000000002 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.129999999999995 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.598 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.299999999999997 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.521 HG21 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 71.049999999999997 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.140000000000001 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.652 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.109999999999999 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.813 HD13 HD22 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 70.129999999999995 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.434 ' HE2' ' HB2' ' A' ' 159' ' ' LEU . 69.7 mtp -62.84 104.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.230000000000004 111.315 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.99 ' HB2' HG22 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -98.77 45.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.652 0.739 . . . . 63.409999999999997 112.155 -176.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -135.85 -50.2 0.71 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.336 -0.847 . . . . 74.439999999999998 110.956 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -150.71 139.05 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.626 -0.509 . . . . 73.450000000000003 109.626 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 p -81.41 90.52 6.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.695 0.284 . . . . 73.209999999999994 110.958 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.434 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 10.6 mp -89.02 -6.66 57.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 72.299999999999997 110.405 176.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.92 99.14 7.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.006 -0.543 . . . . 52.350000000000001 109.902 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -117.61 108.32 15.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.989 -0.55 . . . . 72.140000000000001 110.14 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -142.04 -170.63 3.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.573 -0.739 . . . . 73.530000000000001 110.206 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -143.68 39.02 1.37 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.073 -1.084 . . . . 65.230000000000004 108.073 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -73.48 -4.5 34.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.064 -1.425 . . . . 74.019999999999996 110.584 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.39 164.74 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 74.209999999999994 110.439 172.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.811 -0.614 . . . . 52.049999999999997 109.383 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.111 -0.329 . . . . 72.150000000000006 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 t70 66.79 -162.85 0.23 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.783 0.677 . . . . 73.439999999999998 109.325 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -88.62 109.69 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.444 -0.206 . . . . 74.219999999999999 110.444 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 71.77 160.72 0.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.529 0.518 . . . . 70.420000000000002 111.278 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -73.73 114.52 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 64.010000000000005 109.968 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -110.88 93.31 4.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.137 -0.483 . . . . 63.210000000000001 111.196 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.62 92.85 9.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 72.219999999999999 109.943 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 74.519999999999996 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 74.030000000000001 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.430000000000007 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.599 HD12 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.310000000000002 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.796 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 65.209999999999994 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.299999999999997 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.582 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.409999999999997 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.150000000000006 109.781 178.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.472 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.230000000000004 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.649 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.520000000000003 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.109999999999999 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 75.310000000000002 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.487 HD11 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 73.349999999999994 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.735 HG23 HD23 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.420000000000002 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.467 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.039999999999999 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.219999999999999 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.310000000000002 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 52.119999999999997 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.209999999999994 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.129999999999995 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 71.230000000000004 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 73.120000000000005 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD23 HG23 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.400000000000006 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.530000000000001 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 72.030000000000001 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.485 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.420000000000002 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.519999999999996 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.409999999999997 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.010000000000005 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.605 ' HB ' HG22 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 70.430000000000007 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.617 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 73.340000000000003 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 73.329999999999998 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.617 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.149999999999999 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.439999999999998 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.439999999999998 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.543 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.450000000000003 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.450000000000003 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 110.609 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.420000000000002 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.439999999999998 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.219999999999999 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.507 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.129999999999995 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.439999999999998 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 74.349999999999994 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.109999999999999 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.695 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 74.219999999999999 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.229999999999997 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.020000000000003 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.581 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.239999999999995 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.209999999999994 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 71.310000000000002 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.109999999999999 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.230000000000004 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.581 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 64.310000000000002 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.539999999999999 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 64.299999999999997 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.545 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.409999999999997 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.510000000000005 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.150000000000006 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.508 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.340000000000003 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.649 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.439999999999998 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 73.530000000000001 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.540000000000006 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.439999999999998 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.340000000000003 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.210000000000001 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 63.240000000000002 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.150000000000006 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.782 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 74.349999999999994 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.487 ' O ' HD11 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.420000000000002 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.782 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.310000000000002 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.549999999999997 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 72.209999999999994 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 74.019999999999996 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.239999999999995 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.119999999999997 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.240000000000002 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.582 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.299999999999997 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.599 ' HB3' HD12 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.530000000000001 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.607 ' HB2' HD21 ' A' ' 155' ' ' LEU . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.530000000000001 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.575 HD23 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 75.040000000000006 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.140000000000001 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.586 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.239999999999995 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.219999999999999 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.200000000000003 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 71.439999999999998 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.299999999999997 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.606 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 71.439999999999998 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.525 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.606 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.450000000000003 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.525 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.329999999999998 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.519999999999996 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.219999999999999 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.420000000000002 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.140000000000001 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.310000000000002 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 70.150000000000006 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.109999999999999 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 74.299999999999997 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 74.409999999999997 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.409999999999997 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.230000000000004 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.556 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.450000000000003 110.319 176.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 109.873 174.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.795 ' HA ' ' HE3' ' A' ' 154' ' ' MET . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.549999999999997 110.226 -179.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.519999999999996 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.549999999999997 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.695 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.150000000000006 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.464 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.349999999999994 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.681 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.450000000000003 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.200000000000003 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 72.129999999999995 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.446 ' H ' ' CG ' ' A' ' 137' ' ' ASP . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 73.230000000000004 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 63.219999999999999 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.414 ' H ' ' C ' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 110.376 178.824 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 74.5 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.654 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.100000000000001 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.44 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.450000000000003 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.654 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.430000000000007 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.140000000000001 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.586 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.349999999999994 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.310000000000002 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.681 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.140000000000001 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 74.230000000000004 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 72.120000000000005 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.510000000000005 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.795 ' HE3' ' HA ' ' A' ' 128' ' ' SER . 57.0 mtp -61.18 140.69 57.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.540000000000006 110.335 174.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.607 HD21 ' HB2' ' A' ' 98' ' ' ALA . 94.6 mt -82.41 -1.36 49.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.145 -0.48 . . . . 72.430000000000007 110.965 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.556 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 37.7 t60 -83.39 70.71 10.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.208 -0.664 . . . . 74.040000000000006 109.208 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 72.49 149.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.174 0.921 . . . . 72.109999999999999 110.864 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 t -79.19 90.75 4.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.562 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.78 -176.47 6.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.061 -0.518 . . . . 75.010000000000005 110.102 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.429 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 5.9 mm-40 50.7 83.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.004 -0.998 . . . . 74.319999999999993 112.86 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -119.07 44.96 2.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.659 -1.155 . . . . 74.349999999999994 108.051 172.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -60.93 104.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.208 -1.36 . . . . 62.450000000000003 111.732 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -92.05 -178.58 5.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.623 -0.717 . . . . 71.010000000000005 109.682 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -139.88 156.97 46.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.004 -0.369 . . . . 72.0 110.004 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.32 163.82 13.27 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.379 -0.601 . . . . 63.299999999999997 109.379 175.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.38 -0.819 . . . . 73.310000000000002 110.123 177.699 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.5 mpt? . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.437 0.161 . . . . 75.0 111.334 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.32 -49.82 3.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.129 0.49 . . . . 64.129999999999995 110.151 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.57 159.54 26.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 74.349999999999994 110.512 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.97 139.49 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.122 -0.49 . . . . 64.340000000000003 110.704 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.17 -179.43 6.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.635 -0.711 . . . . 74.209999999999994 110.899 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.551 ' HA ' ' HB3' ' A' ' 115' ' ' ALA . 27.3 mt-30 55.73 69.92 0.69 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.896 -0.593 . . . . 75.209999999999994 111.094 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -81.36 133.95 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.63 -0.507 . . . . 74.540000000000006 109.63 177.467 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.099999999999994 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.109999999999999 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.797 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.239999999999995 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.520000000000003 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.299999999999997 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.849 HD13 ' HH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.420000000000002 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.540000000000006 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.340000000000003 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.418 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.230000000000004 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.530000000000001 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.239999999999995 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.45 HD12 ' N ' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 71.530000000000001 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.619 ' HB ' HG23 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 73.329999999999998 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.763 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 64.209999999999994 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.664 HG21 HG22 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.430000000000007 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.736 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.549999999999997 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.664 HG22 HG21 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 71.010000000000005 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.350000000000001 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.040000000000006 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.450000000000003 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.593 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.540000000000006 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG22 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.040000000000006 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.593 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 75.349999999999994 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.019999999999996 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.299999999999997 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.109999999999999 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.140000000000001 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.450000000000003 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.549999999999997 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.019999999999996 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.239999999999995 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.527 HD21 HD22 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.209999999999994 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 73.019999999999996 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 55.399999999999999 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.499 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.450000000000003 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.229999999999997 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.627 ' HG3' HG21 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.019999999999996 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.468 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 74.349999999999994 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.416 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.230000000000004 112.334 178.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.310000000000002 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.009999999999998 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.100000000000001 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.219999999999999 112.365 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.628 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.120000000000005 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.340000000000003 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.150000000000006 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.59 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 71.019999999999996 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.219999999999999 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.872 ' HE3' ' HA ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.310000000000002 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 71.239999999999995 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.030000000000001 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.340000000000003 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.520000000000003 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.736 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.049999999999997 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.450000000000003 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.763 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.420000000000002 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.632 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.239999999999995 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 74.310000000000002 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.404 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 73.099999999999994 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.416 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.140000000000001 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.584 HG13 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.099999999999994 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.589 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.349999999999994 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 35.850000000000001 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.099999999999994 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.627 HG21 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.109999999999999 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.219999999999999 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.230000000000004 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.310000000000002 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.040000000000006 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.576 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 54.219999999999999 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.619 HG23 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 60.420000000000002 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.439999999999998 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.340000000000003 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.209999999999994 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.439999999999998 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.661 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.535 ' HA ' HD23 ' A' ' 155' ' ' LEU . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 75.25 110.284 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.67 ' HB2' HD11 ' A' ' 155' ' ' LEU . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.340000000000003 109.695 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 61.109999999999999 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 74.310000000000002 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.711 HD13 HD12 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 74.109999999999999 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.841 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.150000000000006 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.711 HD12 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.310000000000002 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 74.310000000000002 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.530000000000001 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.841 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 74.540000000000006 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.319999999999993 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.150000000000006 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.572 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.420000000000002 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.140000000000001 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.299999999999997 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.601 HG23 HD22 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 74.129999999999995 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.340000000000003 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 71.120000000000005 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.551 ' HB3' ' HA ' ' A' ' 6' ' ' GLN . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 73.109999999999999 111.398 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.601 HD22 HG23 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.030000000000001 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.109999999999999 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.329999999999998 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.797 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.239999999999995 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.786 HG21 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 74.049999999999997 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.405 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.240000000000002 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.109999999999999 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 75.239999999999995 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.310000000000002 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.786 ' HB2' HG21 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.329999999999998 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.409999999999997 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.769 HD12 ' HA ' ' A' ' 159' ' ' LEU . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 75.150000000000006 112.69 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.515 ' HB2' HD21 ' A' ' 155' ' ' LEU . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.420000000000002 109.848 172.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.230000000000004 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.400000000000006 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.84 ' HB1' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 35.850000000000001 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.849 ' HH ' HD13 ' A' ' 14' ' ' LEU . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.340000000000003 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.676 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.628 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 70.430000000000007 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.676 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 70.340000000000003 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.708 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.450000000000003 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.48 ' HB2' HG23 ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.239999999999995 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.329999999999998 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 141' ' ' GLU . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 73.420000000000002 113.645 -178.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 62.310000000000002 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 139' ' ' PRO . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.409999999999997 111.307 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.48 HG23 ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.230000000000004 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.239999999999995 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.442 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.140000000000001 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.442 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.030000000000001 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.619 ' HB2' ' HB2' ' A' ' 143' ' ' ALA . 23.8 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 71.420000000000002 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.523 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 64.25 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 75.049999999999997 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.427 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.120000000000005 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 73.120000000000005 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.399999999999999 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.607 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.329999999999998 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.84 ' HG3' ' HB1' ' A' ' 131' ' ' ALA . 59.3 mtm -75.53 27.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.319999999999993 110.931 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.67 HD11 ' HB2' ' A' ' 98' ' ' ALA . 4.2 mm? 70.69 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.562 0.745 . . . . 52.25 111.736 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -61.05 -69.06 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.507 0.504 . . . . 72.439999999999998 111.993 -169.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.2 tt0 176.44 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.101 0.477 . . . . 62.43 109.832 178.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.3 m -132.68 69.24 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.149 -1.056 . . . . 74.450000000000003 108.149 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.769 ' HA ' HD12 ' A' ' 127' ' ' LEU . 10.1 mp 58.39 -99.83 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.032 -0.985 . . . . 74.310000000000002 109.327 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.26 23.99 2.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.861 0.839 . . . . 72.439999999999998 109.895 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 57.0 m-70 -85.88 48.3 1.58 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.586 -1.188 . . . . 73.209999999999994 109.404 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -75.24 51.66 0.55 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.42 -0.809 . . . . 70.430000000000007 112.72 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -155.98 85.78 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.643 -0.873 . . . . 74.129999999999995 108.643 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -154.68 160.79 41.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.604 -0.726 . . . . 75.530000000000001 109.815 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -78.14 137.77 38.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.128 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.338 -0.839 . . . . 63.149999999999999 109.465 176.063 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 110.768 -0.086 . . . . 72.120000000000005 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.425 ' C ' ' H ' ' A' ' 4' ' ' GLU . 8.0 m-20 60.99 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.316 0.647 . . . . 63.039999999999999 110.599 -175.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.5 t80 62.15 -7.31 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.551 0.74 . . . . 74.430000000000007 112.899 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 2' ' ' ASP . 0.0 OUTLIER -103.71 164.2 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 52.130000000000003 112.086 -175.045 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.2 m -102.01 -55.17 2.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.48 -0.933 . . . . 60.100000000000001 108.48 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -178.4 127.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.122 -0.945 . . . . 62.530000000000001 109.078 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -124.62 126.88 46.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.161 -0.311 . . . . 72.109999999999999 110.161 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.129999999999995 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.129999999999995 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.240000000000002 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.722 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 54.039999999999999 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.239999999999995 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.45 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.439999999999998 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.349999999999994 109.434 175.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.429 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.340000000000003 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.310000000000002 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.209999999999994 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.529 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.340000000000003 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.699 HD11 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.540000000000006 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.449 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 75.230000000000004 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.340000000000003 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.678 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 74.349999999999994 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.528 ' O ' HG21 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.119999999999997 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 70.319999999999993 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 72.400000000000006 111.673 -173.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 73.129999999999995 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.540000000000006 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.040000000000006 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.509999999999998 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 73.010000000000005 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 74.319999999999993 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 73.310000000000002 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.310000000000002 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.020000000000003 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.319999999999993 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.612 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.319999999999993 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 61.25 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.420000000000002 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 73.340000000000003 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.049999999999997 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.41 HD11 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.229999999999997 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.409999999999997 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 65.319999999999993 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.503 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 72.049999999999997 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.209999999999994 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 64.310000000000002 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.219999999999999 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 72.040000000000006 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.549999999999997 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.432 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.509999999999998 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.310000000000002 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.310000000000002 110.064 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.663 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.349999999999994 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.441 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.409999999999997 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.801 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 61.509999999999998 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.420000000000002 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.049999999999997 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.439999999999998 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.430000000000007 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.310000000000002 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 74.510000000000005 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.801 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.530000000000001 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.209999999999994 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.678 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 74.230000000000004 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.608 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 75.120000000000005 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.449 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.608 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.549999999999997 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.443 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.439999999999998 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.699 HG11 HD11 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.299999999999997 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.530000000000001 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.310000000000002 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.030000000000001 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.503 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.519999999999996 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.540000000000006 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.120000000000005 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.434 ' H ' HG11 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.150000000000006 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 38.609999999999999 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.477 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.140000000000001 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.434 HG11 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.540000000000006 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 72.120000000000005 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.431 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.310000000000002 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.529 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 75.340000000000003 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 71.340000000000003 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.099999999999994 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.450000000000003 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.420000000000002 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.722 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.329999999999998 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.673 ' HA ' HD22 ' A' ' 155' ' ' LEU . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.319999999999993 110.498 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.664 ' H ' HD21 ' A' ' 155' ' ' LEU . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 60.229999999999997 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.722 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.530000000000001 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.040000000000006 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.310000000000002 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 72.540000000000006 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.150000000000006 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.119999999999997 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.219999999999999 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 75.409999999999997 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.219999999999999 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.439999999999998 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.310000000000002 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 73.409999999999997 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.039999999999999 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.49 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.120000000000005 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.523 ' HA ' HD11 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.329999999999998 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.319999999999993 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.439999999999998 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.523 HD11 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.230000000000004 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.120000000000005 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.499 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.409999999999997 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.869 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.120000000000005 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.230000000000004 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.219999999999999 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.869 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.030000000000001 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.120000000000005 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 74.510000000000005 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD22 ' N ' ' A' ' 127' ' ' LEU . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.299999999999997 110.603 -177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.430000000000007 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.585 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.439999999999998 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.416 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.420000000000002 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.663 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.219999999999999 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.459 ' HB3' HG22 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 64.450000000000003 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.030000000000001 108.901 173.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 62.219999999999999 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.546 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.120000000000005 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.230000000000004 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.603 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.140000000000001 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.603 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.340000000000003 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.239999999999995 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.140000000000001 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.596 HG22 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 75.25 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.596 ' H ' HG22 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.230000000000004 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.405 ' C ' ' H ' ' A' ' 146' ' ' GLN . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.420000000000002 111.218 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 54.219999999999999 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 144' ' ' PRO . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 71.319999999999993 109.847 178.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.439999999999998 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.030000000000001 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.459 HG22 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.340000000000003 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.209999999999994 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.722 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 74.140000000000001 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt -99.2 140.43 33.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.209999999999994 111.416 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.673 HD22 ' HA ' ' A' ' 97' ' ' ALA . 2.7 mm? -114.04 148.29 37.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 72.049999999999997 109.975 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.6 t60 73.71 -50.49 0.69 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.353 0.871 . . . . 75.239999999999995 113.353 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -76.31 92.94 3.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.417 . . . . 72.200000000000003 110.102 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -68.89 104.92 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.73 -0.668 . . . . 71.150000000000006 111.669 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 98.7 mt -85.44 -3.8 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.788 0.804 . . . . 72.109999999999999 109.082 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -148.81 151.34 34.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.76 -1.2 . . . . 71.219999999999999 107.76 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.859 0.724 . . . . 71.420000000000002 112.656 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -120.6 136.64 54.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.774 -0.824 . . . . 71.340000000000003 108.774 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 23.6 m80 64.59 103.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.862 0.726 . . . . 63.539999999999999 109.788 -166.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -82.54 145.34 29.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.063 -0.517 . . . . 75.239999999999995 111.787 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 69.98 149.45 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.291 -0.868 . . . . 73.25 112.427 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.721 -0.672 . . . . 71.409999999999997 109.195 168.935 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.732 ' HB2' ' HB2' ' A' ' 145' ' ' ASP . 89.4 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.546 -0.539 . . . . 74.329999999999998 109.546 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -137.48 31.29 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.024 0.44 . . . . 75.230000000000004 110.902 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -74.85 97.12 3.23 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.867 -0.606 . . . . 73.329999999999998 110.891 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 64.64 174.45 0.2 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.095 -0.957 . . . . 70.329999999999998 112.242 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -148.2 90.91 1.86 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 64.510000000000005 108.842 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.485 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 63.4 tt0 -114.9 114.54 25.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.82 -0.627 . . . . 75.299999999999997 110.668 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.432 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 -121.51 104.25 9.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.454 -0.794 . . . . 74.230000000000004 109.457 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.140000000000001 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 71.299999999999997 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 61.420000000000002 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.43 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 63.039999999999999 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 54.240000000000002 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.209999999999994 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 75.439999999999998 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.040000000000006 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.469 HG21 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.409999999999997 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HD2' HG21 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.009999999999998 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.219999999999999 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.64 HD12 HG21 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.430000000000007 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.468 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 75.129999999999995 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.553 HD11 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.299999999999997 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.428 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.510000000000005 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.585 HG21 HG22 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.349999999999994 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.439999999999998 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.496 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 74.230000000000004 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 62.329999999999998 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.130000000000003 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.130000000000003 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 75.140000000000001 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.530000000000001 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 74.409999999999997 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 75.120000000000005 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.496 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 75.140000000000001 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 75.329999999999998 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.230000000000004 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.520000000000003 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.452 ' O ' HG21 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.509999999999998 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.310000000000002 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 74.0 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.408 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.230000000000004 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.452 HG21 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.420000000000002 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.43 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 64.340000000000003 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.340000000000003 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.209999999999994 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.530000000000001 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 72.150000000000006 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.130000000000003 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 72.219999999999999 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 63.219999999999999 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.340000000000003 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.92 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 60.130000000000003 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.510000000000005 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.574 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.140000000000001 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.445 ' HD1' HG23 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.240000000000002 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.661 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.519999999999996 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.771 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.019999999999996 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.404 ' CD2' HG13 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 71.430000000000007 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.78 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 74.209999999999994 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.099999999999994 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.120000000000005 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.409999999999997 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.140000000000001 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.229999999999997 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.432 ' HD1' HG12 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 75.0 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.499 ' OE2' ' HB3' ' A' ' 25' ' ' GLN . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.299999999999997 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 74.450000000000003 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.661 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.140000000000001 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.468 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.340000000000003 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.200000000000003 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.92 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.030000000000001 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 HG11 HD21 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.120000000000005 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.040000000000006 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.539999999999999 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.329999999999998 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 74.25 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 75.230000000000004 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.310000000000002 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.793 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.219999999999999 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.010000000000005 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 75.420000000000002 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.793 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 54.210000000000001 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 51.340000000000003 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.039999999999999 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.45 HD13 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.510000000000005 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 72.120000000000005 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 62.43 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.109999999999999 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 74.450000000000003 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.48 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.099999999999994 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.230000000000004 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.554 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.576 ' CD1' HG13 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.230000000000004 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.422 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.409999999999997 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.099999999999994 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.439999999999998 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.420000000000002 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 64.349999999999994 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.450000000000003 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.439999999999998 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.576 HG13 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 73.319999999999993 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 73.019999999999996 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.319999999999993 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.340000000000003 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.43 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.489 HG23 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 71.109999999999999 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.120000000000005 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.408 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.099999999999994 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 73.450000000000003 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.489 ' HB2' HG23 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 75.319999999999993 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.541 ' O ' ' HA ' ' A' ' 155' ' ' LEU . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 54.439999999999998 110.277 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.140000000000001 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 65.430000000000007 111.497 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.140000000000001 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.78 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.099999999999994 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.109999999999999 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.65 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 64.019999999999996 109.753 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.219999999999999 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.646 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.420000000000002 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.400000000000006 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.755 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.109999999999999 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.209999999999994 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.519999999999996 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.78 ' HB3' HD12 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.439999999999998 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.409999999999997 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.129999999999995 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.548 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 75.25 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.299999999999997 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.420000000000002 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.732 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.299999999999997 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.548 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.329999999999998 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.78 HD12 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.140000000000001 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.515 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.109999999999999 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.646 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.230000000000004 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 75.549999999999997 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.120000000000005 110.392 -178.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.65 ' HE2' ' HB2' ' A' ' 132' ' ' TYR . 25.7 mmt -78.17 112.75 15.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 110.293 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.618 HD23 ' H ' ' A' ' 155' ' ' LEU . 2.5 pt? -118.59 162.24 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.432 -0.803 . . . . 73.540000000000006 110.641 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.426 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 29.8 t-80 72.18 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.112 0.883 . . . . 73.340000000000003 111.83 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.56 -62.33 0.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.469 -0.787 . . . . 70.140000000000001 111.878 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.455 ' HA ' ' OG ' ' A' ' 128' ' ' SER . 55.4 m 69.62 144.16 0.05 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.479 0.657 . . . . 75.040000000000006 111.682 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 159' ' ' LEU . 2.4 pt? -138.24 157.61 45.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.821 -0.627 . . . . 72.150000000000006 109.388 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.59 124.53 31.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.366 0.603 . . . . 75.120000000000005 112.166 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 15.5 m80 -121.58 164.29 17.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.091 -1.078 . . . . 74.239999999999995 108.091 167.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 62.05 69.33 0.63 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.124 -0.695 . . . . 73.549999999999997 109.124 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 28.7 m170 64.98 -177.59 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.435 -0.802 . . . . 74.450000000000003 111.332 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.3 139.41 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.453 -0.794 . . . . 73.400000000000006 109.06 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.58 123.13 24.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.149 0.499 . . . . 74.329999999999998 111.54 -172.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.147 -0.93 . . . . 72.349999999999994 108.895 173.254 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.247 -0.279 . . . . 74.099999999999994 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -168.47 -171.84 1.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.496 -0.557 . . . . 72.299999999999997 109.496 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -137.29 63.15 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.561 -0.903 . . . . 75.140000000000001 108.561 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.45 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 13.7 pt-20 -103.92 -162.93 0.93 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.092 -0.958 . . . . 70.019999999999996 110.193 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' SG ' ' HG3' ' A' ' 4' ' ' GLU . 54.8 m 69.2 -175.33 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.461 0.476 . . . . 65.099999999999994 110.984 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.631 ' HG2' ' H ' ' A' ' 7' ' ' PHE . 47.3 tt0 -156.33 -178.08 7.06 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.308 -0.997 . . . . 72.040000000000006 108.308 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.631 ' H ' ' HG2' ' A' ' 6' ' ' GLN . 39.1 p90 -164.11 153.4 13.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.936 -0.394 . . . . 75.209999999999994 109.936 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 62.109999999999999 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.584 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.420000000000002 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.420000000000002 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.787 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.430000000000007 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.310000000000002 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.319999999999993 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.099999999999994 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 64.239999999999995 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.409999999999997 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 37.729999999999997 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD11 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.803 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.299999999999997 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.533 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 63.340000000000003 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 64.420000000000002 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.019999999999996 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 71.140000000000001 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.530000000000001 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.020000000000003 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 73.200000000000003 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.400000000000006 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.439999999999998 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.219999999999999 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 75.519999999999996 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.219999999999999 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.567 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.129999999999995 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 72.329999999999998 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.540000000000006 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.646 HD13 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.329999999999998 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.420000000000002 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 63.450000000000003 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.46 HD23 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.329999999999998 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.349999999999994 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.299999999999997 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.592 HE22 HG13 ' A' ' 81' ' ' VAL . 71.3 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.329999999999998 109.701 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.340000000000003 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.209999999999994 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 71.099999999999994 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.520000000000003 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.539999999999999 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.340000000000003 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.658 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 63.100000000000001 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.525 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.310000000000002 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.483 ' HB3' HG23 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 75.150000000000006 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.49 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.200000000000003 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.423 ' HD2' ' HE2' ' A' ' 69' ' ' PHE . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.915 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.329999999999998 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.329999999999998 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.508 ' HB2' HD13 ' A' ' 159' ' ' LEU . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.040000000000006 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.450000000000003 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.423 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 74.319999999999993 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.915 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.010000000000005 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 73.010000000000005 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.803 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.129999999999995 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 70.409999999999997 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.329999999999998 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.646 ' HE1' HD13 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.209999999999994 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.530000000000001 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.400000000000006 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.310000000000002 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.329999999999998 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.519999999999996 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.592 HG13 HE22 ' A' ' 49' ' ' GLN . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.439999999999998 108.473 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.450000000000003 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.140000000000001 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.430000000000007 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.420000000000002 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.530000000000001 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD11 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.219999999999999 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 71.329999999999998 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.129999999999995 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.299999999999997 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 53.049999999999997 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.230000000000004 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.319999999999993 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.405 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.030000000000001 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.450000000000003 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.030000000000001 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.530000000000001 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.684 ' HB2' HD11 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.420000000000002 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.522 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.584 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.129999999999995 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.549 HD11 ' O ' ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.329999999999998 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.310000000000002 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.340000000000003 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.429 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.239999999999995 111.367 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.040000000000006 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.240000000000002 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.230000000000004 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.439999999999998 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.319999999999993 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.010000000000005 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.510000000000005 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.618 ' HA ' HD13 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 71.219999999999999 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.310000000000002 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.684 HD11 ' HB2' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.420000000000002 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.420000000000002 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.787 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.319999999999993 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.559 HG22 ' HB2' ' A' ' 155' ' ' LEU . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.420000000000002 110.895 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 72.430000000000007 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.019999999999996 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.150000000000006 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.737 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.019999999999996 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.71 ' HB2' HD22 ' A' ' 155' ' ' LEU . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.219999999999999 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 37.729999999999997 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.714 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.430000000000007 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 62.43 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 73.450000000000003 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.599 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 74.329999999999998 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.556 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.200000000000003 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.525 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 75.120000000000005 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.658 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.299999999999997 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.704 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 74.340000000000003 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.539999999999999 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.049999999999997 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 71.120000000000005 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.010000000000005 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.704 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.510000000000005 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.319999999999993 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.349999999999994 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 70.239999999999995 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.140000000000001 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 71.450000000000003 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.329999999999998 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.403 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.120000000000005 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.556 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.200000000000003 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.599 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.420000000000002 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 74.430000000000007 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.618 HD13 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.319999999999993 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp -74.87 93.14 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 73.439999999999998 109.421 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.71 HD22 ' HB2' ' A' ' 127' ' ' LEU . 2.1 pt? -71.76 -8.83 56.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.176 0.435 . . . . 64.030000000000001 112.176 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.737 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 79.3 t60 -62.01 -52.75 62.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.805 0.336 . . . . 74.25 110.194 174.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -147.13 110.5 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.510000000000005 110.383 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.9 m -82.01 124.89 30.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.585 -0.524 . . . . 74.219999999999999 109.585 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.508 HD13 ' HB2' ' A' ' 64' ' ' MET . 80.1 mt -100.05 149.35 23.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.777 0.322 . . . . 73.030000000000001 110.398 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 64.28 89.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 73.420000000000002 111.213 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.62 92.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.329 -0.85 . . . . 55.299999999999997 109.522 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -79.79 -90.6 0.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.985 -0.552 . . . . 74.420000000000002 110.335 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -170.62 142.63 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 74.549999999999997 110.13 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -144.98 156.68 44.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 71.129999999999995 108.964 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -154.13 147.57 25.02 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.798 -0.361 . . . . 73.200000000000003 110.517 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.725 -0.655 . . . . 74.140000000000001 109.706 175.151 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' H3 ' ' CD ' ' A' ' 4' ' ' GLU . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.389 -0.226 . . . . 54.119999999999997 110.389 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.71 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.575 0.75 . . . . 72.239999999999995 112.559 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -76.03 80.64 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 74.109999999999999 111.023 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.421 ' CD ' ' H3 ' ' A' ' 1' ' ' MET . 39.3 mt-10 -146.4 180.0 7.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.928 . . . . 74.319999999999993 109.002 177.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.571 ' SG ' ' HA3' ' A' ' 104' ' ' GLY . 57.4 m 58.45 40.69 23.8 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.537 0.523 . . . . 64.549999999999997 111.433 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.71 85.17 1.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 75.099999999999994 110.518 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.487 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 -68.74 112.73 5.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.671 . . . . 72.439999999999998 111.063 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.450000000000003 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 72.400000000000006 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.239999999999995 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.535 HD23 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 62.5 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.402 ' HE3' ' HB3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.329999999999998 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.404 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.530000000000001 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.200000000000003 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 74.310000000000002 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.439999999999998 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 1.1 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.239999999999995 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.676 HD12 HD22 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.010000000000005 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.913 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.409999999999997 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.422 ' N ' HD13 ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.439999999999998 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.506 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.409999999999997 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.540000000000006 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.329999999999998 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.430000000000007 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.099999999999994 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 64.239999999999995 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.109999999999999 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.030000000000001 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.447 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.549999999999997 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.019999999999996 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.230000000000004 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 71.340000000000003 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.510000000000005 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.299999999999997 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.439999999999998 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.540000000000006 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.350000000000001 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.319999999999993 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.119999999999997 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.676 HD22 HD12 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.329999999999998 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 73.209999999999994 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.329999999999998 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 62.109999999999999 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.476 HE22 ' HG ' ' A' ' 45' ' ' LEU . 2.0 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.219999999999999 110.086 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.340000000000003 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.439999999999998 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.340000000000003 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.319999999999993 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.540000000000006 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.439999999999998 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.030000000000001 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.329999999999998 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.491 ' CE1' HG22 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.150000000000006 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.349999999999994 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.614 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.724 ' HD1' HG13 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 73.299999999999997 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 73.230000000000004 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.129999999999995 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.030000000000001 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 75.329999999999998 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 75.120000000000005 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.430000000000007 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.4 ' O ' ' HE1' ' A' ' 161' ' ' HIS . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.530000000000001 109.363 -174.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.409999999999997 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.747 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 71.450000000000003 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.724 HG13 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.400000000000006 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.913 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.109999999999999 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.57 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 75.430000000000007 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.855 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.402 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.200000000000003 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 1.1 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.530000000000001 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 75.450000000000003 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.450000000000003 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 61.109999999999999 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.452 HG12 HE21 ' A' ' 49' ' ' GLN . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.219999999999999 109.923 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.464 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.539999999999999 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.099999999999994 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 54.409999999999997 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 70.409999999999997 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 74.019999999999996 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.783 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 71.430000000000007 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.423 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.319999999999993 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.319999999999993 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.210000000000001 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.240000000000002 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.485 ' HB3' ' HE3' ' A' ' 154' ' ' MET . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.299999999999997 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.200000000000003 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.535 ' HD3' HD23 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.420000000000002 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.140000000000001 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.349999999999994 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 74.209999999999994 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.84 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.040000000000006 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.54 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 75.200000000000003 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.200000000000003 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.572 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.230000000000004 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 74.040000000000006 111.821 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.129999999999995 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.420000000000002 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.129999999999995 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.340000000000003 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.239999999999995 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.219999999999999 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.498 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 73.439999999999998 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.109999999999999 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.530000000000001 110.83 176.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.409999999999997 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.732 HD11 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 110.777 -177.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.530000000000001 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.439999999999998 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.5 HG21 HD12 ' A' ' 155' ' ' LEU . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.206 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.039999999999999 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.150000000000006 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.209999999999994 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.140000000000001 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.239999999999995 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 75.150000000000006 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 157' ' ' GLU . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 71.439999999999998 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 38.07 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.615 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.539999999999999 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.340000000000003 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.487 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.349999999999994 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.310000000000002 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.491 HG22 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.120000000000005 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 74.319999999999993 111.074 -179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.433 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.409999999999997 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.433 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.409999999999997 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.488 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.030000000000001 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.524 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.409999999999997 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 75.530000000000001 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.524 ' H ' ' C ' ' A' ' 139' ' ' PRO . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 74.049999999999997 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.140000000000001 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 73.409999999999997 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.419 ' C ' ' H ' ' A' ' 146' ' ' GLN . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.409999999999997 111.472 168.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.64 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.329999999999998 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.419 ' H ' ' C ' ' A' ' 144' ' ' PRO . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 75.219999999999999 108.716 170.07 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.563 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 74.129999999999995 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.489 ' HB3' HG23 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.129999999999995 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.54 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.450000000000003 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.84 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.010000000000005 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.732 HD21 HD11 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.210000000000001 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.586 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -53.04 -50.84 63.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.530000000000001 110.355 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.5 HD12 HG21 ' A' ' 120' ' ' VAL . 16.8 tp 72.25 -53.46 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.184 0.809 . . . . 71.140000000000001 113.184 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 40.0 t-80 -44.74 -58.81 2.84 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.575 0.954 . . . . 72.340000000000003 113.575 -170.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 128' ' ' SER . 40.6 tt0 -163.15 158.65 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.916 -0.314 . . . . 65.450000000000003 110.214 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 m -71.59 87.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.912 0.387 . . . . 73.340000000000003 111.095 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -98.76 108.67 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.318 -0.623 . . . . 74.510000000000005 109.318 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.94 148.29 31.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.927 -0.579 . . . . 75.109999999999999 109.906 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.4 ' HE1' ' O ' ' A' ' 68' ' ' THR . 4.7 p80 -119.47 93.78 4.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.432 0.634 . . . . 73.140000000000001 109.843 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -131.34 156.08 46.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.858 -0.61 . . . . 73.439999999999998 111.578 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -148.99 -53.39 0.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 74.120000000000005 109.458 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.02 -176.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.476 -0.784 . . . . 73.120000000000005 110.208 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -121.5 152.91 38.62 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.012 -0.366 . . . . 72.040000000000006 110.012 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 C--O 1.244 0.784 0 CA-C-O 118.472 -0.775 . . . . 74.319999999999993 110.072 -177.514 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.202 0.525 . . . . 73.510000000000005 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -124.95 -52.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.939 -0.573 . . . . 73.230000000000004 110.156 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.35 -176.94 0.18 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.361 -0.836 . . . . 74.530000000000001 110.841 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -148.99 141.96 24.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 74.430000000000007 110.31 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.574 ' HA ' ' HB ' ' A' ' 103' ' ' ILE . 55.9 m -76.2 138.2 40.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 73.109999999999999 111.576 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -97.64 66.5 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.791 0.805 . . . . 73.109999999999999 109.84 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -77.75 89.57 4.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.273 -0.876 . . . . 75.140000000000001 111.244 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 HG13 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.209999999999994 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.546 ' HG3' HG13 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.310000000000002 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.578 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 71.519999999999996 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.109999999999999 109.6 176.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 73.200000000000003 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 64.430000000000007 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 63.109999999999999 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.59 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.240000000000002 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.040000000000006 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.039999999999999 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.340000000000003 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.452 ' HB2' HG12 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.319999999999993 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.099999999999994 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.469 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 73.109999999999999 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.451 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.140000000000001 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 73.25 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 62.530000000000001 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.446 HG23 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 63.140000000000001 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 75.530000000000001 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.450000000000003 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' HB3' HG23 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.130000000000003 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.420000000000002 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.530000000000001 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.329999999999998 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.019999999999996 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.450000000000003 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.310000000000002 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 73.120000000000005 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.405 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 73.439999999999998 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.563 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.400000000000006 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.150000000000006 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.502 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.230000000000004 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 64.310000000000002 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.239999999999995 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.553 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.531 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.340000000000003 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.340000000000003 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.530000000000001 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 64.019999999999996 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.099999999999994 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 71.019999999999996 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 72.439999999999998 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.430000000000007 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 50.119999999999997 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.42 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.329999999999998 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.209999999999994 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 73.310000000000002 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.568 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.230000000000004 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.040000000000006 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.200000000000003 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.443 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 74.340000000000003 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.409999999999997 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.464 ' SD ' ' HE1' ' A' ' 154' ' ' MET . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.319999999999993 109.884 176.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.530000000000001 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 73.239999999999995 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.350000000000001 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.230000000000004 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.140000000000001 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.040000000000006 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.409999999999997 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.454 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.200000000000003 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.310000000000002 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 75.439999999999998 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.099999999999994 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.452 HG12 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.310000000000002 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.420000000000002 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 74.230000000000004 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 70.120000000000005 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.099999999999994 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.040000000000006 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.319999999999993 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.240000000000002 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 71.209999999999994 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.469 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.439999999999998 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.530000000000001 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 70.140000000000001 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.524 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.340000000000003 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.219999999999999 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 75.030000000000001 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.140000000000001 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 41.25 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.441 ' HG2' HD13 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.219999999999999 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.200000000000003 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.400000000000006 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 72.420000000000002 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.653 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 73.519999999999996 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.120000000000005 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.574 ' HB ' ' HA ' ' A' ' 5' ' ' CYS . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.209999999999994 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.450000000000003 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.299999999999997 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.430000000000007 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.399999999999999 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.420000000000002 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 73.5 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.140000000000001 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.140000000000001 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.200000000000003 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.519999999999996 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.556 ' HE1' ' HG3' ' A' ' 160' ' ' GLU . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.109999999999999 111.575 -174.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.239999999999995 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.578 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.319999999999993 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.445 HG22 ' HB3' ' A' ' 155' ' ' LEU . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 71.430000000000007 110.07 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.209999999999994 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.450000000000003 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 70.310000000000002 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.319999999999993 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.6 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.420000000000002 112.007 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.749 HD12 HD12 ' A' ' 155' ' ' LEU . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 75.129999999999995 110.191 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.150000000000006 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.209999999999994 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.230000000000004 109.969 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.530000000000001 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.568 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.109999999999999 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.585 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.400000000000006 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.219999999999999 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.673 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.319999999999993 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 74.329999999999998 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.340000000000003 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.230000000000004 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.349999999999994 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 139' ' ' PRO . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.420000000000002 110.677 178.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.465 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 60.219999999999999 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 74.420000000000002 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 146' ' ' GLN . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.039 171.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.489 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.140000000000001 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 144' ' ' PRO . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.409999999999997 110.396 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.465 ' HB3' ' CG2' ' A' ' 142' ' ' THR . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.319999999999993 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.673 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.120000000000005 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.653 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.019999999999996 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.585 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 72.209999999999994 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 73.409999999999997 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 74.439999999999998 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.464 ' HE1' ' SD ' ' A' ' 64' ' ' MET . 51.7 mtm -63.57 154.71 31.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.219999999999999 110.89 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.749 HD12 HD12 ' A' ' 127' ' ' LEU . 98.3 mt -88.81 24.31 2.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.781 -0.822 . . . . 63.240000000000002 108.781 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -114.47 131.22 56.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.88 -1.055 . . . . 65.310000000000002 110.751 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.404 ' C ' ' HG ' ' A' ' 158' ' ' SER . 8.1 pt-20 -53.74 115.05 1.78 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.806 . . . . 64.329999999999998 110.764 175.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.404 ' HG ' ' C ' ' A' ' 157' ' ' GLU . 49.2 m -157.97 -77.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.168 0.803 . . . . 51.329999999999998 113.168 -177.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.2 114.04 22.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.592 0.96 . . . . 64.329999999999998 113.592 -162.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.556 ' HG3' ' HE1' ' A' ' 117' ' ' MET . 27.0 mt-10 -119.77 153.83 35.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 71.239999999999995 109.567 167.405 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -118.45 -95.4 0.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.214 -0.291 . . . . 74.340000000000003 110.214 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -149.29 50.32 0.96 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.022 0.439 . . . . 65.120000000000005 109.857 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -124.0 95.11 4.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.855 -0.612 . . . . 61.229999999999997 109.629 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -75.75 111.5 11.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.409 -0.814 . . . . 72.230000000000004 111.23 -172.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -169.3 172.46 7.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.729 . . . . 73.319999999999993 109.692 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.751 -0.642 . . . . 64.209999999999994 109.478 173.627 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.261 0.553 . . . . 64.409999999999997 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 168.28 27.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.732 -0.667 . . . . 73.230000000000004 110.138 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -150.74 159.94 44.19 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.092 -0.707 . . . . 74.129999999999995 109.092 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -60.66 99.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.192 0.52 . . . . 64.209999999999994 110.234 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.31 120.44 42.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.721 -0.672 . . . . 74.349999999999994 110.62 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -102.45 112.03 24.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 72.420000000000002 109.98 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -80.34 110.83 16.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.038 -0.983 . . . . 74.25 111.167 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 72.439999999999998 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.140000000000001 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.432 HD13 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.510000000000005 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.340000000000003 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.120000000000005 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.481 HD21 ' HB2' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 72.430000000000007 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.039999999999999 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.772 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.400000000000006 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.047 -177.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.446 ' O ' HG23 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.430000000000007 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.681 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.310000000000002 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD12 HG11 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.530000000000001 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.751 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.530000000000001 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.240000000000002 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.239999999999995 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.340000000000003 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.486 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.109999999999999 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 75.5 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.439999999999998 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.540000000000006 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.340000000000003 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' HD21 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.219999999999999 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 74.450000000000003 111.205 179.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.530000000000001 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.109999999999999 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.498 HD21 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.019999999999996 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.530000000000001 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 70.140000000000001 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 60.009999999999998 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.444 ' HA ' HG21 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 74.150000000000006 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.430000000000007 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.200000000000003 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.676 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 73.349999999999994 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.82 HD22 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 73.400000000000006 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.816 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.319999999999993 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.522 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.319999999999993 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.399999999999999 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 62.0 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.099999999999994 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.816 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.439999999999998 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.531 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.049999999999997 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 65.439999999999998 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.120000000000005 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 64.450000000000003 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.530000000000001 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.89 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 109.831 179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 71.340000000000003 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.561 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.140000000000001 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.641 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.956 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.450000000000003 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 54.229999999999997 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.450000000000003 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.310000000000002 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.299999999999997 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.129999999999995 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.486 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.409999999999997 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.641 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.209999999999994 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.956 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 75.349999999999994 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 61.130000000000003 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.74 ' HB3' HD21 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 72.310000000000002 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.751 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 74.200000000000003 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.89 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 75.430000000000007 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.681 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.540000000000006 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.703 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.531 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 75.140000000000001 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.409999999999997 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.329999999999998 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.703 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.030000000000001 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.099999999999994 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.82 ' HA2' HD22 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 73.5 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.399999999999999 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 73.010000000000005 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.676 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.039999999999999 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.299999999999997 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.463 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 74.319999999999993 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.049999999999997 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.010000000000005 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.401 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.219999999999999 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.772 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.450000000000003 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 70.010000000000005 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.526 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.030000000000001 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.481 ' HB2' HD21 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.109999999999999 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.703 ' HB2' HD22 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.419 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.400000000000006 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.109999999999999 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 75.400000000000006 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.502 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.743 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 74.230000000000004 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.340000000000003 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.430000000000007 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.319999999999993 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.209999999999994 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.329999999999998 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.509999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.530000000000001 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.530000000000001 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.819 HD11 HD21 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.040000000000006 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.129999999999995 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.120000000000005 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.150000000000006 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.673 HG22 HD12 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.140000000000001 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.400000000000006 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 71.109999999999999 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.209999999999994 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.310000000000002 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.418 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 73.040000000000006 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD13 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.230000000000004 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.010000000000005 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 38.109999999999999 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.633 ' HB3' HD13 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.409999999999997 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.400000000000006 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.140000000000001 109.779 174.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.412 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.472 ' H ' HD13 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 74.439999999999998 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 64.0 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.543 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.349999999999994 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.582 ' HB3' HG23 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.039999999999999 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.010000000000005 110.297 -174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' C ' ' H ' ' A' ' 141' ' ' GLU . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.140000000000001 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.010000000000005 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.140000000000001 110.501 178.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.582 HG23 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 75.310000000000002 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.049999999999997 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.743 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 71.230000000000004 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.502 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.209999999999994 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.412 HD11 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 72.099999999999994 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.543 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.420000000000002 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.340000000000003 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.439999999999998 110.546 178.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.412 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 74.430000000000007 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 73.219999999999999 109.904 -179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.819 HD21 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.109999999999999 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.77 95.01 7.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 111.363 -174.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.44 -18.26 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 73.329999999999998 110.492 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -81.84 108.08 15.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.827 -0.805 . . . . 63.210000000000001 108.827 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.81 111.8 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.112 0.482 . . . . 72.430000000000007 111.502 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m 72.08 149.59 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.802 -1.09 . . . . 74.530000000000001 111.89 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 pp -96.6 -10.6 26.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.838 -0.619 . . . . 74.230000000000004 110.687 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.21 140.4 57.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 72.219999999999999 109.922 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -65.23 -51.95 57.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.443 -0.577 . . . . 73.109999999999999 109.443 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -90.36 75.38 6.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.083 -0.71 . . . . 72.319999999999993 109.083 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -78.89 98.06 6.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.251 0.548 . . . . 75.340000000000003 110.872 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.1 m80 68.29 167.51 0.26 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.874 -1.057 . . . . 73.129999999999995 111.241 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -126.56 -49.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 75.129999999999995 109.741 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 80.4 t60 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.649 -0.691 . . . . 73.420000000000002 109.5 178.407 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.306 -0.628 . . . . 71.209999999999994 109.306 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.77 -62.32 1.37 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.62 -0.718 . . . . 72.420000000000002 110.685 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.435 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 74.4 m-85 -66.69 -24.13 66.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 75.129999999999995 111.048 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.512 ' HB2' HE21 ' A' ' 6' ' ' GLN . 29.9 mm-40 68.3 177.31 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.958 0.786 . . . . 65.019999999999996 110.587 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.38 79.65 9.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 110.428 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.512 HE21 ' HB2' ' A' ' 4' ' ' GLU . 61.4 mm-40 -91.94 -0.22 57.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 109.783 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -85.38 129.59 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 72.209999999999994 110.422 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 72.140000000000001 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.53 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.329999999999998 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 64.400000000000006 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.647 HD11 HD22 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 55.549999999999997 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.454 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.400000000000006 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.202 178.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.329999999999998 112.093 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 63.310000000000002 109.646 179.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.030000000000001 112.138 175.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.510000000000005 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.443 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.530000000000001 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.129999999999995 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.441 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.329999999999998 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.441 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 75.340000000000003 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.573 ' O ' HG23 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.319999999999993 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.8 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.400000000000006 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.476 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.540000000000006 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.040000000000006 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.129999999999995 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.329999999999998 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.420000000000002 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.571 HD22 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 63.210000000000001 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 74.209999999999994 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.310000000000002 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.420000000000002 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.429 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.129999999999995 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 73.450000000000003 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.449 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.039999999999999 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.457 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.230000000000004 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.030000000000001 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.049999999999997 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.340000000000003 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.129999999999995 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.712 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.400000000000006 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.150000000000006 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.549999999999997 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.329999999999998 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.310000000000002 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.219999999999999 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 70.310000000000002 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.409999999999997 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.492 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 73.239999999999995 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.310000000000002 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 112.23 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.546 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.130000000000003 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 74.219999999999999 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.329999999999998 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.545 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.019999999999996 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.771 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.427 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 73.439999999999998 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.484 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.420000000000002 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.602 ' HE1' ' SD ' ' A' ' 154' ' ' MET . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.120000000000005 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.340000000000003 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.430000000000007 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.64 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.530000000000001 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.571 ' HE1' HD22 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.239999999999995 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.8 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.771 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.409999999999997 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.549 ' HB2' ' HB2' ' A' ' 21' ' ' LEU . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 54.539999999999999 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 73.400000000000006 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.409999999999997 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.530000000000001 109.45 176.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.492 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.129999999999995 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 72.299999999999997 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.140000000000001 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.420000000000002 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.099999999999994 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 75.519999999999996 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.510000000000005 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.712 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.210000000000001 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.428 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.439999999999998 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.558 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.319999999999993 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.239999999999995 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 37.539999999999999 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 75.400000000000006 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 73.310000000000002 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.129999999999995 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 71.5 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.329999999999998 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.454 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.299999999999997 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 74.319999999999993 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.453 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.020000000000003 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.443 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 74.400000000000006 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.423 ' HB2' HG21 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.049999999999997 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.735 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.209999999999994 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.349999999999994 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 74.230000000000004 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.140000000000001 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.409999999999997 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.030000000000001 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.413 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.784 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.340000000000003 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.439999999999998 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 74.420000000000002 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.784 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.340000000000003 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 71.439999999999998 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HG ' HD22 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.230000000000004 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.446 ' O ' HG13 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.129999999999995 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.430000000000007 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.553 ' O ' ' HE3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.109999999999999 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.446 HG13 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.310000000000002 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.150000000000006 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 75.319999999999993 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.647 HD22 HD11 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.310000000000002 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.049999999999997 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.516 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 71.230000000000004 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.481 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.319999999999993 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.481 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.129999999999995 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 37.539999999999999 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.030000000000001 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.593 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.239999999999995 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.450000000000003 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.794 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.400000000000006 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.625 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.557 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.140000000000001 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.546 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 75.540000000000006 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.514 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.399999999999999 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.514 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.230000000000004 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.349999999999994 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.426 ' C ' ' H ' ' A' ' 141' ' ' GLU . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.001 -178.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.409999999999997 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 139' ' ' PRO . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 72.310000000000002 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 73.219999999999999 112.971 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 61.32 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.140000000000001 109.675 174.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.340000000000003 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.735 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 73.209999999999994 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.625 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.319999999999993 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.794 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 72.400000000000006 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.762 HD22 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 75.219999999999999 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.602 ' SD ' ' HE1' ' A' ' 64' ' ' MET . 2.8 mpp? -86.76 123.67 32.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 110.448 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.404 ' O ' ' HB3' ' A' ' 156' ' ' HIS . 3.6 mm? -64.89 117.04 6.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.127 -0.694 . . . . 63.310000000000002 109.127 173.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 51.1 t-80 76.79 136.89 0.06 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.195 0.934 . . . . 75.109999999999999 110.943 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 75.07 -80.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.234 -0.893 . . . . 71.329999999999998 110.872 -178.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.502 ' HA ' ' HE2' ' A' ' 154' ' ' MET . 20.4 t 57.37 54.58 6.5 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.593 0.558 . . . . 75.209999999999994 110.663 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.498 ' CD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 mm? 56.02 -95.66 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.249 0.619 . . . . 73.209999999999994 111.872 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.46 97.4 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.038 -0.528 . . . . 52.140000000000001 110.484 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 5.1 p80 -80.42 88.75 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.159 -1.052 . . . . 74.140000000000001 108.159 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -62.7 135.12 57.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.673 -1.149 . . . . 64.040000000000006 111.894 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -110.53 112.1 23.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 71.230000000000004 109.627 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -119.31 97.48 5.68 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.425 -0.583 . . . . 73.310000000000002 109.425 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -105.31 126.93 52.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.109 -0.496 . . . . 71.340000000000003 111.316 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.542 -0.742 . . . . 73.349999999999994 109.39 174.807 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.575 ' HA ' ' OD2' ' A' ' 145' ' ' ASP . 23.7 ptp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.909 -0.404 . . . . 70.549999999999997 109.909 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -173.44 -59.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 64.439999999999998 110.781 174.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.535 ' CE2' ' HB2' ' A' ' 5' ' ' CYS . 32.5 p90 -151.95 162.56 40.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.774 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -101.79 104.59 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 73.340000000000003 110.245 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.535 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 11.9 t -96.58 108.34 20.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.617 -0.882 . . . . 73.310000000000002 108.617 174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.69 84.54 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 64.030000000000001 111.785 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 42.82 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.517 1.136 . . . . 72.150000000000006 113.64 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.209999999999994 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.099999999999994 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.140000000000001 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.501 ' O ' HD11 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 75.109999999999999 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.140000000000001 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.438 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 64.430000000000007 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.617 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.340000000000003 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.329999999999998 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.319999999999993 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.329999999999998 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.447 ' HA ' HD22 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.329999999999998 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.746 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.219999999999999 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.691 HD21 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.754 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.120000000000005 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.501 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.515 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 61.130000000000003 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.776 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 41.9 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.530000000000001 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.401 HG22 HG13 ' A' ' 71' ' ' VAL . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.319999999999993 111.086 -176.909 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.239999999999995 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.529 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.77 HD11 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 52.399999999999999 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.486 ' N ' HD23 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.420000000000002 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.099999999999994 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.310000000000002 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.129999999999995 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.510000000000005 111.21 -179.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 72.540000000000006 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.329999999999998 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 73.530000000000001 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.340000000000003 110.993 -175.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 74.5 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 71.040000000000006 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.230000000000004 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD23 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.109999999999999 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 63.130000000000003 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.230000000000004 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.530000000000001 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.140000000000001 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 72.549999999999997 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.519999999999996 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.409999999999997 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.040000000000006 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 75.540000000000006 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.140000000000001 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.439999999999998 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 51.219999999999999 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.677 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.687 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.400000000000006 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.976 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.310000000000002 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.530000000000001 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.71 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 71.430000000000007 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.409999999999997 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.477 ' HE1' ' HH ' ' A' ' 113' ' ' TYR . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.409999999999997 110.035 178.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.549999999999997 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.329999999999998 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.210000000000001 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 74.439999999999998 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.430000000000007 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.776 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 71.349999999999994 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.643 HG12 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.622 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.099999999999994 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.687 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.030000000000001 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.691 ' HA3' HD21 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.439999999999998 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.559 ' CZ ' HD12 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.450000000000003 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.677 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.120000000000005 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.340000000000003 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.340000000000003 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.420000000000002 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 62.340000000000003 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 53.539999999999999 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.557 ' HB3' HD23 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.140000000000001 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.010000000000005 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.754 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 74.439999999999998 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.746 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 72.540000000000006 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.400000000000006 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.447 HD22 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.400000000000006 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.129999999999995 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.349999999999994 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 64.230000000000004 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.129999999999995 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 73.120000000000005 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.444 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 73.329999999999998 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.400000000000006 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 74.209999999999994 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.420000000000002 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.739 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.109999999999999 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.439999999999998 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.209999999999994 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.540000000000006 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.229999999999997 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.310000000000002 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.239999999999995 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 73.150000000000006 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.129999999999995 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.468 HG12 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.420000000000002 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.477 ' HH ' ' HE1' ' A' ' 64' ' ' MET . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 72.310000000000002 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.140000000000001 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.210000000000001 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.430000000000007 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.439999999999998 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.140000000000001 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.129999999999995 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.350000000000001 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.420000000000002 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.040000000000006 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.529 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.409999999999997 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.099999999999994 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.71 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.430000000000007 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.520000000000003 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.976 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 74.019999999999996 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.782 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.299999999999997 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.608 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.349999999999994 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 73.030000000000001 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.319999999999993 112.375 169.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.200000000000003 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.340000000000003 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.120000000000005 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.229999999999997 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.109999999999999 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.530000000000001 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.400000000000006 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.150000000000006 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.575 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 71.099999999999994 109.524 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 61.210000000000001 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.739 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.530000000000001 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.647 HG23 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.519999999999996 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.617 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.329999999999998 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.782 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.439999999999998 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.409999999999997 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.529 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 73.0 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.894 ' HE2' ' HA ' ' A' ' 154' ' ' MET . 11.6 mmt -58.03 125.37 22.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.420000000000002 111.093 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.516 HD11 ' N ' ' A' ' 156' ' ' HIS . 1.0 OUTLIER -141.43 143.05 33.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.487 -0.931 . . . . 73.140000000000001 108.487 -176.302 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.516 ' N ' HD11 ' A' ' 155' ' ' LEU . 7.7 t60 71.22 114.7 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.527 0.517 . . . . 73.019999999999996 110.162 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 69.59 84.92 0.14 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.762 -0.654 . . . . 75.439999999999998 110.157 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.3 t -68.99 133.47 48.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.451 -0.795 . . . . 64.299999999999997 110.528 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 96.72 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.436 0.636 . . . . 52.030000000000001 111.505 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -84.68 61.75 6.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.736 . . . . 72.439999999999998 109.436 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -88.49 94.54 9.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.319999999999993 109.295 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.43 114.8 19.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.046 -0.525 . . . . 63.530000000000001 110.957 -174.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -86.44 121.04 28.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 60.539999999999999 110.312 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 66.12 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.166 -0.925 . . . . 74.439999999999998 110.997 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -60.8 -68.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 74.340000000000003 110.161 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.707 -0.664 . . . . 72.420000000000002 109.372 174.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.491 0.182 . . . . 71.340000000000003 111.491 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.56 -154.96 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.754 -0.461 . . . . 65.010000000000005 109.754 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.12 140.61 31.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.936 0.398 . . . . 75.549999999999997 111.293 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.47 161.45 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.534 -0.757 . . . . 73.209999999999994 110.314 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.538 ' SG ' HG12 ' A' ' 103' ' ' ILE . 26.2 p -95.29 -177.08 3.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 70.340000000000003 110.707 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.24 1.47 41.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.446 0.641 . . . . 74.319999999999993 109.384 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 59.81 49.45 8.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.951 . . . . 75.230000000000004 110.346 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 71.5 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.511 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.310000000000002 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 75.099999999999994 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.575 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.409999999999997 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.483 ' HB3' ' HZ1' ' A' ' 12' ' ' LYS . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.299999999999997 110.621 179.75 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.310000000000002 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.637 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 75.409999999999997 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 45.009999999999998 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.681 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.209999999999994 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 65.209999999999994 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 73.109999999999999 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.485 ' HA ' HG21 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.310000000000002 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.525 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 71.140000000000001 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.340000000000003 110.508 179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.729 ' O ' ' HA ' ' A' ' 72' ' ' GLU . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.310000000000002 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.340000000000003 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.430000000000007 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.409999999999997 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.239999999999995 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.109999999999999 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.666 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.540000000000006 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.340000000000003 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.120000000000005 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.666 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 74.150000000000006 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 74.299999999999997 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.420000000000002 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.200000000000003 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.430000000000007 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.672 ' HA ' HG21 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.310000000000002 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.540000000000006 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.420000000000002 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.672 HG21 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 74.420000000000002 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.150000000000006 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 74.409999999999997 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 74.209999999999994 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 64.510000000000005 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.319999999999993 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.430000000000007 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.573 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.430000000000007 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.329999999999998 110.45 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.329999999999998 111.826 176.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.442 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.439999999999998 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.219999999999999 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.791 ' HG2' HD13 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 73.010000000000005 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.568 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.439999999999998 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.463 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 74.120000000000005 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.479 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.120000000000005 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.598 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.399999999999999 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.329999999999998 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.569 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.120000000000005 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 74.109999999999999 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.150000000000006 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.219999999999999 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 73.329999999999998 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.573 ' HB3' HG21 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.200000000000003 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.409999999999997 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.53 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.349999999999994 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.729 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 75.109999999999999 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.722 ' HB3' HD11 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.420000000000002 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.420000000000002 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.568 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.439999999999998 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.463 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.519999999999996 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.319999999999993 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.573 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.230000000000004 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.420000000000002 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG12 HD13 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.200000000000003 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' HA2' HG11 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.140000000000001 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.130000000000003 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 73.129999999999995 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.424 ' O ' HG21 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.319999999999993 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.539 HG11 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 73.030000000000001 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.219999999999999 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.419 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.109999999999999 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 71.439999999999998 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.349999999999994 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.239999999999995 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.681 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.637 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 73.200000000000003 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.445 ' HB3' HD13 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.140000000000001 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 74.140000000000001 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 65.329999999999998 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.408 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.42 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 63.240000000000002 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.200000000000003 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.414 ' HH ' ' HG3' ' A' ' 108' ' ' GLU . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.219999999999999 108.688 176.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.79 HD11 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.239999999999995 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.200000000000003 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.120000000000005 111.599 177.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.484 ' HE1' HG22 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.150000000000006 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.239999999999995 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.414 ' HG3' ' HH ' ' A' ' 102' ' ' TYR . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.349999999999994 110.483 178.376 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.403 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.409999999999997 109.819 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 71.430000000000007 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.120000000000005 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 109' ' ' ILE . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.340000000000003 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.109999999999999 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.319999999999993 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.450000000000003 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.589 HD23 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.099999999999994 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.519999999999996 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.575 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.439999999999998 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.599 HG11 ' H ' ' A' ' 157' ' ' GLU . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.209999999999994 110.57 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 73.209999999999994 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 72.140000000000001 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.567 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.150000000000006 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 64.150000000000006 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.637 ' HB3' HD12 ' A' ' 155' ' ' LEU . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.598 ' C ' ' HB2' ' A' ' 155' ' ' LEU . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.310000000000002 108.727 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.725 ' H ' HD12 ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 71.430000000000007 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 63.350000000000001 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.099999999999994 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.420000000000002 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.731 ' HB1' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.140000000000001 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.150000000000006 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.598 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.450000000000003 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.791 HD13 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.329999999999998 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 62.509999999999998 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.65 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.239999999999995 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.519999999999996 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.484 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.340000000000003 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.697 ' HB3' HD11 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.319999999999993 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.040000000000006 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.319999999999993 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.479 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.010000000000005 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.433 ' HB1' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.130000000000003 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.310000000000002 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.549999999999997 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.433 ' OE1' ' HB1' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.310000000000002 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.697 HD11 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.150000000000006 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.79 ' HG2' HD11 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.430000000000007 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.484 HG22 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.109999999999999 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.040000000000006 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.409999999999997 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.589 ' HB3' HD23 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.040000000000006 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.731 ' HG3' ' HB1' ' A' ' 131' ' ' ALA . 40.7 mtm -65.64 140.11 58.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.030000000000001 109.124 172.305 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.637 HD12 ' HB3' ' A' ' 125' ' ' PHE . 52.9 mt -84.84 177.8 7.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.457 -0.338 . . . . 74.230000000000004 110.248 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 60.96 84.7 0.13 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.9 0.48 . . . . 75.540000000000006 110.032 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.7 ' HG2' ' H ' ' A' ' 158' ' ' SER . 20.2 tt0 61.6 -163.71 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.486 -0.779 . . . . 70.030000000000001 109.758 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.7 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 39.0 m -117.3 177.97 4.54 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.06 -0.4 . . . . 74.430000000000007 111.031 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.3 pp -79.49 22.17 0.46 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.144 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.429 ' OE1' ' HA ' ' A' ' 163' ' ' HIS . 35.0 tt0 -148.99 150.76 33.38 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.044 -0.725 . . . . 70.230000000000004 109.044 -175.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -76.51 60.93 1.68 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.611 0.364 . . . . 75.010000000000005 110.9 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 61.92 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.552 0.741 . . . . 71.209999999999994 109.736 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.429 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 79.9 t60 -49.11 -54.33 16.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.754 . . . . 74.540000000000006 112.75 -168.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -122.22 145.66 48.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.757 -0.377 . . . . 74.129999999999995 110.405 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -71.61 102.12 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 75.519999999999996 110.935 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.675 -0.679 . . . . 74.0 109.214 174.713 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.255 0.55 . . . . 70.120000000000005 110.807 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.51 87.52 2.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.814 -0.63 . . . . 73.310000000000002 109.707 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -164.07 153.72 14.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 75.450000000000003 109.981 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 73.76 164.25 0.28 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.116 0.885 . . . . 73.519999999999996 111.112 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.1 m -57.42 123.78 16.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 73.329999999999998 110.381 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -104.48 -164.51 1.06 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 110.316 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.14 151.01 41.4 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.848 -0.615 . . . . 74.439999999999998 111.645 -170.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 74.019999999999996 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.577 ' HB3' HD12 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 71.109999999999999 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.587 ' O ' HD11 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.109999999999999 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.466 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.009999999999998 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.759 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.230000000000004 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 71.319999999999993 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 38.229999999999997 109.975 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.494 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.409999999999997 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.519999999999996 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.109999999999999 113.695 -179.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.229999999999997 110.746 -176.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.53 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.400000000000006 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.557 HD12 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.409999999999997 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.486 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 72.219999999999999 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.219999999999999 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.628 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.420000000000002 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.430000000000007 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 70.510000000000005 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.439999999999998 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.219999999999999 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.651 HD21 HG12 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.549999999999997 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.209999999999994 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 70.140000000000001 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 55.25 110.283 -176.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.329999999999998 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.230000000000004 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.009999999999998 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 75.430000000000007 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 75.129999999999995 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.310000000000002 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.509 ' H ' ' CG ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.439999999999998 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.219999999999999 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.499 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.409999999999997 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.329999999999998 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.467 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 74.319999999999993 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.499 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.329999999999998 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.299999999999997 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.409999999999997 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 54.439999999999998 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 74.319999999999993 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.489 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 72.239999999999995 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.494 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.109999999999999 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.420000000000002 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.239999999999995 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.409999999999997 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.481 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.349999999999994 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 63.420000000000002 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.230000000000004 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.754 ' HB3' HG11 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.209999999999994 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.588 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.439999999999998 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.010000000000005 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 73.25 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.329999999999998 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.329999999999998 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.020000000000003 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 75.030000000000001 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.628 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.319999999999993 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.754 HG11 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.140000000000001 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.527 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.109999999999999 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.120000000000005 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.319999999999993 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.009999999999998 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.494 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.120000000000005 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 73.319999999999993 109.719 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.450000000000003 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.430000000000007 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.239999999999995 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.509999999999998 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.150000000000006 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.030000000000001 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HA ' HD12 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 65.349999999999994 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.540000000000006 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.150000000000006 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 75.109999999999999 112.6 -178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.340000000000003 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.452 ' HB ' HD22 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.439999999999998 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.549999999999997 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.200000000000003 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.340000000000003 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.759 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.439999999999998 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.627 ' HA ' HD23 ' A' ' 155' ' ' LEU . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 110.935 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.748 ' HB3' HD13 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 74.340000000000003 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 73.239999999999995 110.876 -176.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 74.040000000000006 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.866 HD12 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.329999999999998 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.942 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.299999999999997 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.329999999999998 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.030000000000001 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.510000000000005 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.568 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 61.020000000000003 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.239999999999995 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 74.040000000000006 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.129999999999995 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.310000000000002 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 63.409999999999997 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.430000000000007 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.340000000000003 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.844 ' HG ' HD23 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 70.230000000000004 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.019999999999996 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.519999999999996 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 74.239999999999995 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.319999999999993 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.030000000000001 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 72.120000000000005 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.439999999999998 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.762 ' HD2' ' HG ' ' A' ' 155' ' ' LEU . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.540000000000006 109.188 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.457 ' HB2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 72.430000000000007 108.745 164.547 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 72.439999999999998 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.230000000000004 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.588 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.310000000000002 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.299999999999997 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.420000000000002 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.435 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.049999999999997 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.824 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 75.409999999999997 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.409999999999997 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.049999999999997 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.622 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.219999999999999 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.510000000000005 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 70.549999999999997 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 45.32 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.565 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.019999999999996 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.519999999999996 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.41 ' H ' ' C ' ' A' ' 141' ' ' GLU . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.329999999999998 111.848 -179.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.454 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 75.439999999999998 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.454 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.430000000000007 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 74.120000000000005 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.579 HD22 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.219999999999999 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.866 ' HD3' HD12 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.942 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.329999999999998 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.824 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.435 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 74.420000000000002 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 74.109999999999999 109.353 179.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.844 HD23 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 75.010000000000005 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp -64.6 156.3 30.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.430000000000007 110.727 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.762 ' HG ' ' HD2' ' A' ' 125' ' ' PHE . 4.1 mm? -96.66 -52.2 4.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.973 -0.558 . . . . 55.340000000000003 111.265 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.457 ' HB3' ' HB2' ' A' ' 126' ' ' ASP . 1.8 p80 -88.4 107.28 18.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.252 -0.579 . . . . 72.239999999999995 110.479 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -55.44 -64.68 0.77 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.382 -1.281 . . . . 63.329999999999998 113.455 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.9 t -79.09 8.86 5.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.246 -0.284 . . . . 75.120000000000005 111.092 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.6 mt 61.31 -90.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.08 0.552 . . . . 70.120000000000005 110.336 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -137.98 22.0 2.84 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.076 0.941 . . . . 74.150000000000006 108.722 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 17.9 t60 61.11 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 113.655 -1.611 . . . . 72.219999999999999 111.115 -179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -108.77 98.06 7.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.111 -0.7 . . . . 72.140000000000001 109.111 176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -74.5 135.62 42.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 73.019999999999996 111.635 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -123.16 116.46 23.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.971 -1.122 . . . . 73.230000000000004 107.971 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -67.37 167.6 12.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.142 0.496 . . . . 73.310000000000002 111.754 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.59 -0.732 . . . . 73.129999999999995 109.668 179.427 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.12 -0.696 . . . . 55.119999999999997 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.39 -56.03 2.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.366 0.506 . . . . 73.140000000000001 112.366 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -68.76 -41.82 78.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.181 0.515 . . . . 73.219999999999999 109.96 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -95.32 131.56 41.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.887 -0.783 . . . . 73.239999999999995 108.887 173.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.649 ' HB3' HD12 ' A' ' 103' ' ' ILE . 59.4 m -80.66 -82.82 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.476 -0.565 . . . . 75.340000000000003 109.476 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 63.54 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.377 1.084 . . . . 63.210000000000001 113.341 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.27 84.67 5.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.862 -1.063 . . . . 73.030000000000001 108.634 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.299999999999997 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . 0.411 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.030000000000001 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.450000000000003 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.150000000000006 110.373 -174.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.349999999999994 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 62.439999999999998 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.109999999999999 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.664 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.109999999999999 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.200000000000003 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.200000000000003 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.399999999999999 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.641 HD22 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.219999999999999 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.513 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 75.010000000000005 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.544 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 72.420000000000002 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.502 ' H ' HG21 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.409999999999997 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.310000000000002 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.420000000000002 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.746 HG22 HD23 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 72.400000000000006 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.606 ' HE1' ' HG3' ' A' ' 30' ' ' GLU . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.409999999999997 112.336 179.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.606 ' HG3' ' HE1' ' A' ' 28' ' ' MET . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 64.340000000000003 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.746 HD23 HG22 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 72.209999999999994 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 60.0 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.340000000000003 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 75.510000000000005 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.536 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 61.399999999999999 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.340000000000003 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.120000000000005 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.010000000000005 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.552 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.420000000000002 110.228 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.420000000000002 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.508 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.329999999999998 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 73.099999999999994 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 73.310000000000002 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.454 HD13 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 72.239999999999995 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.509999999999998 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.019999999999996 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.409 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.400000000000006 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.450000000000003 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.209999999999994 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.437 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.140000000000001 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.465 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.120000000000005 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.120000000000005 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.420000000000002 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.577 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.400000000000006 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.120000000000005 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 71.140000000000001 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.533 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 62.43 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.513 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.439999999999998 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 73.450000000000003 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 1.0 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.319999999999993 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.540000000000006 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.519 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.109999999999999 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 71.349999999999994 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 71.349999999999994 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 74.530000000000001 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.420000000000002 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 70.450000000000003 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 1.0 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.040000000000006 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.140000000000001 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 50.299999999999997 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.209999999999994 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 37.18 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 75.329999999999998 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.465 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.219999999999999 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.641 HG21 HD22 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.340000000000003 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . 0.626 ' H ' HG11 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.340000000000003 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.430000000000007 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.450000000000003 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.568 ' HB ' HG12 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.430000000000007 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' N ' HG13 ' A' ' 81' ' ' VAL . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 109.916 -177.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.576 ' HA2' HD13 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 37.18 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.340000000000003 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.109999999999999 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 73.140000000000001 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.601 HG11 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.219999999999999 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.567 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.319999999999993 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.200000000000003 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.319999999999993 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.219999999999999 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.010000000000005 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.129999999999995 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.664 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.510000000000005 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.329999999999998 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 55.119999999999997 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.578 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.340000000000003 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.049999999999997 110.983 -176.028 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.411 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.049999999999997 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 74.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.649 HD12 ' HB3' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 75.409999999999997 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 65.209999999999994 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.130000000000003 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.519999999999996 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.130000000000003 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.239999999999995 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.688 ' O ' HG13 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.439999999999998 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.912 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.109999999999999 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.519999999999996 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.688 HG13 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.100000000000001 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.912 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 74.230000000000004 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 73.340000000000003 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.310000000000002 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.604 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 61.130000000000003 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.699 ' HA ' ' HE1' ' A' ' 117' ' ' MET . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 63.32 111.445 -177.247 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 74.019999999999996 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.455 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.140000000000001 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.57 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 75.200000000000003 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.310000000000002 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.329999999999998 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.299999999999997 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.329999999999998 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.679 ' CD2' HD23 ' A' ' 155' ' ' LEU . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.209999999999994 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.329999999999998 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.517 HD13 ' HE2' ' A' ' 117' ' ' MET . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.219999999999999 109.386 175.38 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.53 ' CB ' ' HB3' ' A' ' 154' ' ' MET . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.430000000000007 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.519 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.109999999999999 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.030000000000001 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.505 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.099999999999994 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.533 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.209999999999994 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.400000000000006 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.577 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.310000000000002 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.421 HD21 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 65.109999999999999 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 70.219999999999999 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.409999999999997 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.310000000000002 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.329999999999998 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.510000000000005 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.200000000000003 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.310000000000002 110.779 -177.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.484 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.409999999999997 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 63.409999999999997 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.099999999999994 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.484 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.239999999999995 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.421 ' HD2' HD21 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 74.239999999999995 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.239999999999995 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.449 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.409 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.010000000000005 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 65.510000000000005 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.639 ' HB2' HD21 ' A' ' 155' ' ' LEU . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.200000000000003 109.167 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.53 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? -53.37 -55.27 26.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.510000000000005 110.529 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.679 HD23 ' CD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER 55.1 22.85 4.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.447 1.647 . . . . 62.219999999999999 115.447 165.224 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -75.54 -32.34 60.41 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.468 -1.308 . . . . 74.310000000000002 107.468 167.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.2 -85.98 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.708 -1.587 . . . . 61.240000000000002 106.886 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 172.44 -179.49 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.42 1.088 . . . . 61.509999999999998 109.341 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.521 ' H ' ' HA ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -105.95 60.93 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.603 -1.258 . . . . 74.319999999999993 107.603 172.076 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -141.24 143.63 34.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.593 -1.185 . . . . 65.349999999999994 110.68 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -98.21 -20.55 17.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.971 -0.559 . . . . 74.510000000000005 110.006 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m80 66.06 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 110.086 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -79.27 57.13 2.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.096 -0.502 . . . . 65.219999999999999 110.764 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 48.59 76.31 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.609 -0.723 . . . . 75.519999999999996 110.639 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -108.62 124.85 51.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.032 -0.531 . . . . 75.519999999999996 111.106 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.6 m80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.507 -0.758 . . . . 64.420000000000002 109.387 174.477 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.649 -0.5 . . . . 75.430000000000007 109.649 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 66.6 -81.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.739 0.649 . . . . 51.140000000000001 110.305 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.0 t80 63.79 178.61 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.167 0.587 . . . . 75.209999999999994 110.599 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 74.43 -49.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.422 0.689 . . . . 65.340000000000003 111.321 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.7 t -77.45 96.25 4.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.348 -0.612 . . . . 63.229999999999997 109.348 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -123.85 -166.97 1.56 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.267 0.556 . . . . 75.409999999999997 110.348 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.73 122.5 24.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.423 -0.808 . . . . 74.140000000000001 109.898 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.019999999999996 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.737 ' H ' HD22 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 74.030000000000001 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.329999999999998 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.030000000000001 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 74.239999999999995 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.329999999999998 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.75 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 73.049999999999997 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 75.450000000000003 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.510000000000005 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.239999999999995 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.835 HD12 HG23 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.219999999999999 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' N ' HD22 ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.329999999999998 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.689 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.329999999999998 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.415 ' CB ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.340000000000003 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.402 ' H ' ' CD ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.150000000000006 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.624 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.109999999999999 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.310000000000002 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.030000000000001 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.240000000000002 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.219999999999999 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.329999999999998 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.409999999999997 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 63.340000000000003 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.43 HD11 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 64.549999999999997 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.040000000000006 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 74.299999999999997 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.402 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.310000000000002 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.020000000000003 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 65.010000000000005 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.535 HD12 HD12 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.209999999999994 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.692 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 62.210000000000001 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.430000000000007 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.439999999999998 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.049999999999997 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 70.420000000000002 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.140000000000001 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.530000000000001 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.329999999999998 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.409999999999997 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.150000000000006 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.219999999999999 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.140000000000001 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 73.150000000000006 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.502 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.109999999999999 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.596 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.420000000000002 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.209999999999994 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.8 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 74.340000000000003 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.515 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 71.040000000000006 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.530000000000001 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.319999999999993 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.605 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.540000000000006 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.400000000000006 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 63.530000000000001 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.400000000000006 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 70.420000000000002 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.624 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.530000000000001 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.450000000000003 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.45 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.689 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.349999999999994 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.219999999999999 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.502 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.299999999999997 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 73.140000000000001 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.835 HG23 HD12 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.120000000000005 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.219999999999999 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.100000000000001 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.240000000000002 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.749 ' H ' HG12 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 73.239999999999995 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.239999999999995 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 74.409999999999997 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.651 HG23 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 73.040000000000006 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.329999999999998 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.319999999999993 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.455 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.439999999999998 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.040000000000006 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . 0.75 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.340000000000003 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.559 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 61.240000000000002 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 62.350000000000001 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.695 ' HB3' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.109999999999999 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.530000000000001 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.504 ' HB2' HD23 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.510000000000005 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.529 HD13 ' CG ' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.519999999999996 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . 0.49 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.150000000000006 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.099999999999994 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.340000000000003 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.340000000000003 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.517 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 74.510000000000005 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.239999999999995 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.56 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . 0.634 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.119999999999997 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.310000000000002 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.219999999999999 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . 0.634 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.219999999999999 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.120000000000005 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.129999999999995 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.644 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.420000000000002 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 75.299999999999997 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . 0.695 ' HZ2' ' HB3' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 74.120000000000005 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.968 ' HA ' HD21 ' A' ' 123' ' ' ASN . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.210000000000001 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.239999999999995 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.329999999999998 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . 0.968 HD21 ' HA ' ' A' ' 120' ' ' VAL . 42.8 m-80 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.229999999999997 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.299999999999997 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.010000000000005 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 73.049999999999997 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.240000000000002 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.540000000000006 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.010000000000005 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.8 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 75.310000000000002 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.687 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.596 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 72.510000000000005 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.319999999999993 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 62.009999999999998 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.908 ' HB3' HG23 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.019999999999996 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . 0.407 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.438 ' C ' ' H ' ' A' ' 141' ' ' GLU . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.009999999999998 112.763 -178.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 64.040000000000006 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . 0.438 ' H ' ' C ' ' A' ' 139' ' ' PRO . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.310000000000002 109.612 177.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' THR . . . . . 0.908 HG23 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.120000000000005 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.120000000000005 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.476 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.409999999999997 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.299999999999997 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.476 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 72.219999999999999 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.219999999999999 108.431 176.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . 0.529 ' CG ' HD13 ' A' ' 101' ' ' LEU . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 75.239999999999995 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.517 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . 0.41 ' HD2' HD13 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.409999999999997 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.687 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.509999999999998 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.631 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 61.219999999999999 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.773 ' H ' HD12 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.530000000000001 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' MET . . . . . 0.849 ' HG2' ' HA ' ' A' ' 158' ' ' SER . 20.7 ttp -91.69 118.55 30.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.129999999999995 111.343 -169.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.401 HD12 ' H ' ' A' ' 156' ' ' HIS . 0.3 OUTLIER -84.92 169.95 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.182 -0.917 . . . . 62.149999999999999 111.147 -174.512 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . 0.401 ' H ' HD12 ' A' ' 155' ' ' LEU . 49.0 t-80 55.52 64.98 1.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.413 -0.812 . . . . 71.299999999999997 112.333 174.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.04 24.76 9.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.499 0.555 . . . . 73.439999999999998 112.499 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.849 ' HA ' ' HG2' ' A' ' 154' ' ' MET . 21.3 m 68.46 165.26 0.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.257 0.551 . . . . 75.540000000000006 111.038 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.64 13.03 18.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.868 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.4 ' O ' ' HB2' ' A' ' 161' ' ' HIS . 44.7 tt0 -149.07 128.49 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 110.01 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . 0.441 ' O ' ' HB2' ' A' ' 162' ' ' HIS . 12.1 m80 74.71 -28.93 0.19 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.514 0.726 . . . . 60.350000000000001 112.688 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 163' ' ' HIS . 51.1 m80 70.47 -64.62 0.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.055 0.542 . . . . 70.099999999999994 112.085 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 24.0 m80 70.91 112.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.538 0.685 . . . . 74.120000000000005 110.286 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -91.32 -172.64 3.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.252 -0.885 . . . . 64.109999999999999 110.976 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -69.26 148.09 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.559 -0.534 . . . . 63.229999999999997 109.559 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.689 -0.672 . . . . 64.310000000000002 110.522 -175.245 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.05 -0.352 . . . . 65.430000000000007 110.05 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.59 -65.76 0.34 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.93 0.769 . . . . 70.420000000000002 109.533 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -75.97 141.62 42.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.492 -1.299 . . . . 75.239999999999995 107.492 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . 0.642 ' HG2' ' HG3' ' A' ' 146' ' ' GLN . 5.6 tp10 -59.76 93.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.225 0.536 . . . . 74.299999999999997 112.075 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 89.1 m -159.29 167.16 29.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.994 -1.003 . . . . 73.319999999999993 108.794 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 68.98 145.55 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.725 0.774 . . . . 73.519999999999996 111.986 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -81.04 150.56 28.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.239 -0.892 . . . . 73.310000000000002 110.919 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.48 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 65.409999999999997 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 73.209999999999994 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.771 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.841 HD13 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 50.25 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.771 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 72.519999999999996 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.239999999999995 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.319999999999993 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.512 ' HB2' HD22 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.299999999999997 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 72.219999999999999 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' HA ' HG21 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.130000000000003 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.503 ' HG ' HG11 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 74.230000000000004 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.479 HD13 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.409999999999997 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.555 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.010000000000005 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.748 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 73.239999999999995 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 74.519999999999996 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.881 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.530000000000001 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.200000000000003 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 72.409999999999997 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.439999999999998 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.439999999999998 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 74.109999999999999 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 73.319999999999993 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 63.039999999999999 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.039999999999999 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.329999999999998 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.409999999999997 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 61.539999999999999 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.299999999999997 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.030000000000001 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 71.140000000000001 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . 0.688 HG23 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.219999999999999 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.688 ' H ' HG23 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.200000000000003 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.455 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.592 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.430000000000007 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.299999999999997 109.562 173.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 61.25 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.530000000000001 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.109999999999999 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 73.209999999999994 110.628 -179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.472 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.420000000000002 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.472 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.239999999999995 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.349999999999994 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 71.549999999999997 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.608 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.229999999999997 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.519999999999996 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.732 ' HB2' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.119999999999997 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 71.049999999999997 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' TYR . . . . . 0.845 ' HB2' ' HB1' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.230000000000004 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.583 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.230000000000004 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.319999999999993 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.547 ' HB2' HD11 ' A' ' 159' ' ' LEU . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.420000000000002 111.685 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 160' ' ' GLU . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 71.129999999999995 110.446 177.274 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.415 ' HB2' ' H ' ' A' ' 162' ' ' HIS . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.520000000000003 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 71.219999999999999 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.881 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.239999999999995 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 74.430000000000007 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' OE1' HD13 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.73 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 74.120000000000005 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.439999999999998 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.329999999999998 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.658 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 64.140000000000001 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.340000000000003 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.430000000000007 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.319999999999993 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.658 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' HB3' HD11 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.140000000000001 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 54.43 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.439999999999998 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . 0.415 ' C ' ' H ' ' A' ' 87' ' ' VAL . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 72.019999999999996 111.409 -177.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.400000000000006 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.555 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.540000000000006 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.049999999999997 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.239999999999995 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.149999999999999 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.512 HD22 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.450000000000003 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.442 ' HG1' ' HD2' ' A' ' 93' ' ' PRO . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 53.43 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' PRO . . . . . 0.442 ' HD2' ' HG1' ' A' ' 92' ' ' THR . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.310000000000002 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.420000000000002 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.519999999999996 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.841 ' HD3' HD13 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.340000000000003 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . 0.553 ' HB2' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 53.119999999999997 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.420000000000002 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' SER . . . . . 0.523 ' HB2' HD23 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 72.239999999999995 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 74.150000000000006 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 72.150000000000006 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ILE . . . . . 0.677 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.420000000000002 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.340000000000003 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.430000000000007 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.409 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.010000000000005 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.549999999999997 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.230000000000004 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.702 HD13 HG22 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 74.340000000000003 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.409999999999997 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 70.219999999999999 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.454 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.140000000000001 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.140000000000001 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.409999999999997 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 63.439999999999998 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.523 HD23 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 73.349999999999994 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.54 ' HA ' HG13 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.420000000000002 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.420000000000002 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.049999999999997 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.67 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.310000000000002 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 71.340000000000003 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 72.439999999999998 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.430000000000007 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.229999999999997 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.67 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.150000000000006 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASP . . . . . 0.683 ' HB3' HD12 ' A' ' 155' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.009999999999998 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.811 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 74.25 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.319999999999993 110.688 178.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.583 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.209999999999994 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.845 ' HB1' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.200000000000003 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.888 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.030000000000001 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.732 ' HB2' ' HB2' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 73.239999999999995 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.340000000000003 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' TYR . . . . . 0.431 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.409999999999997 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.76 HD23 ' H ' ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.109999999999999 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.219999999999999 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.530000000000001 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.452 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.439999999999998 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 52.229999999999997 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.409999999999997 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.450000000000003 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.329999999999998 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' PRO . . . . . 0.447 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.329999999999998 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ASP . . . . . 0.458 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.030000000000001 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLN . . . . . 0.642 ' HG3' ' HG2' ' A' ' 4' ' ' GLU . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.329999999999998 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.677 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.099999999999994 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 74.420000000000002 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.439999999999998 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.702 HG22 HD13 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 63.310000000000002 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.888 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 74.540000000000006 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.340000000000003 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -91.59 148.05 22.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.420000000000002 109.7 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.683 HD12 ' HB3' ' A' ' 126' ' ' ASP . 1.2 mm? -78.92 162.27 26.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.992 -0.744 . . . . 74.519999999999996 108.992 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -86.3 169.03 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.762 -0.459 . . . . 75.430000000000007 109.762 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 71.62 14.16 6.22 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.835 0.709 . . . . 75.099999999999994 110.121 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -96.04 -153.8 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.081 -0.963 . . . . 71.140000000000001 109.411 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.547 HD11 ' HB2' ' A' ' 64' ' ' MET . 57.4 mt -53.66 -56.0 21.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 61.420000000000002 110.937 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 65' ' ' SER . 58.0 mt-10 58.13 -177.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.641 -0.709 . . . . 71.140000000000001 112.186 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -85.52 140.04 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 75.230000000000004 111.53 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' HIS . . . . . 0.415 ' H ' ' HB2' ' A' ' 66' ' ' ALA . 17.7 t-160 -88.1 16.18 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.887 0.851 . . . . 73.549999999999997 109.7 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -131.65 157.42 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.358 -0.837 . . . . 75.129999999999995 109.03 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -116.16 86.66 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.197 0.522 . . . . 73.349999999999994 110.343 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -96.28 140.56 30.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.569 -0.741 . . . . 73.420000000000002 109.685 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.901 -1.047 . . . . 71.239999999999995 109.743 177.066 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.236 0.344 0 CA-C-O 121.239 0.542 . . . . 64.12 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.03 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 41.32 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 44.21 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.35 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.01 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 52.22 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' SER . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.11 109.317 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 54.42 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.44 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 51.21 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.24 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.23 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 64.1 110.465 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.42 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.722 HG21 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.23 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 60.53 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.11 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 71.2 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.32 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.03 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 30.34 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 44.43 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 62.15 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.425 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 74.42 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.3 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.54 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.21 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.24 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.12 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.13 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.24 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD22 HD23 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 63.45 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 63.23 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.75 HD23 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.23 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.14 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 43.41 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.22 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.2 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.45 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.15 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.54 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 63.4 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.22 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.13 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.24 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 73.55 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.1 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.33 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 70.2 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.45 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 64.04 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.53 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.47 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.04 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.12 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.51 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.12 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 71.11 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.34 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.54 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.587 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.15 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.758 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.34 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.45 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.23 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 60.42 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.14 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' OE1' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.45 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.33 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.12 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.425 HG23 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.12 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.24 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.3 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.05 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.15 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 72.44 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.945 HG22 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 74.05 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.33 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.54 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.43 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 51.11 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.42 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.43 110.025 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 44.14 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.12 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.42 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 71.14 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.33 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.24 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.32 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.3 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.05 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.23 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 65.25 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.11 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.33 109.468 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.03 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.34 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.53 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 62.41 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.3 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.31 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.02 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.659 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.4 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.34 110.692 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.05 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.659 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.04 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.631 ' HA ' HD22 ' A' ' 123' ' ' ASN . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 63.32 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.11 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.41 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.631 HD22 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.44 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.619 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.41 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 72.52 111.343 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.757 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.31 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 71.22 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.12 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.44 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 63.12 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 73.32 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 52.0 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.479 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.05 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.41 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 64.03 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 54.43 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.495 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.52 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.904 ' HA ' HD21 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.44 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.04 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.24 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 64.32 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.22 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' A' ' 147' ' ' LEU . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.2 112.254 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.803 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.43 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 64.41 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.904 HD21 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.4 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.3 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.23 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.11 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 70.03 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.22 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.54 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 71.1 110.211 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 73.43 110.379 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 61.2 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.55 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.55 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.42 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 74.21 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.21 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 61.33 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 53.2 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.1 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.02 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 53.2 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.22 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.44 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.34 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.21 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.43 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 62.23 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.34 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 43.32 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.22 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.14 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.34 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.03 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.53 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.11 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.03 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.1 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 63.45 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.22 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.52 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.13 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 63.44 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.42 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 61.34 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.22 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 61.21 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.447 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 64.13 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.4 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.01 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.42 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 52.41 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.02 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 64.54 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 53.02 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.11 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.52 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.35 112.125 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.23 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.34 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 61.41 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.04 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 54.22 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.24 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.23 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.3 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.1 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.31 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.32 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.2 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.21 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.3 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.24 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.845 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 62.05 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.51 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 64.5 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.34 113.254 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 52.23 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.03 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.24 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 78' ' ' GLU . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.02 112.366 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.6 HG23 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.13 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 62.51 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 25.51 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.475 ' H ' HD22 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 54.44 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.33 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.44 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HB ' HD21 ' A' ' 45' ' ' LEU . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.32 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 42.34 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.561 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 73.41 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.31 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 71.42 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.13 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.42 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 65.25 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 61.25 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HB3' HD11 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.33 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.12 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.52 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.01 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 62.01 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 55.13 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.588 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 70.01 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.599 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.779 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.44 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.41 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.23 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 45.14 110.272 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.34 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 64.05 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.01 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.22 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.565 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 72.35 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.02 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 70.05 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.32 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.23 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.46 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.13 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.21 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 62.44 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 65.4 111.296 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.13 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 130' ' ' GLU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.11 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.1 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.706 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.52 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HB2' HD21 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.24 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.32 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.699 ' HB3' HG23 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.41 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.648 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.51 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.23 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.14 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.52 ' HB2' HD13 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.4 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.04 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 54.21 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.31 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.31 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.66 HG23 HD23 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.21 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.54 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.779 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.54 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.35 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.34 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.66 HD23 HG23 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.2 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 148' ' ' ARG . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.54 110.125 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.11 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.11 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 70.52 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.42 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.35 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.706 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.31 111.023 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.886 0.374 . . . . 55.42 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 61.33 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.13 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.43 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.24 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.13 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.41 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 60.41 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.43 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.11 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.23 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.23 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.14 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD13 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.55 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.14 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.45 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.51 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.676 HG21 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.55 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.33 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 55.34 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.03 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.01 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.44 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.35 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 65.42 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.03 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.44 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.41 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 53.32 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.22 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.14 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.23 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.55 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.22 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 72.31 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.41 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.2 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 32.53 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.44 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.44 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.04 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.34 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.52 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.42 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.21 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.834 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.14 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.53 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 61.12 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 72.31 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 62.05 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 64.54 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.11 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.04 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.31 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.32 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 45.43 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 73.11 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.2 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.51 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.11 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.54 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 65.24 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.14 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 64.14 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.04 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 61.53 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.13 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.43 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.24 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 51.5 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 86' ' ' ARG . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.15 110.49 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 71.52 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 62.13 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 55.03 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.44 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.33 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.42 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.23 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 61.2 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.33 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.461 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.22 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.13 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 42.01 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 52.22 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.922 ' HB2' HG23 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 61.44 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.04 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.11 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.584 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.32 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.01 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 52.5 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.41 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.52 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.67 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 55.11 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.43 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.54 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.922 HG23 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.34 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 71.32 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.14 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.33 110.714 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.653 HD22 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.45 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 44.3 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 53.33 109.527 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.54 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.43 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.14 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.05 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.03 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.52 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' HG23 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.33 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.24 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.42 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.31 108.013 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.03 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.13 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.13 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.51 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.12 110.371 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 63.41 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.834 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.44 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.2 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.675 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.01 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.43 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 63.32 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.11 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.695 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.21 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 64.02 111.215 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.33 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.22 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 51.35 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.21 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 43.45 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.82 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.24 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.21 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.22 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.12 111.286 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.986 -0.375 . . . . 75.41 109.986 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.23 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.23 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.51 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.51 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.01 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.13 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.4 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.13 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 63.43 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.03 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 44.04 110.754 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 53.44 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.13 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 23' ' ' ARG . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.23 108.777 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.741 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.14 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.32 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.32 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 72.44 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 63.33 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.4 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 61.04 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.3 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.12 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.741 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.24 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.31 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.14 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.32 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.32 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 64.35 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.44 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.35 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.1 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.02 111.515 -173.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.15 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 72.54 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.32 112.599 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.14 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.1 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' HD13 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.13 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.426 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.23 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.41 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.41 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.32 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.22 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.12 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.54 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.01 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.22 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.41 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 62.5 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.625 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.3 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.02 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.24 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 64.22 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.23 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 74.13 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 55.3 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.31 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 51.13 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.63 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HZ ' HG12 ' A' ' 22' ' ' ILE . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 60.51 111.712 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 51.42 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 52.13 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 64.25 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 53.43 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 54.34 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.01 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.23 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 53.32 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.44 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 86' ' ' ARG . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.03 109.986 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.23 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.21 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.42 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.44 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.34 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.32 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.44 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 62.44 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 73.44 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 70.3 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.44 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.03 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.13 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.41 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.31 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.988 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.53 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.04 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.44 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.31 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.631 ' HE1' HD11 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.3 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 52.31 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.32 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.631 HD11 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 65.01 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.12 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.52 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.22 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.03 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.33 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.04 111.037 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.04 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 72.42 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 71.51 111.165 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.2 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.52 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.01 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.33 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.52 109.248 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 71.1 110.927 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.41 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 72.24 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.22 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.04 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.53 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 65.23 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 74.01 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.04 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.12 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.12 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 65.45 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.54 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.44 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.32 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 73.52 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.1 111.421 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.4 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.02 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.35 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 54.32 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.31 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.988 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 52.43 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.743 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.3 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 41.54 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.1 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 72.33 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.475 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 50.0 ttp . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.51 109.35 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 109.578 -0.527 . . . . 72.21 109.578 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.54 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 41.12 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.52 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.22 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.44 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.35 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.52 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.33 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.21 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.24 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.02 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 65.33 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.34 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.072 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.2 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 86' ' ' ARG . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.34 108.048 165.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 52.23 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.43 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.13 109.878 172.146 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.42 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.21 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.13 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.34 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.35 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.35 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.54 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 71.34 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.12 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.4 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.42 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.15 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.13 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.51 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.53 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.13 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 70.22 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.13 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.31 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.04 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.03 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.676 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.32 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 61.21 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.676 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.05 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 62.15 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.14 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.784 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 60.21 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.11 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.33 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.43 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.14 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.98 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.24 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 72.32 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 63.31 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.55 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.41 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.23 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.02 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.22 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 1.072 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.01 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.35 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.41 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 50.14 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.591 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.1 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 65.12 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.52 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.21 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.43 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.52 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG3' HD12 ' A' ' 22' ' ' ILE . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 71.23 111.115 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.15 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.3 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.03 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 41.23 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.2 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 71.02 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.23 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.12 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.41 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.44 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.35 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.34 110.269 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.43 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.2 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.13 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.43 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.23 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.1 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.42 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 54.13 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 31.24 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.12 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 73.43 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.23 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.44 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.04 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.03 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.12 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.24 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.2 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.431 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.11 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.43 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.21 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 125' ' ' PHE . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.23 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.22 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.44 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.12 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.31 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 73.34 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.35 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.23 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.11 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.23 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.24 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.98 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.53 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 74.14 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 73.34 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.21 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 74.3 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.33 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 65.5 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 54.31 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.53 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.32 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.23 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.12 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.52 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.11 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 72.43 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 54.2 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.13 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.635 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.3 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 52.42 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.11 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.01 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.691 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.11 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.823 HD12 HD21 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 55.01 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.23 111.315 -178.543 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.943 -0.392 . . . . 55.43 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 61.43 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 54.41 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.33 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.31 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.3 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.41 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.15 109.781 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 73.12 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.23 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.52 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.11 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 54.43 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 72.34 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.42 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.04 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.22 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.42 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.31 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 51.12 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.21 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.13 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 53.4 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 52.32 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.4 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.53 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.54 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 63.33 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.42 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.52 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.1 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.01 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.599 ' HB ' HG21 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 60.21 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 61.35 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.53 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 60.53 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.636 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.15 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.44 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.44 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.45 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.45 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.23 110.609 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.42 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.44 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.22 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.13 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.472 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.22 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 73.44 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.11 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 73.24 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.23 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.02 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.668 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.24 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.21 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 44.13 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.11 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.23 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 62.33 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.54 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 43.33 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.547 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.41 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.51 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.15 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.34 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.44 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 72.1 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.54 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.44 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.34 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.21 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 62.52 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.15 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.806 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 52.45 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.42 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.31 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.55 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 54.04 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 72.33 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.24 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.12 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.24 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.3 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.53 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.45 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.11 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.53 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 73.22 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.14 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.606 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.24 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.22 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.2 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 62.12 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.3 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 54.11 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.533 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.22 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.54 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.45 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.33 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.52 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.22 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.42 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.14 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.31 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 53.55 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.11 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 40.1 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 54.43 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.41 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.23 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.45 110.319 176.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' LEU . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.33 109.873 174.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.03 110.226 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.52 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.55 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.15 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.22 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.35 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.667 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.24 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.45 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.2 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 43.02 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.13 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 70.13 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 54.32 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.42 110.376 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 72.22 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.1 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.45 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.669 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.43 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.14 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.606 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.35 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.31 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.667 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.14 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 54.12 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 71.12 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.51 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.507 ' SD ' ' HG3' ' A' ' 64' ' ' MET . 57.0 mtp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.54 110.335 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 28.9 t80 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 74.54 109.63 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.1 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.11 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.54 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.807 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.24 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.52 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.3 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD13 ' OH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.42 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.54 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.34 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.23 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.53 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.24 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 63.13 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 65.21 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 63.15 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 HG23 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.43 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.759 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.55 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.684 HG23 HG22 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 61.33 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.35 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.04 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.45 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.54 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.13 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.04 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.02 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.3 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.11 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.14 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.45 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.55 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.02 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.24 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.21 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 72.12 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 53.04 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.45 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.1 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HG3' HG22 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.02 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 72.04 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.23 112.334 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.12 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.01 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.1 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.22 112.365 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.64 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.12 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.34 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.15 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 65.44 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.22 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.573 ' HA ' ' CE ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.31 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 55.53 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 54.01 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.03 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.34 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.52 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.05 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.45 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.42 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.24 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 24.01 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 52.31 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.14 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.601 HG12 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.01 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.35 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 34.23 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.1 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.643 HG22 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.11 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.22 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.23 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.31 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.04 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 53.24 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.32 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.12 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 43.02 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.44 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.34 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.21 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.44 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.42 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.34 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 71.34 110.284 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 116' ' ' LEU . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.34 109.695 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 55.14 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 43.12 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 72.45 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.856 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.15 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.724 HD11 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.31 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 64.14 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.53 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 73.44 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.32 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.15 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.42 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.14 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.3 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 72.53 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.11 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 55.15 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 71.45 111.398 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.03 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.11 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.33 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.807 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.24 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 72.33 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.24 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.11 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 71.45 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.31 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.823 ' HB2' HG23 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.33 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.41 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 71.43 112.69 -176.523 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.42 109.848 172.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.23 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.4 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.864 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 32.3 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.34 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.64 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 42.31 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 51.2 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.45 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.471 ' HB2' ' CG2' ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.24 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.33 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 72.21 113.645 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 42.15 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.41 111.307 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.23 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.24 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.14 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.03 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.712 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 84.5 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 63.12 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 63.12 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 73.12 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.12 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 71.51 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.4 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.33 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.864 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 59.3 mtm . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.32 110.931 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 110.161 -0.311 . . . . 72.11 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.13 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.13 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.24 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 45.32 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.44 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.35 109.434 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.34 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.31 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.21 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.34 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.748 HD13 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.54 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 54.35 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.34 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 61.51 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.12 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 63.33 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 31' ' ' LEU . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 61.14 111.673 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 72.03 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.54 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.04 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD21 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.51 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 64.42 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 71.43 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 72.11 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.31 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.02 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.32 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.32 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 45.53 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.42 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 55.22 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.05 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.23 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.41 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 64.43 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.55 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 64.12 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.21 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 63.13 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.22 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 60.12 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.55 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.44 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.51 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.31 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 134' ' ' ILE . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.31 110.064 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.04 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.35 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.41 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.826 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 53.33 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.42 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.05 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.44 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.31 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.43 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.31 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 71.34 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.53 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.21 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 73.22 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.611 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 74.22 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.55 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.44 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.3 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.53 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.31 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.03 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.55 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.52 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.54 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.12 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.15 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 32.35 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.14 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.54 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 31.33 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.31 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 71.13 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 43.33 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.1 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.45 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.42 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.737 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.33 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.32 110.498 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.503 ' CB ' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 44.34 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.53 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.04 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.31 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 62.53 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.15 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.12 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.22 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 74.33 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.22 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.44 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.13 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 62.45 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.04 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.12 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.545 ' HA ' HD12 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.33 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.32 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.44 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.2 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.23 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.12 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.41 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.878 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.12 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.23 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.22 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.03 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.12 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 73.04 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.52 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.3 110.603 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.43 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.593 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.44 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.42 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.22 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' HG21 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 45.42 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 58' ' ' PHE . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.03 108.901 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 61.54 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.595 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.12 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.23 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.618 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.14 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.34 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.24 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.14 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 63.53 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.588 ' H ' HG23 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.23 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.42 111.218 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 53.02 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 51.1 109.847 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.44 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.03 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.34 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.21 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.32 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 72.43 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.21 111.416 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.457 -0.572 . . . . 74.23 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.14 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 64.24 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 52.4 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 44.4 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 51.21 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.2 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.21 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 64.14 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.04 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.41 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.01 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.22 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.33 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 63.44 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.3 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.51 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.35 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.44 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.497 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 53.0 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 25.01 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.13 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.13 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 71.01 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.53 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 71.32 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 74.44 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 74.03 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 73.43 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.23 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.52 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.51 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.31 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 73.14 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.23 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.42 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 61.13 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.34 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.21 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.53 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 70.43 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.13 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 65.11 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 61.2 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.34 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.959 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 55.25 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.51 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.14 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.13 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' HD1' HG22 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.24 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.52 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.02 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 64.15 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.788 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 70.14 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.1 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.12 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.41 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.14 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.23 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.44 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' HD1' HG13 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 74.32 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.3 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.31 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 63.02 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.14 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.5 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.34 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.2 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.959 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.03 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.12 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.04 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.54 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.33 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 70.41 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.31 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.839 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.22 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.01 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 53.12 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.839 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 43.24 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 44.03 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.04 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.51 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 71.22 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 54.51 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.33 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.11 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.21 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 33.1 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.1 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.23 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.585 ' CD1' HG11 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.23 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.41 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.1 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.44 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.42 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 61.54 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.45 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.22 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.44 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 71.34 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 72.3 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.32 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.24 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.34 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 70.3 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.12 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.1 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 44.01 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 43.03 110.277 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.14 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 53.2 111.497 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.14 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.788 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.1 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.11 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 54.12 109.753 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.22 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.42 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.4 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.813 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.11 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.21 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.52 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.793 ' HB3' HD11 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.44 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.41 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.13 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 62.04 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.3 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.42 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.3 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.33 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.14 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.43 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.11 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.655 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.23 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 62.14 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.12 110.392 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.617 ' HG3' ' HG3' ' A' ' 130' ' ' GLU . 25.7 mmt . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.41 110.293 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 109.936 -0.394 . . . . 75.21 109.936 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 52.01 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.588 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.42 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.42 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.803 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.43 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.31 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.32 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.1 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 43.04 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.33 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.41 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 33.22 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.41 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.832 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.3 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 62.23 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 61.34 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.02 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 41.43 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.53 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.02 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.34 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 64.2 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.4 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.44 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.22 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 74.44 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.32 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.22 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.13 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 60.44 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.54 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.11 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.1 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.34 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 62.53 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.33 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.35 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.3 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.33 109.701 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.34 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.21 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 64.43 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.52 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.54 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.34 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 62.5 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.31 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 74.34 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.497 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.2 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 71' ' ' VAL . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.23 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.932 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.33 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.33 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.04 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.01 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.45 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.3 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 65.53 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.01 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 71.41 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.832 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.13 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 64.32 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.33 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.21 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.53 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.4 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.31 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.33 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.42 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.44 108.473 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.45 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.14 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.43 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.42 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.53 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.22 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 70.32 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.13 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.3 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 52.3 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.32 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.03 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.45 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.03 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.53 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.42 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.4 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.588 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.13 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.33 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.22 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.31 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.34 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.24 111.367 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.04 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.24 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.1 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.44 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.32 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.01 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.51 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.636 ' HA ' HD11 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 64.44 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.31 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.711 HD12 ' HB1' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.42 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.803 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.03 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.42 110.895 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 64.53 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.41 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.02 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.15 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' C ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.02 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.22 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 31.13 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.719 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.43 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 61.12 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 71.12 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 61.41 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.2 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 74.14 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.3 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 73.54 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.54 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.05 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 54.25 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.01 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.51 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.32 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.35 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 62.4 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.14 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 64.13 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.33 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.12 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.551 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.2 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.42 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 65.34 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.32 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 61.45 109.421 174.503 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.308 0.575 . . . . 71.35 111.063 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.42 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 71.11 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD21 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 53.55 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.02 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.22 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.53 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.3 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.2 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 64.43 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.44 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 1.091 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.24 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.01 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.912 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.41 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.44 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.41 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.54 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.33 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.43 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.23 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.1 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 50.42 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.11 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.03 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.55 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.02 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.23 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 51.31 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.51 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.01 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.44 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.54 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.35 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.32 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.12 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.33 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 72.14 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.24 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 50.32 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.22 110.086 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.34 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.44 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.34 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.32 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.54 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.44 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.03 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.33 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.15 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.35 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.746 ' HD1' HG12 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 63.41 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.756 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 72.22 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.13 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.03 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 74.33 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 72.11 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.43 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.53 109.363 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.41 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 70.23 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.746 HG12 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.04 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.912 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.11 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 71.25 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.33 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.2 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 1.091 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.53 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 73.35 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.32 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.45 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 33.42 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.22 109.923 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.54 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.1 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 41.54 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 64.24 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 71.24 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.782 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 63.31 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.32 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.32 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.21 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.24 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 14' ' ' LEU . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.3 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.34 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.31 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.42 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.14 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.35 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 65.11 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.851 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.04 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 74.33 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.2 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.23 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 72.52 111.821 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.13 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.42 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.13 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.34 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.24 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.22 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 60.42 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.11 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.53 110.83 176.41 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.41 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.758 HD13 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.31 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.44 110.777 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.53 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.44 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.206 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.04 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.15 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.21 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.14 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.24 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 127' ' ' LEU . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 154' ' ' MET . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 55.11 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 31.35 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.54 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.34 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.23 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.31 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.12 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HE2' ' HB3' ' A' ' 59' ' ' ALA . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 70.01 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.41 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.03 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.41 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 44.3 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 138' ' ' ASN . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 65.44 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.14 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 72.34 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.41 111.472 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.651 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.33 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 65.42 108.716 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 65.31 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.13 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.05 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.851 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.01 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.14 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.21 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.53 110.355 176.788 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.842 0.829 . . . . 70.03 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.54 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HG3' HG12 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.31 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 60.42 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.11 109.6 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 63.22 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 63.32 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 61.2 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.24 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.04 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.04 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.34 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.32 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.1 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 61.03 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.14 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 65.45 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 60.23 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.43 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 35.03 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 72.32 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.45 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.13 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.42 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.53 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.33 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.53 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.02 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.45 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.22 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.31 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 71.32 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 64.04 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.4 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.15 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.23 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 62.34 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.24 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.51 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.34 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.34 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.53 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 21.32 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.1 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 62.35 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 55.31 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.43 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 44.03 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.33 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.21 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 72.03 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.23 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.04 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.2 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 73.31 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.41 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.32 109.884 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.53 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 45.33 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.35 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.23 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.14 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.04 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.41 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.2 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.31 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 74.25 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.1 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.31 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.42 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 70.14 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 63.32 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.43 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.1 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.04 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.32 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.24 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 64.2 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.44 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.53 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 62.03 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.34 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.24 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.22 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 65.14 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.14 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 24.52 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.22 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.2 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.4 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 54.14 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 62.32 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.12 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.499 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.21 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.45 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.3 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.43 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.4 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.42 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 71.41 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.14 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.14 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.2 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.35 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.31 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.52 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.11 111.575 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.24 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.32 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 41.11 110.07 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.21 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.45 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 54.13 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.32 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.42 112.007 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 74.42 110.191 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.15 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.21 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.23 109.969 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.53 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.11 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.6 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.4 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.22 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.41 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.32 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 60.04 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.34 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.23 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.35 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.42 110.677 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 53.15 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 73.03 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.12 112.039 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.14 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.41 110.396 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.32 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.703 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.11 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.12 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.685 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.02 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 71.21 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 64.22 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 72.53 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 154' ' ' MET . 51.7 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.22 110.89 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.016 0.436 . . . . 73.51 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.33 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 63.3 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.14 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.51 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.34 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.12 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 61.13 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.04 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.79 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.4 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.23 110.047 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.43 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.31 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.53 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 72' ' ' GLU . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.53 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.24 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.24 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.34 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.11 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 63.23 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.44 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.54 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.34 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.22 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 70.44 111.205 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.53 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.11 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.02 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.53 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 60.52 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.12 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 42.55 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 63.13 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.43 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.2 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.4 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 71.21 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.815 HD21 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 55.33 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.32 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.32 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.4 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 61.02 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.1 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.799 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.44 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.05 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 63.44 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.12 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 53.22 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.53 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.885 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.11 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 76' ' ' PRO . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.45 109.831 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 51.31 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.14 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.954 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.45 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 52.54 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.45 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.31 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.3 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.13 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.21 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.954 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 61.34 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 53.45 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' HD22 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.24 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 64.51 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.753 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 70.21 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.885 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 63.55 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.54 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.14 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 54.24 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.41 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.33 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.03 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.1 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.815 ' HA2' HD21 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.22 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.4 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 71.52 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.04 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.3 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 64.11 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.05 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.01 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.04 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.22 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.45 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 61.31 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.03 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.11 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.21 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.4 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.3 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.11 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 72.35 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 34.31 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.53 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.34 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.43 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.15 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.21 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.33 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.52 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.51 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.53 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.24 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.53 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.04 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.13 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.12 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.15 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.666 HG21 HD11 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.14 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.4 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 70.01 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.52 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.21 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.31 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 72.41 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.23 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.01 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 32.04 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.655 ' HB3' HD12 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.41 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.4 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.14 109.779 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.23 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 73.14 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 63.3 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.2 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.04 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.01 110.297 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.14 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.01 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.14 110.501 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 63.23 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.05 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.75 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 43.32 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.21 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 64.31 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.42 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.34 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.44 110.546 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 44.23 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 64.44 109.904 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.11 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.31 111.363 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.725 0.297 . . . . 72.21 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 70.34 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.33 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 62.04 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.698 HD13 HD21 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 35.51 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 71.22 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.4 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.202 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.33 112.093 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 53.41 109.646 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.03 112.138 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.51 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.53 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.13 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.33 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 74.54 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.32 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.4 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.54 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.04 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.13 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.33 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.42 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD21 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 53.23 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 71.01 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.31 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.14 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.13 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.33 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 72.31 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.04 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.23 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.03 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.05 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.34 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.13 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.4 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.15 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.14 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.33 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.31 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.22 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.03 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 43.54 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.41 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.559 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 52.5 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.31 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.13 112.23 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.13 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 72.31 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.25 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.02 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.786 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.41 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 23' ' ' ARG . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 61.55 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.42 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.47 ' SD ' ' N ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.43 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.12 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.34 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.43 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.53 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HE1' HD21 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.24 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.41 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 52.43 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 65.3 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.41 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 57' ' ' PRO . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.53 109.45 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.13 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 71.31 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.22 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.14 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.42 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.1 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 74.42 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.51 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.21 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.44 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.32 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.24 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.34 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 33.35 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 73.11 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 70.2 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.13 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 63.3 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.33 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.3 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 54.43 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.02 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 63.0 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.451 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.05 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.21 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.35 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 71.0 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.14 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.41 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.24 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.03 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.41 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.34 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.813 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.34 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.44 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 70.34 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.813 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.1 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 65.0 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.802 ' HG ' HD23 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.23 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.458 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.13 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.43 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.554 ' HE3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.11 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.31 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.15 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 70.41 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.698 HD21 HD13 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.31 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.05 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.526 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 61.24 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.498 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.32 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.13 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 34.34 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.03 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.24 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.45 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.4 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.656 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.42 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.14 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 73.13 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.4 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.23 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.35 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.45 113.001 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.41 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 71.41 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' A' ' 147' ' ' LEU . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 72.34 112.971 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 41.52 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.22 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' PRO . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.14 109.675 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.22 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.34 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 61.01 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.32 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.793 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 65.34 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.802 HD23 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 74.53 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 154' ' ' MET . 2.8 mpp? . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.31 110.448 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 113.64 0.978 . . . . 72.15 113.64 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.21 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.1 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.14 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 73.42 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.14 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 62.31 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.635 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.22 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.33 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.32 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.33 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' HD23 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.33 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.77 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.22 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.33 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.12 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.12 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.518 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 54.04 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.804 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 40.1 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.53 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.32 111.086 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.32 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.24 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.55 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.839 ' H ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 44.14 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.42 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.1 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.31 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.13 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.51 111.21 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.33 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 70.33 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.34 110.993 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.34 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 71.14 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 53.54 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.23 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.11 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 61.33 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.23 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.53 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.14 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 65.33 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.52 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.41 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.04 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 53.23 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.14 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.44 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 42.53 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.31 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.981 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.31 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.53 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.73 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 64.52 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.41 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.41 110.035 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.55 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.33 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.21 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 71.44 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.43 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.804 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 51.22 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.11 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.639 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.1 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.03 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.736 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.44 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.45 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.12 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.34 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.34 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.42 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 55.15 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.12 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 50.45 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.44 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.14 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.01 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.42 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 54.2 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 54.11 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.4 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.11 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.13 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.35 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 62.13 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.13 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 65.44 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 61.52 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.4 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 51.41 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.23 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.11 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.44 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.21 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.54 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.23 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.31 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.24 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 61.42 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.13 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.15 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 64.54 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.14 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.21 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.31 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.43 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.44 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.14 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.13 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.35 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.42 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.32 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.04 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.531 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.21 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.1 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.43 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.52 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.981 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 73.33 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.817 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.3 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.35 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 63.45 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 134' ' ' ILE . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.32 112.375 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.2 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.11 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.12 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.23 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.11 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.53 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.4 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.15 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 54.12 109.524 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 54.21 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.53 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.65 HG22 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.52 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.635 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.33 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.817 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.44 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.41 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.531 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 52.31 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.526 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 11.6 mmt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.42 111.093 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.044 0.45 . . . . 55.2 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 61.14 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.31 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 73.25 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.41 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.3 110.621 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.31 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 70.01 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 44.22 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.21 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 64.12 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 70.22 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.31 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 70.03 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 21' ' ' LEU . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.34 110.508 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.733 HD13 ' HB3' ' A' ' 73' ' ' PHE . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.31 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.34 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.43 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.41 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.24 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.35 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.11 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.33 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.54 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.34 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.12 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.41 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 71.05 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 71.31 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.42 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.2 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.02 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.685 ' HA ' HG22 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.31 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.54 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.42 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 62.44 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.15 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 73.33 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 51.41 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 52.42 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.32 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.43 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.43 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.33 110.45 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.33 111.826 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.44 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.22 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.829 ' HG2' HD11 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 71.03 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.44 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 62.35 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.12 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.4 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.33 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.12 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 72.2 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.15 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.22 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 64.24 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' HB3' HG22 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.2 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.41 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.35 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 62.23 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.733 ' HB3' HD13 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.42 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.42 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.44 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.52 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.1 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.32 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.23 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.42 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.2 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.31 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.559 ' HA2' HG13 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.14 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.13 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 52.12 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.32 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 71.24 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.22 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.11 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 65.32 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.35 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.24 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.41 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.656 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 33.4 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.14 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 62.42 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 44.41 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.2 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.22 108.688 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.806 HD12 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.24 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.2 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 139' ' ' PRO . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.12 111.599 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HE1' HG21 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.15 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.24 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.35 110.483 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.41 109.819 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 64.32 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.12 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.34 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.11 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.32 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.45 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.1 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.52 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.53 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.44 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.21 110.57 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 55.31 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 61.3 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.58 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.15 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 45.21 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.58 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.42 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.31 108.727 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 61.54 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 52.35 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.1 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.42 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.73 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.14 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.15 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.45 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.829 HD11 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.33 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 55.1 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.24 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.52 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.34 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.722 ' HB3' HD13 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.32 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.04 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.32 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.493 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.01 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.13 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.31 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.55 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.31 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.15 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.43 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.497 HG21 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.11 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.04 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.41 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.612 ' HB3' HD22 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.04 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.73 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 40.7 mtm . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.03 109.124 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.979 0.419 . . . . 74.44 111.645 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 73.14 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 54.43 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.2 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.11 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.01 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.23 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 70.13 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 32.51 109.975 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.41 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.52 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.11 113.695 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.23 110.746 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.4 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.588 HD13 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.41 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 61.42 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.22 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.42 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 44.13 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.21 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.44 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.22 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.2 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.21 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 63.52 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 53.23 110.283 -176.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.33 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.23 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.01 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 70.32 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.31 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.44 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.22 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.41 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.33 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 61.55 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.33 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.3 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.41 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 20.03 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 73.03 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 62.51 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.01 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.11 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.42 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.24 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.41 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.35 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 62.25 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.23 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.77 ' HB3' HG12 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.21 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.44 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.01 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 64.03 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.33 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.33 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.02 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 74.23 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.43 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.32 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG12 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.14 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.11 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.12 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.32 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.01 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.12 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 19' ' ' ALA . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 71.4 109.719 176.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.44 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.45 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.43 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.24 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.31 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.51 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.21 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.15 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.03 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 63.44 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.54 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.15 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 41.23 112.6 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.34 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.465 ' HB ' HD21 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.11 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.55 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.2 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.34 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.44 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 61.11 110.935 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.753 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 72.54 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 71.52 110.876 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 61.1 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.33 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.951 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.3 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.33 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.03 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.51 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.577 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.21 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 53.24 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.24 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 64.13 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.13 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.31 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 62.44 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.43 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.34 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 63.2 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.02 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.52 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 64.31 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.32 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.03 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 54.41 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.44 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.54 109.188 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 62.41 108.745 164.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 44.14 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.23 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.31 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.3 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.3 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.472 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.05 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 61.14 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.41 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.05 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.642 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.22 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.51 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 62.21 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 42.14 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.02 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.52 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.33 111.848 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 53.34 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.43 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 72.42 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.22 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.876 ' HD3' HD13 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.31 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.951 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.33 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.849 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 52.3 109.353 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 74.31 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.43 110.727 178.787 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.634 -0.876 . . . . 73.03 108.634 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.3 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.03 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.23 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.45 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.15 110.373 -174.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.35 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 55.42 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.11 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.686 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.11 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.2 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.2 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.4 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.22 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.518 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 74.21 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.551 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 70.04 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.41 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.31 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.42 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.765 HG21 HD22 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 62.44 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.41 112.336 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 54.44 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.765 HD22 HG21 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 64.15 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 44.23 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.34 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 72.14 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 54.0 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.34 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.12 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.01 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.15 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.42 110.228 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.42 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.11 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.33 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 61.13 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 54.41 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 70.3 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.51 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.02 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.4 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.45 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.21 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.14 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.12 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.12 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.42 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.4 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.12 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 64.32 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 54.33 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.44 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 63.35 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.32 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.54 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.11 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 62.5 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 64.42 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 40.32 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.42 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 64.14 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 1.016 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.04 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.14 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 35.21 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.21 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 31.1 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 61.55 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.22 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.698 HG21 HD23 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.34 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.34 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.43 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.45 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.579 ' HB ' HG11 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.43 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.33 109.916 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 21.24 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.11 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 64.13 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.22 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.32 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.12 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.32 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.22 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.01 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.13 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.686 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.51 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.33 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 54.21 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.54 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.34 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.05 110.983 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.05 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.11 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 73.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.481 ' N ' HD13 ' A' ' 103' ' ' ILE . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 73.43 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 63.33 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.13 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.52 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.13 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.24 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.693 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.44 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.925 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.11 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.52 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.1 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.925 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 73.32 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 51.03 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.31 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 53.24 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 53.22 111.445 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 72.42 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.451 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.14 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 64.22 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.31 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.33 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.3 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.33 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 120' ' ' VAL . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.21 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.33 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.22 109.386 175.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 154' ' ' MET . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.43 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.11 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.03 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.1 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.21 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.4 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.586 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.31 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.424 HD22 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 62.12 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 65.14 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.41 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.31 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.33 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.23 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.2 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.31 110.779 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.41 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 54.41 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.1 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.24 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HD2' HD22 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 64.44 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.24 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.32 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.402 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.01 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 61.04 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.2 109.167 171.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? . . . . . 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.51 110.529 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.898 -0.408 . . . . 74.14 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.42 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.02 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 71.24 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.33 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.03 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 71.23 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.33 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 55.52 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 64.54 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.51 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.24 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.22 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.33 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.33 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.34 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.15 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.11 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.31 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.03 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.24 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.22 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.33 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.41 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 61.34 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 54.42 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.04 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.31 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.13 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.31 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.02 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 62.32 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.21 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 54.53 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.43 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.44 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.05 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 61.14 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.14 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.53 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.33 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.41 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.15 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.22 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.14 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 65.23 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.11 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.621 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.42 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 72.3 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 61.45 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.53 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.32 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.54 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.35 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 30.23 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.4 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 51.14 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.53 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.45 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.12 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.35 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.22 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.3 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 62.55 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG21 HD13 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.12 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.13 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.22 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.1 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.24 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.822 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 62.1 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.24 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 64.52 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 63.11 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.33 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.32 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.44 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.04 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' SER . . . . . 0.757 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.34 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 50.51 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 55.21 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.33 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB2' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.11 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.3 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.531 ' HB2' HD21 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.51 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.52 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.1 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.34 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.34 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.527 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 63.25 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.24 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . 0.635 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.12 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.31 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.22 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.22 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.12 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.13 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.42 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 74.42 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.14 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' TRP . . . . . 0.752 ' HZ2' ' HB2' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 73.33 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 116' ' ' LEU . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.21 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.24 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.33 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 120' ' ' VAL . 24.7 m120 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.11 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.23 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.3 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.22 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.01 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 44.43 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.24 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.54 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.01 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.823 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 52.21 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.23 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 70.2 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.32 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 53.54 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.928 ' HB3' HG21 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.02 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.22 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.01 112.763 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 62.35 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.31 109.612 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' THR . . . . . 0.928 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.12 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.12 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.41 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.3 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 63.43 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.22 108.431 176.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ARG . . . . . 0.57 ' H ' ' HB2' ' A' ' 137' ' ' ASP . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 71.33 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HD2' HD12 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.41 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.51 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 52.42 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.834 HD13 ' H ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.53 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.13 111.343 -169.625 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.057 0.456 . . . . 62.03 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 63.4 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 62.3 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.803 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.867 HD11 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 45.5 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 71.25 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.24 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.32 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.3 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 63.25 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.13 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HG ' HG12 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 73.23 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD12 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.41 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.01 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.847 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 64.24 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 43.42 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.53 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.2 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 61.43 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.44 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.44 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 71.41 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 70.53 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 61.31 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.04 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.33 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.41 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 52.21 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.3 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.03 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 44.35 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.42 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.22 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.2 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.32 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.43 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.3 109.562 173.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.34 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 60.31 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.53 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.11 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 51.43 110.628 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.42 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.24 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.35 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 64.04 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.656 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.23 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.52 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.31 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.12 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 60.54 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' TYR . . . . . 0.857 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.23 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.03 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.32 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' A' ' 128' ' ' SER . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.42 111.685 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 53.23 110.446 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.52 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 53.43 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.42 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.892 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.24 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 64.13 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.481 ' OE1' HD12 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 64.24 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.44 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.33 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 52.24 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.34 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.43 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.32 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.32 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HB3' HD12 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.14 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 44.12 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.44 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 62.13 111.409 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.4 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.12 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.05 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.22 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.15 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.45 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' HD13 ' A' ' 21' ' ' LEU . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 51.03 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HD2' ' OE2' ' A' ' 72' ' ' GLU . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.31 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.42 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.52 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.867 ' HD3' HD11 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.34 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 51.15 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.42 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' SER . . . . . 0.527 ' HB2' HD21 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 61.05 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 61.52 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 64.4 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.42 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.34 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.43 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.418 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.01 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.55 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.23 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 65.02 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.41 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 53.33 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.14 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.14 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.41 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 55.2 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 72.2 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.529 ' HA ' HG12 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.42 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.42 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.05 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.31 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 53.22 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 55.05 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.43 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.23 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.15 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASP . . . . . 0.4 ' OD2' HD23 ' A' ' 11' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.01 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.839 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 63.15 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.32 110.688 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.594 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.21 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ALA . . . . . 0.857 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.2 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.892 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.03 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 72.01 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.34 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.41 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.11 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.22 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.53 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.44 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 33.14 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.41 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.33 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.33 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.03 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 144' ' ' PRO . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.33 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.1 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 64.23 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.44 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 53.43 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 61.3 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.34 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.42 109.7 175.597 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.089 0.471 . . . . 74.31 111.042 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.36 -68.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 73.12 109.669 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -83.56 85.35 7.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.224 -0.443 . . . . 74.43 110.203 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -99.76 -32.19 11.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 61.12 109.773 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.3 m 63.19 97.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.17 -0.923 . . . . 71.1 111.64 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -149.21 113.49 5.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 65.23 110.088 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 64.94 -178.74 0.18 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.719 -0.673 . . . . 64.12 111.643 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.03 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 41.32 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 44.21 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.35 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.01 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 52.22 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' SER . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.11 109.317 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 54.42 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.44 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 73.41 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 51.21 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.24 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.23 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 64.1 110.465 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.42 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.722 HG21 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.23 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 60.53 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.11 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 71.2 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.32 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.03 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 30.34 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 44.43 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 62.15 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.425 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 74.42 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.3 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.54 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.21 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.24 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.12 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.13 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.24 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD22 HD23 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 63.45 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 63.23 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.75 HD23 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.23 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.14 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 43.41 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.22 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.2 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.45 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.15 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.54 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 63.4 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.22 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.13 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.24 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 73.55 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.1 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.33 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 70.2 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.45 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 64.04 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.53 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.47 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.04 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.12 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.51 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.12 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 71.11 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.34 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.54 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.587 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.15 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.758 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.34 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.45 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.23 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 60.42 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.14 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' OE1' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.45 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.33 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.12 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.425 HG23 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.12 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.24 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.3 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.05 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.15 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 72.44 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.945 HG22 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 74.05 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 74.22 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.33 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.54 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.43 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 51.11 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.42 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.43 110.025 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 44.14 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.12 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.42 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.551 ' H ' HD21 ' A' ' 155' ' ' LEU . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.41 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 71.14 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.33 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.24 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.32 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.3 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.05 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.23 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 65.25 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.11 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.33 109.468 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.03 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.799 ' HG2' ' HA ' ' A' ' 162' ' ' HIS . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.34 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.53 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 62.41 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.3 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.31 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.02 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.659 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.4 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.34 110.692 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.05 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.659 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.04 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 155' ' ' LEU . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 63.32 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.11 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.41 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.631 HD22 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.32 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.44 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.619 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.41 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 72.52 111.343 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.757 HD12 ' H ' ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.31 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 71.22 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.12 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.44 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 63.12 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 73.32 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 52.0 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.479 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.05 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.41 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 64.03 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 54.43 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.495 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.52 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.904 ' HA ' HD21 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.44 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.04 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.24 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 64.32 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.22 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' A' ' 147' ' ' LEU . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.2 112.254 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.803 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.43 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 64.41 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.904 HD21 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.4 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.3 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.23 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.11 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 70.03 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.22 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.54 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm -71.19 148.15 47.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 71.1 110.211 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 120' ' ' VAL . 59.6 mt -94.38 104.34 16.32 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.975 -0.557 . . . . 71.52 111.895 -171.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.8 t60 63.24 78.14 0.3 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.887 -0.597 . . . . 62.12 111.864 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -138.15 -51.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 74.33 111.012 175.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.486 ' H ' ' CD ' ' A' ' 157' ' ' GLU . 26.8 t -176.24 -67.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.192 -0.67 . . . . 33.03 109.192 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.46 43.78 12.39 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.14 0.9 . . . . 70.43 111.551 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.77 90.26 5.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.714 0.768 . . . . 64.23 110.552 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.471 ' CD2' ' HG3' ' A' ' 110' ' ' GLU . 58.7 t60 -133.52 115.89 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.811 -1.086 . . . . 64.21 108.491 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.799 ' HA ' ' HG2' ' A' ' 110' ' ' GLU . 36.9 m80 -145.21 131.68 19.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.698 0.285 . . . . 73.21 111.189 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -81.64 -55.81 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 71.51 109.684 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 73.0 t60 70.09 105.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.802 0.689 . . . . 43.11 111.153 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -107.3 79.34 1.3 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.525 0.679 . . . . 75.13 110.783 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.536 -0.745 . . . . 71.12 109.922 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.932 -0.396 . . . . 72.33 109.932 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -177.41 179.48 0.95 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.319 -0.401 . . . . 70.53 110.006 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -107.74 -31.44 8.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.744 -0.465 . . . . 74.11 109.744 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 54.4 25.38 5.99 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.461 -0.791 . . . . 74.32 111.561 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.6 m 51.61 51.78 15.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 75.21 110.938 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 70.33 108.38 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.805 0.691 . . . . 63.41 111.215 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -61.93 148.67 42.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.591 -0.731 . . . . 73.43 110.379 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 61.2 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.55 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.55 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.42 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 74.21 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.21 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 61.33 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 53.2 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.1 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.52 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.02 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 53.2 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.21 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.22 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.44 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.34 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.21 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.43 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 62.23 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.34 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 43.32 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.22 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.14 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.34 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.03 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.53 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.11 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.03 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.1 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 63.45 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.22 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.52 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.13 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 63.44 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.42 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 61.34 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.22 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 61.21 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.447 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 64.13 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.4 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.01 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.42 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 52.41 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.02 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 64.54 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 53.02 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.11 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.52 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.35 112.125 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.23 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.34 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 61.41 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.04 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 54.22 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.24 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.23 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.3 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.1 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.31 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.32 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.2 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.21 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.3 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.24 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.845 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.12 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 62.05 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.51 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 64.5 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.34 113.254 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 52.23 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.03 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.24 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 78' ' ' GLU . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.02 112.366 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.6 HG23 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.13 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 62.51 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 25.51 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.475 ' H ' HD22 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 54.44 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.33 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.44 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HB ' HD21 ' A' ' 45' ' ' LEU . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.32 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 42.34 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.561 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 73.41 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.31 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.429 ' N ' HD23 ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 71.42 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.13 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.42 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 65.25 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 61.25 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HB3' HD11 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.33 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.12 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.52 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.01 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 62.01 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 55.13 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.588 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 70.01 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.599 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.779 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.44 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.41 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.23 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.596 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 45.14 110.272 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.34 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 64.05 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.01 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.22 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.565 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 72.35 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.02 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 70.05 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.32 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.23 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.46 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.13 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.11 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.21 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 62.44 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.688 ' HB3' HD13 ' A' ' 155' ' ' LEU . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 65.4 111.296 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.13 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' ' 155' ' ' LEU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.11 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.1 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.706 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.52 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HB2' HD21 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.24 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.32 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.699 ' HB3' HG23 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.41 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.648 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.51 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.23 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.438 ' N ' HD23 ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.14 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.52 ' HB2' HD13 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.4 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.04 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 54.21 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.31 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.31 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.66 HG23 HD23 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.21 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.54 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.779 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.54 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.35 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.34 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.66 HD23 HG23 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.2 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 148' ' ' ARG . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.54 110.125 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.11 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.11 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 70.52 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.42 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.35 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.706 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp -67.53 124.34 22.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.31 111.023 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' ' 127' ' ' LEU . 91.8 mt -68.88 161.52 28.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.061 -1.089 . . . . 75.01 108.061 168.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.1 t60 76.0 129.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.746 -0.835 . . . . 74.54 108.746 -164.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.59 134.38 24.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.136 -0.484 . . . . 65.55 111.948 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 m -54.19 127.49 27.13 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.002 -0.999 . . . . 64.54 112.361 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.35 -43.54 56.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.434 -0.803 . . . . 73.35 109.601 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 162' ' ' HIS . 10.0 tp10 -64.89 119.57 10.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.658 -0.701 . . . . 64.11 109.355 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -85.92 80.91 8.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 51.12 111.549 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.688 ' HD2' ' HG3' ' A' ' 160' ' ' GLU . 15.0 m-70 -114.95 114.9 26.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.59 . . . . 72.33 109.727 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 21.3 m80 -140.95 72.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.095 0.474 . . . . 73.31 111.629 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -110.52 128.03 55.45 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.907 -0.588 . . . . 72.22 109.526 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 73.9 m80 -73.91 -76.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.426 -0.583 . . . . 73.24 109.426 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 165' ' ' HIS . 14.3 t-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.388 -0.815 . . . . 63.44 109.937 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.177 0.513 . . . . 74.13 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.36 179.73 5.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.81 -0.632 . . . . 74.14 109.424 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -109.01 106.1 15.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.464 0.649 . . . . 75.13 110.09 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -110.46 7.16 22.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.182 -0.917 . . . . 64.05 111.096 -174.132 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.0 p -134.17 74.21 1.53 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.348 0.594 . . . . 72.41 110.698 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -100.29 109.08 21.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.67 -0.695 . . . . 72.22 110.11 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 63.89 -170.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.331 -0.85 . . . . 55.42 111.321 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 61.33 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.13 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.43 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.24 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.13 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.41 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 60.41 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.43 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.11 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.23 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.23 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.14 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD13 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.55 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.14 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.45 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.51 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.676 HG21 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.23 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.55 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.33 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 55.34 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.03 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.01 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.44 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.35 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 65.42 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.03 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.44 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.41 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 53.32 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.22 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.14 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.23 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.55 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.22 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 72.31 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.41 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.2 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 32.53 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.44 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.44 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.04 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.34 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.52 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.42 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.21 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.834 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.14 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.53 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 61.12 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 72.31 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 62.05 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 64.54 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.11 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.04 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.31 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.32 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 45.43 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 73.11 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.2 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.51 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.11 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.54 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 65.24 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.14 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 64.14 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.04 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 61.53 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.13 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.32 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.43 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.24 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 51.5 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 86' ' ' ARG . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.15 110.49 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 71.52 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 62.13 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 55.03 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.44 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.33 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.42 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.23 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 61.2 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.33 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.461 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.22 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.13 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 42.01 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 52.22 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.922 ' HB2' HG23 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 61.44 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.04 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.11 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.584 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.32 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.01 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 52.5 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.41 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.52 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.67 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 55.11 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.43 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.54 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.922 HG23 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.34 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 71.32 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.14 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.33 110.714 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.653 HD22 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.45 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 44.3 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 4' ' ' GLU . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 53.33 109.527 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.54 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.43 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.14 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.05 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.03 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.52 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' HG23 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.33 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.24 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.633 HD12 ' H ' ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.42 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.864 ' HB2' HD23 ' A' ' 155' ' ' LEU . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.31 108.013 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.03 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.13 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.13 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.51 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.12 110.371 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 63.41 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.834 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.44 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.24 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.2 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.675 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.01 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.43 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 63.32 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.11 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.695 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.21 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 64.02 111.215 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.33 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.22 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 51.35 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.54 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.21 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 43.45 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.22 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.82 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.24 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.21 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.22 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.06 135.06 56.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.12 111.286 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 128' ' ' SER . 4.3 mm? -74.4 100.13 3.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.787 -0.642 . . . . 64.44 109.442 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.56 ' H ' HG11 ' A' ' 120' ' ' VAL . 14.3 p80 60.7 159.52 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.758 1.623 . . . . 71.51 113.52 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 66.27 26.16 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.846 -1.07 . . . . 72.1 111.883 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.2 p -81.89 117.33 22.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.411 -0.588 . . . . 71.52 109.411 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.11 91.58 1.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.291 -0.413 . . . . 73.44 111.851 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 179.28 122.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 72.42 109.975 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -156.28 21.08 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.496 . . . . 75.53 112.341 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -94.97 16.29 16.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.388 0.613 . . . . 74.01 110.099 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -63.13 134.37 55.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.165 -0.925 . . . . 74.45 110.433 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -92.86 170.34 9.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.027 -0.533 . . . . 75.21 110.685 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -115.56 -11.31 11.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.279 0.562 . . . . 51.51 109.852 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.4 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.149 -0.932 . . . . 74.51 108.792 174.08 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.473 0.178 . . . . 72.13 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 3' ' ' PHE . 4.4 p-10 -77.94 -85.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.454 -0.498 . . . . 71.2 111.289 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 86.8 t80 178.75 -41.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.833 0.349 . . . . 70.23 111.397 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.28 91.16 6.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.347 0.594 . . . . 70.24 112.353 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -127.07 84.34 2.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 73.4 109.197 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.26 100.87 12.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.205 -0.452 . . . . 74.33 111.001 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -97.64 139.46 33.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.974 -0.557 . . . . 75.41 109.986 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.23 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.23 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.51 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.51 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.01 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.13 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.4 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.13 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 63.43 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.03 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 44.04 110.754 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.54 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 53.44 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.13 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 23' ' ' ARG . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.23 108.777 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.741 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.14 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.34 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.32 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.32 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 72.44 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 63.33 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.4 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 61.04 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.3 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.12 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.741 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.24 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.31 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.14 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.32 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.32 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 64.35 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.3 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.44 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.35 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.1 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.02 111.515 -173.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.15 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 72.54 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.32 112.599 -178.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.14 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.1 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' HD13 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.13 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.426 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.23 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.41 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.41 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.32 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.22 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.12 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.54 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.01 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.22 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.41 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 62.5 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.625 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.3 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.02 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.24 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 64.22 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.23 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 74.13 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 55.3 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.31 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 51.13 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.63 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.52 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HZ ' HG12 ' A' ' 22' ' ' ILE . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 60.51 111.712 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 51.42 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 52.13 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 64.25 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 53.43 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 54.34 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.01 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.23 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 53.32 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.44 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 86' ' ' ARG . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.03 109.986 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.23 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.21 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.42 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.44 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.34 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.32 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.44 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 62.44 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 73.44 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 70.3 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.44 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 155' ' ' LEU . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.03 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.13 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.41 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.31 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.988 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.53 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.04 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.44 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.31 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.631 ' HE1' HD11 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.3 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 52.31 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.32 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.631 HD11 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 65.01 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.12 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.52 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.22 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.32 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.03 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.33 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.04 111.037 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.04 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 72.42 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 71.51 111.165 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.2 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.52 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.01 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.33 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.874 ' HD2' HD11 ' A' ' 155' ' ' LEU . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.52 109.248 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.648 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 71.1 110.927 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.41 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 72.24 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.22 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.04 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.34 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.53 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 65.23 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 74.01 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.04 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.73 ' H ' HD23 ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.12 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.12 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 65.45 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.54 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.44 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.32 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 73.52 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.1 111.421 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.4 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.02 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.35 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 54.32 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.31 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.988 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 52.43 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.743 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.3 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 41.54 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.1 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 72.33 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 156' ' ' HIS . 50.0 ttp -75.66 89.71 2.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.51 109.35 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.874 HD11 ' HD2' ' A' ' 125' ' ' PHE . 2.1 pt? -79.67 45.82 0.72 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.113 0.958 . . . . 54.53 111.172 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.5 t-80 -71.12 -64.81 0.84 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.377 -1.283 . . . . 74.11 108.37 176.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.528 ' OE2' ' HA ' ' A' ' 163' ' ' HIS . 54.0 mp0 -139.75 -41.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.194 -0.912 . . . . 75.14 109.261 168.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.3 p -163.82 -73.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 72.53 111.588 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -166.53 -37.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.272 -0.876 . . . . 55.02 108.683 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.12 133.52 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.754 -0.657 . . . . 74.01 110.966 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.58 95.26 1.81 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.345 0.593 . . . . 63.23 110.116 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.5 -173.12 2.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.857 -0.794 . . . . 73.01 108.857 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.528 ' HA ' ' OE2' ' A' ' 157' ' ' GLU . 8.2 t-160 -143.88 106.18 4.4 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.61 -0.436 . . . . 72.34 110.387 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -122.46 46.74 2.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.392 0.615 . . . . 75.21 109.779 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -169.74 154.3 5.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.076 -1.083 . . . . 55.44 108.076 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.528 -0.749 . . . . 72.34 110.231 179.073 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.793 0.33 . . . . 74.04 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.15 105.43 15.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.581 -0.282 . . . . 73.13 110.699 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.02 96.33 2.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.967 0.413 . . . . 64.34 111.142 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 44.29 77.88 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.07 -0.968 . . . . 62.22 112.118 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -115.79 88.43 2.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.233 0.54 . . . . 72.22 110.584 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -97.92 98.08 9.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 74.04 110.549 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -128.63 105.39 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 72.21 109.578 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.54 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 41.12 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.52 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.22 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.44 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.35 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.52 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.33 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.21 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.24 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.02 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 65.33 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.34 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.072 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.2 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 86' ' ' ARG . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.34 108.048 165.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 52.23 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.43 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.13 109.878 172.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.42 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.21 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.13 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.34 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.35 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.35 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.54 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 71.34 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.446 HD13 ' O ' ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.12 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.4 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.42 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.15 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.13 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.51 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.53 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.13 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 70.22 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.13 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.22 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.31 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.04 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.03 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.676 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.32 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 61.21 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.676 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.05 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 62.15 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.14 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.784 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 60.21 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.11 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.33 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.43 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.14 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.98 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.24 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 72.32 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 63.31 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.55 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.34 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.41 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.23 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.02 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.22 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 1.072 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.01 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.35 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.41 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 50.14 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.591 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.1 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 65.12 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.52 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.21 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.43 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.52 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG3' HD12 ' A' ' 22' ' ' ILE . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 71.23 111.115 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.15 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.3 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.03 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 41.23 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.2 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 71.02 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.23 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.12 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.41 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.44 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.35 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.84 ' H ' HD22 ' A' ' 155' ' ' LEU . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.34 110.269 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.43 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.2 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.13 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.43 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.23 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.1 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.42 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 54.13 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 31.24 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.12 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 73.43 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.23 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.44 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.04 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.03 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.12 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.24 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.2 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.431 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.11 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.43 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.21 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 1.019 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.23 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.22 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.44 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.12 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.31 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 73.34 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.35 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.23 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.11 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.23 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.24 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.98 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.53 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 74.14 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 73.34 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.21 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 74.3 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.33 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 65.5 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 54.31 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.53 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.32 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.23 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.12 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.52 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.11 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 72.43 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 54.2 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.13 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.635 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.3 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 52.42 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.11 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.01 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.691 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.11 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.823 HD12 HD21 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 55.01 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 69.7 mtp -62.84 104.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.23 111.315 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 1.019 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -98.77 45.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.652 0.739 . . . . 52.15 112.155 -176.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -135.85 -50.2 0.71 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.336 -0.847 . . . . 62.54 110.956 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -150.71 139.05 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.626 -0.509 . . . . 73.45 109.626 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 p -81.41 90.52 6.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.695 0.284 . . . . 73.21 110.958 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.6 mp -89.02 -6.66 57.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 72.3 110.405 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.92 99.14 7.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.006 -0.543 . . . . 43.3 109.902 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -117.61 108.32 15.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.989 -0.55 . . . . 72.14 110.14 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -142.04 -170.63 3.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.573 -0.739 . . . . 73.22 110.206 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -143.68 39.02 1.37 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.073 -1.084 . . . . 65.23 108.073 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -73.48 -4.5 34.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.064 -1.425 . . . . 74.02 110.584 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.39 164.74 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 60.45 110.439 172.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.811 -0.614 . . . . 52.05 109.383 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.111 -0.329 . . . . 72.15 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 t70 66.79 -162.85 0.23 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.783 0.677 . . . . 73.44 109.325 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -88.62 109.69 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.444 -0.206 . . . . 74.04 110.444 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 71.77 160.72 0.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.529 0.518 . . . . 70.42 111.278 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -73.73 114.52 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 44.43 109.968 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -110.88 93.31 4.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.137 -0.483 . . . . 63.21 111.196 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.62 92.85 9.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 55.43 109.943 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 61.43 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 54.41 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.33 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.31 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 64.34 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.3 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.41 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.15 109.781 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 73.12 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.23 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.52 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.11 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 54.43 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 72.34 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.42 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.04 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.22 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.42 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.31 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 51.12 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.21 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.13 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 53.4 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 52.32 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.4 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.53 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.54 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 63.33 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.42 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.52 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.1 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.01 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.599 ' HB ' HG21 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 60.21 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 61.35 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.53 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 60.53 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.636 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.15 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.44 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.44 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.45 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.45 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.23 110.609 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.42 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.44 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.22 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.13 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.472 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.22 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 73.44 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.11 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 73.24 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.23 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.02 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.668 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.24 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.21 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 44.13 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.11 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.23 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 62.33 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.54 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 43.33 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.547 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.41 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.51 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.15 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.34 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.44 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 72.1 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.54 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.44 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.34 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.21 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 62.52 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.15 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.806 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 52.45 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.42 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.31 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.55 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 54.04 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 72.33 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.24 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.12 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.24 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.3 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.53 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.45 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 155' ' ' LEU . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.11 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.53 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 73.22 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.14 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.606 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.24 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.22 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.2 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 62.12 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.3 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 54.11 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.533 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.22 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.54 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.45 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.33 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.52 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.22 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.42 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.14 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.31 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.43 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 53.55 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.11 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 40.1 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 54.43 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.41 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.23 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.45 110.319 176.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' LEU . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.33 109.873 174.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.03 110.226 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.52 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.55 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.15 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.22 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.35 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.667 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.24 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.45 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.2 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 43.02 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.13 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 70.13 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 54.32 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.42 110.376 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 72.22 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.1 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.45 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.669 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.43 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.14 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.606 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.35 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.31 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.667 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.14 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 54.12 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 71.12 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.51 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.507 ' SD ' ' HG3' ' A' ' 64' ' ' MET . 57.0 mtp -61.18 140.69 57.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.54 110.335 174.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 98' ' ' ALA . 94.6 mt -82.41 -1.36 49.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.145 -0.48 . . . . 72.43 110.965 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 37.7 t60 -83.39 70.71 10.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.208 -0.664 . . . . 73.4 109.208 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 72.49 149.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.174 0.921 . . . . 45.04 110.864 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 t -79.19 90.75 4.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.205 -0.452 . . . . 70.31 110.562 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.78 -176.47 6.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.061 -0.518 . . . . 75.01 110.102 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 5.9 mm-40 50.7 83.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.004 -0.998 . . . . 74.32 112.86 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -119.07 44.96 2.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.659 -1.155 . . . . 74.35 108.051 172.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -60.93 104.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.208 -1.36 . . . . 62.45 111.732 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -92.05 -178.58 5.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.623 -0.717 . . . . 71.01 109.682 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -139.88 156.97 46.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.004 -0.369 . . . . 63.44 110.004 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.32 163.82 13.27 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.379 -0.601 . . . . 63.3 109.379 175.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.38 -0.819 . . . . 73.31 110.123 177.699 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.437 0.161 . . . . 75.0 111.334 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.32 -49.82 3.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.129 0.49 . . . . 64.13 110.151 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.57 159.54 26.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 70.4 110.512 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.97 139.49 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.122 -0.49 . . . . 64.34 110.704 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.17 -179.43 6.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.635 -0.711 . . . . 52.23 110.899 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 98.9 mt-30 55.73 69.92 0.69 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.896 -0.593 . . . . 74.12 111.094 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 28.9 t80 -81.36 133.95 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.63 -0.507 . . . . 74.54 109.63 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.1 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.11 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.54 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.807 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.24 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.52 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.3 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD13 ' OH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.42 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.54 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.34 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.23 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.53 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.24 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 63.13 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 65.21 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 63.15 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 HG23 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.43 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.759 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.55 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.684 HG23 HG22 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 61.33 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.35 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.04 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.45 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.54 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.13 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.04 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.02 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.3 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.11 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.14 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.45 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.55 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.02 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.24 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.21 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 72.12 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 53.04 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.45 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.1 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HG3' HG22 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.02 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 72.04 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.23 112.334 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.12 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.01 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.1 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.22 112.365 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.64 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.12 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.34 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.15 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 65.44 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.22 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.573 ' HA ' ' CE ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.31 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 55.53 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 54.01 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.03 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.34 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.52 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.05 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.45 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.42 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.24 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 24.01 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 52.31 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.14 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.601 HG12 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.01 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.35 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 34.23 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.1 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.643 HG22 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.11 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.22 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.23 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.31 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.04 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 53.24 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.32 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.12 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 43.02 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.44 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.34 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.21 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.44 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.42 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.668 ' O ' ' HD2' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.34 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.563 ' HA ' HD21 ' A' ' 155' ' ' LEU . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 71.34 110.284 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 155' ' ' LEU . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.34 109.695 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 55.14 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 43.12 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 72.45 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.856 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.15 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.724 HD11 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.31 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 64.14 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.53 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 73.44 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.32 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.15 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.42 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.14 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.3 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 72.53 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.11 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 55.15 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 71.45 111.398 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.03 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.11 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.33 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.807 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.24 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 72.33 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.24 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.11 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 71.45 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.31 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.823 ' HB2' HG23 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.33 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.41 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.79 HD11 ' HA ' ' A' ' 159' ' ' LEU . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 71.43 112.69 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 155' ' ' LEU . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.42 109.848 172.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.23 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.4 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.864 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 32.3 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.34 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.64 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 42.31 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 51.2 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.776 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.45 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.471 ' HB2' ' CG2' ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.24 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.33 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 72.21 113.645 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 42.15 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.41 111.307 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.23 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.24 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.14 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.03 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.712 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 84.5 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 63.12 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 63.12 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 73.12 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.42 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.12 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 71.51 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.4 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.33 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.864 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 59.3 mtm -75.53 27.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.32 110.931 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 98' ' ' ALA . 4.2 mm? 70.69 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.562 0.745 . . . . 41.45 111.736 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 0.9 OUTLIER -61.05 -69.06 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.507 0.504 . . . . 72.44 111.993 -169.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 3.2 tt0 176.44 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.101 0.477 . . . . 62.43 109.832 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.3 m -132.68 69.24 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.149 -1.056 . . . . 74.45 108.149 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.79 ' HA ' HD11 ' A' ' 127' ' ' LEU . 10.1 mp 58.39 -99.83 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.032 -0.985 . . . . 54.12 109.327 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.26 23.99 2.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.861 0.839 . . . . 72.44 109.895 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 71.1 m80 -85.88 48.3 1.58 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.586 -1.188 . . . . 72.33 109.404 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -75.24 51.66 0.55 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.42 -0.809 . . . . 64.31 112.72 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -155.98 85.78 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.643 -0.873 . . . . 74.13 108.643 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -154.68 160.79 41.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.604 -0.726 . . . . 75.53 109.815 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -78.14 137.77 38.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.118 0.485 . . . . 74.02 111.128 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.338 -0.839 . . . . 63.15 109.465 176.063 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 110.768 -0.086 . . . . 72.12 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 60.99 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.316 0.647 . . . . 63.04 110.599 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.5 t80 62.15 -7.31 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.551 0.74 . . . . 70.21 112.899 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 164.2 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 52.13 112.086 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.2 m -102.01 -55.17 2.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.48 -0.933 . . . . 53.33 108.48 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -178.4 127.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.122 -0.945 . . . . 62.53 109.078 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -124.62 126.88 46.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.161 -0.311 . . . . 72.11 110.161 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.13 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.13 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.24 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 45.32 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.24 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.44 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.35 109.434 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.34 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.31 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.21 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.34 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.748 HD13 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.54 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 54.35 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.34 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 61.51 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.12 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 63.33 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 31' ' ' LEU . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 61.14 111.673 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 72.03 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.54 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.04 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 HD21 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.51 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 64.42 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 71.43 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 72.11 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.31 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.02 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.32 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.32 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 45.53 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.42 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 55.22 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.05 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.23 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.41 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 64.43 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.55 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 64.12 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.21 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 63.13 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.22 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 60.12 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.55 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.44 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.51 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.31 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 134' ' ' ILE . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.31 110.064 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.04 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.35 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.41 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.826 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 53.33 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.42 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.05 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.44 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.31 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.43 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.31 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 71.34 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.53 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.21 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 73.22 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.611 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 74.22 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.55 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.44 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.3 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.53 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.31 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.03 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.55 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.52 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.54 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.12 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.15 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 32.35 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.14 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.54 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 31.33 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.31 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 71.13 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 43.33 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.1 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.45 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.42 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.737 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.33 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 155' ' ' LEU . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.32 110.498 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' H ' HD21 ' A' ' 155' ' ' LEU . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 44.34 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.53 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.04 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.31 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 62.53 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.15 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.12 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.22 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 74.33 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.22 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.44 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.13 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 62.45 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.04 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.12 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.545 ' HA ' HD12 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.33 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.32 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.44 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.2 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.23 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.12 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.41 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.878 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.12 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.23 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.22 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.03 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.12 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 73.04 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.52 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.3 110.603 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.43 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.593 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.44 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.42 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.22 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' HG21 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 45.42 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 58' ' ' PHE . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.03 108.901 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 61.54 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.595 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.12 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.23 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.618 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.14 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.34 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.24 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.14 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 63.53 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.588 ' H ' HG23 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.23 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.42 111.218 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 53.02 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 51.1 109.847 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.44 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.03 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.34 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.21 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.32 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 72.43 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt -99.2 140.43 33.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.21 111.416 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.719 HD21 ' H ' ' A' ' 98' ' ' ALA . 2.7 mm? -114.04 148.29 37.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 62.15 109.975 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.6 t60 73.71 -50.49 0.69 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.353 0.871 . . . . 75.24 113.353 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -76.31 92.94 3.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.417 . . . . 72.2 110.102 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -68.89 104.92 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.73 -0.668 . . . . 71.15 111.669 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 98.7 mt -85.44 -3.8 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.788 0.804 . . . . 72.11 109.082 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -148.81 151.34 34.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.76 -1.2 . . . . 71.22 107.76 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.859 0.724 . . . . 71.42 112.656 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -120.6 136.64 54.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.774 -0.824 . . . . 71.34 108.774 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 23.6 m80 64.59 103.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.862 0.726 . . . . 63.54 109.788 -166.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -82.54 145.34 29.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.063 -0.517 . . . . 70.05 111.787 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 69.98 149.45 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.291 -0.868 . . . . 73.25 112.427 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.721 -0.672 . . . . 62.32 109.195 168.935 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.744 ' HB2' ' HB2' ' A' ' 145' ' ' ASP . 89.4 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.546 -0.539 . . . . 74.33 109.546 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -137.48 31.29 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.024 0.44 . . . . 75.23 110.902 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -74.85 97.12 3.23 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.867 -0.606 . . . . 73.33 110.891 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 64.64 174.45 0.2 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.095 -0.957 . . . . 70.33 112.242 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -148.2 90.91 1.86 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 53.32 108.842 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 63.4 tt0 -114.9 114.54 25.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.82 -0.627 . . . . 72.31 110.668 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 -121.51 104.25 9.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.454 -0.794 . . . . 74.23 109.457 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.14 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 64.24 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 52.4 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 44.4 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 51.21 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.2 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.21 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 64.14 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.04 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.41 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.01 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.22 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.33 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 63.44 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.3 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.51 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.35 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.44 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.497 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 53.0 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 25.01 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.13 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.13 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 71.01 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.53 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 71.32 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 74.44 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 74.03 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 73.43 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.23 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.52 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.51 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.31 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 73.14 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.23 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.42 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.42 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 61.13 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.34 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.21 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.53 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 70.43 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.13 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 65.11 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 61.2 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.34 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.959 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 55.25 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.51 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.14 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.13 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' HD1' HG22 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.24 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.52 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.02 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 64.15 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.788 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 70.14 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.1 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.12 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.41 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.14 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.23 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.44 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' HD1' HG13 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 74.32 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.3 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.31 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 63.02 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.14 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.5 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.34 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.2 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.959 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.03 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.12 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.04 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.54 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.33 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 72.22 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 70.41 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.31 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.839 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.22 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.01 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 53.12 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.839 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 43.24 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 44.03 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.04 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.51 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 71.22 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 54.51 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.33 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.11 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.21 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 33.1 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.1 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.23 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.585 ' CD1' HG11 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.23 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.424 ' N ' HD13 ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.41 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.1 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.44 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.42 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 61.54 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.45 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.22 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.44 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 71.34 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 72.3 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.32 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.42 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.34 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.24 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.34 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 70.3 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.12 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.13 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.1 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 44.01 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 72.24 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 155' ' ' LEU . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 43.03 110.277 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.14 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 53.2 111.497 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.14 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.788 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.1 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.11 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 54.12 109.753 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.22 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.42 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.4 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.813 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.11 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.21 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.52 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.793 ' HB3' HD11 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.44 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.41 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.13 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 62.04 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.3 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.42 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.3 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.33 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.14 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.43 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.11 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.655 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.23 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 62.14 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.12 110.392 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.617 ' HG3' ' HG3' ' A' ' 130' ' ' GLU . 25.7 mmt -78.17 112.75 15.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.41 110.293 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 155' ' ' LEU . 2.5 pt? -118.59 162.24 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.432 -0.803 . . . . 73.54 110.641 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 29.8 t-80 72.18 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.112 0.883 . . . . 64.32 111.83 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.56 -62.33 0.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.469 -0.787 . . . . 61.24 111.878 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 128' ' ' SER . 55.4 m 69.62 144.16 0.05 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.479 0.657 . . . . 75.04 111.682 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.448 ' H ' HD23 ' A' ' 159' ' ' LEU . 2.4 pt? -138.24 157.61 45.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.821 -0.627 . . . . 45.55 109.388 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.59 124.53 31.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.366 0.603 . . . . 75.12 112.166 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 15.5 m80 -121.58 164.29 17.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.091 -1.078 . . . . 71.13 108.091 167.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 62.05 69.33 0.63 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.124 -0.695 . . . . 70.42 109.124 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 28.7 m170 64.98 -177.59 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.435 -0.802 . . . . 74.45 111.332 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.3 139.41 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.453 -0.794 . . . . 73.4 109.06 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.58 123.13 24.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.149 0.499 . . . . 74.33 111.54 -172.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.147 -0.93 . . . . 72.35 108.895 173.254 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.247 -0.279 . . . . 74.1 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -168.47 -171.84 1.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.496 -0.557 . . . . 71.15 109.496 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -137.29 63.15 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.561 -0.903 . . . . 75.04 108.561 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 13.7 pt-20 -103.92 -162.93 0.93 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.092 -0.958 . . . . 70.02 110.193 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 105' ' ' PRO . 54.8 m 69.2 -175.33 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.461 0.476 . . . . 65.1 110.984 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.65 ' HG2' ' H ' ' A' ' 7' ' ' PHE . 47.3 tt0 -156.33 -178.08 7.06 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.308 -0.997 . . . . 72.04 108.308 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' H ' ' HG2' ' A' ' 6' ' ' GLN . 39.1 p90 -164.11 153.4 13.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.936 -0.394 . . . . 75.21 109.936 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 52.01 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.588 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.42 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.42 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.803 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.43 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.31 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.32 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.1 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 43.04 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.33 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.41 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 33.22 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.41 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.832 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.3 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 62.23 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 61.34 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.02 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 41.43 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.53 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.02 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.34 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 64.2 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.4 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.44 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.22 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 74.44 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.32 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.22 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.13 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 60.44 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.54 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.11 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.1 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.34 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 62.53 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.33 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.35 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.3 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.33 109.701 177.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.34 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.21 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 64.43 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.52 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.54 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.34 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 62.5 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.31 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 74.34 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.497 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.2 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 71' ' ' VAL . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.23 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.932 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.33 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.33 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.529 ' HB2' HD12 ' A' ' 159' ' ' LEU . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.04 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.01 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.45 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.3 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 65.53 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.01 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 71.41 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.832 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.13 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 64.32 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.33 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.21 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.53 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.4 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.31 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.33 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.42 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.44 108.473 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.45 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.14 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.43 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.42 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.53 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.22 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 70.32 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.13 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.3 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 52.3 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.23 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.32 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.03 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.45 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.03 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.53 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.42 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.4 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.588 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.13 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.33 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.22 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.31 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.34 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.24 111.367 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.04 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.24 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.1 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.44 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.32 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.01 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.51 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.636 ' HA ' HD11 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 64.44 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.31 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.711 HD12 ' HB1' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.42 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.21 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.803 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.03 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.42 110.895 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 64.53 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.41 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.35 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.02 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.15 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.02 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.725 ' HB2' HD21 ' A' ' 155' ' ' LEU . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.22 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 31.13 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.719 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.43 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 61.12 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 71.12 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 61.41 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.2 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 74.14 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.3 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 73.54 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.54 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.05 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 54.25 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.01 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.51 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.32 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.35 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 62.4 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.14 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 64.13 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.33 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.12 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.551 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.2 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.42 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 65.34 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.32 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp -74.87 93.14 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 61.45 109.421 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.774 ' H ' HD23 ' A' ' 155' ' ' LEU . 2.1 pt? -71.76 -8.83 56.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.176 0.435 . . . . 64.03 112.176 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.762 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 79.3 t60 -62.01 -52.75 62.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.805 0.336 . . . . 74.25 110.194 174.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -147.13 110.5 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.51 110.383 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.9 m -82.01 124.89 30.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.585 -0.524 . . . . 73.42 109.585 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 64' ' ' MET . 80.1 mt -100.05 149.35 23.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.777 0.322 . . . . 71.0 110.398 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 64.28 89.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 72.3 111.213 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.62 92.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.329 -0.85 . . . . 53.25 109.522 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -79.79 -90.6 0.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.985 -0.552 . . . . 70.3 110.335 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -170.62 142.63 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 60.12 110.13 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -144.98 156.68 44.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 62.23 108.964 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -154.13 147.57 25.02 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.798 -0.361 . . . . 64.11 110.517 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.725 -0.655 . . . . 74.14 109.706 175.151 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.389 -0.226 . . . . 33.31 110.389 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.71 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.575 0.75 . . . . 65.32 112.559 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -76.03 80.64 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 74.11 111.023 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -146.4 180.0 7.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.928 . . . . 74.32 109.002 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 104' ' ' GLY . 57.4 m 58.45 40.69 23.8 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.537 0.523 . . . . 64.44 111.433 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.71 85.17 1.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 75.1 110.518 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 -68.74 112.73 5.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.671 . . . . 71.35 111.063 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.42 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 71.11 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.24 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD21 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 53.55 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.02 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.22 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.53 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.3 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.2 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 64.43 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.44 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 1.091 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.24 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.01 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.912 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.41 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.44 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.41 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.54 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.33 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.43 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.23 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.1 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 50.42 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.11 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.03 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.55 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.02 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.23 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 51.31 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.51 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.01 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.44 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.54 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.35 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.32 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.12 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.33 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 72.14 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.24 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 50.32 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.22 110.086 176.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.34 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.44 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.34 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.32 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.54 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.44 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.03 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.33 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.15 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.35 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.746 ' HD1' HG12 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 63.41 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.756 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 72.22 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.13 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.03 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 74.33 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 72.11 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.43 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.53 109.363 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.41 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 70.23 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.746 HG12 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.04 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.912 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.11 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 71.25 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.33 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.2 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 1.091 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.53 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 73.35 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.32 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.45 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 33.42 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.22 109.923 -178.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.54 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.1 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 41.54 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 64.24 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 71.24 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.782 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 63.31 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.32 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.32 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.21 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.24 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 14' ' ' LEU . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.3 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.34 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.2 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.31 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.42 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.14 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.35 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 65.11 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.851 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.04 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 74.33 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.2 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.23 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 72.52 111.821 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.13 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.42 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.13 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.34 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.24 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.22 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 60.42 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.11 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.53 110.83 176.41 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.41 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.758 HD13 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.31 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.44 110.777 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.53 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.44 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.531 HG23 HD12 ' A' ' 155' ' ' LEU . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.11 110.206 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.04 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.15 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.21 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.14 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.24 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 73.42 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 127' ' ' LEU . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 154' ' ' MET . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 55.11 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 31.35 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.54 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.34 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.23 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.31 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.12 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HE2' ' HB3' ' A' ' 59' ' ' ALA . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 70.01 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.41 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.41 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.03 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.41 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 44.3 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 138' ' ' ASN . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 65.44 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.14 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 72.34 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.41 111.472 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.651 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.33 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 65.42 108.716 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 65.31 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.13 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.05 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.851 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.01 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.14 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.41 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.21 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -53.04 -50.84 63.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.53 110.355 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.531 HD12 HG23 ' A' ' 120' ' ' VAL . 16.8 tp 72.25 -53.46 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.184 0.809 . . . . 71.14 113.184 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 40.0 t-80 -44.74 -58.81 2.84 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.575 0.954 . . . . 72.34 113.575 -170.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 128' ' ' SER . 40.6 tt0 -163.15 158.65 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.916 -0.314 . . . . 65.45 110.214 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 m -71.59 87.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.912 0.387 . . . . 73.34 111.095 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -98.76 108.67 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.318 -0.623 . . . . 74.51 109.318 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.94 148.29 31.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.927 -0.579 . . . . 75.11 109.906 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -119.47 93.78 4.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.432 0.634 . . . . 73.14 109.843 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 21.5 p-80 -131.34 156.08 46.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.858 -0.61 . . . . 72.21 111.578 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -148.99 -53.39 0.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 74.12 109.458 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.02 -176.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.476 -0.784 . . . . 65.31 110.208 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -121.5 152.91 38.62 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.012 -0.366 . . . . 72.04 110.012 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 C--O 1.244 0.784 0 CA-C-O 118.472 -0.775 . . . . 74.14 110.072 -177.514 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.202 0.525 . . . . 73.51 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -124.95 -52.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.939 -0.573 . . . . 73.23 110.156 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.35 -176.94 0.18 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.361 -0.836 . . . . 74.53 110.841 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -148.99 141.96 24.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 74.43 110.31 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' HB ' ' A' ' 103' ' ' ILE . 55.9 m -76.2 138.2 40.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 72.13 111.576 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -97.64 66.5 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.791 0.805 . . . . 73.11 109.84 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -77.75 89.57 4.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.273 -0.876 . . . . 70.03 111.244 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.54 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.21 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HG3' HG12 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.31 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 60.42 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.11 109.6 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 63.22 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 63.32 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 61.2 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.24 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.04 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.04 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.34 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.32 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.1 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 61.03 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.14 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 65.45 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 60.23 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.43 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 35.03 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 72.32 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.45 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.13 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.42 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.53 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.33 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.53 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.02 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.45 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.22 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.31 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 71.32 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 64.04 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.4 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.15 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.23 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 62.34 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.24 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.51 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.34 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.34 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.53 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 21.32 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.1 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 62.35 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 55.31 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.43 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 44.03 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.33 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.21 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 72.03 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.23 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.04 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.2 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 73.31 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.41 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.32 109.884 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.53 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 45.33 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.35 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.23 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.14 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.04 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.31 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.41 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.2 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.31 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 74.25 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.1 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.31 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.42 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 70.14 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 63.32 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.43 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.1 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.04 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.32 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.24 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 64.2 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.44 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.53 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 62.03 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.34 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.24 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.22 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 65.14 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.14 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 24.52 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.22 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.2 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.11 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.4 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 54.14 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 62.32 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.12 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 5' ' ' CYS . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.21 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.45 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.3 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.43 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.4 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.42 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 71.41 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.14 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.14 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.2 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.35 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.31 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.52 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.11 111.575 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.24 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.32 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 155' ' ' LEU . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 41.11 110.07 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.21 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.45 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 54.13 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.15 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.32 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.42 112.007 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 155' ' ' LEU . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 74.42 110.191 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.15 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.21 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.23 109.969 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.53 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.11 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.6 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.4 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.22 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.41 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.32 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 60.04 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.34 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.23 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.35 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.42 110.677 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 53.15 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 73.03 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.12 112.039 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.14 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.41 110.396 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.547 ' H ' HD23 ' A' ' 147' ' ' LEU . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.32 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.703 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.11 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.12 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.685 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.02 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 71.21 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 64.22 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 72.53 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.48 ' HE2' ' HB2' ' A' ' 154' ' ' MET . 51.7 mtm -63.57 154.71 31.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.22 110.89 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 127' ' ' LEU . 98.3 mt -88.81 24.31 2.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.781 -0.822 . . . . 60.25 108.781 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -114.47 131.22 56.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.88 -1.055 . . . . 65.31 110.751 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -53.74 115.05 1.78 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.806 . . . . 64.33 110.764 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -157.97 -77.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.168 0.803 . . . . 51.33 113.168 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.2 114.04 22.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.592 0.96 . . . . 64.33 113.592 -162.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -119.77 153.83 35.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 71.24 109.567 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -118.45 -95.4 0.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.214 -0.291 . . . . 65.31 110.214 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -149.29 50.32 0.96 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.022 0.439 . . . . 64.42 109.857 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -124.0 95.11 4.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.855 -0.612 . . . . 61.23 109.629 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -75.75 111.5 11.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.409 -0.814 . . . . 71.43 111.23 -172.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -169.3 172.46 7.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.729 . . . . 73.32 109.692 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.751 -0.642 . . . . 64.21 109.478 173.627 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.261 0.553 . . . . 64.41 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 168.28 27.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.732 -0.667 . . . . 73.23 110.138 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -150.74 159.94 44.19 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.092 -0.707 . . . . 73.22 109.092 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -60.66 99.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.192 0.52 . . . . 64.21 110.234 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.31 120.44 42.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.721 -0.672 . . . . 51.24 110.62 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -102.45 112.03 24.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 72.42 109.98 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -80.34 110.83 16.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.038 -0.983 . . . . 73.51 111.167 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.33 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 63.3 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.14 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.51 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.34 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.12 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 61.13 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.04 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.79 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.4 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.23 110.047 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.43 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.31 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.53 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 72' ' ' GLU . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.53 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.24 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.24 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.34 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.11 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 63.23 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.44 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.54 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.34 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.22 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 70.44 111.205 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.53 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.11 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.02 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.53 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 60.52 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.12 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 42.55 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 63.13 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 24.5 p-80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.43 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.2 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.42 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.4 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 71.21 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.815 HD21 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 55.33 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.32 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.32 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.4 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 31.2 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 61.02 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.1 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.799 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.44 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.05 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 63.44 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.12 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 53.22 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.53 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.885 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.11 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 76' ' ' PRO . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.45 109.831 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 51.31 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.14 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.954 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.45 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 52.54 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.45 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.31 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.3 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.13 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.41 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.21 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.954 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 61.34 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 53.45 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' HD22 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.24 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 64.51 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.753 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 70.21 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.885 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 63.55 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.54 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.14 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 54.24 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.41 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.33 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.03 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.1 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.815 ' HA2' HD21 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 71.1 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.22 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.4 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 71.52 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.04 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.3 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 64.11 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.05 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.01 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.04 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.22 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.45 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 61.31 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.03 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.11 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.21 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.4 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.3 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.11 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 72.35 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.02 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 34.31 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.53 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.34 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.43 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.15 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.21 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.33 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.52 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.51 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.53 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.24 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.53 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.04 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.13 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.12 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.15 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.666 HG21 HD11 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.14 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.4 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 70.01 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.52 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.21 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.31 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 72.41 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.23 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.01 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 32.04 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.655 ' HB3' HD12 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.41 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.4 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.14 109.779 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.23 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 73.14 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 63.3 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.2 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.04 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.01 110.297 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.14 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.01 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.14 110.501 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 63.23 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.05 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.75 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 43.32 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.21 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 64.31 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.42 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.34 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.44 110.546 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 44.23 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 64.44 109.904 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.11 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.77 95.01 7.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.31 111.363 -174.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.44 -18.26 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 73.33 110.492 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -81.84 108.08 15.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.827 -0.805 . . . . 62.12 108.827 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.81 111.8 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.112 0.482 . . . . 72.43 111.502 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m 72.08 149.59 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.802 -1.09 . . . . 74.53 111.89 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 pp -96.6 -10.6 26.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.838 -0.619 . . . . 74.01 110.687 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.21 140.4 57.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 72.22 109.922 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -65.23 -51.95 57.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.443 -0.577 . . . . 73.11 109.443 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -90.36 75.38 6.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.083 -0.71 . . . . 72.32 109.083 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -78.89 98.06 6.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.251 0.548 . . . . 75.34 110.872 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.1 m80 68.29 167.51 0.26 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.874 -1.057 . . . . 52.43 111.241 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -126.56 -49.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 64.14 109.741 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 80.4 t60 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.649 -0.691 . . . . 73.42 109.5 178.407 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.306 -0.628 . . . . 71.21 109.306 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.77 -62.32 1.37 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.62 -0.718 . . . . 72.42 110.685 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 74.4 m-85 -66.69 -24.13 66.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 75.13 111.048 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 3' ' ' PHE . 29.9 mm-40 68.3 177.31 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.958 0.786 . . . . 64.25 110.587 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.38 79.65 9.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 74.34 110.428 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -91.94 -0.22 57.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.463 0.649 . . . . 73.3 109.783 177.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -85.38 129.59 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 72.21 110.422 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 70.34 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.33 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 62.04 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD13 HD21 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 35.51 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 71.22 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.4 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.21 110.202 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.33 112.093 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 53.41 109.646 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.03 112.138 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.51 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.53 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.13 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.33 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 74.54 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.32 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.4 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.54 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.04 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.13 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.33 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.42 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD21 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 53.23 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 71.01 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.31 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.14 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.13 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.33 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 72.31 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.04 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.23 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.03 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.05 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.34 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.13 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.4 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.15 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.14 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.33 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.31 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.22 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.03 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 43.54 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.41 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.559 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 52.5 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.31 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.13 112.23 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.13 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 72.31 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.25 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.02 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.786 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.41 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 23' ' ' ARG . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 61.55 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.42 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.507 ' HG3' ' CD2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.43 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.12 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.34 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.43 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.53 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HE1' HD21 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.24 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.41 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 52.43 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 65.3 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.41 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 57' ' ' PRO . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.53 109.45 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.13 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 71.31 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.22 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.14 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.42 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.1 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 74.42 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.51 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.21 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.44 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.32 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.24 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.34 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 33.35 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 73.11 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 70.2 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.13 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 63.3 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.33 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.3 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 54.43 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.02 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 63.0 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.451 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.05 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.21 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.35 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 71.0 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.14 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.41 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.24 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.03 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.41 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.34 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.813 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.34 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.44 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 70.34 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.813 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.1 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 65.0 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.802 ' HG ' HD23 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.23 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.458 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.13 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.43 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.554 ' HE3' ' O ' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.11 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.31 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.15 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 70.41 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.698 HD21 HD13 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.31 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.05 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.526 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 61.24 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.498 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.32 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.13 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 34.34 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.03 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.24 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.45 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.4 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.656 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.42 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.14 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 73.13 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.4 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.23 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.35 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.45 113.001 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.41 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 71.41 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.14 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' A' ' 147' ' ' LEU . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 72.34 112.971 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 41.52 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.22 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' PRO . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.14 109.675 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.22 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.34 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 61.01 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.32 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.793 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 65.34 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.802 HD23 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 74.53 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.414 ' SD ' ' N ' ' A' ' 154' ' ' MET . 2.8 mpp? -86.76 123.67 32.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.31 110.448 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 156' ' ' HIS . 3.6 mm? -64.89 117.04 6.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.127 -0.694 . . . . 63.31 109.127 173.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 51.1 t-80 76.79 136.89 0.06 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.195 0.934 . . . . 75.11 110.943 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 156' ' ' HIS . 2.5 tt0 75.07 -80.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.234 -0.893 . . . . 71.33 110.872 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 20.4 t 57.37 54.58 6.5 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.593 0.558 . . . . 75.1 110.663 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 mm? 56.02 -95.66 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.249 0.619 . . . . 73.21 111.872 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.46 97.4 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.038 -0.528 . . . . 52.11 110.484 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -80.42 88.75 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.159 -1.052 . . . . 74.14 108.159 168.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -62.7 135.12 57.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.673 -1.149 . . . . 64.04 111.894 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -110.53 112.1 23.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 71.23 109.627 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -119.31 97.48 5.68 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.425 -0.583 . . . . 72.34 109.425 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -105.31 126.93 52.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.109 -0.496 . . . . 71.32 111.316 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.542 -0.742 . . . . 73.35 109.39 174.807 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OD2' ' A' ' 145' ' ' ASP . 23.7 ptp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.909 -0.404 . . . . 70.55 109.909 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -173.44 -59.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 64.44 110.781 174.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 5' ' ' CYS . 32.5 p90 -151.95 162.56 40.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.267 -0.424 . . . . 73.44 110.774 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -101.79 104.59 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 64.14 110.245 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 11.9 t -96.58 108.34 20.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.617 -0.882 . . . . 73.31 108.617 174.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.69 84.54 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 64.03 111.785 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 42.82 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.517 1.136 . . . . 72.15 113.64 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.21 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.1 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.14 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 73.42 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.14 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 62.31 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.635 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.22 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.33 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.32 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.33 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' HD23 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.33 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.12 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.77 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.22 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.33 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.12 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.12 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.518 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 54.04 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.804 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 40.1 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.53 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.32 111.086 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.32 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.24 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.55 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.839 ' H ' HD13 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 44.14 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.42 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.1 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.31 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.13 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.51 111.21 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 70.15 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.33 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 70.33 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.34 110.993 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.34 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 71.14 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 53.54 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.23 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.11 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 61.33 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.23 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.53 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.9 tp60 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.14 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 65.33 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.52 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.41 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.04 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 53.23 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.14 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.44 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 42.53 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.31 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.4 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.981 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.31 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.53 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.73 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 64.52 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.41 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.41 110.035 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.55 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.33 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.21 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 71.44 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.43 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.804 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 51.22 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.11 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.639 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.1 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.03 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.736 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.44 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.45 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.12 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.34 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.34 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.42 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 55.15 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.12 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 50.45 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.44 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.14 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.01 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.42 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 54.2 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 54.11 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.4 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.11 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.13 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.35 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 62.13 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.13 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 65.44 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 61.52 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.4 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.42 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 51.41 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.23 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.42 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.11 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.44 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.21 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.54 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.23 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.31 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.24 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 61.42 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.13 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.42 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.15 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 64.54 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.14 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.21 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.31 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.43 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.44 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.14 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.13 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.35 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.42 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.32 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.04 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.531 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.21 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.1 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.43 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.52 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.981 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 73.33 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.817 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.3 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.35 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 63.45 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 134' ' ' ILE . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.32 112.375 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.2 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.11 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.12 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.23 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.11 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.53 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.4 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.15 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 54.12 109.524 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 54.21 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.53 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.65 HG22 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.52 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.635 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.33 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.817 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.44 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.41 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.531 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 52.31 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.526 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 11.6 mmt -58.03 125.37 22.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.42 111.093 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 156' ' ' HIS . 1.0 OUTLIER -141.43 143.05 33.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.487 -0.931 . . . . 73.14 108.487 -176.302 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.538 ' N ' HD13 ' A' ' 155' ' ' LEU . 7.7 t60 71.22 114.7 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.527 0.517 . . . . 73.02 110.162 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 69.59 84.92 0.14 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.762 -0.654 . . . . 75.44 110.157 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.3 t -68.99 133.47 48.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.451 -0.795 . . . . 44.44 110.528 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 96.72 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.436 0.636 . . . . 52.03 111.505 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -84.68 61.75 6.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.736 . . . . 72.44 109.436 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -88.49 94.54 9.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.32 109.295 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -124.43 114.8 19.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.046 -0.525 . . . . 63.53 110.957 -174.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -86.44 121.04 28.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 60.54 110.312 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 66.12 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.166 -0.925 . . . . 73.4 110.997 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -60.8 -68.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 74.34 110.161 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.707 -0.664 . . . . 61.21 109.372 174.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.491 0.182 . . . . 71.34 111.491 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.56 -154.96 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.754 -0.461 . . . . 65.01 109.754 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.12 140.61 31.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.936 0.398 . . . . 75.55 111.293 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.47 161.45 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.534 -0.757 . . . . 63.14 110.314 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' HG12 ' A' ' 103' ' ' ILE . 26.2 p -95.29 -177.08 3.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 70.34 110.707 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.24 1.47 41.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.446 0.641 . . . . 74.32 109.384 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 59.81 49.45 8.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.951 . . . . 55.2 110.346 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 61.14 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.31 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 73.25 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.41 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.3 110.621 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.31 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 70.01 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 44.22 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.21 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 64.12 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 70.22 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.31 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 70.03 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' H ' HD23 ' A' ' 21' ' ' LEU . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.34 110.508 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.733 HD13 ' HB3' ' A' ' 73' ' ' PHE . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.31 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.34 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.43 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.41 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.24 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.35 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.11 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.33 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.54 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.34 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.12 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.41 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 71.05 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 71.31 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.42 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.2 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.02 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.685 ' HA ' HG22 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.31 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.54 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.42 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 62.44 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.15 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.01 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 73.33 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 51.41 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 52.42 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.32 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.43 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.43 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.33 110.45 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.33 111.826 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.44 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.22 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.829 ' HG2' HD11 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 71.03 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.44 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 62.35 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.12 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.4 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.33 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.12 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 72.2 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.15 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.22 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 64.24 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' HB3' HG22 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.2 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.41 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.35 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 62.23 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.733 ' HB3' HD13 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.42 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.42 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.44 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.52 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.1 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.32 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.23 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.42 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.2 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.31 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.559 ' HA2' HG13 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.14 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.13 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 52.12 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.32 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 71.24 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.22 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.11 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 65.32 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.35 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.24 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.41 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.656 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 33.4 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.14 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 62.42 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.21 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 44.41 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.2 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.22 108.688 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.806 HD12 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.24 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.2 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 139' ' ' PRO . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.12 111.599 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HE1' HG21 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.15 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.24 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.35 110.483 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.41 109.819 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 64.32 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.12 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.34 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.11 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.32 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.45 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.1 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.52 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.53 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.44 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.626 HG11 ' H ' ' A' ' 157' ' ' GLU . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.21 110.57 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 55.31 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 61.3 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.58 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.15 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 45.21 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 155' ' ' LEU . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.42 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.611 ' C ' ' HB2' ' A' ' 155' ' ' LEU . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.31 108.727 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.791 HD12 ' H ' ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 61.54 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 52.35 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.1 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.42 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.73 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.14 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.15 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.45 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.829 HD11 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.33 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 55.1 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.706 HD13 ' H ' ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.24 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.52 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.34 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.722 ' HB3' HD13 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.32 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.04 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.32 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.493 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.01 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.13 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.31 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.55 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.31 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.15 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.43 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.497 HG21 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.11 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.04 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.41 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.612 ' HB3' HD22 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.04 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.73 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 40.7 mtm -65.64 140.11 58.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.03 109.124 172.305 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 125' ' ' PHE . 52.9 mt -84.84 177.8 7.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.457 -0.338 . . . . 74.23 110.248 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 60.96 84.7 0.13 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.9 0.48 . . . . 75.54 110.032 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.719 ' HG2' ' H ' ' A' ' 158' ' ' SER . 20.2 tt0 61.6 -163.71 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.486 -0.779 . . . . 70.03 109.758 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.719 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 39.0 m -117.3 177.97 4.54 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.06 -0.4 . . . . 71.45 111.031 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 pp -79.49 22.17 0.46 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 73.32 111.144 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' A' ' 163' ' ' HIS . 35.0 tt0 -148.99 150.76 33.38 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.044 -0.725 . . . . 70.23 109.044 -175.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -76.51 60.93 1.68 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.611 0.364 . . . . 75.01 110.9 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 61.92 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.552 0.741 . . . . 71.21 109.736 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 79.9 t60 -49.11 -54.33 16.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.754 . . . . 71.35 112.75 -168.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -122.22 145.66 48.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.757 -0.377 . . . . 74.13 110.405 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -71.61 102.12 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 72.14 110.935 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.675 -0.679 . . . . 74.0 109.214 174.713 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.255 0.55 . . . . 70.12 110.807 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.51 87.52 2.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.814 -0.63 . . . . 60.32 109.707 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -164.07 153.72 14.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 75.45 109.981 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 73.76 164.25 0.28 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.116 0.885 . . . . 62.32 111.112 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.1 m -57.42 123.78 16.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 73.33 110.381 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -104.48 -164.51 1.06 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.13 0.49 . . . . 71.42 110.316 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.14 151.01 41.4 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.848 -0.615 . . . . 74.44 111.645 -170.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 73.14 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 54.43 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.2 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.11 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.01 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.23 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 70.13 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 32.51 109.975 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.41 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.52 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.11 113.695 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.23 110.746 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.4 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.588 HD13 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.41 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 61.42 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.22 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.42 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.4 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 44.13 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.21 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.44 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.22 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.2 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.21 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 63.52 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 53.23 110.283 -176.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.23 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.33 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.23 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.01 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 70.32 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 73.21 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.31 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.44 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.22 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.41 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.33 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 61.55 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.33 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.3 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.41 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 20.03 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 73.03 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 62.51 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.01 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.11 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.42 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.24 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.41 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.35 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 62.25 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.23 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.77 ' HB3' HG12 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.21 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.44 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.01 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 64.03 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.33 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.33 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.02 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 74.23 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.43 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.32 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG12 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.14 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.11 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.12 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.32 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.01 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.12 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 19' ' ' ALA . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 71.4 109.719 176.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.44 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.45 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.43 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.24 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.31 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.51 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.21 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.15 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.03 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 63.44 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.54 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.15 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 41.23 112.6 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.34 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.465 ' HB ' HD21 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.11 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.55 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.2 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.34 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.44 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' A' ' 155' ' ' LEU . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 61.11 110.935 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.753 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 72.54 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 71.52 110.876 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 61.1 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.33 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.951 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.3 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.33 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.03 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.51 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.577 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.21 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 53.24 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.24 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 64.13 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.13 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.31 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 62.44 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.43 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.34 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 63.2 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.02 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.52 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 64.31 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.32 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.03 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 54.41 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.44 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.777 ' HD2' ' HG ' ' A' ' 155' ' ' LEU . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.54 109.188 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 62.41 108.745 164.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 44.14 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.23 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.31 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.3 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.3 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.472 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.05 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 61.14 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.41 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.05 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.642 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.22 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.51 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 62.21 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 42.14 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.02 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.52 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.33 111.848 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 53.34 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.43 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 72.42 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.22 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.876 ' HD3' HD13 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.31 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.951 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.33 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.849 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 72.33 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 52.3 109.353 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 74.31 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp -64.6 156.3 30.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.43 110.727 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 125' ' ' PHE . 4.1 mm? -96.66 -52.2 4.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.973 -0.558 . . . . 55.34 111.265 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 126' ' ' ASP . 1.8 p80 -88.4 107.28 18.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.252 -0.579 . . . . 72.24 110.479 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -55.44 -64.68 0.77 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.382 -1.281 . . . . 63.33 113.455 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.9 t -79.09 8.86 5.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.246 -0.284 . . . . 75.12 111.092 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.6 mt 61.31 -90.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.08 0.552 . . . . 54.5 110.336 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -137.98 22.0 2.84 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.076 0.941 . . . . 74.15 108.722 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 162' ' ' HIS . 17.9 t60 61.11 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 113.655 -1.611 . . . . 72.22 111.115 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 161' ' ' HIS . 45.0 t60 -108.77 98.06 7.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.111 -0.7 . . . . 72.14 109.111 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -74.5 135.62 42.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 73.02 111.635 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -123.16 116.46 23.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.971 -1.122 . . . . 71.23 107.971 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -67.37 167.6 12.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.142 0.496 . . . . 73.31 111.754 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.59 -0.732 . . . . 73.13 109.668 179.427 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.12 -0.696 . . . . 55.12 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.39 -56.03 2.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.366 0.506 . . . . 71.35 112.366 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -68.76 -41.82 78.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.181 0.515 . . . . 62.22 109.96 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -95.32 131.56 41.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.887 -0.783 . . . . 73.24 108.887 173.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 103' ' ' ILE . 59.4 m -80.66 -82.82 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.476 -0.565 . . . . 64.51 109.476 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 63.54 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.377 1.084 . . . . 63.21 113.341 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.27 84.67 5.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.862 -1.063 . . . . 73.03 108.634 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.3 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.03 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.23 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.45 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.15 110.373 -174.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.35 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 55.42 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.11 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.686 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.11 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.2 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.2 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.4 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.22 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 74.21 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.551 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 70.04 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.41 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.31 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.42 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.765 HG21 HD22 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.21 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 62.44 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.41 112.336 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 54.44 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.765 HD22 HG21 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 64.15 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 44.23 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.34 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 72.14 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 54.0 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.34 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.12 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.01 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.15 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.42 110.228 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.42 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.11 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.33 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 61.13 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 54.41 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 70.3 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.51 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.02 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.4 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.45 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.21 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.14 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.12 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.12 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.42 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.4 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.12 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 64.32 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 54.33 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.44 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 63.35 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.32 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.54 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.11 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 62.5 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 64.42 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 40.32 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.42 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 64.14 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 1.016 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.04 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.14 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 35.21 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.21 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 31.1 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 61.55 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.22 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.698 HG21 HD23 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.34 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.34 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.43 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.45 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.579 ' HB ' HG11 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.43 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.33 109.916 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 21.24 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.24 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.11 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 64.13 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.22 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.32 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.12 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.32 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.22 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.01 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.13 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.686 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.51 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.33 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 54.21 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.54 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.34 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.05 110.983 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.05 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.483 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.11 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 73.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 73.43 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 63.33 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.13 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.52 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.13 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.24 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.693 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.44 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.925 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.11 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.52 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.1 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.925 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 73.32 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 51.03 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.31 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 53.24 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 53.22 111.445 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 72.42 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.451 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.14 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 64.22 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.31 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.33 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.3 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.33 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.686 ' CD2' HD21 ' A' ' 155' ' ' LEU . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.21 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.33 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.22 109.386 175.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.557 ' HA ' ' H ' ' A' ' 159' ' ' LEU . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.41 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.43 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.11 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.03 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.1 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.21 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.4 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.586 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.31 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.424 HD22 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 62.12 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 65.14 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.41 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.31 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.33 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.23 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.2 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.31 110.779 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.41 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 54.41 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.1 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.24 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HD2' HD22 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 64.44 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.24 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.32 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.402 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.01 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 61.04 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 155' ' ' LEU . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.2 109.167 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? -53.37 -55.27 26.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.51 110.529 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.686 HD21 ' CD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER 55.1 22.85 4.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.447 1.647 . . . . 62.22 115.447 165.224 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -75.54 -32.34 60.41 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.468 -1.308 . . . . 74.31 107.468 167.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.2 -85.98 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.708 -1.587 . . . . 61.24 106.886 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 172.44 -179.49 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.42 1.088 . . . . 61.51 109.341 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -105.95 60.93 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.603 -1.258 . . . . 74.32 107.603 172.076 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -141.24 143.63 34.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.593 -1.185 . . . . 54.3 110.68 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -98.21 -20.55 17.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.971 -0.559 . . . . 74.51 110.006 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m80 66.06 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.441 -0.8 . . . . 74.33 110.086 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -79.27 57.13 2.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.096 -0.502 . . . . 65.22 110.764 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 48.59 76.31 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.609 -0.723 . . . . 75.52 110.639 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -108.62 124.85 51.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.032 -0.531 . . . . 75.52 111.106 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.6 m80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.507 -0.758 . . . . 64.42 109.387 174.477 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.649 -0.5 . . . . 75.43 109.649 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 66.6 -81.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.739 0.649 . . . . 51.14 110.305 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.0 t80 63.79 178.61 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.167 0.587 . . . . 75.21 110.599 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 74.43 -49.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.422 0.689 . . . . 62.44 111.321 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.7 t -77.45 96.25 4.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.348 -0.612 . . . . 63.23 109.348 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -123.85 -166.97 1.56 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.267 0.556 . . . . 75.41 110.348 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.73 122.5 24.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.423 -0.808 . . . . 74.14 109.898 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.42 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.22 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.02 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 71.24 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.33 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.03 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 71.23 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.33 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 55.52 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 64.54 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.51 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.24 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.22 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.33 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.33 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.34 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.15 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.11 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.31 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.03 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.24 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.22 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.33 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.41 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 61.34 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 54.42 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.04 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.31 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 73.45 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.13 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.31 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.02 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 62.32 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.21 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 54.53 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.43 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.44 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.05 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 61.14 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.14 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.53 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.33 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.41 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.15 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.22 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.14 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 65.23 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.11 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.621 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.42 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.21 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 72.3 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 61.45 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.53 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.32 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.54 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.35 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 30.23 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.4 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 51.14 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.53 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.45 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.12 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.35 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.22 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.3 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 62.55 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG21 HD13 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.12 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.13 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.22 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.1 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.24 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.822 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 62.1 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.24 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 64.52 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 63.11 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.33 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.32 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.44 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.04 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . 0.757 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.34 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 50.51 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 55.21 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.33 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB2' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.11 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.3 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.531 ' HB2' HD21 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.51 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.52 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.15 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.1 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.34 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.34 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.527 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 63.25 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.24 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . 0.635 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.12 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.31 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.22 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.22 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.12 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.13 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.42 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 74.42 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.14 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' TRP . . . . . 0.752 ' HZ2' ' HB2' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 73.33 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 116' ' ' LEU . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.21 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.24 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.33 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 120' ' ' VAL . 24.7 m120 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.11 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.23 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.3 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.22 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.01 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 44.43 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.24 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.54 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.01 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.823 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 52.21 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.23 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 70.2 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.32 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 53.54 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.928 ' HB3' HG21 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.02 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.22 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.01 112.763 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 62.35 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.31 109.612 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' THR . . . . . 0.928 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.12 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.12 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.41 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.3 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 63.43 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.22 108.431 176.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ARG . . . . . 0.57 ' H ' ' HB2' ' A' ' 137' ' ' ASP . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 71.33 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.14 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HD2' HD12 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.41 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.51 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 52.42 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.834 HD13 ' H ' ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.53 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 154' ' ' MET . . . . . 0.856 ' HG2' ' HA ' ' A' ' 158' ' ' SER . 20.7 ttp -91.69 118.55 30.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.13 111.343 -169.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.92 169.95 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.182 -0.917 . . . . 62.15 111.147 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 55.52 64.98 1.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.413 -0.812 . . . . 65.42 112.333 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.04 24.76 9.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.499 0.555 . . . . 73.44 112.499 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.856 ' HA ' ' HG2' ' A' ' 154' ' ' MET . 21.3 m 68.46 165.26 0.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.257 0.551 . . . . 75.54 111.038 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.64 13.03 18.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 73.12 110.868 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 161' ' ' HIS . 44.7 tt0 -149.07 128.49 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 74.21 110.01 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 162' ' ' HIS . 12.1 m80 74.71 -28.93 0.19 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.514 0.726 . . . . 60.35 112.688 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' HIS . 51.1 m80 70.47 -64.62 0.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.055 0.542 . . . . 63.34 112.085 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 24.0 m80 70.91 112.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.538 0.685 . . . . 74.12 110.286 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -91.32 -172.64 3.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.252 -0.885 . . . . 64.11 110.976 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -69.26 148.09 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.559 -0.534 . . . . 63.23 109.559 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.689 -0.672 . . . . 64.31 110.522 -175.245 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.05 -0.352 . . . . 65.43 110.05 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.59 -65.76 0.34 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.93 0.769 . . . . 62.43 109.533 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -75.97 141.62 42.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.492 -1.299 . . . . 75.24 107.492 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.677 ' HG2' ' HG3' ' A' ' 146' ' ' GLN . 5.6 tp10 -59.76 93.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.225 0.536 . . . . 74.3 112.075 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 89.1 m -159.29 167.16 29.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.994 -1.003 . . . . 62.32 108.794 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 68.98 145.55 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.725 0.774 . . . . 73.52 111.986 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -81.04 150.56 28.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.239 -0.892 . . . . 62.03 110.919 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 63.4 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 62.3 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.803 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.45 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.867 HD11 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 45.5 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.23 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 71.25 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.24 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.32 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.3 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 63.25 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.13 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HG ' HG12 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 73.23 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD12 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.41 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.01 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.847 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 64.24 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 43.42 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.53 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.2 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 61.43 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.44 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.44 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 71.41 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 70.53 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 61.31 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.04 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.33 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.41 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 52.21 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.3 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.03 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 44.35 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.42 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.22 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.2 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.32 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.666 ' H ' HD23 ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.43 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.3 109.562 173.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.34 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 60.31 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.53 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.11 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 51.43 110.628 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.42 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.24 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.35 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 64.04 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.656 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.23 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.52 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.31 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.12 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 60.54 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' TYR . . . . . 0.857 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.23 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.03 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.32 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.56 ' HB2' HD12 ' A' ' 159' ' ' LEU . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.42 111.685 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 160' ' ' GLU . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 53.23 110.446 177.274 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 162' ' ' HIS . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.52 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 53.43 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.42 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.892 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.24 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 64.13 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' OE1' HD12 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.32 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 64.24 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.44 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.33 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 52.24 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.34 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.43 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.32 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.32 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HB3' HD12 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.14 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 44.12 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.44 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 62.13 111.409 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.4 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.12 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.05 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.22 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.15 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.45 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' HD13 ' A' ' 21' ' ' LEU . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 51.03 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HD2' ' OE2' ' A' ' 72' ' ' GLU . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.31 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.42 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.52 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.867 ' HD3' HD11 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.34 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.04 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 51.15 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.42 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' SER . . . . . 0.527 ' HB2' HD21 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 61.05 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 61.52 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 64.4 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.42 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.34 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.43 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.418 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.01 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.55 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.23 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 65.02 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.41 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 53.33 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.14 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.14 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.41 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 55.2 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 72.2 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.529 ' HA ' HG12 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.42 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.42 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.05 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.31 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 53.22 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 55.05 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.43 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.23 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.15 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB3' HD11 ' A' ' 155' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.01 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.839 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 63.15 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.32 110.688 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.594 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.21 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.857 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.2 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.892 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.03 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 72.01 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.34 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.41 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.11 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.22 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.53 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.44 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 33.14 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.41 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.45 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.33 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.33 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.03 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLN . . . . . 0.677 ' HG3' ' HG2' ' A' ' 4' ' ' GLU . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.33 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.1 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 64.23 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.22 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.44 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 53.43 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 61.3 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.34 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -91.59 148.05 22.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.42 109.7 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 126' ' ' ASP . 1.2 mm? -78.92 162.27 26.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.992 -0.744 . . . . 74.52 108.992 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -86.3 169.03 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.762 -0.459 . . . . 75.43 109.762 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 71.62 14.16 6.22 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.835 0.709 . . . . 75.1 110.121 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -96.04 -153.8 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.081 -0.963 . . . . 71.14 109.411 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 64' ' ' MET . 57.4 mt -53.66 -56.0 21.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 61.42 110.937 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' SER . 58.0 mt-10 58.13 -177.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.641 -0.709 . . . . 71.14 112.186 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -85.52 140.04 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 75.23 111.53 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 17.7 t-160 -88.1 16.18 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.887 0.851 . . . . 73.55 109.7 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -131.65 157.42 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.358 -0.837 . . . . 75.13 109.03 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -116.16 86.66 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.197 0.522 . . . . 73.35 110.343 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -96.28 140.56 30.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.569 -0.741 . . . . 73.42 109.685 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.901 -1.047 . . . . 71.24 109.743 177.066 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 . . . . . 0 C--O 1.236 0.344 0 CA-C-O 121.239 0.542 . . . . 64.120000000000005 111.643 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.030000000000001 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 41.32 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 44.210000000000001 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.349999999999994 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 52.219999999999999 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' SER . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.109999999999999 109.317 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 54.420000000000002 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.439999999999998 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 51.210000000000001 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.230000000000004 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 64.099999999999994 110.465 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.420000000000002 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.722 HG21 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.230000000000004 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 60.530000000000001 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.109999999999999 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 71.200000000000003 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.030000000000001 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 30.34 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 44.43 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 62.149999999999999 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.425 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.299999999999997 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.540000000000006 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.210000000000001 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.239999999999995 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.129999999999995 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.239999999999995 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD22 HD23 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 63.450000000000003 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 63.229999999999997 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.75 HD23 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.230000000000004 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.140000000000001 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 43.409999999999997 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.219999999999999 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.200000000000003 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.450000000000003 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.150000000000006 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.540000000000006 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 63.399999999999999 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.219999999999999 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.129999999999995 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.239999999999995 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.43 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 73.549999999999997 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.100000000000001 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.329999999999998 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 70.200000000000003 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.45 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 64.040000000000006 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.530000000000001 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.47 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.040000000000006 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.120000000000005 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.509999999999998 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.120000000000005 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 71.109999999999999 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.340000000000003 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.540000000000006 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.587 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.150000000000006 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.758 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.340000000000003 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.450000000000003 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.230000000000004 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 60.420000000000002 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.425 ' OE1' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.450000000000003 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.329999999999998 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.119999999999997 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.425 HG23 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.120000000000005 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.239999999999995 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.299999999999997 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.049999999999997 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.150000000000006 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 72.439999999999998 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.945 HG22 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 74.049999999999997 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.540000000000006 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.430000000000007 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 51.109999999999999 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.420000000000002 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.430000000000007 110.025 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 44.140000000000001 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.120000000000005 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.544 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.409999999999997 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 71.140000000000001 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.329999999999998 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.319999999999993 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.299999999999997 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.049999999999997 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.229999999999997 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 65.25 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.109999999999999 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.329999999999998 109.468 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.340000000000003 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 62.409999999999997 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.299999999999997 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.310000000000002 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.019999999999996 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.659 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.340000000000003 110.692 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.049999999999997 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.659 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.040000000000006 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.631 ' HA ' HD22 ' A' ' 123' ' ' ASN . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 63.32 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.109999999999999 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.409999999999997 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.631 HD22 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.439999999999998 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.619 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.409999999999997 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 72.519999999999996 111.343 -177.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.310000000000002 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 71.219999999999999 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.120000000000005 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.439999999999998 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 63.119999999999997 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 73.319999999999993 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 52.0 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.479 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.049999999999997 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.409999999999997 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 64.030000000000001 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 54.43 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.495 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.519999999999996 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.904 ' HA ' HD21 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.439999999999998 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.040000000000006 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.239999999999995 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 64.319999999999993 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.219999999999999 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' A' ' 147' ' ' LEU . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.200000000000003 112.254 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.803 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.430000000000007 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 64.409999999999997 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.904 HD21 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.400000000000006 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.299999999999997 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.230000000000004 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.109999999999999 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 70.030000000000001 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.219999999999999 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.540000000000006 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm . . . . . 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 71.099999999999994 110.211 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 . . . . . 0 N--CA 1.455 -0.197 0 N-CA-C 110.379 -0.23 . . . . 73.430000000000007 110.379 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 61.200000000000003 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.549999999999997 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.549999999999997 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.420000000000002 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.209999999999994 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 61.329999999999998 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 53.200000000000003 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.100000000000001 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.519999999999996 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.019999999999996 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 53.200000000000003 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.209999999999994 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.219999999999999 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.439999999999998 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.340000000000003 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.210000000000001 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.430000000000007 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 62.229999999999997 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.340000000000003 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 43.32 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.219999999999999 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.140000000000001 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.340000000000003 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.030000000000001 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.530000000000001 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.109999999999999 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.099999999999994 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 63.450000000000003 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.219999999999999 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.519999999999996 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.129999999999995 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 63.439999999999998 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.420000000000002 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 61.340000000000003 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.219999999999999 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 61.210000000000001 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.447 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 64.129999999999995 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.400000000000006 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.010000000000005 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.420000000000002 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 52.409999999999997 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.019999999999996 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 64.540000000000006 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 53.020000000000003 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.519999999999996 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.350000000000001 112.125 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.230000000000004 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.340000000000003 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 61.409999999999997 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.040000000000006 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 54.219999999999999 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.239999999999995 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.230000000000004 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.299999999999997 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.099999999999994 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.319999999999993 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.200000000000003 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.209999999999994 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.299999999999997 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.239999999999995 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.845 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 62.049999999999997 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.510000000000005 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 64.5 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.340000000000003 113.254 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 52.229999999999997 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.030000000000001 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.240000000000002 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 78' ' ' GLU . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.019999999999996 112.366 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.6 HG23 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.129999999999995 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 62.509999999999998 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 25.510000000000002 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.475 ' H ' HD22 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 54.439999999999998 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.329999999999998 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.439999999999998 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HB ' HD21 ' A' ' 45' ' ' LEU . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.319999999999993 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 42.340000000000003 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.561 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 73.409999999999997 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.310000000000002 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 71.420000000000002 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.129999999999995 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.420000000000002 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 65.25 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 61.25 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HB3' HD11 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.329999999999998 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.120000000000005 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.519999999999996 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.010000000000005 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 62.009999999999998 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 55.130000000000003 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.588 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 70.010000000000005 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.599 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.779 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.439999999999998 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.409999999999997 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.229999999999997 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 45.140000000000001 110.272 -179.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.565 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 64.049999999999997 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.010000000000005 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.219999999999999 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.565 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 72.349999999999994 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.019999999999996 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 70.049999999999997 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.319999999999993 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.230000000000004 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.46 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.129999999999995 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 62.439999999999998 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 65.400000000000006 111.296 178.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.129999999999995 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.62 HD21 ' HB2' ' A' ' 130' ' ' GLU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.109999999999999 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.099999999999994 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.706 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.519999999999996 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HB2' HD21 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.239999999999995 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.319999999999993 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.699 ' HB3' HG23 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.409999999999997 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.648 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.230000000000004 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.140000000000001 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.52 ' HB2' HD13 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.400000000000006 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.039999999999999 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 54.210000000000001 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.310000000000002 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.310000000000002 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.66 HG23 HD23 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.209999999999994 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.779 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.539999999999999 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.340000000000003 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.66 HD23 HG23 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.200000000000003 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 148' ' ' ARG . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.540000000000006 110.125 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.109999999999999 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.109999999999999 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 70.519999999999996 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.420000000000002 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.349999999999994 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.706 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp . . . . . 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.310000000000002 111.023 178.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.886 0.374 . . . . 55.420000000000002 111.321 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 61.329999999999998 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.129999999999995 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.430000000000007 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.239999999999995 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.129999999999995 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.409999999999997 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 60.409999999999997 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.430000000000007 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.109999999999999 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.481 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.229999999999997 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.230000000000004 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.140000000000001 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.558 HD13 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.549999999999997 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.140000000000001 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.450000000000003 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.510000000000005 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.676 HG21 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.549999999999997 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.329999999999998 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 55.340000000000003 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.030000000000001 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.010000000000005 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.439999999999998 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.350000000000001 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 65.420000000000002 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.030000000000001 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.439999999999998 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.409999999999997 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 53.32 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.219999999999999 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.230000000000004 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.549999999999997 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.219999999999999 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 72.310000000000002 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.409999999999997 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.200000000000003 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 32.530000000000001 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.439999999999998 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.439999999999998 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.040000000000006 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.520000000000003 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.420000000000002 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.451 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.209999999999994 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.834 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.140000000000001 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.530000000000001 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 61.119999999999997 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 72.310000000000002 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 62.049999999999997 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 64.540000000000006 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.109999999999999 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.310000000000002 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.319999999999993 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 45.43 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 73.109999999999999 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.510000000000005 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.109999999999999 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.540000000000006 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 65.239999999999995 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.140000000000001 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 64.140000000000001 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.040000000000006 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 61.530000000000001 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.129999999999995 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.430000000000007 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.239999999999995 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 51.5 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 86' ' ' ARG . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.149999999999999 110.49 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 71.519999999999996 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 62.130000000000003 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 55.030000000000001 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.439999999999998 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.329999999999998 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.420000000000002 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 61.200000000000003 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.329999999999998 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.461 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.219999999999999 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.129999999999995 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 42.009999999999998 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 52.219999999999999 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.922 ' HB2' HG23 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 61.439999999999998 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.040000000000006 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.109999999999999 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.584 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.319999999999993 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.010000000000005 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 52.5 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.409999999999997 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.520000000000003 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.67 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 55.109999999999999 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.430000000000007 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.540000000000006 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.922 HG23 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.340000000000003 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.569 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 71.319999999999993 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.140000000000001 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.329999999999998 110.714 178.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.653 HD22 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 44.299999999999997 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.406 ' C ' ' HD3' ' A' ' 118' ' ' LYS . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 53.329999999999998 109.527 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.540000000000006 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.430000000000007 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.140000000000001 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.049999999999997 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.030000000000001 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.520000000000003 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' HG23 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.329999999999998 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.239999999999995 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.633 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.420000000000002 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.310000000000002 108.013 169.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.030000000000001 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.129999999999995 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.129999999999995 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.510000000000005 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.120000000000005 110.371 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.834 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.439999999999998 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.200000000000003 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.675 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.010000000000005 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.430000000000007 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 63.32 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.109999999999999 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.695 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.209999999999994 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 64.019999999999996 111.215 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.329999999999998 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.219999999999999 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 51.350000000000001 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.209999999999994 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 43.450000000000003 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.82 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.239999999999995 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.209999999999994 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.119999999999997 111.286 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 . . . . . 0 C--O 1.235 0.304 0 N-CA-C 109.986 -0.375 . . . . 75.409999999999997 109.986 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.230000000000004 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.230000000000004 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.510000000000005 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.510000000000005 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.010000000000005 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.129999999999995 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.399999999999999 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.129999999999995 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 63.43 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.030000000000001 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 44.039999999999999 110.754 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 53.439999999999998 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.129999999999995 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 23' ' ' ARG . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.230000000000004 108.777 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.741 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.140000000000001 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.340000000000003 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.319999999999993 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.319999999999993 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 72.439999999999998 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 63.329999999999998 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.400000000000006 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 61.039999999999999 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.299999999999997 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.120000000000005 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.741 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.239999999999995 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.140000000000001 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.319999999999993 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.319999999999993 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 64.349999999999994 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.439999999999998 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.349999999999994 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.099999999999994 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' NE2' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.019999999999996 111.515 -173.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.150000000000006 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 72.540000000000006 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' NE2' ' A' ' 44' ' ' GLN . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.319999999999993 112.599 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.140000000000001 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.099999999999994 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' HD13 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.129999999999995 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.426 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.230000000000004 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.409999999999997 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.319999999999993 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.219999999999999 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.120000000000005 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.219999999999999 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.409999999999997 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 62.5 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.625 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.299999999999997 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.019999999999996 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.239999999999995 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.230000000000004 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 74.129999999999995 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 55.299999999999997 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.310000000000002 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 51.130000000000003 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.63 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.519999999999996 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HZ ' HG12 ' A' ' 22' ' ' ILE . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 60.509999999999998 111.712 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 51.420000000000002 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 52.130000000000003 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 64.25 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 53.43 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 54.340000000000003 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.229999999999997 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 53.32 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.439999999999998 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 86' ' ' ARG . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.030000000000001 109.986 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.210000000000001 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.420000000000002 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.439999999999998 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.340000000000003 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.319999999999993 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.439999999999998 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 62.439999999999998 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 73.439999999999998 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 70.299999999999997 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.439999999999998 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.030000000000001 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.129999999999995 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.409999999999997 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.310000000000002 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.988 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.530000000000001 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.040000000000006 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.439999999999998 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.310000000000002 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.631 ' HE1' HD11 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.299999999999997 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 52.310000000000002 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.319999999999993 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.631 HD11 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 65.010000000000005 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.120000000000005 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.519999999999996 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.319999999999993 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.030000000000001 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.329999999999998 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.040000000000006 111.037 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.039999999999999 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 72.420000000000002 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 71.510000000000005 111.165 -177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.200000000000003 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.519999999999996 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.010000000000005 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.329999999999998 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.519999999999996 109.248 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 71.099999999999994 110.927 176.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 72.239999999999995 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.219999999999999 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.040000000000006 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.530000000000001 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 65.230000000000004 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.040000000000006 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.120000000000005 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 65.450000000000003 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.539999999999999 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.439999999999998 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 73.519999999999996 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.100000000000001 111.421 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.019999999999996 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.349999999999994 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 54.32 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.988 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 52.43 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.743 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.299999999999997 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 41.539999999999999 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.099999999999994 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 72.329999999999998 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.475 ' HG3' ' HA ' ' A' ' 128' ' ' SER . 50.0 ttp . . . . . 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.510000000000005 109.35 172.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 C--O 1.236 0.345 0 N-CA-C 109.578 -0.527 . . . . 72.209999999999994 109.578 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.540000000000006 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 41.119999999999997 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.519999999999996 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.219999999999999 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.439999999999998 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.349999999999994 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.520000000000003 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.329999999999998 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.210000000000001 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.239999999999995 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.019999999999996 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 65.329999999999998 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.340000000000003 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.072 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.200000000000003 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 86' ' ' ARG . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.340000000000003 108.048 165.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 52.229999999999997 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.129999999999995 109.878 172.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.420000000000002 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.209999999999994 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.129999999999995 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.349999999999994 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.349999999999994 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.539999999999999 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 71.340000000000003 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.446 ' O ' HD13 ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.120000000000005 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.400000000000006 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.420000000000002 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.149999999999999 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.130000000000003 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.510000000000005 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.129999999999995 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 70.219999999999999 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.129999999999995 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.219999999999999 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.310000000000002 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.040000000000006 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.030000000000001 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.676 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 61.210000000000001 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.676 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.049999999999997 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 62.149999999999999 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.140000000000001 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.784 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 60.210000000000001 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.109999999999999 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.329999999999998 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.430000000000007 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.140000000000001 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.98 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.239999999999995 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 72.319999999999993 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 63.310000000000002 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.549999999999997 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.340000000000003 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.569 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.409999999999997 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.230000000000004 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.019999999999996 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.219999999999999 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 1.072 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.010000000000005 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.349999999999994 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.409999999999997 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 50.140000000000001 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.591 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.099999999999994 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 65.120000000000005 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.519999999999996 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.209999999999994 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.519999999999996 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG3' HD12 ' A' ' 22' ' ' ILE . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 71.230000000000004 111.115 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.150000000000006 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.299999999999997 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.030000000000001 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 41.229999999999997 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.200000000000003 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 71.019999999999996 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.230000000000004 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.119999999999997 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.409999999999997 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.349999999999994 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.340000000000003 110.269 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.430000000000007 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.200000000000003 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.430000000000007 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.230000000000004 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.099999999999994 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.420000000000002 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 54.130000000000003 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 31.239999999999998 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.119999999999997 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 73.430000000000007 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.230000000000004 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.439999999999998 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.040000000000006 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.030000000000001 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.119999999999997 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.240000000000002 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.200000000000003 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.431 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.109999999999999 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.430000000000007 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 125' ' ' PHE . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.230000000000004 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.219999999999999 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.439999999999998 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.310000000000002 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 73.340000000000003 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.230000000000004 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.109999999999999 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.229999999999997 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.239999999999995 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.98 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.530000000000001 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 74.140000000000001 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 73.340000000000003 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.209999999999994 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.329999999999998 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 65.5 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 54.310000000000002 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.530000000000001 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.319999999999993 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.230000000000004 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.120000000000005 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.519999999999996 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.109999999999999 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 72.430000000000007 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 54.200000000000003 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.129999999999995 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.635 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.299999999999997 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 52.420000000000002 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.009999999999998 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.691 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.109999999999999 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.823 HD12 HD21 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 55.009999999999998 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 69.7 mtp . . . . . 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.230000000000004 111.315 -178.543 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 109.943 -0.392 . . . . 55.43 109.943 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 61.43 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 54.409999999999997 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.329999999999998 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.310000000000002 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.299999999999997 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.409999999999997 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.150000000000006 109.781 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 73.120000000000005 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.230000000000004 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.520000000000003 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.109999999999999 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 54.43 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 72.340000000000003 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.420000000000002 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.039999999999999 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.219999999999999 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.310000000000002 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 51.119999999999997 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.209999999999994 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.129999999999995 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 53.399999999999999 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 52.32 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.400000000000006 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.530000000000001 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 63.329999999999998 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.420000000000002 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.519999999999996 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.100000000000001 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.010000000000005 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.599 ' HB ' HG21 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 60.210000000000001 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 61.350000000000001 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 60.530000000000001 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.636 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.149999999999999 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.439999999999998 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.439999999999998 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.450000000000003 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.450000000000003 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 110.609 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.420000000000002 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.439999999999998 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.219999999999999 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.129999999999995 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.472 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.219999999999999 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.109999999999999 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 73.239999999999995 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.229999999999997 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.020000000000003 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.668 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.239999999999995 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.209999999999994 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 44.130000000000003 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.109999999999999 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.230000000000004 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 62.329999999999998 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.539999999999999 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 43.329999999999998 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.547 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.409999999999997 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.510000000000005 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.150000000000006 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.340000000000003 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.439999999999998 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 72.099999999999994 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.540000000000006 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.439999999999998 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.340000000000003 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.210000000000001 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 62.520000000000003 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.150000000000006 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.806 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 52.450000000000003 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.420000000000002 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.310000000000002 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.549999999999997 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 54.039999999999999 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 72.329999999999998 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.239999999999995 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.119999999999997 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.240000000000002 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.299999999999997 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.530000000000001 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.512 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.530000000000001 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 73.219999999999999 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.140000000000001 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.606 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.239999999999995 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.219999999999999 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.200000000000003 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 62.119999999999997 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.299999999999997 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 54.109999999999999 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.533 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.450000000000003 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.329999999999998 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.519999999999996 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.219999999999999 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.420000000000002 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.140000000000001 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.310000000000002 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 53.549999999999997 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.109999999999999 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 40.100000000000001 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 54.43 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.409999999999997 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.230000000000004 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.450000000000003 110.319 176.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' LEU . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 109.873 174.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.030000000000001 110.226 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.519999999999996 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.549999999999997 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.150000000000006 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.349999999999994 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.667 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.450000000000003 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.200000000000003 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 43.020000000000003 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 70.129999999999995 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 54.32 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 110.376 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.100000000000001 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.450000000000003 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.669 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.430000000000007 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.140000000000001 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.606 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.349999999999994 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.310000000000002 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.667 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.140000000000001 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 54.119999999999997 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 71.120000000000005 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.510000000000005 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.507 ' SD ' ' HG3' ' A' ' 64' ' ' MET . 57.0 mtp . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.540000000000006 110.335 174.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 28.9 t80 . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 109.63 -0.507 . . . . 74.540000000000006 109.63 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.099999999999994 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.109999999999999 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.807 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.239999999999995 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.520000000000003 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.299999999999997 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.403 HD13 ' OH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.420000000000002 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.540000000000006 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.340000000000003 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.230000000000004 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.530000000000001 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.239999999999995 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 63.130000000000003 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 65.209999999999994 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 63.149999999999999 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 HG23 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.430000000000007 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.759 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.549999999999997 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.684 HG23 HG22 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 61.329999999999998 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.350000000000001 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.040000000000006 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.450000000000003 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.540000000000006 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.040000000000006 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.019999999999996 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.299999999999997 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.109999999999999 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.140000000000001 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.450000000000003 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.549999999999997 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.019999999999996 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.239999999999995 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.209999999999994 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 72.120000000000005 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 53.039999999999999 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.450000000000003 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.100000000000001 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HG3' HG22 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.019999999999996 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 72.040000000000006 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.230000000000004 112.334 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.120000000000005 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.009999999999998 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.100000000000001 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.219999999999999 112.365 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.64 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.120000000000005 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.340000000000003 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.150000000000006 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 65.439999999999998 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.219999999999999 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.573 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.310000000000002 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 55.530000000000001 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 54.009999999999998 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.030000000000001 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.340000000000003 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.520000000000003 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.049999999999997 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.450000000000003 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.420000000000002 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.239999999999995 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 24.010000000000002 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 52.310000000000002 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.140000000000001 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.601 HG12 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.349999999999994 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 34.229999999999997 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.099999999999994 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.643 HG22 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.109999999999999 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.219999999999999 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.230000000000004 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.310000000000002 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.040000000000006 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 53.240000000000002 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 43.020000000000003 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.439999999999998 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.340000000000003 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.209999999999994 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.439999999999998 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.668 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 71.340000000000003 110.284 175.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.406 ' HB1' HD11 ' A' ' 116' ' ' LEU . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.340000000000003 109.695 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 55.140000000000001 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 43.119999999999997 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 72.450000000000003 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.856 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.150000000000006 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.724 HD11 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.310000000000002 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 64.140000000000001 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.530000000000001 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 73.439999999999998 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.319999999999993 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.150000000000006 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.420000000000002 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.140000000000001 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.299999999999997 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 72.530000000000001 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 55.149999999999999 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 71.450000000000003 111.398 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.030000000000001 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.109999999999999 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.329999999999998 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.807 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.239999999999995 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 72.329999999999998 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.240000000000002 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.109999999999999 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 71.450000000000003 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.310000000000002 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.823 ' HB2' HG23 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.329999999999998 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.409999999999997 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 71.430000000000007 112.69 -176.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.420000000000002 109.848 172.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.230000000000004 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.400000000000006 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.864 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 32.299999999999997 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.340000000000003 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.64 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 42.310000000000002 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 51.200000000000003 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.776 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.450000000000003 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.471 ' HB2' ' CG2' ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.239999999999995 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.329999999999998 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 72.209999999999994 113.645 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 42.149999999999999 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.409999999999997 111.307 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.230000000000004 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.239999999999995 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.140000000000001 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.030000000000001 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.712 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 23.8 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 63.119999999999997 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 63.119999999999997 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 73.120000000000005 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.120000000000005 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 71.510000000000005 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.399999999999999 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.329999999999998 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.864 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 59.3 mtm . . . . . 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.319999999999993 110.931 178.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 . . . . . 0 CA--C 1.518 -0.261 0 N-CA-C 110.161 -0.311 . . . . 72.109999999999999 110.161 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.129999999999995 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.129999999999995 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.240000000000002 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 45.32 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.239999999999995 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.439999999999998 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.349999999999994 109.434 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.340000000000003 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.310000000000002 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.209999999999994 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.340000000000003 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.748 HD13 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.540000000000006 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 54.350000000000001 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.340000000000003 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 61.509999999999998 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.119999999999997 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 63.329999999999998 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 31' ' ' LEU . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 61.140000000000001 111.673 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 72.030000000000001 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.540000000000006 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.040000000000006 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD21 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.509999999999998 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 64.420000000000002 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 71.430000000000007 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 72.109999999999999 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.310000000000002 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.020000000000003 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.319999999999993 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.319999999999993 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 45.530000000000001 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.420000000000002 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 55.219999999999999 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.049999999999997 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.229999999999997 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.409999999999997 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 64.430000000000007 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.55 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 64.120000000000005 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.209999999999994 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 63.130000000000003 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.219999999999999 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 60.119999999999997 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.549999999999997 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.509999999999998 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.310000000000002 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 134' ' ' ILE . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.310000000000002 110.064 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.349999999999994 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.409999999999997 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.826 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 53.329999999999998 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.420000000000002 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.049999999999997 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.439999999999998 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.430000000000007 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.310000000000002 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 71.340000000000003 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.530000000000001 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.209999999999994 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 73.219999999999999 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.611 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 74.219999999999999 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.549999999999997 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.439999999999998 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.299999999999997 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.530000000000001 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.310000000000002 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.030000000000001 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.55 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.519999999999996 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.540000000000006 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.120000000000005 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.150000000000006 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 32.350000000000001 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.140000000000001 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.540000000000006 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 31.329999999999998 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.310000000000002 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 71.129999999999995 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 43.329999999999998 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.099999999999994 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.450000000000003 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.420000000000002 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.737 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.329999999999998 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.319999999999993 110.498 178.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.503 ' CB ' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 44.340000000000003 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.530000000000001 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.040000000000006 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.310000000000002 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 62.530000000000001 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.150000000000006 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.119999999999997 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.219999999999999 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 74.329999999999998 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.219999999999999 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.439999999999998 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.129999999999995 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 62.450000000000003 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.039999999999999 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.120000000000005 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.545 ' HA ' HD12 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.329999999999998 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.319999999999993 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.439999999999998 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.230000000000004 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.120000000000005 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.409999999999997 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.878 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.120000000000005 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.230000000000004 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.219999999999999 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.030000000000001 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.120000000000005 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 73.040000000000006 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.299999999999997 110.603 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.430000000000007 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.593 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.439999999999998 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.420000000000002 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.219999999999999 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' HG21 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 45.420000000000002 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 58' ' ' PHE . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.030000000000001 108.901 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 61.539999999999999 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.595 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.120000000000005 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.230000000000004 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.618 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.140000000000001 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.340000000000003 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.239999999999995 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.140000000000001 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 63.530000000000001 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.588 ' H ' HG23 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.230000000000004 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.420000000000002 111.218 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 53.020000000000003 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 51.100000000000001 109.847 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.439999999999998 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.030000000000001 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.340000000000003 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.209999999999994 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 72.430000000000007 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt . . . . . 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.209999999999994 111.416 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 109.457 -0.572 . . . . 74.230000000000004 109.457 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.140000000000001 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 64.239999999999995 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 52.399999999999999 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 44.399999999999999 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 51.210000000000001 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.209999999999994 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 64.140000000000001 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.040000000000006 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.409999999999997 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.009999999999998 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.219999999999999 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.329999999999998 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 63.439999999999998 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.299999999999997 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.510000000000005 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.349999999999994 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.439999999999998 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.497 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 53.0 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 25.010000000000002 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.130000000000003 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.130000000000003 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 71.010000000000005 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.530000000000001 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 71.319999999999993 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 74.439999999999998 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 73.430000000000007 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.230000000000004 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.520000000000003 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.509999999999998 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.310000000000002 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 73.140000000000001 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.230000000000004 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.420000000000002 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.420000000000002 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 61.130000000000003 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.340000000000003 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.209999999999994 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.530000000000001 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 70.430000000000007 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.130000000000003 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 65.109999999999999 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 61.200000000000003 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.340000000000003 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.959 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 55.25 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.510000000000005 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.140000000000001 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.449 ' HD1' HG22 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.240000000000002 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.519999999999996 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.019999999999996 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 64.150000000000006 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.788 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 70.140000000000001 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.099999999999994 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.120000000000005 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.409999999999997 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.140000000000001 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.229999999999997 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' HD1' HG13 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 74.319999999999993 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.299999999999997 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 63.020000000000003 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.140000000000001 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.5 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.340000000000003 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.200000000000003 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.959 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.030000000000001 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.120000000000005 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.040000000000006 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.539999999999999 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.329999999999998 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 72.219999999999999 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 70.409999999999997 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.310000000000002 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.839 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.219999999999999 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.010000000000005 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 53.119999999999997 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.839 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 43.240000000000002 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 44.030000000000001 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.039999999999999 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.510000000000005 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 71.219999999999999 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 54.509999999999998 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.109999999999999 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 33.100000000000001 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.099999999999994 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.230000000000004 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.585 ' CD1' HG11 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.230000000000004 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.409999999999997 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.099999999999994 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.439999999999998 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.420000000000002 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 61.539999999999999 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.450000000000003 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.439999999999998 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 71.340000000000003 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 72.299999999999997 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.319999999999993 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.340000000000003 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 70.299999999999997 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.120000000000005 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.099999999999994 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 44.009999999999998 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 72.239999999999995 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 43.030000000000001 110.277 177.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.140000000000001 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 53.200000000000003 111.497 -178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.140000000000001 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.788 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.099999999999994 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.109999999999999 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 54.119999999999997 109.753 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.219999999999999 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.420000000000002 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.400000000000006 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.813 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.109999999999999 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.209999999999994 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.519999999999996 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.793 ' HB3' HD11 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.439999999999998 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.409999999999997 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.129999999999995 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 62.039999999999999 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.299999999999997 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.420000000000002 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.495 ' HB3' ' O ' ' A' ' 104' ' ' GLY . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.299999999999997 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.329999999999998 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.140000000000001 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.109999999999999 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.655 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.230000000000004 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 62.140000000000001 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.120000000000005 110.392 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.617 ' HG3' ' HG3' ' A' ' 130' ' ' GLU . 25.7 mmt . . . . . 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 110.293 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 39.1 p90 . . . . . 0 CA--C 1.521 -0.156 0 N-CA-C 109.936 -0.394 . . . . 75.209999999999994 109.936 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 52.009999999999998 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.588 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.420000000000002 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.420000000000002 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.803 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.430000000000007 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.310000000000002 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.319999999999993 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.099999999999994 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 43.039999999999999 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.409999999999997 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 33.219999999999999 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.832 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.299999999999997 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 62.229999999999997 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 61.340000000000003 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.019999999999996 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 41.43 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.530000000000001 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.020000000000003 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 64.200000000000003 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.400000000000006 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.439999999999998 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.219999999999999 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 74.439999999999998 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.219999999999999 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.129999999999995 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 60.439999999999998 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.540000000000006 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.109999999999999 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.099999999999994 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 62.530000000000001 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.329999999999998 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.349999999999994 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.299999999999997 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.67 HE22 HG13 ' A' ' 81' ' ' VAL . 71.3 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.329999999999998 109.701 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.340000000000003 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.209999999999994 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 64.430000000000007 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.520000000000003 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.539999999999999 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.340000000000003 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 62.5 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.310000000000002 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 74.340000000000003 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.497 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.200000000000003 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 71' ' ' VAL . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.932 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.329999999999998 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.329999999999998 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.040000000000006 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.450000000000003 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 65.530000000000001 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.010000000000005 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 71.409999999999997 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.832 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.129999999999995 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 64.319999999999993 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.329999999999998 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.209999999999994 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.530000000000001 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.400000000000006 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.310000000000002 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.329999999999998 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.420000000000002 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.67 HG13 HE22 ' A' ' 49' ' ' GLN . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.439999999999998 108.473 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.450000000000003 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.140000000000001 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.430000000000007 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.420000000000002 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.530000000000001 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.219999999999999 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 70.319999999999993 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.129999999999995 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.299999999999997 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 52.299999999999997 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.230000000000004 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.319999999999993 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.408 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.030000000000001 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.450000000000003 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.030000000000001 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.530000000000001 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.420000000000002 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.588 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.129999999999995 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.329999999999998 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.310000000000002 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.340000000000003 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.239999999999995 111.367 175.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.040000000000006 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.240000000000002 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.099999999999994 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.439999999999998 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.319999999999993 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.010000000000005 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.510000000000005 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.636 ' HA ' HD11 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 64.439999999999998 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.310000000000002 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.711 HD12 ' HB1' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.420000000000002 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.420000000000002 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.803 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.030000000000001 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.420000000000002 110.895 -176.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 64.530000000000001 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.019999999999996 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.150000000000006 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.451 ' C ' HD22 ' A' ' 127' ' ' LEU . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.019999999999996 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.451 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.219999999999999 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 31.129999999999999 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.719 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.430000000000007 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 61.119999999999997 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 71.120000000000005 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.200000000000003 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 74.140000000000001 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.299999999999997 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 73.540000000000006 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.539999999999999 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.049999999999997 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 54.25 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.010000000000005 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.510000000000005 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.319999999999993 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.349999999999994 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 62.399999999999999 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.140000000000001 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 64.129999999999995 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.329999999999998 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.120000000000005 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.551 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.200000000000003 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.420000000000002 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 65.340000000000003 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.319999999999993 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp . . . . . 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 61.450000000000003 109.421 174.503 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 . . . . . 0 N--CA 1.452 -0.329 0 CA-C-O 121.308 0.575 . . . . 71.349999999999994 111.063 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.420000000000002 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 71.109999999999999 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.239999999999995 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD21 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 53.549999999999997 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.219999999999999 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.530000000000001 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.200000000000003 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 64.430000000000007 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.439999999999998 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 1.091 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.239999999999995 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.010000000000005 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.912 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.409999999999997 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.439999999999998 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.409999999999997 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.540000000000006 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.329999999999998 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.430000000000007 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.099999999999994 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 50.420000000000002 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.109999999999999 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.030000000000001 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.549999999999997 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.019999999999996 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.230000000000004 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 51.310000000000002 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.510000000000005 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.010000000000005 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.439999999999998 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.540000000000006 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.350000000000001 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.319999999999993 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.119999999999997 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.329999999999998 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 72.140000000000001 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.239999999999995 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 50.32 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.528 HE22 ' HG ' ' A' ' 45' ' ' LEU . 2.0 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.219999999999999 110.086 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.340000000000003 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.439999999999998 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.340000000000003 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.319999999999993 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.540000000000006 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.439999999999998 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.030000000000001 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.329999999999998 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.150000000000006 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.349999999999994 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.746 ' HD1' HG12 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 63.409999999999997 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.756 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 72.219999999999999 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.129999999999995 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.030000000000001 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 74.329999999999998 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.430000000000007 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.530000000000001 109.363 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.409999999999997 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 70.230000000000004 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.746 HG12 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.040000000000006 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.912 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.109999999999999 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 71.25 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.200000000000003 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 1.091 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.530000000000001 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 73.349999999999994 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.450000000000003 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 33.420000000000002 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.471 HG13 HE21 ' A' ' 49' ' ' GLN . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.219999999999999 109.923 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.539999999999999 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.099999999999994 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 41.539999999999999 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 71.239999999999995 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.782 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 63.310000000000002 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.319999999999993 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.319999999999993 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.210000000000001 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.240000000000002 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 14' ' ' LEU . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.299999999999997 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.200000000000003 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.420000000000002 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.140000000000001 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.349999999999994 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 65.109999999999999 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.851 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.040000000000006 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 74.329999999999998 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.200000000000003 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.230000000000004 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 72.519999999999996 111.821 178.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.129999999999995 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.420000000000002 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.129999999999995 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.340000000000003 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.239999999999995 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.219999999999999 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 60.420000000000002 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.109999999999999 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.530000000000001 110.83 176.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.409999999999997 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.758 HD13 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 110.777 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.530000000000001 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.439999999999998 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.206 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.039999999999999 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.150000000000006 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.209999999999994 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.140000000000001 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.239999999999995 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 127' ' ' LEU . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 154' ' ' MET . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 55.109999999999999 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 31.350000000000001 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.539999999999999 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.340000000000003 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.230000000000004 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.310000000000002 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.120000000000005 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HE2' ' HB3' ' A' ' 59' ' ' ALA . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 70.010000000000005 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.409999999999997 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.466 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.409999999999997 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.030000000000001 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.409999999999997 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 44.299999999999997 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 138' ' ' ASN . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 65.439999999999998 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.140000000000001 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 72.340000000000003 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.409999999999997 111.472 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.651 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.329999999999998 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 65.420000000000002 108.716 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 65.310000000000002 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.129999999999995 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.049999999999997 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.851 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.010000000000005 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.210000000000001 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.530000000000001 110.355 176.788 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.842 0.829 . . . . 70.030000000000001 111.244 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.209999999999994 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HG3' HG12 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.310000000000002 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 60.420000000000002 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.109999999999999 109.6 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 63.219999999999999 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 63.32 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 61.200000000000003 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.240000000000002 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.040000000000006 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.039999999999999 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.340000000000003 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.319999999999993 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.099999999999994 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 61.030000000000001 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.140000000000001 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 65.450000000000003 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 60.229999999999997 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 35.030000000000001 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 72.319999999999993 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.450000000000003 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.130000000000003 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.420000000000002 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.530000000000001 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.329999999999998 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.019999999999996 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.450000000000003 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.310000000000002 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 71.319999999999993 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 64.040000000000006 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.400000000000006 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.150000000000006 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.230000000000004 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 62.340000000000003 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.239999999999995 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.340000000000003 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.340000000000003 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.530000000000001 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 21.32 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.099999999999994 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 62.350000000000001 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 55.310000000000002 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.430000000000007 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 44.030000000000001 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.329999999999998 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.209999999999994 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 72.030000000000001 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.230000000000004 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.040000000000006 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.200000000000003 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 73.310000000000002 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.409999999999997 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.319999999999993 109.884 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.530000000000001 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 45.329999999999998 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.350000000000001 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.230000000000004 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.140000000000001 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.040000000000006 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.409999999999997 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.200000000000003 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.310000000000002 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 74.25 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.099999999999994 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.310000000000002 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.420000000000002 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 70.140000000000001 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 63.32 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.099999999999994 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.040000000000006 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.319999999999993 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.240000000000002 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 64.200000000000003 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.439999999999998 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.530000000000001 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 62.030000000000001 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.340000000000003 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.219999999999999 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 65.140000000000001 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.140000000000001 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 24.52 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.219999999999999 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.200000000000003 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.400000000000006 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 54.140000000000001 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 62.32 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.120000000000005 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.499 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.209999999999994 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.450000000000003 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.299999999999997 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.430000000000007 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.399999999999999 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.420000000000002 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 71.409999999999997 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.140000000000001 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.140000000000001 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.200000000000003 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.519999999999996 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.109999999999999 111.575 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.239999999999995 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.319999999999993 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 41.109999999999999 110.07 -179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.209999999999994 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.450000000000003 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 54.130000000000003 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.319999999999993 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.420000000000002 112.007 -179.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 74.420000000000002 110.191 172.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.150000000000006 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.209999999999994 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.230000000000004 109.969 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.530000000000001 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.109999999999999 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.6 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.400000000000006 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.219999999999999 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.319999999999993 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 60.039999999999999 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.340000000000003 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.230000000000004 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.349999999999994 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.420000000000002 110.677 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 53.149999999999999 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.039 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.140000000000001 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.409999999999997 110.396 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 147' ' ' LEU . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.319999999999993 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.703 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.120000000000005 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.685 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.019999999999996 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 64.219999999999999 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 72.530000000000001 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.48 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 51.7 mtm . . . . . 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.219999999999999 110.89 175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 . . . . . 0 N--CA 1.456 -0.156 0 CA-C-O 121.016 0.436 . . . . 73.510000000000005 111.167 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 63.299999999999997 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.140000000000001 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.510000000000005 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.340000000000003 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.120000000000005 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 61.130000000000003 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.039999999999999 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.79 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.400000000000006 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.047 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.430000000000007 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.310000000000002 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.530000000000001 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 72' ' ' GLU . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.530000000000001 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.240000000000002 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.239999999999995 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.340000000000003 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.109999999999999 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 63.229999999999997 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.439999999999998 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.540000000000006 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.340000000000003 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.219999999999999 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 70.439999999999998 111.205 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.530000000000001 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.109999999999999 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.019999999999996 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.530000000000001 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 60.520000000000003 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 42.549999999999997 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 63.130000000000003 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.430000000000007 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.200000000000003 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 71.209999999999994 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.815 HD21 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 55.329999999999998 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.319999999999993 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.319999999999993 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.399999999999999 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 61.020000000000003 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.099999999999994 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.799 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.439999999999998 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.049999999999997 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 63.439999999999998 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.120000000000005 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 53.219999999999999 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.530000000000001 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.885 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 76' ' ' PRO . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 109.831 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 51.310000000000002 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.140000000000001 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.954 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.450000000000003 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 52.539999999999999 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.450000000000003 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.310000000000002 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.299999999999997 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.129999999999995 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.409999999999997 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.209999999999994 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.954 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 61.340000000000003 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 53.450000000000003 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' HD22 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 64.510000000000005 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.753 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 70.209999999999994 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.885 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 63.549999999999997 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.540000000000006 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 54.240000000000002 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.409999999999997 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.329999999999998 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.030000000000001 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.099999999999994 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.815 ' HA2' HD21 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 71.099999999999994 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.399999999999999 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 71.519999999999996 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.039999999999999 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.299999999999997 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 64.109999999999999 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.049999999999997 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.010000000000005 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.219999999999999 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.450000000000003 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 61.310000000000002 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.030000000000001 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.109999999999999 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.299999999999997 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.109999999999999 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 72.349999999999994 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 34.310000000000002 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.340000000000003 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.430000000000007 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.150000000000006 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.209999999999994 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.329999999999998 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.509999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.530000000000001 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.530000000000001 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.040000000000006 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.129999999999995 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.120000000000005 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.150000000000006 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.666 HG21 HD11 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.140000000000001 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.400000000000006 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 70.010000000000005 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.209999999999994 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.310000000000002 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 72.409999999999997 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.230000000000004 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.010000000000005 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 32.039999999999999 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.655 ' HB3' HD12 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.409999999999997 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.400000000000006 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.140000000000001 109.779 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 73.140000000000001 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 63.299999999999997 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.200000000000003 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.039999999999999 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.010000000000005 110.297 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.140000000000001 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.010000000000005 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.140000000000001 110.501 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 63.229999999999997 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.049999999999997 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.75 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 43.32 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.209999999999994 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 64.310000000000002 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.420000000000002 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.340000000000003 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.439999999999998 110.546 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 44.229999999999997 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 64.439999999999998 109.904 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.109999999999999 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 111.363 -174.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.725 0.297 . . . . 72.209999999999994 110.422 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 70.340000000000003 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.329999999999998 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 62.039999999999999 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.698 HD13 HD21 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 35.509999999999998 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.400000000000006 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.202 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.329999999999998 112.093 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 53.409999999999997 109.646 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.030000000000001 112.138 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.510000000000005 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.530000000000001 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.129999999999995 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.329999999999998 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.449 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 74.540000000000006 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.319999999999993 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.400000000000006 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.540000000000006 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.040000000000006 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.129999999999995 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.329999999999998 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.420000000000002 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.595 HD21 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 53.229999999999997 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 71.010000000000005 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.310000000000002 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.140000000000001 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.129999999999995 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 72.310000000000002 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.039999999999999 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.230000000000004 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.030000000000001 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.049999999999997 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.340000000000003 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.129999999999995 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.400000000000006 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.150000000000006 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.140000000000001 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.329999999999998 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.310000000000002 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.219999999999999 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 43.539999999999999 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.409999999999997 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.559 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 52.5 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.310000000000002 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 112.23 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.130000000000003 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 72.310000000000002 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.25 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.019999999999996 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.786 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 23' ' ' ARG . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 61.549999999999997 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.420000000000002 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.47 ' N ' ' SD ' ' A' ' 64' ' ' MET . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.120000000000005 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.340000000000003 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.430000000000007 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.530000000000001 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HE1' HD21 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.239999999999995 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.409999999999997 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 52.43 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 65.299999999999997 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.409999999999997 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 57' ' ' PRO . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.530000000000001 109.45 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.129999999999995 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 71.310000000000002 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.140000000000001 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.420000000000002 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.099999999999994 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 74.420000000000002 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.510000000000005 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.210000000000001 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.439999999999998 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.319999999999993 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.239999999999995 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 33.350000000000001 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 73.109999999999999 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 70.200000000000003 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.129999999999995 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 63.299999999999997 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.329999999999998 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.299999999999997 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 54.43 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.020000000000003 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 63.0 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.451 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.049999999999997 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.209999999999994 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.349999999999994 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 71.0 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.140000000000001 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.409999999999997 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.030000000000001 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.813 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.340000000000003 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.486 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.439999999999998 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 70.340000000000003 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.813 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.099999999999994 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 65.0 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.802 ' HG ' HD23 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.230000000000004 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.458 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.129999999999995 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.430000000000007 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.554 ' O ' ' HE3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.109999999999999 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.310000000000002 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.150000000000006 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 70.409999999999997 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.698 HD21 HD13 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.310000000000002 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.049999999999997 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.526 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 61.240000000000002 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.498 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.319999999999993 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.129999999999995 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 34.340000000000003 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.030000000000001 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.239999999999995 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.450000000000003 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.400000000000006 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.656 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.140000000000001 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 73.129999999999995 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.399999999999999 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.230000000000004 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.349999999999994 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.001 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.409999999999997 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 71.409999999999997 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' A' ' 147' ' ' LEU . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 72.340000000000003 112.971 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 41.520000000000003 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' PRO . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.140000000000001 109.675 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.340000000000003 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 61.009999999999998 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.319999999999993 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.793 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 65.340000000000003 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.802 HD23 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 74.530000000000001 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 154' ' ' MET . 2.8 mpp? . . . . . 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 110.448 -177.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 N--CA 1.467 0.404 0 N-CA-C 113.64 0.978 . . . . 72.150000000000006 113.64 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.209999999999994 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.099999999999994 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.140000000000001 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 73.420000000000002 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.140000000000001 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 62.310000000000002 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.635 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.219999999999999 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.329999999999998 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.319999999999993 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.329999999999998 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' HD23 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.329999999999998 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.77 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.219999999999999 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.120000000000005 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.518 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 54.039999999999999 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.804 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 41.9 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.530000000000001 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.319999999999993 111.086 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.239999999999995 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.839 HD13 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 44.140000000000001 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.420000000000002 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.099999999999994 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.310000000000002 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.129999999999995 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.510000000000005 111.21 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 70.150000000000006 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.329999999999998 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 70.329999999999998 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.340000000000003 110.993 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 71.140000000000001 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 53.539999999999999 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.230000000000004 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.109999999999999 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 61.329999999999998 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.230000000000004 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.530000000000001 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.140000000000001 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 65.329999999999998 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.519999999999996 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.409999999999997 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.040000000000006 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 53.229999999999997 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.140000000000001 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.439999999999998 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 42.530000000000001 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.400000000000006 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.981 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.310000000000002 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.530000000000001 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.73 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 64.519999999999996 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.409999999999997 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.409999999999997 110.035 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.549999999999997 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.329999999999998 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.210000000000001 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 71.439999999999998 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.430000000000007 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.804 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 51.219999999999999 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.639 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.099999999999994 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.030000000000001 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.736 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.439999999999998 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.450000000000003 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.120000000000005 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.340000000000003 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.340000000000003 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.420000000000002 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 55.149999999999999 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 50.450000000000003 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.140000000000001 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.010000000000005 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 54.200000000000003 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 54.109999999999999 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.400000000000006 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.109999999999999 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.129999999999995 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.349999999999994 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 62.130000000000003 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.129999999999995 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 65.439999999999998 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 61.520000000000003 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.400000000000006 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 51.409999999999997 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.109999999999999 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.439999999999998 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.209999999999994 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.540000000000006 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.229999999999997 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.310000000000002 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.239999999999995 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 61.420000000000002 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.129999999999995 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.420000000000002 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 64.540000000000006 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.140000000000001 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.210000000000001 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.430000000000007 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.439999999999998 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.140000000000001 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.129999999999995 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.350000000000001 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.420000000000002 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.040000000000006 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.531 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.209999999999994 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.099999999999994 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.430000000000007 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.520000000000003 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.981 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 73.329999999999998 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.817 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.299999999999997 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.349999999999994 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 63.450000000000003 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 134' ' ' ILE . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.319999999999993 112.375 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.200000000000003 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.109999999999999 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.120000000000005 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.229999999999997 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.109999999999999 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.530000000000001 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.400000000000006 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.150000000000006 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 54.119999999999997 109.524 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 54.210000000000001 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.530000000000001 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.65 HG22 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.519999999999996 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.635 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.329999999999998 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.817 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.439999999999998 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.409999999999997 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.531 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 52.310000000000002 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 154' ' ' MET . 11.6 mmt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.420000000000002 111.093 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 . . . . . 0 C--O 1.232 0.149 0 CA-C-O 121.044 0.45 . . . . 55.200000000000003 110.346 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 61.140000000000001 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.310000000000002 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 73.25 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.409999999999997 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.299999999999997 110.621 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.310000000000002 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 70.010000000000005 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 44.219999999999999 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.209999999999994 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 64.120000000000005 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 70.219999999999999 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.310000000000002 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 70.030000000000001 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 21' ' ' LEU . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.340000000000003 110.508 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.733 HD13 ' HB3' ' A' ' 73' ' ' PHE . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.310000000000002 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.340000000000003 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.430000000000007 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.635 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.409999999999997 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.239999999999995 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.109999999999999 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.540000000000006 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.340000000000003 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.120000000000005 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 71.049999999999997 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 71.310000000000002 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.420000000000002 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.200000000000003 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.685 ' HA ' HG22 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.310000000000002 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.540000000000006 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.420000000000002 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 62.439999999999998 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.150000000000006 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 73.329999999999998 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 51.409999999999997 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 52.420000000000002 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.319999999999993 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.430000000000007 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.430000000000007 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.329999999999998 110.45 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.329999999999998 111.826 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.439999999999998 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.219999999999999 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.829 ' HG2' HD11 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 71.030000000000001 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.439999999999998 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 62.350000000000001 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.120000000000005 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.399999999999999 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.329999999999998 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.120000000000005 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 72.200000000000003 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.150000000000006 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.219999999999999 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 64.239999999999995 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.592 ' HB3' HG22 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.200000000000003 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.409999999999997 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.349999999999994 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 62.229999999999997 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.733 ' HB3' HD13 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.420000000000002 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.420000000000002 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.439999999999998 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.519999999999996 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.319999999999993 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.230000000000004 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.420000000000002 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.200000000000003 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.559 ' HA2' HG13 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.140000000000001 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.130000000000003 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.319999999999993 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 71.239999999999995 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.219999999999999 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.109999999999999 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 65.319999999999993 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.349999999999994 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.239999999999995 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.656 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 33.399999999999999 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.140000000000001 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 62.420000000000002 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 44.409999999999997 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.200000000000003 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.219999999999999 108.688 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.806 HD12 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.239999999999995 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.200000000000003 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 139' ' ' PRO . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.120000000000005 111.599 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HE1' HG21 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.150000000000006 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.239999999999995 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.349999999999994 110.483 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.409999999999997 109.819 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 64.319999999999993 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.120000000000005 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.340000000000003 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.109999999999999 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.319999999999993 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.450000000000003 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.099999999999994 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.519999999999996 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.439999999999998 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.209999999999994 110.57 176.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 55.310000000000002 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 61.299999999999997 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 0.58 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.150000000000006 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 45.210000000000001 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.58 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.310000000000002 108.727 176.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 61.539999999999999 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 52.350000000000001 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.099999999999994 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.420000000000002 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.73 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.140000000000001 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.150000000000006 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.450000000000003 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.829 HD11 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.329999999999998 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 55.100000000000001 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.706 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.239999999999995 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.519999999999996 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.340000000000003 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.722 ' HB3' HD13 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.319999999999993 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.040000000000006 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.319999999999993 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.493 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.010000000000005 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.130000000000003 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.310000000000002 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.549999999999997 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.310000000000002 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.150000000000006 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.430000000000007 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.497 HG21 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.109999999999999 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.040000000000006 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.409999999999997 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.612 ' HB3' HD22 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.040000000000006 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.73 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 40.7 mtm . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.030000000000001 109.124 172.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 120.979 0.419 . . . . 74.439999999999998 111.645 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 73.140000000000001 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 54.43 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.109999999999999 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.009999999999998 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.230000000000004 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 70.129999999999995 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 32.509999999999998 109.975 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.409999999999997 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.519999999999996 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.109999999999999 113.695 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.229999999999997 110.746 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.400000000000006 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.588 HD13 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.409999999999997 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 61.420000000000002 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.219999999999999 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.420000000000002 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.400000000000006 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 44.130000000000003 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.439999999999998 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.219999999999999 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.200000000000003 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.209999999999994 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 63.520000000000003 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 53.229999999999997 110.283 -176.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.329999999999998 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.230000000000004 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.009999999999998 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 70.319999999999993 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 73.209999999999994 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.310000000000002 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.439999999999998 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.219999999999999 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.409999999999997 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.329999999999998 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 61.549999999999997 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.329999999999998 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.299999999999997 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.409999999999997 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 20.030000000000001 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 73.030000000000001 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 62.509999999999998 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.109999999999999 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.420000000000002 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.239999999999995 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.409999999999997 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.349999999999994 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 62.25 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.230000000000004 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.77 ' HB3' HG12 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.209999999999994 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.439999999999998 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.010000000000005 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 64.030000000000001 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.329999999999998 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.329999999999998 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.020000000000003 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.319999999999993 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.77 HG12 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.140000000000001 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.109999999999999 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.120000000000005 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.319999999999993 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.009999999999998 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.120000000000005 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 19' ' ' ALA . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 71.400000000000006 109.719 176.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.450000000000003 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.430000000000007 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.239999999999995 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.509999999999998 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.150000000000006 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.030000000000001 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 63.439999999999998 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.512 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.540000000000006 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.150000000000006 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 41.229999999999997 112.6 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.340000000000003 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.465 ' HB ' HD21 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.109999999999999 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.549999999999997 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.200000000000003 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.340000000000003 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.439999999999998 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 61.109999999999999 110.935 -176.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.753 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 72.540000000000006 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 71.519999999999996 110.876 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 61.100000000000001 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.329999999999998 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.951 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.299999999999997 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.329999999999998 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.030000000000001 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.510000000000005 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.577 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 53.240000000000002 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.239999999999995 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 64.129999999999995 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.129999999999995 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.310000000000002 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.430000000000007 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.340000000000003 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 63.200000000000003 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.019999999999996 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.519999999999996 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 64.310000000000002 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.319999999999993 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.030000000000001 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 54.409999999999997 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.439999999999998 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.540000000000006 109.188 176.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 62.409999999999997 108.745 164.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 44.140000000000001 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.230000000000004 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.310000000000002 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.299999999999997 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.472 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.049999999999997 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 61.140000000000001 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.409999999999997 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.049999999999997 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.642 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.219999999999999 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.510000000000005 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 62.210000000000001 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 42.140000000000001 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.019999999999996 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.519999999999996 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.329999999999998 111.848 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 53.340000000000003 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.430000000000007 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 72.420000000000002 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.219999999999999 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.876 ' HD3' HD13 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.951 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.329999999999998 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.849 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 72.329999999999998 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 52.299999999999997 109.353 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 74.310000000000002 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.430000000000007 110.727 178.787 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 . . . . . 0 N--CA 1.45 -0.434 0 N-CA-C 108.634 -0.876 . . . . 73.030000000000001 108.634 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.299999999999997 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.030000000000001 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.450000000000003 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.150000000000006 110.373 -174.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.349999999999994 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 55.420000000000002 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.109999999999999 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.686 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.109999999999999 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.200000000000003 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.200000000000003 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.399999999999999 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.219999999999999 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.518 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 74.209999999999994 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.551 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 70.040000000000006 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.409999999999997 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.310000000000002 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.420000000000002 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.765 HG21 HD22 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 62.439999999999998 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.409999999999997 112.336 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 54.439999999999998 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.765 HD22 HG21 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 64.150000000000006 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 44.229999999999997 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.340000000000003 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 72.140000000000001 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 54.0 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.340000000000003 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.120000000000005 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.010000000000005 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.420000000000002 110.228 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.420000000000002 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.329999999999998 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 61.130000000000003 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 54.409999999999997 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 70.299999999999997 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.509999999999998 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.019999999999996 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.400000000000006 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.450000000000003 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.209999999999994 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.140000000000001 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.120000000000005 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.120000000000005 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.420000000000002 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.400000000000006 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.120000000000005 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 64.319999999999993 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 54.329999999999998 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.439999999999998 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 63.350000000000001 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.319999999999993 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.540000000000006 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.109999999999999 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 62.5 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 64.420000000000002 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 40.32 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.420000000000002 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 64.140000000000001 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 1.016 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.040000000000006 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.140000000000001 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 35.210000000000001 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.209999999999994 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 31.100000000000001 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 61.549999999999997 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.219999999999999 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.698 HG21 HD23 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.340000000000003 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.340000000000003 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.430000000000007 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.450000000000003 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.579 ' HB ' HG11 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.430000000000007 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 109.916 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 21.239999999999998 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.109999999999999 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 64.129999999999995 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.219999999999999 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.319999999999993 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.319999999999993 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.219999999999999 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.010000000000005 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.129999999999995 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.686 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.510000000000005 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.329999999999998 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 54.210000000000001 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.340000000000003 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.049999999999997 110.983 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.049999999999997 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.483 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 73.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.481 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 73.430000000000007 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 63.329999999999998 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.130000000000003 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.519999999999996 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.130000000000003 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.239999999999995 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.693 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.439999999999998 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.925 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.109999999999999 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.519999999999996 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.100000000000001 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.925 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 51.030000000000001 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.310000000000002 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 53.240000000000002 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 53.219999999999999 111.445 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 72.420000000000002 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.451 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.140000000000001 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 64.219999999999999 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.310000000000002 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.329999999999998 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.299999999999997 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.329999999999998 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 120' ' ' VAL . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.209999999999994 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.329999999999998 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.219999999999999 109.386 175.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.54 ' CB ' ' HB3' ' A' ' 154' ' ' MET . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.430000000000007 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.109999999999999 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.030000000000001 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.099999999999994 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.209999999999994 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.400000000000006 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.586 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.310000000000002 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.424 HD22 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 62.119999999999997 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 65.140000000000001 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.409999999999997 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.310000000000002 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.329999999999998 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.230000000000004 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.200000000000003 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.310000000000002 110.779 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.409999999999997 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 54.409999999999997 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.099999999999994 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.239999999999995 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HD2' HD22 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 64.439999999999998 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.239999999999995 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.402 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.010000000000005 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 61.039999999999999 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.200000000000003 109.167 171.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? . . . . . 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.510000000000005 110.529 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.452 -0.374 0 N-CA-C 109.898 -0.408 . . . . 74.140000000000001 109.898 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.019999999999996 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 71.239999999999995 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.329999999999998 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.030000000000001 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 71.230000000000004 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.329999999999998 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 55.520000000000003 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 64.540000000000006 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.510000000000005 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.239999999999995 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.219999999999999 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.329999999999998 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.329999999999998 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.340000000000003 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.150000000000006 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.109999999999999 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.310000000000002 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.030000000000001 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.240000000000002 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.219999999999999 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.329999999999998 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.409999999999997 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 61.340000000000003 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.040000000000006 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.310000000000002 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.020000000000003 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 62.32 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.209999999999994 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 54.530000000000001 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.430000000000007 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.439999999999998 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.049999999999997 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 61.140000000000001 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.140000000000001 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.530000000000001 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.329999999999998 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.409999999999997 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.150000000000006 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.219999999999999 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.140000000000001 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 65.230000000000004 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.109999999999999 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.621 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.420000000000002 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.209999999999994 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 72.299999999999997 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 61.450000000000003 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.530000000000001 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.319999999999993 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.540000000000006 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.349999999999994 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 30.23 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.400000000000006 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 51.140000000000001 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.530000000000001 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.450000000000003 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.349999999999994 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.219999999999999 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.299999999999997 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 62.549999999999997 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.864 HG21 HD13 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.120000000000005 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.219999999999999 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.100000000000001 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.240000000000002 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.822 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 62.100000000000001 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.239999999999995 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 64.519999999999996 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 63.109999999999999 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.329999999999998 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.319999999999993 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.439999999999998 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.040000000000006 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . 0.757 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.340000000000003 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 50.509999999999998 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 55.210000000000001 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB2' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.109999999999999 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.299999999999997 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.531 ' HB2' HD21 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.510000000000005 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.519999999999996 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.150000000000006 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.099999999999994 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.340000000000003 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.340000000000003 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.527 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 63.25 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.239999999999995 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . 0.635 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.119999999999997 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.310000000000002 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.219999999999999 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.219999999999999 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.120000000000005 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.129999999999995 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.420000000000002 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . 0.752 ' HZ2' ' HB2' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 73.329999999999998 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 1.019 ' HA ' HD22 ' A' ' 123' ' ' ASN . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.210000000000001 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.239999999999995 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.329999999999998 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . 1.019 HD22 ' HA ' ' A' ' 120' ' ' VAL . 42.8 m-80 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.229999999999997 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.299999999999997 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.010000000000005 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 44.43 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.240000000000002 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.540000000000006 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.010000000000005 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.823 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 52.210000000000001 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 70.200000000000003 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.319999999999993 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 53.539999999999999 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.928 ' HB3' HG21 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.019999999999996 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.009999999999998 112.763 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 62.350000000000001 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.310000000000002 109.612 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . 0.928 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.120000000000005 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.120000000000005 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.409999999999997 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.299999999999997 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 63.43 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.219999999999999 108.431 176.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . 0.57 ' H ' ' HB2' ' A' ' 137' ' ' ASP . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 71.329999999999998 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HD2' HD12 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.409999999999997 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.509999999999998 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 52.420000000000002 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.834 ' H ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.530000000000001 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 20.7 ttp . . . . . 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.129999999999995 111.343 -169.625 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 N--CA 1.453 -0.284 0 CA-C-O 121.057 0.456 . . . . 62.030000000000001 110.919 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 63.399999999999999 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 62.299999999999997 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.803 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.867 HD11 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 45.5 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 71.25 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.239999999999995 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.319999999999993 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.299999999999997 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 63.25 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.130000000000003 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HG ' HG12 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 73.230000000000004 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD12 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.409999999999997 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.010000000000005 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.847 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 64.239999999999995 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 43.420000000000002 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.530000000000001 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.200000000000003 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 61.43 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.439999999999998 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.439999999999998 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 71.409999999999997 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 70.530000000000001 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 61.310000000000002 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.039999999999999 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.329999999999998 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.409999999999997 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 52.210000000000001 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.299999999999997 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.030000000000001 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 44.350000000000001 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.219999999999999 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.200000000000003 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.430000000000007 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.299999999999997 109.562 173.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 60.310000000000002 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.530000000000001 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.109999999999999 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 51.43 110.628 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.420000000000002 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.239999999999995 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.349999999999994 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 64.040000000000006 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.656 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.229999999999997 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.519999999999996 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.119999999999997 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 60.539999999999999 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' TYR . . . . . 0.857 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.230000000000004 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.030000000000001 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.319999999999993 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.407 ' SD ' ' HB2' ' A' ' 128' ' ' SER . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.420000000000002 111.685 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 53.229999999999997 110.446 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.520000000000003 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 53.43 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.892 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.239999999999995 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 64.129999999999995 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.481 ' OE1' HD12 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 64.239999999999995 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.439999999999998 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.329999999999998 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 52.240000000000002 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.340000000000003 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.430000000000007 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.319999999999993 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HB3' HD12 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.140000000000001 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 44.119999999999997 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.439999999999998 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 62.130000000000003 111.409 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.400000000000006 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.120000000000005 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.049999999999997 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.219999999999999 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.149999999999999 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.450000000000003 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' HD13 ' A' ' 21' ' ' LEU . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 51.030000000000001 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HD2' ' OE2' ' A' ' 72' ' ' GLU . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.310000000000002 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.420000000000002 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.519999999999996 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.867 ' HD3' HD11 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.340000000000003 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 51.149999999999999 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.420000000000002 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' SER . . . . . 0.527 ' HB2' HD21 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 61.049999999999997 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 61.520000000000003 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 64.400000000000006 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.420000000000002 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.340000000000003 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.430000000000007 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.418 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.010000000000005 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.549999999999997 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.230000000000004 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 65.019999999999996 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.409999999999997 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 53.329999999999998 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.140000000000001 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.140000000000001 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.409999999999997 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 55.200000000000003 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 72.200000000000003 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.529 ' HA ' HG12 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.420000000000002 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.420000000000002 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.049999999999997 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.310000000000002 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 53.219999999999999 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 55.049999999999997 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.430000000000007 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.229999999999997 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.150000000000006 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASP . . . . . 0.4 ' OD2' HD23 ' A' ' 11' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.009999999999998 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.839 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 63.149999999999999 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.319999999999993 110.688 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.594 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.209999999999994 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . 0.857 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.200000000000003 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.892 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.030000000000001 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 72.010000000000005 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.340000000000003 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.409999999999997 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.831 HD23 ' H ' ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.109999999999999 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.219999999999999 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.530000000000001 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.439999999999998 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 33.140000000000001 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.409999999999997 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.450000000000003 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.329999999999998 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.329999999999998 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.030000000000001 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLN . . . . . 0.417 ' H ' ' C ' ' A' ' 144' ' ' PRO . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.329999999999998 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.099999999999994 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 64.230000000000004 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.439999999999998 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 53.43 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 61.299999999999997 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.340000000000003 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? . . . . . 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.420000000000002 109.7 175.597 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.2 ptp . . . . . 0 N--CA 1.484 1.257 0 CA-C-O 121.089 0.471 . . . . 74.310000000000002 111.042 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -97.36 -68.84 0.78 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.023 -0.535 . . . . 73.120000000000005 109.669 174.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -83.56 85.35 7.27 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.224 -0.443 . . . . 74.430000000000007 110.203 174.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -99.76 -32.19 11.16 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.971 -0.559 . . . . 61.119999999999997 109.773 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.3 m 63.19 97.51 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.17 -0.923 . . . . 71.099999999999994 111.64 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -149.21 113.49 5.23 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.743 -0.662 . . . . 65.230000000000004 110.088 179.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 64.94 -178.74 0.18 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.719 -0.673 . . . . 64.120000000000005 111.643 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -121.02 107.12 19.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.896 -0.593 . . . . 72.030000000000001 109.752 175.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 39.5 m -100.0 139.76 35.2 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.967 -0.56 . . . . 41.32 110.827 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.449 ' OE2' ' HD2' ' A' ' 12' ' ' LYS . 20.0 pt-20 -119.25 143.9 47.05 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.134 0.492 . . . . 44.210000000000001 111.091 -179.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.483 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 57.5 tp -84.92 102.74 13.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.314 -0.995 . . . . 73.349999999999994 108.314 172.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.449 ' HD2' ' OE2' ' A' ' 10' ' ' GLU . 20.0 tttp -119.3 144.39 46.84 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 116.067 -0.515 . . . . 75.010000000000005 110.394 -173.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.51 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -88.8 155.43 19.56 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.808 -0.633 . . . . 52.219999999999999 110.883 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 ' O ' ' HA ' ' A' ' 94' ' ' SER . 52.6 mt -88.6 143.16 27.13 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.205 -0.907 . . . . 75.109999999999999 109.317 175.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -97.47 146.31 31.17 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-O 120.693 0.282 . . . . 54.420000000000002 111.307 -176.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.499 ' HA ' ' O ' ' A' ' 92' ' ' THR . 5.2 Cg_exo -78.11 103.06 1.64 Allowed 'Trans proline' 0 N--CA 1.461 -0.425 0 C-N-CA 123.166 2.577 . . . . 64.439999999999998 111.768 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.2 t -122.92 141.78 36.4 Favored Pre-proline 0 C--N 1.322 -0.624 0 CA-C-N 116.21 -0.45 . . . . 73.409999999999997 110.285 -176.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.33 111.02 2.82 Favored 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.503 2.135 . . . . 74.25 110.363 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' A' ' 75' ' ' PHE . . . -138.77 131.21 28.71 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.838 -0.345 . . . . 51.210000000000001 111.52 -173.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.679 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.0 pp -92.73 145.14 24.64 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.477 -0.935 . . . . 74.5 108.477 173.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.639 ' HB3' ' H ' ' A' ' 74' ' ' GLY . 1.3 pp -159.52 155.06 25.74 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.122 0.487 . . . . 74.25 111.403 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.945 ' HB ' HG22 ' A' ' 87' ' ' VAL . 9.9 tt -104.12 110.93 31.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.836 0 CA-C-N 115.498 -0.774 . . . . 73.239999999999995 108.926 171.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.554 ' HD3' ' OE1' ' A' ' 70' ' ' GLU . 14.7 ttm180 -82.55 99.93 9.81 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.397 -0.594 . . . . 64.230000000000004 109.397 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 71' ' ' VAL . 10.0 t -128.34 135.93 50.26 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.872 -0.604 . . . . 64.099999999999994 110.465 -175.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.44 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 5.4 pm0 -89.67 129.84 36.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.905 0.384 . . . . 64.420000000000002 109.987 179.309 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.722 HG21 HD22 ' A' ' 34' ' ' LEU . 5.5 p -145.65 175.77 10.13 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.828 -0.624 . . . . 65.230000000000004 111.117 -175.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -105.13 169.57 8.36 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.201 -0.454 . . . . 60.530000000000001 110.944 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.532 ' HG3' ' HE1' ' A' ' 69' ' ' PHE . 74.9 mtm -69.02 -33.67 74.01 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.826 0.346 . . . . 74.109999999999999 110.804 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 26.1 m -88.67 58.32 4.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.251 0.548 . . . . 71.200000000000003 109.765 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -177.59 -36.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.191 -0.913 . . . . 73.319999999999993 109.475 -174.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 4.9 tt -50.88 -39.46 54.16 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 114.951 -1.022 . . . . 74.030000000000001 112.338 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -64.53 -53.6 34.43 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.91 -0.662 . . . . 30.34 112.367 -177.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.7 m -65.98 -30.67 71.27 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.102 0.477 . . . . 44.43 110.685 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' HZ ' ' A' ' 73' ' ' PHE . 43.2 tp -63.57 -50.07 70.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.891 -0.595 . . . . 62.149999999999999 110.773 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.425 ' HA ' ' CE2' ' A' ' 73' ' ' PHE . 9.9 m-30 -61.42 -44.21 97.53 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.434 -0.348 . . . . 74.420000000000002 111.55 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -52.05 -55.07 22.91 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 120.887 0.375 . . . . 74.299999999999997 111.52 -179.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -72.53 -29.32 63.48 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.157 -0.474 . . . . 74.540000000000006 111.464 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.627 ' HA3' ' CE2' ' A' ' 73' ' ' PHE . . . -70.54 -37.58 68.7 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.983 -0.627 . . . . 60.210000000000001 112.849 -178.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -75.27 -32.09 60.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.918 0.389 . . . . 74.239999999999995 110.649 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -72.52 -50.96 22.15 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.969 -0.56 . . . . 73.120000000000005 111.286 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -115.32 97.73 6.35 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.861 -0.422 . . . . 72.129999999999995 109.861 -177.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.3 tp -129.4 99.13 4.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-O 121.393 0.616 . . . . 74.239999999999995 112.434 -175.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD22 HD23 ' A' ' 45' ' ' LEU . 15.3 mt 61.83 117.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 114.73 1.382 . . . . 63.450000000000003 114.73 172.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -66.23 -13.64 60.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.085 -0.961 . . . . 63.229999999999997 109.795 168.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.75 HD23 HD22 ' A' ' 43' ' ' LEU . 3.7 mm? -71.05 -50.12 37.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.738 -0.664 . . . . 72.230000000000004 110.07 175.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.491 HD22 HD21 ' A' ' 20' ' ' LEU . 25.7 tp -74.66 -58.99 2.94 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.485 0.66 . . . . 73.140000000000001 110.137 -178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.57 -0.45 15.26 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.082 -0.963 . . . . 43.409999999999997 111.899 -176.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -117.27 -4.35 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.833 -0.699 . . . . 64.219999999999999 112.622 179.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 -95.0 -7.92 38.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.216 0.531 . . . . 75.200000000000003 109.734 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 80.82 45.5 7.7 Favored Glycine 0 N--CA 1.449 -0.495 0 CA-C-N 115.615 -0.721 . . . . 74.450000000000003 112.798 177.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.0 ptmt -147.85 169.68 19.29 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 122.695 -0.297 . . . . 61.25 110.512 179.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.4 m -130.0 154.95 81.31 Favored Pre-proline 0 C--N 1.32 -0.692 0 CA-C-N 116.117 -0.492 . . . . 64.150000000000006 110.506 -175.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.26 140.17 93.44 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.468 2.112 . . . . 64.540000000000006 111.331 173.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.1 t -82.35 3.21 28.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.1 -0.5 . . . . 63.399999999999999 111.052 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -165.9 -179.22 39.33 Favored Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 121.096 -0.573 . . . . 55.219999999999999 111.691 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.659 ' HG2' ' HG ' ' A' ' 136' ' ' LEU . 13.2 Cg_exo -71.36 153.4 61.3 Favored 'Trans proline' 0 N--CA 1.464 -0.219 0 C-N-CA 122.828 2.352 . . . . 73.129999999999995 111.885 177.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 4.9 Cg_exo -74.57 135.32 19.78 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 122.872 2.381 . . . . 75.239999999999995 112.363 -178.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.43 ' HB3' HD12 ' A' ' 134' ' ' ILE . 24.9 p90 -120.77 118.16 29.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.397 0.618 . . . . 73.549999999999997 110.443 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.73 110.52 22.14 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.703 -0.68 . . . . 53.100000000000001 110.521 -174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.536 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 5.8 ptm180 -108.37 136.71 47.55 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.74 -0.663 . . . . 64.329999999999998 109.888 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.564 ' HB3' HG12 ' A' ' 71' ' ' VAL . 53.4 p90 -129.06 136.42 50.24 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.177 0.513 . . . . 70.200000000000003 111.088 177.124 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.45 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 67.6 t80 -107.78 132.13 53.72 Favored 'General case' 0 C--O 1.244 0.781 0 CA-C-N 115.262 -0.881 . . . . 64.040000000000006 110.063 -178.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 123.01 120.34 2.58 Favored Glycine 0 N--CA 1.442 -0.903 0 CA-C-N 115.268 -0.878 . . . . 52.530000000000001 111.298 -178.247 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.47 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 4.2 mpp? -63.63 167.13 6.04 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.416 -0.216 . . . . 74.040000000000006 110.416 178.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 16.3 p -46.18 113.14 0.57 Allowed 'General case' 0 C--O 1.234 0.288 0 O-C-N 123.666 0.604 . . . . 71.120000000000005 112.258 -172.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -151.28 -174.56 4.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.41 -0.814 . . . . 65.0 109.735 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -71.31 -55.53 7.66 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.539 -0.838 . . . . 44.509999999999998 111.803 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 30.6 m -119.14 126.79 52.44 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.791 0.329 . . . . 73.120000000000005 110.196 177.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.532 ' HE1' ' HG3' ' A' ' 28' ' ' MET . 14.8 p90 -125.8 167.5 15.11 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.12 -0.491 . . . . 71.109999999999999 109.932 -179.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' OE1' ' HD3' ' A' ' 23' ' ' ARG . 24.9 tt0 -103.62 112.09 24.85 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.092 -0.243 . . . . 73.340000000000003 110.638 -169.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 16.8 m -106.52 149.76 9.68 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-O 121.216 0.531 . . . . 74.540000000000006 111.779 -174.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.587 ' HB3' HD22 ' A' ' 21' ' ' LEU . 42.2 mt-10 -131.82 121.72 24.58 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.356 -0.838 . . . . 73.150000000000006 109.296 176.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.758 ' HZ ' ' HG ' ' A' ' 34' ' ' LEU . 17.3 m-85 -63.81 -35.97 82.35 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.699 0.629 . . . . 73.340000000000003 112.699 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.639 ' H ' ' HB3' ' A' ' 21' ' ' LEU . . . 58.34 84.47 0.04 OUTLIER Glycine 0 CA--C 1.522 0.478 0 N-CA-C 114.548 0.579 . . . . 73.450000000000003 114.548 172.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.452 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 77.4 m-85 -102.74 139.11 19.86 Favored Pre-proline 0 C--N 1.326 -0.426 0 N-CA-C 109.282 -0.636 . . . . 70.230000000000004 109.282 172.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 1.7 Cg_endo -87.06 121.78 1.77 Allowed 'Trans proline' 0 N--CA 1.455 -0.745 0 C-N-CA 123.058 2.505 . . . . 60.420000000000002 112.839 -176.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.7 m -119.35 -170.82 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-N 116.079 -0.509 . . . . 72.140000000000001 109.804 177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.425 ' OE1' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -98.67 -30.25 12.57 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.938 0.399 . . . . 74.450000000000003 111.06 -179.693 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 140.85 -29.26 2.35 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.919 -0.658 . . . . 61.329999999999998 112.054 176.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -89.01 53.51 3.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 121.006 -0.616 . . . . 45.119999999999997 112.215 -178.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.425 HG23 ' OE1' ' A' ' 78' ' ' GLU . 17.5 t -133.38 155.25 40.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 109.052 -0.722 . . . . 72.120000000000005 109.052 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -129.73 150.98 50.81 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 109.477 -0.564 . . . . 73.239999999999995 109.477 178.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.652 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -111.16 -177.47 20.43 Favored Glycine 0 N--CA 1.444 -0.798 0 C-N-CA 120.817 -0.706 . . . . 72.299999999999997 111.808 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.2 t -157.54 149.11 21.92 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.73 -0.47 . . . . 74.049999999999997 109.73 -178.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.11 -116.84 7.49 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.819 -0.705 . . . . 64.150000000000006 111.426 -177.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.52 ' HD3' ' O ' ' A' ' 23' ' ' ARG . 19.1 ttm180 -106.3 -12.31 15.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.77 0.319 . . . . 72.439999999999998 110.701 178.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.945 HG22 ' HB ' ' A' ' 22' ' ' ILE . 2.8 t -93.8 95.43 5.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.042 -0.725 . . . . 74.049999999999997 109.042 177.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.652 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 28.7 m -124.97 160.57 30.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 116.214 -0.448 . . . . 74.219999999999999 111.446 -173.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.679 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -81.13 143.19 32.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.931 -0.577 . . . . 73.329999999999998 110.857 179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.02 -170.06 18.21 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.238 -0.506 . . . . 73.540000000000006 112.174 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 53.2 tp -134.14 139.2 45.73 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.939 -0.393 . . . . 74.430000000000007 109.939 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 40.5 p -94.15 143.78 26.97 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 51.109999999999999 110.717 177.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -90.9 170.76 3.37 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 122.815 2.343 . . . . 61.420000000000002 112.108 174.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 7.8 t -97.37 143.02 28.53 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.388 -0.369 . . . . 65.430000000000007 110.025 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.435 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -167.16 153.68 23.44 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 111.36 -0.696 . . . . 44.140000000000001 111.36 179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.51 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 74.4 mmtt -87.9 130.62 34.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.892 0.346 . . . . 64.120000000000005 110.48 -177.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.95 164.34 34.83 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 110.897 -179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.551 ' H ' HD21 ' A' ' 155' ' ' LEU . . . -84.51 118.43 24.31 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 109.653 -0.499 . . . . 72.409999999999997 109.653 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 44.0 t -130.48 147.05 52.13 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.323 -0.853 . . . . 71.140000000000001 109.26 -178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 56.8 m -151.12 132.28 14.42 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.485 -0.561 . . . . 75.329999999999998 109.485 175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.591 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 0.3 OUTLIER -82.04 117.33 22.15 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 122.009 0.909 . . . . 74.239999999999995 111.692 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.85 99.55 11.91 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.525 -1.216 . . . . 75.319999999999993 108.427 176.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -108.36 117.07 53.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.001 -0.545 . . . . 62.299999999999997 110.489 -176.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.803 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 133.67 -164.22 24.37 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.831 -0.699 . . . . 73.049999999999997 112.173 178.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -64.46 158.68 48.16 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.619 2.213 . . . . 62.229999999999997 111.781 178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 58.9 m-85 -96.16 175.84 6.31 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.162 0.506 . . . . 65.25 111.181 -176.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 176.61 -138.67 4.14 Favored Glycine 0 N--CA 1.447 -0.567 0 N-CA-C 109.793 -1.323 . . . . 63.109999999999999 109.793 -178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 70.2 mt-10 -74.4 101.55 4.14 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 117.361 0.58 . . . . 72.329999999999998 109.468 173.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 18.9 tt -71.07 -11.59 15.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.558 0.694 . . . . 73.030000000000001 110.149 -177.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.799 ' HG2' ' HA ' ' A' ' 162' ' ' HIS . 13.0 mp0 -61.19 -31.48 71.23 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.509 -0.768 . . . . 75.340000000000003 110.528 177.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.53 -35.79 74.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.679 -0.691 . . . . 75.530000000000001 111.644 -177.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.7 p -81.06 -28.55 11.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 C-N-CA 120.824 -0.35 . . . . 62.409999999999997 110.206 -179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.79 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 35.3 m-85 -62.45 -46.83 86.74 Favored 'General case' 0 CA--C 1.521 -0.17 0 N-CA-C 109.974 -0.38 . . . . 63.299999999999997 109.974 175.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -58.39 -35.1 71.49 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-N 115.967 -0.56 . . . . 74.310000000000002 111.5 178.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -67.28 -53.59 28.51 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-O 120.909 0.385 . . . . 65.019999999999996 111.049 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.659 ' HA ' ' CD1' ' A' ' 119' ' ' TRP . 9.3 mp -67.49 -26.42 66.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.092 -0.504 . . . . 70.400000000000006 111.118 -179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 41.0 ttm -64.02 -35.98 82.5 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.972 0.415 . . . . 65.340000000000003 110.692 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.8 tppp? -78.5 -44.74 23.7 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 112.879 0.696 . . . . 71.049999999999997 112.879 -172.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.659 ' CD1' ' HA ' ' A' ' 116' ' ' LEU . 15.2 p-90 -65.69 -41.0 92.93 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 120.612 -0.435 . . . . 75.040000000000006 111.597 -172.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.765 HG21 ' HB3' ' A' ' 155' ' ' LEU . 5.8 p -71.67 -31.18 41.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-O 121.151 0.5 . . . . 63.32 110.638 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -55.85 -49.87 72.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.107 -0.952 . . . . 45.109999999999999 109.891 173.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -63.35 -38.51 91.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.632 -0.713 . . . . 73.409999999999997 111.011 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.631 HD22 ' HA ' ' A' ' 120' ' ' VAL . 93.6 m-20 -60.3 -37.76 81.56 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.078 -0.51 . . . . 71.319999999999993 111.363 179.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.13 38.99 11.94 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.564 -0.827 . . . . 60.439999999999998 111.74 -175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.619 ' HD2' ' HB3' ' A' ' 123' ' ' ASN . 32.1 m-85 -105.66 163.39 12.72 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.977 -0.379 . . . . 73.409999999999997 109.977 176.06 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 155' ' ' LEU . 10.1 p-10 -118.95 175.73 5.62 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.807 0.337 . . . . 72.519999999999996 111.343 -177.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.757 ' H ' HD12 ' A' ' 127' ' ' LEU . 5.4 mp -43.44 139.7 1.95 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 124.407 1.083 . . . . 75.310000000000002 113.558 -172.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.1 p -92.57 -28.65 16.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.67 -1.15 . . . . 71.219999999999999 111.384 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.44 -91.51 0.19 Allowed Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.833 -0.699 . . . . 72.120000000000005 112.186 -176.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -122.62 170.66 9.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.769 0.319 . . . . 73.439999999999998 110.819 -179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -104.88 153.79 20.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.229 -0.441 . . . . 63.119999999999997 111.027 -178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.501 ' HB2' ' HB3' ' A' ' 152' ' ' SER . 13.1 m-85 -131.39 130.09 42.16 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.641 0.608 . . . . 73.319999999999993 112.641 -174.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -118.03 167.42 11.47 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.181 -1.044 . . . . 52.0 108.181 163.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.479 ' H ' HG23 ' A' ' 149' ' ' THR . 18.1 tt -163.82 134.42 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.135 0.493 . . . . 73.049999999999997 111.047 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 80.1 m-85 -109.83 106.43 16.02 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.04 -0.527 . . . . 73.409999999999997 110.835 -178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.659 ' HG ' ' HG2' ' A' ' 56' ' ' PRO . 6.8 mp -95.28 111.91 23.69 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.069 -0.514 . . . . 64.030000000000001 110.252 177.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 69.94 -178.2 0.22 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 124.128 0.892 . . . . 54.43 111.507 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.495 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 64.0 t30 -99.47 139.78 21.15 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.942 -0.572 . . . . 75.519999999999996 109.652 -177.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.904 ' HA ' HD21 ' A' ' 147' ' ' LEU . 26.2 Cg_exo -66.36 156.92 62.84 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.709 2.273 . . . . 74.439999999999998 113.169 177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.46 -38.03 0.35 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 124.422 1.089 . . . . 71.040000000000006 113.122 173.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -81.54 -17.79 47.21 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.677 -0.409 . . . . 73.239999999999995 111.717 -173.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 12.5 t -123.86 27.04 7.41 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.211 0.529 . . . . 64.319999999999993 109.869 178.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 72.79 142.55 0.09 OUTLIER Pre-proline 0 N--CA 1.468 0.455 0 CA-C-N 114.531 -1.213 . . . . 73.219999999999999 111.099 -175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.444 ' HA ' HD23 ' A' ' 147' ' ' LEU . 39.6 Cg_endo -67.64 -34.11 26.19 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.54 2.16 . . . . 73.200000000000003 112.254 -177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.803 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 11.2 p-10 -77.73 8.35 4.6 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.843 -0.617 . . . . 72.430000000000007 111.23 -176.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 19.1 mm-40 -119.22 6.36 11.23 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.237 -0.438 . . . . 64.409999999999997 110.831 174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.904 HD21 ' HA ' ' A' ' 139' ' ' PRO . 4.2 mm? -80.97 118.54 22.54 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.718 -0.845 . . . . 74.400000000000006 108.718 171.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -122.99 131.53 53.75 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.297 0.57 . . . . 74.299999999999997 110.637 -174.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.479 HG23 ' H ' ' A' ' 134' ' ' ILE . 84.8 m -136.73 103.87 5.34 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.627 -0.715 . . . . 72.230000000000004 110.138 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.591 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.2 ptm180 -74.65 97.76 3.27 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.234 -0.654 . . . . 74.109999999999999 109.234 175.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -89.41 116.81 31.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.64 0.733 . . . . 70.030000000000001 109.954 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.544 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 9.1 t -114.24 141.22 47.84 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.27 -0.877 . . . . 75.219999999999999 108.825 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.504 HD11 HD22 ' A' ' 116' ' ' LEU . 0.0 OUTLIER -137.67 174.53 10.48 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 120.056 -0.658 . . . . 73.540000000000006 111.992 -179.497 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.47 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 40.7 mtm -71.19 148.15 47.59 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.367 -0.833 . . . . 71.099999999999994 110.211 179.37 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.765 ' HB3' HG21 ' A' ' 120' ' ' VAL . 59.6 mt -94.38 104.34 16.32 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.975 -0.557 . . . . 71.519999999999996 111.895 -171.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 81.8 t60 63.24 78.14 0.3 Allowed 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 115.887 -0.597 . . . . 62.119999999999997 111.864 169.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.486 ' CD ' ' H ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -138.15 -51.05 0.59 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.295 -0.411 . . . . 74.329999999999998 111.012 175.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.486 ' H ' ' CD ' ' A' ' 157' ' ' GLU . 26.8 t -176.24 -67.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.192 -0.67 . . . . 33.030000000000001 109.192 -179.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 46.46 43.78 12.39 Favored 'General case' 0 N--CA 1.465 0.29 0 O-C-N 124.14 0.9 . . . . 70.430000000000007 111.551 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -79.77 90.26 5.24 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.714 0.768 . . . . 64.230000000000004 110.552 178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.471 ' CD2' ' HG3' ' A' ' 110' ' ' GLU . 58.7 t60 -133.52 115.89 15.29 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 114.811 -1.086 . . . . 64.209999999999994 108.491 173.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.799 ' HA ' ' HG2' ' A' ' 110' ' ' GLU . 36.9 m80 -145.21 131.68 19.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.698 0.285 . . . . 73.209999999999994 111.189 -177.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -81.64 -55.81 4.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.739 -0.664 . . . . 71.510000000000005 109.684 173.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 73.0 t60 70.09 105.72 0.06 Allowed 'General case' 0 N--CA 1.466 0.337 0 O-C-N 123.802 0.689 . . . . 43.109999999999999 111.153 177.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 52.9 p-80 -107.3 79.34 1.3 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.525 0.679 . . . . 75.129999999999995 110.783 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 11.8 t60 . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.536 -0.745 . . . . 71.120000000000005 109.922 -179.123 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' OE2' ' A' ' 108' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 109.932 -0.396 . . . . 72.329999999999998 109.932 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -177.41 179.48 0.95 Allowed 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.319 -0.401 . . . . 70.530000000000001 110.006 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -107.74 -31.44 8.05 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.744 -0.465 . . . . 74.109999999999999 109.744 177.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 54.4 25.38 5.99 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 115.461 -0.791 . . . . 74.319999999999993 111.561 178.096 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 63.6 m 51.61 51.78 15.99 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.938 -178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 95.7 mt-30 70.33 108.38 0.06 Allowed 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.805 0.691 . . . . 63.409999999999997 111.215 -179.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -61.93 148.67 42.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.591 -0.731 . . . . 73.430000000000007 110.379 178.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.19 122.31 2.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.355 0.598 . . . . 61.200000000000003 111.755 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.6 p -123.16 126.59 47.28 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.546 -0.752 . . . . 74.549999999999997 109.58 176.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -146.91 166.4 26.85 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.005 0.431 . . . . 74.549999999999997 111.462 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.553 HD11 ' HB3' ' A' ' 96' ' ' LYS . 49.7 tp -86.23 132.34 34.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.863 -0.608 . . . . 74.420000000000002 109.924 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -135.69 139.87 44.01 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.123 -0.489 . . . . 74.209999999999994 110.436 -177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.492 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 1.7 pm0 -92.18 129.78 38.05 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.109 0.481 . . . . 65.209999999999994 110.26 175.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.9 127.3 31.84 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.857 -0.611 . . . . 61.329999999999998 110.405 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.44 143.3 27.96 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 116.204 -0.453 . . . . 53.200000000000003 109.82 174.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 2.9 Cg_exo -77.02 125.88 8.28 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.738 2.292 . . . . 50.100000000000001 111.862 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -136.0 141.63 37.23 Favored Pre-proline 0 C--N 1.324 -0.508 0 N-CA-C 109.66 -0.496 . . . . 74.519999999999996 109.66 175.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -61.42 123.38 12.65 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.527 2.151 . . . . 71.019999999999996 112.129 177.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -145.85 174.04 11.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.713 -0.676 . . . . 53.200000000000003 110.294 -176.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.561 HD23 ' HA ' ' A' ' 89' ' ' THR . 63.0 mt -111.2 128.48 55.93 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.645 -0.502 . . . . 71.209999999999994 109.645 174.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.3 mp -131.36 169.02 16.58 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 121.474 0.654 . . . . 71.219999999999999 111.692 -174.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.442 HD13 ' O ' ' A' ' 86' ' ' ARG . 6.4 tp -174.73 132.63 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 114.41 -1.268 . . . . 62.439999999999998 108.997 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.845 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -94.77 113.82 25.63 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.73 0.776 . . . . 74.340000000000003 111.222 -177.977 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 8.4 m -112.08 157.81 20.34 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 114.889 -1.05 . . . . 62.210000000000001 109.032 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 12.0 mm100 -116.25 138.93 50.89 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.426 -0.583 . . . . 75.430000000000007 109.426 177.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -129.16 153.57 47.58 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.704 -0.48 . . . . 62.229999999999997 109.704 176.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.9 173.09 9.13 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.293 0.568 . . . . 61.340000000000003 111.042 -178.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 19.0 ptt? -68.18 134.54 50.65 Favored 'General case' 0 N--CA 1.441 -0.913 0 CA-C-N 115.525 -0.761 . . . . 43.32 109.887 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.3 m 74.03 5.27 4.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.944 -1.026 . . . . 70.219999999999999 111.72 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -106.23 -4.61 19.98 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.939 0.4 . . . . 63.140000000000001 110.716 -175.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.4 ' O ' ' HD1' ' A' ' 35' ' ' PHE . 7.8 tt -51.52 -57.75 8.2 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.538 -0.756 . . . . 75.340000000000003 111.897 -172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.05 -47.13 92.78 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.031 -0.604 . . . . 72.030000000000001 112.886 -174.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 15.4 m -65.3 -36.03 82.83 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.752 0.31 . . . . 71.530000000000001 111.193 -177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -65.54 -46.39 79.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.215 -0.448 . . . . 64.109999999999999 110.102 -178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.486 ' O ' ' HD1' ' A' ' 39' ' ' TYR . 21.7 m-85 -62.87 -39.96 96.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.234 -0.439 . . . . 73.030000000000001 112.057 -177.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -57.78 -44.68 86.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.721 0.296 . . . . 72.099999999999994 111.478 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -76.66 -35.02 58.22 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.769 0.318 . . . . 63.450000000000003 110.66 179.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.45 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -57.72 -54.79 34.54 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.607 -0.724 . . . . 44.219999999999999 113.758 -176.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.486 ' HD1' ' O ' ' A' ' 35' ' ' PHE . 11.5 p90 -79.13 -16.33 56.84 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 117.273 0.537 . . . . 73.519999999999996 110.944 -175.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -70.81 -45.04 65.31 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.69 -0.485 . . . . 74.129999999999995 109.69 178.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -114.22 77.94 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.456 0.646 . . . . 63.439999999999998 110.143 177.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 38' ' ' GLY . 16.2 tt -152.12 -22.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.644 -0.707 . . . . 74.420000000000002 110.777 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.447 HD22 HD13 ' A' ' 46' ' ' LEU . 87.2 mt -90.02 20.53 4.2 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.253 -0.43 . . . . 61.340000000000003 111.306 -176.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 25.1 tp60 -56.82 -53.63 55.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.447 -0.342 . . . . 70.219999999999999 111.467 -177.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.557 HD21 ' HB ' ' A' ' 87' ' ' VAL . 4.1 pp -67.71 -34.1 76.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.042 0.448 . . . . 61.210000000000001 110.95 -178.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.447 HD13 HD22 ' A' ' 43' ' ' LEU . 3.1 tt -67.3 -50.88 58.46 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.888 -0.596 . . . . 64.129999999999995 109.851 -177.416 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.89 -30.37 70.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.383 -0.826 . . . . 72.400000000000006 110.893 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.33 -42.3 94.1 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.98 -0.555 . . . . 72.010000000000005 112.478 179.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 45' ' ' LEU . 85.6 mt-30 -77.07 -16.73 59.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.796 0.332 . . . . 75.420000000000002 110.815 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 75.57 38.79 36.74 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.789 -0.719 . . . . 52.409999999999997 111.826 -178.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.494 ' HG3' HG22 ' A' ' 81' ' ' VAL . 66.2 mmtt -102.22 -176.47 3.12 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.705 0.288 . . . . 74.019999999999996 110.79 -178.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 42.0 m -147.75 146.91 25.65 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.452 -0.34 . . . . 64.540000000000006 110.455 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -69.46 151.78 70.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.92 2.413 . . . . 53.020000000000003 111.814 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -105.7 0.24 26.12 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.183 0.516 . . . . 74.109999999999999 110.769 -177.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.09 177.28 36.62 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.753 -0.737 . . . . 73.519999999999996 111.53 -179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.442 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 59.6 Cg_endo -73.44 152.92 49.78 Favored 'Trans proline' 0 N--CA 1.461 -0.438 0 C-N-CA 122.226 1.951 . . . . 63.350000000000001 112.125 179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 14.4 Cg_exo -70.31 153.44 66.38 Favored 'Trans proline' 0 C--O 1.238 0.495 0 C-N-CA 122.965 2.444 . . . . 73.230000000000004 111.937 177.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.648 ' HD1' HG12 ' A' ' 134' ' ' ILE . 64.4 m-85 -115.56 -179.66 3.71 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.971 -0.381 . . . . 72.340000000000003 109.971 -179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.422 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -148.4 107.71 3.92 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.914 -0.772 . . . . 61.409999999999997 108.914 168.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.413 HH21 ' CD ' ' A' ' 130' ' ' GLU . 3.0 tmt_? -104.27 122.75 46.05 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.584 -0.524 . . . . 74.040000000000006 109.584 -179.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.517 ' HA ' ' O ' ' A' ' 70' ' ' GLU . 7.6 p90 -130.81 140.01 50.24 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.807 0.813 . . . . 54.219999999999999 111.842 -177.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.547 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 90.0 t80 -120.39 139.61 52.55 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-N 114.331 -1.304 . . . . 74.239999999999995 110.392 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.49 84.56 1.1 Allowed Glycine 0 N--CA 1.448 -0.505 0 CA-C-N 115.504 -0.771 . . . . 72.230000000000004 112.893 176.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 11.3 ptp -113.94 92.39 3.96 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.259 0.552 . . . . 70.299999999999997 110.777 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 35.0 t -175.48 -63.49 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.447 -0.797 . . . . 75.099999999999994 109.752 179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -171.92 165.61 6.37 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 116.171 -0.468 . . . . 72.310000000000002 110.753 -179.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.21 -90.11 0.65 Allowed Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 121.187 -0.53 . . . . 65.319999999999993 112.392 175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 38.8 m -150.69 139.47 20.79 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.908 -0.404 . . . . 54.200000000000003 109.908 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -95.48 124.42 39.5 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 109.902 -0.407 . . . . 73.209999999999994 109.902 -176.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.547 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 35.9 tt0 -95.83 116.28 28.67 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.691 -0.485 . . . . 75.299999999999997 109.691 -179.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.0 m -122.2 123.91 69.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.64 0.733 . . . . 73.239999999999995 112.422 -173.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.845 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 32.6 mt-10 -122.69 112.4 17.9 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.416 -0.957 . . . . 74.120000000000005 108.416 172.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 75' ' ' PHE . 47.1 t80 -66.41 -61.64 1.89 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.78 -0.368 . . . . 62.049999999999997 110.598 -173.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.29 119.18 0.02 OUTLIER Glycine 0 CA--C 1.523 0.552 0 C-N-CA 120.967 -0.635 . . . . 71.510000000000005 113.782 177.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.415 ' HD2' ' HD2' ' A' ' 73' ' ' PHE . 7.4 p90 -137.32 142.41 37.52 Favored Pre-proline 0 C--N 1.321 -0.657 0 O-C-N 122.242 -0.564 . . . . 64.5 110.462 173.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 89.5 Cg_endo -87.4 141.38 5.74 Favored 'Trans proline' 0 N--CA 1.458 -0.575 0 C-N-CA 122.907 2.405 . . . . 42.340000000000003 113.254 -173.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 36.0 m -116.43 179.28 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.646 -0.706 . . . . 52.229999999999997 110.476 -178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.6 ' OE2' HG23 ' A' ' 81' ' ' VAL . 0.0 OUTLIER -79.68 -32.27 41.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.711 -0.222 . . . . 55.030000000000001 111.183 -179.208 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 136.51 -6.73 3.91 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.607 -0.806 . . . . 52.240000000000002 112.899 175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.42 ' H ' ' CD ' ' A' ' 78' ' ' GLU . . . -103.11 -15.92 22.47 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.915 -0.66 . . . . 64.019999999999996 112.366 -178.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.6 HG23 ' OE2' ' A' ' 78' ' ' GLU . 7.8 t -71.17 150.03 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 74.129999999999995 110.073 177.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -137.18 139.42 41.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.026 -0.534 . . . . 62.509999999999998 110.588 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -64.49 148.77 51.25 Favored Glycine 0 N--CA 1.444 -0.777 0 CA-C-N 115.864 -0.607 . . . . 25.510000000000002 112.32 178.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.475 ' H ' HD22 ' A' ' 45' ' ' LEU . 21.1 m -153.44 115.55 4.34 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.894 0.378 . . . . 54.439999999999998 110.009 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 86.39 -108.61 3.31 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.822 -0.704 . . . . 63.329999999999998 112.609 177.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.547 ' HG3' HG23 ' A' ' 87' ' ' VAL . 1.2 ptp180 -77.96 -41.44 36.17 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 111.648 0.24 . . . . 71.439999999999998 111.648 -177.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.557 ' HB ' HD21 ' A' ' 45' ' ' LEU . 21.9 t -92.97 132.85 36.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.819 -0.437 . . . . 73.319999999999993 109.819 -176.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 28.1 m -119.62 154.56 22.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.651 0.262 . . . . 42.340000000000003 110.921 -178.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.561 ' HA ' HD23 ' A' ' 20' ' ' LEU . 3.0 m -74.16 151.54 40.02 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.227 0.536 . . . . 73.409999999999997 110.057 176.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -173.7 -153.38 9.67 Favored Glycine 0 N--CA 1.439 -1.134 0 N-CA-C 110.917 -0.873 . . . . 65.310000000000002 110.917 179.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.429 HD23 ' N ' ' A' ' 91' ' ' LEU . 2.3 pt? -157.15 171.94 19.55 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 110.084 -0.339 . . . . 71.420000000000002 110.084 179.434 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.435 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 2.7 p -80.24 143.48 56.47 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 116.177 -0.465 . . . . 72.129999999999995 111.215 -179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 6.3 Cg_exo -73.97 121.79 7.21 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.983 2.455 . . . . 52.420000000000002 111.801 179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.2 p -78.79 135.07 36.99 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.366 -0.379 . . . . 65.25 110.712 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 168.31 -169.06 41.31 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.875 -0.679 . . . . 61.25 111.725 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.553 ' HB3' HD11 ' A' ' 11' ' ' LEU . 63.3 mmtt -108.44 127.24 53.73 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.646 0.223 . . . . 73.329999999999998 110.414 -178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -142.08 153.45 44.18 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.451 -0.34 . . . . 73.120000000000005 110.628 178.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -90.63 126.6 36.01 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.393 -0.367 . . . . 72.519999999999996 110.383 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 10.1 t -124.2 139.99 53.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.965 0.412 . . . . 71.010000000000005 110.887 -176.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 23.0 t -132.18 145.37 51.31 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.004 -0.739 . . . . 62.009999999999998 109.004 176.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 6.0 tt -107.32 117.68 34.71 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 120.817 0.342 . . . . 55.130000000000003 110.284 -175.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.588 ' HE1' ' HB ' ' A' ' 151' ' ' VAL . 6.5 p90 -101.07 131.63 46.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.104 -0.498 . . . . 70.010000000000005 110.976 -179.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.599 ' CG2' ' HA ' ' A' ' 145' ' ' ASP . 36.2 mm -100.65 115.35 41.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.449 -178.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.779 ' HA2' ' HB2' ' A' ' 144' ' ' PRO . . . 132.21 -156.14 21.85 Favored Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.062 -1.066 . . . . 72.439999999999998 112.893 179.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -79.93 -175.02 2.5 Favored 'Trans proline' 0 N--CA 1.463 -0.315 0 C-N-CA 123.124 2.549 . . . . 71.409999999999997 113.034 -177.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -95.52 140.75 29.92 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.247 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 116.96 -23.53 9.94 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.314 -0.715 . . . . 54.229999999999997 111.314 -176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.596 ' OE2' ' HA ' ' A' ' 1' ' ' MET . 23.7 tt0 -86.78 29.7 0.78 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.728 0.775 . . . . 45.140000000000001 110.272 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 112' ' ' VAL . 17.2 mm -73.61 -16.52 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 CA-C-N 115.501 -0.772 . . . . 71.340000000000003 110.168 -178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.565 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 21.8 mm-40 -53.79 -40.31 66.18 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.896 -0.593 . . . . 64.049999999999997 111.194 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.88 -37.67 85.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.725 -0.67 . . . . 71.010000000000005 111.452 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 109' ' ' ILE . 3.1 m -79.94 -27.71 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 C-N-CA 120.977 -0.289 . . . . 64.219999999999999 110.314 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.565 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 13.5 m-85 -59.82 -44.75 93.87 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.98 0.419 . . . . 72.349999999999994 109.927 173.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.594 ' O ' ' HG2' ' A' ' 117' ' ' MET . 27.6 t70 -60.9 -32.95 72.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.694 -0.685 . . . . 64.019999999999996 110.998 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -74.06 -37.6 64.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.97 0.414 . . . . 43.0 110.996 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.401 HD13 ' HA ' ' A' ' 116' ' ' LEU . 3.5 mm? -74.42 -32.89 62.82 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.263 0.468 . . . . 70.049999999999997 112.263 -176.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.594 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 23.8 ptm -55.05 -40.34 70.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 120.729 0.299 . . . . 73.319999999999993 111.266 -176.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.426 ' N ' ' HG3' ' A' ' 117' ' ' MET . 65.2 tttp -78.05 -49.96 12.99 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.357 -0.383 . . . . 71.230000000000004 110.627 177.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.46 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 58.7 t90 -56.12 -44.13 78.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.904 -0.589 . . . . 74.5 111.762 -172.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.1 p -64.02 -44.58 97.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.596 -0.274 . . . . 72.129999999999995 111.316 -175.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -72.26 -37.83 68.99 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.206 -0.452 . . . . 72.109999999999999 110.804 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -62.44 -52.48 63.36 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.596 -0.729 . . . . 75.209999999999994 111.181 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -76.03 -37.3 58.53 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.947 0.404 . . . . 62.439999999999998 110.347 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.39 63.46 1.36 Allowed Glycine 0 CA--C 1.519 0.297 0 C-N-CA 120.901 -0.666 . . . . 51.0 113.237 174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.688 ' HB3' HD13 ' A' ' 155' ' ' LEU . 43.7 m-85 -124.42 153.6 41.68 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 116.909 0.355 . . . . 65.400000000000006 111.296 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -134.64 141.2 46.52 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.824 -0.625 . . . . 71.129999999999995 109.713 -176.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' ' 155' ' ' LEU . 13.6 tp -137.84 161.96 35.22 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 110.213 -0.291 . . . . 75.109999999999999 110.213 -176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.8 t -75.96 -22.49 55.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.56 0.219 . . . . 75.099999999999994 111.1 179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.706 ' HA2' ' SD ' ' A' ' 154' ' ' MET . . . 134.07 32.18 0.36 Allowed Glycine 0 C--N 1.329 0.163 0 C-N-CA 119.984 -1.103 . . . . 75.519999999999996 113.505 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HB2' HD21 ' A' ' 127' ' ' LEU . 20.1 mm-40 -86.49 114.1 22.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.659 0.23 . . . . 65.239999999999995 110.465 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -131.32 131.12 43.54 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.618 -0.512 . . . . 55.32 109.618 174.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 44.8 p90 -144.05 140.88 29.78 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.802 -0.359 . . . . 74.319999999999993 110.951 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.699 ' HB3' HG23 ' A' ' 151' ' ' VAL . 11.2 pt-20 -118.13 153.81 33.17 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.787 0.327 . . . . 62.409999999999997 110.273 176.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.648 HG12 ' HD1' ' A' ' 58' ' ' PHE . 50.4 mt -111.4 121.81 64.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.213 -0.449 . . . . 72.510000000000005 110.461 -176.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.427 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 43.9 m-85 -99.61 113.91 26.62 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.199 0.524 . . . . 71.230000000000004 111.114 -178.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.438 HD23 ' N ' ' A' ' 136' ' ' LEU . 2.0 pt? -136.82 21.39 3.07 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.785 -0.643 . . . . 71.140000000000001 109.518 177.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.52 ' HB2' HD13 ' A' ' 147' ' ' LEU . 11.7 p-10 -101.22 175.65 5.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.314 -0.857 . . . . 72.400000000000006 110.915 -175.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.517 ' O ' HG22 ' A' ' 142' ' ' THR . 63.5 t30 -159.96 82.11 2.32 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.825 -0.625 . . . . 60.039999999999999 109.504 173.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.477 ' HD3' ' OD2' ' A' ' 137' ' ' ASP . 12.0 Cg_endo -55.52 157.18 15.72 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 123.74 2.96 . . . . 54.210000000000001 113.329 -176.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.16 -36.74 0.32 Allowed 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.236 1.014 . . . . 51.310000000000002 111.888 177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -88.77 -48.28 7.62 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.966 0.413 . . . . 73.310000000000002 110.164 -179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.66 HG23 HD23 ' A' ' 147' ' ' LEU . 7.4 t -112.89 156.76 22.4 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.162 -0.681 . . . . 72.209999999999994 109.162 177.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.68 144.29 80.08 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-O 120.833 0.349 . . . . 72.540000000000006 111.312 -175.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.779 ' HB2' ' HA2' ' A' ' 104' ' ' GLY . 28.2 Cg_endo -62.46 -26.15 76.33 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.031 2.487 . . . . 41.539999999999999 112.864 -177.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.599 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 9.1 p-10 -83.48 -7.76 59.48 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.244 -0.435 . . . . 75.349999999999994 110.415 179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -96.89 -32.72 11.92 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.587 -0.523 . . . . 72.340000000000003 109.587 177.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.66 HD23 HG23 ' A' ' 142' ' ' THR . 1.7 pp -84.29 103.09 13.18 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-O 121.896 0.855 . . . . 73.200000000000003 109.891 179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.45 ' H ' ' HG2' ' A' ' 148' ' ' ARG . 12.4 ptp180 -90.37 102.11 14.84 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.301 -0.863 . . . . 75.540000000000006 110.125 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.7 m -103.05 135.7 44.24 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.067 -0.969 . . . . 73.109999999999999 109.912 -174.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.451 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -127.57 136.25 51.43 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.349 0.595 . . . . 74.109999999999999 111.716 -174.75 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.699 HG23 ' HB3' ' A' ' 133' ' ' GLU . 14.8 p -116.51 148.06 19.48 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-N 115.089 -0.959 . . . . 70.519999999999996 109.562 179.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.488 ' HA ' ' HA ' ' A' ' 99' ' ' SER . 8.5 t -118.54 120.17 36.7 Favored 'General case' 0 C--N 1.312 -1.049 0 N-CA-C 107.978 -1.119 . . . . 71.420000000000002 107.978 172.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.639 HD13 ' H ' ' A' ' 154' ' ' MET . 0.2 OUTLIER -101.66 164.74 11.59 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 121.316 0.579 . . . . 75.349999999999994 111.231 -168.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.706 ' SD ' ' HA2' ' A' ' 129' ' ' GLY . 45.0 ttp -67.53 124.34 22.95 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.745 -1.116 . . . . 71.310000000000002 111.023 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.907 ' HB2' ' HB2' ' A' ' 127' ' ' LEU . 91.8 mt -68.88 161.52 28.49 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.061 -1.089 . . . . 75.010000000000005 108.061 168.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.577 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.1 t60 76.0 129.14 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.746 -0.835 . . . . 74.540000000000006 108.746 -164.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -50.59 134.38 24.34 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.136 -0.484 . . . . 65.549999999999997 111.948 -173.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 10.1 m -54.19 127.49 27.13 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-N 115.002 -0.999 . . . . 64.540000000000006 112.361 -174.616 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.5 mp -74.35 -43.54 56.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.434 -0.803 . . . . 73.349999999999994 109.601 174.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.688 ' HG3' ' HD2' ' A' ' 162' ' ' HIS . 10.0 tp10 -64.89 119.57 10.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.658 -0.701 . . . . 64.109999999999999 109.355 174.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 57.8 m80 -85.92 80.91 8.73 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.999 0.428 . . . . 51.119999999999997 111.549 -172.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.688 ' HD2' ' HG3' ' A' ' 160' ' ' GLU . 15.0 m-70 -114.95 114.9 26.06 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.903 -0.59 . . . . 72.329999999999998 109.727 172.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 48.0 m-70 -140.95 72.03 1.38 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.095 0.474 . . . . 73.310000000000002 111.629 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -110.52 128.03 55.45 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.907 -0.588 . . . . 72.219999999999999 109.526 172.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . 0.41 ' O ' ' HB2' ' A' ' 166' ' ' HIS . 73.9 m80 -73.91 -76.43 0.13 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 109.426 -0.583 . . . . 73.239999999999995 109.426 176.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 165' ' ' HIS . 14.3 t-80 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.388 -0.815 . . . . 63.439999999999998 109.937 174.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.6 ptm . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 121.177 0.513 . . . . 74.129999999999995 110.712 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -127.36 179.73 5.32 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.81 -0.632 . . . . 74.140000000000001 109.424 179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -109.01 106.1 15.9 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.464 0.649 . . . . 75.129999999999995 110.09 174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' H ' ' CD ' ' A' ' 4' ' ' GLU . 0.2 OUTLIER -110.46 7.16 22.6 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.182 -0.917 . . . . 64.049999999999997 111.096 -174.132 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 9.0 p -134.17 74.21 1.53 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.348 0.594 . . . . 72.409999999999997 110.698 177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.419 ' HG2' ' HA ' ' A' ' 115' ' ' ALA . 0.9 OUTLIER -100.29 109.08 21.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.67 -0.695 . . . . 72.219999999999999 110.11 178.279 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 63.89 -170.01 0.19 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.331 -0.85 . . . . 55.420000000000002 111.321 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.2 p -111.92 122.44 66.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.189 0.519 . . . . 61.329999999999998 110.885 -178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 14.8 p -118.2 158.37 25.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.936 -0.574 . . . . 70.129999999999995 110.535 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.0 tt0 -163.52 152.19 13.96 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.088 -0.505 . . . . 75.430000000000007 109.976 -179.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.416 HD23 ' C ' ' A' ' 11' ' ' LEU . 6.8 tt -82.14 126.28 31.86 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.254 -1.017 . . . . 65.239999999999995 108.254 173.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.828 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 1.0 OUTLIER -126.45 128.95 47.77 Favored 'General case' 0 N--CA 1.442 -0.847 0 C-N-CA 119.972 -0.691 . . . . 75.129999999999995 111.62 -176.394 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' HG2' ' HB3' ' A' ' 96' ' ' LYS . 38.3 mt-10 -95.65 128.59 42.65 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.204 -0.907 . . . . 74.409999999999997 109.293 172.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -96.0 139.36 32.31 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.258 -0.428 . . . . 60.409999999999997 111.395 -172.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -111.28 145.35 32.35 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 116.033 -0.53 . . . . 64.430000000000007 110.216 175.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.443 ' HD3' ' HB2' ' A' ' 94' ' ' SER . 55.6 Cg_endo -69.74 144.4 53.99 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 122.951 2.434 . . . . 41.109999999999999 113.741 -175.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.481 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.0 p -140.02 142.38 30.29 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.895 -0.78 . . . . 51.229999999999997 108.895 172.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HD2' HG23 ' A' ' 17' ' ' VAL . 13.8 Cg_endo -57.81 127.7 26.2 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.85 2.367 . . . . 71.230000000000004 112.522 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -150.92 154.46 37.21 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.001 -0.545 . . . . 72.140000000000001 111.435 -175.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.558 HD13 HG11 ' A' ' 77' ' ' VAL . 9.0 mp -108.37 137.62 46.03 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.114 -0.698 . . . . 73.549999999999997 109.114 171.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.46 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.0 OUTLIER -147.2 156.89 43.35 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.109 0.481 . . . . 53.140000000000001 111.696 -176.23 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.0 mt -105.74 114.81 46.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.503 -0.771 . . . . 65.450000000000003 108.927 171.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.595 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 30.0 ptt180 -82.26 108.99 16.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.215 0.531 . . . . 72.510000000000005 110.216 -178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.676 HG21 HD21 ' A' ' 34' ' ' LEU . 39.9 m -127.96 147.34 50.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.136 -0.484 . . . . 74.230000000000004 110.888 -175.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -105.87 123.85 48.62 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.478 -0.934 . . . . 53.43 108.478 171.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 68' ' ' THR . 14.3 t -120.87 159.82 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 C-N-CA 120.545 -0.462 . . . . 63.549999999999997 111.361 -174.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 67' ' ' GLY . . . -94.16 168.74 10.74 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.56 -0.745 . . . . 61.329999999999998 109.848 175.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 28.2 ttt -58.71 -44.08 90.26 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.132 -0.485 . . . . 55.340000000000003 111.949 -175.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 11.8 t -94.85 -5.37 45.19 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.887 0.375 . . . . 62.030000000000001 111.526 -174.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -96.0 -0.02 51.11 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 122.174 -0.329 . . . . 75.010000000000005 110.9 -178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 41.0 tp -57.06 -44.6 83.2 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.799 -0.637 . . . . 74.439999999999998 111.957 -175.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.19 -54.51 34.16 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 121.06 -0.591 . . . . 52.350000000000001 113.087 -175.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 50.9 m -68.59 -29.79 68.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.691 0.281 . . . . 65.420000000000002 111.338 -178.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.676 HD21 HG21 ' A' ' 24' ' ' THR . 2.0 tm? -60.77 -40.97 94.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.388 -0.369 . . . . 72.030000000000001 110.052 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -58.61 -36.04 73.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 116.324 -0.398 . . . . 73.439999999999998 111.707 179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 3.0 tm-20 -65.4 -51.85 57.48 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.352 -0.611 . . . . 63.409999999999997 109.352 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.42 -39.93 92.56 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.87 -0.604 . . . . 53.32 111.519 -178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -70.03 -45.31 57.35 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.741 -0.743 . . . . 74.0 112.611 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 89.2 t80 -71.76 -20.57 61.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.256 0.55 . . . . 74.219999999999999 110.53 -179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 4.3 t60 -62.53 -37.56 86.56 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.357 -0.838 . . . . 74.140000000000001 111.393 -176.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.3 m-20 -90.03 0.1 57.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.801 0.334 . . . . 64.230000000000004 111.894 -175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.1 mm -89.49 -28.1 5.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.336 0.588 . . . . 73.549999999999997 109.772 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -64.79 -58.73 5.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.294 -0.867 . . . . 72.219999999999999 110.836 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -74.92 -9.28 58.39 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.675 0.274 . . . . 72.310000000000002 111.255 -172.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 45.0 tp -78.2 -60.51 2.34 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.924 -0.399 . . . . 75.409999999999997 109.924 176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -67.06 -45.69 76.61 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.274 -0.421 . . . . 74.200000000000003 110.964 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.55 -27.77 63.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.76 0.314 . . . . 32.530000000000001 110.789 -179.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.98 -46.57 51.3 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.974 -0.631 . . . . 61.32 112.283 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.1 mt-30 -74.97 -13.23 60.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.945 0.402 . . . . 72.439999999999998 110.433 177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 74.35 38.85 44.69 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.581 -0.736 . . . . 72.439999999999998 112.175 178.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 41.4 mtpt -128.64 -176.74 3.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.726 0.298 . . . . 74.040000000000006 110.45 -179.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 70.1 m -134.57 153.47 79.07 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.11 -0.496 . . . . 73.340000000000003 111.177 -177.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -64.95 157.7 55.47 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 122.892 2.395 . . . . 54.520000000000003 111.311 172.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.4 t -106.9 22.88 15.27 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.327 0.584 . . . . 64.5 109.903 -177.747 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -178.82 -178.14 47.91 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.691 -0.686 . . . . 44.420000000000002 111.749 179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.451 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 95.0 Cg_endo -78.53 160.68 28.48 Favored 'Trans proline' 0 N--CA 1.464 -0.257 0 C-N-CA 123.045 2.497 . . . . 74.209999999999994 112.06 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.834 ' HG2' ' HB2' ' A' ' 135' ' ' TYR . 26.7 Cg_endo -64.29 145.65 88.87 Favored 'Trans proline' 0 C--O 1.238 0.494 0 C-N-CA 122.452 2.101 . . . . 62.140000000000001 112.557 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CE1' ' HG3' ' A' ' 76' ' ' PRO . 4.2 m-85 -113.83 170.82 7.98 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.598 -0.519 . . . . 74.530000000000001 109.598 179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.868 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -161.46 113.55 1.81 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.231 -0.44 . . . . 61.119999999999997 110.295 172.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -113.7 141.74 46.88 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.114 0.483 . . . . 72.310000000000002 110.554 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.761 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 25.2 m-85 -124.33 124.78 43.13 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.629 -0.714 . . . . 62.049999999999997 109.52 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 83.7 t80 -117.1 138.17 51.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.895 0.379 . . . . 64.540000000000006 110.758 -178.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.71 -56.83 0.57 Allowed Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.902 -0.666 . . . . 41.109999999999999 111.892 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.6 mmm 58.1 31.25 20.47 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 121.175 0.512 . . . . 73.040000000000006 111.182 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 28.8 t -76.0 -15.16 60.19 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.631 -0.713 . . . . 74.25 110.405 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 71.29 -57.78 0.59 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 115.485 -0.779 . . . . 63.310000000000002 111.464 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 27' ' ' ALA . . . -55.19 -48.84 66.12 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.193 -0.527 . . . . 74.319999999999993 111.976 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.454 ' HA ' ' O ' ' A' ' 26' ' ' THR . 73.1 m -153.98 130.27 10.47 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.036 -0.728 . . . . 45.43 109.036 172.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -154.48 170.1 22.21 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.773 0.32 . . . . 73.109999999999999 111.231 -179.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.577 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 18.9 tp10 -87.39 125.74 34.44 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.673 -0.694 . . . . 74.25 110.289 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 28.3 m -123.25 124.11 69.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.326 0.584 . . . . 72.200000000000003 110.85 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.595 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 34.4 mt-10 -138.71 105.2 5.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.568 -0.742 . . . . 72.510000000000005 109.038 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.868 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.3 p90 -75.48 -62.53 1.54 Allowed 'General case' 0 C--N 1.322 -0.594 0 C-N-CA 120.527 -0.469 . . . . 73.109999999999999 111.408 -176.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.46 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 78.31 142.01 1.92 Allowed Glycine 0 CA--C 1.524 0.606 0 C-N-CA 120.246 -0.978 . . . . 70.540000000000006 113.815 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.552 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 72.0 m-85 -132.63 141.37 40.9 Favored Pre-proline 0 C--N 1.326 -0.444 0 N-CA-C 108.923 -0.769 . . . . 65.239999999999995 108.923 173.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.564 ' HG3' ' CE1' ' A' ' 58' ' ' PHE . 5.1 Cg_exo -79.48 134.38 11.15 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 122.727 2.284 . . . . 73.140000000000001 111.168 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.594 ' HB ' HG21 ' A' ' 81' ' ' VAL . 28.9 m -115.91 152.83 17.56 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.033 0.444 . . . . 64.140000000000001 111.267 -176.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 16.7 tt0 -64.87 -41.44 95.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.597 -0.729 . . . . 75.040000000000006 110.732 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 137.7 153.43 6.32 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.64 -0.709 . . . . 61.530000000000001 111.406 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 75.54 28.73 60.9 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.849 -0.691 . . . . 74.25 111.555 -178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.594 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.5 t -104.95 149.91 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 N-CA-C 109.474 -0.565 . . . . 75.129999999999995 109.474 -178.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -125.89 138.73 53.81 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.191 -0.459 . . . . 72.319999999999993 110.753 -172.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -68.89 137.47 30.16 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 116.004 -0.544 . . . . 72.430000000000007 111.876 178.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 6.3 p -84.55 -15.65 45.01 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.874 0.369 . . . . 70.239999999999995 111.311 -178.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 148.42 -81.96 0.19 Allowed Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.843 -0.694 . . . . 51.5 111.721 -178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 86' ' ' ARG . 14.0 ptt-85 -78.63 -14.38 59.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.035 0.445 . . . . 62.149999999999999 110.49 176.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.9 t -90.67 104.58 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.545 0 N-CA-C 108.48 -0.933 . . . . 71.519999999999996 108.48 171.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.5 m -98.65 157.9 3.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 120.929 0.395 . . . . 62.130000000000003 110.914 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.6 p -99.62 141.73 32.04 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.695 -0.684 . . . . 55.030000000000001 110.939 -177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -177.71 -145.33 5.83 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 120.894 -0.669 . . . . 52.439999999999998 111.573 178.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.5 pp -142.38 167.22 22.63 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.704 0.287 . . . . 74.329999999999998 110.681 177.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 30.3 p -80.74 145.35 57.85 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.026 -0.534 . . . . 64.420000000000002 110.848 178.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -68.66 145.18 62.76 Favored 'Trans proline' 0 C--O 1.235 0.342 0 C-N-CA 122.584 2.189 . . . . 74.230000000000004 112.937 -177.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.443 ' HB2' ' HD3' ' A' ' 16' ' ' PRO . 14.4 t -96.36 161.81 13.77 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.672 -0.695 . . . . 61.200000000000003 109.182 177.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 148.32 -147.08 17.34 Favored Glycine 0 N--CA 1.447 -0.607 0 N-CA-C 111.051 -0.82 . . . . 71.329999999999998 111.051 -178.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.461 ' HB3' ' HG2' ' A' ' 13' ' ' GLU . 18.8 ptpt -152.67 158.6 42.62 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 117.44 0.62 . . . . 75.219999999999999 110.749 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -162.67 175.37 11.43 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.614 -0.721 . . . . 72.129999999999995 110.256 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.653 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -91.23 121.42 32.97 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.481 -0.563 . . . . 42.009999999999998 109.481 174.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 60.8 p -120.62 158.9 26.39 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.15 0.5 . . . . 52.219999999999999 111.575 -174.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.922 ' HB2' HG23 ' A' ' 112' ' ' VAL . 40.8 m -144.38 156.04 44.05 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.675 -0.693 . . . . 61.439999999999998 109.183 171.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 76.8 mt -95.04 109.04 21.13 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.938 0.399 . . . . 64.040000000000006 110.379 -179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.583 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 92.6 t80 -92.46 100.37 12.93 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.846 -0.616 . . . . 75.109999999999999 109.452 177.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.584 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -100.12 122.14 51.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.524 -0.307 . . . . 72.319999999999993 110.715 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 145' ' ' ASP . . . 137.37 -171.17 23.29 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.857 -0.687 . . . . 71.010000000000005 112.126 175.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_exo -72.12 -179.71 4.18 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 122.691 2.26 . . . . 75.25 110.462 173.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -95.15 133.74 38.66 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.015 -0.674 . . . . 52.5 110.059 -175.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -162.11 -112.71 0.29 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.409 -0.814 . . . . 73.409999999999997 111.123 179.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' HB2' ' HG2' ' A' ' 110' ' ' GLU . 8.6 pt-20 -83.76 89.08 7.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.669 0.747 . . . . 61.520000000000003 110.666 177.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.67 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -74.64 -10.49 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.468 -0.787 . . . . 55.109999999999999 110.197 -179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.569 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 8.6 pt-20 -49.67 -22.33 1.32 Allowed 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 115.712 -0.676 . . . . 73.430000000000007 111.959 174.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -54.33 -40.3 67.88 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.899 -0.591 . . . . 72.540000000000006 111.661 178.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.922 HG23 ' HB2' ' A' ' 100' ' ' SER . 14.7 p -74.49 -33.14 32.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 C-N-CA 120.938 -0.305 . . . . 72.340000000000003 110.858 -178.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.569 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 91.2 m-85 -61.52 -48.21 82.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 71.319999999999993 109.807 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -67.78 -37.82 82.56 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.434 -0.803 . . . . 75.140000000000001 111.143 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.419 ' HA ' ' HG2' ' A' ' 6' ' ' GLN . . . -61.46 -49.8 75.32 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.238 0.542 . . . . 55.329999999999998 110.714 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.653 HD22 ' HB1' ' A' ' 98' ' ' ALA . 91.2 mt -66.26 -37.29 85.14 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.792 -0.64 . . . . 72.450000000000003 110.618 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.464 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.0 OUTLIER -54.66 -44.58 73.39 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-N 116.19 -0.459 . . . . 44.299999999999997 111.017 178.206 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.409 ' HE3' ' HB2' ' A' ' 4' ' ' GLU . 12.2 tmtt? -63.13 -55.22 27.15 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.527 -0.546 . . . . 53.329999999999998 109.527 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 79.6 t90 -56.79 -53.68 55.03 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.814 -0.63 . . . . 74.540000000000006 112.48 -173.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.632 HG23 ' HB2' ' A' ' 125' ' ' PHE . 9.4 p -68.32 -42.22 84.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 N-CA-C 111.875 0.324 . . . . 70.430000000000007 111.875 -173.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -70.36 -37.44 74.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.149 0.499 . . . . 74.140000000000001 110.573 -177.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -75.29 -34.6 61.31 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.73 -0.668 . . . . 73.049999999999997 111.035 -176.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -87.2 -35.0 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.407 -0.36 . . . . 72.030000000000001 111.466 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.22 63.16 1.32 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.835 -0.698 . . . . 44.520000000000003 112.981 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.632 ' HB2' HG23 ' A' ' 120' ' ' VAL . 65.3 m-85 -102.18 161.53 13.62 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 110.475 -0.194 . . . . 73.329999999999998 110.475 176.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -89.12 161.03 16.72 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 110.156 -0.313 . . . . 75.239999999999995 110.156 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.633 ' H ' HD12 ' A' ' 127' ' ' LEU . 3.9 mp -63.49 152.24 38.99 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-O 121.822 0.82 . . . . 51.420000000000002 112.42 -173.28 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.864 ' HB2' HD23 ' A' ' 155' ' ' LEU . 25.6 m -146.19 85.7 1.68 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.56 -1.2 . . . . 63.310000000000002 108.013 169.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -76.03 61.11 3.02 Favored Glycine 0 CA--C 1.517 0.197 0 CA-C-N 115.255 -0.884 . . . . 51.030000000000001 114.153 -173.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -141.55 133.05 26.84 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.735 -0.469 . . . . 72.129999999999995 109.735 174.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.761 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -99.68 134.49 42.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.706 0.289 . . . . 75.129999999999995 110.313 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 17.4 t80 -143.63 110.13 5.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.453 -0.573 . . . . 74.510000000000005 109.453 -177.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 14.3 pt-20 -129.47 149.15 51.37 Favored 'General case' 0 C--N 1.322 -0.624 0 C-N-CA 120.827 -0.349 . . . . 72.120000000000005 110.371 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 32.0 pt -136.84 134.58 48.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 110.708 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.834 ' HB2' ' HG2' ' A' ' 57' ' ' PRO . 63.5 m-85 -92.39 85.5 5.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.168 -0.678 . . . . 74.439999999999998 109.168 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 137' ' ' ASP . 1.6 tt -74.06 157.0 36.87 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 72.239999999999995 110.071 -173.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.695 ' HB3' HG21 ' A' ' 142' ' ' THR . 20.4 m-20 71.93 -167.21 0.13 Allowed 'General case' 0 N--CA 1.467 0.407 0 O-C-N 123.926 0.766 . . . . 71.200000000000003 110.413 -174.379 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.675 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 67.3 t30 -148.04 139.81 14.06 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.108 -0.701 . . . . 72.010000000000005 109.108 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 24.7 Cg_endo -65.05 154.66 72.34 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.454 2.103 . . . . 74.430000000000007 112.503 177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 58.38 19.6 6.56 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.356 -0.838 . . . . 63.32 111.758 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -57.98 0.74 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.269 -0.641 . . . . 71.109999999999999 109.269 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.695 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.8 t -87.0 18.94 3.27 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.0 -0.545 . . . . 74.209999999999994 110.321 -179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 75.07 145.16 0.11 Allowed Pre-proline 0 N--CA 1.464 0.269 0 CA-C-N 115.285 -0.87 . . . . 64.019999999999996 111.215 -174.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.02 155.83 56.75 Favored 'Trans proline' 0 N--CA 1.451 -0.996 0 C-N-CA 122.165 1.91 . . . . 74.329999999999998 111.464 174.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.52 ' O ' ' HA2' ' A' ' 104' ' ' GLY . 16.5 t70 75.11 0.16 3.45 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 114.989 -1.005 . . . . 64.219999999999999 111.846 173.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 13.4 mt-30 -124.07 23.23 8.55 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 121.965 -0.46 . . . . 51.350000000000001 111.424 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.1 123.86 20.6 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.405 -0.591 . . . . 74.540000000000006 109.405 175.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.584 ' HG2' HG13 ' A' ' 103' ' ' ILE . 91.2 mtm180 -102.24 107.07 18.0 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.2 0.524 . . . . 75.209999999999994 111.308 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.583 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 41.0 m -99.21 111.35 23.75 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.078 -0.51 . . . . 43.450000000000003 110.138 178.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 52.2 mtp85 -88.34 95.57 10.24 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.189 -0.671 . . . . 72.219999999999999 109.189 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.82 HG13 HG21 ' A' ' 112' ' ' VAL . 2.4 p -108.91 128.65 64.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.699 -0.682 . . . . 73.239999999999995 111.283 -174.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 7.3 m -115.9 136.02 53.44 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.404 -0.816 . . . . 71.209999999999994 109.297 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 70.7 mt -133.85 -167.67 1.99 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.071 0.462 . . . . 74.219999999999999 111.984 -173.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.06 135.06 56.08 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-N 115.207 -0.906 . . . . 54.119999999999997 111.286 -176.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.864 HD23 ' HB2' ' A' ' 128' ' ' SER . 4.3 mm? -74.4 100.13 3.72 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.787 -0.642 . . . . 64.439999999999998 109.442 171.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.56 ' H ' HG11 ' A' ' 120' ' ' VAL . 14.3 p80 60.7 159.52 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 125.758 1.623 . . . . 71.510000000000005 113.52 -179.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 66.27 26.16 10.41 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 114.846 -1.07 . . . . 72.099999999999994 111.883 -176.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 9.2 p -81.89 117.33 22.06 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 109.411 -0.588 . . . . 71.519999999999996 109.411 171.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -72.11 91.58 1.27 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.291 -0.413 . . . . 73.439999999999998 111.851 -172.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 179.28 122.41 0.05 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.811 -0.631 . . . . 72.420000000000002 109.975 174.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -156.28 21.08 0.36 Allowed 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.341 0.496 . . . . 75.530000000000001 112.341 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 19.5 p-80 -94.97 16.29 16.55 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.388 0.613 . . . . 74.010000000000005 110.099 177.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -63.13 134.37 55.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.165 -0.925 . . . . 74.450000000000003 110.433 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -92.86 170.34 9.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.027 -0.533 . . . . 75.209999999999994 110.685 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 8.8 p80 -115.56 -11.31 11.77 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.279 0.562 . . . . 51.509999999999998 109.852 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 6.4 t60 . . . . . 0 C--O 1.249 1.062 0 CA-C-N 115.149 -0.932 . . . . 74.510000000000005 108.792 174.08 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.5 ttm . . . . . 0 N--CA 1.483 1.212 0 CA-C-O 120.473 0.178 . . . . 72.129999999999995 111.167 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 3' ' ' PHE . 4.4 p-10 -77.94 -85.81 0.06 Allowed 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 120.454 -0.498 . . . . 71.200000000000003 111.289 -177.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.431 ' H ' ' CG ' ' A' ' 2' ' ' ASP . 86.8 t80 178.75 -41.7 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.833 0.349 . . . . 70.230000000000004 111.397 -178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -95.28 91.16 6.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.347 0.594 . . . . 70.239999999999995 112.353 -168.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -127.07 84.34 2.25 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.521 -0.763 . . . . 73.400000000000006 109.197 173.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 52.0 mt-30 -85.26 100.87 12.08 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 111.001 -173.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -97.64 139.46 33.5 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.974 -0.557 . . . . 75.409999999999997 109.986 174.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 10.9 p -61.45 132.65 27.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.251 0.548 . . . . 74.230000000000004 111.187 -177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 100' ' ' SER . 14.6 m -103.33 141.96 35.03 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.68 -0.691 . . . . 73.230000000000004 110.496 -175.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -116.02 155.36 28.24 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.255 0.55 . . . . 72.510000000000005 111.042 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.463 HD21 ' HB3' ' A' ' 96' ' ' LYS . 3.4 tm? -86.71 114.73 23.64 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.334 -1.358 . . . . 75.510000000000005 107.334 166.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -120.99 147.19 45.82 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.7 -0.481 . . . . 73.010000000000005 109.7 -177.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -113.04 132.81 55.25 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.297 0.57 . . . . 75.129999999999995 110.48 177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 94' ' ' SER . 0.2 OUTLIER -76.41 124.66 27.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.442 -0.799 . . . . 63.399999999999999 109.877 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -87.72 147.14 40.67 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 116.111 -0.495 . . . . 74.5 110.11 177.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 16.1 Cg_exo -67.96 99.96 0.59 Allowed 'Trans proline' 0 N--CA 1.463 -0.29 0 C-N-CA 122.506 2.137 . . . . 71.129999999999995 111.517 176.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 60.8 t -119.11 141.59 30.63 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.837 -0.62 . . . . 63.43 109.865 -177.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 11.7 Cg_exo -72.32 104.91 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.628 2.219 . . . . 74.030000000000001 111.408 173.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -118.54 151.77 37.24 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.195 -0.457 . . . . 44.039999999999999 110.754 -178.023 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.601 HD12 ' HB ' ' A' ' 89' ' ' THR . 10.4 tt -132.94 139.74 47.48 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.205 -0.665 . . . . 73.540000000000006 109.205 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.63 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.72 167.54 28.07 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.283 0.563 . . . . 53.439999999999998 111.997 -178.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.517 HD13 ' HA ' ' A' ' 87' ' ' VAL . 46.5 mm -96.39 119.46 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 N-CA-C 108.11 -1.07 . . . . 73.129999999999995 108.11 168.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.402 ' HG3' ' O ' ' A' ' 23' ' ' ARG . 31.6 ptt180 -81.16 100.86 9.31 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.985 0.897 . . . . 74.230000000000004 108.777 177.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.741 ' HB ' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -108.1 167.99 9.61 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.624 -1.171 . . . . 64.140000000000001 111.043 -171.438 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 23.7 pt20 -138.26 146.43 42.52 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.713 -0.477 . . . . 73.340000000000003 109.713 177.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.615 ' HB ' HD22 ' A' ' 34' ' ' LEU . 9.9 t -150.31 -179.22 7.02 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.459 -0.337 . . . . 71.319999999999993 110.387 -174.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.35 -174.43 4.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.368 -0.378 . . . . 74.319999999999993 110.535 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 46.1 ttp -75.33 99.19 4.03 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.651 -0.5 . . . . 72.439999999999998 109.651 179.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.9 t 71.43 74.52 0.18 Allowed 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.324 -0.853 . . . . 63.329999999999998 110.386 -175.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.512 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 5.4 tm-20 -148.07 -6.22 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.444 -0.798 . . . . 73.400000000000006 109.405 176.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.6 pp -59.7 -16.53 27.63 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 112.942 0.719 . . . . 61.039999999999999 112.942 -172.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -56.38 -44.73 89.82 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.906 -0.664 . . . . 62.299999999999997 112.403 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.3 -31.3 58.12 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.11 0.481 . . . . 64.120000000000005 111.089 179.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.741 HD21 ' HB ' ' A' ' 24' ' ' THR . 31.5 tp -73.25 -37.48 66.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.825 -0.625 . . . . 75.239999999999995 111.437 -175.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -60.36 -39.48 87.34 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.699 0.285 . . . . 74.310000000000002 111.496 179.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 -44.43 96.68 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.128 0.489 . . . . 73.140000000000001 109.989 178.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.23 -42.88 96.37 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.624 -0.716 . . . . 74.319999999999993 110.801 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -62.85 -38.34 96.37 Favored Glycine 0 N--CA 1.452 -0.237 0 CA-C-N 116.073 -0.512 . . . . 75.319999999999993 112.732 -179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 60.5 t80 -63.77 -42.56 97.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.063 0.458 . . . . 64.349999999999994 110.364 179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.9 m80 -72.33 -30.98 65.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 74.299999999999997 111.523 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -61.08 -35.7 77.66 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.067 -0.515 . . . . 72.439999999999998 111.935 -174.466 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 34.5 pt -85.68 5.8 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.191 0.441 . . . . 65.349999999999994 112.191 -176.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.5 tp -54.83 -48.98 72.16 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 111.996 0.369 . . . . 73.099999999999994 111.996 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' NE2' ' HA3' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -62.56 -42.42 99.53 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.863 0.363 . . . . 72.019999999999996 111.515 -173.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 34.1 tp -75.45 -24.52 57.01 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 122.051 -0.406 . . . . 75.150000000000006 111.29 -173.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD13 ' HG3' ' A' ' 51' ' ' LYS . 4.1 mm? -91.79 -55.08 3.6 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 121.058 -0.257 . . . . 72.540000000000006 111.544 178.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -85.34 -26.78 26.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.597 -0.274 . . . . 51.0 111.422 -172.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' HA3' ' NE2' ' A' ' 44' ' ' GLN . . . -61.37 -34.37 88.0 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.022 -0.608 . . . . 75.319999999999993 112.599 -178.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -93.07 -65.16 1.02 Allowed 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.705 -0.48 . . . . 70.140000000000001 109.705 176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 140.76 58.61 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.786 -0.721 . . . . 72.099999999999994 111.579 -177.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.464 ' HG3' HD13 ' A' ' 46' ' ' LEU . 12.1 ptpt -147.19 175.19 10.93 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 110.107 -0.331 . . . . 74.129999999999995 110.107 178.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.426 ' HA ' HD12 ' A' ' 46' ' ' LEU . 30.3 m -152.43 164.71 19.43 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-N 116.717 -0.22 . . . . 74.230000000000004 110.514 -175.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -64.58 151.45 85.54 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.284 1.989 . . . . 40.409999999999997 110.725 170.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.6 t -103.99 -31.83 9.52 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 120.676 0.274 . . . . 74.409999999999997 111.066 -176.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.22 -178.18 15.2 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.428 -0.891 . . . . 72.319999999999993 112.404 -175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.612 ' CB ' ' HA ' ' A' ' 136' ' ' LEU . 7.0 Cg_exo -73.93 152.5 46.58 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.761 2.307 . . . . 71.219999999999999 111.868 179.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -82.75 155.88 15.69 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.749 2.3 . . . . 73.120000000000005 113.534 -175.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' HB3' HG13 ' A' ' 134' ' ' ILE . 12.2 p90 -137.96 118.51 13.9 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.373 -0.83 . . . . 74.540000000000006 109.761 176.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.593 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -93.63 113.55 25.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.97 -0.559 . . . . 73.010000000000005 111.392 -172.216 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 17.6 mtt180 -96.06 123.91 39.86 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.587 -0.733 . . . . 74.219999999999999 109.653 179.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.525 ' HB3' HG12 ' A' ' 71' ' ' VAL . 29.2 p90 -129.64 131.66 46.49 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.816 0.817 . . . . 74.409999999999997 111.553 175.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.603 ' HB2' ' HG3' ' A' ' 130' ' ' GLU . 78.6 t80 -114.14 110.7 20.41 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.87 -1.059 . . . . 62.5 109.434 177.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.625 ' HA3' ' HD2' ' A' ' 69' ' ' PHE . . . -155.06 25.88 0.62 Allowed Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.953 -0.641 . . . . 61.299999999999997 111.603 177.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.1 ptp -105.51 3.35 29.33 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.5 0.667 . . . . 74.019999999999996 110.285 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 27.0 m -153.95 164.32 38.61 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.399 -0.819 . . . . 73.239999999999995 109.06 177.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 73.27 -49.39 0.69 Allowed 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.515 0.726 . . . . 64.219999999999999 111.751 178.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 121.11 -17.19 9.19 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.841 -0.695 . . . . 73.230000000000004 112.248 178.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 20.4 m -93.04 144.28 25.41 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.067 -0.346 . . . . 74.129999999999995 110.067 178.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.625 ' HD2' ' HA3' ' A' ' 63' ' ' GLY . 44.3 t80 -116.97 114.65 24.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.104 0.478 . . . . 55.299999999999997 109.751 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 31.9 mt-10 -116.31 158.22 23.75 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.722 -0.672 . . . . 71.310000000000002 110.982 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.525 HG12 ' HB3' ' A' ' 61' ' ' TYR . 4.1 m -139.6 135.01 39.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.821 -0.627 . . . . 51.130000000000003 111.905 -175.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.63 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 47.6 mt-10 -128.74 103.37 7.03 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.967 -0.753 . . . . 72.519999999999996 108.967 172.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.414 ' HZ ' HG12 ' A' ' 22' ' ' ILE . 24.7 p90 -63.97 -24.04 67.57 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 111.712 0.264 . . . . 60.509999999999998 111.712 -176.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.595 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 50.23 91.16 0.01 OUTLIER Glycine 0 C--N 1.335 0.517 0 N-CA-C 115.741 1.056 . . . . 51.420000000000002 115.741 167.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -101.55 140.7 21.46 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.462 -0.57 . . . . 52.130000000000003 109.462 171.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.406 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 5.9 Cg_exo -76.7 139.62 20.2 Favored 'Trans proline' 0 N--CA 1.458 -0.612 0 C-N-CA 122.402 2.068 . . . . 63.5 110.234 171.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.6 m -114.39 167.84 6.8 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.337 0.589 . . . . 72.25 111.677 -172.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -68.29 -35.38 77.76 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.773 -1.103 . . . . 64.25 111.156 -176.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 116.18 135.49 5.66 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.253 -0.739 . . . . 53.43 111.253 -176.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.74 50.15 4.3 Favored Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.606 -0.807 . . . . 54.340000000000003 111.233 -177.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.433 HG22 ' HD3' ' A' ' 51' ' ' LYS . 4.9 t -120.33 150.93 23.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 109.881 -0.414 . . . . 75.5 109.881 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -88.19 -174.66 4.74 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.253 -0.431 . . . . 74.010000000000005 111.288 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.53 151.24 21.11 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 110.912 -0.875 . . . . 63.229999999999997 110.912 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 49.5 m -146.73 77.89 1.48 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 117.107 0.454 . . . . 53.32 111.341 -177.373 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.76 -92.85 0.11 Allowed Glycine 0 C--N 1.33 0.237 0 CA-C-N 115.786 -0.643 . . . . 44.439999999999998 113.31 173.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 86' ' ' ARG . 16.5 ptt-85 -76.09 -23.53 54.97 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.986 -0.376 . . . . 65.030000000000001 109.986 178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.517 ' HA ' HD13 ' A' ' 22' ' ' ILE . 2.4 t -91.55 99.7 10.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 115.743 -0.662 . . . . 72.230000000000004 109.438 178.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.4 m -124.38 151.22 29.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.241 0.544 . . . . 54.210000000000001 112.152 -174.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 20' ' ' LEU . 10.8 t -131.78 171.25 13.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.148 -0.933 . . . . 72.420000000000002 110.049 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 158.55 -176.93 35.39 Favored Glycine 0 C--N 1.315 -0.624 0 CA-C-N 115.552 -0.749 . . . . 64.439999999999998 111.743 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.415 ' HA ' ' O ' ' A' ' 17' ' ' VAL . 10.8 mp -100.77 144.56 29.58 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.941 0.371 . . . . 73.340000000000003 110.427 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.434 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 4.1 p -81.58 144.12 52.29 Favored Pre-proline 0 C--N 1.321 -0.65 0 CA-C-N 115.838 -0.619 . . . . 64.319999999999993 111.386 178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -73.78 143.91 34.21 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.348 2.032 . . . . 70.439999999999998 111.268 175.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 8.6 t -86.46 134.87 33.65 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.093 0.473 . . . . 62.439999999999998 110.481 -178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -167.82 160.33 33.88 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 111.19 -0.764 . . . . 73.439999999999998 111.19 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.463 ' HB3' HD21 ' A' ' 11' ' ' LEU . 1.8 mptp? -100.55 126.88 47.04 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.852 -0.425 . . . . 70.299999999999997 109.852 -178.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.73 168.02 20.32 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.025 -0.534 . . . . 75.439999999999998 111.414 -176.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.854 ' HB2' HD13 ' A' ' 155' ' ' LEU . . . -94.61 121.8 36.54 Favored 'General case' 0 C--O 1.244 0.809 0 CA-C-N 116.161 -0.472 . . . . 75.030000000000001 110.798 179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 26.6 t -135.82 130.79 34.51 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 115.382 -0.826 . . . . 74.129999999999995 109.851 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.509 ' HA ' ' HA ' ' A' ' 9' ' ' CYS . 30.3 t -102.26 153.66 19.77 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.858 -0.423 . . . . 74.409999999999997 109.858 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 97.5 mt -92.73 99.37 12.07 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.95 0.405 . . . . 75.310000000000002 110.098 179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.988 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 15.7 t80 -81.05 102.38 10.17 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.548 -0.908 . . . . 72.530000000000001 108.548 176.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 69.3 mt -93.45 123.35 45.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.191 -0.459 . . . . 72.040000000000006 111.047 -172.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.86 -154.67 16.51 Favored Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.625 -0.716 . . . . 44.439999999999998 111.549 -178.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -72.83 169.24 22.54 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.444 2.096 . . . . 45.310000000000002 112.049 178.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.631 ' HE1' HD11 ' A' ' 109' ' ' ILE . 63.3 t80 -96.44 134.84 39.1 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.374 -0.376 . . . . 74.299999999999997 110.303 -178.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -169.16 -77.2 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.225 -0.988 . . . . 52.310000000000002 113.522 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -97.37 106.34 18.64 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.238 0.458 . . . . 64.319999999999993 112.238 -171.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.631 HD11 ' HE1' ' A' ' 106' ' ' TYR . 35.9 mm -76.63 -47.17 29.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.011 -0.54 . . . . 65.010000000000005 111.016 176.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.512 ' CD ' ' H ' ' A' ' 110' ' ' GLU . 0.5 OUTLIER -60.68 -31.49 70.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.555 -0.293 . . . . 70.120000000000005 111.568 -174.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.34 -46.59 83.13 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 116.377 -0.374 . . . . 65.519999999999996 111.246 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 9.6 p -85.92 -27.67 6.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.148 0.499 . . . . 74.219999999999999 110.282 177.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.448 ' HB2' ' O ' ' A' ' 109' ' ' ILE . 9.7 t80 -57.08 -39.52 75.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.47 -0.786 . . . . 73.319999999999993 110.805 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -57.93 -42.05 84.02 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.919 0.39 . . . . 51.43 110.945 177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.56 -41.11 76.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.158 -0.474 . . . . 63.030000000000001 110.786 179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.798 ' HB3' HD21 ' A' ' 153' ' ' LEU . 7.2 mt -57.9 -46.83 84.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.688 -0.687 . . . . 70.329999999999998 111.838 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -71.16 -27.66 63.69 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 121.019 -0.273 . . . . 73.040000000000006 111.037 -178.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -73.45 -35.85 65.82 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.331 -0.618 . . . . 63.039999999999999 109.331 176.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 83.0 t90 -59.04 -45.6 90.34 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.871 -0.604 . . . . 72.420000000000002 110.788 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.565 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.4 p -72.08 -32.78 44.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.236 -0.438 . . . . 71.510000000000005 111.165 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -51.31 -40.85 59.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.84 -0.618 . . . . 72.200000000000003 110.326 173.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -80.72 -45.11 17.63 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.631 -0.713 . . . . 71.519999999999996 111.538 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 -65.26 -38.83 91.53 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.03 0.382 . . . . 72.010000000000005 112.03 -174.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.51 9.14 67.12 Favored Glycine 0 CA--C 1.524 0.616 0 C-N-CA 120.825 -0.702 . . . . 71.329999999999998 114.047 175.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.874 ' HD2' HD11 ' A' ' 155' ' ' LEU . 19.8 t80 -86.01 174.22 9.36 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.248 -0.649 . . . . 64.519999999999996 109.248 177.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.648 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 2.6 p-10 -165.77 145.98 6.62 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.911 0.386 . . . . 71.099999999999994 110.927 176.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.413 HD11 ' O ' ' A' ' 96' ' ' LYS . 82.3 mt -140.85 167.17 22.82 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.944 -0.761 . . . . 73.409999999999997 108.944 172.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.475 ' HA ' ' HG3' ' A' ' 154' ' ' MET . 4.3 p -143.75 80.85 1.67 Allowed 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.165 0.507 . . . . 72.239999999999995 111.12 176.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -140.5 -128.49 2.45 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 120.839 -0.696 . . . . 75.219999999999999 112.026 176.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.603 ' HG3' ' HB2' ' A' ' 62' ' ' PHE . 10.1 mp0 -104.04 169.69 8.35 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.956 0.407 . . . . 64.040000000000006 110.496 -178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -105.93 123.17 47.55 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.82 -0.807 . . . . 73.340000000000003 108.82 171.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.593 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.0 p90 -130.28 133.97 46.88 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.403 0.621 . . . . 60.530000000000001 111.729 -175.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 68.9 mt-10 -110.67 119.32 38.76 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.077 -0.965 . . . . 65.230000000000004 110.618 -177.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 4.0 mp -89.95 113.6 26.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.237 -0.438 . . . . 74.010000000000005 109.895 179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 49.3 m-85 -96.52 86.58 4.17 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.251 -0.648 . . . . 74.040000000000006 109.251 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.73 HD23 ' H ' ' A' ' 136' ' ' LEU . 1.4 pt? -89.98 159.09 17.07 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.705 0.288 . . . . 75.120000000000005 111.261 -175.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.645 ' HB3' HG21 ' A' ' 142' ' ' THR . 47.3 m-20 65.07 178.33 0.19 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.177 -0.92 . . . . 71.120000000000005 110.929 -177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.44 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 11.9 p30 -103.69 143.4 26.57 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.637 -0.505 . . . . 65.450000000000003 109.637 176.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.487 ' HA ' HD11 ' A' ' 147' ' ' LEU . 7.4 Cg_exo -74.04 151.24 44.38 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 121.668 1.579 . . . . 54.539999999999999 111.852 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 69.82 -39.09 0.43 Allowed 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.048 0.939 . . . . 71.439999999999998 112.545 176.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 139' ' ' PRO . 7.9 mm-40 -77.73 -19.95 54.33 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.116 0.484 . . . . 75.319999999999993 110.661 -175.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.645 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.8 OUTLIER -86.17 1.48 50.5 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.676 -0.693 . . . . 73.519999999999996 111.655 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.423 ' HB3' ' O ' ' A' ' 142' ' ' THR . . . 73.71 152.28 0.14 Allowed Pre-proline 0 C--O 1.233 0.22 0 O-C-N 123.991 0.807 . . . . 52.100000000000001 111.421 -175.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.412 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 51.4 Cg_exo -55.05 148.22 49.33 Favored 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 122.694 2.263 . . . . 72.400000000000006 112.363 175.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.412 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 18.6 t70 76.72 -16.03 0.67 Allowed 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 114.633 -1.167 . . . . 72.019999999999996 112.529 174.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 47.7 mt-30 -102.13 21.51 14.75 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 121.961 -0.462 . . . . 73.349999999999994 111.851 -177.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.487 HD11 ' HA ' ' A' ' 139' ' ' PRO . 3.6 mm? -95.29 135.93 36.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.616 -0.265 . . . . 54.32 110.478 175.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -124.48 128.06 48.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.79 0.329 . . . . 72.310000000000002 110.841 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.988 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 11.7 m -113.2 101.99 9.94 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 109.222 -0.658 . . . . 52.43 109.222 170.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.743 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 99.5 mtt180 -83.45 95.06 8.14 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.913 0.387 . . . . 73.299999999999997 110.413 -176.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 99' ' ' SER . 3.4 p -91.43 114.7 29.11 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.825 0 CA-C-O 121.083 0.468 . . . . 41.539999999999999 110.218 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.47 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 19.9 t -110.41 133.45 53.26 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.179 -0.674 . . . . 73.099999999999994 109.179 178.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.798 HD21 ' HB3' ' A' ' 116' ' ' LEU . 0.7 OUTLIER -128.45 175.83 8.21 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.56 0.948 . . . . 72.329999999999998 113.56 -171.282 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.49 ' HG2' ' HB2' ' A' ' 156' ' ' HIS . 50.0 ttp -75.66 89.71 2.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.058 -0.974 . . . . 75.510000000000005 109.35 172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.874 HD11 ' HD2' ' A' ' 125' ' ' PHE . 2.1 pt? -79.67 45.82 0.72 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 122.113 0.958 . . . . 54.530000000000001 111.172 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.494 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 7.5 t-80 -71.12 -64.81 0.84 Allowed 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.377 -1.283 . . . . 74.109999999999999 108.37 176.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.528 ' OE2' ' HA ' ' A' ' 163' ' ' HIS . 54.0 mp0 -139.75 -41.84 0.44 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.194 -0.912 . . . . 75.140000000000001 109.261 168.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 26.3 p -163.82 -73.16 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.836 -0.62 . . . . 72.530000000000001 111.588 -176.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -166.53 -37.14 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.272 -0.876 . . . . 55.020000000000003 108.683 -170.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -63.12 133.52 54.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.754 -0.657 . . . . 74.010000000000005 110.966 178.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -72.58 95.26 1.81 Allowed 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.345 0.593 . . . . 63.229999999999997 110.116 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 11.2 p-80 -164.5 -173.12 2.93 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.857 -0.794 . . . . 73.010000000000005 108.857 -176.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.528 ' HA ' ' OE2' ' A' ' 157' ' ' GLU . 8.2 t-160 -143.88 106.18 4.4 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.61 -0.436 . . . . 72.340000000000003 110.387 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 t60 -122.46 46.74 2.07 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.392 0.615 . . . . 75.209999999999994 109.779 -177.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -169.74 154.3 5.34 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.076 -1.083 . . . . 55.439999999999998 108.076 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.528 -0.749 . . . . 72.340000000000003 110.231 179.073 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttp . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 120.793 0.33 . . . . 74.040000000000006 110.78 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -84.15 105.43 15.01 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.581 -0.282 . . . . 73.129999999999995 110.699 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.02 96.33 2.83 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.967 0.413 . . . . 64.340000000000003 111.142 176.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 44.29 77.88 0.06 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.07 -0.968 . . . . 62.219999999999999 112.118 175.416 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 64.3 m -115.79 88.43 2.88 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.233 0.54 . . . . 72.219999999999999 110.584 -177.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 96.6 mt-30 -97.92 98.08 9.5 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.791 -0.64 . . . . 74.040000000000006 110.549 -178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -128.63 105.39 8.24 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 72.209999999999994 109.578 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.07 111.54 12.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.793 0.806 . . . . 64.540000000000006 111.454 -176.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.44 ' HB3' ' HB2' ' A' ' 100' ' ' SER . 1.6 p -102.33 148.71 25.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.439 -0.8 . . . . 41.119999999999997 110.509 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -155.55 161.17 40.93 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 110.102 -0.333 . . . . 70.519999999999996 110.102 -178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.512 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 34.3 tp -86.73 110.57 19.99 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.524 -0.547 . . . . 65.219999999999999 109.524 175.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.42 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 64.2 mmtt -117.28 142.85 46.57 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.55 -0.295 . . . . 72.439999999999998 110.803 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.638 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 16.3 pt-20 -100.07 134.86 42.37 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 109.565 -0.531 . . . . 74.349999999999994 109.565 177.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -93.68 117.5 30.17 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.965 -0.562 . . . . 60.520000000000003 110.371 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -79.18 152.0 76.06 Favored Pre-proline 0 C--N 1.321 -0.662 0 N-CA-C 109.414 -0.587 . . . . 75.329999999999998 109.414 174.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.42 ' HG3' ' OG ' ' A' ' 94' ' ' SER . 9.0 Cg_exo -69.14 101.33 0.81 Allowed 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.215 1.943 . . . . 44.210000000000001 111.512 178.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 89.4 t -103.62 141.38 22.38 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.073 -0.512 . . . . 71.239999999999995 110.044 -177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_exo -69.54 112.93 3.18 Favored 'Trans proline' 0 C--O 1.234 0.302 0 C-N-CA 122.67 2.247 . . . . 75.019999999999996 111.866 176.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.892 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -119.8 160.63 22.24 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.024 -0.534 . . . . 65.329999999999998 110.387 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.444 HD12 HG23 ' A' ' 89' ' ' THR . 0.5 OUTLIER -126.71 132.16 51.2 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.736 -0.468 . . . . 75.340000000000003 109.736 176.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.072 ' HB3' ' HA3' ' A' ' 74' ' ' GLY . 2.9 pp -174.12 168.95 4.03 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.35 0.595 . . . . 73.200000000000003 111.652 -175.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.408 HD12 ' HG3' ' A' ' 86' ' ' ARG . 9.2 tt -114.2 117.66 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 108.048 -1.093 . . . . 71.340000000000003 108.048 165.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.418 ' HB3' ' OE2' ' A' ' 72' ' ' GLU . 16.0 ptm180 -80.84 119.65 23.69 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 109.062 -0.718 . . . . 52.229999999999997 109.062 179.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.9 t -136.38 146.11 46.11 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.961 -0.563 . . . . 71.430000000000007 110.349 -175.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.411 ' HA ' ' O ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -80.28 148.0 30.94 Favored 'General case' 0 C--N 1.315 -0.923 0 C-N-CA 120.574 -0.45 . . . . 73.129999999999995 109.878 172.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.3 t -99.16 148.29 24.23 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.335 -0.393 . . . . 64.420000000000002 110.087 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -145.94 154.81 42.34 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.502 -0.317 . . . . 74.209999999999994 111.372 -174.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.5 mmt 60.19 -86.4 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.375 0 O-C-N 124.219 0.949 . . . . 65.129999999999995 113.093 173.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.5 m -139.46 10.3 2.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.049 0.452 . . . . 74.340000000000003 110.718 -175.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.447 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 0.3 OUTLIER -81.24 28.34 0.38 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 112.965 0.728 . . . . 75.349999999999994 112.965 -170.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 10.5 mp -75.43 -16.54 60.33 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.204 0.526 . . . . 71.349999999999994 109.788 169.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -109.69 -50.39 0.7 Allowed Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.821 -0.704 . . . . 60.539999999999999 112.089 175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.447 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 2.6 m -54.5 -45.97 73.36 Favored 'General case' 0 N--CA 1.463 0.214 0 N-CA-C 112.064 0.394 . . . . 71.340000000000003 112.064 -176.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.446 ' O ' HD13 ' A' ' 34' ' ' LEU . 3.1 tm? -62.2 -32.67 73.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.092 -0.503 . . . . 70.120000000000005 110.667 -176.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -83.72 -48.86 9.69 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.085 -0.507 . . . . 65.400000000000006 110.81 -176.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.51 -39.85 88.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.45 . . . . 54.420000000000002 111.919 -175.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -89.75 -14.37 34.76 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.023 0.44 . . . . 61.149999999999999 110.602 179.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -63.88 -55.16 26.17 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.736 -0.665 . . . . 55.130000000000003 113.597 -175.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.484 ' HB3' ' HE2' ' A' ' 73' ' ' PHE . 52.2 p90 -65.82 -20.78 66.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 117.211 0.505 . . . . 75.510000000000005 111.678 -173.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -71.69 -40.84 69.28 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.68 -0.489 . . . . 63.32 109.68 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -72.44 -42.87 64.56 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 115.779 -0.646 . . . . 73.530000000000001 110.961 -177.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.522 HG12 ' O ' ' A' ' 38' ' ' GLY . 34.3 mm -59.12 -29.8 42.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 115.815 -0.63 . . . . 64.129999999999995 111.24 -178.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 55.9 tp -57.5 -31.13 65.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.729 -0.668 . . . . 70.219999999999999 111.843 -176.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.4 tp60 -64.16 -27.09 68.84 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.561 0.219 . . . . 70.129999999999995 111.415 -176.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.85 -54.82 7.14 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.443 -0.577 . . . . 70.219999999999999 109.443 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -62.98 -51.71 65.82 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 115.898 -0.592 . . . . 63.310000000000002 111.381 -176.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.02 -28.79 66.89 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.338 -0.392 . . . . 75.040000000000006 110.698 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.36 -44.86 72.29 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.902 -0.59 . . . . 70.030000000000001 112.412 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.676 ' HB3' ' HE3' ' A' ' 51' ' ' LYS . 77.8 mt-30 -80.52 -15.74 55.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 110.774 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 78.11 51.31 5.82 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.974 -0.632 . . . . 61.210000000000001 112.554 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.676 ' HE3' ' HB3' ' A' ' 49' ' ' GLN . 14.2 ptpt -147.79 178.35 8.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 120.6 0.238 . . . . 63.049999999999997 110.956 -177.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.4 m -125.72 154.5 73.16 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-O 120.865 0.364 . . . . 62.149999999999999 111.391 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -80.54 -171.9 1.37 Allowed 'Trans proline' 0 N--CA 1.461 -0.418 0 C-N-CA 123.301 2.668 . . . . 65.140000000000001 112.319 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.784 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 35.9 t -95.08 -24.88 16.68 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.838 -0.619 . . . . 63.43 110.23 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.05 -170.73 36.31 Favored Glycine 0 N--CA 1.443 -0.887 0 C-N-CA 121.006 -0.616 . . . . 60.210000000000001 111.636 -179.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_exo -72.35 160.36 47.16 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 123.01 2.473 . . . . 74.109999999999999 112.07 179.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.918 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 26.7 Cg_endo -62.77 147.91 94.08 Favored 'Trans proline' 0 C--O 1.237 0.432 0 C-N-CA 122.825 2.35 . . . . 61.25 112.537 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -126.84 154.62 44.11 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.014 -0.539 . . . . 74.329999999999998 110.122 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -104.47 109.56 21.49 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 109.515 -0.55 . . . . 75.430000000000007 109.515 175.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.557 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 54.8 ttt180 -96.48 121.95 38.85 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.036 -0.529 . . . . 64.140000000000001 109.824 177.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.98 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 75.2 m-85 -108.89 110.23 21.52 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-N 116.03 -0.532 . . . . 70.239999999999995 110.669 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.683 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.4 t80 -113.37 98.69 7.25 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.61 -0.723 . . . . 72.319999999999993 109.504 177.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -138.25 -18.9 0.56 Allowed Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.117 -1.039 . . . . 53.43 113.658 -176.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 92.3 mmm -77.34 -9.77 59.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.316 0.558 . . . . 72.25 111.335 -177.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 62' ' ' PHE . 47.5 m -128.5 32.39 4.85 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.322 0.582 . . . . 63.310000000000002 110.162 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.87 153.98 27.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.661 -0.7 . . . . 62.549999999999997 110.389 -179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -86.26 -47.68 4.85 Favored Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 111.045 -0.822 . . . . 70.25 111.045 175.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.7 m -85.97 134.08 33.89 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.61 -0.885 . . . . 72.340000000000003 108.61 173.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.569 ' HE2' ' HD1' ' A' ' 61' ' ' TYR . 23.3 t80 -79.91 118.14 21.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.187 0.518 . . . . 71.409999999999997 111.332 -169.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.683 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 3.9 tp10 -92.64 131.8 37.43 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.145 -0.934 . . . . 72.230000000000004 110.359 -176.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 29.3 m -130.7 136.55 58.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.442 0.639 . . . . 71.019999999999996 111.197 176.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.712 ' HB3' HD22 ' A' ' 21' ' ' LEU . 49.7 mt-10 -121.46 97.05 5.33 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.466 -0.788 . . . . 71.219999999999999 109.507 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.484 ' HE2' ' HB3' ' A' ' 39' ' ' TYR . 42.0 t80 -78.59 -2.72 40.31 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.667 -0.697 . . . . 70.25 112.384 -178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 1.072 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -68.39 -168.85 5.03 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 120.782 -0.723 . . . . 72.010000000000005 113.976 -175.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.918 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 7.6 p90 -150.6 158.7 35.44 Favored Pre-proline 0 C--N 1.326 -0.42 0 O-C-N 122.677 -0.308 . . . . 74.349999999999994 111.195 -175.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.892 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 15.5 Cg_exo -68.64 156.52 65.23 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.87 2.38 . . . . 73.409999999999997 112.063 178.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 81' ' ' VAL . 30.7 m -133.25 148.84 31.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 120.825 0.345 . . . . 50.140000000000001 111.146 -177.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.591 ' HG3' ' CB ' ' A' ' 54' ' ' SER . 45.4 mt-10 -118.45 -44.54 2.66 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.491 -0.322 . . . . 73.5 111.803 -178.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -77.85 58.95 3.86 Favored Glycine 0 C--N 1.329 0.162 0 C-N-CA 120.981 -0.628 . . . . 72.099999999999994 114.072 -171.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.0 49.74 35.18 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.65 -0.309 . . . . 54.43 112.961 175.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.504 ' CG2' ' HB ' ' A' ' 77' ' ' VAL . 3.9 t -89.91 145.48 7.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.924 -0.398 . . . . 65.120000000000005 109.924 -177.433 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -136.11 149.07 48.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 109.343 -0.614 . . . . 75.519999999999996 109.343 -173.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -93.32 130.04 10.15 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 121.05 -0.595 . . . . 73.209999999999994 112.529 -173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.3 t -118.52 96.88 5.48 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 120.907 0.384 . . . . 72.430000000000007 111.028 -175.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.49 -98.84 1.29 Allowed Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.977 -0.556 . . . . 75.519999999999996 113.478 174.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.408 ' HG3' HD12 ' A' ' 22' ' ' ILE . 66.3 ttt180 -65.14 -63.04 1.2 Allowed 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 122.694 0.398 . . . . 71.230000000000004 111.115 -177.474 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 42.4 t -85.32 108.82 17.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 109.578 -0.527 . . . . 64.150000000000006 109.578 177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.59 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.1 m -108.5 -178.36 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.105 0.478 . . . . 74.299999999999997 111.331 -175.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.444 HG23 HD12 ' A' ' 20' ' ' LEU . 2.3 m -93.53 154.53 17.83 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.788 -0.642 . . . . 74.030000000000001 109.939 177.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -152.37 173.88 31.39 Favored Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 111.432 -0.667 . . . . 41.229999999999997 111.432 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 96.0 mt -134.85 150.26 50.44 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 110.003 -0.369 . . . . 74.200000000000003 110.003 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.3 p -80.76 144.56 56.21 Favored Pre-proline 0 C--N 1.318 -0.765 0 CA-C-N 116.273 -0.421 . . . . 71.019999999999996 110.442 177.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_endo -64.95 138.09 55.82 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.594 2.196 . . . . 70.230000000000004 112.19 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.42 ' OG ' ' HG3' ' A' ' 16' ' ' PRO . 22.2 m -83.15 132.28 35.09 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 52.119999999999997 110.368 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 149.15 -173.03 29.14 Favored Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.396 -0.682 . . . . 55.409999999999997 111.396 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.638 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -116.47 153.65 31.75 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.893 0.378 . . . . 74.439999999999998 111.337 -179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -152.78 172.23 17.02 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.051 -0.522 . . . . 75.349999999999994 110.858 -179.563 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.84 ' H ' HD22 ' A' ' 155' ' ' LEU . . . -95.36 115.15 27.04 Favored 'General case' 0 C--O 1.24 0.565 0 CA-C-O 121.087 0.47 . . . . 64.340000000000003 110.269 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 25.1 m -122.17 141.02 51.87 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.232 -0.894 . . . . 72.430000000000007 110.354 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.44 ' HB2' ' HB3' ' A' ' 9' ' ' CYS . 22.6 t -133.62 148.39 51.55 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.257 -0.645 . . . . 52.200000000000003 109.257 177.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.4 mp -97.98 118.81 35.4 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.781 0.324 . . . . 75.129999999999995 110.573 -178.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 2.4 t80 -92.3 112.44 24.38 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.019 -0.734 . . . . 75.430000000000007 109.019 174.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.635 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.8 mp -101.34 120.5 50.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.588 -0.278 . . . . 70.230000000000004 110.474 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 116.14 -154.86 16.6 Favored Glycine 0 CA--C 1.518 0.272 0 C-N-CA 120.61 -0.805 . . . . 73.099999999999994 112.81 175.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.97 110.37 0.84 Allowed 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.098 2.532 . . . . 63.420000000000002 112.279 179.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 33.6 t80 -96.87 139.99 32.09 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.475 -0.784 . . . . 54.130000000000003 110.312 -173.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 177.42 -41.36 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.564 -0.827 . . . . 31.239999999999998 112.666 178.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.409 ' HG2' ' O ' ' A' ' 108' ' ' GLU . 0.5 OUTLIER -98.85 110.41 23.02 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.52 0.676 . . . . 61.119999999999997 111.083 -179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.421 HG22 ' HB2' ' A' ' 113' ' ' TYR . 28.1 mm -66.31 -36.91 78.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.435 -0.802 . . . . 73.430000000000007 110.84 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -49.13 -40.23 31.62 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.974 -0.557 . . . . 73.230000000000004 112.247 -174.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.81 -52.05 65.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.722 0.296 . . . . 63.439999999999998 111.589 -177.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 15.0 p -79.02 -28.68 13.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.026 0.441 . . . . 75.040000000000006 110.806 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.748 ' CD2' HD13 ' A' ' 153' ' ' LEU . 27.0 t80 -61.44 -46.8 88.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.801 -0.636 . . . . 72.030000000000001 109.982 178.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -68.31 -36.06 78.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.693 -0.685 . . . . 63.119999999999997 110.564 -178.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -60.85 -47.18 87.54 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.743 -0.662 . . . . 61.240000000000002 111.668 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.823 HD21 HD12 ' A' ' 153' ' ' LEU . 4.3 pp -75.2 -28.11 59.86 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.759 -0.376 . . . . 73.200000000000003 110.709 179.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.431 ' HA ' ' CE ' ' A' ' 117' ' ' MET . 0.3 OUTLIER -57.27 -47.12 82.24 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.002 -0.545 . . . . 62.109999999999999 110.492 177.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -56.82 -45.86 82.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.37 -0.377 . . . . 72.430000000000007 111.817 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.512 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 91.4 t90 -65.49 -49.78 67.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 111.402 -175.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 1.019 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.3 p -70.06 -36.01 66.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 C-N-CA 120.932 -0.307 . . . . 75.230000000000004 110.71 -176.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -58.37 -33.54 69.7 Favored 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 116.053 -0.521 . . . . 71.219999999999999 110.924 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -72.34 -45.6 59.18 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.989 -0.55 . . . . 72.439999999999998 111.348 178.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -82.25 -37.37 26.03 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.062 -0.517 . . . . 72.120000000000005 112.253 -172.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.49 63.02 1.81 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.835 -0.698 . . . . 53.310000000000002 112.434 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.497 ' HB2' HG23 ' A' ' 120' ' ' VAL . 32.3 m-85 -103.17 167.25 9.94 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.251 -0.277 . . . . 73.340000000000003 110.251 178.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -130.76 127.04 37.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.641 0.734 . . . . 72.349999999999994 112.923 -172.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.674 ' HG ' ' H ' ' A' ' 129' ' ' GLY . 40.6 tp -147.6 147.29 29.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 114.786 -1.097 . . . . 73.230000000000004 108.377 164.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 18.3 m -56.21 -35.54 67.43 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.985 0.421 . . . . 73.109999999999999 110.196 174.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.674 ' H ' ' HG ' ' A' ' 127' ' ' LEU . . . 111.45 69.62 0.57 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.36 -0.924 . . . . 63.229999999999997 113.486 175.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -94.25 142.22 27.65 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.641 -0.874 . . . . 73.239999999999995 108.641 172.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.98 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -105.02 135.43 46.37 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.669 -0.412 . . . . 71.530000000000001 111.061 -176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 63.5 t80 -139.13 112.45 8.16 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.306 -0.406 . . . . 74.140000000000001 110.878 -175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.434 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.4 mt-10 -116.59 119.85 36.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.689 -0.232 . . . . 73.340000000000003 110.464 176.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 149' ' ' THR . 12.9 tt -96.48 122.69 48.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 120.974 0.416 . . . . 65.209999999999994 110.558 177.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 74.5 m-85 -106.42 106.86 17.59 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.812 0.339 . . . . 74.299999999999997 110.777 -176.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.523 ' H ' HD12 ' A' ' 136' ' ' LEU . 5.5 mp -63.27 -70.17 0.23 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.839 -0.619 . . . . 72.329999999999998 110.684 -178.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 5.3 t70 179.6 -162.49 0.04 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 108.307 -0.997 . . . . 65.5 108.307 178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.463 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 7.3 t30 -74.62 141.79 76.57 Favored Pre-proline 0 C--N 1.326 -0.414 0 N-CA-C 109.822 -0.436 . . . . 54.310000000000002 109.822 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 6.3 Cg_exo -75.03 167.2 27.54 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.818 2.345 . . . . 73.530000000000001 113.047 -178.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 68.34 17.57 9.21 Favored 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.402 -0.817 . . . . 74.319999999999993 112.056 172.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -136.74 -67.62 0.5 Allowed 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.924 -0.311 . . . . 65.230000000000004 110.411 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -71.08 -32.82 69.56 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.435 -0.348 . . . . 71.120000000000005 111.562 -170.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.643 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -169.88 85.72 0.58 Allowed Pre-proline 0 C--N 1.324 -0.5 0 CA-C-N 116.486 -0.324 . . . . 71.519999999999996 110.3 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -58.96 125.4 18.1 Favored 'Trans proline' 0 N--CA 1.46 -0.493 0 C-N-CA 122.667 2.245 . . . . 71.109999999999999 112.129 -177.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 21.6 t70 76.13 -15.89 0.66 Allowed 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 114.606 -1.179 . . . . 72.430000000000007 111.77 -179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.643 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 2.1 mp0 -86.99 -2.39 58.59 Favored 'General case' 0 C--N 1.327 -0.405 0 O-C-N 121.927 -0.483 . . . . 54.200000000000003 111.339 -179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 3.7 mp -69.29 99.63 1.21 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.304 0.574 . . . . 75.129999999999995 110.431 176.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.635 ' HG2' HG13 ' A' ' 103' ' ' ILE . 50.9 mtm180 -117.3 116.18 26.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.09 -0.959 . . . . 75.299999999999997 109.476 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 134' ' ' ILE . 23.5 m -98.85 105.02 17.12 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 120.976 0.417 . . . . 52.420000000000002 110.181 -179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 15.7 ttm180 -78.87 99.08 6.6 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.705 . . . . 74.109999999999999 109.367 176.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.526 ' O ' ' HA ' ' A' ' 99' ' ' SER . 11.2 p -99.47 129.99 49.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 121.126 0.489 . . . . 63.009999999999998 110.638 -178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.691 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 36.3 t -104.4 125.76 50.9 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.415 -0.957 . . . . 71.109999999999999 108.415 176.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.823 HD12 HD21 ' A' ' 116' ' ' LEU . 61.4 mt -136.4 178.49 7.03 Favored 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 120.14 -0.624 . . . . 55.009999999999998 112.556 -171.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 69.7 mtp -62.84 104.06 0.51 Allowed 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.353 -0.84 . . . . 73.230000000000004 111.315 -178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 1.019 ' HB2' HG21 ' A' ' 120' ' ' VAL . 0.9 OUTLIER -98.77 45.85 1.0 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.652 0.739 . . . . 52.149999999999999 112.155 -176.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 16.4 p80 -135.85 -50.2 0.71 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.336 -0.847 . . . . 62.539999999999999 110.956 174.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -150.71 139.05 20.35 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.626 -0.509 . . . . 73.450000000000003 109.626 -177.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 p -81.41 90.52 6.19 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 120.695 0.284 . . . . 73.209999999999994 110.958 -179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.6 mp -89.02 -6.66 57.02 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.973 0.416 . . . . 72.299999999999997 110.405 176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.92 99.14 7.44 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 116.006 -0.543 . . . . 43.299999999999997 109.902 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -117.61 108.32 15.31 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.989 -0.55 . . . . 72.140000000000001 110.14 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.7 m80 -142.04 -170.63 3.19 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.573 -0.739 . . . . 73.219999999999999 110.206 -179.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.4 p80 -143.68 39.02 1.37 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 108.073 -1.084 . . . . 65.230000000000004 108.073 171.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 22.3 t-160 -73.48 -4.5 34.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 114.064 -1.425 . . . . 74.019999999999996 110.584 -175.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -60.39 164.74 4.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.932 0.396 . . . . 60.450000000000003 110.439 172.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 . . . . . 0 C--O 1.246 0.909 0 CA-C-O 118.811 -0.614 . . . . 52.049999999999997 109.383 178.613 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.4 tpp . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.111 -0.329 . . . . 72.150000000000006 110.111 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 t70 66.79 -162.85 0.23 Allowed 'General case' 0 N--CA 1.467 0.38 0 O-C-N 123.783 0.677 . . . . 73.439999999999998 109.325 -178.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.7 t80 -88.62 109.69 20.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.444 -0.206 . . . . 74.040000000000006 110.444 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 71.77 160.72 0.23 Allowed 'General case' 0 CA--C 1.537 0.469 0 O-C-N 123.529 0.518 . . . . 70.420000000000002 111.278 176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 66.2 m -73.73 114.52 12.09 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.239 -0.437 . . . . 44.43 109.968 177.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -110.88 93.31 4.42 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.137 -0.483 . . . . 63.210000000000001 111.196 -174.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -90.62 92.85 9.02 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.056 -0.52 . . . . 55.43 109.943 177.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 50.0 t -71.6 106.66 2.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.178 -0.464 . . . . 61.43 110.378 -179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 57.8 m -88.29 114.88 25.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.751 -0.463 . . . . 54.409999999999997 109.751 179.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.27 156.65 44.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.033 0.444 . . . . 74.329999999999998 110.433 -176.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.62 HD11 ' HB3' ' A' ' 96' ' ' LYS . 57.4 tp -91.22 115.46 28.04 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.961 -0.563 . . . . 74.310000000000002 110.101 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HA ' ' HE3' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -107.26 126.09 51.98 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.19 -0.459 . . . . 64.340000000000003 110.022 177.451 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -88.37 121.05 30.32 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.464 -0.569 . . . . 65.299999999999997 109.464 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.595 ' O ' ' HA ' ' A' ' 94' ' ' SER . 97.9 mt -70.31 111.04 5.61 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.985 -0.552 . . . . 63.409999999999997 110.479 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.417 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -86.35 148.77 47.87 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 115.653 -0.703 . . . . 64.150000000000006 109.781 178.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.439 ' HA ' ' O ' ' A' ' 92' ' ' THR . 1.3 Cg_endo -80.3 101.48 1.34 Allowed 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.564 2.176 . . . . 71.25 111.446 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 62.3 t -125.21 140.99 37.41 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 116.091 -0.504 . . . . 73.120000000000005 110.068 -176.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 13.7 Cg_exo -70.98 130.24 17.54 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.817 2.345 . . . . 75.230000000000004 112.509 177.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.64 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -139.01 155.89 47.63 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 63.520000000000003 110.194 177.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 10.6 mp -103.06 122.56 44.9 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.205 0.526 . . . . 75.109999999999999 109.632 175.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -153.0 172.76 16.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.685 -0.689 . . . . 54.43 111.686 -173.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.484 HD13 ' O ' ' A' ' 86' ' ' ARG . 3.2 tp -134.11 136.85 52.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.224 -0.898 . . . . 72.340000000000003 108.987 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 43.6 mtm105 -79.8 124.3 28.5 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 109.531 -0.544 . . . . 74.25 109.531 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.758 HG21 HD21 ' A' ' 34' ' ' LEU . 27.8 m -130.69 120.98 24.69 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 116.04 -0.527 . . . . 73.420000000000002 110.613 -179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.515 ' H ' ' HG3' ' A' ' 25' ' ' GLN . 1.5 pp0? -80.01 117.06 20.51 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.086 -0.709 . . . . 60.039999999999999 109.086 172.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 12.2 t -91.41 148.57 22.22 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.298 -0.865 . . . . 72.219999999999999 111.822 -169.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -87.74 -174.77 4.9 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.55 -0.75 . . . . 71.420000000000002 109.581 173.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 66.6 mtt -74.73 -37.11 62.62 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.87 0.322 . . . . 73.310000000000002 111.87 -174.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.5 t -147.72 35.97 0.86 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.829 0.347 . . . . 51.119999999999997 111.036 -177.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -105.22 15.62 27.1 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.446 0.641 . . . . 75.209999999999994 110.504 -179.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 7.6 mp -64.99 -30.87 71.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.822 -0.626 . . . . 72.129999999999995 111.944 -174.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -58.75 -67.29 2.26 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 121.188 -0.529 . . . . 53.399999999999999 113.152 -174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 20.0 m -67.24 -30.41 70.3 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.655 0.264 . . . . 52.32 111.324 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.758 HD21 HG21 ' A' ' 24' ' ' THR . 4.8 tt -65.1 -56.64 11.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.384 -0.371 . . . . 70.400000000000006 110.652 -177.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -69.94 -39.87 75.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.455 -0.339 . . . . 73.530000000000001 111.612 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -60.41 -57.8 11.22 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.861 0.362 . . . . 73.540000000000006 110.835 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -64.58 -39.75 94.31 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-N 116.094 -0.503 . . . . 63.329999999999998 110.534 179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.495 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -54.03 -51.61 48.89 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 115.584 -0.735 . . . . 73.420000000000002 112.869 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -56.49 -42.88 79.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.887 0.343 . . . . 74.519999999999996 111.442 -178.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 31.5 m-70 -72.45 -32.37 66.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.871 0.367 . . . . 63.100000000000001 111.213 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -81.08 -34.33 32.74 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.918 -0.583 . . . . 75.010000000000005 111.877 -175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.599 ' HB ' HG21 ' A' ' 87' ' ' VAL . 39.2 pt -85.89 163.92 2.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.146 0.498 . . . . 60.210000000000001 111.816 -176.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.636 ' HG ' ' HB3' ' A' ' 46' ' ' LEU . 16.9 tp 61.0 26.19 16.17 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 114.973 -1.012 . . . . 61.350000000000001 110.896 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 33.6 tt0 -67.05 -23.56 65.89 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.906 -0.588 . . . . 74.530000000000001 110.665 -176.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.56 ' O ' ' HB2' ' A' ' 49' ' ' GLN . 8.9 tt -70.99 -23.4 62.18 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 60.530000000000001 110.548 177.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.636 ' HB3' ' HG ' ' A' ' 43' ' ' LEU . 6.9 tt -95.36 -56.02 2.85 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.306 0.574 . . . . 62.149999999999999 109.677 178.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -57.36 -41.66 80.54 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.024 -0.989 . . . . 74.439999999999998 111.322 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.43 12.51 62.69 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.877 -0.678 . . . . 54.439999999999998 112.288 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.56 ' HB2' ' O ' ' A' ' 45' ' ' LEU . 8.9 tt0 -103.77 -21.07 13.74 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.712 -0.477 . . . . 61.450000000000003 109.712 176.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.97 14.81 19.98 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 62.32 113.598 176.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -106.0 172.52 6.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.372 0.586 . . . . 72.450000000000003 110.459 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.411 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 9.8 p -111.71 149.67 41.11 Favored Pre-proline 0 C--N 1.318 -0.763 0 CA-C-N 115.911 -0.586 . . . . 74.230000000000004 110.609 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HB3' ' HE2' ' A' ' 75' ' ' PHE . 15.7 Cg_exo -68.76 160.88 47.76 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.913 2.409 . . . . 74.420000000000002 112.026 178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.0 t -74.79 -20.85 59.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.265 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 175.92 -164.52 34.65 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 111.578 -0.609 . . . . 62.439999999999998 111.578 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.3 167.75 26.1 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 74.219999999999999 112.278 179.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.481 ' HA ' ' CD1' ' A' ' 75' ' ' PHE . 17.3 Cg_exo -66.86 141.4 58.84 Favored 'Trans proline' 0 C--O 1.237 0.46 0 C-N-CA 122.741 2.294 . . . . 73.129999999999995 112.484 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.472 ' HD1' ' HB ' ' A' ' 134' ' ' ILE . 25.0 m-85 -123.13 117.23 24.92 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.477 -0.564 . . . . 62.219999999999999 109.477 178.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -97.69 110.62 23.15 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 110.758 -176.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.1 ptm180 -97.12 141.22 30.52 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.259 -0.645 . . . . 74.109999999999999 109.259 175.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.712 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 82.8 m-85 -114.87 110.51 19.77 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.939 -0.573 . . . . 73.239999999999995 110.39 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -117.24 148.26 41.8 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-O 121.291 0.567 . . . . 63.229999999999997 111.257 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 110.86 -58.53 0.39 Allowed Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.585 -0.734 . . . . 55.020000000000003 112.259 176.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.668 ' H ' ' HE1' ' A' ' 69' ' ' PHE . 24.9 mmt 55.92 71.69 0.54 Allowed 'General case' 0 CA--C 1.52 -0.197 0 CA-C-O 121.48 0.657 . . . . 65.239999999999995 110.799 -176.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 25.2 m -145.45 158.08 43.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.412 -0.813 . . . . 74.209999999999994 109.348 -179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.93 137.01 33.37 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.871 0.367 . . . . 44.130000000000003 110.498 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 90.01 -74.26 1.87 Allowed Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.731 -0.747 . . . . 71.109999999999999 112.077 -179.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 31.1 m -94.95 126.63 40.42 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 75.230000000000004 110.461 178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.668 ' HE1' ' H ' ' A' ' 64' ' ' MET . 4.0 t80 -144.4 130.53 19.56 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.909 -0.587 . . . . 62.329999999999998 109.628 -176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.1 tp10 -91.76 121.74 33.67 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 110.24 -0.282 . . . . 54.539999999999999 110.24 -173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.551 HG22 ' O ' ' A' ' 24' ' ' THR . 14.1 m -127.17 135.74 62.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.097 0.475 . . . . 43.329999999999998 110.924 178.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.547 ' OE1' ' HD3' ' A' ' 60' ' ' ARG . 88.6 mt-10 -126.82 98.32 5.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.849 -0.614 . . . . 65.409999999999997 109.628 176.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.532 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 23.1 p90 -77.85 -0.55 27.73 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.525 -0.761 . . . . 74.510000000000005 112.648 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -62.86 -170.39 1.24 Allowed Glycine 0 CA--C 1.527 0.812 0 C-N-CA 121.442 -0.409 . . . . 72.150000000000006 113.859 -176.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' HE2' ' HB3' ' A' ' 53' ' ' PRO . 16.6 p90 -162.69 156.01 17.13 Favored Pre-proline 0 C--N 1.328 -0.348 0 O-C-N 122.342 -0.505 . . . . 75.340000000000003 111.473 -176.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 20.5 Cg_endo -61.53 164.05 16.53 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.887 2.391 . . . . 73.439999999999998 112.431 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 19.2 m -116.19 178.88 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.196 0.522 . . . . 72.099999999999994 111.624 -173.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.5 tm-20 -67.42 -31.27 71.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.327 -0.851 . . . . 65.540000000000006 110.563 -178.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 105.91 96.73 2.46 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.565 -0.826 . . . . 62.439999999999998 112.014 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 128.22 24.74 1.13 Allowed Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.968 -0.634 . . . . 74.340000000000003 111.582 -177.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 7.6 t -121.16 153.74 24.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.536 -0.542 . . . . 54.210000000000001 109.536 -179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 26.1 mp0 -84.37 166.82 17.06 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.357 -0.383 . . . . 62.520000000000003 110.306 -178.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -67.21 145.35 46.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.77 -0.932 . . . . 64.150000000000006 110.77 172.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.806 ' HB3' ' HB ' ' A' ' 87' ' ' VAL . 1.9 t -89.52 19.87 4.28 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.926 0.363 . . . . 52.450000000000003 110.785 -172.375 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.82 -76.02 0.86 Allowed Glycine 0 C--N 1.333 0.408 0 CA-C-N 116.275 -0.421 . . . . 51.43 112.461 178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.484 ' O ' HD13 ' A' ' 22' ' ' ILE . 39.2 ttm180 -67.15 -34.66 78.03 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.862 -0.792 . . . . 74.420000000000002 108.862 174.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.806 ' HB ' ' HB3' ' A' ' 84' ' ' SER . 57.5 t -98.4 118.05 44.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 114.988 -1.005 . . . . 70.310000000000002 109.512 176.584 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.3 m -102.63 171.9 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.016 0.436 . . . . 75.549999999999997 111.21 -174.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.1 p -92.72 141.15 28.78 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-N 116.052 -0.522 . . . . 54.039999999999999 110.341 177.367 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -151.87 -173.45 21.59 Favored Glycine 0 N--CA 1.447 -0.629 0 N-CA-C 111.224 -0.75 . . . . 72.329999999999998 111.224 178.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.89 159.1 41.63 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 117.169 0.485 . . . . 73.239999999999995 110.369 -179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 1.1 p -86.1 144.15 38.35 Favored Pre-proline 0 C--N 1.319 -0.719 0 CA-C-N 115.945 -0.571 . . . . 62.119999999999997 110.842 176.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -78.71 162.73 26.92 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.523 2.148 . . . . 60.240000000000002 111.861 177.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.595 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 15.3 m -89.2 132.82 34.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.534 -0.303 . . . . 71.25 110.773 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 174.2 174.15 40.8 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.998 -0.62 . . . . 75.299999999999997 111.999 179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.62 ' HB3' HD11 ' A' ' 11' ' ' LEU . 62.3 mmtt -95.75 133.11 40.24 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.97 -0.382 . . . . 73.530000000000001 109.97 -179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.71 143.83 43.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.862 0.363 . . . . 74.450000000000003 111.166 178.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.638 ' HB2' HD21 ' A' ' 155' ' ' LEU . . . -81.83 119.66 24.18 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.526 -0.546 . . . . 44.32 109.526 175.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 9.0 t -126.84 140.34 52.42 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.066 0.46 . . . . 72.109999999999999 110.971 -175.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 8.3 t -158.09 171.37 20.36 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.26 -1.015 . . . . 72.530000000000001 108.26 175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.595 HD22 ' HD3' ' A' ' 148' ' ' ARG . 0.6 OUTLIER -117.13 133.89 55.44 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.695 0.76 . . . . 73.219999999999999 112.373 -177.268 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 34.0 t80 -98.93 126.19 44.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.998 -1.001 . . . . 74.140000000000001 109.361 173.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.606 HG13 ' HG2' ' A' ' 148' ' ' ARG . 4.5 mp -96.65 128.46 47.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.789 0.328 . . . . 72.239999999999995 110.943 -174.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 117.03 -172.32 14.19 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.935 -0.65 . . . . 63.219999999999999 112.56 174.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -71.08 179.86 4.07 Favored 'Trans proline' 0 N--CA 1.463 -0.271 0 C-N-CA 122.77 2.313 . . . . 61.200000000000003 111.472 176.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 80.8 t80 -94.01 134.36 36.49 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.255 0.55 . . . . 62.119999999999997 110.388 -174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 169.04 -80.42 0.1 OUTLIER Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.178 -0.919 . . . . 54.32 111.161 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -88.97 49.1 1.72 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.396 0.617 . . . . 74.299999999999997 110.345 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.1 tt -71.06 -16.44 19.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.763 -0.653 . . . . 54.109999999999999 111.05 -176.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.533 ' HA ' ' HD1' ' A' ' 113' ' ' TYR . 39.3 tt0 -59.13 -22.67 61.24 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 74.219999999999999 111.368 -178.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.6 -37.02 62.6 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.479 -0.328 . . . . 74.540000000000006 111.854 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.616 HG12 ' O ' ' A' ' 109' ' ' ILE . 11.8 p -78.58 -32.31 16.15 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-O 120.787 0.327 . . . . 71.450000000000003 110.814 -178.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.533 ' HD1' ' HA ' ' A' ' 110' ' ' GLU . 97.7 m-85 -68.28 -31.44 70.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.385 0.612 . . . . 73.329999999999998 109.546 176.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -68.74 -22.61 64.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.061 -0.972 . . . . 74.519999999999996 110.697 179.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -87.0 -35.16 18.96 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.143 -0.48 . . . . 74.219999999999999 110.483 176.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 95.0 mt -71.4 -28.81 64.27 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.06 -0.518 . . . . 75.420000000000002 111.602 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.68 -36.66 84.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 111.715 0.265 . . . . 61.140000000000001 111.715 -175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.3 ptmt -77.94 -28.99 49.72 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 120.857 0.36 . . . . 75.310000000000002 110.563 177.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -68.53 -45.95 70.86 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.227 -0.442 . . . . 75.430000000000007 110.561 -176.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 13.5 p -66.38 -36.86 78.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.156 0.503 . . . . 53.549999999999997 110.231 178.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -62.62 -46.51 87.9 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.401 -0.818 . . . . 62.109999999999999 110.503 177.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -62.86 -46.71 86.61 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.922 -0.581 . . . . 40.100000000000001 111.555 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -70.21 -30.02 67.01 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.46 -0.336 . . . . 54.43 111.323 -178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.61 51.74 34.35 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.032 -0.604 . . . . 72.409999999999997 112.488 177.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -136.42 168.95 18.49 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.751 -0.463 . . . . 71.230000000000004 109.751 -177.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.581 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.2 OUTLIER -158.32 144.32 17.06 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.736 0.303 . . . . 63.450000000000003 110.319 176.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 127' ' ' LEU . 19.8 mt -146.15 143.78 29.53 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.103 -0.499 . . . . 74.329999999999998 109.873 174.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 16.3 m -110.02 65.76 0.62 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.135 0.493 . . . . 65.030000000000001 110.226 -179.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -99.52 -104.42 2.56 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.843 -0.694 . . . . 71.519999999999996 112.212 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -151.24 170.55 19.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.65 0.262 . . . . 72.549999999999997 110.307 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.712 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -101.02 150.95 22.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.463 -0.569 . . . . 74.150000000000006 109.463 174.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 69.9 t80 -143.11 108.31 4.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.126 0.488 . . . . 72.219999999999999 110.152 -177.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -120.83 118.68 30.6 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.62 -0.718 . . . . 74.349999999999994 110.691 -173.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.667 HG12 ' HB2' ' A' ' 150' ' ' ARG . 5.6 pt -91.0 151.17 3.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 C-N-CA 120.792 -0.363 . . . . 74.239999999999995 110.584 -179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -116.47 173.58 6.53 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 110.001 -0.37 . . . . 73.450000000000003 110.001 175.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -118.51 -176.94 3.18 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.119 -0.326 . . . . 71.200000000000003 110.119 179.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' CG ' ' H ' ' A' ' 138' ' ' ASN . 7.0 t70 -90.01 -163.43 1.01 Allowed 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.625 -0.509 . . . . 43.020000000000003 109.625 179.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.434 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 33.7 m-80 -71.83 146.88 91.17 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.794 0.33 . . . . 72.129999999999995 111.27 -175.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 16.5 Cg_exo -67.15 152.44 79.77 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 122.192 1.928 . . . . 70.129999999999995 110.652 174.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 61.57 1.37 0.57 Allowed 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.335 0.494 . . . . 54.32 112.335 -177.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.66 -38.66 9.43 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.935 0.398 . . . . 75.420000000000002 110.376 178.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.0 t -142.26 -41.06 0.34 Allowed 'General case' 0 N--CA 1.45 -0.463 0 CA-C-N 116.254 -0.43 . . . . 72.219999999999999 112.036 -178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.669 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . -147.12 86.14 6.63 Favored Pre-proline 0 C--N 1.329 -0.295 0 N-CA-C 112.199 0.444 . . . . 44.100000000000001 112.199 -174.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 146' ' ' GLN . 59.5 Cg_endo -74.21 129.38 13.03 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.405 2.07 . . . . 71.450000000000003 111.281 174.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 28.7 t70 71.34 -16.1 0.39 Allowed 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 115.48 -0.782 . . . . 75.25 111.457 -178.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.669 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 50.5 mt-30 -98.51 14.1 29.49 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.346 0.593 . . . . 65.430000000000007 109.937 -175.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 94.8 mt -67.99 104.01 1.64 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.016 -0.993 . . . . 43.140000000000001 109.256 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.606 ' HG2' HG13 ' A' ' 103' ' ' ILE . 82.6 mtt180 -116.87 126.96 53.8 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.222 -0.445 . . . . 71.349999999999994 110.968 -175.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 33.5 m -100.4 105.6 17.11 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.698 -0.683 . . . . 53.310000000000002 109.938 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.667 ' HB2' HG12 ' A' ' 134' ' ' ILE . 95.2 mtt180 -74.85 111.47 10.09 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.395 -0.366 . . . . 64.140000000000001 110.082 176.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 99' ' ' SER . 6.5 p -99.1 133.02 43.34 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.605 -0.725 . . . . 54.119999999999997 109.711 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.2 m -129.4 118.43 22.18 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.488 -0.931 . . . . 71.120000000000005 108.488 177.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 40.5 tp -124.78 156.76 37.22 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-O 121.28 0.562 . . . . 73.510000000000005 111.739 -169.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.507 ' SD ' ' HG3' ' A' ' 64' ' ' MET . 57.0 mtp -61.18 140.69 57.87 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 114.901 -1.045 . . . . 73.540000000000006 110.335 174.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.638 HD21 ' HB2' ' A' ' 98' ' ' ALA . 94.6 mt -82.41 -1.36 49.78 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.145 -0.48 . . . . 72.430000000000007 110.965 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.581 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 37.7 t60 -83.39 70.71 10.24 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.208 -0.664 . . . . 73.400000000000006 109.208 176.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 72.49 149.64 0.1 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 124.174 0.921 . . . . 45.039999999999999 110.864 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 46.7 t -79.19 90.75 4.91 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.205 -0.452 . . . . 70.310000000000002 110.562 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 10.9 mp -85.78 -176.47 6.03 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.061 -0.518 . . . . 75.010000000000005 110.102 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 5.9 mm-40 50.7 83.91 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.004 -0.998 . . . . 74.319999999999993 112.86 -178.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 13.2 m-70 -119.07 44.96 2.2 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.659 -1.155 . . . . 74.349999999999994 108.051 172.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 55.3 t60 -60.93 104.8 0.4 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.208 -1.36 . . . . 62.450000000000003 111.732 -172.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.8 m80 -92.05 -178.58 5.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.623 -0.717 . . . . 71.010000000000005 109.682 176.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 25.9 p80 -139.88 156.97 46.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.004 -0.369 . . . . 63.439999999999998 110.004 174.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 3.0 p80 -94.32 163.82 13.27 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.379 -0.601 . . . . 63.299999999999997 109.379 175.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 39.8 t60 . . . . . 0 C--O 1.245 0.816 0 CA-C-O 118.38 -0.819 . . . . 73.310000000000002 110.123 177.699 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 mpt? . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.437 0.161 . . . . 75.0 111.334 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -101.32 -49.82 3.95 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-O 121.129 0.49 . . . . 64.129999999999995 110.151 179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.57 159.54 26.81 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.486 -0.779 . . . . 70.400000000000006 110.512 179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -62.97 139.49 58.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.122 -0.49 . . . . 64.340000000000003 110.704 178.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 56.7 m -87.17 -179.43 6.44 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.635 -0.711 . . . . 52.229999999999997 110.899 -176.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 115' ' ' ALA . 27.3 mt-30 55.73 69.92 0.69 Allowed 'General case' 0 C--O 1.231 0.091 0 CA-C-N 115.896 -0.593 . . . . 74.120000000000005 111.094 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.406 ' HB3' ' HA ' ' A' ' 112' ' ' VAL . 28.9 t80 -81.36 133.95 35.5 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.63 -0.507 . . . . 74.540000000000006 109.63 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -54.45 129.77 15.84 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-O 121.498 0.666 . . . . 71.099999999999994 112.284 -176.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 7.5 p -126.47 159.53 33.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.545 -0.752 . . . . 54.109999999999999 110.498 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -150.35 165.94 31.54 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.35 -0.386 . . . . 74.540000000000006 110.605 -179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.807 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 31.3 tp -92.2 115.04 27.74 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.752 -0.833 . . . . 74.239999999999995 108.752 174.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp -115.85 144.53 43.89 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-O 120.956 0.408 . . . . 63.520000000000003 111.2 -174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -85.31 123.64 31.02 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.78 -0.645 . . . . 70.299999999999997 109.506 176.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.403 HD13 ' OH ' ' A' ' 132' ' ' TYR . 95.1 mt -92.0 152.77 19.84 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.178 0.513 . . . . 74.420000000000002 111.486 -177.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -101.92 151.54 38.0 Favored Pre-proline 0 C--N 1.326 -0.433 0 CA-C-N 115.486 -0.779 . . . . 75.540000000000006 110.86 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -81.15 101.47 1.26 Allowed 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.502 2.134 . . . . 71.340000000000003 111.663 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.435 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 47.5 t -87.76 140.35 31.38 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 115.793 -0.64 . . . . 75.230000000000004 109.758 -178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 4.0 Cg_exo -77.84 102.55 1.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.529 2.153 . . . . 74.530000000000001 111.056 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.08 155.17 46.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.29 -0.413 . . . . 75.25 110.797 -176.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' HB3' HG22 ' A' ' 89' ' ' THR . 4.3 pp -111.62 140.26 46.39 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.078 -0.712 . . . . 74.239999999999995 109.078 174.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.452 ' N ' HD13 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -148.73 161.38 41.89 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.475 0.655 . . . . 63.130000000000003 111.74 -176.125 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.626 ' HB ' HG22 ' A' ' 87' ' ' VAL . 5.9 tt -128.91 115.57 37.25 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 114.802 -1.09 . . . . 65.209999999999994 108.408 171.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.771 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 7.3 ptt-85 -81.05 117.61 21.79 Favored 'General case' 0 CA--C 1.508 -0.639 0 CA-C-O 121.803 0.811 . . . . 63.149999999999999 110.75 -177.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.684 HG22 HG23 ' A' ' 26' ' ' THR . 28.1 m -112.54 102.44 10.53 Favored 'General case' 0 N--CA 1.436 -1.126 0 CA-C-N 114.193 -1.367 . . . . 73.430000000000007 110.322 -176.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.759 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -90.7 110.08 21.26 Favored 'General case' 0 C--N 1.312 -1.062 0 CA-C-O 121.83 0.824 . . . . 73.549999999999997 109.852 178.242 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.684 HG23 HG22 ' A' ' 24' ' ' THR . 32.5 p -115.04 143.42 45.22 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 114.788 -1.096 . . . . 61.329999999999998 110.642 -172.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.51 162.48 18.29 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.07 -0.514 . . . . 60.350000000000001 109.768 177.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 28' ' ' MET . 42.1 ttp 67.83 15.61 9.62 Favored 'General case' 0 CA--C 1.536 0.424 0 O-C-N 123.479 0.487 . . . . 74.0 110.867 176.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.5 m 61.07 69.08 0.69 Allowed 'General case' 0 N--CA 1.462 0.164 0 CA-C-O 121.502 0.668 . . . . 75.040000000000006 110.162 -174.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -107.71 19.5 20.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.526 -0.761 . . . . 73.450000000000003 110.069 -175.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 35' ' ' PHE . 10.4 tt -67.66 -48.72 65.87 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.476 -0.784 . . . . 70.540000000000006 111.399 -174.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.19 -69.39 1.08 Allowed Glycine 0 CA--C 1.523 0.557 0 N-CA-C 114.809 0.684 . . . . 63.25 114.809 -171.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -66.2 -34.35 77.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.951 0.405 . . . . 73.129999999999995 111.629 -173.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.653 HD22 HG21 ' A' ' 24' ' ' THR . 7.9 tt -73.26 -39.8 65.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.494 -0.321 . . . . 75.040000000000006 110.343 -176.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.612 ' HB2' ' O ' ' A' ' 31' ' ' LEU . 1.9 t80 -59.14 -42.88 91.71 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.712 -177.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.62 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 41.0 mt-10 -56.95 -51.2 70.12 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 115.705 -0.68 . . . . 64.0 111.125 -179.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.53 -30.66 71.44 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.797 -0.638 . . . . 73.019999999999996 110.816 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -68.84 -55.22 11.56 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.879 -0.601 . . . . 52.299999999999997 113.032 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.62 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 8.7 p90 -74.31 -15.65 60.95 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.989 0.395 . . . . 72.109999999999999 110.85 -175.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -57.05 -38.9 73.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.194 -0.457 . . . . 53.140000000000001 111.069 178.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 46.6 m-20 -82.56 -30.14 29.84 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.049 0.452 . . . . 62.450000000000003 110.698 179.002 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 61.9 mt -70.99 87.89 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.657 0.742 . . . . 63.549999999999997 111.075 -176.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 59.0 tp -173.71 -43.84 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 114.702 -1.135 . . . . 73.25 108.742 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.417 ' O ' ' HA3' ' A' ' 48' ' ' GLY . 28.5 tt0 -69.12 -14.16 62.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.912 -1.04 . . . . 73.019999999999996 110.84 -178.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 tp -74.51 -59.4 2.75 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.042 -0.355 . . . . 72.239999999999995 110.042 176.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.577 HD21 HD21 ' A' ' 20' ' ' LEU . 3.5 mm? -64.93 -56.78 11.23 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.902 0.382 . . . . 71.209999999999994 111.098 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.61 62.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.121 -0.491 . . . . 72.120000000000005 111.321 -175.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.417 ' HA3' ' O ' ' A' ' 44' ' ' GLN . . . -82.19 -40.62 10.07 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.801 -0.714 . . . . 53.039999999999999 112.376 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 81' ' ' VAL . 36.7 tt0 -79.91 -19.88 47.09 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.152 0.501 . . . . 62.450000000000003 110.328 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.15 41.9 4.18 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.946 -0.645 . . . . 53.100000000000001 112.122 179.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.643 ' HG3' HG22 ' A' ' 81' ' ' VAL . 75.7 mmtt -130.17 161.19 31.67 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.192 -0.299 . . . . 75.019999999999996 110.192 -179.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.486 ' H ' ' HB2' ' A' ' 78' ' ' GLU . 15.4 m -132.34 148.61 70.38 Favored Pre-proline 0 C--N 1.323 -0.545 0 N-CA-C 110.208 -0.293 . . . . 72.040000000000006 110.208 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.16 124.51 15.78 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.493 2.129 . . . . 71.230000000000004 112.334 178.023 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.3 t -91.49 49.45 1.59 Allowed 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.822 -0.626 . . . . 71.120000000000005 110.4 -177.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 156.95 -166.3 33.45 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 120.893 -0.67 . . . . 40.009999999999998 111.933 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -92.27 154.05 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 123.058 2.505 . . . . 44.100000000000001 112.331 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.403 ' HB3' ' CD1' ' A' ' 75' ' ' PHE . 46.6 Cg_endo -69.98 159.27 53.85 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 122.529 2.153 . . . . 64.219999999999999 112.365 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.64 ' HD1' HG12 ' A' ' 134' ' ' ILE . 35.1 m-85 -116.27 -179.3 3.63 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.665 -0.414 . . . . 74.0 110.119 -178.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.654 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -151.96 109.58 3.63 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.645 -0.502 . . . . 73.120000000000005 109.645 170.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HB3' ' HB2' ' A' ' 72' ' ' GLU . 38.1 ttm180 -109.74 127.17 54.44 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.069 0.461 . . . . 62.340000000000003 111.679 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -109.19 120.02 41.27 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.357 -0.838 . . . . 73.150000000000006 109.078 171.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.623 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 15.0 t80 -106.55 120.69 42.61 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.209 -0.451 . . . . 65.439999999999998 109.832 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 84.97 57.36 2.28 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.956 -0.64 . . . . 61.219999999999999 112.823 177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.573 ' CE ' ' HA ' ' A' ' 64' ' ' MET . 4.2 mmt -82.59 61.08 5.53 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.974 0.416 . . . . 72.310000000000002 111.089 179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 62.2 m -155.98 17.06 0.36 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.065 -0.516 . . . . 55.530000000000001 110.684 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -148.18 168.24 22.97 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.378 -0.374 . . . . 54.009999999999998 110.324 -178.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -70.46 -22.77 77.83 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.917 -0.659 . . . . 62.030000000000001 111.699 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 28.3 m -97.36 125.89 42.26 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 109.821 -0.437 . . . . 73.340000000000003 109.821 174.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 24.7 p90 -136.87 138.17 40.46 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.133 -0.485 . . . . 63.520000000000003 110.206 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.759 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 23.9 tt0 -97.0 121.4 38.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.891 -0.411 . . . . 74.049999999999997 109.891 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.621 HG22 ' O ' ' A' ' 24' ' ' THR . 29.8 m -105.97 121.66 58.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 121.467 0.651 . . . . 73.450000000000003 111.548 -176.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.771 ' HG2' ' HB3' ' A' ' 23' ' ' ARG . 37.6 mt-10 -121.08 89.24 3.09 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.327 -0.852 . . . . 64.420000000000002 108.889 174.051 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.654 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 5.1 p90 -69.33 -59.83 2.74 Favored 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 120.443 -0.503 . . . . 74.239999999999995 110.21 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.39 132.22 0.25 Allowed Glycine 0 C--O 1.243 0.663 0 C-N-CA 120.556 -0.83 . . . . 24.010000000000002 113.846 174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' HA ' ' HD3' ' A' ' 76' ' ' PRO . 89.4 m-85 -118.94 142.18 31.48 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.786 -0.82 . . . . 52.310000000000002 108.786 172.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 23.7 Cg_exo -65.78 157.05 60.93 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 122.509 2.139 . . . . 55.140000000000001 112.052 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.601 HG12 HD23 ' A' ' 20' ' ' LEU . 21.9 m -115.87 169.32 6.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.263 -0.426 . . . . 74.010000000000005 110.311 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.598 ' HB3' ' HD2' ' A' ' 51' ' ' LYS . 9.9 tp10 -84.19 -63.27 1.37 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.16 0.505 . . . . 74.349999999999994 109.705 178.223 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 164.17 127.46 0.89 Allowed Glycine 0 N--CA 1.446 -0.689 0 N-CA-C 111.082 -0.807 . . . . 34.229999999999997 111.082 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.23 26.06 55.94 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.605 -0.807 . . . . 71.099999999999994 111.643 -178.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.643 HG22 ' HG3' ' A' ' 51' ' ' LYS . 15.1 t -89.65 156.79 3.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 109.931 -0.396 . . . . 73.109999999999999 109.931 -178.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -118.88 -166.85 1.29 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.686 -0.234 . . . . 72.219999999999999 110.568 179.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.03 -168.5 12.66 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.698 -0.763 . . . . 72.230000000000004 112.684 -178.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.9 p -160.43 119.68 2.72 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.921 -0.399 . . . . 72.310000000000002 109.921 -179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 64.78 -119.66 15.95 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.946 -0.645 . . . . 73.040000000000006 112.042 -178.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.585 ' HD2' HG13 ' A' ' 22' ' ' ILE . 17.7 ttm180 -88.26 -14.94 37.15 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.057 0.456 . . . . 53.240000000000002 110.261 179.357 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.626 HG22 ' HB ' ' A' ' 22' ' ' ILE . 19.3 t -78.53 106.56 9.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.136 -0.484 . . . . 74.319999999999993 109.824 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 29.6 m -126.48 152.39 34.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.046 0.45 . . . . 74.120000000000005 111.705 -176.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.696 HG22 ' HB3' ' A' ' 20' ' ' LEU . 23.1 p -81.05 143.8 32.21 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.58 -0.736 . . . . 43.020000000000003 110.685 175.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -163.89 -173.55 32.69 Favored Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.761 -0.733 . . . . 71.439999999999998 112.357 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 90.1 mt -118.81 151.86 37.29 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.766 -0.457 . . . . 64.340000000000003 109.766 178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.5 p -79.98 144.74 59.88 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.606 -0.27 . . . . 74.209999999999994 110.689 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_exo -53.21 129.69 34.68 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.954 2.436 . . . . 73.439999999999998 112.722 -179.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.3 m -92.83 138.19 31.71 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.889 -0.596 . . . . 72.420000000000002 110.134 178.468 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 141.9 -167.56 25.93 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.575 -0.821 . . . . 72.25 111.97 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.668 ' HD2' ' O ' ' A' ' 96' ' ' LYS . 0.0 OUTLIER -79.31 149.51 31.75 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.961 0.41 . . . . 63.340000000000003 112.007 -178.159 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.563 ' HA ' HD21 ' A' ' 155' ' ' LEU . . . -159.8 156.69 27.94 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.907 -0.588 . . . . 71.340000000000003 110.284 175.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 155' ' ' LEU . . . -79.07 101.93 8.12 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.695 -0.483 . . . . 74.340000000000003 109.695 177.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 24.1 m -131.38 143.68 50.66 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.017 -0.538 . . . . 55.140000000000001 110.933 -175.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 46.7 t -151.09 154.67 37.41 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.068 -0.716 . . . . 43.119999999999997 109.068 176.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.724 HD13 HD11 ' A' ' 103' ' ' ILE . 0.3 OUTLIER -104.4 123.84 48.16 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.73 0.776 . . . . 72.450000000000003 111.516 -178.649 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.856 ' HE2' ' HA ' ' A' ' 106' ' ' TYR . 62.4 t80 -89.44 107.31 19.0 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 115.018 -0.992 . . . . 72.150000000000006 109.968 179.135 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.724 HD11 HD13 ' A' ' 101' ' ' LEU . 5.2 mp -94.84 135.81 27.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.376 -0.375 . . . . 62.310000000000002 110.429 -177.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.61 -166.15 12.21 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.715 -0.755 . . . . 64.140000000000001 112.45 175.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.22 149.91 88.86 Favored 'Trans proline' 0 N--CA 1.463 -0.296 0 C-N-CA 122.598 2.199 . . . . 75.530000000000001 111.183 176.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.856 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 59.7 t80 -94.15 134.04 37.02 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.012 0.434 . . . . 73.439999999999998 110.225 -173.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 173.58 -48.66 0.16 Allowed Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 120.741 -0.743 . . . . 72.319999999999993 112.386 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -102.93 83.4 2.22 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.262 0.553 . . . . 72.150000000000006 112.456 -175.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.567 ' O ' HG12 ' A' ' 112' ' ' VAL . 32.9 mm -76.3 -22.88 15.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 108.283 -1.006 . . . . 70.420000000000002 108.283 168.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 23.6 tp10 -55.12 -35.15 64.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 114.905 -1.043 . . . . 65.140000000000001 110.559 175.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.88 -37.01 80.69 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.946 -0.57 . . . . 65.299999999999997 111.67 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.62 HG22 HD23 ' A' ' 116' ' ' LEU . 7.7 p -83.69 -30.47 7.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 120.838 -0.345 . . . . 72.530000000000001 110.247 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -62.52 -37.31 85.56 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.642 0.258 . . . . 74.109999999999999 110.866 176.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -51.45 -41.58 60.95 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.413 -0.812 . . . . 55.149999999999999 111.301 -177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.535 ' HB2' ' HA ' ' A' ' 6' ' ' GLN . . . -94.96 -31.25 13.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.451 -0.34 . . . . 71.450000000000003 111.398 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.62 HD23 HG22 ' A' ' 112' ' ' VAL . 0.1 OUTLIER -53.68 -56.12 20.07 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.041 -0.527 . . . . 75.030000000000001 111.002 -177.402 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 24.3 ptm -63.9 -28.45 69.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 73.109999999999999 111.23 -174.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -73.04 -55.92 5.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.243 -0.651 . . . . 74.329999999999998 109.243 178.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.807 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 88.7 t90 -52.7 -52.48 55.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.238 -0.892 . . . . 72.239999999999995 112.246 -173.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.823 HG23 ' HB2' ' A' ' 125' ' ' PHE . 7.4 p -69.38 -42.96 81.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-N 116.369 -0.378 . . . . 72.329999999999998 111.746 -174.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.408 ' N ' HG13 ' A' ' 120' ' ' VAL . 15.2 t70 -67.3 -42.1 84.29 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.95 -0.568 . . . . 62.240000000000002 111.366 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.32 -33.52 61.15 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 121.19 -0.204 . . . . 75.109999999999999 111.023 -177.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 24.5 m-80 -75.82 -25.99 56.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.055 0.455 . . . . 71.450000000000003 110.548 176.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 36.05 7.53 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.921 -0.657 . . . . 64.310000000000002 113.782 173.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.823 ' HB2' HG23 ' A' ' 120' ' ' VAL . 78.4 m-85 -86.78 147.61 25.76 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.328 -0.619 . . . . 74.329999999999998 109.328 173.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -104.27 171.39 7.36 Favored 'General case' 0 C--N 1.322 -0.6 0 C-N-CA 120.768 -0.373 . . . . 72.409999999999997 111.096 -174.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.79 HD11 ' HA ' ' A' ' 159' ' ' LEU . 65.8 mt -57.47 149.26 21.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.584 -0.735 . . . . 71.430000000000007 112.69 -176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.556 ' HB2' HD23 ' A' ' 155' ' ' LEU . 16.0 t -112.27 1.33 16.08 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.397 -0.82 . . . . 74.420000000000002 109.848 172.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 86.43 -55.18 4.71 Favored Glycine 0 C--N 1.331 0.283 0 CA-C-N 115.819 -0.628 . . . . 73.230000000000004 113.565 175.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -102.35 149.75 24.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.957 0.408 . . . . 71.400000000000006 111.788 -175.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.864 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -129.58 124.28 33.43 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.545 -0.909 . . . . 32.299999999999997 108.545 170.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.448 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 17.3 p90 -142.38 133.43 25.92 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.107 -0.637 . . . . 74.340000000000003 111.529 -177.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.689 ' HB2' ' CE2' ' A' ' 135' ' ' TYR . 1.2 mp0 -97.17 149.08 22.4 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.502 -0.772 . . . . 75.5 109.273 174.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.64 HG12 ' HD1' ' A' ' 58' ' ' PHE . 64.0 mt -104.36 116.82 48.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 109.443 -0.577 . . . . 42.310000000000002 109.443 177.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.689 ' CE2' ' HB2' ' A' ' 133' ' ' GLU . 76.8 m-85 -108.52 105.77 15.56 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.268 0.556 . . . . 51.200000000000003 111.599 -173.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.776 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.17 -165.0 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.528 -0.76 . . . . 75.450000000000003 109.85 173.392 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.471 ' HB2' ' CG2' ' A' ' 142' ' ' THR . 4.1 m-20 -59.67 133.84 56.47 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.018 -0.364 . . . . 74.239999999999995 110.018 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -61.83 156.36 56.63 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.423 -0.353 . . . . 74.329999999999998 111.435 -174.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_exo -47.88 153.01 2.74 Favored 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 123.329 2.686 . . . . 72.209999999999994 113.645 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 73.51 -22.43 0.24 Allowed 'General case' 0 N--CA 1.469 0.51 0 CA-C-N 114.994 -1.003 . . . . 42.149999999999999 112.252 -179.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -86.93 -27.87 23.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.614 0.245 . . . . 74.409999999999997 111.307 -179.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.471 ' CG2' ' HB2' ' A' ' 137' ' ' ASP . 6.6 t -144.83 142.24 29.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.705 -0.225 . . . . 71.230000000000004 110.711 -177.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.712 ' HB1' ' HB2' ' A' ' 146' ' ' GLN . . . 44.33 78.63 0.38 Allowed Pre-proline 0 N--CA 1.467 0.382 0 N-CA-C 113.763 1.023 . . . . 64.239999999999995 113.763 169.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.452 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 28.0 Cg_endo -64.37 133.41 37.42 Favored 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 121.987 1.791 . . . . 73.140000000000001 110.978 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.452 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 24.1 t70 75.09 -27.54 0.19 Allowed 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.357 -0.838 . . . . 74.030000000000001 111.925 -178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.712 ' HB2' ' HB1' ' A' ' 143' ' ' ALA . 23.8 mt-30 -89.67 1.41 56.07 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.971 0.415 . . . . 63.119999999999997 110.345 -178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 143' ' ' ALA . 47.6 mt -61.42 115.05 3.57 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.544 -0.753 . . . . 63.119999999999997 111.36 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.449 ' HB2' ' HB2' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -138.62 128.1 24.62 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.183 0.516 . . . . 73.120000000000005 110.044 176.017 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 23.4 m -102.87 105.49 15.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.875 -0.602 . . . . 74.420000000000002 110.267 -178.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.461 ' HG3' ' HB ' ' A' ' 134' ' ' ILE . 13.6 ptt180 -77.08 106.99 9.13 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.254 0.55 . . . . 72.120000000000005 110.775 179.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' SER . 12.0 p -100.73 140.34 19.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.311 -0.859 . . . . 71.510000000000005 110.357 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -124.81 122.13 36.55 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.681 -0.489 . . . . 63.399999999999999 109.681 176.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.594 ' HG ' ' H ' ' A' ' 154' ' ' MET . 26.1 tp -101.35 176.9 5.09 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.619 -0.264 . . . . 74.329999999999998 110.567 -176.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.864 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 59.3 mtm -75.53 27.81 0.1 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 122.704 0.402 . . . . 75.319999999999993 110.931 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 98' ' ' ALA . 4.2 mm? 70.69 -82.43 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.562 0.745 . . . . 41.450000000000003 111.736 -177.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' O ' ' HB2' ' A' ' 157' ' ' GLU . 0.9 OUTLIER -61.05 -69.06 0.25 Allowed 'General case' 0 CA--C 1.533 0.313 0 O-C-N 123.507 0.504 . . . . 72.439999999999998 111.993 -169.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HB2' ' O ' ' A' ' 156' ' ' HIS . 3.2 tt0 176.44 -86.4 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.101 0.477 . . . . 62.43 109.832 178.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 20.3 m -132.68 69.24 1.48 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.149 -1.056 . . . . 74.450000000000003 108.149 173.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.79 ' HA ' HD11 ' A' ' 127' ' ' LEU . 10.1 mp 58.39 -99.83 0.1 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-N 115.032 -0.985 . . . . 54.119999999999997 109.327 -169.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.26 23.99 2.15 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.861 0.839 . . . . 72.439999999999998 109.895 172.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.464 ' HD2' ' HB2' ' A' ' 159' ' ' LEU . 57.0 m-70 -85.88 48.3 1.58 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.586 -1.188 . . . . 72.329999999999998 109.404 178.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -75.24 51.66 0.55 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.42 -0.809 . . . . 64.310000000000002 112.72 -173.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 19.7 t60 -155.98 85.78 1.03 Allowed 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.643 -0.873 . . . . 74.129999999999995 108.643 173.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 5.5 p80 -154.68 160.79 41.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.604 -0.726 . . . . 75.530000000000001 109.815 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 63.8 t60 -78.14 137.77 38.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.118 0.485 . . . . 74.019999999999996 111.128 -172.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 3.9 p80 . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.338 -0.839 . . . . 63.149999999999999 109.465 176.063 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.3 mtm . . . . . 0 N--CA 1.486 1.365 0 N-CA-C 110.768 -0.086 . . . . 72.120000000000005 110.768 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 60.99 -89.45 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 123.316 0.647 . . . . 63.039999999999999 110.599 -175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 28.5 t80 62.15 -7.31 0.12 Allowed 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.551 0.74 . . . . 70.209999999999994 112.899 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.71 164.2 11.83 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.253 0.549 . . . . 52.130000000000003 112.086 -175.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 60.2 m -102.01 -55.17 2.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.48 -0.933 . . . . 53.329999999999998 108.48 171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -178.4 127.22 0.12 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.122 -0.945 . . . . 62.530000000000001 109.078 174.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -124.62 126.88 46.49 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.161 -0.311 . . . . 72.109999999999999 110.161 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 87.0 t -69.56 106.6 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.127 0.489 . . . . 64.129999999999995 110.399 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.51 118.32 15.13 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.522 -0.763 . . . . 74.129999999999995 109.066 179.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.67 -178.6 5.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.357 0.599 . . . . 54.240000000000002 110.75 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.737 ' HG ' ' HB3' ' A' ' 96' ' ' LYS . 26.1 tp -83.94 107.66 16.45 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.458 -0.792 . . . . 45.32 109.639 -179.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -102.93 154.01 19.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.939 -0.573 . . . . 74.239999999999995 109.901 -178.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' HA ' ' HG3' ' A' ' 96' ' ' LYS . 1.8 pp20? -78.83 152.33 31.39 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.288 0.566 . . . . 72.439999999999998 111.651 -177.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.444 HD13 ' HA ' ' A' ' 14' ' ' LEU . 3.9 mm? -124.68 140.38 52.99 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.085 -0.962 . . . . 64.349999999999994 109.434 175.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -99.7 159.01 31.08 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.303 -0.408 . . . . 71.340000000000003 110.789 -176.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -63.62 104.63 0.46 Allowed 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 122.546 2.164 . . . . 54.310000000000002 111.491 174.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 15' ' ' ALA . 67.8 t -117.74 89.95 34.66 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.379 -0.828 . . . . 72.209999999999994 111.214 -175.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.507 ' HA ' ' HB3' ' A' ' 91' ' ' LEU . 49.0 Cg_exo -54.77 122.23 11.25 Favored 'Trans proline' 0 C--N 1.346 0.4 0 C-N-CA 122.502 2.135 . . . . 73.340000000000003 110.827 174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -147.82 170.31 17.89 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.358 0.599 . . . . 44.25 112.207 -170.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.748 HD13 HG11 ' A' ' 77' ' ' VAL . 8.2 mp -124.95 130.95 53.39 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.974 -1.012 . . . . 73.540000000000006 109.498 172.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.48 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 5.6 mp -119.71 132.85 55.76 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.0 -0.546 . . . . 54.350000000000001 110.094 -177.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.488 HG13 ' O ' ' A' ' 86' ' ' ARG . 11.1 tt -111.01 120.66 62.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.56 -0.533 . . . . 71.340000000000003 109.56 177.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.694 ' HA ' ' HG2' ' A' ' 72' ' ' GLU . 28.1 ptt180 -80.82 112.66 18.4 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.605 0.717 . . . . 61.509999999999998 110.734 -175.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' HG22 ' A' ' 71' ' ' VAL . 39.5 m -127.64 114.59 17.56 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 114.763 -1.108 . . . . 63.119999999999997 110.039 -176.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -81.23 129.98 34.83 Favored 'General case' 0 C--N 1.318 -0.798 0 O-C-N 121.647 -0.658 . . . . 63.329999999999998 109.768 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.401 HG21 ' HA ' ' A' ' 31' ' ' LEU . 89.3 m -135.01 137.99 43.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.203 -0.453 . . . . 61.140000000000001 111.673 -173.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.66 148.25 33.25 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.628 -0.508 . . . . 72.030000000000001 109.628 174.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -66.34 -28.05 68.36 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.916 -0.314 . . . . 73.540000000000006 111.575 -173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.7 m -85.27 0.46 51.87 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.003 0.43 . . . . 72.040000000000006 110.886 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -128.5 15.04 6.58 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.202 0.525 . . . . 73.0 110.111 -177.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 HD21 ' HE2' ' A' ' 61' ' ' TYR . 2.1 tm? -54.89 -48.12 73.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.246 -0.888 . . . . 63.509999999999998 111.004 -175.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.0 -42.61 96.69 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.864 -0.684 . . . . 63.5 113.054 -174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.8 m -64.76 -36.0 82.9 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.32 0.489 . . . . 64.420000000000002 112.32 -174.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.85 -52.58 55.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.514 0.197 . . . . 71.430000000000007 111.417 -178.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -66.55 -33.74 76.34 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.769 0.319 . . . . 74.5 110.841 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.7 -49.89 73.81 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.641 -0.709 . . . . 72.109999999999999 111.233 -178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -87.09 -38.73 16.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.399 -0.364 . . . . 62.310000000000002 111.493 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -61.43 -34.3 87.82 Favored Glycine 0 C--N 1.33 0.199 0 C-N-CA 121.229 -0.51 . . . . 44.020000000000003 113.112 -176.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 76.1 t80 -55.84 -36.04 67.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.848 0.356 . . . . 65.5 111.08 -179.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -73.46 -47.33 42.29 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.173 0.511 . . . . 65.319999999999993 111.332 -177.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.627 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 26.9 t70 -71.38 -36.44 71.44 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.581 -0.736 . . . . 70.319999999999993 112.634 -167.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 30.4 pt -73.8 1.59 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.65 0.611 . . . . 45.530000000000001 112.65 -173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 50.0 tp -76.29 -17.1 59.62 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.438 0.161 . . . . 64.420000000000002 111.432 -178.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 61.8 mm-40 -55.45 -41.48 72.93 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.934 0.397 . . . . 55.219999999999999 111.45 -175.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 58.4 tp -67.57 -36.46 80.95 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.024 -0.534 . . . . 71.049999999999997 111.318 -175.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.42 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -79.66 -39.54 31.18 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.874 0.368 . . . . 61.229999999999997 110.753 -179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -66.37 -27.98 68.29 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.035 -0.529 . . . . 63.409999999999997 111.005 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -62.84 -42.58 99.65 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.126 -0.559 . . . . 64.430000000000007 112.531 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.55 HE22 ' HA ' ' A' ' 81' ' ' VAL . 69.3 mt-30 -85.59 -16.57 38.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.844 0.354 . . . . 64.120000000000005 110.836 178.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 79.91 37.53 22.19 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.736 -0.745 . . . . 70.209999999999994 112.494 177.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -139.06 164.98 28.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.794 0.33 . . . . 63.130000000000003 110.248 177.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.481 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 11.9 p -120.13 166.25 15.67 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 116.077 -0.511 . . . . 65.219999999999999 110.417 -174.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 5.6 Cg_endo -48.78 141.78 20.34 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 122.894 2.396 . . . . 60.119999999999997 112.332 176.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.5 t -89.61 34.13 0.83 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.379 0.609 . . . . 75.549999999999997 110.25 -178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 151.98 -168.98 31.32 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.826 -0.702 . . . . 65.439999999999998 111.785 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.416 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 7.1 Cg_exo -73.89 153.57 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.747 2.298 . . . . 52.509999999999998 111.743 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 2.1 Cg_endo -81.73 148.11 15.67 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.001 2.467 . . . . 72.310000000000002 112.343 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.425 ' HB3' HG13 ' A' ' 134' ' ' ILE . 28.5 p90 -127.29 116.18 20.16 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.48 0.657 . . . . 75.310000000000002 110.064 176.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 72' ' ' GLU . . . -96.46 111.72 23.73 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.69 -0.686 . . . . 71.040000000000006 110.447 -176.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.681 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -94.84 126.71 40.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.091 0.472 . . . . 72.349999999999994 110.774 -179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.43 ' HE1' ' HG3' ' A' ' 133' ' ' GLU . 45.0 m-85 -103.51 117.18 33.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.514 -0.766 . . . . 75.409999999999997 109.938 -179.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.826 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 3.5 m-85 -82.57 109.96 17.23 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.702 -0.681 . . . . 53.329999999999998 110.225 173.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.34 32.41 1.03 Allowed Glycine 0 N--CA 1.447 -0.585 0 CA-C-N 115.267 -0.878 . . . . 74.420000000000002 111.124 176.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.593 ' HG3' ' C ' ' A' ' 129' ' ' GLY . 2.3 mpp? -62.6 -44.91 95.13 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.187 0.518 . . . . 73.049999999999997 110.312 -177.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 23.1 t -142.49 31.73 1.49 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.549 -0.908 . . . . 73.439999999999998 108.549 176.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -126.3 140.41 52.54 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.262 -0.881 . . . . 71.310000000000002 110.653 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -88.24 -24.08 35.45 Favored Glycine 0 N--CA 1.45 -0.425 0 N-CA-C 111.351 -0.699 . . . . 72.430000000000007 111.351 177.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 84.6 m -99.7 130.56 45.93 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.173 -0.677 . . . . 75.310000000000002 109.173 174.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.14 119.99 23.66 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.095 0.474 . . . . 71.340000000000003 111.096 -173.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 27.7 tt0 -92.19 104.8 17.14 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.16 -1.052 . . . . 70.530000000000001 108.16 173.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 24' ' ' THR . 3.9 m -105.56 142.13 19.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.272 0.558 . . . . 74.209999999999994 111.348 -168.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.694 ' HG2' ' HA ' ' A' ' 23' ' ' ARG . 37.7 mt-10 -124.47 122.97 39.11 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.806 -0.633 . . . . 73.219999999999999 109.53 172.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.611 ' HB3' ' HE1' ' A' ' 75' ' ' PHE . 29.7 m-85 -57.56 -37.15 72.64 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.083 0.865 . . . . 74.219999999999999 111.722 -176.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.48 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 54.74 83.94 0.04 OUTLIER Glycine 0 C--N 1.335 0.517 0 O-C-N 123.777 0.673 . . . . 71.25 114.088 172.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.611 ' HE1' ' HB3' ' A' ' 73' ' ' PHE . 37.3 m-85 -107.93 140.58 21.76 Favored Pre-proline 0 C--N 1.323 -0.575 0 O-C-N 122.233 -0.569 . . . . 74.549999999999997 110.109 176.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.452 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 6.0 Cg_exo -80.07 141.89 15.06 Favored 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 123.011 2.474 . . . . 74.439999999999998 111.13 177.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.748 HG11 HD13 ' A' ' 20' ' ' LEU . 27.5 m -120.59 154.16 23.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.824 0 CA-C-O 121.092 0.472 . . . . 62.299999999999997 111.459 -177.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 7.2 tm-20 -68.5 -54.24 18.07 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.365 -0.834 . . . . 74.530000000000001 109.81 178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 162.02 158.67 9.67 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 111.515 -0.634 . . . . 74.310000000000002 111.515 179.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 76.11 4.87 79.46 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.227 -0.511 . . . . 65.030000000000001 112.698 177.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.55 ' HA ' HE22 ' A' ' 49' ' ' GLN . 5.8 t -87.98 144.72 8.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 N-CA-C 109.845 -0.428 . . . . 74.519999999999996 109.845 -178.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -129.27 143.21 50.77 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.682 -0.69 . . . . 72.540000000000006 111.088 -174.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -78.33 152.64 38.17 Favored Glycine 0 N--CA 1.446 -0.686 0 C-N-CA 120.747 -0.739 . . . . 72.120000000000005 112.291 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.452 ' H ' HG13 ' A' ' 87' ' ' VAL . 23.1 m -100.91 13.49 34.93 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.737 0.303 . . . . 75.150000000000006 111.412 -175.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 96.35 -51.23 1.61 Allowed Glycine 0 N--CA 1.453 -0.181 0 C-N-CA 120.721 -0.752 . . . . 32.350000000000001 111.834 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.488 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.1 OUTLIER -65.81 -31.1 71.88 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.4 -0.963 . . . . 74.140000000000001 108.4 171.255 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.452 HG13 ' H ' ' A' ' 84' ' ' SER . 7.5 p -119.69 134.57 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 114.609 -1.178 . . . . 72.540000000000006 109.247 175.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 33.0 m -111.89 172.68 2.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 109.748 -0.464 . . . . 31.329999999999998 109.748 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.456 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 14.8 t -120.59 176.04 5.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.569 0.7 . . . . 73.310000000000002 111.225 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 159.54 -146.86 13.47 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 114.816 -1.084 . . . . 53.43 110.865 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.507 ' HB3' ' HA ' ' A' ' 18' ' ' PRO . 2.2 pp -160.28 163.05 33.7 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 116.758 0.279 . . . . 71.129999999999995 110.613 178.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.0 m -80.87 140.12 50.33 Favored Pre-proline 0 N--CA 1.447 -0.598 0 N-CA-C 108.511 -0.922 . . . . 43.329999999999998 108.511 171.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -76.68 146.42 26.86 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.03 1.82 . . . . 75.099999999999994 112.169 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 24.0 p -78.78 131.85 36.68 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.604 -0.517 . . . . 72.450000000000003 109.604 176.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' C ' ' HD2' ' A' ' 96' ' ' LYS . . . 158.88 -142.3 8.27 Favored Glycine 0 N--CA 1.441 -0.987 0 N-CA-C 110.362 -1.095 . . . . 74.420000000000002 110.362 -175.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.737 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 10.6 mptt -136.11 159.2 42.43 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.452 0.626 . . . . 65.329999999999998 111.046 178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.667 ' HA ' HD23 ' A' ' 155' ' ' LEU . . . -151.6 153.71 35.02 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.347 -0.842 . . . . 73.319999999999993 110.498 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.719 ' H ' HD21 ' A' ' 155' ' ' LEU . . . -78.62 114.38 17.49 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.281 -0.418 . . . . 44.340000000000003 110.288 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.725 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 1.5 p -143.41 152.35 41.46 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.232 -0.44 . . . . 65.530000000000001 111.527 -175.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 21.5 t -144.88 173.08 12.17 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.837 -0.619 . . . . 73.040000000000006 109.505 177.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 6.6 mp -102.68 110.99 23.1 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.039 0.447 . . . . 72.310000000000002 110.778 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.445 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 86.9 t80 -82.16 111.65 18.47 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.912 -0.773 . . . . 62.530000000000001 108.912 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.475 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 56.3 mt -121.77 119.8 59.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 120.87 0.367 . . . . 74.150000000000006 111.124 -174.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 140.96 -156.62 25.59 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.864 -0.684 . . . . 53.119999999999997 111.608 179.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.42 154.54 55.75 Favored 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.231 1.954 . . . . 72.219999999999999 110.45 173.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 54.1 t80 -94.97 133.53 38.62 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.278 -0.569 . . . . 74.329999999999998 110.369 -175.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 149.55 -45.47 0.69 Allowed Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.484 -0.78 . . . . 75.219999999999999 111.76 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -89.75 38.76 0.93 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.265 0.555 . . . . 74.439999999999998 110.655 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 16.7 tt -75.45 -18.03 15.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.21 0.529 . . . . 70.129999999999995 110.824 -178.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.55 -22.55 60.99 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.589 -0.444 . . . . 62.450000000000003 110.443 177.173 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -66.66 -44.88 80.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.999 -0.546 . . . . 41.039999999999999 110.783 175.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.501 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 13.6 p -76.17 -29.1 19.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 N-CA-C 109.925 -0.398 . . . . 65.120000000000005 109.925 177.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.545 ' HA ' HD12 ' A' ' 116' ' ' LEU . 63.7 t80 -66.05 -35.62 81.02 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.325 -0.398 . . . . 74.329999999999998 110.201 177.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -58.31 -45.45 88.01 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.064 -0.517 . . . . 64.319999999999993 109.649 175.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.82 -35.93 81.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.784 -0.644 . . . . 64.439999999999998 111.365 178.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.545 HD12 ' HA ' ' A' ' 113' ' ' TYR . 96.8 mt -60.24 -39.57 87.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.925 0.393 . . . . 75.200000000000003 110.604 177.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 49.3 ttp -72.0 -31.03 65.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.415 0.626 . . . . 75.230000000000004 110.22 177.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 31.1 tttm -70.62 -48.17 56.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.284 -0.871 . . . . 65.120000000000005 111.865 -176.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.503 ' HZ2' ' CB ' ' A' ' 98' ' ' ALA . 7.7 p-90 -72.91 -32.97 65.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.047 0.451 . . . . 75.409999999999997 111.434 -174.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.878 ' HA ' ' ND2' ' A' ' 123' ' ' ASN . 9.4 p -71.99 -35.43 54.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.128 0.489 . . . . 75.120000000000005 111.072 -174.558 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -63.86 -30.55 71.63 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.572 -0.74 . . . . 74.230000000000004 109.924 174.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -72.86 -46.12 54.61 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.694 -0.685 . . . . 74.219999999999999 111.716 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.878 ' ND2' ' HA ' ' A' ' 120' ' ' VAL . 9.9 p30 -71.88 -21.25 61.68 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 120.482 -0.487 . . . . 62.030000000000001 110.904 -177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.7 50.42 3.13 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.946 -0.645 . . . . 73.120000000000005 113.396 174.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -125.49 166.88 15.84 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.706 0.289 . . . . 73.040000000000006 110.296 173.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -104.33 152.88 21.72 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.17 -0.468 . . . . 71.519999999999996 110.419 -178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -104.05 139.21 39.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.887 -0.597 . . . . 72.299999999999997 110.603 -177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 8.1 t -79.09 -33.59 44.32 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.797 -0.816 . . . . 64.430000000000007 108.797 171.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.593 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 112.74 -22.47 16.67 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.582 -0.735 . . . . 75.0 113.587 173.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -79.85 148.24 31.42 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.391 0.595 . . . . 74.439999999999998 109.924 -178.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 61' ' ' TYR . . . -128.8 119.12 23.93 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.31 -0.405 . . . . 63.420000000000002 109.974 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.681 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 10.7 p90 -116.32 130.54 56.83 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.08 0.467 . . . . 73.219999999999999 111.339 -178.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.461 ' HB3' HG21 ' A' ' 149' ' ' THR . 40.6 mt-10 -95.16 118.85 32.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.457 -0.792 . . . . 45.420000000000002 110.574 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.425 HG13 ' HB3' ' A' ' 58' ' ' PHE . 3.8 mp -88.26 107.83 17.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 108.901 -0.777 . . . . 74.030000000000001 108.901 173.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 15.8 m-85 -89.45 81.92 6.5 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.18 0.515 . . . . 61.539999999999999 110.991 -178.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.595 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -82.43 -16.73 47.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.661 -0.699 . . . . 74.120000000000005 109.687 174.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -126.35 107.64 10.49 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.199 -0.91 . . . . 71.230000000000004 109.441 178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.618 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 53.6 t30 -70.71 140.2 86.54 Favored Pre-proline 0 C--N 1.323 -0.576 0 N-CA-C 109.173 -0.677 . . . . 74.140000000000001 109.173 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.618 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 77.9 Cg_exo -54.07 151.38 27.96 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.845 1.697 . . . . 64.340000000000003 112.529 177.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 62.8 11.33 4.87 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.493 -0.776 . . . . 70.239999999999995 112.377 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 29.9 tt0 -89.89 -58.36 2.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.799 0.333 . . . . 54.140000000000001 110.607 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.588 HG23 ' H ' ' A' ' 143' ' ' ALA . 5.0 t -82.43 -59.98 2.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.412 -0.358 . . . . 63.530000000000001 111.083 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.588 ' H ' HG23 ' A' ' 142' ' ' THR . . . 179.32 145.69 0.37 Allowed Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.281 -0.637 . . . . 75.230000000000004 109.281 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -56.6 137.01 79.16 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.296 1.997 . . . . 74.420000000000002 111.218 174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 22.7 t70 75.19 -17.03 0.52 Allowed 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 115.312 -0.858 . . . . 53.020000000000003 111.463 178.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 27.9 tt0 -97.18 2.75 51.39 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.604 0.716 . . . . 51.100000000000001 109.847 178.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.475 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 67.0 mt -67.56 138.59 56.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.317 -0.856 . . . . 71.439999999999998 109.645 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 0.0 OUTLIER -134.93 122.07 21.42 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.494 0.664 . . . . 75.030000000000001 111.587 -178.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.461 HG21 ' HB3' ' A' ' 133' ' ' GLU . 34.5 m -116.87 132.2 56.76 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.475 -0.784 . . . . 75.340000000000003 110.297 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 68.6 ttt180 -85.14 100.3 11.64 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.879 -0.415 . . . . 70.209999999999994 109.879 177.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.6 p -90.92 130.67 39.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 109.819 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.725 ' HB2' ' HB3' ' A' ' 99' ' ' SER . 25.7 t -137.9 151.56 48.14 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.791 0.329 . . . . 72.430000000000007 111.057 -175.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 7.4 mp -116.42 170.22 8.72 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.982 -0.554 . . . . 71.25 109.772 177.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.425 ' HG2' ' HE1' ' A' ' 132' ' ' TYR . 15.4 mmt -99.2 140.43 33.37 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.97 0.414 . . . . 71.209999999999994 111.416 177.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.719 HD21 ' H ' ' A' ' 98' ' ' ALA . 2.7 mm? -114.04 148.29 37.26 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.6 -0.727 . . . . 62.149999999999999 109.975 -178.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 72.6 t60 73.71 -50.49 0.69 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 113.353 0.871 . . . . 75.239999999999995 113.353 169.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -76.31 92.94 3.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.977 0.417 . . . . 72.200000000000003 110.102 -177.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.5 m -68.89 104.92 2.19 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.73 -0.668 . . . . 71.150000000000006 111.669 -176.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 98.7 mt -85.44 -3.8 58.96 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.788 0.804 . . . . 72.109999999999999 109.082 172.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -148.81 151.34 34.6 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 107.76 -1.2 . . . . 71.219999999999999 107.76 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 78.69 110.12 0.07 Allowed 'General case' 0 N--CA 1.465 0.313 0 O-C-N 123.859 0.724 . . . . 71.420000000000002 112.656 175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -120.6 136.64 54.75 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 108.774 -0.824 . . . . 71.340000000000003 108.774 170.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 23.6 m80 64.59 103.99 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.862 0.726 . . . . 63.539999999999999 109.788 -166.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -82.54 145.34 29.8 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.063 -0.517 . . . . 70.049999999999997 111.787 -173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 40.2 t-80 69.98 149.45 0.08 Allowed 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.291 -0.868 . . . . 73.25 112.427 175.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 26.4 m80 . . . . . 0 C--O 1.248 1.024 0 CA-C-N 115.721 -0.672 . . . . 62.32 109.195 168.935 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.744 ' HB2' ' HB2' ' A' ' 145' ' ' ASP . 89.4 mmm . . . . . 0 N--CA 1.48 1.028 0 N-CA-C 109.546 -0.539 . . . . 74.329999999999998 109.546 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -137.48 31.29 2.59 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.024 0.44 . . . . 75.230000000000004 110.902 -176.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -74.85 97.12 3.23 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.867 -0.606 . . . . 73.329999999999998 110.891 -177.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 64.64 174.45 0.2 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.095 -0.957 . . . . 70.329999999999998 112.242 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 70.9 m -148.2 90.91 1.86 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.212 -0.904 . . . . 53.32 108.842 174.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' TYR . 63.4 tt0 -114.9 114.54 25.62 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.82 -0.627 . . . . 72.310000000000002 110.668 -174.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.441 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 16.2 m-85 -121.51 104.25 9.52 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.454 -0.794 . . . . 74.230000000000004 109.457 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 p -121.26 129.31 75.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.145 0.498 . . . . 64.140000000000001 110.999 -177.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 55.9 m -94.26 152.19 18.87 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.717 -0.674 . . . . 64.239999999999995 110.937 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -151.7 162.13 41.52 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.944 -0.571 . . . . 52.399999999999999 109.825 177.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.434 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 2.5 tm? -120.77 116.56 25.47 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.789 -0.819 . . . . 44.399999999999999 108.789 178.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.2 ptmt -141.86 164.5 30.02 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 116.003 -0.544 . . . . 51.210000000000001 110.789 -175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -107.74 143.09 36.76 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.173 -0.467 . . . . 73.200000000000003 109.903 174.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -99.99 147.38 25.66 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.308 -0.405 . . . . 71.209999999999994 110.854 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -91.88 144.28 29.07 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.928 -0.578 . . . . 64.140000000000001 110.386 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 6.2 Cg_exo -79.11 115.5 3.52 Favored 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 123.209 2.606 . . . . 71.040000000000006 112.554 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 18' ' ' PRO . 7.3 p -133.35 141.67 41.38 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.292 -0.633 . . . . 64.409999999999997 109.292 177.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 17' ' ' VAL . 23.2 Cg_endo -63.12 138.24 66.15 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.812 2.342 . . . . 62.009999999999998 113.124 179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -148.18 157.74 43.68 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.826 -0.624 . . . . 72.219999999999999 111.231 -178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.672 HD12 HG22 ' A' ' 87' ' ' VAL . 3.6 mm? -115.41 122.66 46.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.876 -0.602 . . . . 65.329999999999998 109.625 176.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.5 ' HG ' ' HA2' ' A' ' 74' ' ' GLY . 4.7 mp -117.08 132.68 56.62 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.887 0.375 . . . . 63.439999999999998 111.433 -173.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.562 HD13 ' HB ' ' A' ' 87' ' ' VAL . 28.0 mm -88.0 116.01 29.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.037 -0.727 . . . . 70.299999999999997 109.037 171.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 86' ' ' ARG . 13.0 ptt180 -82.93 113.3 20.43 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 72.510000000000005 110.223 -178.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.606 HG23 HG23 ' A' ' 71' ' ' VAL . 8.8 t -150.32 168.25 24.63 Favored 'General case' 0 C--N 1.32 -0.715 0 C-N-CA 120.634 -0.426 . . . . 74.349999999999994 110.93 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.505 ' HB3' ' OE2' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -131.49 139.62 49.36 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.757 -0.831 . . . . 73.439999999999998 108.757 178.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.497 ' HB ' HD22 ' A' ' 34' ' ' LEU . 11.6 t -155.53 -173.9 4.74 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 119.54 -0.864 . . . . 53.0 112.482 -171.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.8 177.72 6.12 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.303 -0.862 . . . . 25.010000000000002 110.333 -178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.2 mmt -58.48 -46.54 86.44 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.672 0.619 . . . . 52.130000000000003 112.672 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.1 p -92.26 -2.93 56.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.745 0.646 . . . . 60.130000000000003 112.745 -173.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -94.81 -2.39 50.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.014 0.435 . . . . 71.010000000000005 110.854 -177.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 95.5 mt -54.49 -36.91 64.68 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.077 -0.511 . . . . 74.530000000000001 111.49 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -62.47 -61.01 6.98 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.61 -0.805 . . . . 71.319999999999993 112.36 178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 m -59.11 -34.22 71.76 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.926 0.393 . . . . 74.439999999999998 111.471 -177.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.497 HD22 ' HB ' ' A' ' 26' ' ' THR . 57.2 tp -68.09 -53.71 23.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.15 -0.477 . . . . 74.030000000000001 111.454 -177.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -64.72 -34.55 78.58 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.489 -0.323 . . . . 73.430000000000007 111.429 -176.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -66.98 -33.47 75.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.819 0.342 . . . . 75.230000000000004 110.913 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -73.82 -43.63 58.18 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.009 0.433 . . . . 62.520000000000003 110.756 177.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 42' ' ' ILE . . . -66.64 -42.13 93.55 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.858 -0.61 . . . . 62.509999999999998 112.646 -179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -61.24 -36.46 80.03 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.193 0.52 . . . . 73.310000000000002 110.437 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 52.3 t-80 -71.65 -30.88 66.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.747 -0.66 . . . . 73.140000000000001 110.916 178.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 86' ' ' ARG . 31.6 t70 -75.34 -49.3 19.54 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.15 -0.477 . . . . 71.230000000000004 111.456 -175.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.465 HG22 ' O ' ' A' ' 38' ' ' GLY . 8.4 tt -90.58 90.85 3.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.842 0.83 . . . . 42.420000000000002 111.227 -178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 93.1 mt -126.0 -61.06 1.25 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.695 -0.684 . . . . 63.420000000000002 110.287 178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.2 tt0 -64.59 -33.49 76.04 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.734 -0.666 . . . . 61.130000000000003 111.159 -177.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 82' ' ' GLU . 36.1 tp -61.41 -23.56 65.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.106 -0.497 . . . . 75.340000000000003 111.021 -178.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.7 tp -113.85 -67.89 0.97 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.058 0.456 . . . . 71.209999999999994 110.592 -178.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.45 -46.75 46.52 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.574 -0.739 . . . . 65.25 111.001 -173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -60.54 -35.96 90.28 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 121.012 -0.613 . . . . 53.530000000000001 112.652 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 20.2 tt0 -84.59 7.73 19.14 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.417 0.627 . . . . 70.430000000000007 110.652 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 68.42 43.66 77.21 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.695 -0.684 . . . . 54.130000000000003 113.006 174.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 40.2 mmtm -124.05 154.9 39.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.805 0.336 . . . . 65.109999999999999 110.221 178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.7 m -107.89 152.24 41.56 Favored Pre-proline 0 C--N 1.318 -0.779 0 CA-C-N 115.984 -0.553 . . . . 61.200000000000003 110.864 -176.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -74.5 140.19 26.63 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.466 2.111 . . . . 73.340000000000003 110.796 170.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.959 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 34.1 t -87.15 5.84 35.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.066 0.46 . . . . 55.25 110.635 -178.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 149.21 -161.54 28.77 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.74 -0.743 . . . . 75.510000000000005 112.36 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.57 ' HG2' ' HA ' ' A' ' 136' ' ' LEU . 2.9 Cg_exo -77.65 167.56 23.91 Favored 'Trans proline' 0 CA--C 1.535 0.537 0 C-N-CA 123.813 3.009 . . . . 72.140000000000001 112.359 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.86 152.58 32.46 Favored 'Trans proline' 0 C--O 1.243 0.737 0 C-N-CA 122.789 2.326 . . . . 74.129999999999995 114.206 -174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.449 ' HD1' HG22 ' A' ' 134' ' ' ILE . 1.8 m-85 -125.07 116.35 21.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.942 -1.026 . . . . 63.240000000000002 108.675 175.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.663 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -103.82 114.86 29.42 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.088 0.47 . . . . 64.519999999999996 111.624 -171.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.798 ' HG3' ' HB2' ' A' ' 72' ' ' GLU . 4.9 ptm180 -92.64 119.6 32.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.076 0.465 . . . . 72.019999999999996 110.18 174.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.444 ' CD2' HG12 ' A' ' 71' ' ' VAL . 73.0 m-85 -105.14 112.11 25.11 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.185 -0.916 . . . . 64.150000000000006 110.025 -178.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.788 ' HD1' ' HB3' ' A' ' 130' ' ' GLU . 87.2 t80 -92.77 119.61 32.31 Favored 'General case' 0 C--N 1.32 -0.692 0 C-N-CA 120.747 -0.381 . . . . 70.140000000000001 110.023 176.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.23 56.62 0.28 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.898 -0.668 . . . . 74.099999999999994 112.069 -179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 49.3 mtm -62.87 -47.96 81.07 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.097 0.475 . . . . 75.120000000000005 109.849 179.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 24.2 m -106.57 87.42 2.53 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.667 -0.697 . . . . 63.409999999999997 109.351 173.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -168.0 -39.85 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.062 -0.517 . . . . 72.140000000000001 110.775 -176.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.22 0.48 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.796 -0.716 . . . . 54.229999999999997 111.518 -179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 19.7 m -88.41 126.57 35.28 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 108.945 -0.761 . . . . 73.439999999999998 108.945 174.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' HD1' HG13 ' A' ' 71' ' ' VAL . 3.2 p90 -118.39 143.66 46.49 Favored 'General case' 0 C--O 1.244 0.764 0 CA-C-O 121.823 0.82 . . . . 74.319999999999993 113.012 -172.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 1.8 tp10 -86.1 127.66 34.73 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 114.081 -1.418 . . . . 74.299999999999997 107.598 172.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.606 HG23 HG23 ' A' ' 24' ' ' THR . 31.5 m -123.19 133.86 67.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 122.019 0.914 . . . . 72.310000000000002 112.685 -172.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.798 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 26.8 mt-10 -127.61 95.79 4.34 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 114.358 -1.292 . . . . 63.020000000000003 108.119 171.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.663 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 6.2 p90 -75.14 -8.19 55.88 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 113.179 0.807 . . . . 72.140000000000001 113.179 -172.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.5 ' HA2' ' HG ' ' A' ' 21' ' ' LEU . . . 43.27 104.17 0.01 OUTLIER Glycine 0 N--CA 1.47 0.927 0 N-CA-C 116.552 1.381 . . . . 61.340000000000003 116.552 161.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -98.93 141.9 23.69 Favored Pre-proline 0 C--N 1.322 -0.602 0 O-C-N 122.051 -0.676 . . . . 73.200000000000003 109.69 174.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.959 ' HB2' ' HB3' ' A' ' 54' ' ' SER . 72.8 Cg_endo -80.96 137.69 11.11 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.331 2.02 . . . . 73.030000000000001 110.918 175.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 20' ' ' LEU . 22.6 m -116.3 175.8 2.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 112.301 0.482 . . . . 74.120000000000005 112.301 -171.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -57.79 -37.79 74.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.951 -1.022 . . . . 71.040000000000006 110.932 -179.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 153.89 -72.46 0.26 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.735 -0.745 . . . . 60.539999999999999 112.343 178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -90.34 71.12 2.12 Favored Glycine 0 N--CA 1.447 -0.589 0 C-N-CA 121.119 -0.562 . . . . 73.329999999999998 112.195 -177.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.412 HG21 ' HB ' ' A' ' 77' ' ' VAL . 13.8 t -122.02 149.63 25.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.508 -0.553 . . . . 72.219999999999999 109.508 178.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HD11 ' A' ' 45' ' ' LEU . 43.0 tt0 -124.72 158.42 33.28 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.954 -0.566 . . . . 70.409999999999997 109.921 -174.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.91 165.96 25.86 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.667 -0.778 . . . . 73.310000000000002 112.084 -179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.839 ' H ' HG13 ' A' ' 87' ' ' VAL . 14.2 t -152.33 97.84 2.33 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.746 -0.464 . . . . 74.219999999999999 109.746 -179.019 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 88.4 -120.06 5.54 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.8 -0.714 . . . . 72.010000000000005 112.258 177.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.439 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 14.6 ptt180 -73.05 -9.65 58.95 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 111.828 0.307 . . . . 53.119999999999997 111.828 -178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.839 HG13 ' H ' ' A' ' 84' ' ' SER . 7.2 p -102.45 122.95 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-O 121.191 0.52 . . . . 43.240000000000002 109.811 174.33 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.4 m -116.11 148.9 18.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.2 -0.454 . . . . 44.030000000000001 110.357 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.4 t -99.96 158.29 15.93 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.201 0.524 . . . . 63.039999999999999 110.207 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 176.42 -143.16 6.29 Favored Glycine 0 N--CA 1.442 -0.904 0 CA-C-N 115.427 -0.806 . . . . 74.5 112.0 -179.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.449 HD12 ' HB3' ' A' ' 16' ' ' PRO . 2.6 pt? -149.59 175.23 11.72 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 110.067 -0.346 . . . . 70.510000000000005 110.067 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.3 p -79.83 151.68 73.96 Favored Pre-proline 0 C--N 1.32 -0.717 0 CA-C-N 115.733 -0.667 . . . . 71.219999999999999 111.298 -179.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -57.26 122.37 11.69 Favored 'Trans proline' 0 C--N 1.343 0.274 0 C-N-CA 122.744 2.296 . . . . 54.509999999999998 111.741 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 9.3 m -98.44 133.0 43.43 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 116.015 -0.539 . . . . 64.329999999999998 110.286 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 128.42 -165.12 21.44 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.826 -0.702 . . . . 45.109999999999999 111.82 -179.137 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -86.63 142.49 28.21 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.816 0.341 . . . . 73.209999999999994 110.532 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -136.84 141.55 42.83 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.958 -0.564 . . . . 33.100000000000001 110.499 178.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.498 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -85.18 105.89 16.22 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.42 -0.585 . . . . 65.099999999999994 109.42 176.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 20.3 m -109.63 148.17 31.78 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.933 -0.576 . . . . 75.230000000000004 111.531 -173.168 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 28.7 p -143.22 123.23 13.59 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.523 -0.547 . . . . 62.43 109.523 170.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.549 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 3.9 pp -94.46 145.93 24.44 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 120.339 -0.544 . . . . 75.5 110.069 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.585 ' CD1' HG11 ' A' ' 112' ' ' VAL . 46.6 p90 -137.91 141.6 40.63 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 121.258 0.551 . . . . 75.230000000000004 112.194 -176.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.424 HD13 ' N ' ' A' ' 103' ' ' ILE . 0.0 OUTLIER -132.3 142.01 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 CA-C-N 114.708 -1.133 . . . . 71.5 108.933 169.629 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 145' ' ' ASP . . . 134.78 -154.45 21.51 Favored Glycine 0 N--CA 1.44 -1.042 0 N-CA-C 110.308 -1.117 . . . . 71.409999999999997 110.308 -174.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo -49.06 110.69 0.38 Allowed 'Trans proline' 0 C--O 1.235 0.364 0 C-N-CA 122.69 2.26 . . . . 71.099999999999994 112.498 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 68.0 t80 -94.48 134.19 37.28 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.286 0.565 . . . . 72.439999999999998 110.347 -177.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 125.53 -43.69 1.34 Allowed Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 110.86 -0.896 . . . . 43.420000000000002 110.86 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -94.28 81.75 4.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.485 0.66 . . . . 61.539999999999999 109.727 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.2 tt -76.14 -10.27 13.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.59 -0.732 . . . . 74.450000000000003 110.419 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tp10 -48.86 -45.61 41.11 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.402 -0.817 . . . . 72.219999999999999 111.322 178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -57.81 -50.91 71.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.905 -0.589 . . . . 55.439999999999998 112.011 -175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.585 HG11 ' CD1' ' A' ' 102' ' ' TYR . 11.2 p -77.96 -34.75 19.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.571 -0.286 . . . . 71.340000000000003 111.455 -175.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -65.47 -38.85 91.01 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.795 0.331 . . . . 72.299999999999997 110.529 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -55.78 -50.46 70.4 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.841 -0.618 . . . . 64.319999999999993 110.902 -179.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -64.6 -36.83 85.5 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.93 -0.577 . . . . 73.420000000000002 111.228 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.9 tp -70.7 -41.84 71.44 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.229 -0.441 . . . . 75.340000000000003 110.672 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.1 ttp -63.82 -45.3 90.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 74.239999999999995 111.129 -178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.65 -25.42 63.91 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.725 -0.39 . . . . 73.340000000000003 110.628 -179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.434 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 51.9 t90 -71.77 -46.61 57.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.596 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.509 HG22 ' HB2' ' A' ' 125' ' ' PHE . 12.6 p -68.67 -33.76 61.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.344 0.592 . . . . 70.299999999999997 110.344 179.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -67.82 -45.7 73.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.285 -0.87 . . . . 64.120000000000005 110.61 177.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -63.53 -37.56 87.8 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.171 -0.468 . . . . 64.129999999999995 110.945 178.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.425 ' HB3' ' CE2' ' A' ' 125' ' ' PHE . 8.7 m-80 -71.36 -27.76 63.57 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.141 -0.481 . . . . 65.099999999999994 111.377 179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.31 57.03 1.82 Allowed Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.733 -0.746 . . . . 44.009999999999998 112.606 177.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.509 ' HB2' HG22 ' A' ' 120' ' ' VAL . 74.7 m-85 -119.29 167.36 11.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 N-CA-C 110.247 -0.279 . . . . 72.239999999999995 110.247 175.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.548 ' O ' ' HA ' ' A' ' 155' ' ' LEU . 32.0 m-20 -83.05 157.53 22.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.414 . . . . 43.030000000000001 110.277 177.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 6.9 mp -122.04 129.79 52.73 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.402 -0.592 . . . . 74.140000000000001 109.402 173.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.462 ' OG ' ' HA ' ' A' ' 158' ' ' SER . 20.2 m -85.67 -16.61 38.56 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.934 0.397 . . . . 53.200000000000003 111.497 -178.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 96.87 -2.06 61.69 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 120.494 -0.86 . . . . 70.140000000000001 112.765 179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.788 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 6.9 pt-20 -121.95 147.81 45.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.873 0.368 . . . . 73.099999999999994 110.769 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -121.95 134.41 54.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.055 -0.521 . . . . 73.109999999999999 110.703 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 85.8 t80 -100.13 111.41 23.7 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.743 -0.662 . . . . 54.119999999999997 109.753 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -104.06 151.67 22.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.011 -0.54 . . . . 75.219999999999999 110.348 -178.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.655 HD11 ' HB3' ' A' ' 150' ' ' ARG . 15.4 pt -133.3 123.83 47.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-O 120.956 0.408 . . . . 65.420000000000002 110.954 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -113.01 83.26 1.8 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.597 -0.52 . . . . 74.400000000000006 109.597 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.813 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -93.21 179.93 5.27 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.504 -0.771 . . . . 73.109999999999999 112.296 -172.721 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 59.4 -160.54 0.28 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 115.425 -0.807 . . . . 72.209999999999994 110.064 -176.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.9 p-10 -127.36 144.85 52.26 Favored Pre-proline 0 C--N 1.323 -0.551 0 C-N-CA 120.751 -0.38 . . . . 75.519999999999996 110.336 176.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.793 ' HB3' HD11 ' A' ' 147' ' ' LEU . 94.8 Cg_endo -89.11 -167.24 0.28 Allowed 'Trans proline' 0 N--CA 1.456 -0.685 0 C-N-CA 122.899 2.399 . . . . 74.439999999999998 113.452 -178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.34 -53.35 0.6 Allowed 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 124.574 1.15 . . . . 65.409999999999997 111.589 173.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -83.21 -10.91 58.32 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-O 121.102 0.477 . . . . 64.129999999999995 111.024 -173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.561 ' O ' ' HB3' ' A' ' 146' ' ' GLN . 9.7 t -129.35 18.37 5.9 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.786 -0.643 . . . . 62.039999999999999 109.953 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 68.51 152.01 0.13 Allowed Pre-proline 0 N--CA 1.47 0.532 0 CA-C-N 115.61 -0.723 . . . . 74.299999999999997 111.373 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -74.13 -36.38 3.38 Favored 'Trans proline' 0 CA--C 1.529 0.253 0 C-N-CA 122.352 2.035 . . . . 71.420000000000002 112.921 -179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.744 ' HB2' ' HB2' ' A' ' 1' ' ' MET . 8.4 m-20 -79.91 -16.08 56.03 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.983 0.421 . . . . 44.299999999999997 111.415 -175.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.561 ' HB3' ' O ' ' A' ' 142' ' ' THR . 51.2 tt0 -95.79 2.87 54.07 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.25 0.548 . . . . 64.329999999999998 110.152 -177.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.793 HD11 ' HB3' ' A' ' 139' ' ' PRO . 85.5 mt -68.5 127.72 34.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.736 -0.666 . . . . 75.140000000000001 110.071 176.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 44.3 ttp180 -78.1 103.45 8.05 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.555 0.693 . . . . 64.430000000000007 109.292 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.543 ' O ' ' HA ' ' A' ' 101' ' ' LEU . 3.7 m -113.5 140.28 48.26 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.078 -0.964 . . . . 74.109999999999999 109.516 -172.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.655 ' HB3' HD11 ' A' ' 134' ' ' ILE . 35.4 ttm105 -130.83 106.22 8.3 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.721 -0.392 . . . . 75.230000000000004 111.318 -173.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.5 p -90.05 130.73 38.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 109.708 -0.478 . . . . 62.140000000000001 109.708 179.039 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.2 m -123.1 120.07 32.17 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.18 -0.464 . . . . 62.25 109.95 -178.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HD12 ' A' ' 153' ' ' LEU . 4.4 pp -85.42 147.45 26.49 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 120.065 -0.654 . . . . 72.120000000000005 110.392 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.617 ' HG3' ' HG3' ' A' ' 130' ' ' GLU . 25.7 mmt -78.17 112.75 15.45 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.083 0.468 . . . . 73.409999999999997 110.293 178.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.706 HD23 ' H ' ' A' ' 155' ' ' LEU . 2.5 pt? -118.59 162.24 18.72 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.432 -0.803 . . . . 73.540000000000006 110.641 -176.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.439 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 29.8 t-80 72.18 129.55 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.424 0 O-C-N 124.112 0.883 . . . . 64.319999999999993 111.83 177.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 74.56 -62.33 0.46 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 115.469 -0.787 . . . . 61.240000000000002 111.878 171.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.462 ' HA ' ' OG ' ' A' ' 128' ' ' SER . 55.4 m 69.62 144.16 0.05 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.479 0.657 . . . . 75.040000000000006 111.682 -178.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.448 HD23 ' H ' ' A' ' 159' ' ' LEU . 2.4 pt? -138.24 157.61 45.94 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.821 -0.627 . . . . 45.549999999999997 109.388 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -84.59 124.53 31.53 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-O 121.366 0.603 . . . . 75.120000000000005 112.166 -177.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.408 ' HB2' ' CE1' ' A' ' 62' ' ' PHE . 15.5 m80 -121.58 164.29 17.5 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 108.091 -1.078 . . . . 71.129999999999995 108.091 167.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 62.05 69.33 0.63 Allowed 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 109.124 -0.695 . . . . 70.420000000000002 109.124 -173.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 28.7 m170 64.98 -177.59 0.18 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 115.435 -0.802 . . . . 74.450000000000003 111.332 -174.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -167.3 139.41 3.28 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.453 -0.794 . . . . 73.400000000000006 109.06 176.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 54.0 t-80 -75.58 123.13 24.97 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 121.149 0.499 . . . . 74.329999999999998 111.54 -172.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 66.0 t60 . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.147 -0.93 . . . . 72.349999999999994 108.895 173.254 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtm . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 110.247 -0.279 . . . . 74.099999999999994 110.247 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -168.47 -171.84 1.55 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.496 -0.557 . . . . 71.150000000000006 109.496 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -137.29 63.15 1.57 Allowed 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.561 -0.903 . . . . 75.040000000000006 108.561 173.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.455 ' HG3' ' SG ' ' A' ' 5' ' ' CYS . 13.7 pt-20 -103.92 -162.93 0.93 Allowed 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.092 -0.958 . . . . 70.019999999999996 110.193 -177.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.457 ' SG ' ' HD2' ' A' ' 105' ' ' PRO . 54.8 m 69.2 -175.33 0.2 Allowed 'General case' 0 C--O 1.235 0.331 0 O-C-N 123.461 0.476 . . . . 65.099999999999994 110.984 177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.65 ' HG2' ' H ' ' A' ' 7' ' ' PHE . 47.3 tt0 -156.33 -178.08 7.06 Favored 'General case' 0 N--CA 1.444 -0.748 0 N-CA-C 108.308 -0.997 . . . . 72.040000000000006 108.308 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.65 ' H ' ' HG2' ' A' ' 6' ' ' GLN . 39.1 p90 -164.11 153.4 13.92 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 109.936 -0.394 . . . . 75.209999999999994 109.936 -177.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.5 t -121.58 108.98 23.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 110.073 -0.343 . . . . 52.009999999999998 110.073 178.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.588 ' HA ' ' OG ' ' A' ' 100' ' ' SER . 3.1 p -76.56 113.03 13.73 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.241 -0.436 . . . . 55.420000000000002 111.184 -179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -136.74 179.37 6.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.337 0.589 . . . . 72.420000000000002 110.627 -178.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.803 ' HB2' ' HH2' ' A' ' 119' ' ' TRP . 0.7 OUTLIER -98.45 121.65 40.65 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 107.879 -1.156 . . . . 64.430000000000007 107.879 166.432 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 99' ' ' SER . 13.4 ttmm -119.69 130.94 55.28 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 120.564 -0.454 . . . . 72.310000000000002 110.22 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.503 ' HA ' ' HA ' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -79.74 149.06 31.26 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.43 -0.805 . . . . 74.319999999999993 111.495 -172.959 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.0 mp -103.65 144.71 31.08 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.164 -0.925 . . . . 72.099999999999994 108.833 172.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.503 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -122.94 158.87 56.09 Favored Pre-proline 0 C--N 1.317 -0.813 0 CA-C-N 116.562 -0.29 . . . . 43.039999999999999 110.49 -176.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.408 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 36.5 Cg_exo -61.88 102.92 0.26 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.601 2.2 . . . . 73.25 111.211 174.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 15' ' ' ALA . 65.1 t -117.88 89.99 35.39 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.622 -0.717 . . . . 73.329999999999998 111.185 -175.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.427 ' HD2' ' HA ' ' A' ' 17' ' ' VAL . 19.3 Cg_endo -58.77 111.51 0.91 Allowed 'Trans proline' 0 N--CA 1.462 -0.339 0 C-N-CA 122.312 2.008 . . . . 73.409999999999997 110.72 173.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -134.18 164.13 28.06 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.138 0.494 . . . . 33.219999999999999 111.272 -173.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.632 HD12 HG12 ' A' ' 87' ' ' VAL . 4.6 mm? -105.26 128.91 53.68 Favored 'General case' 0 C--O 1.244 0.796 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 108.896 174.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.832 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -153.38 160.34 42.62 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.859 -0.609 . . . . 73.299999999999997 111.48 -175.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 87' ' ' VAL . 4.4 mp -118.79 160.55 18.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.127 -1.064 . . . . 55.0 108.127 174.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 27.6 ptt180 -93.83 100.11 12.36 Favored 'General case' 0 C--N 1.316 -0.874 0 O-C-N 121.869 -0.519 . . . . 62.229999999999997 109.874 173.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 19.5 m -112.04 157.03 21.24 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 110.082 -0.34 . . . . 72.5 110.082 -176.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -130.85 135.67 47.94 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.514 -0.55 . . . . 61.340000000000003 109.514 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 2.9 t -89.86 100.52 13.32 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-O 121.458 0.647 . . . . 74.019999999999996 111.041 -177.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.93 125.59 49.8 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.917 -0.583 . . . . 41.43 110.88 177.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 27.7 ttt 64.88 -82.23 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.208 -0.905 . . . . 71.530000000000001 112.543 173.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.0 m -120.1 -9.04 9.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.06 0.393 . . . . 42.020000000000003 112.06 -171.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.68 -31.13 71.23 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.795 0.665 . . . . 73.340000000000003 112.795 -171.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 2.8 tm? -45.2 -59.31 2.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 122.876 0.47 . . . . 64.200000000000003 112.131 -173.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -72.83 -36.65 57.61 Favored Glycine 0 CA--C 1.516 0.133 0 C-N-CA 120.495 -0.859 . . . . 74.400000000000006 113.072 -175.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 25.4 m -74.74 -31.1 61.71 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.024 0.379 . . . . 74.439999999999998 112.024 -173.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 31' ' ' LEU . 4.4 pp -67.83 -27.97 67.16 Favored 'General case' 0 C--O 1.226 -0.147 0 C-N-CA 121.009 -0.276 . . . . 63.219999999999999 111.36 -176.252 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 55.8 m-85 -74.06 -57.22 4.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.9 -0.32 . . . . 74.439999999999998 110.458 177.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -58.19 -52.31 66.08 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.169 -0.469 . . . . 73.319999999999993 112.019 -176.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -22.56 42.64 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.312 -0.404 . . . . 74.219999999999999 111.171 -176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.565 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -62.49 -56.62 20.57 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.848 -0.691 . . . . 65.129999999999995 112.981 -175.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.487 ' O ' ' HB2' ' A' ' 43' ' ' LEU . 38.7 p90 -72.48 -19.85 61.48 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 117.168 0.484 . . . . 74.5 110.55 -176.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -72.26 -39.69 68.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.916 -0.584 . . . . 60.439999999999998 110.619 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -81.62 -45.1 16.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.937 -0.574 . . . . 74.540000000000006 111.598 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.626 HD12 ' HE1' ' A' ' 75' ' ' PHE . 19.7 pt -82.53 0.11 4.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 112.113 0.412 . . . . 72.109999999999999 112.113 -174.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.487 ' HB2' ' O ' ' A' ' 39' ' ' TYR . 52.9 tp -63.92 -26.47 68.61 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.915 0.388 . . . . 74.099999999999994 110.803 -179.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 68.6 mt-30 -56.73 -32.56 65.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.813 -0.63 . . . . 74.340000000000003 111.669 -178.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 61.6 tp -60.89 -44.33 97.26 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.479 -0.328 . . . . 62.530000000000001 111.149 -176.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 75' ' ' PHE . 4.6 mm? -86.05 -33.42 21.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.523 -0.308 . . . . 64.329999999999998 110.937 -178.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.54 -18.53 61.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.384 -0.371 . . . . 75.349999999999994 111.114 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.36 0.66 88.6 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.065 -0.588 . . . . 72.299999999999997 111.81 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.67 HE22 HG13 ' A' ' 81' ' ' VAL . 71.3 mt-30 -117.0 -47.68 2.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.12 0.486 . . . . 61.329999999999998 109.701 177.247 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 106.18 34.42 3.18 Favored Glycine 0 N--CA 1.447 -0.61 0 CA-C-N 115.546 -0.752 . . . . 71.340000000000003 111.335 -176.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -119.98 164.04 16.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.198 0.523 . . . . 71.209999999999994 111.37 -176.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.1 p -123.68 159.09 57.23 Favored Pre-proline 0 C--N 1.318 -0.768 0 CA-C-N 115.267 -0.879 . . . . 64.430000000000007 109.748 175.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.96 144.47 99.46 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.507 2.138 . . . . 61.520000000000003 111.824 176.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.0 t -76.53 -13.71 60.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.105 0.478 . . . . 63.539999999999999 110.535 -178.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.58 -179.53 34.45 Favored Glycine 0 N--CA 1.444 -0.769 0 N-CA-C 110.415 -1.074 . . . . 64.340000000000003 110.415 177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.698 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 42.6 Cg_endo -68.63 151.84 74.8 Favored 'Trans proline' 0 N--CA 1.461 -0.395 0 C-N-CA 121.982 1.788 . . . . 62.5 111.766 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 17.1 Cg_exo -68.79 153.72 72.48 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.781 2.321 . . . . 75.310000000000002 111.911 177.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HB3' HG22 ' A' ' 134' ' ' ILE . 33.1 p90 -132.48 122.77 25.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.179 -0.464 . . . . 64.25 110.075 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -90.55 114.73 27.02 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.614 -0.513 . . . . 74.340000000000003 109.614 -175.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.497 ' CG ' ' HB3' ' A' ' 72' ' ' GLU . 5.1 ptm180 -98.91 136.19 39.26 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.282 -0.872 . . . . 64.200000000000003 111.156 -174.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.429 ' CD2' HG12 ' A' ' 71' ' ' VAL . 25.7 m-85 -127.86 108.62 10.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 114.71 -1.132 . . . . 75.230000000000004 108.781 177.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.932 ' HB3' ' HB2' ' A' ' 70' ' ' GLU . 77.7 t80 -91.86 108.64 20.07 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.105 0.478 . . . . 74.329999999999998 109.857 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.5 170.74 40.39 Favored Glycine 0 N--CA 1.443 -0.858 0 CA-C-N 115.058 -0.973 . . . . 74.329999999999998 112.119 -179.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.529 ' HB2' HD12 ' A' ' 159' ' ' LEU . 21.7 mmt -121.88 -41.87 2.43 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.277 -0.638 . . . . 63.32 109.277 173.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 18.5 t 59.68 -161.19 0.27 Allowed 'General case' 0 C--O 1.236 0.39 0 CA-C-N 115.477 -0.783 . . . . 73.040000000000006 110.663 173.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.85 44.27 1.05 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.248 -0.433 . . . . 75.010000000000005 110.599 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 126.73 -57.87 0.7 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.494 -0.86 . . . . 74.450000000000003 112.901 177.082 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 16.7 m -96.13 125.33 40.58 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.724 0.297 . . . . 75.299999999999997 110.678 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.42 ' HE2' ' HD2' ' A' ' 61' ' ' TYR . 36.8 p90 -142.31 177.52 8.19 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.408 -0.36 . . . . 65.530000000000001 110.304 178.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.932 ' HB2' ' HB3' ' A' ' 62' ' ' PHE . 12.8 mm-40 -88.12 142.05 28.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.998 -0.281 . . . . 75.010000000000005 110.256 -173.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.429 HG12 ' CD2' ' A' ' 61' ' ' TYR . 16.5 m -142.75 161.23 18.45 Favored 'Isoleucine or valine' 0 C--O 1.244 0.776 0 CA-C-O 121.271 0.558 . . . . 71.409999999999997 111.562 -179.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.832 ' HG2' ' HB2' ' A' ' 21' ' ' LEU . 18.9 tp10 -165.95 145.04 6.06 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.972 -1.013 . . . . 65.129999999999995 110.696 171.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -66.94 -46.76 73.77 Favored 'General case' 0 C--O 1.225 -0.195 0 CA-C-N 115.793 -0.639 . . . . 64.319999999999993 109.874 176.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 57.14 102.35 0.01 OUTLIER Glycine 0 C--N 1.338 0.658 0 O-C-N 124.022 0.826 . . . . 51.329999999999998 114.77 170.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.626 ' HE1' HD12 ' A' ' 42' ' ' ILE . 46.8 p90 -120.63 141.67 32.71 Favored Pre-proline 0 C--N 1.325 -0.487 0 O-C-N 121.71 -0.876 . . . . 75.209999999999994 110.594 177.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 10.2 Cg_endo -90.39 141.09 3.31 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 123.417 2.745 . . . . 75.530000000000001 113.001 -176.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 30.1 m -116.45 -174.72 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.826 -0.624 . . . . 73.400000000000006 109.805 178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.3 -30.36 18.5 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.762 -0.375 . . . . 75.310000000000002 111.095 -177.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 138.17 -7.08 3.44 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.817 -0.706 . . . . 65.329999999999998 112.201 177.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -110.59 47.96 0.99 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.552 -0.619 . . . . 74.420000000000002 111.552 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.67 HG13 HE22 ' A' ' 49' ' ' GLN . 39.4 t -130.87 157.81 43.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 108.473 -0.936 . . . . 72.439999999999998 108.473 178.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -130.68 159.83 36.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 110.306 -0.257 . . . . 74.450000000000003 110.306 -173.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -90.72 167.79 32.49 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.074 -0.584 . . . . 62.140000000000001 111.889 -178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 22.8 t -162.68 108.54 1.19 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.834 0.349 . . . . 75.430000000000007 110.931 -178.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.98 -97.16 0.49 Allowed Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 115.776 -0.647 . . . . 51.420000000000002 113.131 173.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 47.0 mtm180 -81.89 -45.54 15.32 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 74.530000000000001 110.715 -178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.632 HG12 HD12 ' A' ' 20' ' ' LEU . 14.2 t -80.01 113.96 20.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.523 -0.762 . . . . 65.219999999999999 109.891 -176.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 30.6 m -112.76 156.12 13.84 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.974 0.416 . . . . 70.319999999999993 110.907 -178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -82.92 142.33 31.51 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.536 -0.756 . . . . 65.129999999999995 110.374 177.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -154.36 166.8 32.29 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.692 -0.766 . . . . 53.299999999999997 111.859 178.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.5 tt -141.61 129.32 21.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.661 -0.496 . . . . 52.299999999999997 109.661 178.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.0 t -82.74 143.4 46.76 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 116.256 -0.429 . . . . 64.230000000000004 110.021 -179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -68.21 150.54 76.86 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 122.577 2.185 . . . . 74.319999999999993 112.592 -178.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.408 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 13.3 p -84.01 148.86 26.64 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.941 -0.572 . . . . 54.030000000000001 110.403 177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 161.41 -140.08 6.41 Favored Glycine 0 N--CA 1.445 -0.747 0 N-CA-C 111.436 -0.666 . . . . 71.450000000000003 111.436 -178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -159.29 151.27 20.79 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.983 0.42 . . . . 65.030000000000001 111.443 179.181 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -148.68 175.5 11.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.759 -0.655 . . . . 53.530000000000001 110.383 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.711 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -79.18 114.13 17.87 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.915 0.388 . . . . 73.420000000000002 110.188 178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 12' ' ' LYS . 47.5 t -143.38 147.39 34.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.889 -0.596 . . . . 73.400000000000006 110.431 -176.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.588 ' OG ' ' HA ' ' A' ' 9' ' ' CYS . 21.9 m -137.26 152.94 50.38 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.494 -0.558 . . . . 73.129999999999995 109.494 177.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 101' ' ' LEU . 1.7 pp -91.52 133.87 35.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.47 0.652 . . . . 73.329999999999998 110.861 176.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 44.1 t80 -111.76 116.24 30.4 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.05 -0.977 . . . . 74.219999999999999 109.312 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.456 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 55.6 mt -115.71 110.13 30.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.306 -0.406 . . . . 74.310000000000002 111.306 -174.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.72 -163.58 27.93 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.077 -0.583 . . . . 63.340000000000003 111.941 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.457 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 11.3 Cg_exo -71.3 -175.66 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 123.032 2.488 . . . . 74.239999999999995 111.367 175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -96.56 134.85 39.25 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 122.134 -0.354 . . . . 75.040000000000006 110.822 -177.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 150.29 -51.77 0.52 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.892 -0.67 . . . . 61.240000000000002 112.368 177.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -78.97 -0.64 31.89 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.063 0.459 . . . . 64.099999999999994 111.083 -174.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.8 tt -63.18 -16.23 17.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.943 -0.571 . . . . 72.439999999999998 111.04 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -63.71 -38.25 90.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.987 0.422 . . . . 64.319999999999993 110.159 176.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -67.86 -34.71 77.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.899 -0.592 . . . . 73.010000000000005 110.087 178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 22.1 t -64.5 -49.21 81.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.643 -0.708 . . . . 70.510000000000005 109.539 175.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.636 ' HA ' HD11 ' A' ' 153' ' ' LEU . 9.9 t80 -54.94 -48.81 72.67 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.241 -0.89 . . . . 64.439999999999998 110.978 -178.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -72.45 -23.6 61.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.957 -0.565 . . . . 73.310000000000002 111.525 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -69.79 -37.48 76.32 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 63.32 112.031 -176.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.711 HD12 ' HB1' ' A' ' 98' ' ' ALA . 3.5 mm? -60.68 -29.17 69.15 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-O 120.558 0.218 . . . . 75.420000000000002 111.211 -178.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 14.9 tmm? -58.32 -39.68 80.06 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 63.420000000000002 110.433 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 9.9 ttpp -74.72 -35.9 62.69 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.209 -0.451 . . . . 63.210000000000001 110.332 -178.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.803 ' HH2' ' HB2' ' A' ' 11' ' ' LEU . 82.1 t90 -72.67 -43.22 63.39 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.834 -0.621 . . . . 64.030000000000001 111.087 -175.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.573 HG21 ' HB2' ' A' ' 155' ' ' LEU . 12.8 p -62.78 -38.31 81.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 65.420000000000002 110.895 -176.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -65.87 -35.07 79.63 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.697 -0.683 . . . . 64.530000000000001 110.549 176.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -69.17 -44.28 72.55 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.6 -0.727 . . . . 74.409999999999997 110.924 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -74.78 -35.6 62.54 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.211 -0.45 . . . . 74.349999999999994 110.95 -177.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.25 53.23 2.53 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.888 -0.672 . . . . 73.019999999999996 112.861 176.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.1 m-85 -138.42 169.23 18.15 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 110.241 -0.281 . . . . 72.150000000000006 110.241 178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.762 ' HB2' ' HA ' ' A' ' 156' ' ' HIS . 0.8 OUTLIER -167.38 126.39 1.35 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.555 -0.535 . . . . 74.019999999999996 109.555 171.02 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.725 ' HB2' HD21 ' A' ' 155' ' ' LEU . 3.4 mm? -130.07 127.97 40.97 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.017 -0.538 . . . . 74.219999999999999 110.226 179.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.4 m -87.45 76.79 8.97 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.158 0.504 . . . . 75.25 110.265 178.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -114.82 -124.81 3.94 Favored Glycine 0 N--CA 1.447 -0.567 0 CA-C-N 115.667 -0.697 . . . . 31.129999999999999 111.881 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.719 ' HB3' ' HD1' ' A' ' 62' ' ' PHE . 11.1 pt-20 -145.46 169.64 17.95 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 110.22 -0.289 . . . . 64.430000000000007 110.22 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -106.03 141.51 37.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.836 -0.431 . . . . 61.119999999999997 109.836 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -143.58 145.01 32.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.06 0.457 . . . . 71.120000000000005 111.053 178.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.634 ' HG2' HG23 ' A' ' 151' ' ' VAL . 38.4 mt-10 -122.12 124.18 43.3 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.401 -0.818 . . . . 61.409999999999997 109.188 178.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.551 HG12 ' HB3' ' A' ' 150' ' ' ARG . 29.3 pt -89.52 141.27 14.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 120.522 -0.471 . . . . 53.200000000000003 110.772 -179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.541 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 84.8 m-85 -122.96 110.14 15.01 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.714 -0.476 . . . . 74.140000000000001 109.714 178.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.698 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 6.8 mp -59.91 -40.25 88.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.393 -0.367 . . . . 71.299999999999997 110.653 -178.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.718 ' HB3' ' HB ' ' A' ' 142' ' ' THR . 3.9 t0 179.09 -174.18 0.19 Allowed 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.337 -1.357 . . . . 73.540000000000006 107.337 178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -96.86 149.6 35.93 Favored Pre-proline 0 C--N 1.319 -0.746 0 N-CA-C 109.625 -0.509 . . . . 62.539999999999999 109.625 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -57.34 155.42 30.2 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 123.034 2.489 . . . . 60.049999999999997 112.801 -176.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.61 -34.76 0.25 Allowed 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 123.867 0.867 . . . . 54.25 111.303 -179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 32.0 mm-40 -82.83 -41.93 18.46 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.228 0.537 . . . . 72.010000000000005 109.592 175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.718 ' HB ' ' HB3' ' A' ' 137' ' ' ASP . 7.3 t -105.4 178.42 4.57 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.689 -0.687 . . . . 72.510000000000005 109.895 175.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -45.17 93.22 0.06 OUTLIER Pre-proline 0 N--CA 1.472 0.655 0 C-N-CA 124.869 1.268 . . . . 64.319999999999993 113.481 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 142' ' ' THR . 37.8 Cg_endo -64.15 136.65 52.88 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.211 1.941 . . . . 64.349999999999994 111.539 -175.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 30.7 t70 75.05 -8.7 1.51 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.992 -1.004 . . . . 62.399999999999999 111.39 176.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 33.4 mt-30 -105.81 28.27 7.7 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.483 0.659 . . . . 74.140000000000001 109.65 -177.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.456 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 84.3 mt -81.28 100.43 9.16 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.021 -0.991 . . . . 64.129999999999995 110.844 -176.245 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 19.7 ptt180 -98.14 108.42 21.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.816 -0.629 . . . . 75.329999999999998 110.002 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.409 HG23 ' O ' ' A' ' 134' ' ' ILE . 25.3 m -102.15 116.85 33.54 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.937 -0.574 . . . . 74.120000000000005 111.154 -172.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.551 ' HB3' HG12 ' A' ' 134' ' ' ILE . 30.1 ttm180 -79.89 101.24 8.45 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.837 -0.431 . . . . 75.200000000000003 109.837 175.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.634 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.6 p -101.05 121.14 51.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 121.189 0.519 . . . . 62.420000000000002 109.895 176.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 23.0 t -114.67 132.22 56.47 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 108.949 -0.76 . . . . 65.340000000000003 108.949 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.636 HD11 ' HA ' ' A' ' 113' ' ' TYR . 61.9 mt -118.34 169.09 10.02 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.064 0.459 . . . . 71.319999999999993 112.139 -171.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 84.0 mtp -74.87 93.14 2.61 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.598 -0.728 . . . . 61.450000000000003 109.421 174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.774 HD23 ' H ' ' A' ' 155' ' ' LEU . 2.1 pt? -71.76 -8.83 56.59 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.176 0.435 . . . . 64.030000000000001 112.176 -173.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.762 ' HA ' ' HB2' ' A' ' 126' ' ' ASP . 79.3 t60 -62.01 -52.75 62.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.805 0.336 . . . . 74.25 110.194 174.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 53.8 mt-10 -147.13 110.5 4.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.095 -0.502 . . . . 72.510000000000005 110.383 -179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.9 m -82.01 124.89 30.19 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.585 -0.524 . . . . 73.420000000000002 109.585 175.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.529 HD12 ' HB2' ' A' ' 64' ' ' MET . 80.1 mt -100.05 149.35 23.58 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 120.777 0.322 . . . . 71.0 110.398 -175.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 64.28 89.67 0.09 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.922 -1.035 . . . . 72.299999999999997 111.213 -177.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 2.8 t60 -72.62 92.05 1.48 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.329 -0.85 . . . . 53.25 109.522 176.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 31.5 t-80 -79.79 -90.6 0.05 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.985 -0.552 . . . . 70.299999999999997 110.335 -175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -170.62 142.63 2.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 60.119999999999997 110.13 -178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 35.2 p-80 -144.98 156.68 44.1 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.964 -0.754 . . . . 62.229999999999997 108.964 175.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -154.13 147.57 25.02 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.798 -0.361 . . . . 64.109999999999999 110.517 -176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 54.0 m-70 . . . . . 0 C--O 1.245 0.863 0 CA-C-O 118.725 -0.655 . . . . 74.140000000000001 109.706 175.151 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.9 mtt . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.389 -0.226 . . . . 33.310000000000002 110.389 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 64.71 -83.42 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.575 0.75 . . . . 65.319999999999993 112.559 176.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 61.4 t80 -76.03 80.64 2.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.394 0.616 . . . . 74.109999999999999 111.023 -174.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -146.4 180.0 7.14 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.157 -0.928 . . . . 74.319999999999993 109.002 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.583 ' SG ' ' HA3' ' A' ' 104' ' ' GLY . 57.4 m 58.45 40.69 23.8 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.537 0.523 . . . . 64.439999999999998 111.433 174.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.71 85.17 1.64 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.308 0.575 . . . . 75.099999999999994 110.518 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 2.7 p90 -68.74 112.73 5.65 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.725 -0.671 . . . . 71.349999999999994 111.063 179.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -92.5 133.2 34.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.721 -0.672 . . . . 71.420000000000002 110.131 177.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -99.14 122.07 41.86 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.098 -0.501 . . . . 71.109999999999999 110.88 -176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -122.06 136.41 54.91 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.142 -0.481 . . . . 75.239999999999995 110.423 177.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD21 ' HD3' ' A' ' 96' ' ' LYS . 8.9 tt -90.22 117.64 29.12 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.235 -1.024 . . . . 53.549999999999997 108.235 171.143 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.437 ' HB3' ' HE3' ' A' ' 12' ' ' LYS . 24.3 mmmt -129.19 177.01 7.46 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.143 0.497 . . . . 72.019999999999996 111.625 -175.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 19.3 mp0 -87.68 145.56 26.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.289 -0.869 . . . . 64.219999999999999 109.796 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.428 HD12 ' O ' ' A' ' 93' ' ' PRO . 0.2 OUTLIER -122.52 109.92 14.94 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.831 -0.803 . . . . 74.530000000000001 108.831 174.27 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -93.83 143.72 26.98 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.053 -0.521 . . . . 74.299999999999997 110.52 -178.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -79.36 105.24 1.86 Allowed 'Trans proline' 0 N--CA 1.455 -0.752 0 C-N-CA 122.557 2.171 . . . . 71.200000000000003 111.673 177.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.9 t -119.22 141.99 31.49 Favored Pre-proline 0 C--N 1.318 -0.775 0 CA-C-N 115.683 -0.689 . . . . 64.430000000000007 109.268 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -67.17 102.21 0.66 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.284 1.989 . . . . 71.439999999999998 111.656 175.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 1.091 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -93.08 149.05 21.5 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.989 -0.551 . . . . 73.239999999999995 109.94 179.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.68 HD11 HD23 ' A' ' 45' ' ' LEU . 0.8 OUTLIER -109.93 122.4 47.48 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.796 -0.816 . . . . 71.010000000000005 108.796 178.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.912 ' HG ' ' HB3' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -159.53 173.06 16.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.361 0.601 . . . . 74.409999999999997 112.298 -175.828 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 22' ' ' ILE . 4.0 mp -104.08 105.56 18.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 107.549 -1.278 . . . . 72.439999999999998 107.549 165.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HB3' ' HG2' ' A' ' 72' ' ' GLU . 38.2 ptt180 -90.92 119.88 31.48 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.202 0.525 . . . . 73.409999999999997 110.202 -177.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.2 t -149.73 167.57 26.09 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.084 -0.507 . . . . 64.540000000000006 110.597 -177.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 -92.37 155.0 18.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.26 -0.427 . . . . 64.329999999999998 109.855 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.9 t -157.26 147.61 21.05 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.827 -0.434 . . . . 70.430000000000007 109.827 177.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.85 155.23 48.19 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 116.07 -0.514 . . . . 72.230000000000004 110.089 177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 55.0 mtm 64.58 -162.1 0.27 Allowed 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.72 0.771 . . . . 75.099999999999994 111.101 173.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.6 m -74.9 19.41 0.14 Allowed 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 114.665 -1.152 . . . . 50.420000000000002 112.289 -175.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -73.26 -22.63 60.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.925 0.393 . . . . 70.109999999999999 110.888 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 32' ' ' GLY . 3.8 pp -53.28 -32.54 49.18 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 115.774 -0.648 . . . . 74.030000000000001 112.416 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.453 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -61.76 -53.38 43.82 Favored Glycine 0 C--N 1.33 0.242 0 C-N-CA 120.78 -0.724 . . . . 73.549999999999997 112.092 179.658 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 12.5 m -70.54 -31.0 67.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.11 0.481 . . . . 71.019999999999996 110.489 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -62.48 -53.41 55.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.847 -0.615 . . . . 75.230000000000004 110.244 -179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -67.82 -40.41 83.8 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.664 -0.244 . . . . 51.310000000000002 111.45 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 29.2 tp10 -54.95 -46.55 75.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 120.833 0.349 . . . . 75.510000000000005 111.269 -179.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -27.02 40.02 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.926 0.393 . . . . 62.25 110.625 178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -60.36 -54.72 34.85 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.614 -0.721 . . . . 74.010000000000005 113.325 -177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 33.1 p90 -73.61 -15.25 61.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.231 0.516 . . . . 74.439999999999998 110.696 -178.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.9 t60 -69.72 -45.86 67.26 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.071 -0.513 . . . . 64.540000000000006 110.805 177.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -102.29 -1.29 31.37 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.859 0.318 . . . . 63.350000000000001 111.859 -170.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 16.3 tt -67.14 -21.82 28.54 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.101 0.477 . . . . 65.319999999999993 110.979 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -71.08 -15.16 62.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.365 -0.38 . . . . 64.25 111.311 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -56.78 -44.89 82.3 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.975 0.417 . . . . 63.119999999999997 111.24 -178.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.68 HD23 HD11 ' A' ' 20' ' ' LEU . 46.0 tp -74.73 -37.54 62.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.261 -0.427 . . . . 73.329999999999998 110.986 -177.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.9 mt -65.92 -32.18 73.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.643 0.259 . . . . 72.140000000000001 110.638 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.13 -25.09 67.93 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.187 -0.46 . . . . 70.239999999999995 110.72 175.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.3 -39.6 70.82 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.874 -0.679 . . . . 50.32 111.796 177.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.528 HE22 ' HG ' ' A' ' 45' ' ' LEU . 2.0 mp0 -79.32 -30.63 42.9 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.402 . . . . 75.219999999999999 110.086 176.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 92.08 26.51 18.72 Favored Glycine 0 N--CA 1.446 -0.65 0 CA-C-N 115.732 -0.667 . . . . 65.340000000000003 112.646 177.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -127.43 176.89 7.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.989 0.424 . . . . 74.439999999999998 111.428 -178.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.488 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 22.6 p -108.75 164.56 14.45 Favored Pre-proline 0 C--N 1.322 -0.602 0 CA-C-N 115.602 -0.726 . . . . 74.340000000000003 110.435 -178.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 11.8 Cg_endo -56.44 137.25 79.68 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.929 2.42 . . . . 71.319999999999993 112.411 177.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.6 m -91.44 7.52 40.77 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.047 -0.524 . . . . 73.540000000000006 111.046 -178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.17 179.42 48.15 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.794 -0.717 . . . . 75.439999999999998 112.129 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -81.43 168.86 16.13 Favored 'Trans proline' 0 CA--C 1.533 0.428 0 C-N-CA 123.108 2.539 . . . . 53.030000000000001 111.786 176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -68.12 132.54 26.37 Favored 'Trans proline' 0 C--O 1.238 0.488 0 C-N-CA 122.591 2.194 . . . . 72.329999999999998 113.13 -178.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.508 ' CE1' HG23 ' A' ' 134' ' ' ILE . 36.4 m-85 -125.77 117.49 23.52 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.078 -0.712 . . . . 65.150000000000006 109.078 174.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.591 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -99.84 113.14 25.46 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.976 0.417 . . . . 74.349999999999994 111.407 -175.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.615 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 4.9 ptm180 -104.23 140.03 38.41 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.551 -0.537 . . . . 75.25 109.551 174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.746 ' HD1' HG12 ' A' ' 71' ' ' VAL . 16.1 m-85 -123.12 116.57 23.67 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.1 -0.5 . . . . 63.409999999999997 111.08 -173.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.756 ' HB2' ' HB2' ' A' ' 70' ' ' GLU . 74.4 m-85 -88.13 107.96 19.03 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.225 -0.658 . . . . 72.219999999999999 109.225 171.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 166.77 -100.87 0.17 Allowed Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.387 -0.911 . . . . 70.129999999999995 112.0 178.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 96.5 mmm 67.24 -65.72 0.22 Allowed 'General case' 0 N--CA 1.464 0.228 0 C-N-CA 123.381 0.672 . . . . 74.030000000000001 111.843 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 56.8 m -100.0 -73.44 0.63 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 113.108 0.781 . . . . 74.329999999999998 113.108 -172.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -128.36 140.67 51.73 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 113.215 0.82 . . . . 72.109999999999999 113.215 -168.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 112.35 -98.66 0.99 Allowed Glycine 0 N--CA 1.444 -0.814 0 CA-C-N 115.523 -0.762 . . . . 73.430000000000007 112.754 170.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -141.32 152.52 44.5 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 109.363 -0.606 . . . . 73.530000000000001 109.363 -174.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -104.67 114.18 28.23 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.196 0.522 . . . . 70.409999999999997 109.685 177.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.756 ' HB2' ' HB2' ' A' ' 62' ' ' PHE . 33.2 mt-10 -111.61 140.56 46.12 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.188 -0.915 . . . . 70.230000000000004 110.375 -175.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.746 HG12 ' HD1' ' A' ' 61' ' ' TYR . 34.7 m -126.26 132.91 69.93 Favored 'Isoleucine or valine' 0 C--O 1.242 0.668 0 CA-C-O 121.291 0.567 . . . . 73.040000000000006 112.085 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.912 ' HB3' ' HG ' ' A' ' 21' ' ' LEU . 52.6 mt-10 -124.58 88.37 2.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 114.92 -1.036 . . . . 75.109999999999999 108.48 169.214 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 24.6 p90 -78.73 -2.28 38.61 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 113.652 0.982 . . . . 71.25 113.652 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.857 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -74.93 -158.96 6.84 Favored Glycine 0 C--O 1.227 -0.335 0 C-N-CA 120.946 -0.645 . . . . 74.329999999999998 114.59 -169.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.408 ' CZ ' ' HB3' ' A' ' 53' ' ' PRO . 6.8 p90 -142.67 146.77 39.62 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.539 -0.331 . . . . 74.200000000000003 110.562 -175.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 1.091 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 38.1 Cg_endo -66.39 149.36 84.84 Favored 'Trans proline' 0 C--O 1.233 0.245 0 C-N-CA 122.669 2.246 . . . . 64.530000000000001 112.621 -179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 31.6 m -116.62 170.18 6.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 115.773 -0.648 . . . . 73.349999999999994 110.076 177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -86.4 -65.29 1.03 Allowed 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.049 0.452 . . . . 75.319999999999993 110.797 -178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -173.43 166.91 39.43 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.827 -0.702 . . . . 70.450000000000003 111.887 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.84 25.29 76.01 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 121.028 -0.606 . . . . 33.420000000000002 111.883 -177.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.471 HG13 HE21 ' A' ' 49' ' ' GLN . 6.2 t -126.96 151.08 33.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 109.923 -0.399 . . . . 70.219999999999999 109.923 -178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HD21 ' A' ' 45' ' ' LEU . 29.8 tt0 -149.53 162.32 40.39 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.48 -0.563 . . . . 62.539999999999999 109.48 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 88' ' ' VAL . . . -112.48 152.1 17.95 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.96 -0.638 . . . . 73.099999999999994 112.352 -179.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -145.32 120.31 10.02 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.779 0.323 . . . . 51.0 110.866 -176.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 70.79 -112.41 4.23 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.169 -0.539 . . . . 41.539999999999999 112.95 175.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -77.36 -49.22 15.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.178 0.513 . . . . 64.239999999999995 110.574 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.35 99.6 7.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.595 -0.73 . . . . 71.239999999999995 109.551 -178.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.782 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 16.8 m -126.91 -170.32 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.07 0.462 . . . . 63.310000000000002 110.925 -175.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.426 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -115.19 155.22 27.58 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.099 -0.5 . . . . 73.319999999999993 110.875 178.539 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -145.32 151.68 23.84 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.126 -0.943 . . . . 74.319999999999993 111.164 179.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 11.1 mp -101.09 138.79 37.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.995 0.426 . . . . 61.210000000000001 111.066 -179.505 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.2 p -80.47 160.46 67.38 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 115.404 -0.816 . . . . 62.240000000000002 111.346 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.428 ' O ' HD12 ' A' ' 14' ' ' LEU . 47.1 Cg_exo -56.72 143.38 90.14 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.807 2.338 . . . . 75.299999999999997 112.369 178.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.9 m -106.3 132.45 52.33 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.402 -0.363 . . . . 72.340000000000003 110.755 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 129.19 -119.99 3.1 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.781 -0.723 . . . . 60.200000000000003 112.122 177.162 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HD3' HD21 ' A' ' 11' ' ' LEU . 93.2 mttt -125.83 155.54 40.98 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.931 -0.396 . . . . 74.310000000000002 109.931 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -143.72 153.32 42.32 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.401 -0.363 . . . . 62.420000000000002 110.823 -178.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -93.79 109.03 20.73 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.039 -0.528 . . . . 54.140000000000001 109.643 176.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 22.3 p -113.66 120.56 41.31 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 120.972 0.415 . . . . 73.349999999999994 111.363 -174.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 20.7 m -132.56 135.42 45.93 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.296 -0.411 . . . . 65.109999999999999 110.174 179.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.851 ' HB3' ' HG2' ' A' ' 150' ' ' ARG . 3.2 pp -111.58 140.15 46.43 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.508 -0.477 . . . . 74.040000000000006 110.705 178.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.542 ' CE1' ' HB ' ' A' ' 149' ' ' THR . 44.6 p90 -115.82 137.46 52.07 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.589 -0.445 . . . . 74.329999999999998 110.139 175.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.648 ' HB ' ' O ' ' A' ' 145' ' ' ASP . 0.1 OUTLIER -112.71 106.76 21.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 CA-C-N 115.44 -0.8 . . . . 75.200000000000003 110.408 -178.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.651 ' HA2' ' H ' ' A' ' 145' ' ' ASP . . . 163.28 -153.66 24.26 Favored Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.36 -0.924 . . . . 73.230000000000004 112.007 -177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.556 ' HD2' ' SG ' ' A' ' 5' ' ' CYS . 41.6 Cg_endo -66.82 150.93 83.22 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 122.602 2.201 . . . . 72.519999999999996 111.821 178.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -95.98 138.43 33.62 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.29 -0.633 . . . . 74.129999999999995 109.29 -177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 123.96 -39.27 2.21 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.71 -0.757 . . . . 64.420000000000002 111.408 -178.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -82.6 29.68 0.44 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.319 0.58 . . . . 74.129999999999995 110.839 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 19.1 tt -69.5 -13.27 17.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.765 -0.652 . . . . 74.340000000000003 110.017 178.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -64.56 -33.9 77.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.766 -0.652 . . . . 72.239999999999995 110.646 176.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.84 -32.12 73.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.331 0.586 . . . . 65.219999999999999 109.771 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.515 ' O ' ' HG ' ' A' ' 116' ' ' LEU . 42.4 t -70.9 -44.79 75.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.413 -0.812 . . . . 60.420000000000002 109.509 175.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -60.6 -34.19 73.85 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-N 116.021 -0.536 . . . . 72.109999999999999 111.341 178.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 117' ' ' MET . 0.3 OUTLIER -60.9 -41.45 96.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.962 0.41 . . . . 72.530000000000001 110.83 176.41 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -70.65 -42.58 70.64 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.044 0.45 . . . . 73.409999999999997 110.058 175.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.758 HD13 HD21 ' A' ' 153' ' ' LEU . 95.3 mt -62.22 -43.55 98.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.692 -0.686 . . . . 73.310000000000002 111.94 -178.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 114' ' ' ASP . 26.7 ptm -65.72 -32.82 74.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.516 -0.311 . . . . 74.439999999999998 110.777 -177.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -79.19 -36.9 39.49 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.666 -0.413 . . . . 64.530000000000001 110.151 175.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 51.8 t90 -62.67 -47.5 83.42 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.034 -0.53 . . . . 74.439999999999998 110.597 -179.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.531 HG23 HD12 ' A' ' 155' ' ' LEU . 14.5 p -61.42 -40.01 84.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 110.206 179.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -62.48 -52.38 63.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.611 -0.722 . . . . 63.039999999999999 110.745 176.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.33 -34.54 72.48 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.575 -0.739 . . . . 70.150000000000006 111.402 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -83.09 -6.8 59.62 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.346 -0.388 . . . . 75.209999999999994 110.82 -177.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.42 9.21 67.21 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.027 -0.606 . . . . 75.140000000000001 113.875 174.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -97.3 177.86 5.41 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 117.192 0.496 . . . . 75.239999999999995 111.03 -178.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -129.67 158.19 40.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.215 -0.448 . . . . 73.420000000000002 110.099 -177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.4 ' N ' HD12 ' A' ' 127' ' ' LEU . 5.3 mp -86.65 115.64 24.24 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.769 0.319 . . . . 74.5 110.58 -177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.437 ' HB3' ' HB3' ' A' ' 154' ' ' MET . 32.2 t -77.6 -9.42 58.93 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.871 0.367 . . . . 55.109999999999999 111.198 -179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 91.84 -1.63 75.05 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.541 -0.838 . . . . 31.350000000000001 112.478 -179.322 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.62 ' HA ' ' O ' ' A' ' 61' ' ' TYR . 45.6 tt0 -101.7 126.55 48.57 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.962 0.41 . . . . 60.539999999999999 110.631 177.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -112.58 153.54 27.38 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.443 -0.799 . . . . 74.340000000000003 109.169 174.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.504 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 77.8 t80 -139.39 111.13 7.21 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.523 0.202 . . . . 73.230000000000004 110.573 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -108.37 119.81 40.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.187 0.517 . . . . 62.310000000000002 111.268 -179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.508 HG23 ' CE1' ' A' ' 58' ' ' PHE . 74.3 mt -85.37 119.0 33.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.575 -0.739 . . . . 75.120000000000005 110.237 176.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.441 ' HE2' ' HB3' ' A' ' 59' ' ' ALA . 91.3 m-85 -106.11 162.33 13.72 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.974 0.416 . . . . 70.010000000000005 111.074 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 137' ' ' ASP . 2.3 pt? -159.01 -47.23 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.663 -0.699 . . . . 74.409999999999997 109.656 176.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.466 ' N ' ' HG ' ' A' ' 136' ' ' LEU . 5.8 m-20 -133.68 146.88 51.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.809 -0.632 . . . . 65.409999999999997 109.427 176.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.497 ' O ' ' HB3' ' A' ' 141' ' ' GLU . 3.7 m-20 -92.38 158.41 38.84 Favored Pre-proline 0 C--N 1.32 -0.682 0 N-CA-C 110.17 -0.307 . . . . 75.030000000000001 110.17 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' C ' ' H ' ' A' ' 141' ' ' GLU . 14.9 Cg_endo -60.96 152.91 67.56 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 121.926 1.751 . . . . 62.409999999999997 111.152 174.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 70.81 -33.8 0.28 Allowed 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.578 0.751 . . . . 44.299999999999997 110.899 -175.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 138' ' ' ASN . 45.2 tt0 -71.87 -25.34 61.9 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.704 0.764 . . . . 65.439999999999998 109.093 174.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 14.9 t -145.58 162.89 36.41 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.851 -1.068 . . . . 75.140000000000001 108.65 170.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -78.58 148.4 73.21 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 112.964 0.727 . . . . 72.340000000000003 112.964 -170.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -55.15 154.87 21.09 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.8 2.333 . . . . 75.409999999999997 111.472 168.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.651 ' H ' ' HA2' ' A' ' 104' ' ' GLY . 16.3 t70 76.01 -34.7 0.24 Allowed 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 114.635 -1.166 . . . . 74.329999999999998 110.106 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -90.92 -12.67 35.36 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.716 -0.846 . . . . 65.420000000000002 108.716 170.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.568 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 1.3 tm? -72.19 95.4 1.67 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.669 -1.151 . . . . 65.310000000000002 108.567 173.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.513 ' HB3' HG22 ' A' ' 103' ' ' ILE . 18.2 ptt180 -105.13 112.56 25.73 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.312 0.577 . . . . 64.129999999999995 111.107 -177.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.542 ' HB ' ' CE1' ' A' ' 102' ' ' TYR . 25.4 m -109.07 118.51 36.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.469 -0.787 . . . . 51.049999999999997 109.999 179.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.851 ' HG2' ' HB3' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -97.14 95.91 8.08 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.776 0.322 . . . . 75.010000000000005 110.468 -176.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 7.9 p -98.71 136.6 29.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.066 0.46 . . . . 52.140000000000001 110.322 -179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 6.7 m -131.74 156.56 45.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.38 -178.082 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.758 HD21 HD13 ' A' ' 116' ' ' LEU . 2.6 mm? -111.01 154.23 24.45 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.557 -0.534 . . . . 51.210000000000001 109.557 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.599 ' HB2' ' HB3' ' A' ' 130' ' ' GLU . 0.3 OUTLIER -53.04 -50.84 63.47 Favored 'General case' 0 N--CA 1.448 -0.54 0 O-C-N 123.509 0.506 . . . . 73.530000000000001 110.355 176.788 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.531 HD12 HG23 ' A' ' 120' ' ' VAL . 16.8 tp 72.25 -53.46 0.69 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.184 0.809 . . . . 71.140000000000001 113.184 170.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.4 ' HB3' ' SD ' ' A' ' 154' ' ' MET . 40.0 t-80 -44.74 -58.81 2.84 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 113.575 0.954 . . . . 72.340000000000003 113.575 -170.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 128' ' ' SER . 40.6 tt0 -163.15 158.65 22.06 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 120.916 -0.314 . . . . 65.450000000000003 110.214 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.6 m -71.59 87.17 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.912 0.387 . . . . 73.340000000000003 111.095 179.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 7.8 tt -98.76 108.67 21.42 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.318 -0.623 . . . . 74.510000000000005 109.318 177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -79.94 148.29 31.28 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.927 -0.579 . . . . 75.109999999999999 109.906 -179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -119.47 93.78 4.19 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 121.432 0.634 . . . . 73.140000000000001 109.843 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -131.34 156.08 46.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.858 -0.61 . . . . 72.209999999999994 111.578 -174.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 29.4 m80 -148.99 -53.39 0.17 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.324 -0.853 . . . . 74.120000000000005 109.458 177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 61.02 -176.24 0.12 Allowed 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.476 -0.784 . . . . 65.310000000000002 110.208 -179.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 26.6 m80 -121.5 152.91 38.62 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 110.012 -0.366 . . . . 72.040000000000006 110.012 173.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 . . . . . 0 C--O 1.244 0.784 0 CA-C-O 118.472 -0.775 . . . . 74.140000000000001 110.072 -177.514 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.935 0 CA-C-O 121.202 0.525 . . . . 73.510000000000005 110.803 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -124.95 -52.79 1.66 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.939 -0.573 . . . . 73.230000000000004 110.156 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 65.35 -176.94 0.18 Allowed 'General case' 0 C--O 1.234 0.257 0 CA-C-N 115.361 -0.836 . . . . 74.530000000000001 110.841 -179.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -148.99 141.96 24.77 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.726 0.298 . . . . 74.430000000000007 110.31 -178.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.585 ' HA ' ' HB ' ' A' ' 103' ' ' ILE . 55.9 m -76.2 138.2 40.5 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.94 -0.573 . . . . 72.129999999999995 111.576 -177.452 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -97.64 66.5 1.96 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.791 0.805 . . . . 73.109999999999999 109.84 175.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -77.75 89.57 4.01 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.273 -0.876 . . . . 70.030000000000001 111.244 -177.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.558 HG12 ' HG3' ' A' ' 10' ' ' GLU . 34.9 t -93.64 106.3 17.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.371 -0.831 . . . . 64.540000000000006 109.501 175.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 58.3 m -75.78 103.41 5.86 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.764 -0.653 . . . . 74.209999999999994 110.776 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.558 ' HG3' HG12 ' A' ' 8' ' ' VAL . 43.8 mt-10 -131.15 159.61 37.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.054 -0.521 . . . . 74.310000000000002 110.98 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.592 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 48.7 tp -95.36 121.8 37.41 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.362 -0.835 . . . . 60.420000000000002 109.656 177.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.415 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 8.3 ptmm? -122.81 156.07 35.29 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 109.6 -0.519 . . . . 73.109999999999999 109.6 176.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.15 155.4 19.45 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.777 -0.647 . . . . 63.219999999999999 110.525 179.474 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.592 ' O ' ' HA ' ' A' ' 94' ' ' SER . 3.6 mm? -116.39 108.55 16.19 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.793 -0.639 . . . . 63.32 109.684 177.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.51 155.72 68.68 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-N 115.993 -0.549 . . . . 61.200000000000003 110.922 179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.596 ' HB3' HD23 ' A' ' 91' ' ' LEU . 26.0 Cg_exo -63.89 112.22 1.77 Allowed 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.281 1.987 . . . . 61.240000000000002 111.523 174.183 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.52 ' O ' ' HA ' ' A' ' 91' ' ' LEU . 64.4 t -124.25 139.98 33.97 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 109.196 -0.668 . . . . 64.040000000000006 109.196 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.566 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.7 Cg_endo -71.36 113.95 3.77 Favored 'Trans proline' 0 N--CA 1.462 -0.38 0 C-N-CA 122.272 1.981 . . . . 45.039999999999999 112.117 178.198 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -136.55 161.21 36.52 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.916 -0.583 . . . . 45.340000000000003 111.122 -176.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.469 ' HB2' HG11 ' A' ' 77' ' ' VAL . 8.9 tt -119.18 136.66 54.08 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.865 -0.791 . . . . 74.319999999999993 108.865 176.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -155.13 173.19 16.95 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-O 121.466 0.651 . . . . 75.099999999999994 111.194 -178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 87' ' ' VAL . 4.9 mm -127.89 173.96 12.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.016 -1.105 . . . . 61.030000000000001 108.016 177.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.41 ' H ' HG22 ' A' ' 22' ' ' ILE . 0.6 OUTLIER -116.42 99.84 7.46 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.057 -0.72 . . . . 75.140000000000001 109.057 167.221 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 58.2 m -105.46 111.56 24.33 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.117 -0.492 . . . . 65.450000000000003 110.963 -175.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -80.58 134.43 35.91 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.153 -0.684 . . . . 60.229999999999997 109.153 176.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.468 HG22 ' HB3' ' A' ' 30' ' ' GLU . 7.1 m -130.44 145.7 51.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.277 -0.42 . . . . 75.430000000000007 111.164 -173.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.59 -178.96 6.52 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.989 -0.374 . . . . 35.030000000000001 109.989 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 64.7 mtt -76.71 134.19 39.29 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.988 -0.375 . . . . 72.319999999999993 109.988 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.2 m 68.49 19.63 8.7 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.94 -1.027 . . . . 71.450000000000003 111.733 179.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.468 ' HB3' HG22 ' A' ' 26' ' ' THR . 41.7 tt0 -104.13 -10.3 18.07 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.422 0.63 . . . . 60.130000000000003 110.169 -178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 6.2 tt -57.3 -34.76 69.05 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.202 -0.908 . . . . 63.420000000000002 112.652 -175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -59.79 -71.65 0.74 Allowed Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.077 -0.582 . . . . 75.530000000000001 113.694 -173.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.8 m -60.3 -28.21 67.92 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 122.858 0.463 . . . . 74.329999999999998 112.098 -176.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 37.8 tp -52.94 -38.38 61.9 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.993 -0.549 . . . . 73.530000000000001 112.182 -177.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -65.03 -40.77 95.3 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 111.819 0.303 . . . . 74.019999999999996 111.819 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.485 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 10.3 mp0 -63.03 -33.21 74.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.072 0.463 . . . . 53.450000000000003 110.624 178.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.58 -18.85 50.79 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.847 -0.615 . . . . 71.219999999999999 111.183 179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.08 -55.95 7.46 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 121.026 -0.607 . . . . 52.310000000000002 112.783 -176.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.485 ' CE2' ' HA ' ' A' ' 36' ' ' GLU . 42.2 p90 -76.13 -14.8 60.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.192 0.52 . . . . 71.319999999999993 110.205 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.3 t-80 -58.14 -32.06 67.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.265 -0.88 . . . . 64.040000000000006 110.253 176.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.588 ' O ' HG12 ' A' ' 42' ' ' ILE . 29.2 t70 -124.61 177.88 5.72 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.774 -0.648 . . . . 74.400000000000006 109.287 -179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.588 HG12 ' O ' ' A' ' 41' ' ' ASP . 3.0 pt 64.22 -21.78 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 125.315 1.446 . . . . 64.150000000000006 113.005 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' H ' ' C ' ' A' ' 41' ' ' ASP . 3.0 tm? -61.23 -39.84 91.77 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 122.498 0.319 . . . . 73.230000000000004 110.494 -177.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 39.5 mt-30 -77.68 0.43 23.39 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.458 -0.337 . . . . 62.340000000000003 111.858 -176.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.1 tt -90.35 -37.85 13.74 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 109.05 -0.722 . . . . 74.239999999999995 109.05 173.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.556 ' HG ' ' HE1' ' A' ' 75' ' ' PHE . 2.2 tm? -83.54 -66.08 0.93 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.803 -0.635 . . . . 73.510000000000005 109.975 179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.538 ' HA ' ' O ' ' A' ' 51' ' ' LYS . . . -69.65 -27.53 65.12 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.831 -0.622 . . . . 71.340000000000003 110.638 -177.386 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.34 -7.5 85.03 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.921 -0.657 . . . . 52.340000000000003 112.362 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -93.58 1.55 56.66 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.421 -0.585 . . . . 74.530000000000001 109.421 177.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 85.08 14.03 70.23 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.664 -0.698 . . . . 21.32 111.994 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 47' ' ' ALA . 94.0 mttt -121.1 161.88 21.0 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.978 -0.379 . . . . 71.099999999999994 109.978 -178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 8.6 p -140.71 155.52 69.35 Favored Pre-proline 0 C--N 1.32 -0.681 0 C-N-CA 121.05 -0.26 . . . . 62.350000000000001 111.53 -176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -58.78 140.11 93.67 Favored 'Trans proline' 0 C--N 1.344 0.313 0 C-N-CA 122.715 2.277 . . . . 55.310000000000002 111.599 176.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.5 t -105.94 22.11 16.17 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.494 0.664 . . . . 72.430000000000007 109.726 -178.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -170.05 167.06 40.22 Favored Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 111.066 -0.814 . . . . 44.030000000000001 111.066 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HA ' ' HD3' ' A' ' 57' ' ' PRO . 13.9 Cg_exo -70.39 153.36 66.09 Favored 'Trans proline' 0 N--CA 1.464 -0.262 0 C-N-CA 122.671 2.247 . . . . 72.329999999999998 111.899 179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 56' ' ' PRO . 5.5 Cg_exo -80.16 159.36 23.49 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 122.922 2.414 . . . . 72.209999999999994 112.243 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 41.3 p90 -125.33 -175.85 3.42 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.152 -0.477 . . . . 72.030000000000001 109.988 177.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -137.35 110.38 7.74 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.917 -0.401 . . . . 74.230000000000004 109.917 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -95.1 134.21 38.06 Favored 'General case' 0 C--O 1.241 0.656 0 CA-C-O 121.152 0.501 . . . . 74.040000000000006 110.697 -179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 19.3 m-85 -124.95 115.84 21.23 Favored 'General case' 0 C--O 1.242 0.661 0 CA-C-N 114.869 -1.06 . . . . 72.200000000000003 109.924 177.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 61.1 t80 -108.34 94.56 5.13 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.13 -0.693 . . . . 73.310000000000002 109.13 172.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -132.97 18.26 4.52 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.469 -0.872 . . . . 64.409999999999997 112.918 -176.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 89.5 mmm -77.23 -22.88 51.58 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.375 0.607 . . . . 64.319999999999993 109.884 176.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 44.6 t -93.04 108.52 20.08 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.144 -1.058 . . . . 74.530000000000001 108.144 169.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -79.04 26.75 0.25 Allowed 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.461 0.541 . . . . 45.329999999999998 112.461 -171.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -96.66 -57.73 1.09 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.54 -0.838 . . . . 62.350000000000001 111.173 176.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.58 126.63 35.29 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.562 -0.319 . . . . 74.230000000000004 110.663 176.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -82.72 113.51 20.43 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.125 -0.695 . . . . 65.140000000000001 109.125 178.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.447 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 34.5 tt0 -105.92 114.12 28.07 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 115.466 -0.788 . . . . 75.040000000000006 109.987 -175.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.02 168.17 16.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.194 -0.457 . . . . 71.310000000000002 110.04 -176.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 178.7 155.05 0.42 Allowed 'General case' 0 CA--C 1.51 -0.579 0 O-C-N 123.926 0.766 . . . . 73.409999999999997 109.735 167.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.462 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 10.8 p90 -77.56 -60.61 2.29 Favored 'General case' 0 N--CA 1.445 -0.702 0 C-N-CA 119.666 -0.814 . . . . 63.200000000000003 110.148 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 66.69 141.74 0.05 OUTLIER Glycine 0 C--O 1.244 0.728 0 C-N-CA 120.41 -0.9 . . . . 62.310000000000002 113.145 -177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.556 ' HE1' ' HG ' ' A' ' 46' ' ' LEU . 41.3 p90 -151.15 144.41 17.07 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 122.543 -0.387 . . . . 74.25 111.243 177.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.491 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 26.1 Cg_endo -64.39 141.3 73.93 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.764 2.309 . . . . 64.099999999999994 110.995 174.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.469 HG11 ' HB2' ' A' ' 20' ' ' LEU . 31.1 m -115.94 -175.16 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.776 0.658 . . . . 71.310000000000002 112.776 -170.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -65.84 -37.17 85.51 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.69 -1.141 . . . . 72.420000000000002 110.895 -177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 100.98 119.54 4.49 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 111.047 -0.821 . . . . 70.140000000000001 111.047 -173.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 103.63 15.68 22.05 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.869 -0.682 . . . . 63.32 111.622 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 4.9 t -102.68 151.02 6.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.462 -0.57 . . . . 64.430000000000007 109.462 179.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -121.06 162.19 20.41 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 110.123 -0.325 . . . . 71.099999999999994 110.123 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.09 -171.57 36.9 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.827 -0.702 . . . . 64.040000000000006 112.43 -179.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 66.9 m -159.33 106.99 1.77 Allowed 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.898 -0.408 . . . . 73.319999999999993 109.898 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.66 -108.85 2.61 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.856 -0.688 . . . . 42.240000000000002 112.425 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 98.2 mtt180 -78.18 -30.34 49.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.122 0.487 . . . . 64.200000000000003 110.22 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.482 ' HA ' ' CD1' ' A' ' 22' ' ' ILE . 46.2 t -68.72 119.39 14.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.564 -0.743 . . . . 74.439999999999998 110.008 179.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 16.9 m -125.38 140.41 48.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.27 0.557 . . . . 70.530000000000001 111.472 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.2 m -115.93 157.88 23.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.579 -0.737 . . . . 62.030000000000001 109.174 175.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . 169.32 -140.02 5.9 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 120.837 -0.697 . . . . 64.340000000000003 111.53 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.596 HD23 ' HB3' ' A' ' 16' ' ' PRO . 0.0 OUTLIER -137.5 154.45 49.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.736 0.303 . . . . 72.239999999999995 110.291 177.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 16' ' ' PRO . 17.2 p -80.38 143.72 56.32 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.0 -0.545 . . . . 73.219999999999999 110.855 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.22 143.81 72.43 Favored 'Trans proline' 0 C--O 1.233 0.274 0 C-N-CA 122.504 2.136 . . . . 65.140000000000001 112.114 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.592 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 24.7 p -78.74 133.89 37.1 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.138 0.494 . . . . 72.140000000000001 110.711 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -175.08 -144.59 5.01 Favored Glycine 0 N--CA 1.449 -0.484 0 CA-C-N 115.649 -0.705 . . . . 24.52 111.384 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.467 ' HG2' HD11 ' A' ' 11' ' ' LEU . 0.0 OUTLIER -163.9 157.43 18.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 117.01 0.405 . . . . 74.219999999999999 110.495 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -161.6 167.36 25.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 72.200000000000003 110.905 -176.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -95.14 135.56 36.55 Favored 'General case' 0 C--O 1.235 0.333 0 CA-C-N 116.288 -0.415 . . . . 73.109999999999999 110.643 -179.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 18.4 p -140.32 159.49 42.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.424 -0.353 . . . . 73.400000000000006 111.296 -176.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 73.4 m -146.0 154.46 41.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.123 -0.49 . . . . 54.140000000000001 110.415 175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.685 ' HG ' ' HG2' ' A' ' 150' ' ' ARG . 6.6 mp -95.21 110.5 22.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.418 -0.355 . . . . 62.32 111.058 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.08 131.53 34.24 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.333 -0.618 . . . . 64.120000000000005 109.333 175.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.585 ' HB ' ' HA ' ' A' ' 5' ' ' CYS . 50.2 mm -106.71 104.39 16.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.289 0.566 . . . . 73.209999999999994 109.495 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.76 175.36 13.99 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.779 -0.928 . . . . 71.450000000000003 110.779 -175.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -76.92 -57.39 0.04 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 122.345 2.03 . . . . 72.299999999999997 112.311 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -166.5 176.31 7.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 74.409999999999997 110.137 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 134.03 -68.36 0.54 Allowed Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 120.844 -0.693 . . . . 65.430000000000007 112.071 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -100.64 37.33 1.73 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.291 0.567 . . . . 54.399999999999999 110.323 -178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 7.7 tp -67.25 -23.59 30.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 115.67 -0.695 . . . . 72.420000000000002 110.306 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.3 mp0 -66.53 -46.79 75.01 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.581 -0.281 . . . . 71.409999999999997 110.585 174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -55.08 -47.25 75.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.789 -0.641 . . . . 44.140000000000001 112.115 -176.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 13.3 p -66.69 -31.7 54.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.423 -0.353 . . . . 70.140000000000001 111.257 -177.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -67.88 -46.36 71.87 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.674 0.273 . . . . 74.200000000000003 110.847 177.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -66.9 -22.77 65.95 Favored 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.178 -0.464 . . . . 74.349999999999994 110.743 179.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -84.03 -35.03 24.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.097 -0.501 . . . . 72.310000000000002 111.304 179.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.78 -46.92 76.94 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.428 -0.351 . . . . 74.519999999999996 111.744 -179.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 55.1 ttp -67.3 -34.51 77.52 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.504 -0.316 . . . . 72.109999999999999 111.575 -174.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.15 -22.74 66.38 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 121.081 -0.247 . . . . 73.239999999999995 111.273 -177.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.592 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 88.8 t90 -74.49 -49.16 23.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.675 -0.41 . . . . 75.319999999999993 110.272 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 155' ' ' LEU . 11.9 p -70.79 -31.76 46.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.174 0.512 . . . . 41.109999999999999 110.07 -179.243 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -59.78 -40.13 87.24 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.208 -0.905 . . . . 71.209999999999994 110.311 174.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -77.93 -39.4 42.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.704 -0.68 . . . . 74.450000000000003 110.705 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -63.34 -35.29 79.89 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.851 -0.613 . . . . 54.130000000000003 111.395 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 83.85 54.63 3.01 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.775 -0.726 . . . . 72.150000000000006 112.275 177.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -136.43 165.82 24.92 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.937 -0.764 . . . . 74.319999999999993 108.937 178.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.613 ' HA ' ' O ' ' A' ' 155' ' ' LEU . 15.9 t70 -151.29 126.29 9.79 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.007 0.373 . . . . 74.420000000000002 112.007 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 155' ' ' LEU . 38.9 mt -145.61 116.18 7.63 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 115.802 -0.635 . . . . 74.420000000000002 110.191 172.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 38.0 m -91.08 70.64 6.3 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.155 0.502 . . . . 74.150000000000006 110.57 -179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -94.04 -122.12 3.47 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.729 -0.748 . . . . 71.209999999999994 112.115 178.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.412 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 50.1 mt-10 -135.89 169.51 17.46 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.969 -0.382 . . . . 72.230000000000004 109.969 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -103.35 132.78 49.33 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.398 -0.593 . . . . 62.530000000000001 109.398 176.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.583 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 24.9 p90 -143.48 127.45 17.38 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.474 0.654 . . . . 75.109999999999999 111.978 -179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.6 ' HG2' HG23 ' A' ' 151' ' ' VAL . 46.1 mt-10 -97.13 118.73 34.2 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.445 -0.798 . . . . 71.400000000000006 109.605 176.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 63.1 mt -91.84 113.2 26.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 110.137 -0.32 . . . . 74.219999999999999 110.137 179.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -96.23 95.96 8.47 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.894 0.378 . . . . 65.409999999999997 110.132 -176.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.703 ' HB2' ' HG3' ' A' ' 148' ' ' ARG . 2.9 mm? -67.39 -41.54 84.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.177 -0.675 . . . . 75.319999999999993 109.177 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -130.12 130.63 45.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.082 -0.963 . . . . 60.039999999999999 109.289 177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.666 ' OD1' ' HD2' ' A' ' 139' ' ' PRO . 66.1 t30 -80.53 140.14 51.66 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 109.781 -0.451 . . . . 72.340000000000003 109.781 -176.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HD2' ' OD1' ' A' ' 138' ' ' ASN . 31.8 Cg_endo -67.3 161.97 40.72 Favored 'Trans proline' 0 N--CA 1.463 -0.299 0 C-N-CA 122.299 1.999 . . . . 71.230000000000004 112.209 174.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.21 -35.92 0.3 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.871 0.868 . . . . 72.349999999999994 111.453 179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.2 mm-40 -84.47 1.46 45.47 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.991 0.424 . . . . 72.420000000000002 110.677 178.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.48 ' CG2' ' HB3' ' A' ' 147' ' ' LEU . 14.3 t -154.91 176.89 11.93 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.868 -0.606 . . . . 53.149999999999999 110.053 178.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -90.6 157.83 43.64 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.531 -0.304 . . . . 73.030000000000001 111.382 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -51.69 146.11 28.35 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.596 2.197 . . . . 74.120000000000005 112.039 171.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.499 ' HA ' ' CG2' ' A' ' 103' ' ' ILE . 26.7 t70 75.83 -27.19 0.18 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.904 -1.044 . . . . 63.140000000000001 111.693 179.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -87.53 -4.2 58.98 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.141 0.496 . . . . 72.409999999999997 110.396 -179.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.547 HD23 ' H ' ' A' ' 147' ' ' LEU . 2.4 pt? -111.33 144.39 40.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.71 -0.677 . . . . 74.319999999999993 109.669 174.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.703 ' HG3' ' HB2' ' A' ' 136' ' ' LEU . 8.3 ptp85 -135.24 132.41 37.81 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.934 -0.576 . . . . 71.109999999999999 110.969 -176.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.8 m -123.26 112.79 18.06 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.708 -0.678 . . . . 65.120000000000005 110.349 178.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.685 ' HG2' ' HG ' ' A' ' 101' ' ' LEU . 62.2 mtt180 -88.45 99.03 11.96 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.531 -0.544 . . . . 65.019999999999996 109.531 176.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.6 HG23 ' HG2' ' A' ' 133' ' ' GLU . 7.5 p -89.96 126.85 42.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 109.66 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 15.1 t -119.44 131.04 55.56 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.077 -0.511 . . . . 64.219999999999999 109.981 -178.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -114.94 170.89 8.0 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.844 -0.616 . . . . 72.530000000000001 110.975 -176.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.48 ' HB2' ' HE2' ' A' ' 154' ' ' MET . 51.7 mtm -63.57 154.71 31.77 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.712 -0.677 . . . . 74.219999999999999 110.89 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.738 HD12 HD12 ' A' ' 127' ' ' LEU . 98.3 mt -88.81 24.31 2.08 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.781 -0.822 . . . . 60.25 108.781 172.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -114.47 131.22 56.69 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.88 -1.055 . . . . 65.310000000000002 110.751 -173.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -53.74 115.05 1.78 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.427 -0.806 . . . . 64.329999999999998 110.764 175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 49.2 m -157.97 -77.53 0.08 Allowed 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 113.168 0.803 . . . . 51.329999999999998 113.168 -177.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 95.1 mt -86.2 114.04 22.71 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 113.592 0.96 . . . . 64.329999999999998 113.592 -162.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -119.77 153.83 35.11 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.28 -0.873 . . . . 71.239999999999995 109.567 167.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 53.4 m80 -118.45 -95.4 0.48 Allowed 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 110.214 -0.291 . . . . 65.310000000000002 110.214 175.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 48.8 m80 -149.29 50.32 0.96 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.022 0.439 . . . . 64.420000000000002 109.857 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 42.0 m80 -124.0 95.11 4.44 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.855 -0.612 . . . . 61.229999999999997 109.629 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -75.75 111.5 11.16 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.409 -0.814 . . . . 71.430000000000007 111.23 -172.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 2.8 p-80 -169.3 172.46 7.24 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.595 -0.729 . . . . 73.319999999999993 109.692 178.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 73.8 m80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.751 -0.642 . . . . 64.209999999999994 109.478 173.627 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.483 1.181 0 CA-C-O 121.261 0.553 . . . . 64.409999999999997 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -156.33 168.28 27.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.732 -0.667 . . . . 73.230000000000004 110.138 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 82.5 t80 -150.74 159.94 44.19 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.092 -0.707 . . . . 73.219999999999999 109.092 -177.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -60.66 99.99 0.1 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.192 0.52 . . . . 64.209999999999994 110.234 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 p -110.31 120.44 42.46 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.721 -0.672 . . . . 51.240000000000002 110.62 -177.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.6 mm100 -102.45 112.03 24.58 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.394 0.616 . . . . 72.420000000000002 109.98 -178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.1 m-85 -80.34 110.83 16.15 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.038 -0.983 . . . . 73.510000000000005 111.167 -175.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 48.9 t -97.77 119.72 46.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.065 -0.516 . . . . 72.329999999999998 110.685 -178.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 53.3 t -94.22 129.55 40.8 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.674 -0.491 . . . . 63.299999999999997 109.674 177.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -130.71 155.5 46.52 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.839 0.352 . . . . 74.140000000000001 110.797 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.447 HD11 ' HB3' ' A' ' 96' ' ' LYS . 2.8 tm? -86.37 126.67 34.52 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.685 -0.487 . . . . 71.510000000000005 109.685 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -129.95 164.29 24.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.984 0.421 . . . . 75.340000000000003 110.914 176.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.546 ' HG3' ' HE2' ' A' ' 96' ' ' LYS . 2.1 mp0 -86.53 134.95 33.62 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.836 -0.62 . . . . 74.120000000000005 109.976 178.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 97' ' ' ALA . 0.2 OUTLIER -98.57 126.23 44.08 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.011 -0.54 . . . . 61.130000000000003 109.681 179.405 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.477 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -104.68 144.14 28.13 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 55.039999999999999 110.669 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.79 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 2.0 Cg_endo -82.68 84.24 1.83 Allowed 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 123.017 2.478 . . . . 72.400000000000006 111.346 176.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.44 HG23 ' HD2' ' A' ' 18' ' ' PRO . 6.4 p -103.91 141.77 23.22 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.816 -0.629 . . . . 73.230000000000004 110.047 -177.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' O ' HG22 ' A' ' 77' ' ' VAL . 57.2 Cg_endo -74.61 113.24 3.74 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.259 1.973 . . . . 75.430000000000007 112.044 175.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.71 ' HA ' ' HA ' ' A' ' 76' ' ' PRO . . . -109.4 141.96 41.05 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.043 -0.526 . . . . 71.310000000000002 110.383 177.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.518 HD12 HG12 ' A' ' 87' ' ' VAL . 2.5 mm? -102.08 127.53 48.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.406 -0.59 . . . . 71.530000000000001 109.406 176.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.765 HD22 ' HB3' ' A' ' 72' ' ' GLU . 2.0 pp -157.33 170.02 23.41 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.534 0.683 . . . . 71.530000000000001 112.508 -173.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.529 HD13 ' HA ' ' A' ' 87' ' ' VAL . 40.4 mm -116.24 130.39 71.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 114.694 -1.139 . . . . 62.240000000000002 108.35 173.049 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 62.9 mtp180 -81.4 104.62 11.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.052 0.453 . . . . 75.239999999999995 109.944 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.8 m -112.41 142.56 44.8 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.52 -0.764 . . . . 71.340000000000003 109.735 -178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.5 ' HB3' ' HB ' ' A' ' 68' ' ' THR . 66.4 mt-30 -109.76 118.5 36.69 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.548 -0.538 . . . . 74.109999999999999 109.548 177.514 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 13.0 t -103.36 154.65 19.17 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.375 0.607 . . . . 63.229999999999997 111.072 -173.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.46 164.45 34.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.318 -0.855 . . . . 73.439999999999998 108.84 179.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 ptt? 44.38 38.98 2.8 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 124.061 0.851 . . . . 74.540000000000006 112.451 178.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.3 m 60.32 32.74 20.8 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-N 115.79 -0.641 . . . . 71.340000000000003 112.544 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.51 ' O ' HD23 ' A' ' 34' ' ' LEU . 9.0 mm-40 -89.29 59.92 5.07 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.001 0.429 . . . . 62.219999999999999 111.009 177.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 31' ' ' LEU . 4.3 mm? -76.71 -60.04 2.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.324 -0.398 . . . . 70.439999999999998 111.205 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -63.12 -37.52 95.06 Favored Glycine 0 N--CA 1.453 -0.213 0 CA-C-N 116.099 -0.5 . . . . 71.530000000000001 113.184 -173.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.3 m -57.14 -44.14 83.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.806 0.336 . . . . 44.109999999999999 111.484 -178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.51 HD23 ' O ' ' A' ' 30' ' ' GLU . 4.4 mm? -73.39 -33.48 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.523 -0.308 . . . . 72.019999999999996 111.345 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.2 m-30 -63.6 -38.63 91.85 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.383 -0.371 . . . . 72.530000000000001 111.109 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -72.8 -20.02 61.23 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.343 -0.39 . . . . 60.520000000000003 111.825 -178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -97.48 -7.21 32.03 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.823 0.344 . . . . 70.120000000000005 111.709 -177.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.4 -43.08 16.73 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 120.832 -0.699 . . . . 42.549999999999997 114.623 -175.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.477 ' HA ' HG22 ' A' ' 42' ' ' ILE . 38.7 p90 -63.08 -31.03 72.08 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.613 0.968 . . . . 63.130000000000003 113.613 -163.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 7.0 p80 -65.07 -31.47 72.71 Favored 'General case' 0 N--CA 1.466 0.33 0 C-N-CA 120.636 -0.425 . . . . 72.430000000000007 111.5 -174.664 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -89.43 -44.95 9.81 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 120.954 -0.298 . . . . 53.200000000000003 111.166 -176.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.706 HG13 HG13 ' A' ' 87' ' ' VAL . 11.7 tt -64.09 -30.88 51.25 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 CA-C-N 116.151 -0.477 . . . . 74.420000000000002 111.544 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 tp -64.79 -27.85 69.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 75.400000000000006 111.789 -176.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -61.97 -61.83 2.21 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 111.848 0.314 . . . . 71.209999999999994 111.848 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.815 HD21 ' HA2' ' A' ' 83' ' ' GLY . 43.7 tp -64.17 -33.92 76.88 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.984 0.421 . . . . 55.329999999999998 110.733 -179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.799 ' HG ' ' HG3' ' A' ' 51' ' ' LYS . 15.3 tp -64.32 -61.47 2.21 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.79 -0.641 . . . . 72.319999999999993 110.261 179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.532 ' HA ' ' CD ' ' A' ' 51' ' ' LYS . . . -67.31 -29.45 69.03 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.827 -0.624 . . . . 64.319999999999993 112.116 -174.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.0 -26.34 55.88 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.851 -0.69 . . . . 61.399999999999999 113.935 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -96.43 -6.63 36.92 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 117.407 0.604 . . . . 61.020000000000003 111.672 -174.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 98.14 64.84 0.87 Allowed Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 120.547 -0.835 . . . . 74.099999999999994 111.984 179.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.799 ' HG3' ' HG ' ' A' ' 46' ' ' LEU . 0.0 OUTLIER -87.92 -179.66 6.28 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.249 0.833 . . . . 73.439999999999998 113.249 -173.187 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.536 ' HB3' ' HB2' ' A' ' 78' ' ' GLU . 33.4 t -175.3 140.03 0.61 Allowed Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 113.814 -1.539 . . . . 70.049999999999997 107.577 166.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 4.0 Cg_exo -86.2 146.85 8.85 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 122.971 2.447 . . . . 63.439999999999998 112.218 176.373 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.462 ' HB3' ' HA ' ' A' ' 78' ' ' GLU . 18.0 p -104.62 -22.0 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.056 0.455 . . . . 71.120000000000005 110.418 176.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -155.89 172.08 33.85 Favored Glycine 0 N--CA 1.442 -0.941 0 C-N-CA 120.684 -0.77 . . . . 53.219999999999999 112.051 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_exo -65.31 160.32 42.99 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 123.223 2.615 . . . . 74.530000000000001 112.117 177.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.885 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 33.7 Cg_endo -64.13 152.36 81.44 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.799 2.333 . . . . 75.109999999999999 112.429 -179.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.416 ' CD1' ' HD3' ' A' ' 76' ' ' PRO . 50.8 p90 -134.9 146.32 49.07 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.204 -0.453 . . . . 71.450000000000003 109.831 179.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.92 110.01 22.37 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.584 -0.524 . . . . 51.310000000000002 109.584 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.578 ' HD3' ' OE1' ' A' ' 72' ' ' GLU . 70.0 ttt180 -92.05 130.55 37.76 Favored 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.398 -0.521 . . . . 62.140000000000001 110.255 175.413 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.643 ' HB3' ' CE2' ' A' ' 69' ' ' PHE . 50.3 m-85 -105.67 109.91 22.04 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.179 -0.919 . . . . 55.0 108.709 175.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.954 ' HB3' ' HB3' ' A' ' 70' ' ' GLU . 84.8 t80 -101.6 124.65 47.6 Favored 'General case' 0 C--O 1.243 0.731 0 CA-C-N 115.897 -0.592 . . . . 74.450000000000003 109.932 -179.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -150.97 5.75 0.59 Allowed Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.517 -0.765 . . . . 52.539999999999999 113.234 -178.16 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 62.1 mtp -60.61 -42.38 96.7 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.504 0.652 . . . . 64.450000000000003 111.214 178.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 40.7 m -151.51 91.71 1.69 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.506 -0.316 . . . . 61.310000000000002 110.262 178.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -157.74 170.74 21.68 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.31 -0.405 . . . . 52.299999999999997 110.706 -177.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -99.71 -72.47 1.02 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 110.349 -1.1 . . . . 75.129999999999995 110.349 174.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.5 ' HB ' ' HB3' ' A' ' 25' ' ' GLN . 3.2 m -73.89 159.03 33.41 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 108.054 -1.091 . . . . 72.409999999999997 108.054 167.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.643 ' CE2' ' HB3' ' A' ' 61' ' ' TYR . 11.1 t80 -79.26 123.85 27.82 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.341 -0.614 . . . . 73.209999999999994 109.341 -177.423 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.954 ' HB3' ' HB3' ' A' ' 62' ' ' PHE . 4.8 tp10 -89.67 135.31 33.69 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.102 -0.499 . . . . 61.340000000000003 109.984 -171.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 60' ' ' ARG . 34.9 m -132.25 128.97 59.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-O 121.463 0.649 . . . . 53.450000000000003 111.066 179.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.765 ' HB3' HD22 ' A' ' 21' ' ' LEU . 58.9 mt-10 -114.56 93.26 4.25 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.509 -0.769 . . . . 74.239999999999995 109.34 176.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -76.85 -1.31 27.68 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 115.191 -0.913 . . . . 64.510000000000005 112.863 -175.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.753 ' HA3' ' HB3' ' A' ' 21' ' ' LEU . . . -65.65 -168.56 2.38 Favored Glycine 0 CA--C 1.522 0.514 0 C-N-CA 121.188 -0.53 . . . . 70.209999999999994 114.075 -174.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.885 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 30.9 p90 -145.24 154.12 53.42 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 122.539 -0.389 . . . . 63.549999999999997 111.163 -175.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.71 ' HA ' ' HA ' ' A' ' 19' ' ' ALA . 39.8 Cg_endo -67.78 148.94 78.15 Favored 'Trans proline' 0 C--O 1.237 0.464 0 C-N-CA 122.559 2.173 . . . . 71.540000000000006 111.763 178.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.719 HG21 ' HB ' ' A' ' 81' ' ' VAL . 26.2 m -114.69 165.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.288 -0.415 . . . . 75.140000000000001 110.313 -177.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.536 ' HB2' ' HB3' ' A' ' 52' ' ' SER . 0.6 OUTLIER -48.78 -55.34 11.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.603 -0.726 . . . . 54.240000000000002 110.999 -173.959 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 173.81 -50.8 0.15 Allowed Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.18 -1.009 . . . . 75.409999999999997 112.653 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -95.31 48.42 1.92 Allowed Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.633 -0.794 . . . . 45.329999999999998 112.991 -177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.719 ' HB ' HG21 ' A' ' 77' ' ' VAL . 4.6 t -130.36 146.07 34.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 109.271 -0.64 . . . . 72.030000000000001 109.271 177.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -152.86 -167.86 2.87 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.525 -0.307 . . . . 74.099999999999994 110.448 -174.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.815 ' HA2' HD21 ' A' ' 45' ' ' LEU . . . -149.43 176.38 28.18 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.689 -0.767 . . . . 71.099999999999994 112.622 -175.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 28.4 t -155.29 -73.8 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.862 0.363 . . . . 74.219999999999999 111.123 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . -89.93 101.17 2.75 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 121.032 -0.604 . . . . 63.399999999999999 112.783 -175.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.3 ttp180 69.0 -53.22 0.58 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.842 0.857 . . . . 71.519999999999996 111.612 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.706 HG13 HG13 ' A' ' 42' ' ' ILE . 26.2 t -69.83 102.25 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 N-CA-C 108.357 -0.979 . . . . 54.039999999999999 108.357 173.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 25.0 m -117.41 166.01 12.18 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-O 121.012 0.435 . . . . 73.299999999999997 111.07 -172.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 1.4 t -117.89 152.25 35.78 Favored 'General case' 0 N--CA 1.441 -0.892 0 CA-C-O 121.249 0.547 . . . . 64.109999999999999 110.191 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -142.13 144.39 14.12 Favored Glycine 0 N--CA 1.44 -1.078 0 CA-C-N 115.056 -0.975 . . . . 74.049999999999997 111.274 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 8.6 mp -115.65 136.06 53.44 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 109.73 -0.47 . . . . 75.010000000000005 109.73 176.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.402 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 0.9 OUTLIER -80.39 144.84 58.28 Favored Pre-proline 0 C--N 1.316 -0.861 0 CA-C-N 115.806 -0.633 . . . . 64.040000000000006 111.085 -179.772 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -64.78 135.17 43.62 Favored 'Trans proline' 0 N--CA 1.462 -0.364 0 C-N-CA 122.458 2.105 . . . . 74.219999999999999 111.983 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.79 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 5.4 p -78.48 145.94 34.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.944 -0.571 . . . . 54.450000000000003 110.796 -178.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 146.32 -148.09 19.52 Favored Glycine 0 N--CA 1.443 -0.846 0 N-CA-C 111.585 -0.606 . . . . 61.310000000000002 111.585 179.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' HE2' ' HG3' ' A' ' 13' ' ' GLU . 34.6 mmtp -112.83 136.05 52.89 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.85 0.357 . . . . 63.030000000000001 110.385 179.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.523 ' HB3' HD23 ' A' ' 14' ' ' LEU . . . -139.24 152.01 46.98 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.275 -0.42 . . . . 60.109999999999999 110.62 -178.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.702 ' HB3' HD21 ' A' ' 153' ' ' LEU . . . -85.31 132.61 34.23 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.214 -0.448 . . . . 53.210000000000001 109.903 178.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 10.2 t -136.72 130.09 31.53 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.708 -0.678 . . . . 73.400000000000006 109.853 -175.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.457 ' HB2' HD23 ' A' ' 116' ' ' LEU . 22.9 t -122.84 127.75 49.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.748 0.308 . . . . 74.299999999999997 110.172 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 2.2 tt -85.76 108.8 18.25 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.338 0.589 . . . . 75.109999999999999 109.678 178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -76.25 117.98 18.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.815 -1.084 . . . . 72.349999999999994 109.954 -178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.5 HD11 ' HA ' ' A' ' 146' ' ' GLN . 10.7 tp -121.95 145.38 28.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.259 -0.428 . . . . 74.019999999999996 110.019 -179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.75 ' HA2' ' HA ' ' A' ' 145' ' ' ASP . . . 117.68 -159.74 14.01 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.744 -0.741 . . . . 34.310000000000002 111.322 -177.041 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -91.12 -175.66 0.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.795 0 C-N-CA 122.913 2.408 . . . . 74.530000000000001 111.262 173.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -96.32 133.93 40.09 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 110.186 -0.302 . . . . 75.340000000000003 110.186 176.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -166.06 76.18 0.14 Allowed Glycine 0 N--CA 1.446 -0.693 0 C-N-CA 120.936 -0.649 . . . . 74.430000000000007 111.817 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 63.66 100.91 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.413 0.625 . . . . 72.150000000000006 110.933 -176.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 18.2 tt -68.0 -11.39 14.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.777 -0.647 . . . . 75.209999999999994 110.927 -176.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -57.49 -35.79 70.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.946 -0.57 . . . . 74.329999999999998 110.527 176.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.2 -47.19 87.27 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.016 -0.538 . . . . 74.519999999999996 111.387 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 7.6 p -76.45 -33.46 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 C-N-CA 120.908 -0.317 . . . . 51.509999999999998 110.601 -179.502 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -62.87 -36.02 81.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.632 0.253 . . . . 73.530000000000001 110.341 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -61.86 -51.44 68.2 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.36 -0.382 . . . . 74.239999999999995 110.806 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.9 -41.45 99.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.065 0.46 . . . . 53.530000000000001 110.568 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.826 HD11 HD22 ' A' ' 153' ' ' LEU . 3.0 tm? -55.96 -51.03 69.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.455 -0.793 . . . . 72.040000000000006 110.105 175.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.5 ttp -73.03 -28.93 62.63 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.936 -0.575 . . . . 72.129999999999995 111.459 -176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -61.29 -47.27 86.73 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.696 0.284 . . . . 64.120000000000005 110.29 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 85.7 t90 -62.98 -33.63 75.82 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.416 0.627 . . . . 74.150000000000006 109.853 177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.666 HG21 HD11 ' A' ' 153' ' ' LEU . 84.3 t -67.64 -48.93 74.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.407 -0.815 . . . . 74.140000000000001 110.914 178.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -64.69 -35.14 80.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.293 -0.412 . . . . 72.400000000000006 110.756 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -58.37 -29.11 65.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.653 -0.703 . . . . 70.010000000000005 110.973 176.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -98.03 7.18 46.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.07 -0.514 . . . . 74.519999999999996 111.077 179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.42 32.14 35.41 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.837 -0.696 . . . . 73.209999999999994 113.216 175.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -124.22 173.68 8.18 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.945 0.373 . . . . 75.310000000000002 110.158 175.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.428 ' O ' HD22 ' A' ' 127' ' ' LEU . 17.1 t70 -169.63 137.71 1.79 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 110.107 -0.331 . . . . 72.409999999999997 110.107 -177.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.655 HD12 ' HB3' ' A' ' 130' ' ' GLU . 3.5 mm? -129.42 131.65 46.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.955 0.407 . . . . 75.230000000000004 110.373 175.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.5 m -82.25 55.56 2.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.825 -0.625 . . . . 64.010000000000005 111.288 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 89.81 0.83 77.82 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.931 -0.652 . . . . 32.039999999999999 112.686 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.655 ' HB3' HD12 ' A' ' 127' ' ' LEU . 29.9 tp10 -80.62 99.81 8.33 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.995 -0.372 . . . . 73.409999999999997 109.995 -178.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.42 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -156.17 153.27 28.98 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.003 -0.544 . . . . 71.400000000000006 110.596 -178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ARG . 8.7 p90 -129.49 130.34 45.72 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.779 -0.452 . . . . 72.140000000000001 109.779 174.572 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.424 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 10.0 pt-20 -114.34 123.41 49.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.226 0.536 . . . . 74.230000000000004 110.977 -177.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.509 ' H ' HD12 ' A' ' 134' ' ' ILE . 4.1 mp -86.1 127.93 39.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.802 -0.635 . . . . 73.140000000000001 110.09 -178.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -97.0 93.65 6.72 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.775 -0.454 . . . . 63.299999999999997 109.775 176.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.568 ' HB2' ' HB3' ' A' ' 148' ' ' ARG . 2.8 mm? -62.14 -32.76 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.218 0.532 . . . . 72.200000000000003 109.68 178.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.608 ' HB3' HG21 ' A' ' 142' ' ' THR . 3.8 m-20 -138.3 136.9 36.91 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.095 -0.957 . . . . 63.039999999999999 108.828 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 6.0 t30 -77.64 141.78 65.27 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 110.297 -0.26 . . . . 72.010000000000005 110.297 -174.203 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ASN . 38.3 Cg_exo -62.62 161.26 28.92 Favored 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 123.017 2.478 . . . . 75.140000000000001 112.654 177.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.36 -32.54 0.22 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.944 0.898 . . . . 71.010000000000005 111.721 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 61.2 mm-40 -97.44 6.3 48.4 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.137 0.494 . . . . 71.140000000000001 110.501 178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.608 HG21 ' HB3' ' A' ' 137' ' ' ASP . 0.6 OUTLIER -120.54 -176.06 3.15 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.829 -0.623 . . . . 63.229999999999997 111.871 -177.313 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -97.15 156.3 36.46 Favored Pre-proline 0 C--N 1.327 -0.406 0 CA-C-N 115.82 -0.627 . . . . 52.049999999999997 110.834 178.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -73.44 159.3 46.75 Favored 'Trans proline' 0 N--CA 1.455 -0.778 0 C-N-CA 122.311 2.008 . . . . 72.25 111.296 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.75 ' HA ' ' HA2' ' A' ' 104' ' ' GLY . 39.1 t70 75.65 -24.89 0.21 Allowed 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.031 0.932 . . . . 43.32 112.044 176.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.5 ' HA ' HD11 ' A' ' 103' ' ' ILE . 72.6 mt-30 -125.82 31.63 5.45 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.073 0.463 . . . . 72.209999999999994 111.093 -178.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD13 ' N ' ' A' ' 148' ' ' ARG . 2.9 tm? -67.01 142.32 57.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.087 -0.708 . . . . 64.310000000000002 109.087 175.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.568 ' HB3' ' HB2' ' A' ' 136' ' ' LEU . 22.0 mmt180 -105.47 104.22 13.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.463 0.173 . . . . 72.420000000000002 111.309 -173.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 88.8 m -145.2 132.08 20.16 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.94 -0.393 . . . . 73.340000000000003 109.94 174.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.409 ' O ' ' HA ' ' A' ' 133' ' ' GLU . 63.4 ttp85 -128.46 108.86 10.89 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 120.727 -0.389 . . . . 62.439999999999998 110.546 178.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.424 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 7.3 p -90.56 129.86 40.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.986 -0.552 . . . . 44.229999999999997 110.589 -177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 132' ' ' TYR . 1.5 m -131.71 132.13 43.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.904 -0.406 . . . . 64.439999999999998 109.904 -179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.826 HD22 HD11 ' A' ' 116' ' ' LEU . 2.4 pt? -112.69 148.84 33.85 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.438 -0.505 . . . . 71.109999999999999 111.096 -177.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -81.77 95.01 7.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.052 -0.522 . . . . 75.310000000000002 111.363 -174.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 34.9 mt -69.44 -18.26 63.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.147 0.499 . . . . 73.329999999999998 110.492 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 54.2 t-80 -81.84 108.08 15.08 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.827 -0.805 . . . . 62.119999999999997 108.827 173.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -58.81 111.8 1.41 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.112 0.482 . . . . 72.430000000000007 111.502 -176.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 67.1 m 72.08 149.59 0.09 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-N 114.802 -1.09 . . . . 74.530000000000001 111.89 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.9 pp -96.6 -10.6 26.79 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.838 -0.619 . . . . 74.010000000000005 110.687 178.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -67.21 140.4 57.43 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.791 -0.64 . . . . 72.219999999999999 109.922 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -65.23 -51.95 57.72 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.443 -0.577 . . . . 73.109999999999999 109.443 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 74.5 m-70 -90.36 75.38 6.86 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 109.083 -0.71 . . . . 72.319999999999993 109.083 171.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 12.8 p80 -78.89 98.06 6.23 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.251 0.548 . . . . 75.340000000000003 110.872 -178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.1 m80 68.29 167.51 0.26 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-N 114.874 -1.057 . . . . 52.43 111.241 177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 20.9 m-70 -126.56 -49.97 1.51 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.764 -0.653 . . . . 64.140000000000001 109.741 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 80.4 t60 . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.649 -0.691 . . . . 73.420000000000002 109.5 178.407 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mpp? . . . . . 0 N--CA 1.481 1.079 0 N-CA-C 109.306 -0.628 . . . . 71.209999999999994 109.306 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.77 -62.32 1.37 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.62 -0.718 . . . . 72.420000000000002 110.685 -169.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.433 ' O ' ' HB2' ' A' ' 4' ' ' GLU . 74.4 m-85 -66.69 -24.13 66.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.777 -0.647 . . . . 75.129999999999995 111.048 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.577 ' HB2' HE21 ' A' ' 6' ' ' GLN . 29.9 mm-40 68.3 177.31 0.25 Allowed 'General case' 0 C--O 1.235 0.297 0 O-C-N 123.958 0.786 . . . . 64.25 110.587 -172.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 t -83.38 79.65 9.34 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.234 0.54 . . . . 74.340000000000003 110.428 -177.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.577 HE21 ' HB2' ' A' ' 4' ' ' GLU . 61.4 mm-40 -91.94 -0.22 57.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.463 0.649 . . . . 73.299999999999997 109.783 177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -85.38 129.59 34.78 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.203 -0.908 . . . . 72.209999999999994 110.422 -174.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 p -71.3 106.74 2.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.636 0.732 . . . . 70.340000000000003 110.609 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.543 ' HB2' ' CD1' ' A' ' 119' ' ' TRP . 2.0 p -90.12 117.07 28.61 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.344 -0.844 . . . . 65.329999999999998 110.156 178.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -108.58 157.12 18.78 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.264 0.555 . . . . 62.039999999999999 111.114 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.698 HD13 HD21 ' A' ' 123' ' ' ASN . 62.5 tp -116.91 102.48 9.4 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.248 -1.019 . . . . 35.509999999999998 108.248 171.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp -114.63 165.86 12.33 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.227 -0.442 . . . . 71.219999999999999 111.258 -172.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 6.5 pt-20 -113.15 133.54 54.99 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.818 -0.628 . . . . 72.25 110.083 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.57 138.97 30.95 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.475 -0.33 . . . . 74.400000000000006 110.316 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.426 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -102.45 143.87 27.47 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.221 -0.445 . . . . 74.209999999999994 110.202 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 15' ' ' ALA . 9.1 Cg_exo -71.61 99.66 0.97 Allowed 'Trans proline' 0 N--CA 1.463 -0.312 0 C-N-CA 122.781 2.32 . . . . 74.329999999999998 112.093 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' HD3' ' A' ' 18' ' ' PRO . 59.9 t -116.68 141.82 28.71 Favored Pre-proline 0 C--N 1.321 -0.67 0 CA-C-N 115.544 -0.753 . . . . 53.409999999999997 109.646 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 17' ' ' VAL . 10.3 Cg_exo -73.11 123.55 8.91 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.778 2.319 . . . . 75.030000000000001 112.138 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.461 ' O ' ' HA ' ' A' ' 89' ' ' THR . . . -136.29 160.91 37.27 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.853 -0.612 . . . . 72.510000000000005 110.695 -179.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.441 HD23 ' HB ' ' A' ' 89' ' ' THR . 95.4 mt -97.26 122.75 40.64 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.575 -0.528 . . . . 72.530000000000001 109.575 174.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.571 ' HB2' ' HB2' ' A' ' 72' ' ' GLU . 0.0 OUTLIER -135.58 159.98 39.91 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.311 0.577 . . . . 75.129999999999995 111.888 -177.884 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.449 HD13 ' N ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -151.12 132.17 4.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.777 -1.194 . . . . 75.329999999999998 107.777 175.126 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.449 ' N ' HD13 ' A' ' 22' ' ' ILE . 59.8 mtt-85 -84.96 123.55 30.66 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.398 0.618 . . . . 74.540000000000006 111.666 -170.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.578 ' O ' HG22 ' A' ' 71' ' ' VAL . 99.0 m -134.12 109.6 9.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.438 -0.801 . . . . 65.319999999999993 110.841 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.811 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 7.7 pt20 -90.37 133.64 34.85 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.874 0.369 . . . . 73.400000000000006 111.337 -178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.485 ' OG1' ' HB3' ' A' ' 30' ' ' GLU . 8.7 t -154.7 179.13 9.36 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.187 -0.671 . . . . 75.540000000000006 109.187 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.673 ' HB2' ' HA ' ' A' ' 68' ' ' THR . . . -158.19 135.87 10.44 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.566 0.58 . . . . 72.040000000000006 112.566 -177.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 39.8 ttp 57.31 85.72 0.08 Allowed 'General case' 0 C--O 1.235 0.327 0 CA-C-N 114.852 -1.067 . . . . 74.129999999999995 113.708 168.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 55.1 m 62.5 30.74 17.2 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 114.988 -1.006 . . . . 75.329999999999998 113.218 169.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.485 ' HB3' ' OG1' ' A' ' 26' ' ' THR . 2.3 tm-20 -115.11 4.91 14.74 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.921 0.867 . . . . 74.420000000000002 109.005 175.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.595 HD21 ' HE1' ' A' ' 69' ' ' PHE . 7.0 mp -75.73 -33.69 60.3 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.088 -0.96 . . . . 53.229999999999997 111.475 -175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -50.89 -52.7 29.37 Favored Glycine 0 C--N 1.332 0.342 0 CA-C-N 116.091 -0.504 . . . . 71.010000000000005 113.272 -175.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 14.9 m -59.18 -34.74 72.48 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.99 0.424 . . . . 51.310000000000002 110.943 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 89.6 mt -72.22 -40.51 67.75 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.923 -0.581 . . . . 73.140000000000001 110.987 -178.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.444 ' CE2' ' HB3' ' A' ' 31' ' ' LEU . 20.1 m-85 -61.22 -48.25 82.36 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.698 0.285 . . . . 74.129999999999995 110.772 179.17 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -61.1 -39.43 89.95 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.393 -0.367 . . . . 73.329999999999998 110.901 178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.46 ' HA ' ' CD2' ' A' ' 40' ' ' HIS . . . -64.3 -53.35 50.3 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.278 -0.419 . . . . 72.0 111.236 179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -56.07 -37.7 72.74 Favored Glycine 0 N--CA 1.451 -0.359 0 CA-C-N 115.91 -0.586 . . . . 72.310000000000002 112.736 -177.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.461 ' O ' ' HG ' ' A' ' 43' ' ' LEU . 4.0 m-85 -58.73 -58.05 10.3 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 111.908 0.336 . . . . 63.039999999999999 111.908 179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.474 ' HA ' HD12 ' A' ' 43' ' ' LEU . 34.8 p80 -67.69 -32.75 73.62 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 120.637 -0.425 . . . . 70.230000000000004 111.71 -173.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -70.52 -49.74 45.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.729 0.299 . . . . 72.030000000000001 111.42 -179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 66.7 mt -70.97 -24.05 24.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.77 0.319 . . . . 74.049999999999997 110.608 -178.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.474 HD12 ' HA ' ' A' ' 40' ' ' HIS . 19.2 mt -57.77 -45.15 86.36 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.461 -0.336 . . . . 61.340000000000003 110.342 172.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 16.6 mm100 -62.54 -32.05 72.94 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.114 -0.494 . . . . 72.129999999999995 111.295 -179.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 84' ' ' SER . 2.3 tm? -66.08 -55.16 17.9 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.609 -0.515 . . . . 73.400000000000006 109.609 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 83.8 mt -71.3 -44.95 64.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.277 -0.419 . . . . 74.150000000000006 111.663 -176.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -69.3 -37.61 77.89 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.627 0.251 . . . . 75.140000000000001 110.766 -178.284 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -69.48 -31.32 71.05 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.13 -0.557 . . . . 42.329999999999998 111.917 178.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.7 tp60 -75.51 -37.82 59.87 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.292 -0.633 . . . . 74.310000000000002 109.292 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 104.83 34.32 3.54 Favored Glycine 0 N--CA 1.448 -0.507 0 CA-C-N 115.652 -0.704 . . . . 72.219999999999999 112.37 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -138.93 178.98 6.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.03 0.443 . . . . 75.030000000000001 110.941 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 50.9 m -136.76 163.48 49.35 Favored Pre-proline 0 C--N 1.322 -0.626 0 CA-C-N 115.939 -0.573 . . . . 43.539999999999999 110.178 179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB3' ' HD2' ' A' ' 76' ' ' PRO . 24.3 Cg_exo -63.51 157.89 48.51 Favored 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 122.478 2.119 . . . . 41.409999999999997 112.218 178.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.559 ' H ' ' HB2' ' A' ' 76' ' ' PRO . 11.0 t -93.03 15.54 14.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.331 0.586 . . . . 52.5 110.061 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.92 -161.48 34.33 Favored Glycine 0 N--CA 1.444 -0.78 0 N-CA-C 111.355 -0.698 . . . . 73.310000000000002 111.355 -179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.441 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 2.5 Cg_endo -81.66 153.52 17.68 Favored 'Trans proline' 0 N--CA 1.46 -0.462 0 C-N-CA 123.16 2.573 . . . . 64.129999999999995 112.23 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.534 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 57.0 Cg_endo -73.02 143.71 36.74 Favored 'Trans proline' 0 C--O 1.244 0.776 0 C-N-CA 122.645 2.23 . . . . 53.130000000000003 113.124 177.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -117.69 116.14 26.46 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.282 -0.872 . . . . 72.310000000000002 108.964 177.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.93 120.1 39.66 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.773 0.321 . . . . 64.25 110.262 -177.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.581 ' HG2' ' HG2' ' A' ' 72' ' ' GLU . 3.9 ptm180 -123.1 142.24 51.09 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 120.092 -0.643 . . . . 73.019999999999996 109.654 -178.412 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.786 ' HB3' HG12 ' A' ' 71' ' ' VAL . 41.9 p90 -138.24 130.92 29.44 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.338 0.589 . . . . 74.409999999999997 111.67 -179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.42 ' HZ ' ' HD3' ' A' ' 23' ' ' ARG . 16.9 p90 -119.79 135.22 54.94 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.052 -0.976 . . . . 61.549999999999997 110.336 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.511 ' HA3' ' HA ' ' A' ' 69' ' ' PHE . . . 169.81 50.82 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.346 -0.701 . . . . 62.420000000000002 111.346 -178.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.507 ' HG3' ' CD2' ' A' ' 159' ' ' LEU . 0.3 OUTLIER -86.32 86.1 7.34 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 121.3 0.571 . . . . 74.430000000000007 109.789 -177.853 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 31.5 t -152.57 -67.23 0.16 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.403 -0.817 . . . . 73.120000000000005 110.02 -176.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -136.34 -63.06 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.535 -0.302 . . . . 63.340000000000003 111.46 -178.126 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -155.17 -41.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.151 -1.024 . . . . 72.430000000000007 113.158 -177.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.673 ' HA ' ' HB2' ' A' ' 27' ' ' ALA . 31.8 m -76.16 126.68 31.44 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.993 0.425 . . . . 74.530000000000001 111.148 -177.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.595 ' HE1' HD21 ' A' ' 31' ' ' LEU . 10.2 p90 -128.4 150.64 50.02 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.699 -0.682 . . . . 75.239999999999995 110.035 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.811 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 9.2 tt0 -104.54 126.49 51.68 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.33 -0.395 . . . . 64.25 110.47 -177.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.786 HG12 ' HB3' ' A' ' 61' ' ' TYR . 22.2 m -105.76 155.67 6.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.673 -0.694 . . . . 75.409999999999997 111.418 -174.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.581 ' HG2' ' HG2' ' A' ' 60' ' ' ARG . 9.8 pt-20 -140.98 137.25 32.9 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.606 -0.725 . . . . 52.43 109.167 168.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -74.94 -34.62 62.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.48 -0.782 . . . . 65.299999999999997 112.007 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 54.28 76.77 0.17 Allowed Glycine 0 CA--C 1.522 0.494 0 O-C-N 123.595 0.559 . . . . 64.409999999999997 114.362 173.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 57' ' ' PRO . 76.4 m-85 -98.37 140.19 21.68 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.45 -0.574 . . . . 75.530000000000001 109.45 176.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.559 ' HB2' ' H ' ' A' ' 54' ' ' SER . 14.4 Cg_exo -70.67 154.44 64.13 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 122.563 2.175 . . . . 74.129999999999995 111.894 -179.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 33.6 m -114.97 150.56 16.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 120.986 0.422 . . . . 71.310000000000002 110.814 -178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 12.3 tm-20 -63.16 -53.08 58.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.374 -0.83 . . . . 72.219999999999999 110.424 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -162.98 -100.33 0.15 Allowed Glycine 0 N--CA 1.448 -0.532 0 N-CA-C 111.524 -0.63 . . . . 55.140000000000001 111.524 179.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -88.92 63.6 3.49 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.871 -0.68 . . . . 75.420000000000002 111.853 179.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.9 t -103.97 144.58 14.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.875 0.369 . . . . 74.099999999999994 110.232 -178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -115.92 170.25 8.62 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.442 -0.799 . . . . 74.420000000000002 110.123 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.566 ' HA3' ' O ' ' A' ' 87' ' ' VAL . . . -89.66 -178.16 45.22 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.763 -0.732 . . . . 64.510000000000005 111.931 178.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 45' ' ' LEU . 78.8 p -93.65 12.74 24.38 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.979 0.418 . . . . 72.0 110.858 -177.176 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 104.19 -52.84 0.73 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.202 -0.759 . . . . 50.210000000000001 111.202 -177.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.441 ' HG2' HG13 ' A' ' 22' ' ' ILE . 42.6 ttt180 -72.98 -55.72 6.15 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.87 -0.789 . . . . 73.439999999999998 108.87 174.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.566 ' O ' ' HA3' ' A' ' 83' ' ' GLY . 14.1 p -85.0 139.69 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 CA-C-N 115.356 -0.838 . . . . 73.319999999999993 108.832 174.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 18.8 m -135.67 162.04 37.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.512 -0.181 . . . . 73.239999999999995 110.512 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.461 ' HA ' ' O ' ' A' ' 19' ' ' ALA . 10.1 t -91.08 163.63 14.23 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.625 0.726 . . . . 71.340000000000003 111.07 177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 177.06 172.17 41.38 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 114.4 -1.273 . . . . 33.350000000000001 110.412 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.14 146.86 26.93 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 117.432 0.616 . . . . 73.109999999999999 110.754 -179.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 t -81.28 143.3 51.97 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.971 -0.558 . . . . 70.200000000000003 109.93 174.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -59.35 153.77 51.51 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.983 2.456 . . . . 74.129999999999995 112.249 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 p -111.33 165.31 12.06 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.886 -0.597 . . . . 63.299999999999997 110.313 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 137.59 176.33 14.38 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.677 -0.773 . . . . 74.329999999999998 112.58 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.473 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 71.9 mmtt -89.45 121.53 31.78 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 110.109 -0.33 . . . . 71.299999999999997 110.109 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -131.86 145.36 51.5 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.314 -0.403 . . . . 54.43 110.295 179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.452 ' HB1' ' CD1' ' A' ' 119' ' ' TRP . . . -82.16 124.21 29.68 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-O 121.049 0.452 . . . . 42.020000000000003 110.398 -179.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.446 ' HA ' ' HA ' ' A' ' 152' ' ' SER . 30.4 t -143.11 127.95 18.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.37 -0.832 . . . . 63.0 110.209 -176.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.451 ' HB2' HG22 ' A' ' 112' ' ' VAL . 15.6 m -113.25 132.91 55.35 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.463 -0.569 . . . . 64.049999999999997 109.463 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.741 ' HA ' ' HA ' ' A' ' 150' ' ' ARG . 4.2 pp -100.36 142.39 31.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.365 0.602 . . . . 73.209999999999994 111.579 -175.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 72.4 t80 -107.77 140.95 40.08 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.439 -0.801 . . . . 74.349999999999994 109.377 175.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 73.2 mt -112.6 114.64 47.57 Favored 'Isoleucine or valine' 0 C--O 1.237 0.423 0 CA-C-N 116.395 -0.366 . . . . 71.0 110.347 -179.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 -154.59 22.87 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.337 -0.705 . . . . 74.140000000000001 111.337 -179.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -80.19 176.75 8.97 Favored 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.572 2.181 . . . . 61.409999999999997 111.786 175.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -96.07 134.34 39.23 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.813 0.34 . . . . 74.239999999999995 110.184 -178.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -159.43 -101.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.984 -0.627 . . . . 64.030000000000001 112.017 179.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.486 ' HG3' ' H ' ' A' ' 111' ' ' ALA . 10.0 tp10 -77.32 100.7 5.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.006 0.431 . . . . 73.409999999999997 110.506 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.85 -29.76 20.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.924 -0.58 . . . . 74.340000000000003 111.086 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.813 ' HA ' ' HB3' ' A' ' 113' ' ' TYR . 45.8 mt-10 -75.42 -22.07 57.7 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.7 0.259 . . . . 75.340000000000003 111.7 -174.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.486 ' H ' ' HG3' ' A' ' 108' ' ' GLU . . . -58.0 -44.67 87.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.007 0.432 . . . . 60.439999999999998 110.82 178.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 100' ' ' SER . 15.0 p -85.35 -27.81 6.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.162 0.506 . . . . 70.340000000000003 110.034 176.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.813 ' HB3' ' HA ' ' A' ' 110' ' ' GLU . 83.9 t80 -56.01 -37.32 69.0 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-N 115.25 -0.886 . . . . 75.099999999999994 111.627 179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 117' ' ' MET . 7.5 t70 -51.66 -44.49 63.05 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.181 -0.463 . . . . 65.25 111.415 177.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.54 -24.9 67.76 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.908 -0.587 . . . . 65.0 112.2 -175.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.802 ' HG ' HD23 ' A' ' 153' ' ' LEU . 3.0 mm? -76.17 -43.84 40.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.722 0.296 . . . . 74.230000000000004 111.639 -177.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.458 ' O ' HG12 ' A' ' 120' ' ' VAL . 0.0 OUTLIER -73.74 -27.0 60.95 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.316 0.579 . . . . 74.129999999999995 109.729 177.791 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 64.7 tttm -75.22 -24.06 57.68 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.373 -0.831 . . . . 65.430000000000007 110.427 176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.554 ' O ' ' HE3' ' A' ' 119' ' ' TRP . 0.0 OUTLIER -63.6 -51.12 66.66 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.198 -0.91 . . . . 74.109999999999999 111.08 -177.871 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 117' ' ' MET . 12.0 p -51.91 -37.16 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-N 115.672 -0.695 . . . . 74.310000000000002 112.653 -170.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -50.46 -48.68 56.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.854 -0.612 . . . . 75.150000000000006 111.44 179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -82.61 -30.56 29.4 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.035 0.445 . . . . 70.409999999999997 110.898 177.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.698 HD21 HD13 ' A' ' 11' ' ' LEU . 7.3 t-20 -62.66 -39.07 92.77 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.617 -0.72 . . . . 72.310000000000002 111.492 -173.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 81.31 -5.19 68.61 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 121.07 -0.586 . . . . 74.049999999999997 113.153 178.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.526 ' HB2' ' OD1' ' A' ' 123' ' ' ASN . 1.3 m-85 -97.2 177.05 5.7 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.661 0.267 . . . . 61.240000000000002 111.074 -179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.498 ' C ' HD22 ' A' ' 127' ' ' LEU . 5.2 p-10 -153.44 124.58 7.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.281 0.562 . . . . 72.319999999999993 109.678 168.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.498 HD22 ' C ' ' A' ' 126' ' ' ASP . 3.3 mm? -139.72 116.18 10.65 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.613 -0.884 . . . . 74.129999999999995 108.613 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 59.6 m -116.01 34.57 4.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 121.048 0.451 . . . . 34.340000000000003 110.208 178.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -73.9 -71.21 1.13 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.68 -0.691 . . . . 45.030000000000001 112.432 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.477 ' HG3' ' HE ' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -153.59 169.18 23.86 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.024 0.44 . . . . 74.239999999999995 110.89 178.812 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -96.36 143.98 26.92 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.012 -0.736 . . . . 60.450000000000003 109.012 170.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 152' ' ' SER . 92.4 t80 -123.17 112.5 17.76 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 120.799 0.333 . . . . 72.400000000000006 111.142 -172.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.656 ' HG2' HG23 ' A' ' 151' ' ' VAL . 0.0 OUTLIER -115.48 156.57 25.43 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.135 -0.484 . . . . 73.420000000000002 109.896 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.624 HD11 ' HG2' ' A' ' 150' ' ' ARG . 42.0 pt -140.44 145.53 25.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 120.814 0.34 . . . . 75.140000000000001 110.763 177.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.534 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 73.0 m-85 -128.01 122.76 33.05 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.574 -0.451 . . . . 73.129999999999995 110.487 177.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.447 ' HB3' ' H ' ' A' ' 137' ' ' ASP . 4.5 mm? -80.15 -154.86 0.1 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.321 -0.854 . . . . 61.399999999999999 111.938 -172.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' H ' ' HB3' ' A' ' 136' ' ' LEU . 3.9 m-20 -58.67 153.81 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.43 -0.804 . . . . 74.230000000000004 111.424 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 6.4 t30 -61.53 142.16 94.3 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 115.743 -0.662 . . . . 65.349999999999994 109.825 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -65.91 178.87 2.09 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.755 2.303 . . . . 74.450000000000003 113.001 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.41 -38.54 0.37 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.024 0.929 . . . . 54.409999999999997 111.06 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -72.62 -41.45 65.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.909 -0.587 . . . . 73.25 110.08 177.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 10.1 t -125.91 166.04 17.63 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.845 -0.616 . . . . 71.409999999999997 110.437 -178.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.73 148.64 62.09 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 116.156 -0.474 . . . . 71.140000000000001 111.15 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.411 ' HA ' HD23 ' A' ' 147' ' ' LEU . 52.2 Cg_exo -56.03 -23.66 44.96 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 123.173 2.582 . . . . 72.340000000000003 112.971 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -66.99 -22.83 65.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.765 0.316 . . . . 41.520000000000003 111.083 177.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -95.39 -9.58 32.39 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.857 0.36 . . . . 65.219999999999999 110.628 179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 144' ' ' PRO . 4.2 mm? -79.69 75.01 6.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.174 0.512 . . . . 65.140000000000001 109.675 174.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 4.3 ptp85 -78.36 102.13 7.58 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.625 0.726 . . . . 72.219999999999999 109.804 -178.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 9.5 m -103.05 97.97 7.99 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.602 -0.726 . . . . 73.340000000000003 109.903 -176.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.741 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 30.0 ptt180 -99.97 114.11 27.15 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.345 0.593 . . . . 61.009999999999998 110.193 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.656 HG23 ' HG2' ' A' ' 133' ' ' GLU . 14.8 p -94.8 122.86 46.63 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.038 0 N-CA-C 109.357 -0.609 . . . . 73.319999999999993 109.357 178.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.793 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 23.1 t -103.88 132.78 49.8 Favored 'General case' 0 C--N 1.316 -0.853 0 N-CA-C 109.081 -0.711 . . . . 65.340000000000003 109.081 179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.802 HD23 ' HG ' ' A' ' 116' ' ' LEU . 3.4 mm? -121.7 -173.78 2.72 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.675 0.75 . . . . 74.530000000000001 111.914 -174.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.414 ' N ' ' SD ' ' A' ' 154' ' ' MET . 2.8 mpp? -86.76 123.67 32.16 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.564 -1.198 . . . . 72.310000000000002 110.448 -177.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.421 ' O ' ' HB3' ' A' ' 156' ' ' HIS . 3.6 mm? -64.89 117.04 6.99 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.127 -0.694 . . . . 63.310000000000002 109.127 173.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.421 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 51.1 t-80 76.79 136.89 0.06 Allowed 'General case' 0 N--CA 1.468 0.433 0 O-C-N 124.195 0.934 . . . . 75.109999999999999 110.943 -177.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.41 ' HB3' ' O ' ' A' ' 156' ' ' HIS . 2.5 tt0 75.07 -80.36 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.451 0 CA-C-N 115.234 -0.893 . . . . 71.329999999999998 110.872 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.402 ' HA ' ' CE ' ' A' ' 154' ' ' MET . 20.4 t 57.37 54.58 6.5 Favored 'General case' 0 CA--C 1.532 0.278 0 O-C-N 123.593 0.558 . . . . 75.099999999999994 110.663 -177.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.507 ' CD2' ' HG3' ' A' ' 64' ' ' MET . 3.9 mm? 56.02 -95.66 0.05 Allowed 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 123.249 0.619 . . . . 73.209999999999994 111.872 179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -126.46 97.4 5.02 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 116.038 -0.528 . . . . 52.109999999999999 110.484 -177.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.417 ' CD2' ' H ' ' A' ' 161' ' ' HIS . 5.1 p80 -80.42 88.75 5.58 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 108.159 -1.052 . . . . 74.140000000000001 108.159 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -62.7 135.12 57.2 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.673 -1.149 . . . . 64.040000000000006 111.894 -167.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 13.1 p80 -110.53 112.1 23.78 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.968 -0.56 . . . . 71.230000000000004 109.627 173.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.4 t-160 -119.31 97.48 5.68 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.425 -0.583 . . . . 72.340000000000003 109.425 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 56.8 t-80 -105.31 126.93 52.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.109 -0.496 . . . . 71.319999999999993 111.316 -173.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.542 -0.742 . . . . 73.349999999999994 109.39 174.807 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.585 ' HA ' ' OD2' ' A' ' 145' ' ' ASP . 23.7 ptp . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 109.909 -0.404 . . . . 70.549999999999997 109.909 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -173.44 -59.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.804 0.335 . . . . 64.439999999999998 110.781 174.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.545 ' CE2' ' HB2' ' A' ' 5' ' ' CYS . 32.5 p90 -151.95 162.56 40.88 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.267 -0.424 . . . . 73.439999999999998 110.774 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -101.79 104.59 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.824 -0.626 . . . . 64.140000000000001 110.245 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.545 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 11.9 t -96.58 108.34 20.92 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.617 -0.882 . . . . 73.310000000000002 108.617 174.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.2 mm100 -73.69 84.54 1.61 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.861 -0.609 . . . . 64.030000000000001 111.785 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 5.4 p90 42.82 90.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 O-C-N 124.517 1.136 . . . . 72.150000000000006 113.64 171.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 100' ' ' SER . 42.3 t -65.3 105.12 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.199 -0.667 . . . . 71.209999999999994 109.199 176.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 1.6 p -112.15 113.39 25.62 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.317 0.58 . . . . 64.099999999999994 110.944 -175.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -149.7 145.58 26.77 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.576 -0.738 . . . . 75.140000000000001 109.633 179.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.506 ' O ' HD12 ' A' ' 11' ' ' LEU . 0.8 OUTLIER -96.35 137.13 35.88 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.311 0.577 . . . . 73.420000000000002 110.936 179.347 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 58.8 pttt -155.4 168.96 25.37 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-N 116.026 -0.533 . . . . 61.140000000000001 110.753 175.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 13' ' ' GLU . 1.6 pm0 -78.7 114.84 17.97 Favored 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.44 -0.8 . . . . 62.310000000000002 110.869 -177.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.635 HD22 HH22 ' A' ' 150' ' ' ARG . 23.5 mt -83.13 143.82 30.27 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.172 -0.922 . . . . 73.219999999999999 109.907 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -89.66 143.25 30.11 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 110.064 -0.347 . . . . 74.329999999999998 110.064 178.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -75.77 113.14 3.66 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 122.353 2.035 . . . . 73.319999999999993 111.888 178.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 50.6 t -97.59 140.56 22.06 Favored Pre-proline 0 C--N 1.321 -0.656 0 CA-C-N 115.961 -0.563 . . . . 71.329999999999998 109.955 -178.44 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.428 ' HA ' HD23 ' A' ' 91' ' ' LEU . 8.7 Cg_exo -74.55 122.56 7.49 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.872 2.381 . . . . 75.329999999999998 111.745 175.578 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -155.63 173.49 16.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.168 -0.469 . . . . 73.120000000000005 110.632 -178.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.77 ' HA ' ' HA ' ' A' ' 89' ' ' THR . 4.3 pp -123.06 137.09 55.03 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 108.82 -0.807 . . . . 62.219999999999999 108.82 171.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.736 HD23 ' HA3' ' A' ' 74' ' ' GLY . 84.8 mt -118.82 135.73 54.38 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.208 -0.451 . . . . 72.329999999999998 111.627 -169.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.777 HG13 ' HB ' ' A' ' 87' ' ' VAL . 3.8 mp -105.16 110.18 30.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 108.608 -0.886 . . . . 73.120000000000005 108.608 176.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.507 ' HB2' ' OE2' ' A' ' 72' ' ' GLU . 14.6 ttm180 -102.2 127.71 49.02 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.216 0.531 . . . . 72.120000000000005 111.537 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.518 HG21 ' HB3' ' A' ' 34' ' ' LEU . 3.4 t -147.07 149.7 33.58 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.146 -0.934 . . . . 54.039999999999999 108.937 173.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.804 ' HG2' ' HG2' ' A' ' 70' ' ' GLU . 41.9 mt-30 -102.01 139.8 37.15 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.026 0.441 . . . . 74.530000000000001 110.376 -176.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.5 t -120.96 145.7 47.44 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.894 -0.593 . . . . 74.319999999999993 111.086 -176.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.14 123.73 46.51 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.201 -0.666 . . . . 62.43 109.201 169.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.0 ttt 57.04 -85.6 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.825 0.85 . . . . 74.319999999999993 112.35 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.3 t -142.64 84.12 1.84 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.372 0.606 . . . . 75.239999999999995 110.328 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.538 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 36.3 tt0 -125.43 -8.12 6.93 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 109.935 177.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.839 HD13 ' H ' ' A' ' 31' ' ' LEU . 0.0 OUTLIER -63.17 -18.26 63.28 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.496 -0.774 . . . . 44.140000000000001 112.399 -175.316 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' N ' HD22 ' A' ' 31' ' ' LEU . . . -59.38 -54.77 35.06 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.835 -0.698 . . . . 54.420000000000002 112.192 178.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.4 t -70.63 -30.42 67.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.017 0.437 . . . . 74.099999999999994 110.131 178.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 81.0 mt -63.15 -45.61 91.05 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.861 -0.609 . . . . 64.310000000000002 110.9 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -63.87 -48.12 77.98 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.892 -0.41 . . . . 74.129999999999995 109.892 177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 40' ' ' HIS . 15.3 tt0 -51.55 -58.66 5.7 Favored 'General case' 0 C--O 1.232 0.178 0 O-C-N 123.911 0.757 . . . . 72.510000000000005 111.21 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -65.39 -31.37 72.44 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.935 -0.575 . . . . 70.150000000000006 111.297 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -59.08 -54.82 34.79 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.135 -0.555 . . . . 73.329999999999998 112.882 -179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 11.2 p90 -81.88 -15.69 53.16 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.83 -0.348 . . . . 70.329999999999998 111.263 -178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.403 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 20.7 t60 -57.5 -53.2 60.86 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.398 -0.364 . . . . 74.340000000000003 110.993 -175.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -121.18 88.31 2.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.408 0.623 . . . . 72.340000000000003 110.035 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 14.8 tt -159.55 -23.0 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.172 -0.922 . . . . 71.140000000000001 109.509 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 86.0 mt -62.47 -16.65 56.57 Favored 'General case' 0 C--O 1.226 -0.162 0 CA-C-N 115.594 -0.73 . . . . 53.539999999999999 110.799 177.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 2.8 mp0 -59.48 -32.04 69.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.29 -0.414 . . . . 75.230000000000004 110.821 175.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.596 HD21 ' HB3' ' A' ' 84' ' ' SER . 3.3 mm? -74.88 -8.63 57.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.352 -0.385 . . . . 71.109999999999999 110.95 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.453 HD11 ' HE1' ' A' ' 75' ' ' PHE . 86.6 mt -111.22 -52.16 2.81 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.53 -0.304 . . . . 61.329999999999998 110.634 178.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.44 -34.09 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.856 0.36 . . . . 73.230000000000004 110.918 -178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.61 -4.66 85.27 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.817 -0.706 . . . . 64.530000000000001 111.458 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 7.9 tp-100 -98.71 -41.81 7.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.172 0.51 . . . . 70.140000000000001 110.281 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 109.71 25.77 5.31 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.25 -0.74 . . . . 65.329999999999998 111.25 -176.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -129.22 164.23 23.89 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.712 0.292 . . . . 72.519999999999996 110.79 -177.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 5.2 p -129.57 162.22 54.35 Favored Pre-proline 0 C--N 1.32 -0.687 0 CA-C-N 116.064 -0.516 . . . . 70.409999999999997 109.865 178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -53.9 138.59 69.5 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.322 2.014 . . . . 65.040000000000006 111.705 177.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.4 t -93.01 14.29 18.19 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.291 -0.413 . . . . 53.229999999999997 110.796 -175.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 162.25 -172.42 38.35 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.869 -0.681 . . . . 64.140000000000001 112.013 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo -71.12 156.91 58.83 Favored 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.27 2.647 . . . . 64.439999999999998 112.069 179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -65.5 156.42 63.66 Favored 'Trans proline' 0 C--O 1.245 0.864 0 C-N-CA 122.592 2.195 . . . . 42.530000000000001 112.714 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.675 ' CZ ' ' HG3' ' A' ' 76' ' ' PRO . 17.7 m-85 -113.86 176.94 4.82 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.876 -0.602 . . . . 75.310000000000002 109.574 -179.055 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.709 ' HA ' ' HA ' ' A' ' 73' ' ' PHE . . . -158.31 110.55 2.29 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.225 -0.443 . . . . 74.400000000000006 110.23 174.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.981 ' HB3' ' HD1' ' A' ' 132' ' ' TYR . 0.0 OUTLIER -124.86 144.54 50.25 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.256 0.55 . . . . 74.310000000000002 110.21 174.859 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . . . . . . . . . 63.6 m-85 -127.33 117.64 22.62 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.17 -0.923 . . . . 74.530000000000001 109.62 -175.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.73 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 14.7 t80 -106.42 155.07 19.94 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.94 -1.027 . . . . 64.519999999999996 109.678 -176.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.13 21.13 23.72 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.292 -0.956 . . . . 63.409999999999997 112.019 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 86.9 mmm -70.72 -9.67 57.75 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 121.237 0.541 . . . . 73.409999999999997 110.035 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 8.4 t -129.91 23.35 5.33 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.798 -0.816 . . . . 74.549999999999997 108.798 178.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -133.29 -173.08 3.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.366 -0.834 . . . . 64.329999999999998 110.709 -177.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -73.05 -63.51 2.8 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.881 -0.676 . . . . 40.210000000000001 113.018 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 p -85.66 152.65 22.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.136 0.421 . . . . 71.439999999999998 112.136 -176.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -96.05 116.29 28.73 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.919 -0.771 . . . . 75.430000000000007 108.919 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.804 ' HG2' ' HG2' ' A' ' 25' ' ' GLN . 41.4 mt-10 -100.81 128.73 46.73 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 115.916 -0.584 . . . . 51.219999999999999 110.985 -175.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.663 HG11 ' HB3' ' A' ' 31' ' ' LEU . 16.5 m -109.37 126.38 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.827 0 CA-C-O 121.621 0.724 . . . . 71.109999999999999 110.22 178.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.639 ' O ' ' HG3' ' A' ' 60' ' ' ARG . 39.3 tt0 -142.52 88.69 2.09 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 115.187 -0.915 . . . . 73.099999999999994 109.029 -177.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 9.5 p90 -77.01 -61.05 2.11 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.266 -0.425 . . . . 72.030000000000001 111.393 -175.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.736 ' HA3' HD23 ' A' ' 21' ' ' LEU . . . 63.78 171.12 1.94 Allowed Glycine 0 CA--C 1.526 0.736 0 C-N-CA 121.029 -0.605 . . . . 73.439999999999998 114.063 179.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.572 ' CZ ' HD11 ' A' ' 20' ' ' LEU . 40.1 p90 -151.3 155.93 34.8 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.475 -0.362 . . . . 74.450000000000003 110.143 176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.675 ' HG3' ' CZ ' ' A' ' 58' ' ' PHE . 3.9 Cg_exo -77.69 142.77 20.69 Favored 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 123.039 2.493 . . . . 64.5 113.774 -170.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.82 175.86 9.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.019 -0.991 . . . . 73.120000000000005 108.792 174.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.49 -49.19 5.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.241 -0.584 . . . . 73.340000000000003 111.403 -178.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 155.54 133.32 1.68 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.908 -0.663 . . . . 62.340000000000003 111.678 179.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.63 49.1 2.6 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 120.487 -0.863 . . . . 54.420000000000002 111.201 -176.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.4 t -124.43 152.69 30.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.133 -0.691 . . . . 55.149999999999999 109.133 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -107.9 155.89 19.79 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.342 . . . . 71.120000000000005 110.739 -175.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -108.17 148.52 16.71 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 111.33 -0.708 . . . . 50.450000000000003 111.33 179.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.596 ' HB3' HD21 ' A' ' 45' ' ' LEU . 57.9 p -90.01 12.16 18.44 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.995 0.426 . . . . 73.439999999999998 111.389 -175.032 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 115.77 -59.35 0.44 Allowed Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.766 -0.731 . . . . 61.140000000000001 112.42 178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 4.6 mmp_? -79.21 1.8 23.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.101 0.477 . . . . 64.010000000000005 110.763 -179.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.777 ' HB ' HG13 ' A' ' 22' ' ' ILE . 5.1 p -134.77 137.72 50.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 71.420000000000002 111.204 -175.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 15.9 m -132.33 139.65 49.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.877 -0.601 . . . . 54.200000000000003 110.234 175.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.77 ' HA ' ' HA ' ' A' ' 20' ' ' LEU . 8.8 t -94.72 161.21 14.28 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.515 0.674 . . . . 54.109999999999999 112.118 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.51 -153.81 23.09 Favored Glycine 0 N--CA 1.45 -0.432 0 CA-C-N 114.734 -1.121 . . . . 73.400000000000006 111.443 -177.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.428 HD23 ' HA ' ' A' ' 18' ' ' PRO . 54.1 mt -110.13 150.2 28.96 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.922 0.392 . . . . 71.109999999999999 110.94 178.001 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.8 p -83.27 163.75 48.85 Favored Pre-proline 0 C--N 1.323 -0.564 0 CA-C-N 115.862 -0.608 . . . . 74.129999999999995 110.975 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_exo -60.03 151.64 70.79 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.006 2.471 . . . . 75.349999999999994 113.032 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 32.3 t -135.58 156.27 49.14 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.657 -0.701 . . . . 62.130000000000003 109.809 -179.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 133.51 -179.43 17.42 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.003 -0.617 . . . . 70.129999999999995 111.988 179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.9 tptp -74.12 113.96 11.9 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.564 -0.532 . . . . 65.439999999999998 109.564 178.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -131.55 144.28 50.98 Favored 'General case' 0 C--N 1.318 -0.794 0 C-N-CA 121.156 -0.218 . . . . 61.520000000000003 110.793 -178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -78.23 105.72 9.65 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.143 -0.481 . . . . 64.400000000000006 109.811 -179.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.55 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 20.1 m -106.05 133.41 50.81 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.171 -0.468 . . . . 75.420000000000002 110.521 -176.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 8' ' ' VAL . 37.6 m -117.45 128.47 55.03 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.986 -0.552 . . . . 51.409999999999997 110.451 177.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HA ' ' O ' ' A' ' 149' ' ' THR . 66.0 mt -92.71 134.75 34.73 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.765 -0.652 . . . . 74.230000000000004 110.014 178.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.741 ' O ' ' HA ' ' A' ' 148' ' ' ARG . 3.3 m-30 -91.52 133.76 35.24 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.186 -0.461 . . . . 73.420000000000002 110.717 -178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 4.3 mp -128.83 104.81 12.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.548 -0.538 . . . . 73.109999999999999 109.548 175.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 144.4 -154.09 25.52 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.825 -0.703 . . . . 44.439999999999998 111.594 -179.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_exo -71.01 141.97 41.37 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.927 2.418 . . . . 75.209999999999994 111.972 176.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -96.54 133.85 40.49 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.945 -0.761 . . . . 74.540000000000006 108.945 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.94 -72.6 0.24 Allowed Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.102 -1.047 . . . . 63.229999999999997 112.698 179.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -82.28 84.45 7.1 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 73.310000000000002 110.477 -177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 20.6 tt -75.49 -20.84 16.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.022 -0.99 . . . . 71.239999999999995 110.667 -177.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -57.13 -43.48 82.43 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.842 -0.617 . . . . 61.420000000000002 111.435 -179.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.44 -47.27 79.46 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.065 -0.516 . . . . 70.129999999999995 111.784 -176.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.474 HG11 ' CE2' ' A' ' 102' ' ' TYR . 2.1 p -80.65 -28.34 11.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 116.174 -0.466 . . . . 64.420000000000002 111.029 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -62.79 -31.39 72.35 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-O 120.585 0.231 . . . . 74.5 110.774 177.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -52.67 -40.27 62.7 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.053 0.454 . . . . 62.32 110.745 173.77 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -66.34 -41.2 89.92 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.789 -0.641 . . . . 74.150000000000006 110.947 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.0 mt -62.5 -44.73 95.67 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.94 0.4 . . . . 64.540000000000006 111.094 178.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 45.1 ttp -64.53 -34.35 78.03 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.817 -0.629 . . . . 61.140000000000001 110.567 -179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -77.25 -39.97 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.952 -0.567 . . . . 61.210000000000001 110.535 177.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 73.1 t90 -56.5 -52.43 64.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.009 -0.541 . . . . 74.310000000000002 111.583 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 14.8 p -60.54 -40.23 83.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.504 . . . . 71.430000000000007 111.136 -176.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.37 -43.67 66.47 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.598 -0.728 . . . . 71.439999999999998 111.063 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -64.11 -35.08 79.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.875 -0.602 . . . . 62.140000000000001 111.794 -178.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 30.1 m-80 -83.46 -9.62 58.88 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.356 . . . . 72.129999999999995 111.287 -179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.32 47.67 6.8 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.925 -0.655 . . . . 61.350000000000001 113.115 175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -119.44 164.34 15.89 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-O 120.599 0.237 . . . . 74.420000000000002 110.733 176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -83.06 178.82 7.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.031 -0.531 . . . . 71.319999999999993 110.109 -178.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.8 mt -70.42 143.57 51.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 73.040000000000006 110.924 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.531 ' OG ' ' HG ' ' A' ' 153' ' ' LEU . 12.9 m -73.98 -46.82 41.45 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.651 -0.704 . . . . 73.209999999999994 111.657 -176.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.07 -17.13 10.08 Favored Glycine 0 CA--C 1.524 0.635 0 C-N-CA 120.638 -0.791 . . . . 74.099999999999994 113.522 -178.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.73 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -144.59 142.79 30.43 Favored 'General case' 0 C--O 1.237 0.426 0 CA-C-N 117.005 0.403 . . . . 70.430000000000007 110.322 -175.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -136.97 117.54 13.85 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.234 0.334 . . . . 63.520000000000003 110.531 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.981 ' HD1' ' HB3' ' A' ' 60' ' ' ARG . 57.5 t80 -127.6 120.2 27.63 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.547 -0.297 . . . . 73.329999999999998 111.685 -173.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.817 ' HB3' ' HA ' ' A' ' 151' ' ' VAL . 11.9 pt-20 -135.87 168.25 19.68 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-O 121.239 0.542 . . . . 53.299999999999997 111.518 175.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.585 HD12 ' CD1' ' A' ' 58' ' ' PHE . 18.0 mm -112.97 133.15 59.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.467 -0.788 . . . . 73.349999999999994 109.45 -177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -75.4 -19.13 59.71 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 120.554 -0.458 . . . . 63.450000000000003 111.391 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.421 ' H ' HG22 ' A' ' 134' ' ' ILE . 5.8 tp 60.53 -153.47 0.38 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 115.762 -0.653 . . . . 73.319999999999993 112.375 169.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -70.72 135.98 48.64 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.492 -0.776 . . . . 65.200000000000003 111.469 -177.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -66.01 143.65 98.51 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 115.454 -0.794 . . . . 73.109999999999999 110.077 176.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -59.43 175.62 0.74 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.041 2.494 . . . . 64.120000000000005 113.372 178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.85 -38.05 0.33 Allowed 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 123.891 0.876 . . . . 62.229999999999997 111.05 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -81.05 -31.27 34.56 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.028 -0.73 . . . . 74.109999999999999 109.028 175.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 8.9 t -105.42 175.0 5.64 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.328 -0.851 . . . . 72.530000000000001 108.851 172.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.37 143.15 87.58 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-O 120.894 0.378 . . . . 64.400000000000006 111.978 -173.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 143' ' ' ALA . 5.9 Cg_exo -74.49 144.13 31.84 Favored 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 122.964 2.443 . . . . 72.150000000000006 111.067 174.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.585 ' OD2' ' HA ' ' A' ' 1' ' ' MET . 38.9 t70 66.2 26.4 10.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.993 0.902 . . . . 54.119999999999997 109.524 179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 15.9 tt0 -144.79 23.75 1.55 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.198 -0.91 . . . . 63.32 109.17 178.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 86.0 mt -74.02 105.48 5.27 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.482 -0.781 . . . . 54.210000000000001 110.746 -177.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.741 ' HA ' ' O ' ' A' ' 102' ' ' TYR . 5.0 ptm180 -95.51 116.92 29.49 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.75 -0.659 . . . . 73.530000000000001 111.921 -176.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.65 HG22 ' CG ' ' A' ' 102' ' ' TYR . 1.0 OUTLIER -100.27 172.02 7.42 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 107.434 -1.321 . . . . 70.519999999999996 107.434 169.015 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.635 HH22 HD22 ' A' ' 14' ' ' LEU . 6.6 ptm180 -133.23 90.67 2.76 Favored 'General case' 0 C--N 1.315 -0.927 0 C-N-CA 120.822 -0.351 . . . . 71.329999999999998 110.164 174.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.817 ' HA ' ' HB3' ' A' ' 133' ' ' GLU . 11.9 p -88.63 115.84 29.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.518 0.675 . . . . 75.439999999999998 109.908 -177.085 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 48.1 m -104.26 119.69 39.52 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.697 -0.683 . . . . 74.409999999999997 109.942 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.531 ' HG ' ' OG ' ' A' ' 128' ' ' SER . 16.2 tp -105.08 134.51 48.07 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 108.832 -0.803 . . . . 52.310000000000002 108.832 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 154' ' ' MET . 11.6 mmt -58.03 125.37 22.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.215 0.531 . . . . 72.420000000000002 111.093 -177.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.538 HD13 ' N ' ' A' ' 156' ' ' HIS . 1.0 OUTLIER -141.43 143.05 33.69 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.487 -0.931 . . . . 73.140000000000001 108.487 -176.302 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.538 ' N ' HD13 ' A' ' 155' ' ' LEU . 7.7 t60 71.22 114.7 0.05 Allowed 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.527 0.517 . . . . 73.019999999999996 110.162 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 69.59 84.92 0.14 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-N 115.762 -0.654 . . . . 75.439999999999998 110.157 -177.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 39.3 t -68.99 133.47 48.2 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.451 -0.795 . . . . 44.439999999999998 110.528 -177.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.99 96.72 6.1 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.436 0.636 . . . . 52.030000000000001 111.505 -179.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -84.68 61.75 6.93 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.645 0.736 . . . . 72.439999999999998 109.436 177.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -88.49 94.54 9.9 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.678 -0.692 . . . . 73.319999999999993 109.295 179.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -124.43 114.8 19.97 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.046 -0.525 . . . . 63.530000000000001 110.957 -174.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 51.4 p-80 -86.44 121.04 28.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.825 -0.625 . . . . 60.539999999999999 110.312 179.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 9.4 t-80 66.12 119.61 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 115.166 -0.925 . . . . 73.400000000000006 110.997 -177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -60.8 -68.73 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.038 -0.528 . . . . 74.340000000000003 110.161 -178.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 . . . . . 0 C--O 1.245 0.857 0 CA-C-O 118.707 -0.664 . . . . 61.210000000000001 109.372 174.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.4 mtt . . . . . 0 N--CA 1.483 1.18 0 N-CA-C 111.491 0.182 . . . . 71.340000000000003 111.491 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.8 t70 64.56 -154.96 0.3 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 109.754 -0.461 . . . . 65.010000000000005 109.754 -178.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -97.12 140.61 31.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.936 0.398 . . . . 75.549999999999997 111.293 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -91.47 161.45 14.97 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.534 -0.757 . . . . 63.140000000000001 110.314 -177.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.556 ' SG ' HG12 ' A' ' 103' ' ' ILE . 26.2 p -95.29 -177.08 3.99 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.906 0.384 . . . . 70.340000000000003 110.707 179.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -100.24 1.47 41.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.446 0.641 . . . . 74.319999999999993 109.384 176.167 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 59.81 49.45 8.0 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.109 -0.951 . . . . 55.200000000000003 110.346 -177.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -57.57 115.57 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.679 0.752 . . . . 61.140000000000001 111.912 -179.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.52 ' SG ' ' HG ' ' A' ' 116' ' ' LEU . 46.5 t -111.61 130.25 55.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.585 -0.734 . . . . 75.310000000000002 109.798 177.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -151.94 156.62 40.42 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.446 -0.343 . . . . 73.25 110.329 -178.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.591 ' HB2' ' CH2' ' A' ' 119' ' ' TRP . 31.2 tp -85.05 119.44 25.45 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.87 -0.605 . . . . 74.409999999999997 110.07 177.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -128.26 149.33 50.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.912 0.387 . . . . 73.299999999999997 110.621 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.423 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 43.5 tt0 -88.57 117.9 27.84 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.769 -0.65 . . . . 75.310000000000002 109.436 175.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.656 ' HB2' ' HB3' ' A' ' 94' ' ' SER . 3.8 mm? -79.97 119.78 23.27 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.221 -0.445 . . . . 70.010000000000005 111.182 -176.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.05 143.11 69.76 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 115.948 -0.569 . . . . 44.219999999999999 109.94 176.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.632 ' HB3' ' HA ' ' A' ' 93' ' ' PRO . 97.5 Cg_endo -80.85 156.1 20.6 Favored 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.472 2.115 . . . . 72.209999999999994 112.644 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.8 p -150.4 143.38 16.43 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.131 -0.486 . . . . 64.120000000000005 110.118 -176.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -61.46 116.31 3.33 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.716 2.277 . . . . 70.219999999999999 111.495 171.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.521 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -150.15 -178.32 6.44 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.042 -0.526 . . . . 74.310000000000002 111.487 -173.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.544 ' HG ' HG11 ' A' ' 77' ' ' VAL . 41.4 mt -106.52 122.64 46.72 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.471 -0.786 . . . . 70.030000000000001 109.449 171.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 HD23 ' H ' ' A' ' 21' ' ' LEU . 1.2 pt? -116.85 141.25 48.46 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.325 0.583 . . . . 75.340000000000003 110.508 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.733 HD13 ' HB3' ' A' ' 73' ' ' PHE . 4.8 mp -122.74 106.05 17.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 108.728 -0.842 . . . . 53.310000000000002 108.728 177.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 23' ' ' ARG . 14.9 ptt180 -88.76 109.98 20.63 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.628 0.727 . . . . 75.340000000000003 110.423 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.1 m -128.72 133.7 48.23 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.28 -0.873 . . . . 73.430000000000007 110.48 -178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.635 ' H ' ' NE2' ' A' ' 25' ' ' GLN . 0.5 OUTLIER -99.14 116.3 31.02 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.132 -0.692 . . . . 73.409999999999997 109.132 172.481 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.592 HG22 ' HB3' ' A' ' 69' ' ' PHE . 12.7 t -82.67 137.71 34.37 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.079 0.466 . . . . 70.239999999999995 110.353 -176.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -108.9 133.07 53.41 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.592 -0.731 . . . . 74.349999999999994 110.064 -179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 83.5 mtp 61.25 28.37 17.94 Favored 'General case' 0 N--CA 1.464 0.255 0 O-C-N 123.625 0.578 . . . . 74.109999999999999 111.022 177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.8 m 58.15 38.21 26.37 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 115.738 -0.665 . . . . 74.329999999999998 111.466 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.68 ' HG3' ' HB2' ' A' ' 33' ' ' SER . 6.2 tp10 -83.99 59.5 5.3 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.615 0.721 . . . . 75.540000000000006 109.112 177.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.496 ' HG ' ' CE2' ' A' ' 35' ' ' PHE . 30.4 tp -73.47 -56.14 5.42 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.211 -0.904 . . . . 74.340000000000003 111.599 -171.743 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -61.38 -40.88 99.26 Favored Glycine 0 CA--C 1.517 0.192 0 C-N-CA 121.202 -0.523 . . . . 73.120000000000005 112.871 -175.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . 0.68 ' HB2' ' HG3' ' A' ' 30' ' ' GLU . 18.4 m -62.85 -34.88 78.28 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.716 0.293 . . . . 73.409999999999997 111.365 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 30' ' ' GLU . 74.8 mt -72.83 -38.11 67.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.598 -0.274 . . . . 71.049999999999997 110.407 179.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.496 ' CE2' ' HG ' ' A' ' 31' ' ' LEU . 10.3 m-85 -59.66 -45.91 90.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.461 -0.336 . . . . 71.310000000000002 110.554 176.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -51.7 -42.42 62.21 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 123.77 0.668 . . . . 74.420000000000002 111.595 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -79.9 -38.4 32.63 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.421 -0.354 . . . . 65.200000000000003 110.991 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.37 -55.86 28.18 Favored Glycine 0 N--CA 1.451 -0.318 0 CA-C-N 115.817 -0.629 . . . . 72.019999999999996 113.726 -175.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.685 ' HA ' HG22 ' A' ' 42' ' ' ILE . 25.0 p90 -76.11 -18.87 58.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 117.359 0.58 . . . . 74.310000000000002 110.756 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -71.12 -42.92 68.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.481 -0.327 . . . . 75.540000000000006 110.618 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -85.88 -19.65 30.25 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.019 0.377 . . . . 73.420000000000002 112.019 -177.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.685 HG22 ' HA ' ' A' ' 39' ' ' TYR . 12.9 tt -89.6 -11.68 10.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.229 0.538 . . . . 62.439999999999998 110.449 -179.699 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 61.5 tp -61.94 -43.2 99.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.874 -0.603 . . . . 75.150000000000006 110.913 -178.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 23.6 mp0 -73.44 -17.81 61.21 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 73.010000000000005 111.007 -176.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 52.7 tp -70.04 -32.23 70.26 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.141 0.496 . . . . 73.329999999999998 110.2 178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -99.43 -64.06 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.04 -0.527 . . . . 51.409999999999997 110.738 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -67.6 -36.08 80.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 52.420000000000002 111.446 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.29 -38.8 58.49 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.643 -0.789 . . . . 65.319999999999993 112.258 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -72.7 -27.9 62.35 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.764 0.316 . . . . 63.43 110.784 179.531 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 105.32 35.33 3.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.519 -0.848 . . . . 64.430000000000007 112.483 178.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.584 ' HE2' ' O ' ' A' ' 79' ' ' GLY . 27.2 mtpp -134.42 -178.95 5.29 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 110.158 -0.312 . . . . 75.430000000000007 110.158 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.405 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 50.5 m -143.69 155.26 59.99 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 116.518 -0.31 . . . . 53.329999999999998 110.45 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 52' ' ' SER . 13.8 Cg_exo -70.13 159.3 53.63 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.849 2.366 . . . . 61.329999999999998 111.826 176.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.45 ' HB3' ' HB2' ' A' ' 76' ' ' PRO . 21.0 t -93.54 -17.89 22.86 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.504 0.669 . . . . 74.439999999999998 109.257 178.377 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.1 157.16 27.09 Favored Glycine 0 N--CA 1.442 -0.925 0 CA-C-N 115.619 -0.719 . . . . 62.219999999999999 111.82 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.829 ' HG2' HD11 ' A' ' 134' ' ' ILE . 37.5 Cg_endo -66.76 155.1 72.08 Favored 'Trans proline' 0 N--CA 1.463 -0.308 0 C-N-CA 122.742 2.295 . . . . 71.030000000000001 112.016 179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.581 ' HA ' ' HB3' ' A' ' 75' ' ' PHE . 36.0 Cg_exo -61.78 147.87 94.32 Favored 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.781 2.321 . . . . 44.439999999999998 112.927 -178.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.478 ' HE1' ' HD3' ' A' ' 76' ' ' PRO . 42.2 m-85 -115.11 -178.95 3.49 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.762 -0.654 . . . . 62.350000000000001 109.944 177.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' O ' ' HA ' ' A' ' 132' ' ' TYR . . . -135.31 107.19 7.05 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.832 -1.173 . . . . 75.120000000000005 107.832 160.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 40.7 mtp180 -109.19 110.04 21.15 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.333 -0.618 . . . . 75.25 109.333 -174.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.601 ' HE1' ' HG2' ' A' ' 133' ' ' GLU . 26.7 p90 -130.27 149.55 51.91 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 122.236 1.017 . . . . 62.399999999999999 113.495 -167.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -120.48 118.3 29.91 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 113.396 -1.729 . . . . 75.329999999999998 108.417 169.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.576 ' HA3' ' CE2' ' A' ' 69' ' ' PHE . . . -156.14 40.85 0.58 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.284 -0.96 . . . . 64.120000000000005 112.738 -177.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -35.98 51.71 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.618 -0.882 . . . . 72.200000000000003 108.618 176.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 15.5 m -86.74 124.67 33.25 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.213 -0.903 . . . . 73.150000000000006 110.105 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -73.58 145.35 45.54 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.348 -0.387 . . . . 53.0 111.597 -177.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 130.05 -78.83 0.37 Allowed Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 121.03 -0.605 . . . . 73.219999999999999 111.798 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 10.4 m -114.69 136.77 52.7 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 64.239999999999995 109.622 177.397 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.592 ' HB3' HG22 ' A' ' 26' ' ' THR . 3.8 t80 -114.15 118.32 33.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.021 0.439 . . . . 71.200000000000003 110.039 -175.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -88.59 123.97 33.59 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.561 -0.745 . . . . 64.409999999999997 110.457 -176.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.564 HG12 ' HB3' ' A' ' 61' ' ' TYR . 31.2 m -133.62 123.17 45.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.393 0.616 . . . . 72.349999999999994 111.483 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.728 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 3.4 mp0 -103.89 126.4 50.99 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.23 -0.656 . . . . 62.229999999999997 109.23 170.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.733 ' HB3' HD13 ' A' ' 22' ' ' ILE . 51.7 t80 -65.42 -62.65 1.41 Allowed 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.289 -0.634 . . . . 74.420000000000002 109.289 178.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.52 ' HA2' ' O ' ' A' ' 20' ' ' LEU . . . 63.87 127.17 0.01 OUTLIER Glycine 0 CA--C 1.527 0.821 0 N-CA-C 115.644 1.018 . . . . 75.420000000000002 115.644 169.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.581 ' HB3' ' HA ' ' A' ' 57' ' ' PRO . 52.9 p90 -160.99 143.87 9.55 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.049 -0.352 . . . . 74.439999999999998 110.049 167.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.478 ' HD3' ' HE1' ' A' ' 58' ' ' PHE . 16.6 Cg_exo -67.61 144.43 66.31 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 123.109 2.539 . . . . 73.519999999999996 112.271 -178.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.544 HG11 ' HG ' ' A' ' 20' ' ' LEU . 22.2 m -124.5 160.84 28.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 120.841 0.353 . . . . 72.099999999999994 111.086 -178.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -65.56 -61.05 2.31 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.753 -0.658 . . . . 72.319999999999993 110.074 179.287 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.584 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . 159.97 161.82 11.71 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.99 -0.624 . . . . 64.230000000000004 111.872 179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.04 8.1 77.82 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.909 -0.662 . . . . 61.420000000000002 112.626 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.488 HG11 HD11 ' A' ' 20' ' ' LEU . 8.7 t -87.67 154.55 3.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 109.622 -0.51 . . . . 72.200000000000003 109.622 -178.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -141.27 150.19 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.068 -0.345 . . . . 73.310000000000002 110.068 -174.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.559 ' HA2' HG13 ' A' ' 87' ' ' VAL . . . -76.04 144.08 30.58 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.714 -0.755 . . . . 52.140000000000001 112.638 -178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 36.2 p -100.5 6.17 44.24 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 111.926 0.343 . . . . 63.130000000000003 111.926 -176.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 117.72 -55.66 0.57 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.662 -0.78 . . . . 52.119999999999997 111.733 -178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 mmt180 -68.84 -36.95 78.8 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.609 0.719 . . . . 64.319999999999993 109.146 172.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.559 HG13 ' HA2' ' A' ' 83' ' ' GLY . 10.7 p -112.69 149.76 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 114.925 -1.034 . . . . 71.239999999999995 109.913 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.43 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 22.2 m -131.83 142.31 43.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 109.494 -0.558 . . . . 75.219999999999999 109.494 172.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.429 ' HB ' ' CD2' ' A' ' 20' ' ' LEU . 8.9 t -89.61 160.43 16.66 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.546 0.689 . . . . 62.109999999999999 111.312 176.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 157.73 -162.03 31.8 Favored Glycine 0 C--N 1.311 -0.806 0 CA-C-N 114.415 -1.266 . . . . 65.319999999999993 110.949 179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.432 ' O ' ' HD3' ' A' ' 93' ' ' PRO . 8.4 mp -100.87 138.75 37.5 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 109.409 -0.589 . . . . 75.349999999999994 109.409 176.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.7 p -104.34 87.92 1.88 Allowed Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.329 -0.396 . . . . 74.239999999999995 110.753 177.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.632 ' HA ' ' HB3' ' A' ' 16' ' ' PRO . 74.3 Cg_endo -76.35 175.62 11.11 Favored 'Trans proline' 0 N--CA 1.459 -0.517 0 C-N-CA 122.256 1.971 . . . . 74.409999999999997 111.789 -179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.656 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 8.5 t -171.28 -172.39 1.08 Allowed 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.433 -0.581 . . . . 63.32 109.433 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . -134.83 -125.86 2.57 Favored Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.666 -0.778 . . . . 33.399999999999999 111.986 -178.436 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.464 ' HB3' HD11 ' A' ' 11' ' ' LEU . 11.8 mptt -98.65 117.76 33.83 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.937 0.398 . . . . 70.140000000000001 110.12 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -132.52 142.99 49.44 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.896 -0.593 . . . . 73.25 110.81 179.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -93.76 126.2 38.81 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.589 -0.523 . . . . 62.420000000000002 109.589 177.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.422 ' O ' ' HA ' ' A' ' 9' ' ' CYS . 18.2 p -137.86 148.56 45.51 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.191 -0.458 . . . . 74.209999999999994 111.617 -174.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 9' ' ' CYS . 38.7 t -128.53 159.25 36.06 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.683 -0.69 . . . . 44.409999999999997 109.308 175.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 61.5 mt -107.29 105.42 15.37 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.962 0.41 . . . . 73.200000000000003 110.894 -178.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 20.3 t80 -88.92 118.96 29.01 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.688 -0.856 . . . . 74.219999999999999 108.688 176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.806 HD12 ' HG2' ' A' ' 148' ' ' ARG . 7.6 mm -105.54 125.02 60.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.044 -0.263 . . . . 75.239999999999995 110.947 -174.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.97 -154.61 16.75 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.419 -0.896 . . . . 74.200000000000003 112.36 174.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.401 ' HA ' ' HG2' ' A' ' 139' ' ' PRO . 72.8 Cg_endo -78.23 169.58 19.98 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 122.373 2.049 . . . . 73.120000000000005 111.599 177.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HE1' HG21 ' A' ' 149' ' ' THR . 97.3 m-85 -96.14 133.09 40.84 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 120.935 0.398 . . . . 75.150000000000006 110.04 -178.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -167.05 -87.25 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.988 -0.625 . . . . 72.239999999999995 111.663 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -86.88 64.43 8.48 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.648 0.737 . . . . 65.349999999999994 110.483 178.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 15.9 tt -75.5 -13.86 15.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.628 0.728 . . . . 70.409999999999997 109.819 178.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -59.84 -32.68 70.91 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.214 -0.903 . . . . 64.319999999999993 110.909 178.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.25 -49.3 78.15 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.758 -0.655 . . . . 74.120000000000005 111.305 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.411 ' O ' ' HB2' ' A' ' 116' ' ' LEU . 10.5 p -74.34 -28.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.511 -0.313 . . . . 65.340000000000003 110.647 -178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -62.28 -51.6 67.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.427 -0.351 . . . . 74.109999999999999 111.054 177.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -65.81 -37.71 86.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.052 0.453 . . . . 74.319999999999993 110.52 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -68.46 -35.38 77.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.12 -0.491 . . . . 72.450000000000003 111.245 179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.612 HD22 ' HB3' ' A' ' 153' ' ' LEU . 1.6 tt -67.34 -37.12 82.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.455 . . . . 73.099999999999994 109.85 179.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -63.83 -36.44 83.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 116.21 -0.45 . . . . 64.519999999999996 109.977 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 51.2 tttm -58.47 -30.74 67.2 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.97 -0.559 . . . . 75.530000000000001 110.646 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.591 ' CH2' ' HB2' ' A' ' 11' ' ' LEU . 23.4 t90 -66.72 -38.72 87.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.053 -0.521 . . . . 74.439999999999998 110.064 -179.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.626 HG11 ' H ' ' A' ' 157' ' ' GLU . 27.0 t -59.04 -46.34 91.81 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-N 116.304 -0.407 . . . . 74.209999999999994 110.57 176.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -67.75 -30.4 69.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.777 -0.647 . . . . 55.310000000000002 110.751 -178.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -75.7 -50.43 15.37 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.62 -0.718 . . . . 61.299999999999997 111.741 -177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 0.58 ' HB3' ' HD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER -93.19 -17.17 24.03 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 112.138 0.422 . . . . 73.150000000000006 112.138 -172.674 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 70.96 58.53 5.63 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.837 -0.697 . . . . 45.210000000000001 112.719 178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.665 ' HB3' HD13 ' A' ' 155' ' ' LEU . 21.6 m-85 -122.54 155.24 36.65 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.261 0.553 . . . . 72.420000000000002 111.394 179.406 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.611 ' C ' ' HB2' ' A' ' 155' ' ' LEU . 4.9 p-10 -122.66 168.21 12.47 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.0 -1.0 . . . . 72.310000000000002 108.727 176.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.791 ' H ' HD12 ' A' ' 127' ' ' LEU . 1.6 mp -44.14 114.65 0.7 Allowed 'General case' 0 N--CA 1.469 0.477 0 O-C-N 123.623 0.577 . . . . 61.539999999999999 111.705 -175.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -127.74 22.13 6.37 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.359 0.6 . . . . 52.350000000000001 109.545 177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -172.07 -119.09 0.51 Allowed Glycine 0 N--CA 1.445 -0.702 0 CA-C-N 115.048 -0.978 . . . . 71.099999999999994 111.723 -177.196 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -152.07 169.88 21.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 110.044 -0.354 . . . . 62.420000000000002 110.044 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.73 ' HB2' ' HG3' ' A' ' 154' ' ' MET . . . -111.42 128.74 56.08 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.882 -0.784 . . . . 72.140000000000001 108.882 175.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.481 ' HA ' ' O ' ' A' ' 59' ' ' ALA . 42.6 p90 -143.71 142.58 31.02 Favored 'General case' 0 C--N 1.321 -0.667 0 C-N-CA 119.844 -0.743 . . . . 73.150000000000006 112.539 -177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.601 ' HG2' ' HE1' ' A' ' 61' ' ' TYR . 7.9 pt-20 -121.7 121.05 36.45 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.011 -0.995 . . . . 75.450000000000003 108.794 172.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.829 HD11 ' HG2' ' A' ' 56' ' ' PRO . 6.0 tt -95.01 136.98 24.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 120.817 0.342 . . . . 63.329999999999998 111.169 -176.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -113.24 93.34 4.36 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.449 0.642 . . . . 55.100000000000001 110.086 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.706 ' H ' HD13 ' A' ' 136' ' ' LEU . 0.0 OUTLIER -83.61 55.35 3.18 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.304 -0.862 . . . . 75.239999999999995 111.496 -177.123 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 35.4 t0 74.5 160.38 0.23 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.22 -0.9 . . . . 73.519999999999996 109.517 -176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.501 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 32.6 m-80 -74.82 143.68 78.64 Favored Pre-proline 0 C--N 1.32 -0.677 0 CA-C-O 120.834 0.35 . . . . 74.340000000000003 110.566 -175.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.722 ' HB3' HD13 ' A' ' 147' ' ' LEU . 6.8 Cg_exo -74.14 -169.05 0.52 Allowed 'Trans proline' 0 N--CA 1.462 -0.353 0 C-N-CA 123.086 2.524 . . . . 74.319999999999993 113.399 -176.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 77.01 -44.3 0.46 Allowed 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 114.778 -1.101 . . . . 73.040000000000006 112.353 175.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.35 -7.55 13.49 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.941 0.4 . . . . 74.319999999999993 111.763 -174.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.493 ' OG1' HD21 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -71.03 -84.97 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.725 -0.67 . . . . 72.010000000000005 112.052 -179.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.467 ' HB3' ' OE1' ' A' ' 146' ' ' GLN . . . -179.91 158.44 0.82 Allowed Pre-proline 0 C--O 1.234 0.273 0 CA-C-N 116.111 -0.495 . . . . 61.130000000000003 109.923 -179.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.438 ' HD2' ' HB1' ' A' ' 143' ' ' ALA . 52.9 Cg_endo -70.5 136.05 30.14 Favored 'Trans proline' 0 N--CA 1.462 -0.359 0 C-N-CA 122.379 2.053 . . . . 60.310000000000002 112.956 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 36.8 t0 66.4 9.91 6.84 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 114.68 -1.145 . . . . 60.549999999999997 113.407 170.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.467 ' OE1' ' HB3' ' A' ' 143' ' ' ALA . 9.7 pt20 -100.96 -1.86 33.35 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.8 -0.815 . . . . 74.310000000000002 108.8 169.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.722 HD13 ' HB3' ' A' ' 139' ' ' PRO . 84.5 mt -88.84 35.74 0.79 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.76 -1.109 . . . . 74.150000000000006 110.071 -179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.806 ' HG2' HD12 ' A' ' 103' ' ' ILE . 98.6 mtt180 -78.79 104.48 9.45 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.063 -0.971 . . . . 74.430000000000007 109.873 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.497 HG21 ' HE1' ' A' ' 106' ' ' TYR . 85.1 m -96.87 105.69 17.87 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 72.109999999999999 109.966 -176.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.2 mtt180 -74.24 96.58 2.81 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 114.883 -1.053 . . . . 74.040000000000006 109.502 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.6 p -91.77 113.86 27.92 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 N-CA-C 109.244 -0.65 . . . . 64.409999999999997 109.244 175.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 11.0 t -115.15 135.38 54.25 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.162 -0.681 . . . . 74.25 109.162 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.612 ' HB3' HD22 ' A' ' 116' ' ' LEU . 52.3 tp -118.4 149.63 40.9 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 120.923 0.392 . . . . 74.040000000000006 111.223 -174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.73 ' HG3' ' HB2' ' A' ' 131' ' ' ALA . 40.7 mtm -65.64 140.11 58.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.657 -0.701 . . . . 64.030000000000001 109.124 172.305 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.665 HD13 ' HB3' ' A' ' 125' ' ' PHE . 52.9 mt -84.84 177.8 7.85 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.457 -0.338 . . . . 74.230000000000004 110.248 -176.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 19.5 t-80 60.96 84.7 0.13 Allowed 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 122.9 0.48 . . . . 75.540000000000006 110.032 -169.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.719 ' HG2' ' H ' ' A' ' 158' ' ' SER . 20.2 tt0 61.6 -163.71 0.25 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 115.486 -0.779 . . . . 70.030000000000001 109.758 -178.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.719 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 39.0 m -117.3 177.97 4.54 Favored 'General case' 0 C--N 1.323 -0.573 0 O-C-N 122.06 -0.4 . . . . 71.450000000000003 111.031 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' H ' ' HG ' ' A' ' 159' ' ' LEU . 1.3 pp -79.49 22.17 0.46 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.035 -0.53 . . . . 73.319999999999993 111.144 178.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' OE1' ' HA ' ' A' ' 163' ' ' HIS . 35.0 tt0 -148.99 150.76 33.38 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.044 -0.725 . . . . 70.230000000000004 109.044 -175.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 14.2 t60 -76.51 60.93 1.68 Allowed 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.611 0.364 . . . . 75.010000000000005 110.9 -174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 7.5 t-160 61.92 110.55 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 123.552 0.741 . . . . 71.209999999999994 109.736 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.426 ' HA ' ' OE1' ' A' ' 160' ' ' GLU . 79.9 t60 -49.11 -54.33 16.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.542 -0.754 . . . . 71.349999999999994 112.75 -168.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -122.22 145.66 48.0 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.757 -0.377 . . . . 74.129999999999995 110.405 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 58.5 t-80 -71.61 102.12 2.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.948 0.404 . . . . 72.140000000000001 110.935 -179.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.675 -0.679 . . . . 74.0 109.214 174.713 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.1 ptt? . . . . . 0 N--CA 1.48 1.028 0 CA-C-O 121.255 0.55 . . . . 70.120000000000005 110.807 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -114.51 87.52 2.66 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.814 -0.63 . . . . 60.32 109.707 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -164.07 153.72 14.33 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.007 -0.542 . . . . 75.450000000000003 109.981 -177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 73.76 164.25 0.28 Allowed 'General case' 0 C--O 1.234 0.244 0 O-C-N 124.116 0.885 . . . . 62.32 111.112 175.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 26.1 m -57.42 123.78 16.65 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.766 -0.652 . . . . 73.329999999999998 110.381 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -104.48 -164.51 1.06 Allowed 'General case' 0 N--CA 1.441 -0.894 0 CA-C-O 121.13 0.49 . . . . 71.420000000000002 110.316 -178.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -122.14 151.01 41.4 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.848 -0.615 . . . . 74.439999999999998 111.645 -170.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.82 125.09 71.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.528 -0.76 . . . . 73.140000000000001 110.174 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.574 ' HB3' HD13 ' A' ' 116' ' ' LEU . 57.7 m -94.22 117.6 30.35 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.931 -0.577 . . . . 54.43 110.475 -178.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -142.22 167.96 20.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 109.819 179.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.599 ' O ' HD12 ' A' ' 11' ' ' LEU . 2.7 pp -93.0 141.15 28.71 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-O 121.132 0.492 . . . . 61.109999999999999 110.879 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.479 ' HD2' ' O ' ' A' ' 11' ' ' LEU . 30.1 mmmt -132.28 160.51 36.0 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.126 -1.065 . . . . 53.009999999999998 108.126 174.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 96' ' ' LYS . 11.0 pt-20 -113.46 122.15 46.44 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 120.125 -0.63 . . . . 73.230000000000004 110.547 177.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.53 ' O ' ' HA ' ' A' ' 94' ' ' SER . 50.2 tp -73.29 143.26 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.198 -0.91 . . . . 70.129999999999995 110.068 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -107.5 149.37 38.76 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.13 -0.486 . . . . 32.509999999999998 109.975 178.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.49 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 16.9 Cg_exo -67.38 113.33 2.86 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.862 2.375 . . . . 72.409999999999997 111.643 177.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.7 p -135.97 91.47 17.38 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.19 -0.459 . . . . 65.519999999999996 110.914 -175.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 90' ' ' GLY . 53.6 Cg_exo -36.78 130.6 0.46 Allowed 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 123.978 3.119 . . . . 73.109999999999999 113.695 -179.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.435 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -144.47 166.45 25.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.584 -0.735 . . . . 44.229999999999997 110.746 -176.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.7 tp -114.41 123.54 49.72 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.418 -0.956 . . . . 60.32 108.418 175.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.554 ' HB3' ' HA2' ' A' ' 74' ' ' GLY . 0.3 OUTLIER -133.55 152.1 51.84 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.904 0.705 . . . . 75.400000000000006 112.904 -167.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.588 HD13 ' HA ' ' A' ' 87' ' ' VAL . 37.6 mm -107.22 114.47 46.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 114.995 -1.002 . . . . 75.409999999999997 108.321 171.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.512 ' HD2' HG21 ' A' ' 88' ' ' VAL . 1.6 ptm180 -110.13 119.73 40.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.142 0.496 . . . . 61.420000000000002 111.366 -176.209 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 9.4 t -150.52 149.02 29.41 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.852 -0.613 . . . . 63.219999999999999 109.989 178.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.655 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 11.0 pt20 -104.3 126.49 51.45 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.259 0.552 . . . . 74.420000000000002 110.196 176.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 15.2 t -150.11 -164.96 2.14 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.818 -0.628 . . . . 71.400000000000006 109.548 -176.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.6 162.04 14.1 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.596 0.236 . . . . 44.130000000000003 110.47 178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.8 mtp -61.06 -25.76 67.16 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.216 -0.447 . . . . 64.209999999999994 112.007 -176.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.5 m -74.46 -16.95 60.84 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.875 0.369 . . . . 74.439999999999998 111.833 -177.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -108.55 2.47 22.17 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.345 0.593 . . . . 72.219999999999999 110.453 -177.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.666 HD21 HG11 ' A' ' 71' ' ' VAL . 0.4 OUTLIER -59.95 -50.06 75.24 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.442 -0.799 . . . . 72.200000000000003 110.769 -175.792 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 36' ' ' GLU . . . -63.68 -40.36 98.49 Favored Glycine 0 N--CA 1.45 -0.373 0 CA-C-N 116.044 -0.526 . . . . 71.209999999999994 112.743 -177.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 43.0 t -68.69 -43.02 76.93 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.614 0.245 . . . . 63.520000000000003 111.042 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.402 HD22 ' HA ' ' A' ' 34' ' ' LEU . 0.3 OUTLIER -63.33 -50.91 68.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.104 -0.498 . . . . 53.229999999999997 110.283 -176.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.4 m-30 -64.04 -36.99 85.82 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.145 -0.479 . . . . 74.230000000000004 111.247 -178.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 0.6 OUTLIER -62.62 -50.36 71.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.213 -0.448 . . . . 62.329999999999998 110.408 -179.548 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.76 -32.46 70.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.963 -0.562 . . . . 71.230000000000004 111.32 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -66.01 -55.03 21.25 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 121.103 -0.57 . . . . 52.009999999999998 112.946 -178.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -74.5 -16.17 60.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.162 0.506 . . . . 70.319999999999993 110.684 -177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 26.0 t-80 -62.79 -32.56 73.76 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.833 -0.621 . . . . 73.209999999999994 110.945 175.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 42' ' ' ILE . 9.2 t70 -118.76 -154.2 0.56 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 110.083 -0.34 . . . . 64.310000000000002 110.083 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 41' ' ' ASP . 13.1 pt 54.57 16.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 124.913 1.285 . . . . 62.439999999999998 112.446 -178.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 10.4 tt -76.55 -34.29 58.51 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.058 -0.519 . . . . 73.219999999999999 109.638 177.512 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.539 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 75.4 mt-30 -74.74 -12.47 60.42 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.989 -0.551 . . . . 75.409999999999997 110.335 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -69.88 -43.07 72.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.703 -0.851 . . . . 74.329999999999998 108.703 174.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 51' ' ' LYS . 99.3 mt -77.9 -37.3 48.23 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.62 -0.718 . . . . 61.549999999999997 110.668 177.761 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.539 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -64.07 -43.18 96.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.82 -0.627 . . . . 75.329999999999998 110.638 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.81 50.08 4.2 Favored Glycine 0 N--CA 1.451 -0.365 0 N-CA-C 110.782 -0.927 . . . . 61.299999999999997 110.782 175.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -163.58 -37.77 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.591 -0.892 . . . . 72.409999999999997 108.591 -177.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 94.77 30.99 8.03 Favored Glycine 0 N--CA 1.446 -0.685 0 CA-C-N 115.168 -0.923 . . . . 20.030000000000001 112.588 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 46' ' ' LEU . 96.6 mttt -141.97 162.15 36.19 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 110.307 -0.257 . . . . 73.030000000000001 110.307 -179.57 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.491 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 13.4 p -140.38 165.41 30.45 Favored Pre-proline 0 C--N 1.322 -0.613 0 CA-C-N 116.329 -0.396 . . . . 62.509999999999998 110.427 -177.011 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.504 ' HA ' ' O ' ' A' ' 76' ' ' PRO . 17.3 Cg_endo -58.33 139.76 91.81 Favored 'Trans proline' 0 C--N 1.35 0.626 0 C-N-CA 122.668 2.245 . . . . 74.010000000000005 112.096 177.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 9.7 p -94.49 0.34 55.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.033 -0.53 . . . . 72.109999999999999 112.03 -176.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 179.03 -163.05 30.4 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.146 -1.026 . . . . 62.420000000000002 112.737 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.59 154.36 44.54 Favored 'Trans proline' 0 CA--C 1.528 0.196 0 C-N-CA 122.892 2.395 . . . . 74.239999999999995 112.258 -179.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -71.34 151.47 60.05 Favored 'Trans proline' 0 C--O 1.241 0.635 0 C-N-CA 122.343 2.029 . . . . 71.409999999999997 113.039 -179.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD1' HG12 ' A' ' 134' ' ' ILE . 4.6 m-85 -117.94 116.35 26.75 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 108.483 -0.932 . . . . 74.349999999999994 108.483 176.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -92.54 111.26 22.78 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 120.835 0.35 . . . . 62.25 110.551 -173.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.59 ' HG3' ' CE2' ' A' ' 132' ' ' TYR . 2.0 ttm-85 -101.27 126.68 48.03 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.013 -0.539 . . . . 64.230000000000004 109.725 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.77 ' HB3' HG12 ' A' ' 71' ' ' VAL . 4.9 p90 -128.33 135.35 49.47 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-O 121.706 0.765 . . . . 75.209999999999994 111.705 175.131 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.602 ' HD1' ' HG3' ' A' ' 130' ' ' GLU . 64.1 t80 -118.02 169.61 9.52 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-N 113.765 -1.561 . . . . 74.439999999999998 109.394 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.55 -83.56 0.72 Allowed Glycine 0 N--CA 1.443 -0.848 0 N-CA-C 110.228 -1.149 . . . . 73.010000000000005 110.228 -174.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 45.7 mtm 54.44 26.5 7.16 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.995 0.468 . . . . 64.030000000000001 112.054 171.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 17.6 m -94.06 -72.32 0.62 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.618 -0.264 . . . . 71.329999999999998 111.236 -175.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -165.8 -7.93 0.02 OUTLIER 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 112.944 0.72 . . . . 65.329999999999998 112.944 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -147.54 -77.91 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 119.816 -1.183 . . . . 42.020000000000003 112.854 -177.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 29.3 m -64.98 126.46 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.944 0.402 . . . . 74.230000000000004 110.762 -178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -122.81 114.67 20.82 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.87 -0.604 . . . . 75.430000000000007 109.435 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 30.6 tt0 -100.37 112.61 24.97 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.892 -0.595 . . . . 74.319999999999993 109.579 -175.474 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.77 HG12 ' HB3' ' A' ' 61' ' ' TYR . 26.1 m -121.0 147.84 24.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.427 0.632 . . . . 75.140000000000001 112.497 -170.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.537 ' HA ' ' O ' ' A' ' 22' ' ' ILE . 60.1 mt-10 -130.91 124.58 31.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 114.778 -1.101 . . . . 72.109999999999999 109.318 175.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -63.65 -57.28 10.56 Favored 'General case' 0 C--O 1.223 -0.317 0 O-C-N 123.434 0.459 . . . . 75.120000000000005 110.468 -179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.554 ' HA2' ' HB3' ' A' ' 21' ' ' LEU . . . 61.37 89.87 0.02 OUTLIER Glycine 0 C--O 1.226 -0.399 0 N-CA-C 115.053 0.781 . . . . 65.319999999999993 115.053 169.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 17.2 p90 -108.99 142.05 24.7 Favored Pre-proline 0 C--N 1.326 -0.434 0 O-C-N 122.201 -0.588 . . . . 61.009999999999998 109.549 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.504 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 57.1 Cg_endo -71.28 141.26 38.82 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.69 2.26 . . . . 74.120000000000005 113.305 -171.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.435 HG22 ' HA ' ' A' ' 19' ' ' ALA . 17.4 m -132.54 170.18 20.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.634 -0.712 . . . . 71.400000000000006 109.719 176.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -78.33 -58.39 3.28 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.853 0.359 . . . . 74.439999999999998 110.61 -177.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 159.22 174.53 29.06 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 111.028 -0.829 . . . . 65.450000000000003 111.028 -178.547 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 61.79 30.54 75.32 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.849 -0.691 . . . . 73.430000000000007 112.101 -178.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 3.6 t -104.93 149.44 8.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.498 -0.556 . . . . 64.239999999999995 109.498 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -105.51 160.84 14.85 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.337 -0.392 . . . . 75.310000000000002 110.672 -174.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -121.64 163.33 15.1 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 121.109 -0.567 . . . . 63.509999999999998 111.939 174.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 23.0 t -151.73 108.4 3.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.865 0.364 . . . . 74.209999999999994 110.16 -178.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.22 -115.22 4.39 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.036 -0.602 . . . . 74.150000000000006 112.107 178.695 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 92.0 mtt180 -85.95 -12.46 50.43 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.008 0.432 . . . . 63.030000000000001 110.488 178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.588 ' HA ' HD13 ' A' ' 22' ' ' ILE . 15.1 t -79.28 93.71 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 108.762 -0.829 . . . . 63.439999999999998 108.762 175.384 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.512 HG21 ' HD2' ' A' ' 23' ' ' ARG . 27.6 m -111.01 136.23 47.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 121.39 0.614 . . . . 73.540000000000006 111.635 -175.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.17 143.4 29.67 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.293 -0.867 . . . . 65.150000000000006 109.786 174.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 18' ' ' PRO . . . -169.31 -162.07 20.85 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.341 -0.933 . . . . 41.229999999999997 112.6 -178.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -151.96 160.5 43.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 62.340000000000003 110.823 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.465 ' HB ' HD21 ' A' ' 14' ' ' LEU . 13.5 p -83.75 143.96 44.52 Favored Pre-proline 0 C--N 1.323 -0.581 0 CA-C-N 115.769 -0.651 . . . . 65.109999999999999 111.676 -177.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -79.12 138.53 14.39 Favored 'Trans proline' 0 N--CA 1.461 -0.43 0 C-N-CA 122.508 2.138 . . . . 73.549999999999997 112.098 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 14' ' ' LEU . 12.3 p -86.95 132.58 33.76 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.419 -0.355 . . . . 74.200000000000003 110.721 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.502 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 179.68 161.4 26.93 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.707 -0.759 . . . . 62.340000000000003 112.509 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.771 ' HD3' ' HB3' ' A' ' 13' ' ' GLU . 1.8 tppt? -87.56 116.32 25.6 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 122.427 0.291 . . . . 70.439999999999998 110.248 -178.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.66 ' HA ' HD21 ' A' ' 155' ' ' LEU . . . -135.88 160.49 38.42 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.823 0.344 . . . . 61.109999999999999 110.935 -176.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.753 ' HB1' HD12 ' A' ' 116' ' ' LEU . . . -78.98 128.1 32.84 Favored 'General case' 0 C--O 1.238 0.48 0 CA-C-N 116.292 -0.413 . . . . 72.540000000000006 110.268 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 16.8 t -139.86 161.36 37.76 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 120.997 0.427 . . . . 71.519999999999996 110.876 -176.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 16.9 p -153.08 165.78 34.53 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.878 -0.601 . . . . 61.100000000000001 110.002 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.876 HD13 ' HD3' ' A' ' 148' ' ' ARG . 53.9 mt -106.27 119.82 40.23 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.233 0.539 . . . . 62.329999999999998 111.141 -178.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.951 ' HB3' ' HB ' ' A' ' 149' ' ' THR . 79.5 t80 -93.2 116.54 29.11 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.476 -0.784 . . . . 73.299999999999997 109.822 177.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 3.6 pt -118.24 146.6 22.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.303 -0.408 . . . . 60.329999999999998 111.355 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.63 -156.51 15.57 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 121.049 -0.596 . . . . 40.030000000000001 111.931 178.667 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -69.0 144.93 59.86 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.742 2.295 . . . . 64.510000000000005 110.903 174.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.577 ' HA ' ' HE2' ' A' ' 102' ' ' TYR . 8.2 t80 -95.5 133.23 39.74 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 120.723 -0.391 . . . . 72.209999999999994 110.26 -174.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 172.93 -68.96 0.11 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.984 -0.627 . . . . 53.240000000000002 111.976 179.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -89.94 83.2 6.12 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.595 0.712 . . . . 73.239999999999995 110.975 -179.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.3 tp -74.43 -16.67 16.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.64 -0.709 . . . . 64.129999999999995 109.584 176.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -58.19 -40.2 80.93 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.0 -1.0 . . . . 74.129999999999995 111.715 -177.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.93 -46.7 71.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 70.310000000000002 111.705 -176.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 12.7 p -84.72 -30.35 6.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.827 0.346 . . . . 62.439999999999998 110.798 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 27.0 t80 -60.57 -38.83 85.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.151 0.5 . . . . 72.430000000000007 110.752 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.81 -33.44 75.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 75.5 111.026 -179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.49 -36.54 84.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 55.340000000000003 111.984 -174.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.866 ' HG ' HD21 ' A' ' 153' ' ' LEU . 4.3 mm? -58.39 -36.25 73.26 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.534 -0.303 . . . . 63.200000000000003 111.08 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 13.0 tpt -59.08 -40.61 85.75 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 116.282 -0.417 . . . . 70.019999999999996 110.883 179.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 8.8 mmtt -70.02 -31.15 68.66 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.401 -0.363 . . . . 74.519999999999996 111.041 -178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 53.3 t90 -76.06 -50.52 14.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.928 0.394 . . . . 64.310000000000002 110.866 179.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 11.9 p -64.58 -30.19 49.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.322 -0.399 . . . . 64.319999999999993 110.34 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -48.42 -44.08 34.79 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.214 -0.903 . . . . 52.43 111.09 175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -82.55 -43.67 16.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.998 -0.547 . . . . 62.030000000000001 111.631 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 13.7 t-20 -67.56 -38.22 83.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.316 -0.402 . . . . 54.409999999999997 111.619 -174.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 67.1 42.32 91.94 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 121.15 -0.548 . . . . 64.439999999999998 113.357 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.777 ' HD2' ' HG ' ' A' ' 155' ' ' LEU . 28.4 t80 -94.51 165.7 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 109.188 -0.671 . . . . 75.540000000000006 109.188 176.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.473 ' HB2' ' HB3' ' A' ' 156' ' ' HIS . 0.0 OUTLIER -154.8 135.75 13.77 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 74.25 111.962 -178.601 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 127' ' ' LEU . 16.5 mt -145.37 135.04 23.41 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 114.935 -1.029 . . . . 62.409999999999997 108.745 164.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.0 m -95.15 76.23 3.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 121.163 0.506 . . . . 44.140000000000001 111.07 179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -126.34 -135.24 4.19 Favored Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.634 -0.793 . . . . 74.230000000000004 111.615 175.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.602 ' HG3' ' HD1' ' A' ' 62' ' ' PHE . 11.4 mp0 -129.97 169.89 14.66 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 109.199 -0.667 . . . . 53.310000000000002 109.199 -177.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.536 ' HB3' ' CE2' ' A' ' 61' ' ' TYR . . . -93.89 145.98 24.23 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 120.402 -0.519 . . . . 74.299999999999997 110.501 179.652 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.59 ' CE2' ' HG3' ' A' ' 60' ' ' ARG . 2.2 m-85 -131.13 121.09 24.31 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.209 -0.451 . . . . 74.299999999999997 111.343 -175.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.472 ' HG2' HG23 ' A' ' 151' ' ' VAL . 45.2 mt-10 -103.06 116.82 33.25 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.835 -0.432 . . . . 74.049999999999997 109.835 170.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.849 ' HB ' ' HB2' ' A' ' 150' ' ' ARG . 70.4 mt -94.92 109.91 23.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 109.035 -0.728 . . . . 61.140000000000001 109.035 175.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -63.34 170.1 3.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.06 0.457 . . . . 74.409999999999997 111.79 -171.274 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 78.5 mt -52.49 145.13 12.04 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 115.351 -0.84 . . . . 72.049999999999997 112.463 -177.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.642 ' O ' ' HD3' ' A' ' 139' ' ' PRO . 2.4 m-20 -54.42 149.46 10.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 114.784 -1.098 . . . . 72.219999999999999 111.895 178.174 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -100.68 86.46 0.67 Allowed Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.716 -0.675 . . . . 73.510000000000005 109.486 169.411 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.642 ' HD3' ' O ' ' A' ' 137' ' ' ASP . 56.3 Cg_endo -87.93 -161.95 0.13 Allowed 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.646 2.897 . . . . 62.210000000000001 112.186 -170.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -70.88 30.79 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.482 0 CA-C-O 121.036 0.446 . . . . 42.140000000000001 110.867 172.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . 0.557 ' H ' ' C ' ' A' ' 139' ' ' PRO . 61.4 mt-10 60.32 40.05 18.11 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.766 0.827 . . . . 71.019999999999996 111.569 -179.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 7.8 t -80.35 24.18 0.46 Allowed 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 114.375 -1.284 . . . . 64.519999999999996 111.051 178.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 70.54 159.81 0.16 Allowed Pre-proline 0 N--CA 1.468 0.474 0 C-N-CA 123.575 0.75 . . . . 65.329999999999998 111.848 -179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.461 ' O ' ' HB3' ' A' ' 145' ' ' ASP . 11.9 Cg_exo -72.29 -164.61 0.18 Allowed 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.569 2.179 . . . . 53.340000000000003 111.21 170.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.461 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 11.6 t70 75.06 -42.79 0.5 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.818 0.847 . . . . 75.430000000000007 111.519 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -90.0 -15.17 32.44 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.036 -0.529 . . . . 72.420000000000002 111.374 -176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.596 HD21 ' HG3' ' A' ' 139' ' ' PRO . 3.5 mm? -89.09 173.6 8.35 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.556 -0.535 . . . . 72.219999999999999 109.556 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.876 ' HD3' HD13 ' A' ' 101' ' ' LEU . 59.1 mtt85 -123.21 137.73 54.81 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.038 0.447 . . . . 75.310000000000002 111.824 -172.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.951 ' HB ' ' HB3' ' A' ' 102' ' ' TYR . 55.9 m -98.39 121.55 40.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.966 -0.753 . . . . 74.329999999999998 108.966 175.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.849 ' HB2' ' HB ' ' A' ' 134' ' ' ILE . 62.8 mtt85 -92.49 90.45 7.18 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.241 -0.436 . . . . 64.5 110.174 -174.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.472 HG23 ' HG2' ' A' ' 133' ' ' GLU . 6.1 p -95.2 125.87 47.79 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.239 -0.437 . . . . 72.329999999999998 110.558 -178.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 11.0 t -127.46 144.78 51.01 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.353 -0.61 . . . . 52.299999999999997 109.353 179.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.866 HD21 ' HG ' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -139.78 -176.32 4.53 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.259 0.466 . . . . 74.310000000000002 112.259 -175.293 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 16.5 ptp -64.6 156.3 30.45 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.208 -0.906 . . . . 75.430000000000007 110.727 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.777 ' HG ' ' HD2' ' A' ' 125' ' ' PHE . 4.1 mm? -96.66 -52.2 4.01 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.973 -0.558 . . . . 55.340000000000003 111.265 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . 0.473 ' HB3' ' HB2' ' A' ' 126' ' ' ASP . 1.8 p80 -88.4 107.28 18.77 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.252 -0.579 . . . . 72.239999999999995 110.479 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -55.44 -64.68 0.77 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 114.382 -1.281 . . . . 63.329999999999998 113.455 -169.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.9 t -79.09 8.86 5.07 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 122.246 -0.284 . . . . 75.120000000000005 111.092 -174.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 97.6 mt 61.31 -90.84 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.129 0 C-N-CA 123.08 0.552 . . . . 54.5 110.336 -175.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -137.98 22.0 2.84 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-O 122.076 0.941 . . . . 74.150000000000006 108.722 176.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.41 ' HB3' ' H ' ' A' ' 162' ' ' HIS . 17.9 t60 61.11 -88.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 113.655 -1.611 . . . . 72.219999999999999 111.115 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.41 ' H ' ' HB3' ' A' ' 161' ' ' HIS . 45.0 t60 -108.77 98.06 7.61 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.111 -0.7 . . . . 72.140000000000001 109.111 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 53.2 t-80 -74.5 135.62 42.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.04 -0.527 . . . . 73.019999999999996 111.635 -172.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -123.16 116.46 23.48 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.971 -1.122 . . . . 71.230000000000004 107.971 176.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -67.37 167.6 12.23 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.142 0.496 . . . . 73.310000000000002 111.754 -170.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 12.9 m170 . . . . . 0 C--O 1.248 0.976 0 CA-C-N 115.59 -0.732 . . . . 73.129999999999995 109.668 179.427 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 35.4 ttm . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 109.12 -0.696 . . . . 55.119999999999997 109.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -109.39 -56.03 2.35 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 112.366 0.506 . . . . 71.349999999999994 112.366 -169.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -68.76 -41.82 78.32 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.181 0.515 . . . . 62.219999999999999 109.96 -176.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 29.6 mm-40 -95.32 131.56 41.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.887 -0.783 . . . . 73.239999999999995 108.887 173.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.676 ' HB3' HD11 ' A' ' 103' ' ' ILE . 59.4 m -80.66 -82.82 0.11 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.476 -0.565 . . . . 64.510000000000005 109.476 177.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 63.54 153.84 0.05 OUTLIER 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 122.377 1.084 . . . . 63.210000000000001 113.341 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -91.27 84.67 5.66 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 114.862 -1.063 . . . . 73.030000000000001 108.634 171.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 53.7 t -100.66 129.36 51.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.776 -0.647 . . . . 71.299999999999997 111.257 -174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . 0.428 ' SG ' ' HB3' ' A' ' 100' ' ' SER . 20.6 m -100.35 132.06 45.93 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.665 -0.698 . . . . 43.030000000000001 109.549 175.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -141.83 152.7 43.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.808 0.337 . . . . 71.230000000000004 110.43 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -81.74 108.76 15.55 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.49 -0.93 . . . . 71.450000000000003 108.49 176.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.423 ' HG3' ' HB2' ' A' ' 99' ' ' SER . 31.4 mmmt -112.24 177.82 4.51 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.26 -0.882 . . . . 74.150000000000006 110.373 -174.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.55 155.31 25.63 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.121 0.486 . . . . 71.349999999999994 110.882 178.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 70.7 mt -120.19 126.35 50.44 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.96 -0.564 . . . . 55.420000000000002 109.958 176.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 16' ' ' PRO . . . -95.39 144.29 27.56 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.913 -0.585 . . . . 62.109999999999999 110.58 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.686 ' HG3' ' HB3' ' A' ' 94' ' ' SER . 6.2 Cg_exo -74.3 110.63 3.13 Favored 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.845 2.363 . . . . 53.109999999999999 111.598 177.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 56.5 t -116.11 141.49 27.81 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.754 -0.657 . . . . 73.200000000000003 109.64 -178.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -71.66 109.14 2.57 Favored 'Trans proline' 0 N--CA 1.461 -0.414 0 C-N-CA 122.352 2.035 . . . . 73.200000000000003 111.626 174.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -123.66 151.69 42.8 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 116.087 -0.506 . . . . 55.399999999999999 111.31 -177.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.698 HD23 HG21 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -99.65 124.63 45.06 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.262 -1.014 . . . . 74.219999999999999 108.262 172.952 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.518 ' HG ' ' NH2' ' A' ' 60' ' ' ARG . 0.0 OUTLIER -152.83 171.32 18.46 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 121.626 0.727 . . . . 74.209999999999994 112.493 -174.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.551 HG13 HG13 ' A' ' 87' ' ' VAL . 1.2 mp -131.59 174.24 13.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 114.386 -1.279 . . . . 70.040000000000006 108.185 177.097 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.472 ' H ' HG22 ' A' ' 22' ' ' ILE . 51.6 mtt180 -101.91 100.33 10.62 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.472 -0.936 . . . . 71.409999999999997 108.472 167.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.5 m -101.86 134.15 45.51 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-O 120.575 0.226 . . . . 75.310000000000002 111.024 -171.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HB3' ' OE1' ' A' ' 70' ' ' GLU . 8.5 pt20 -114.82 143.59 44.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.85 0.357 . . . . 72.420000000000002 110.062 174.786 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.765 HG21 HD22 ' A' ' 31' ' ' LEU . 47.2 p -102.01 129.59 48.34 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 116.178 -0.465 . . . . 74.209999999999994 110.771 -177.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -144.62 177.65 8.53 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.772 -0.455 . . . . 62.439999999999998 109.772 -177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.5 ptt? 47.53 33.52 2.95 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 124.098 0.874 . . . . 74.409999999999997 112.336 179.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 t 63.45 34.18 13.04 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.424 0.63 . . . . 72.5 110.604 178.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 34' ' ' LEU . 5.4 mm-40 -116.54 77.61 1.12 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.602 -0.726 . . . . 54.439999999999998 110.37 -179.012 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.765 HD22 HG21 ' A' ' 26' ' ' THR . 2.1 tm? -75.49 -60.81 2.14 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 64.150000000000006 110.139 178.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -76.34 -49.45 8.29 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.764 -0.731 . . . . 44.229999999999997 113.343 -174.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.2 m -58.21 -30.71 66.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.703 0.287 . . . . 75.340000000000003 111.632 -174.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.476 ' HB2' ' O ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -56.64 -54.4 46.5 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.01 -0.541 . . . . 72.140000000000001 111.039 -174.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.55 ' HB2' ' HD1' ' A' ' 73' ' ' PHE . 22.3 p90 -87.99 -18.57 28.74 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.414 -0.514 . . . . 54.0 111.51 -177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.431 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 6.0 tm-20 -58.33 -52.21 66.56 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.249 -0.649 . . . . 73.340000000000003 109.249 176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -68.1 -12.89 61.68 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.529 -0.76 . . . . 72.120000000000005 111.126 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' ILE . . . -73.67 -57.41 4.98 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.642 -0.789 . . . . 70.010000000000005 112.146 -179.37 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB3' ' CE2' ' A' ' 73' ' ' PHE . 18.4 p90 -75.26 -19.35 59.77 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.975 0.416 . . . . 72.150000000000006 110.619 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.419 ' HB2' ' O ' ' A' ' 36' ' ' GLU . 2.1 t60 -67.55 -32.49 73.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.598 -0.728 . . . . 73.420000000000002 110.228 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -100.0 -28.22 13.18 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.905 -0.589 . . . . 75.420000000000002 112.038 -172.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 39' ' ' TYR . 37.8 pt -91.98 10.49 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 N-CA-C 112.336 0.495 . . . . 74.109999999999999 112.336 -174.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 47.2 tp -64.38 -23.48 67.31 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.993 0.425 . . . . 70.329999999999998 111.158 -177.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.45 ' HA ' ' HB3' ' A' ' 47' ' ' ALA . 13.1 mp0 -66.43 -12.51 57.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.058 -0.519 . . . . 61.130000000000003 112.371 -177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 54.1 tp -67.97 -43.68 78.43 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.154 0.502 . . . . 54.409999999999997 109.695 176.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.472 HD11 HG13 ' A' ' 77' ' ' VAL . 4.6 mm? -81.85 -40.7 22.07 Favored 'General case' 0 C--O 1.238 0.475 0 CA-C-N 115.889 -0.596 . . . . 70.299999999999997 110.227 178.099 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -70.4 -16.91 63.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.707 -0.679 . . . . 52.509999999999998 111.362 -179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -66.15 -52.99 32.26 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 121.007 -0.616 . . . . 75.019999999999996 112.03 177.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.43 ' HB2' ' CD ' ' A' ' 51' ' ' LYS . 78.1 mt-30 -76.89 -37.88 54.62 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.016 0.436 . . . . 75.400000000000006 110.706 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 110.54 50.66 0.64 Allowed Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.594 -0.813 . . . . 70.450000000000003 112.612 179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.436 ' HB3' ' HE2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -149.97 -177.8 6.12 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.859 -0.423 . . . . 72.209999999999994 109.859 175.315 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.43 ' HB2' ' HD2' ' A' ' 53' ' ' PRO . 6.1 p -151.0 166.02 16.01 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 116.393 -0.367 . . . . 75.140000000000001 110.447 -174.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 52' ' ' SER . 1.5 Cg_endo -45.7 134.83 13.42 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 123.556 2.837 . . . . 72.120000000000005 112.984 177.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.6 t -94.29 26.82 3.16 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.807 -0.633 . . . . 74.120000000000005 110.199 -178.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.5 -178.5 48.42 Favored Glycine 0 N--CA 1.446 -0.675 0 N-CA-C 111.0 -0.84 . . . . 54.420000000000002 111.0 -179.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.586 ' HB2' ' O ' ' A' ' 135' ' ' TYR . 74.1 Cg_endo -76.11 152.87 36.15 Favored 'Trans proline' 0 N--CA 1.461 -0.404 0 C-N-CA 122.234 1.956 . . . . 64.400000000000006 112.027 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.6 163.26 39.03 Favored 'Trans proline' 0 C--O 1.238 0.483 0 C-N-CA 122.888 2.392 . . . . 64.120000000000005 112.855 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.1 m-85 -115.89 -178.67 3.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.209 -0.451 . . . . 64.319999999999993 110.241 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.557 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -157.42 139.71 14.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.82 -0.807 . . . . 54.329999999999998 108.82 172.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.518 ' NH2' ' HG ' ' A' ' 21' ' ' LEU . 29.7 ptt180 -147.75 138.27 23.12 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-O 121.466 0.651 . . . . 71.439999999999998 112.187 176.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 22.1 m-85 -107.04 129.44 54.81 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.61 -1.177 . . . . 63.350000000000001 110.03 177.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.016 ' HB2' ' HB3' ' A' ' 70' ' ' GLU . 97.3 m-85 -107.19 100.43 9.9 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 121.205 0.526 . . . . 73.319999999999993 110.418 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -120.02 30.63 5.6 Favored Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.045 -0.98 . . . . 65.540000000000006 110.809 173.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.535 ' SD ' ' HB2' ' A' ' 130' ' ' GLU . 89.3 mtp -80.26 -62.23 1.74 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.949 0.404 . . . . 72.109999999999999 110.518 -178.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 12.6 p -162.07 113.44 1.65 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.941 -0.572 . . . . 62.5 110.472 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -170.38 -27.69 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.815 0.34 . . . . 64.420000000000002 111.562 -178.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 92.16 -73.49 1.5 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 110.793 -0.923 . . . . 40.32 110.793 -171.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 57.8 m -69.93 152.85 43.99 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.325 -0.62 . . . . 64.420000000000002 109.325 171.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 61' ' ' TYR . 53.3 t80 -80.16 115.73 19.88 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.209 -0.664 . . . . 64.140000000000001 109.209 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 1.016 ' HB3' ' HB2' ' A' ' 62' ' ' PHE . 4.3 tp10 -94.48 147.97 22.72 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.661 -0.7 . . . . 64.040000000000006 109.383 -173.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 35.1 m -146.95 169.28 4.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.257 0.551 . . . . 74.140000000000001 110.73 -179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.7 tp10 -172.05 134.05 0.73 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.086 -0.961 . . . . 35.210000000000001 110.007 169.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.561 ' CE2' ' HB3' ' A' ' 39' ' ' TYR . 15.1 p90 -77.06 -58.77 3.09 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.378 -0.374 . . . . 72.209999999999994 110.105 174.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.42 123.7 0.02 OUTLIER Glycine 0 CA--C 1.524 0.63 0 C-N-CA 120.788 -0.72 . . . . 31.100000000000001 112.591 -173.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 46.2 p90 -124.65 142.88 41.86 Favored Pre-proline 0 C--N 1.322 -0.599 0 O-C-N 121.981 -0.717 . . . . 61.549999999999997 110.034 175.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 53' ' ' PRO . 62.7 Cg_endo -74.2 154.77 46.84 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.44 2.093 . . . . 71.219999999999999 112.373 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.698 HG21 HD23 ' A' ' 20' ' ' LEU . 1.9 t -116.98 178.21 2.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 109.102 -0.703 . . . . 72.340000000000003 109.102 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . 0.605 ' H ' HG12 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -91.99 -32.32 15.27 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.986 -0.286 . . . . 74.340000000000003 111.344 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 127.28 12.16 3.21 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.522 -0.847 . . . . 65.430000000000007 113.241 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -129.82 24.34 4.59 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.6 -0.81 . . . . 63.450000000000003 111.913 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.579 ' HB ' HG11 ' A' ' 77' ' ' VAL . 39.9 t -124.55 157.33 32.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.696 -0.483 . . . . 72.430000000000007 109.696 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 31.0 tt0 -127.78 133.94 49.47 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.271 -0.422 . . . . 73.329999999999998 109.916 -177.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.607 ' HA2' HD11 ' A' ' 20' ' ' LEU . . . -54.63 119.59 13.12 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 121.223 -0.513 . . . . 21.239999999999998 112.412 177.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 32.2 m -141.36 149.87 41.7 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.757 -0.46 . . . . 73.239999999999995 109.757 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.37 49.58 8.14 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.551 -0.833 . . . . 63.109999999999999 112.073 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 75.59 -38.25 0.35 Allowed 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.774 0.829 . . . . 64.129999999999995 111.097 178.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.623 HG12 HD12 ' A' ' 20' ' ' LEU . 13.1 t -74.14 131.93 34.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 109.128 -0.693 . . . . 74.219999999999999 109.128 177.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.583 ' HA ' ' HA3' ' A' ' 83' ' ' GLY . 21.5 m -125.68 160.23 32.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.068 0.461 . . . . 71.319999999999993 112.151 -172.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.53 147.12 35.95 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.621 -0.718 . . . . 71.120000000000005 109.767 175.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -159.85 165.53 34.68 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.608 -0.806 . . . . 73.319999999999993 111.93 178.485 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -100.7 151.0 22.17 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.905 -0.405 . . . . 73.219999999999999 109.905 178.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 p -80.47 159.73 69.03 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 115.731 -0.668 . . . . 74.010000000000005 110.291 176.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.03 125.37 18.95 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.474 2.116 . . . . 75.129999999999995 111.786 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.686 ' HB3' ' HG3' ' A' ' 16' ' ' PRO . 2.1 p -103.83 132.33 50.19 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.253 -0.431 . . . . 65.510000000000005 110.75 -179.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.42 19.2 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.352 -0.699 . . . . 70.329999999999998 111.352 -179.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 47.3 mmtm -104.39 154.6 19.65 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.885 -0.413 . . . . 54.210000000000001 109.885 177.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -150.92 142.63 23.7 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.174 -0.466 . . . . 73.540000000000006 110.417 178.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.594 ' O ' ' HA ' ' A' ' 152' ' ' SER . . . -78.18 110.24 13.0 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.241 -0.651 . . . . 52.340000000000003 109.241 175.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.423 ' HB2' ' HG3' ' A' ' 12' ' ' LYS . 43.3 m -115.58 123.84 49.47 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.949 -0.569 . . . . 51.049999999999997 110.983 -176.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.428 ' HB3' ' SG ' ' A' ' 9' ' ' CYS . 10.9 p -115.75 125.63 53.02 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.329 -0.619 . . . . 74.049999999999997 109.329 172.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.483 ' H ' ' CD1' ' A' ' 101' ' ' LEU . 0.0 OUTLIER -95.82 141.92 28.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 120.966 0.412 . . . . 64.109999999999999 110.471 -178.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.96 147.92 48.27 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.954 -0.566 . . . . 73.25 109.574 175.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.676 HD11 ' HB3' ' A' ' 5' ' ' CYS . 0.1 OUTLIER -123.98 120.98 61.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 115.782 -0.645 . . . . 73.430000000000007 110.169 179.422 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 162.7 -170.31 38.21 Favored Glycine 0 N--CA 1.445 -0.707 0 C-N-CA 120.782 -0.723 . . . . 63.329999999999998 111.76 -179.253 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 161.97 42.76 Favored 'Trans proline' 0 N--CA 1.461 -0.386 0 C-N-CA 122.536 2.157 . . . . 63.130000000000003 111.916 178.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -96.28 132.97 41.2 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.768 -0.456 . . . . 72.519999999999996 109.768 -177.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 156.98 -72.63 0.24 Allowed Glycine 0 N--CA 1.45 -0.416 0 N-CA-C 110.954 -0.858 . . . . 53.130000000000003 110.954 -177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 86.1 mt-10 -84.09 61.94 6.77 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.33 0.586 . . . . 75.239999999999995 110.262 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.693 ' O ' HG12 ' A' ' 112' ' ' VAL . 15.5 tt -73.03 -20.54 18.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-N 115.691 -0.686 . . . . 51.439999999999998 110.427 -178.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.925 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 30.4 tt0 -61.71 -21.74 64.75 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.725 0.298 . . . . 72.109999999999999 110.873 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -59.7 -28.08 67.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.351 -0.386 . . . . 74.519999999999996 111.653 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.693 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.8 p -81.92 -28.82 9.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.187 0.518 . . . . 53.100000000000001 110.164 178.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.925 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 97.3 m-85 -71.16 -29.58 65.38 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.078 -0.51 . . . . 73.319999999999993 109.746 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -59.25 -43.56 92.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.646 -0.707 . . . . 51.030000000000001 110.73 176.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.28 -36.22 83.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.066 -0.516 . . . . 72.310000000000002 110.621 178.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.618 HD12 ' HA ' ' A' ' 113' ' ' TYR . 77.8 mt -57.2 -41.91 80.26 Favored 'General case' 0 C--O 1.224 -0.253 0 CA-C-N 115.863 -0.608 . . . . 53.240000000000002 110.946 178.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 26.6 mmt -54.52 -39.35 67.53 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.404 -0.362 . . . . 53.219999999999999 111.445 -177.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -70.76 -50.17 38.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.002 -0.544 . . . . 72.420000000000002 110.728 179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.451 ' CE3' ' HE1' ' A' ' 125' ' ' PHE . 8.9 t90 -68.03 -30.38 69.6 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.755 -0.657 . . . . 73.140000000000001 111.048 -175.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.584 ' HA ' ' CE1' ' A' ' 125' ' ' PHE . 19.7 t -53.06 -48.49 52.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.225 -0.443 . . . . 64.219999999999999 112.083 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -69.43 -32.21 71.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.883 0.373 . . . . 72.310000000000002 111.049 -175.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -74.99 -52.05 12.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.133 -0.485 . . . . 71.329999999999998 110.86 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 12.2 t-20 -71.96 -37.49 69.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.269 -0.423 . . . . 72.299999999999997 111.278 -177.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.75 60.67 1.41 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.902 -0.666 . . . . 43.329999999999998 112.932 179.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.686 ' CD2' HD21 ' A' ' 155' ' ' LEU . 29.7 p90 -134.8 178.51 6.96 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.95 -0.389 . . . . 73.209999999999994 109.95 173.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -126.55 176.16 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.834 0.349 . . . . 52.329999999999998 110.352 -178.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 7.4 mp -82.31 116.75 21.95 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.386 -0.598 . . . . 70.219999999999999 109.386 175.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.557 ' HA ' ' H ' ' A' ' 159' ' ' LEU . 16.2 m -84.25 1.86 42.69 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.227 -0.442 . . . . 73.409999999999997 111.806 -175.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 80.85 -44.2 2.94 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 120.878 -0.677 . . . . 72.430000000000007 112.7 178.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.535 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 36.2 tt0 -82.04 128.47 34.14 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 110.096 -0.335 . . . . 63.109999999999999 110.096 177.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -116.13 138.88 50.87 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.825 -0.625 . . . . 64.030000000000001 109.33 176.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.508 ' CE2' ' HD3' ' A' ' 60' ' ' ARG . 3.2 t80 -130.54 111.31 12.14 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 121.046 0.451 . . . . 75.099999999999994 110.616 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.557 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 11.0 mp0 -101.22 156.31 17.51 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.035 -0.53 . . . . 75.209999999999994 109.856 179.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 48.2 mm -122.32 126.82 74.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.679 -0.237 . . . . 72.400000000000006 110.378 179.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.586 ' O ' ' HB2' ' A' ' 56' ' ' PRO . 3.4 m-85 -103.77 129.18 51.15 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.737 -0.468 . . . . 71.310000000000002 109.737 179.052 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.424 HD22 ' HD2' ' A' ' 148' ' ' ARG . 6.3 mp -117.23 -71.31 0.74 Allowed 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.582 -0.447 . . . . 62.119999999999997 111.502 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -117.18 163.82 15.71 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.795 0.331 . . . . 65.140000000000001 111.288 -177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -93.7 141.94 24.46 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 116.128 -0.487 . . . . 54.409999999999997 110.871 -173.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -84.56 -164.96 0.27 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.298 2.665 . . . . 74.310000000000002 113.572 -178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.27 -44.86 0.54 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 124.414 1.085 . . . . 72.329999999999998 111.757 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -94.2 -4.63 48.67 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.186 0.517 . . . . 71.230000000000004 110.689 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 9.9 t -136.32 166.83 22.55 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.483 -0.78 . . . . 64.200000000000003 109.116 177.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 144' ' ' PRO . . . -71.72 142.76 86.29 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-O 120.603 0.24 . . . . 75.310000000000002 110.779 -177.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.479 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 21.4 Cg_exo -66.65 -25.54 46.91 Favored 'Trans proline' 0 C--N 1.341 0.154 0 C-N-CA 122.944 2.429 . . . . 75.409999999999997 112.329 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -58.95 -28.14 65.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.804 -0.635 . . . . 54.409999999999997 111.962 -177.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.31 8.64 27.79 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.578 -0.449 . . . . 72.099999999999994 111.925 -176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.479 ' CD1' ' HA ' ' A' ' 144' ' ' PRO . 94.3 mt -75.43 92.53 2.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.941 0.4 . . . . 74.239999999999995 110.036 177.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.424 ' HD2' HD22 ' A' ' 136' ' ' LEU . 0.6 OUTLIER -80.56 114.89 19.77 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.412 0.625 . . . . 64.439999999999998 111.454 -173.051 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 20.5 m -132.84 118.07 18.51 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.004 -0.544 . . . . 75.239999999999995 110.528 176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' LEU . 13.4 ptm180 -104.55 117.12 33.36 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.948 0.404 . . . . 75.319999999999993 110.521 178.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.402 HG23 ' OE2' ' A' ' 133' ' ' GLU . 7.5 p -96.28 134.17 34.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 N-CA-C 109.33 -0.618 . . . . 73.010000000000005 109.33 175.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.594 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 4.4 m -128.63 155.56 44.8 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.349 -0.387 . . . . 61.039999999999999 111.177 -175.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.669 ' HB2' HD23 ' A' ' 155' ' ' LEU . 6.4 mp -104.08 162.01 13.52 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.167 -0.679 . . . . 73.200000000000003 109.167 171.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 128' ' ' SER . 1.9 tmt? -53.37 -55.27 26.31 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 123.183 0.302 . . . . 74.510000000000005 110.529 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.686 HD21 ' CD2' ' A' ' 125' ' ' PHE . 0.4 OUTLIER 55.1 22.85 4.8 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.447 1.647 . . . . 62.219999999999999 115.447 165.224 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 22.1 t-80 -75.54 -32.34 60.41 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 107.468 -1.308 . . . . 74.310000000000002 107.468 167.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 19.1 tp10 -151.2 -85.98 0.08 Allowed 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 113.708 -1.587 . . . . 61.240000000000002 106.886 168.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 m 172.44 -179.49 0.07 Allowed 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 124.42 1.088 . . . . 61.509999999999998 109.341 168.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.557 ' H ' ' HA ' ' A' ' 128' ' ' SER . 0.3 OUTLIER -105.95 60.93 0.66 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 107.603 -1.258 . . . . 74.319999999999993 107.603 172.076 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -141.24 143.63 34.25 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.593 -1.185 . . . . 54.299999999999997 110.68 -174.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 78.5 m-70 -98.21 -20.55 17.2 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.971 -0.559 . . . . 74.510000000000005 110.006 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . . . . . . . . . 35.5 m80 66.06 101.49 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 110.086 -173.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 8.2 t60 -79.27 57.13 2.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.096 -0.502 . . . . 65.219999999999999 110.764 -177.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 26.7 t-80 48.59 76.31 0.12 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.609 -0.723 . . . . 75.519999999999996 110.639 178.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -108.62 124.85 51.14 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.032 -0.531 . . . . 75.519999999999996 111.106 -173.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.6 m80 . . . . . 0 C--O 1.244 0.781 0 CA-C-O 118.507 -0.758 . . . . 64.420000000000002 109.387 174.477 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.5 tpp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.649 -0.5 . . . . 75.430000000000007 109.649 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 66.6 -81.1 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.739 0.649 . . . . 51.140000000000001 110.305 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 26.0 t80 63.79 178.61 0.16 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.167 0.587 . . . . 75.209999999999994 110.599 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 74.43 -49.38 0.67 Allowed 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.422 0.689 . . . . 62.439999999999998 111.321 178.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 41.7 t -77.45 96.25 4.66 Favored 'General case' 0 C--N 1.318 -0.762 0 N-CA-C 109.348 -0.612 . . . . 63.229999999999997 109.348 174.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -123.85 -166.97 1.56 Allowed 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.267 0.556 . . . . 75.409999999999997 110.348 -174.471 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -132.73 122.5 24.67 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.423 -0.808 . . . . 74.140000000000001 109.898 -179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.5 131.14 30.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.005 0.431 . . . . 72.420000000000002 110.177 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 45.8 m -125.78 157.09 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.12 -0.491 . . . . 73.219999999999999 110.658 -176.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -142.53 145.76 33.97 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 110.017 -0.364 . . . . 73.019999999999996 110.017 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.831 ' H ' HD23 ' A' ' 11' ' ' LEU . 1.5 pt? -96.97 102.62 14.43 Favored 'General case' 0 N--CA 1.445 -0.682 0 N-CA-C 109.749 -0.463 . . . . 71.239999999999995 109.749 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -96.78 161.2 13.97 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 109.772 -0.455 . . . . 54.329999999999998 109.772 -179.046 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' GLY . 33.3 tt0 -98.07 116.89 31.21 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.865 0.364 . . . . 74.030000000000001 110.3 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 9.3 mp -81.55 166.04 20.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.813 -0.631 . . . . 71.230000000000004 111.045 -178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -113.63 150.93 44.08 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-N 116.01 -0.541 . . . . 54.329999999999998 110.292 179.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.757 ' HD3' ' HB3' ' A' ' 94' ' ' SER . 41.7 Cg_endo -69.12 108.71 2.02 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.252 1.968 . . . . 55.520000000000003 111.871 178.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 48.8 t -119.67 139.91 28.66 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.006 -0.543 . . . . 64.540000000000006 109.63 -178.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -69.99 133.55 25.41 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.925 2.417 . . . . 73.510000000000005 111.95 177.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.63 151.71 40.47 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.121 0.486 . . . . 64.239999999999995 111.793 -175.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.864 HD13 HG21 ' A' ' 77' ' ' VAL . 5.7 mp -111.43 126.04 54.53 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.48 -0.933 . . . . 73.219999999999999 108.48 171.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 21' ' ' LEU . 2.1 pt? -135.99 148.34 48.4 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.344 0.592 . . . . 72.329999999999998 111.565 -173.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.7 ' HB ' ' HD2' ' A' ' 73' ' ' PHE . 3.9 mp -116.63 125.37 73.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 114.831 -1.077 . . . . 74.329999999999998 108.248 172.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.475 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -100.51 122.87 43.94 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.155 0.503 . . . . 74.25 109.738 178.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.2 t -127.31 102.11 6.77 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.549 0.69 . . . . 72.340000000000003 110.313 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.491 ' CD ' ' H ' ' A' ' 25' ' ' GLN . 5.0 pm0 -88.73 137.34 32.4 Favored 'General case' 0 C--N 1.315 -0.919 0 CA-C-N 115.503 -0.771 . . . . 74.150000000000006 109.723 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.634 ' O ' ' HB3' ' A' ' 69' ' ' PHE . 9.5 t -168.97 -163.8 0.44 Allowed 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.086 -0.709 . . . . 74.109999999999999 109.086 -173.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -90.45 159.3 16.62 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 110.24 -0.282 . . . . 72.310000000000002 110.24 178.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.9 ptm -66.33 -19.49 65.83 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.634 0.605 . . . . 71.030000000000001 112.634 -171.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 40.8 t -69.17 -24.73 64.1 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.797 0.332 . . . . 61.240000000000002 110.898 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.27 8.21 44.49 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.741 0.274 . . . . 53.219999999999999 111.741 -175.15 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -59.53 -50.9 72.13 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.846 0.355 . . . . 71.329999999999998 110.27 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -65.3 -37.67 94.19 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.844 -0.693 . . . . 62.409999999999997 112.505 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.0 m -59.46 -53.33 59.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.726 0.298 . . . . 61.340000000000003 111.647 -177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 34' ' ' LEU . 4.2 mm? -65.5 -33.99 77.22 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.359 -0.382 . . . . 54.420000000000002 111.314 -176.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -72.82 -47.74 43.84 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.594 -0.275 . . . . 74.040000000000006 111.322 179.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -62.68 -55.6 25.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.459 -0.337 . . . . 72.310000000000002 111.063 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -69.42 -37.33 77.38 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.206 -0.452 . . . . 73.450000000000003 110.925 -178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' ' HB ' ' A' ' 42' ' ' ILE . . . -64.85 -47.93 77.5 Favored Glycine 0 N--CA 1.45 -0.395 0 CA-C-N 115.786 -0.643 . . . . 64.129999999999995 112.845 -177.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 55.2 t80 -59.99 -27.53 66.94 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.984 0.421 . . . . 71.310000000000002 111.3 -176.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 78.7 t60 -69.03 -33.91 74.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.093 -0.503 . . . . 63.020000000000003 112.153 -177.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -126.5 5.03 6.86 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.174 0.511 . . . . 62.32 111.378 -171.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.545 HD11 HD13 ' A' ' 22' ' ' ILE . 8.5 tp -63.33 -34.59 68.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 112.606 0.595 . . . . 75.209999999999994 112.606 -173.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.782 HD23 ' H ' ' A' ' 43' ' ' LEU . 2.5 pt? -97.43 12.67 32.45 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.02 0.378 . . . . 54.530000000000001 112.02 -171.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -67.27 -35.54 79.72 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 111.897 0.332 . . . . 71.430000000000007 111.897 -177.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.584 HD13 HG11 ' A' ' 87' ' ' VAL . 8.7 tt -61.44 -34.58 75.65 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-O 121.01 0.433 . . . . 71.439999999999998 110.038 176.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -78.9 -51.92 9.01 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.993 -0.549 . . . . 73.049999999999997 110.438 178.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.47 72.72 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.822 -0.626 . . . . 61.140000000000001 111.574 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -68.06 -28.39 73.4 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 121.336 -0.459 . . . . 72.140000000000001 112.504 178.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -87.12 -8.64 56.8 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.084 0.469 . . . . 74.530000000000001 110.01 176.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 84.85 32.92 20.04 Favored Glycine 0 N--CA 1.445 -0.712 0 CA-C-N 115.639 -0.71 . . . . 61.32 112.524 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -132.77 173.7 11.08 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.727 0.299 . . . . 73.329999999999998 110.306 177.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.9 p -140.11 156.89 70.03 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.467 -0.333 . . . . 73.409999999999997 110.986 -176.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -57.92 144.61 93.81 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.839 2.36 . . . . 74.150000000000006 112.178 175.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 30.8 m -79.86 -8.12 59.12 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.883 -0.599 . . . . 74.219999999999999 111.228 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.2 178.87 36.96 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.667 -0.778 . . . . 52.140000000000001 111.908 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.32 153.68 70.61 Favored 'Trans proline' 0 CA--C 1.529 0.272 0 C-N-CA 122.498 2.132 . . . . 65.230000000000004 111.787 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HB3' ' CE2' ' A' ' 75' ' ' PHE . 58.9 Cg_endo -72.32 143.32 39.02 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.48 2.12 . . . . 71.109999999999999 112.502 -178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.621 ' HB3' HG12 ' A' ' 134' ' ' ILE . 21.3 p90 -125.27 114.33 18.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 74.420000000000002 109.778 175.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -95.2 117.29 29.99 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.601 -0.727 . . . . 74.209999999999994 109.865 -174.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.823 ' HB3' ' HB3' ' A' ' 132' ' ' TYR . 2.2 ptm85 -99.07 128.21 45.16 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.746 0.784 . . . . 72.299999999999997 112.179 -176.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.512 ' HE1' ' CE2' ' A' ' 69' ' ' PHE . 21.3 t80 -99.42 117.98 35.04 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.91 -1.495 . . . . 61.450000000000003 109.055 179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.501 ' CE1' ' HB2' ' A' ' 64' ' ' MET . 1.7 t80 -119.16 109.62 16.08 Favored 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.699 0.762 . . . . 72.530000000000001 111.233 -173.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -119.12 2.53 14.43 Favored Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 114.953 -1.022 . . . . 74.319999999999993 110.984 175.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.61 ' HG2' ' O ' ' A' ' 129' ' ' GLY . 94.4 mmm -69.39 -7.57 38.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 121.053 0.454 . . . . 64.540000000000006 110.321 178.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . . . . . . . . . 20.4 m -78.92 -6.74 56.96 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.822 -0.626 . . . . 73.349999999999994 111.01 178.544 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . 68.83 114.08 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 O-C-N 123.841 0.713 . . . . 30.23 112.309 175.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 76.94 -62.16 3.31 Favored Glycine 0 N--CA 1.451 -0.314 0 CA-C-N 115.86 -0.609 . . . . 73.400000000000006 112.644 178.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 27.9 m -69.94 126.73 30.54 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.238 0.542 . . . . 51.140000000000001 110.994 -178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.634 ' HB3' ' O ' ' A' ' 26' ' ' THR . 65.8 t80 -88.23 114.6 25.0 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.26 -0.882 . . . . 71.530000000000001 109.58 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 -123.14 132.85 54.23 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.84 -174.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.01 142.5 39.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.936 0.398 . . . . 70.450000000000003 110.755 178.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.462 ' HB2' ' HG3' ' A' ' 60' ' ' ARG . 28.2 mt-10 -127.75 127.42 43.57 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.077 -0.51 . . . . 72.120000000000005 109.818 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.7 ' HD2' ' HB ' ' A' ' 22' ' ' ILE . 76.5 m-85 -59.56 -57.63 12.1 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 115.965 -0.561 . . . . 74.349999999999994 112.386 -174.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 67.02 89.37 0.06 OUTLIER Glycine 0 CA--C 1.525 0.705 0 N-CA-C 114.447 0.539 . . . . 73.219999999999999 114.447 173.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.518 ' CE2' ' HB3' ' A' ' 57' ' ' PRO . 14.3 m-85 -113.7 140.4 24.59 Favored Pre-proline 0 C--N 1.327 -0.373 0 O-C-N 122.478 -0.424 . . . . 75.299999999999997 110.007 172.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 75' ' ' PHE . 2.2 Cg_endo -82.65 128.6 5.37 Favored 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.14 2.56 . . . . 62.549999999999997 112.056 -179.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.864 HG21 HD13 ' A' ' 20' ' ' LEU . 27.1 m -128.72 -171.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.513 -0.312 . . . . 74.120000000000005 110.979 -176.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -61.39 -61.43 2.55 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.982 -0.554 . . . . 74.129999999999995 110.417 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 148.18 -60.63 0.45 Allowed Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.496 -0.775 . . . . 73.219999999999999 111.9 -179.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -81.54 48.05 3.76 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 121.3 -0.476 . . . . 54.100000000000001 112.747 -178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.0 t -102.14 151.47 5.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 N-CA-C 108.701 -0.852 . . . . 75.25 108.701 177.323 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -103.16 118.6 37.14 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.199 0.523 . . . . 63.0 110.729 -178.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.21 48.55 Favored Glycine 0 N--CA 1.444 -0.778 0 CA-C-N 115.436 -0.802 . . . . 63.240000000000002 111.678 177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.822 ' H ' HG13 ' A' ' 87' ' ' VAL . 5.3 t -140.24 98.42 3.43 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-O 121.013 0.435 . . . . 74.5 110.174 -176.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.0 -94.08 0.88 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.674 -0.694 . . . . 62.100000000000001 112.909 175.369 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -84.49 -33.29 23.6 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.763 0.283 . . . . 74.239999999999995 111.763 -176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.822 HG13 ' H ' ' A' ' 84' ' ' SER . 3.7 p -79.93 107.75 12.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.262 0.553 . . . . 63.25 110.064 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 35.7 m -103.82 156.82 5.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.86 -0.609 . . . . 64.519999999999996 111.077 -176.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.649 HG22 HD11 ' A' ' 20' ' ' LEU . 16.2 p -92.58 147.59 22.76 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.659 -0.701 . . . . 63.109999999999999 110.989 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -174.98 -161.75 25.22 Favored Glycine 0 N--CA 1.446 -0.676 0 N-CA-C 111.389 -0.684 . . . . 64.329999999999998 111.389 176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -153.0 156.59 39.12 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.767 -0.457 . . . . 74.319999999999993 109.767 177.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.464 ' HA ' ' HD3' ' A' ' 93' ' ' PRO . 5.1 t -83.16 142.93 44.6 Favored Pre-proline 0 C--N 1.323 -0.587 0 N-CA-C 109.622 -0.51 . . . . 61.439999999999998 109.622 177.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 92' ' ' THR . 8.7 Cg_exo -72.88 156.68 52.43 Favored 'Trans proline' 0 N--CA 1.462 -0.381 0 C-N-CA 122.817 2.345 . . . . 71.040000000000006 112.219 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . 0.757 ' HB3' ' HD3' ' A' ' 16' ' ' PRO . 5.9 p -105.05 133.32 50.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.025 -0.534 . . . . 70.340000000000003 110.555 178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.58 ' O ' ' HA ' ' A' ' 13' ' ' GLU . . . 161.9 -172.99 38.18 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 111.462 -0.655 . . . . 50.509999999999998 111.462 -179.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -79.11 133.9 36.75 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.955 0.407 . . . . 55.210000000000001 110.619 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.439 ' O ' ' HA ' ' A' ' 11' ' ' LEU . . . -148.45 138.27 22.27 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.043 -0.526 . . . . 74.329999999999998 109.719 179.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.752 ' HB2' ' HZ2' ' A' ' 119' ' ' TRP . . . -78.74 105.86 10.33 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 120.865 -0.334 . . . . 75.109999999999999 110.62 -177.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . . . . . . . . . 46.7 m -99.84 121.59 41.53 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.595 -0.729 . . . . 74.299999999999997 110.423 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.531 ' HB2' HD21 ' A' ' 116' ' ' LEU . 10.9 t -113.88 121.58 44.41 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 109.21 -0.663 . . . . 72.510000000000005 109.21 174.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.541 HD11 ' HG2' ' A' ' 148' ' ' ARG . 20.9 tp -85.47 101.62 12.79 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.537 -0.542 . . . . 74.519999999999996 109.537 178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . 0.491 ' CD1' ' HB ' ' A' ' 112' ' ' VAL . 34.6 t80 -83.49 104.35 13.56 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.13 -0.486 . . . . 71.150000000000006 110.444 -175.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . . . . . . . . . 50.9 mm -109.23 112.78 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.789 -0.641 . . . . 73.099999999999994 109.542 176.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 153.76 -154.01 25.22 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.732 -0.747 . . . . 54.340000000000003 111.909 -178.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -73.13 124.58 9.65 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.61 2.207 . . . . 73.340000000000003 111.532 178.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.527 ' OH ' HG21 ' A' ' 149' ' ' THR . 4.1 t80 -95.48 157.34 15.94 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 120.652 -0.419 . . . . 63.25 110.285 -174.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 117.28 -41.6 2.05 Favored Glycine 0 N--CA 1.447 -0.576 0 N-CA-C 110.572 -1.011 . . . . 65.25 110.572 -172.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -85.02 71.65 10.91 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 71.239999999999995 109.907 174.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.569 ' O ' HG12 ' A' ' 112' ' ' VAL . 10.1 tp -75.15 -25.91 18.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.895 -0.593 . . . . 72.5 110.438 -176.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . 0.635 ' HA ' ' HD2' ' A' ' 113' ' ' TYR . 44.5 mt-10 -72.57 -22.34 61.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.868 0.366 . . . . 63.119999999999997 110.823 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -60.34 -38.38 83.59 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.853 -0.612 . . . . 52.310000000000002 110.763 178.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.569 HG12 ' O ' ' A' ' 109' ' ' ILE . 9.2 p -80.12 -28.05 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.08 -0.341 . . . . 74.219999999999999 110.08 177.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.635 ' HD2' ' HA ' ' A' ' 110' ' ' GLU . 11.2 m-85 -61.22 -35.61 77.69 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.506 -0.316 . . . . 73.219999999999999 110.848 176.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -57.0 -50.1 73.75 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 121.113 0.482 . . . . 72.120000000000005 110.059 175.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.37 -44.54 94.48 Favored 'General case' 0 C--O 1.234 0.282 0 CA-C-N 115.612 -0.722 . . . . 70.129999999999995 111.049 177.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.652 ' HA ' ' HD1' ' A' ' 119' ' ' TRP . 94.4 mt -58.93 -40.08 83.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.924 -0.58 . . . . 73.420000000000002 110.91 178.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 52.0 ttp -58.24 -40.24 81.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.776 -0.647 . . . . 74.420000000000002 110.776 179.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 59.4 tttp -73.62 -47.33 40.99 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 112.006 -176.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . 0.752 ' HZ2' ' HB2' ' A' ' 98' ' ' ALA . 1.9 p-90 -62.23 -44.61 96.16 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 120.875 -0.33 . . . . 73.329999999999998 110.742 -171.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 1.019 ' HA ' HD22 ' A' ' 123' ' ' ASN . 14.3 p -76.18 -29.33 19.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.957 0.408 . . . . 62.210000000000001 110.605 -176.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -57.39 -35.0 69.45 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.425 -0.807 . . . . 72.239999999999995 109.973 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -67.04 -28.74 68.46 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.791 -0.64 . . . . 75.329999999999998 110.908 176.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . 1.019 HD22 ' HA ' ' A' ' 120' ' ' VAL . 42.8 m-80 -80.96 -23.14 39.0 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.255 -0.43 . . . . 73.109999999999999 109.889 176.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 89.27 42.12 5.64 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.875 -0.679 . . . . 53.229999999999997 112.141 -177.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -146.47 169.71 18.35 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.766 -0.457 . . . . 72.299999999999997 109.766 177.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -166.82 155.42 10.25 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.25 -0.432 . . . . 63.219999999999999 110.331 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -125.53 136.6 53.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.053 -0.721 . . . . 74.010000000000005 109.053 176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 74.4 p -85.98 -16.25 38.91 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.738 -0.385 . . . . 44.43 111.373 -177.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.61 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 173.02 76.31 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 119.821 -1.18 . . . . 60.240000000000002 113.567 178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -152.83 100.63 2.54 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.031 -0.729 . . . . 73.540000000000006 109.031 174.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 153' ' ' LEU . . . -154.2 126.87 8.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.153 -0.476 . . . . 72.010000000000005 111.129 -178.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.823 ' HB3' ' HB3' ' A' ' 60' ' ' ARG . 3.1 p90 -111.06 120.5 42.57 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.261 0.553 . . . . 52.210000000000001 110.787 176.511 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 151' ' ' VAL . 6.9 pt-20 -95.12 118.02 31.21 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.61 -0.723 . . . . 70.230000000000004 110.638 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.621 HG12 ' HB3' ' A' ' 58' ' ' PHE . 26.6 mt -93.51 113.18 27.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.521 -0.763 . . . . 70.200000000000003 110.045 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -80.8 90.82 5.87 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.901 -0.407 . . . . 73.319999999999993 109.901 -179.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 83.0 mt -72.83 -50.68 22.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.911 -0.586 . . . . 53.539999999999999 110.416 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.928 ' HB3' HG21 ' A' ' 142' ' ' THR . 6.5 m-20 -108.4 111.59 23.58 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.838 -0.619 . . . . 64.019999999999996 109.955 177.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 142' ' ' THR . 34.6 m-80 -93.3 144.21 27.94 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.129 -0.487 . . . . 72.219999999999999 111.024 -176.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.88 155.68 42.58 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 123.07 2.514 . . . . 62.009999999999998 112.763 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 75.09 -32.38 0.22 Allowed 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.889 0.875 . . . . 62.350000000000001 111.435 -179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -89.91 -50.66 5.9 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.612 -0.514 . . . . 63.310000000000002 109.612 177.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . 0.928 HG21 ' HB3' ' A' ' 137' ' ' ASP . 4.4 t -92.52 -175.59 4.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.05 -0.523 . . . . 75.120000000000005 110.802 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -81.54 154.92 71.48 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.888 -0.596 . . . . 73.120000000000005 111.826 -176.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.434 ' C ' ' H ' ' A' ' 146' ' ' GLN . 37.5 Cg_endo -67.64 151.28 79.47 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 122.375 2.05 . . . . 74.409999999999997 110.353 170.005 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.422 ' HB3' ' O ' ' A' ' 144' ' ' PRO . 30.2 t70 72.84 -31.22 0.22 Allowed 'General case' 0 N--CA 1.473 0.694 0 O-C-N 123.804 0.69 . . . . 53.299999999999997 111.542 -178.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.434 ' H ' ' C ' ' A' ' 144' ' ' PRO . 0.0 OUTLIER -90.38 40.9 1.03 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.748 -0.834 . . . . 63.43 108.748 177.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 147' ' ' LEU . 0.2 OUTLIER -79.43 94.5 5.56 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 108.431 -0.952 . . . . 71.219999999999999 108.431 176.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . 0.57 ' H ' ' HB2' ' A' ' 137' ' ' ASP . 17.3 ttm180 -94.5 104.87 16.83 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.429 -0.805 . . . . 71.329999999999998 111.491 -170.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' OH ' ' A' ' 106' ' ' TYR . 35.1 m -117.38 126.2 52.28 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.175 -0.466 . . . . 73.140000000000001 110.621 175.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . 0.425 ' HD2' HD12 ' A' ' 134' ' ' ILE . 40.9 ttm-85 -97.56 94.51 7.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.48 -0.563 . . . . 64.409999999999997 109.48 177.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.709 ' HA ' ' HA ' ' A' ' 133' ' ' GLU . 5.6 p -89.57 117.95 33.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.271 0.558 . . . . 63.509999999999998 109.83 -179.092 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.646 ' HA ' ' O ' ' A' ' 98' ' ' ALA . 8.6 m -123.85 124.08 41.86 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.779 -0.646 . . . . 52.420000000000002 111.104 -174.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.834 ' H ' HD13 ' A' ' 153' ' ' LEU . 0.0 OUTLIER -99.7 148.97 23.8 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.712 -0.477 . . . . 70.530000000000001 109.712 176.25 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . 0.856 ' HG2' ' HA ' ' A' ' 158' ' ' SER . 20.7 ttp -91.69 118.55 30.76 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.377 0.608 . . . . 74.129999999999995 111.343 -169.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.92 169.95 13.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.182 -0.917 . . . . 62.149999999999999 111.147 -174.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 49.0 t-80 55.52 64.98 1.59 Allowed 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.413 -0.812 . . . . 65.420000000000002 112.333 174.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 57.04 24.76 9.93 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 112.499 0.555 . . . . 73.439999999999998 112.499 172.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.856 ' HA ' ' HG2' ' A' ' 154' ' ' MET . 21.3 m 68.46 165.26 0.24 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.257 0.551 . . . . 75.540000000000006 111.038 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 92.0 mt -113.64 13.03 18.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.21 -0.45 . . . . 73.120000000000005 110.868 -179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 161' ' ' HIS . 44.7 tt0 -149.07 128.49 13.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.024 -0.535 . . . . 74.209999999999994 110.01 176.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . 0.447 ' O ' ' HB2' ' A' ' 162' ' ' HIS . 12.1 m80 74.71 -28.93 0.19 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.514 0.726 . . . . 60.350000000000001 112.688 175.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' HIS . 51.1 m80 70.47 -64.62 0.36 Allowed 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 123.055 0.542 . . . . 63.340000000000003 112.085 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' HIS . 24.0 m80 70.91 112.04 0.06 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 121.538 0.685 . . . . 74.120000000000005 110.286 -171.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 21.5 p80 -91.32 -172.64 3.35 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.252 -0.885 . . . . 64.109999999999999 110.976 -173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -69.26 148.09 50.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.559 -0.534 . . . . 63.229999999999997 109.559 178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 29.4 m170 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.689 -0.672 . . . . 64.310000000000002 110.522 -175.245 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 110.05 -0.352 . . . . 65.430000000000007 110.05 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.59 -65.76 0.34 Allowed 'General case' 0 N--CA 1.472 0.66 0 O-C-N 123.93 0.769 . . . . 62.43 109.533 -175.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -75.97 141.62 42.17 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 107.492 -1.299 . . . . 75.239999999999995 107.492 169.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.677 ' HG2' ' HG3' ' A' ' 146' ' ' GLN . 5.6 tp10 -59.76 93.77 0.02 OUTLIER 'General case' 0 C--O 1.234 0.274 0 CA-C-O 121.225 0.536 . . . . 74.299999999999997 112.075 -172.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 89.1 m -159.29 167.16 29.63 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 114.994 -1.003 . . . . 62.32 108.794 178.021 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 51.7 mt-30 68.98 145.55 0.05 Allowed 'General case' 0 C--O 1.233 0.205 0 CA-C-O 121.725 0.774 . . . . 73.519999999999996 111.986 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 52.6 p90 -81.04 150.56 28.79 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.239 -0.892 . . . . 62.030000000000001 110.919 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 10' ' ' GLU . 8.4 p -122.02 131.42 73.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.982 -0.554 . . . . 63.399999999999999 109.807 172.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' CYS . . . . . . . . . . . . . 61.8 m -108.39 109.83 21.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.887 0.375 . . . . 62.299999999999997 110.474 -178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.803 ' HB2' ' HE2' ' A' ' 12' ' ' LYS . 44.5 mt-10 -139.17 162.37 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.155 -0.475 . . . . 75.450000000000003 110.388 -179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.867 HD11 ' HD3' ' A' ' 96' ' ' LYS . 1.0 OUTLIER -81.87 123.22 28.64 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.099 -1.074 . . . . 45.5 108.099 170.29 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.803 ' HE2' ' HB2' ' A' ' 10' ' ' GLU . 75.3 mmtt -118.07 141.6 48.3 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.118 -0.492 . . . . 74.230000000000004 110.879 -176.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 45.5 tt0 -100.68 118.6 37.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.418 -0.81 . . . . 71.25 109.103 174.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 92.2 mt -66.19 108.1 2.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.012 -0.54 . . . . 73.239999999999995 110.393 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.74 144.39 80.06 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.271 -0.422 . . . . 74.319999999999993 110.741 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.527 ' HB2' HD23 ' A' ' 91' ' ' LEU . 54.9 Cg_endo -70.04 130.95 19.87 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 122.526 2.15 . . . . 64.299999999999997 111.717 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.7 p -137.38 142.43 37.43 Favored Pre-proline 0 C--N 1.32 -0.717 0 N-CA-C 109.664 -0.495 . . . . 63.25 109.664 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -59.41 118.65 5.56 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.642 2.228 . . . . 62.5 111.354 173.657 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.595 ' HA ' HG22 ' A' ' 77' ' ' VAL . . . -151.43 166.49 30.9 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.107 -0.497 . . . . 54.130000000000003 110.851 -175.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.536 ' HG ' HG12 ' A' ' 87' ' ' VAL . 20.1 tp -99.24 121.06 40.54 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.348 -1.352 . . . . 73.230000000000004 107.348 172.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD12 ' OE1' ' A' ' 72' ' ' GLU . 2.4 pt? -141.51 156.04 45.76 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.674 0.749 . . . . 74.409999999999997 112.357 -166.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.571 ' HB ' ' HA ' ' A' ' 87' ' ' VAL . 5.2 tp -148.82 109.84 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.782 0 CA-C-N 114.981 -1.008 . . . . 73.010000000000005 109.159 171.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.847 ' HD3' ' H ' ' A' ' 23' ' ' ARG . 0.0 OUTLIER -81.04 115.76 20.66 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.877 -0.786 . . . . 64.239999999999995 108.877 176.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.415 ' O ' HG22 ' A' ' 71' ' ' VAL . 54.9 m -121.52 112.44 18.5 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.85 -1.068 . . . . 43.420000000000002 111.048 -172.803 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.892 ' HA ' ' HA ' ' A' ' 70' ' ' GLU . 8.9 pt20 -78.91 121.58 25.05 Favored 'General case' 0 C--N 1.315 -0.929 0 N-CA-C 108.153 -1.054 . . . . 71.530000000000001 108.153 174.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 14.8 t -91.38 139.37 30.78 Favored 'General case' 0 C--N 1.317 -0.804 0 C-N-CA 119.872 -0.731 . . . . 61.200000000000003 111.445 -169.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.22 177.46 6.61 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.34 -0.846 . . . . 61.43 110.95 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 87.3 mtp -60.85 121.98 13.7 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-N 115.866 -0.606 . . . . 75.439999999999998 110.229 179.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 49.3 m 72.36 13.77 5.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.138 -0.937 . . . . 73.439999999999998 111.872 176.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -96.42 -10.93 26.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 120.98 0.419 . . . . 71.409999999999997 110.495 179.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -55.92 -55.52 31.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.805 -0.634 . . . . 70.530000000000001 110.677 -176.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -66.67 -37.59 92.56 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.769 -0.729 . . . . 51.32 112.159 -179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 24.5 m -64.06 -33.0 74.76 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.826 0.346 . . . . 61.310000000000002 111.339 -178.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 58.0 tp -66.87 -41.02 87.96 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.362 -0.381 . . . . 60.039999999999999 110.86 179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 62.7 m-85 -68.99 -39.45 79.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.751 0.31 . . . . 74.329999999999998 110.423 177.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -52.57 -51.35 60.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.782 -0.644 . . . . 74.409999999999997 110.591 176.629 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -77.65 -42.8 33.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.966 -0.561 . . . . 52.210000000000001 111.3 -179.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -57.56 -44.85 93.69 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 114.086 0.394 . . . . 72.299999999999997 114.086 -173.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -71.11 -39.15 72.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 117.107 0.453 . . . . 74.030000000000001 111.218 -178.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 75.5 t60 -72.48 -43.24 63.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.251 -0.432 . . . . 44.350000000000001 111.44 -178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -86.07 -169.37 2.61 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.184 -0.462 . . . . 73.420000000000002 109.842 -175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.692 HG22 ' H ' ' A' ' 43' ' ' LEU . 10.2 mt 62.81 176.96 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.555 0 N-CA-C 109.835 -0.432 . . . . 71.219999999999999 109.835 -175.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.692 ' H ' HG22 ' A' ' 42' ' ' ILE . 3.3 mm? 69.83 -12.31 0.48 Allowed 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 122.995 0.518 . . . . 73.200000000000003 111.965 179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.41 ' H ' ' C ' ' A' ' 42' ' ' ILE . 35.1 tt0 -56.23 -52.25 65.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.959 0.409 . . . . 71.319999999999993 111.284 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.666 HD23 ' H ' ' A' ' 45' ' ' LEU . 2.6 pt? -84.59 9.65 13.13 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.375 -0.375 . . . . 73.430000000000007 110.958 -178.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' 46' ' ' LEU . 4.1 mm? -98.68 -54.51 3.0 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.562 -0.533 . . . . 74.299999999999997 109.562 173.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.7 -37.67 87.1 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.809 -0.632 . . . . 73.340000000000003 110.429 179.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.77 -12.14 78.17 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.838 -0.696 . . . . 60.310000000000002 112.02 176.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -97.22 -3.91 39.96 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.187 0.518 . . . . 62.530000000000001 109.823 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 77.36 15.97 80.92 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.988 -0.625 . . . . 72.109999999999999 112.45 -179.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.422 ' HE3' ' HB3' ' A' ' 51' ' ' LYS . 27.5 mtpp -120.67 -178.49 3.73 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.768 0.318 . . . . 51.43 110.628 -179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.462 ' HB3' ' HD2' ' A' ' 53' ' ' PRO . 48.9 m -150.91 164.26 20.91 Favored Pre-proline 0 C--N 1.321 -0.636 0 CA-C-N 116.47 -0.332 . . . . 70.420000000000002 110.152 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 52' ' ' SER . 14.2 Cg_endo -59.06 139.89 92.76 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.132 1.888 . . . . 70.239999999999995 111.107 173.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.4 m -87.55 23.6 1.89 Allowed 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 116.204 -0.453 . . . . 73.349999999999994 110.957 -176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 171.83 -172.78 44.87 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.768 -0.73 . . . . 64.040000000000006 112.157 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.656 ' HB3' ' HA ' ' A' ' 136' ' ' LEU . 85.4 Cg_endo -81.82 159.08 18.69 Favored 'Trans proline' 0 N--CA 1.461 -0.407 0 C-N-CA 122.923 2.416 . . . . 55.229999999999997 112.955 -178.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.447 ' HD2' ' O ' ' A' ' 135' ' ' TYR . 19.4 Cg_exo -66.02 146.38 82.18 Favored 'Trans proline' 0 C--O 1.239 0.555 0 C-N-CA 122.864 2.376 . . . . 73.519999999999996 112.027 176.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.1 m-85 -116.16 -177.4 3.16 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.287 -0.415 . . . . 75.310000000000002 109.89 179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.752 ' HB3' ' HB2' ' A' ' 133' ' ' GLU . . . -152.48 110.71 3.7 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.976 0.417 . . . . 53.119999999999997 111.145 174.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 7.8 mpt_? -102.93 136.26 43.09 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.979 -0.378 . . . . 60.539999999999999 109.979 175.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' TYR . . . . . 0.857 ' HB2' ' HB3' ' A' ' 131' ' ' ALA . 76.6 m-85 -123.15 108.5 12.92 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.297 -0.41 . . . . 74.230000000000004 110.245 178.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.594 ' HD1' ' HG2' ' A' ' 130' ' ' GLU . 87.7 t80 -105.59 118.21 36.01 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.081 0.467 . . . . 64.030000000000001 109.769 177.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.58 91.69 1.34 Allowed Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.545 -1.022 . . . . 74.319999999999993 110.545 -174.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.56 ' HB2' HD12 ' A' ' 159' ' ' LEU . 64.3 mtt -93.51 16.44 13.6 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 111.685 0.254 . . . . 75.420000000000002 111.685 -172.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 160' ' ' GLU . 4.3 t -125.72 -170.89 2.26 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.814 -0.354 . . . . 53.229999999999997 110.446 177.274 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.551 ' HB3' ' H ' ' A' ' 162' ' ' HIS . . . -111.49 121.5 45.36 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.9 0.381 . . . . 72.25 111.041 -176.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.28 -68.66 0.32 Allowed Glycine 0 N--CA 1.448 -0.51 0 N-CA-C 111.164 -0.775 . . . . 54.520000000000003 111.164 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 22.6 m -133.88 125.58 28.63 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.404 -0.591 . . . . 53.43 109.404 174.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 25.6 p90 -153.57 136.76 15.63 Favored 'General case' 0 C--O 1.245 0.848 0 CA-C-O 121.195 0.522 . . . . 74.420000000000002 110.351 176.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.892 ' HA ' ' HA ' ' A' ' 25' ' ' GLN . 15.7 pt-20 -105.37 128.92 53.75 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.384 -0.825 . . . . 75.239999999999995 110.9 -175.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 24' ' ' THR . 21.9 m -107.78 134.74 48.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.656 -1.157 . . . . 64.129999999999995 110.427 -178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.481 ' OE1' HD12 ' A' ' 21' ' ' LEU . 25.8 tt0 -135.45 101.25 4.75 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 116.095 -0.502 . . . . 73.319999999999993 110.027 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.74 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 3.0 p90 -71.0 -61.05 1.91 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.562 . . . . 64.239999999999995 110.313 178.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.38 141.23 0.26 Allowed Glycine 0 C--O 1.244 0.736 0 C-N-CA 120.696 -0.764 . . . . 71.439999999999998 113.784 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -120.51 142.11 33.4 Favored Pre-proline 0 C--N 1.325 -0.459 0 N-CA-C 108.446 -0.946 . . . . 71.329999999999998 108.446 173.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -78.31 130.32 10.01 Favored 'Trans proline' 0 N--CA 1.46 -0.489 0 C-N-CA 122.104 1.87 . . . . 60.32 111.848 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.638 ' HB ' HG21 ' A' ' 81' ' ' VAL . 17.5 m -117.05 153.64 18.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.204 0.526 . . . . 52.240000000000002 110.949 -178.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.26 -46.94 78.51 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.112 -0.949 . . . . 74.340000000000003 111.816 -174.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . 139.33 131.65 2.84 Favored Glycine 0 N--CA 1.446 -0.692 0 N-CA-C 111.383 -0.687 . . . . 75.430000000000007 111.383 -177.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 86.05 32.16 18.26 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.936 -0.649 . . . . 70.319999999999993 111.48 -177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.638 HG21 ' HB ' ' A' ' 77' ' ' VAL . 15.9 t -102.43 153.82 5.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 120.923 0.392 . . . . 73.319999999999993 110.17 -177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' HB3' HD12 ' A' ' 45' ' ' LEU . 9.2 tp10 -97.63 156.24 16.62 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.066 -0.515 . . . . 72.140000000000001 110.122 -178.604 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -118.46 117.21 3.63 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 111.252 -0.739 . . . . 44.119999999999997 111.252 178.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 21.3 t -146.79 149.0 32.49 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.748 -0.464 . . . . 73.439999999999998 109.748 -178.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.93 53.75 3.08 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.677 -0.773 . . . . 62.130000000000003 111.409 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.1 ttt180 75.23 -36.52 0.31 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.549 0.739 . . . . 72.400000000000006 111.489 179.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.571 ' HA ' ' HB ' ' A' ' 22' ' ' ILE . 18.8 t -82.31 140.8 15.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.449 -0.341 . . . . 64.120000000000005 110.608 -177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 27.8 m -126.78 158.05 37.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 74.049999999999997 110.84 -178.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -87.96 150.95 23.15 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.381 -0.372 . . . . 75.219999999999999 110.89 179.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 163.0 -143.2 8.46 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.676 -0.773 . . . . 61.149999999999999 112.263 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.527 HD23 ' HB2' ' A' ' 16' ' ' PRO . 7.7 mp -120.13 141.05 50.19 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.038 -0.356 . . . . 63.450000000000003 110.038 177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.409 ' HA ' HD13 ' A' ' 21' ' ' LEU . 5.7 t -80.36 145.41 59.64 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-N 116.046 -0.525 . . . . 51.030000000000001 109.774 -179.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' PRO . . . . . 0.445 ' HD2' ' OE2' ' A' ' 72' ' ' GLU . 10.7 Cg_endo -52.94 151.57 20.12 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 123.765 2.977 . . . . 71.310000000000002 113.652 -177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 47.4 m -114.09 132.65 55.96 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.451 -0.795 . . . . 75.420000000000002 110.63 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -161.29 168.97 36.73 Favored Glycine 0 N--CA 1.447 -0.633 0 N-CA-C 111.554 -0.618 . . . . 75.519999999999996 111.554 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.867 ' HD3' HD11 ' A' ' 11' ' ' LEU . 84.8 mttt -106.42 146.7 30.18 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.935 0.368 . . . . 75.340000000000003 110.879 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 152' ' ' SER . . . -161.23 159.43 28.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.865 -0.607 . . . . 73.040000000000006 110.427 179.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -76.4 120.67 21.95 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.042 -0.725 . . . . 51.149999999999999 109.042 178.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 151' ' ' VAL . 5.4 m -124.61 134.23 53.0 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.264 0.554 . . . . 74.420000000000002 111.753 -171.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . 0.527 ' HB2' HD21 ' A' ' 116' ' ' LEU . 12.4 t -136.66 147.46 46.87 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 108.298 -1.001 . . . . 61.049999999999997 108.298 174.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 4.4 pp -105.68 140.81 38.18 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 120.848 0.356 . . . . 61.520000000000003 110.767 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -114.57 127.89 56.03 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.039 -0.726 . . . . 64.400000000000006 109.039 173.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ILE . . . . . 0.685 ' HA ' ' O ' ' A' ' 147' ' ' LEU . 2.7 pt -102.66 118.52 49.68 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.317 0.579 . . . . 65.420000000000002 111.353 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 135.21 -154.9 21.82 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.2 -0.909 . . . . 71.340000000000003 111.091 -178.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.05 166.25 29.53 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.417 2.078 . . . . 75.430000000000007 111.727 175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.418 ' HE1' HD12 ' A' ' 109' ' ' ILE . 85.6 t80 -95.64 134.42 38.57 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.736 0.303 . . . . 73.010000000000005 110.526 -178.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -179.9 -75.41 0.06 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.996 -0.547 . . . . 52.549999999999997 111.789 179.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 19.9 pt-20 -80.8 64.55 5.61 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.337 0.589 . . . . 74.230000000000004 111.871 -178.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.717 HD11 HG21 ' A' ' 151' ' ' VAL . 19.3 tt -76.72 -23.89 15.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.371 -0.377 . . . . 65.019999999999996 110.852 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -68.87 -25.47 64.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.969 -0.382 . . . . 61.409999999999997 109.969 177.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -65.58 -32.79 74.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.282 0.563 . . . . 53.329999999999998 109.541 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.464 ' HB ' ' O ' ' A' ' 109' ' ' ILE . 92.8 t -71.54 -38.88 69.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.313 -0.858 . . . . 74.140000000000001 109.685 173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -60.9 -41.14 95.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.505 -0.771 . . . . 72.140000000000001 110.116 179.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -60.5 -38.26 83.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.844 0.354 . . . . 73.409999999999997 111.148 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -63.05 -45.07 93.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.007 0.432 . . . . 55.200000000000003 110.357 177.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.527 HD21 ' HB2' ' A' ' 100' ' ' SER . 95.1 mt -67.21 -35.44 79.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.992 -0.549 . . . . 72.200000000000003 110.694 176.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.529 ' HA ' HG12 ' A' ' 120' ' ' VAL . 46.8 ttp -65.58 -28.4 69.11 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.973 -0.558 . . . . 75.420000000000002 110.625 178.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -71.16 -45.83 62.69 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.336 -0.393 . . . . 64.420000000000002 109.965 173.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -66.58 -39.97 88.72 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.195 -0.457 . . . . 75.049999999999997 111.103 -176.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.662 ' CG2' ' HA ' ' A' ' 125' ' ' PHE . 11.4 p -66.86 -41.43 87.67 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.391 0 N-CA-C 110.161 -0.311 . . . . 75.310000000000002 110.161 178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -63.99 -38.05 89.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.1 0.476 . . . . 53.219999999999999 110.648 177.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -63.1 -38.21 90.29 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.529 -0.759 . . . . 55.049999999999997 111.697 -177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -100.54 0.09 38.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.456 0.646 . . . . 74.430000000000007 110.419 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 80.43 -17.38 10.5 Favored Glycine 0 CA--C 1.52 0.403 0 CA-C-N 115.048 -0.978 . . . . 51.229999999999997 112.859 -178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.662 ' HA ' ' CG2' ' A' ' 120' ' ' VAL . 50.7 p90 178.7 178.06 0.44 Allowed 'General case' 0 CA--C 1.513 -0.467 0 CA-C-O 121.609 0.719 . . . . 73.150000000000006 111.388 166.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASP . . . . . 0.707 ' HB3' HD11 ' A' ' 155' ' ' LEU . 30.5 t0 -137.86 179.8 6.21 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.013 -1.449 . . . . 51.009999999999998 107.3 169.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.839 HD22 ' HD2' ' A' ' 96' ' ' LYS . 6.5 mp -79.41 126.28 30.63 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.977 0.418 . . . . 63.149999999999999 111.24 -176.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.407 ' HB2' ' SD ' ' A' ' 64' ' ' MET . 8.7 p -98.27 77.86 2.42 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.358 0.599 . . . . 72.319999999999993 110.688 178.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -84.23 -80.95 1.04 Allowed Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.656 -0.783 . . . . 73.0 111.966 176.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.594 ' HG2' ' HD1' ' A' ' 62' ' ' PHE . 32.8 mt-10 -142.46 156.53 45.18 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.263 -0.273 . . . . 64.209999999999994 110.263 -178.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.857 ' HB3' ' HB2' ' A' ' 61' ' ' TYR . . . -88.71 146.8 24.84 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.514 -0.55 . . . . 74.200000000000003 109.514 177.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.892 ' HB3' ' HB2' ' A' ' 152' ' ' SER . 47.9 t80 -143.14 121.77 12.53 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.127 0.489 . . . . 75.030000000000001 111.432 -175.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.752 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 41.1 mt-10 -113.93 163.03 15.66 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.826 -0.624 . . . . 72.010000000000005 110.031 171.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 10.5 tt -143.77 131.27 17.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 N-CA-C 109.221 -0.659 . . . . 75.340000000000003 109.221 175.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' TYR . . . . . 0.447 ' O ' ' HD2' ' A' ' 57' ' ' PRO . 34.2 m-85 -122.81 87.77 2.81 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.565 0.698 . . . . 72.409999999999997 110.975 178.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.831 HD23 ' H ' ' A' ' 136' ' ' LEU . 2.0 pt? -78.78 -175.46 4.45 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.919 -1.037 . . . . 74.109999999999999 109.57 176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -73.94 170.63 15.0 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 110.185 -0.302 . . . . 70.219999999999999 110.185 -178.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -74.72 156.54 86.57 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-O 120.72 0.295 . . . . 70.530000000000001 110.86 -174.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.437 ' HD3' ' HG ' ' A' ' 147' ' ' LEU . 10.0 Cg_endo -52.51 155.22 10.32 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 123.051 2.5 . . . . 75.439999999999998 112.242 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . 76.01 -6.49 1.98 Allowed 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.462 -0.79 . . . . 33.140000000000001 111.892 -179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.42 -72.47 0.39 Allowed 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.419 -0.956 . . . . 74.409999999999997 108.419 172.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' THR . . . . . . . . . . . . . 3.3 t -80.95 -41.76 22.36 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.841 -0.618 . . . . 74.450000000000003 109.756 176.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -170.64 143.83 1.85 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.804 -0.634 . . . . 73.329999999999998 110.403 176.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' PRO . . . . . 0.417 ' C ' ' H ' ' A' ' 146' ' ' GLN . 85.9 Cg_endo -86.33 144.04 7.86 Favored 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.794 2.329 . . . . 71.329999999999998 111.406 172.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ASP . . . . . 0.462 ' O ' ' HB ' ' A' ' 103' ' ' ILE . 27.2 t70 73.16 -37.42 0.38 Allowed 'General case' 0 N--CA 1.474 0.767 0 O-C-N 123.969 0.793 . . . . 75.030000000000001 111.546 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLN . . . . . 0.677 ' HG3' ' HG2' ' A' ' 4' ' ' GLU . 19.4 tt0 -85.78 26.77 0.93 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.336 0.589 . . . . 72.329999999999998 110.233 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.685 ' O ' ' HA ' ' A' ' 103' ' ' ILE . 0.8 OUTLIER -82.23 84.59 7.03 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.178 -0.675 . . . . 73.099999999999994 109.178 -179.625 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ARG . . . . . . . . . . . . . 12.2 mtp180 -83.27 106.56 15.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.01 -0.541 . . . . 64.230000000000004 111.823 -174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 4.7 m -100.74 100.04 10.65 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.392 -0.595 . . . . 74.219999999999999 109.392 172.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 29.9 ptt180 -85.21 124.76 32.22 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 74.439999999999998 110.28 -178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.717 HG21 HD11 ' A' ' 109' ' ' ILE . 7.3 p -120.67 126.95 75.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.166 0.508 . . . . 53.43 111.131 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.892 ' HB2' ' HB3' ' A' ' 132' ' ' TYR . 17.0 m -104.73 130.15 52.83 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.406 -0.816 . . . . 61.299999999999997 109.067 175.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 87.7 mt -131.89 177.34 7.61 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.34 0.59 . . . . 74.340000000000003 112.287 -172.24 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' MET . . . . . . . . . . . . . 21.7 ptt? -91.59 148.05 22.56 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-N 115.005 -0.998 . . . . 71.420000000000002 109.7 175.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.707 HD11 ' HB3' ' A' ' 126' ' ' ASP . 1.2 mm? -78.92 162.27 26.12 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.992 -0.744 . . . . 74.519999999999996 108.992 174.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' HIS . . . . . . . . . . . . . 43.7 m170 -86.3 169.03 13.35 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.762 -0.459 . . . . 75.430000000000007 109.762 176.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 71.62 14.16 6.22 Favored 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.835 0.709 . . . . 75.099999999999994 110.121 -176.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 22.8 t -96.04 -153.8 0.42 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.081 -0.963 . . . . 71.140000000000001 109.411 178.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.56 HD12 ' HB2' ' A' ' 64' ' ' MET . 57.4 mt -53.66 -56.0 21.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.439 -0.346 . . . . 61.420000000000002 110.937 179.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.588 ' O ' ' HA ' ' A' ' 65' ' ' SER . 58.0 mt-10 58.13 -177.44 0.07 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 115.641 -0.709 . . . . 71.140000000000001 112.186 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -85.52 140.04 30.98 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.015 0.436 . . . . 75.230000000000004 111.53 -174.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' HIS . . . . . 0.551 ' H ' ' HB3' ' A' ' 66' ' ' ALA . 17.7 t-160 -88.1 16.18 6.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.887 0.851 . . . . 73.549999999999997 109.7 177.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' HIS . . . . . . . . . . . . . 27.5 m80 -131.65 157.42 43.74 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.358 -0.837 . . . . 75.129999999999995 109.03 175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 32.9 m170 -116.16 86.66 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.197 0.522 . . . . 73.349999999999994 110.343 178.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' HIS . . . . . . . . . . . . . 59.6 t-80 -96.28 140.56 30.78 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.569 -0.741 . . . . 73.420000000000002 109.685 178.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' HIS . . . . . . . . . . . . . 4.0 p80 . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.901 -1.047 . . . . 71.239999999999995 109.743 177.066 . . . . . . . . 0 0 . 1 stop_ save_